Citrus Sinensis ID: 012975
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | 2.2.26 [Sep-21-2011] | |||||||
| Q0V7T5 | 427 | Probable receptor-like pr | no | no | 0.842 | 0.892 | 0.571 | 1e-117 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.603 | 0.366 | 0.492 | 1e-70 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.621 | 0.616 | 0.494 | 1e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.637 | 0.405 | 0.426 | 1e-66 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.628 | 0.553 | 0.435 | 1e-65 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.623 | 0.393 | 0.439 | 2e-65 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.632 | 0.398 | 0.431 | 2e-65 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.654 | 0.714 | 0.453 | 6e-65 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.637 | 0.4 | 0.419 | 7e-65 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.617 | 0.680 | 0.455 | 9e-65 |
| >sp|Q0V7T5|Y1864_ARATH Probable receptor-like protein kinase At1g80640 OS=Arabidopsis thaliana GN=At1g80640 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 231/404 (57%), Positives = 286/404 (70%), Gaps = 23/404 (5%)
Query: 38 ISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILAL--LCLWLY- 94
IS S M A SPG + D + K+LIALI++ S LC+ ++ L L LW Y
Sbjct: 42 ISQASPRMGAQSPGPPIVKVVLRQ---DLNKKILIALIVSSSLLCVTVMFLVYLLLWRYR 98
Query: 95 HLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFH 154
++K SF + + DS V + K SVR KG+ I EY+LLE AT+ F
Sbjct: 99 NMKNSFTGIKRKS---DSVKSVTTKPTVHKIDSVR----KGT-IPVYEYQLLESATNKFS 150
Query: 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLL 213
+SN+L GG GC+Y+A LD+ V VKKLD + D ++FE EVD L+ I H N+V LL
Sbjct: 151 DSNVLSRGGRGCLYRACLDEKSSVTVKKLDGGGETDIEKQFETEVDWLAKIRHQNIVSLL 210
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G+ + T IVYELM+N SL+ QLHGPS GS LTW +RMKIA+D ARGLEYLHEHC+P
Sbjct: 211 GFCVYRQTSCIVYELMQNGSLESQLHGPSQGSGLTWQLRMKIAVDIARGLEYLHEHCHPP 270
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
V+HRDLKSS+ILLDS FNAK+SDFG A +QNKN L + A E LLDGK+TDK
Sbjct: 271 VVHRDLKSSSILLDSDFNAKISDFGFATVLTTQNKN-------LIHKASEDLLDGKVTDK 323
Query: 334 SDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLK 393
+DVY+FGV+LLELLLG++ VEK ++ +SIVTWA+P+L+DR+ LPNI+DP IK TMDLK
Sbjct: 324 NDVYSFGVILLELLLGKKSVEK-PSSEPESIVTWAVPKLSDRANLPNILDPAIKGTMDLK 382
Query: 394 HLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRV 437
HLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL+PVELGG+LR+
Sbjct: 383 HLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLLPVELGGSLRI 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 138/280 (49%), Positives = 184/280 (65%), Gaps = 7/280 (2%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH 205
LEKATD F +LGEGGFG VY+ ++D VAVK L Q+ REF EV++LS +H
Sbjct: 342 LEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAEVEMLSRLH 401
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
H N+V L+G TR ++YEL+ N S++ LH L W R+KIAL ARGL Y
Sbjct: 402 HRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHE----GTLDWDARLKIALGAARGLAY 457
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
LHE NP VIHRD K+SN+LL+ F K+SDFGLA T+GSQ+ + ++ GT GYVAPE
Sbjct: 458 LHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHIST-RVMGTFGYVAPE 516
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
Y + G L KSDVY++GVVLLELL GRRPV+ P+ +++VTWA P L +R L +VD
Sbjct: 517 YAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANREGLEQLVD 576
Query: 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P + T + + +VAA+A +CV E S+RP + +V+ +L
Sbjct: 577 PALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 141/285 (49%), Positives = 183/285 (64%), Gaps = 4/285 (1%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFENEVDLL 201
++ L AT +FH LGEGGFG VYK +LD V AVK+LD REF EV +L
Sbjct: 76 FRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLML 135
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTA 260
S +HHPN+V L+GY A D R +VYE M SL+ LH P AL W+MRMKIA A
Sbjct: 136 SLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAA 195
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLG 318
+GLE+LH+ NP VI+RD KSSNILLD F+ KLSDFGLA + +K+++ ++ GT G
Sbjct: 196 KGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 255
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378
Y APEY + G+LT KSDVY+FGVV LEL+ GR+ ++ P Q++V WA P DR K
Sbjct: 256 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKF 315
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ DP +K + LYQ AVA +C+Q + + RPLI DV+ +L
Sbjct: 316 IKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 125/293 (42%), Positives = 187/293 (63%), Gaps = 5/293 (1%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L T+ F + NILGEGGFGCVYK KL+D VAVK+L + REF
Sbjct: 335 GSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREF 394
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 395 KAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGR-PVLEWARRVR 453
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD +F A+++DFGLA + D +Q + ++
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRV 513
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--- 370
GT GY+APEY GKLTD+SDV++FGVVLLEL+ GR+PV++ P +S+V WA P
Sbjct: 514 MGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLH 573
Query: 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ + +VD ++ ++++ A CV+ RP + V+ +L
Sbjct: 574 KAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 126/289 (43%), Positives = 181/289 (62%), Gaps = 5/289 (1%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEV 198
S Y L +AT+ F E+N+LGEGGFG VYK L++ VAVK+L + +EF+ EV
Sbjct: 169 STFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEV 228
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+++S IHH N+V L+GY R +VYE + N +L+ LHG + W +R+KIA+
Sbjct: 229 NIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSLRLKIAVS 287
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTL 317
+++GL YLHE+CNP +IHRD+K++NIL+D KF AK++DFGLA I + + ++ GT
Sbjct: 288 SSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTF 347
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP---QLTD 374
GY+APEY GKLT+KSDVY+FGVVLLEL+ GRRPV+ S+V WA P Q +
Sbjct: 348 GYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALE 407
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
S + D + + D + + ++ A A CV+ RP + V+ L
Sbjct: 408 ESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVL 456
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 126/287 (43%), Positives = 181/287 (63%), Gaps = 5/287 (1%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDL 200
Y+ L +AT+ F E+N+LG+GGFG V+K L + VAVK+L + REF+ EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+S +HH ++V L+GY D R +VYE + N +L+ LHG + W R+KIA+ +A
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGR-PTMEWSSRLKIAVGSA 460
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGY 319
+GL YLHE+CNP +IHRD+K+SNIL+D KF AK++DFGLA I + + ++ GT GY
Sbjct: 461 KGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGY 520
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
+APEY GKLT+KSDV++FGVVLLEL+ GRRP++ S+V WA P L S+L
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELG 580
Query: 380 N---IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
N +VD + + D + + ++ A A CV+ RP + V L
Sbjct: 581 NFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVL 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 126/292 (43%), Positives = 192/292 (65%), Gaps = 6/292 (2%)
Query: 136 SAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE 195
S I F Y+ L + T+ F +S ++GEGGFGCVYK L + VA+K+L + + REF+
Sbjct: 354 SKIHFT-YEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFK 412
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
EV+++S +HH ++V L+GY + RF++YE + N +LD LHG + L W R++I
Sbjct: 413 AEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-PVLEWSRRVRI 471
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS 314
A+ A+GL YLHE C+P +IHRD+KSSNILLD +F A+++DFGLA + D +Q+ + ++
Sbjct: 472 AIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVM 531
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL-- 372
GT GY+APEY GKLTD+SDV++FGVVLLEL+ GR+PV+ P +S+V WA P+L
Sbjct: 532 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIE 591
Query: 373 -TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
++ + +VDP +++ +Y++ A CV+ RP + V+ +L
Sbjct: 592 AIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 140/309 (45%), Positives = 189/309 (61%), Gaps = 13/309 (4%)
Query: 137 AISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFE 195
A ++ L AT +F + ++GEGGFG VYK KL+ + VAVK+LD +EF
Sbjct: 63 AAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFI 122
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS-ALTWHMRMK 254
EV +LS +HH ++V L+GY A D R +VYE M SL+ L + L W R++
Sbjct: 123 VEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIR 182
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--K 312
IAL A GLEYLH+ NP VI+RDLK++NILLD +FNAKLSDFGLA +K ++ +
Sbjct: 183 IALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSR 242
Query: 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372
+ GT GY APEY G+LT KSDVY+FGVVLLEL+ GRR ++ P Q++VTWA P
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302
Query: 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432
+ S+ P + DP ++ K L Q AVA +C+Q E + RPL++DV+ +L
Sbjct: 303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL--------- 353
Query: 433 GTLRVAPSG 441
G L AP G
Sbjct: 354 GFLGTAPDG 362
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 123/293 (41%), Positives = 185/293 (63%), Gaps = 5/293 (1%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
GS + Y+ L + T F NILGEGGFGCVYK L D VAVK+L + REF
Sbjct: 353 GSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREF 412
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ EV+++S +HH ++V L+GY D R ++YE + N++L+ LHG L W R++
Sbjct: 413 KAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGL-PVLEWSKRVR 471
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKL 313
IA+ +A+GL YLHE C+P +IHRD+KS+NILLD ++ A+++DFGLA + D +Q + ++
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--- 370
GT GY+APEY GKLTD+SDV++FGVVLLEL+ GR+PV++ P +S+V WA P
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL 591
Query: 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ + L ++D ++ ++++ A CV+ RP + V+ +L
Sbjct: 592 KAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 132/290 (45%), Positives = 181/290 (62%), Gaps = 11/290 (3%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-------DAGREFENEV 198
LE T SF ILGEGGFG VYK +DDNL V +K L A + RE+ EV
Sbjct: 62 LETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEV 121
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+ L + HPN+V L+GY DD R +VYE M SL+ L + + L+W RM IAL
Sbjct: 122 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTT-APLSWSRRMMIALG 180
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--DGSQNKNNLKLSGT 316
A+GL +LH P VI+RD K+SNILLDS + AKLSDFGLA G + + ++ GT
Sbjct: 181 AAKGLAFLHNAERP-VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376
GY APEY++ G LT +SDVY+FGVVLLE+L GR+ V+K P++ Q++V WA P+L D+
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426
KL I+DP +++ ++ + ++A C+ P RPL++DV+ +L PL
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | ||||||
| 359475853 | 455 | PREDICTED: probable receptor-like protei | 0.971 | 0.964 | 0.692 | 1e-175 | |
| 356552492 | 440 | PREDICTED: probable receptor-like protei | 0.922 | 0.947 | 0.738 | 1e-174 | |
| 356563914 | 452 | PREDICTED: probable receptor-like protei | 0.942 | 0.942 | 0.715 | 1e-173 | |
| 357468623 | 458 | Wall-associated receptor kinase-like pro | 0.944 | 0.932 | 0.729 | 1e-171 | |
| 356518228 | 412 | PREDICTED: probable receptor-like protei | 0.845 | 0.927 | 0.737 | 1e-163 | |
| 255641950 | 391 | unknown [Glycine max] | 0.847 | 0.979 | 0.741 | 1e-162 | |
| 356509894 | 414 | PREDICTED: probable receptor-like protei | 0.851 | 0.929 | 0.712 | 1e-155 | |
| 297743614 | 456 | unnamed protein product [Vitis vinifera] | 0.951 | 0.942 | 0.641 | 1e-155 | |
| 449442156 | 400 | PREDICTED: probable receptor-like protei | 0.873 | 0.987 | 0.692 | 1e-154 | |
| 240254530 | 414 | protein kinase domain-containing protein | 0.887 | 0.968 | 0.695 | 1e-154 |
| >gi|359475853|ref|XP_002285386.2| PREDICTED: probable receptor-like protein kinase At1g80640-like [Vitis vinifera] gi|296082091|emb|CBI21096.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1601), Expect = e-175, Method: Compositional matrix adjust.
Identities = 316/456 (69%), Positives = 367/456 (80%), Gaps = 17/456 (3%)
Query: 8 FVVLFVFLHQSFW-IHASI---------EPLPGPLVFSPL--ISPVSTSMAAFSPGIQMG 55
F +L + L QS W H SI + PL P+ SP+S+SMAAFSP IQ G
Sbjct: 3 FFLLILPLLQSIWSFHFSIVEAISDPPLSSISAPLSSPPIGATSPISSSMAAFSPAIQEG 62
Query: 56 SEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENG 115
SE+ + D+H K IAL +A +AL + IL LL LW+ H K S KS NA+S D+E
Sbjct: 63 SEE---NQKDSHKKTFIALTVASAALGVTILILLSLWI-HKKCSQKSHKSNAQSSDAEKA 118
Query: 116 VVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDN 175
+ L L KF +++++ +KGS +S I+YK+LE AT++F ESNILGEGGFGCVYKA+LDDN
Sbjct: 119 LTLGPLLAKFNTMKVIGRKGS-VSCIDYKVLETATNNFQESNILGEGGFGCVYKARLDDN 177
Query: 176 LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235
HVAVKK+D QDA REFENEVDLL+ I HPN++ LLGYS+H++++F+VYELM+N SL+
Sbjct: 178 SHVAVKKIDGRGQDAEREFENEVDLLTKIQHPNIISLLGYSSHEESKFLVYELMQNGSLE 237
Query: 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295
+LHGPSHGS+LTWH+RMKIALD ARGLEYLHEHCNP VIHRDLKSSNILLDS FNAKLS
Sbjct: 238 TELHGPSHGSSLTWHIRMKIALDAARGLEYLHEHCNPPVIHRDLKSSNILLDSNFNAKLS 297
Query: 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
DFGLA+ DG QNKNNLKLSGTLGY+APEYLLDGKLTDKSDVYAFGVVLLELLLGR+PVEK
Sbjct: 298 DFGLAVIDGPQNKNNLKLSGTLGYLAPEYLLDGKLTDKSDVYAFGVVLLELLLGRKPVEK 357
Query: 356 LAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415
LAPAQCQSIVTWAMPQLTDRSKLP IVDPV++ TMDLKHLYQVAAVAVLCVQPEPSYRPL
Sbjct: 358 LAPAQCQSIVTWAMPQLTDRSKLPGIVDPVVRDTMDLKHLYQVAAVAVLCVQPEPSYRPL 417
Query: 416 ITDVLHSLIPLVPVELGGTLRVAPSGPPADSTIPSG 451
ITDVLHSLIPLVPVELGG L+V PP ++T PS
Sbjct: 418 ITDVLHSLIPLVPVELGGMLKVTQQAPPINTTAPSA 453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552492|ref|XP_003544601.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 313/424 (73%), Positives = 354/424 (83%), Gaps = 7/424 (1%)
Query: 16 HQSFWIHASIEPL-PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIAL 74
H+ WI AS PL P P V P SP TSM+A SPGI MG+E HMD+H K++IA+
Sbjct: 17 HKPTWILASAYPLAPSPQV--PPFSPFPTSMSASSPGIVMGAE---QQHMDSHKKMVIAV 71
Query: 75 IIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK 134
+A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL KF+S+++V KK
Sbjct: 72 AVASTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKK 131
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + I+YK +EK T +F E NILGEGGFGCVYKA LDDNL VAVKKL C Q A +EF
Sbjct: 132 G-CVPIIDYKQIEKTTGNFEEINILGEGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEF 190
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
ENEVDLLS I HPNV+ LLG S++DDTR IVYELM N SL+ QLHGPSHGSALTWH+RMK
Sbjct: 191 ENEVDLLSKIQHPNVISLLGCSSNDDTRIIVYELMHNGSLETQLHGPSHGSALTWHLRMK 250
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
IALDTARGL+YLHEHC P VIHRDLKSSN+LLD+KFNAKLSDFGLAIT+GSQNKNNLKLS
Sbjct: 251 IALDTARGLKYLHEHCYPPVIHRDLKSSNVLLDTKFNAKLSDFGLAITNGSQNKNNLKLS 310
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374
GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLG++PVEKLAPAQCQSIVTWAMP LTD
Sbjct: 311 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGKKPVEKLAPAQCQSIVTWAMPLLTD 370
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGT 434
RSKLPNIVDPVIK+TMD KHLYQVAAVAVLCVQPEPSYRPLI DVLHSLIPLVPVELGGT
Sbjct: 371 RSKLPNIVDPVIKNTMDPKHLYQVAAVAVLCVQPEPSYRPLIADVLHSLIPLVPVELGGT 430
Query: 435 LRVA 438
L+V+
Sbjct: 431 LKVS 434
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563914|ref|XP_003550202.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1584), Expect = e-173, Method: Compositional matrix adjust.
Identities = 315/440 (71%), Positives = 360/440 (81%), Gaps = 14/440 (3%)
Query: 16 HQSFWIHASIEPL-PGPLVFSPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIAL 74
H+ W AS PL P P V P SP TSM+A SPGI MG+E HMD+H K++IA+
Sbjct: 18 HKPTWFLASAYPLAPSPQV--PPFSPFPTSMSASSPGIVMGAE---QQHMDSHKKMVIAV 72
Query: 75 IIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKK 134
+A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL KF+S+++V KK
Sbjct: 73 AVASTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLSKFSSIKLVGKK 132
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G + I+YK +EKAT +F E NILG+GGFGCVYKA LDDNL VAVKKL C Q A +EF
Sbjct: 133 G-CVPIIDYKQIEKATGNFKEINILGKGGFGCVYKAHLDDNLDVAVKKLHCENQYAEQEF 191
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
ENEVDLLS I HPNV+ LLG S+++DTR IVYELM N SL+ QLHGPSHGSALTWH+R+K
Sbjct: 192 ENEVDLLSKIQHPNVISLLGCSSNEDTRIIVYELMHNGSLETQLHGPSHGSALTWHLRIK 251
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
IALDTARGL+YLHEHC P VIHRDLKSSNILLD+KFNAKLSDFGLAIT+GSQNKNNLKLS
Sbjct: 252 IALDTARGLKYLHEHCYPPVIHRDLKSSNILLDTKFNAKLSDFGLAITNGSQNKNNLKLS 311
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374
GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLG++PVEKLA AQCQSIVT AMPQLTD
Sbjct: 312 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGKKPVEKLAQAQCQSIVTLAMPQLTD 371
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGT 434
RSKLPNIVDPVIK+TMD KHLYQVAAVAVLCVQPEPSYRPLI DVLHSLIPLVPVELGGT
Sbjct: 372 RSKLPNIVDPVIKNTMDPKHLYQVAAVAVLCVQPEPSYRPLIADVLHSLIPLVPVELGGT 431
Query: 435 LRVA-------PSGPPADST 447
L+V+ P+ PP DS+
Sbjct: 432 LKVSQLPKQVLPADPPEDSS 451
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357468623|ref|XP_003604596.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355505651|gb|AES86793.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 321/440 (72%), Positives = 364/440 (82%), Gaps = 13/440 (2%)
Query: 1 MKLLLILFVVLFVFLHQSFWIHASIEPLPGPLVFSPLISPVSTSMA--AFSPGIQMGSED 58
MKLL + F++ H+ WI ASI PLV SP ISP+ TS+A A SP I +G E
Sbjct: 20 MKLLFMFFLIP----HKPIWILASIV---DPLVPSPQISPILTSIAVSASSPDIHVGDE- 71
Query: 59 PHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVL 118
H +MD+H K ++A + A + L IIL LL W++++KYS KS KN ++ D E G+ L
Sbjct: 72 --HQNMDSHMKKVMAFVAASTGLGAIILCLLSFWIFYIKYSSKSKKKNLQNSDGEKGLRL 129
Query: 119 SSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHV 178
FL KF+SVR+V KKG + I+YK LEKAT +F ESNI+GEGGFGCVYKA+LDDNL V
Sbjct: 130 VPFLSKFSSVRLVGKKG-CVPIIDYKQLEKATGNFKESNIIGEGGFGCVYKARLDDNLDV 188
Query: 179 AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL 238
A+KKL+C Q A REFENEVDLLS I HPNV+ LLG S+++D+RFIVYELM+N SL+ QL
Sbjct: 189 AIKKLNCECQYAEREFENEVDLLSKIQHPNVISLLGCSSNEDSRFIVYELMQNGSLETQL 248
Query: 239 HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
HGPSHGSALTWHMRMKIALDTARGL+YLHEHC PAVIHRDLKSSNILLD+ FNAKLSDFG
Sbjct: 249 HGPSHGSALTWHMRMKIALDTARGLKYLHEHCYPAVIHRDLKSSNILLDANFNAKLSDFG 308
Query: 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
LAITDGSQNKNN+KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR+PVEKL P
Sbjct: 309 LAITDGSQNKNNIKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRKPVEKLTP 368
Query: 359 AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITD 418
+QCQSIVTWAMPQLTDRSKLPNIVD VIK+TMD KHLYQVAAVAVLCVQPEP YRPLI D
Sbjct: 369 SQCQSIVTWAMPQLTDRSKLPNIVDNVIKNTMDPKHLYQVAAVAVLCVQPEPCYRPLIAD 428
Query: 419 VLHSLIPLVPVELGGTLRVA 438
VLHSLIPLVPVELGGTLRV+
Sbjct: 429 VLHSLIPLVPVELGGTLRVS 448
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518228|ref|XP_003527781.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 290/393 (73%), Positives = 333/393 (84%), Gaps = 11/393 (2%)
Query: 47 AFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYH-LKYSFKSSNK 105
AFSPG + HHM+ K++IA+++A +AL +I LC W+YH KY KS +K
Sbjct: 27 AFSPGEE-------QHHMNK--KVVIAIVVATTALAALIFTFLCFWIYHHTKYPTKSKSK 77
Query: 106 NAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFG 165
N +S D+E G+ L+ FL KF+S+++V GS + I+YK +EK T++F ESNILGEGGFG
Sbjct: 78 NVQSPDAEKGITLAPFLNKFSSIKIVGMNGS-VPIIDYKQIEKTTNNFQESNILGEGGFG 136
Query: 166 CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225
VY+A+LD N VAVKKL C TQ A REFENEV+LLS I HPN++ LLG S +RFIV
Sbjct: 137 RVYRARLDHNFDVAVKKLHCETQHAEREFENEVNLLSKIQHPNIISLLGCSIDGYSRFIV 196
Query: 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285
YELM+N SL+ QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC+PAVIHRD+KSSNIL
Sbjct: 197 YELMQNGSLETQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCHPAVIHRDMKSSNIL 256
Query: 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLE 345
LD+ FNAKLSDFGLA+TDGSQ+K N+KLSGTLGYVAPEYLLDGKL+DKSDVYAFGVVLLE
Sbjct: 257 LDANFNAKLSDFGLALTDGSQSKKNIKLSGTLGYVAPEYLLDGKLSDKSDVYAFGVVLLE 316
Query: 346 LLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLC 405
LLLGR+PVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK+TMD KHLYQVAAVAVLC
Sbjct: 317 LLLGRKPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKNTMDPKHLYQVAAVAVLC 376
Query: 406 VQPEPSYRPLITDVLHSLIPLVPVELGGTLRVA 438
VQPEPSYRPLITDVLHSLIPLVP+ELGGTLRV+
Sbjct: 377 VQPEPSYRPLITDVLHSLIPLVPIELGGTLRVS 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255641950|gb|ACU21242.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-162, Method: Compositional matrix adjust.
Identities = 290/391 (74%), Positives = 333/391 (85%), Gaps = 8/391 (2%)
Query: 64 MDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLG 123
MD+H K++IA+ +A ++L +IL +LC+W+Y+ KY KS KN + D+E G+ S FL
Sbjct: 1 MDSHKKMVIAVAVAGTSLGAVILCVLCIWIYYTKYPSKSKGKNVQRSDAEKGLASSPFLS 60
Query: 124 KFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL 183
KF+S+++V KKG + I+YK +EKAT +F E NILG+GGFGCVYKA LDDNL VAVKKL
Sbjct: 61 KFSSIKLVGKKG-CVPIIDYKQIEKATGNFKEINILGKGGFGCVYKAHLDDNLDVAVKKL 119
Query: 184 DCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSH 243
C Q A +EFENEVDLLS I HPNV+ LLG S+++DT+ IVYELM N SL+ QLHGPSH
Sbjct: 120 HCENQYAEQEFENEVDLLSKIQHPNVISLLGCSSNEDTKIIVYELMHNGSLETQLHGPSH 179
Query: 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303
GSALTWH+R+KIALDTARGL+YLHEHC P VIHRDLKSSNILLD+KFNAKLSDFGLAIT+
Sbjct: 180 GSALTWHLRIKIALDTARGLKYLHEHCYPPVIHRDLKSSNILLDTKFNAKLSDFGLAITN 239
Query: 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS 363
GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLG++PVEKLA AQCQS
Sbjct: 240 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGKKPVEKLAQAQCQS 299
Query: 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
IVT AMPQLTDRSKLPNIVDPVIK+TMD KHLYQVAAVAVLCVQPEPSYRPLI DVLHSL
Sbjct: 300 IVTLAMPQLTDRSKLPNIVDPVIKNTMDPKHLYQVAAVAVLCVQPEPSYRPLIADVLHSL 359
Query: 424 IPLVPVELGGTLRVA-------PSGPPADST 447
IPLVPVELGGTL+V+ P+ PP DS+
Sbjct: 360 IPLVPVELGGTLKVSQLPKQVLPADPPEDSS 390
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509894|ref|XP_003523677.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1431), Expect = e-155, Method: Compositional matrix adjust.
Identities = 282/396 (71%), Positives = 326/396 (82%), Gaps = 11/396 (2%)
Query: 44 SMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYH-LKYSFKS 102
S A SPG E+ HH + +K++IA+++A +AL +I + LC W+YH KY KS
Sbjct: 26 SSPALSPG-----EEQHHRN----NKVVIAIVVATTALAALIFSFLCFWVYHHTKYPTKS 76
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEG 162
K+ + E G+ L+ F+ KF+S+++V G + I+YK +EK T++F ESNILGEG
Sbjct: 77 KFKSKNFRSPEKGITLAPFVSKFSSIKIVGMDG-YVPIIDYKQIEKTTNNFQESNILGEG 135
Query: 163 GFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222
GFG VYKA LD NL VAVKKL C TQ A REFENEV++LS I HPN++ LLG S TR
Sbjct: 136 GFGRVYKACLDHNLDVAVKKLHCETQHAEREFENEVNMLSKIQHPNIISLLGCSMDGYTR 195
Query: 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSS 282
F+VYELM N SL+ QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC+PAVIHRD+KSS
Sbjct: 196 FVVYELMHNGSLEAQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCHPAVIHRDMKSS 255
Query: 283 NILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVV 342
NILLD+ FNAKLSDFGLA+TDGSQ+K N+KLSGTLGYVAPEYLLDGKL+DKSDVYAFGVV
Sbjct: 256 NILLDANFNAKLSDFGLALTDGSQSKKNIKLSGTLGYVAPEYLLDGKLSDKSDVYAFGVV 315
Query: 343 LLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVA 402
LLELLLGR+PVEKL PAQCQSIVTWAMP LTDRSKLP+IVDPVIK+TMD KHLYQVAAVA
Sbjct: 316 LLELLLGRKPVEKLVPAQCQSIVTWAMPHLTDRSKLPSIVDPVIKNTMDPKHLYQVAAVA 375
Query: 403 VLCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRVA 438
VLCVQPEPSYRPLI DVLHSLIPLVP+ELGGTLRV+
Sbjct: 376 VLCVQPEPSYRPLIIDVLHSLIPLVPIELGGTLRVS 411
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743614|emb|CBI36481.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1429), Expect = e-155, Method: Compositional matrix adjust.
Identities = 283/441 (64%), Positives = 337/441 (76%), Gaps = 11/441 (2%)
Query: 18 SFWIHASIEPLP----GPLVFS--PLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLL 71
S +HA +PL PL+ S P IS +S + A SPG+ E HH D + ++L
Sbjct: 21 SLPVHARPDPLVSTIYNPLLPSHYPPISQISAQLEAVSPGM---PEVRVVHHQDVNKRIL 77
Query: 72 IALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMV 131
IAL++A + L I+L L C W+ + S K+ ++ D+ G+ L LGKF S+R
Sbjct: 78 IALVVASTLLGGILLFLSCFWIQRQRNLRNSGRKSQQNLDAAKGLSLGPILGKFNSLRAN 137
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG 191
KK S ++ IEY LL AT++F ESN+LGEGG G VYKA+ ++N AVK+LD QD
Sbjct: 138 GKKDS-VTVIEYHLLVAATNNFSESNVLGEGGSGRVYKARFNENFLAAVKRLDRGGQDGE 196
Query: 192 REFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251
REFENEVD LS I H N+V LLG H +TRF+VYE+M+N SL+ QLHGPSHGS LTWH+
Sbjct: 197 REFENEVDWLSKIQHQNIVSLLGCCIHGETRFLVYEMMQNGSLEAQLHGPSHGSTLTWHL 256
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311
RMKIA+D ARGLE+LHEHCNP VIHRDLKSSNILLDS FNAKLSDFGLAIT G+QNKNNL
Sbjct: 257 RMKIAVDVARGLEHLHEHCNPPVIHRDLKSSNILLDSDFNAKLSDFGLAITSGTQNKNNL 316
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371
KLSGT+GYVAPEYLLDGKLTDKSDVYAFGV+LLELL+GR+PVEK+A A+CQSIVTWAMPQ
Sbjct: 317 KLSGTVGYVAPEYLLDGKLTDKSDVYAFGVILLELLMGRKPVEKMASAECQSIVTWAMPQ 376
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431
LTDRSKLPNIVDP+++ TMD+KHLYQV+AVAVLCVQPEPSYRPLITDVLHSLIPL+PVEL
Sbjct: 377 LTDRSKLPNIVDPIVRDTMDMKHLYQVSAVAVLCVQPEPSYRPLITDVLHSLIPLLPVEL 436
Query: 432 GGTLRVAPSGPPADSTIPSGH 452
GG+LR+ PP PS H
Sbjct: 437 GGSLRITEPLPPV-CPEPSSH 456
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442156|ref|XP_004138848.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus] gi|449499334|ref|XP_004160788.1| PREDICTED: probable receptor-like protein kinase At1g80640-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1422), Expect = e-154, Method: Compositional matrix adjust.
Identities = 277/400 (69%), Positives = 330/400 (82%), Gaps = 5/400 (1%)
Query: 45 MAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSN 104
M A SPGI +G E + D H K+LIALI+ C++ +++ L LW+Y+ + S
Sbjct: 1 MTASSPGIPIGMETLSN---DTHKKMLIALIV-CASFGAVLVVSLFLWIYYRRNSPNFHK 56
Query: 105 KNAKSKDSENGVV-LSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGG 163
+N +S D+E GVV L+ L KF+S +M+ ++ I+Y++LEKAT+ F ESNILGEGG
Sbjct: 57 RNGQSSDAEKGVVGLAPILRKFSSNKMMGSNKVSVPLIDYEVLEKATNIFEESNILGEGG 116
Query: 164 FGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223
FG VYKA+L++NL VAVKKL+C +D+ +EFENEVDLLS IHH N++ LLGY+ H ++R
Sbjct: 117 FGRVYKARLEENLCVAVKKLECTDKDSEKEFENEVDLLSKIHHSNIIRLLGYTIHGESRL 176
Query: 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283
+VYELMEN SL+ LHGPSHG ALTWHMRMKIALD AR LEYLHEHC P+VIHRDLKSSN
Sbjct: 177 LVYELMENGSLETLLHGPSHGEALTWHMRMKIALDAARALEYLHEHCKPSVIHRDLKSSN 236
Query: 284 ILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVL 343
ILLD+ FNAKLSDFGL++ G+QNKN++KLSGT+GYVAPEYLLDGKLTDKSDVYAFGVVL
Sbjct: 237 ILLDANFNAKLSDFGLSVIVGAQNKNDIKLSGTMGYVAPEYLLDGKLTDKSDVYAFGVVL 296
Query: 344 LELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAV 403
LELLLGRRPVEKLAP+QCQSIVTWAMPQLTDRSKLP+IVDPVI++TMD KHL+QVAAVAV
Sbjct: 297 LELLLGRRPVEKLAPSQCQSIVTWAMPQLTDRSKLPDIVDPVIRNTMDPKHLFQVAAVAV 356
Query: 404 LCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRVAPSGPP 443
LCVQPEPSYRPLITDVLHSLIPLVPVELGGT R + S P
Sbjct: 357 LCVQPEPSYRPLITDVLHSLIPLVPVELGGTHRSSTSQAP 396
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240254530|ref|NP_180094.5| protein kinase domain-containing protein [Arabidopsis thaliana] gi|330252578|gb|AEC07672.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1419), Expect = e-154, Method: Compositional matrix adjust.
Identities = 281/404 (69%), Positives = 321/404 (79%), Gaps = 3/404 (0%)
Query: 35 SPLISPVSTSMAAFSPGIQMGSEDPHHHHMDAHHKLLIALIIACSALCLIILALLCLWLY 94
+P ++PV +SMA FSP IQMGS + DAH KLLI LII+ S+L LIIL W+Y
Sbjct: 13 NPSLAPVYSSMATFSPRIQMGSGE--EDRFDAHKKLLIGLIISFSSLGLIILFCFGFWVY 70
Query: 95 HLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFH 154
S KS N N+ S+ + +L LG + R S + + F + K LEKAT F
Sbjct: 71 RKNQSPKSIN-NSDSESGNSFSLLMRRLGSIKTQRRTSIQKGYVQFFDIKTLEKATGGFK 129
Query: 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
ES+++G+GGFGCVYK LD+N+ AVKK++ +Q+A REF+NEVDLLS IHH NV+ LLG
Sbjct: 130 ESSVIGQGGFGCVYKGCLDNNVKAAVKKIENVSQEAKREFQNEVDLLSKIHHSNVISLLG 189
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
++ ++ FIVYELME SLD QLHGPS GSALTWHMRMKIALDTARGLEYLHEHC P V
Sbjct: 190 SASEINSSFIVYELMEKGSLDEQLHGPSRGSALTWHMRMKIALDTARGLEYLHEHCRPPV 249
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
IHRDLKSSNILLDS FNAK+SDFGLA++ KNN+KLSGTLGYVAPEYLLDGKLTDKS
Sbjct: 250 IHRDLKSSNILLDSSFNAKISDFGLAVSLDEHGKNNIKLSGTLGYVAPEYLLDGKLTDKS 309
Query: 335 DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394
DVYAFGVVLLELLLGRRPVEKL PAQCQS+VTWAMPQLTDRSKLPNIVD VIK TMDLKH
Sbjct: 310 DVYAFGVVLLELLLGRRPVEKLTPAQCQSLVTWAMPQLTDRSKLPNIVDAVIKDTMDLKH 369
Query: 395 LYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRVA 438
LYQVAA+AVLCVQPEPSYRPLITDVLHSL+PLVPVELGGTLR+
Sbjct: 370 LYQVAAMAVLCVQPEPSYRPLITDVLHSLVPLVPVELGGTLRLT 413
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 452 | ||||||
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.699 | 0.729 | 0.671 | 6.7e-119 | |
| TAIR|locus:2198998 | 427 | AT1G80640 [Arabidopsis thalian | 0.654 | 0.693 | 0.611 | 3e-92 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.668 | 0.755 | 0.445 | 8.8e-63 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.634 | 0.257 | 0.438 | 3e-59 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.699 | 0.432 | 0.404 | 6.9e-59 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.621 | 0.616 | 0.466 | 7.3e-59 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.628 | 0.391 | 0.435 | 1.2e-58 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.639 | 0.388 | 0.439 | 8.4e-58 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.688 | 0.799 | 0.424 | 2.8e-57 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.641 | 0.751 | 0.445 | 7.5e-57 |
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 215/320 (67%), Positives = 259/320 (80%)
Query: 120 SFLGKFTSVRMVSK---KGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNL 176
+FL +F+ + + K K +S I+Y +LE+ T F ESNILG+GGFGCVY A L++N+
Sbjct: 105 TFLNRFSRSKTLDKRTTKQGTVSLIDYNILEEGTSGFKESNILGQGGFGCVYSATLENNI 164
Query: 177 HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236
AVKKLDCA +DA +EF++EV++LS + HPN++ LLGYS +D RFIVYELM N SL+
Sbjct: 165 SAAVKKLDCANEDAAKEFKSEVEILSKLQHPNIISLLGYSTNDTARFIVYELMPNVSLES 224
Query: 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296
LHG S GSA+TW MRMKIALD RGLEYLHEHC+PA+IHRDLKSSNILLDS FNAK+SD
Sbjct: 225 HLHGSSQGSAITWPMRMKIALDVTRGLEYLHEHCHPAIIHRDLKSSNILLDSNFNAKISD 284
Query: 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKL 356
FGLA+ DG +NKN+ KLSGT+GYVAPEYLL+G+LT+KSDVYAF KL
Sbjct: 285 FGLAVVDGPKNKNH-KLSGTVGYVAPEYLLNGQLTEKSDVYAFGVVLLELLLGKKPVEKL 343
Query: 357 APAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416
AP +CQSI+TWAMP LTDR+KLP+++DP IK TMDLKHLYQVAAVA+LCVQPEPSYRPLI
Sbjct: 344 APGECQSIITWAMPYLTDRTKLPSVIDPAIKDTMDLKHLYQVAAVAILCVQPEPSYRPLI 403
Query: 417 TDVLHSLIPLVPVELGGTLR 436
TDVLHSLIPLVP+ELGGTL+
Sbjct: 404 TDVLHSLIPLVPMELGGTLK 423
|
|
| TAIR|locus:2198998 AT1G80640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 919 (328.6 bits), Expect = 3.0e-92, P = 3.0e-92
Identities = 187/306 (61%), Positives = 228/306 (74%)
Query: 133 KKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAG 191
+KG+ I EY+LLE AT+ F +SN+L GG GC+Y+A LD+ V VKKLD + D
Sbjct: 130 RKGT-IPVYEYQLLESATNKFSDSNVLSRGGRGCLYRACLDEKSSVTVKKLDGGGETDIE 188
Query: 192 REFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251
++FE EVD L+ I H N+V LLG+ + T IVYELM+N SL+ QLHGPS GS LTW +
Sbjct: 189 KQFETEVDWLAKIRHQNIVSLLGFCVYRQTSCIVYELMQNGSLESQLHGPSQGSGLTWQL 248
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311
RMKIA+D ARGLEYLHEHC+P V+HRDLKSS+ILLDS FNAK+SDFG A +QNKN
Sbjct: 249 RMKIAVDIARGLEYLHEHCHPPVVHRDLKSSSILLDSDFNAKISDFGFATVLTTQNKN-- 306
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTWAMPQ 371
L + A E LLDGK+TDK+DVY+F K + ++ +SIVTWA+P+
Sbjct: 307 -----LIHKASEDLLDGKVTDKNDVYSFGVILLELLLGKKSVEKPS-SEPESIVTWAVPK 360
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431
L+DR+ LPNI+DP IK TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL+PVEL
Sbjct: 361 LSDRANLPNILDPAIKGTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLLPVEL 420
Query: 432 GGTLRV 437
GG+LR+
Sbjct: 421 GGSLRI 426
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
Identities = 139/312 (44%), Positives = 191/312 (61%)
Query: 123 GKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKK 182
G V+ V++ G + +K L AT F +SN++G GGFG VY+ L+D VA+K
Sbjct: 59 GDCQKVQDVTENG--LQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKL 116
Query: 183 LDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS 242
+D A + EF+ EV+LLS + P ++ LLGY + + + +VYE M N L L+ P+
Sbjct: 117 MDHAGKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPN 176
Query: 243 H-GSA---LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
GS L W RM+IA++ A+GLEYLHE +P VIHRD KSSNILLD FNAK+SDFG
Sbjct: 177 RSGSVPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFG 236
Query: 299 LAI--TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXX-XXXK 355
LA +D + + ++ GT GYVAPEY L G LT KSDVY++ K
Sbjct: 237 LAKVGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMK 296
Query: 356 LAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415
A + +V+WA+PQL DR K+ +I+DP ++ K + QVAA+A +CVQ E YRPL
Sbjct: 297 RATGE-GVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPL 355
Query: 416 ITDVLHSLIPLV 427
+ DV+ SL+PLV
Sbjct: 356 MADVVQSLVPLV 367
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 3.0e-59, Sum P(2) = 3.0e-59
Identities = 128/292 (43%), Positives = 175/292 (59%)
Query: 136 SAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE 195
SA +F +++ KAT++F ES +LGEGGFG VY+ DD VAVK L Q REF
Sbjct: 707 SAKTFTASEIM-KATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFL 765
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMK 254
EV++LS +HH N+V L+G D R +VYEL+ N S++ LHG S+ L W R+K
Sbjct: 766 AEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLK 825
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKN-NL 311
IAL ARGL YLHE +P VIHRD KSSNILL++ F K+SDFGLA D N++ +
Sbjct: 826 IALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHIST 885
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTWAMPQ 371
++ GT GYVAPEY + G L KSDVY++ P +++V+W P
Sbjct: 886 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPF 945
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
LT L I+D + + + +VAA+A +CVQPE S+RP + +V+ +L
Sbjct: 946 LTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQAL 997
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 6.9e-59, Sum P(2) = 6.9e-59
Identities = 133/329 (40%), Positives = 186/329 (56%)
Query: 131 VSKKGSAIS-FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD 189
V+K S S Y+ L KAT F E N+LGEGGFG V+K L + VAVK+L +
Sbjct: 366 VAKNISMPSGMFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQ 425
Query: 190 AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTW 249
REF+ EVD +S +HH ++V L+GY + D R +VYE + +L+ LH + GS L W
Sbjct: 426 GEREFQAEVDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLH-ENRGSVLEW 484
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGS 305
MR++IA+ A+GL YLHE C+P +IHRD+K++NILLDSKF AK+SDFGLA T+ S
Sbjct: 485 EMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSS 544
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIV 365
+ ++ GT GY+APEY GK+TDKSDVY+F + QS+V
Sbjct: 545 FTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQSLV 604
Query: 366 TWAMPQLTDR---SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
WA P LT +VD ++ D + +AA A C++ RP ++ V+ +
Sbjct: 605 DWARPLLTKAISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRA 664
Query: 423 L---IPLVPVE-LGGTLRVAPSGPPADST 447
L + L VE G ++ + S P D T
Sbjct: 665 LEGEVALRKVEETGNSVTYSSSENPNDIT 693
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 133/285 (46%), Positives = 171/285 (60%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFENEVDLL 201
++ L AT +FH LGEGGFG VYK +LD V AVK+LD REF EV +L
Sbjct: 76 FRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLML 135
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTA 260
S +HHPN+V L+GY A D R +VYE M SL+ LH P AL W+MRMKIA A
Sbjct: 136 SLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAA 195
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLG 318
+GLE+LH+ NP VI+RD KSSNILLD F+ KLSDFGLA + +K+++ ++ GT G
Sbjct: 196 KGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 255
Query: 319 YVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTWAMPQLTDRSKL 378
Y APEY + G+LT KSDVY+F P Q++V WA P DR K
Sbjct: 256 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKF 315
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ DP +K + LYQ AVA +C+Q + + RPLI DV+ +L
Sbjct: 316 IKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
Identities = 126/289 (43%), Positives = 177/289 (61%)
Query: 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVD 199
F+ Y+ L++AT +F ++ILGEGGFG VY+ L D VA+KKL +EF+ E+D
Sbjct: 367 FLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEID 426
Query: 200 LLSNIHHPNVVCLLGY-SAHDDTRFIV-YELMENRSLDIQLHGP-SHGSALTWHMRMKIA 256
+LS +HH N+V L+GY S+ D ++ ++ YEL+ N SL+ LHGP L W RMKIA
Sbjct: 427 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIA 486
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS 314
LD ARGL YLHE P+VIHRD K+SNILL++ FNAK++DFGLA +G N + ++
Sbjct: 487 LDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVM 546
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTWAMPQLTD 374
GT GYVAPEY + G L KSDVY++ P+ +++VTW P L D
Sbjct: 547 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRD 606
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ +L +VD ++ + +V +A CV PE S RP + +V+ SL
Sbjct: 607 KDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSL 655
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 131/298 (43%), Positives = 179/298 (60%)
Query: 130 MVSKKGSAISFIEYKL--LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT 187
M S A+S + L LEKATD F +LGEGGFG VY+ ++D VAVK L
Sbjct: 324 MSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDN 383
Query: 188 QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSAL 247
Q+ REF EV++LS +HH N+V L+G TR ++YEL+ N S++ LH G+ L
Sbjct: 384 QNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH---EGT-L 439
Query: 248 TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
W R+KIAL ARGL YLHE NP VIHRD K+SN+LL+ F K+SDFGLA T+GS
Sbjct: 440 DWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGS 499
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIV 365
Q+ + ++ GT GYVAPEY + G L KSDVY++ P+ +++V
Sbjct: 500 QHIST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLV 558
Query: 366 TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
TWA P L +R L +VDP + T + + +VAA+A +CV E S+RP + +V+ +L
Sbjct: 559 TWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 2.8e-57, P = 2.8e-57
Identities = 134/316 (42%), Positives = 184/316 (58%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDL 200
++K L ATD+F ++GEGGFG VYK L N VAVK+LD REF EV +
Sbjct: 74 KFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVMV 133
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS-ALTWHMRMKIALDT 259
LS HPN+V L+GY D+ R +VYE M N SL+ L GS +L W RM+I
Sbjct: 134 LSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGA 193
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTL 317
A+GLEYLH++ +P VI+RD K+SNILL S FN+KLSDFGLA ++ K+++ ++ GT
Sbjct: 194 AKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTY 253
Query: 318 GYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTWAMPQLTDRSK 377
GY APEY + G+LT KSDVY+F P + Q++++WA P L DR
Sbjct: 254 GYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRM 313
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV-PVELGGTLR 436
IVDP + +K L+Q A+A +C+Q E RPL+ DV+ +L L P+E+
Sbjct: 314 FAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLAKPIEVVDNTN 373
Query: 437 VAPSGPPADSTIPSGH 452
P+ P S+ S +
Sbjct: 374 TTPASPTQTSSSDSSN 389
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
Identities = 132/296 (44%), Positives = 177/296 (59%)
Query: 134 KGSAISFI-EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAG 191
KG+ + I ++ L AT +F+ N LGEGGFG VYK +++ V AVK+LD
Sbjct: 62 KGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGN 121
Query: 192 REFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA--LTW 249
REF EV +LS +HH N+V L+GY A D R +VYE M+N SL+ L + L W
Sbjct: 122 REFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDW 181
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD--GSQN 307
RMK+A ARGLEYLHE +P VI+RD K+SNILLD +FN KLSDFGLA G +
Sbjct: 182 DTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGET 241
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFXXXXXXXXXXXXXXXKLAPAQCQSIVTW 367
+ ++ GT GY APEY L G+LT KSDVY+F P + Q++VTW
Sbjct: 242 HVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTW 301
Query: 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
A P DR K + DP+++ +K LYQ AVA +C+Q E + RP+++DV+ +L
Sbjct: 302 ASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTAL 357
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 452 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 8e-54
Identities = 78/213 (36%), Positives = 111/213 (52%), Gaps = 18/213 (8%)
Query: 159 LGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG VYK L VAVK L + A+++ EF E ++ + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
LG + +IV E M L L HG LT +++AL A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAIT----DGSQNKNNLKLSGTLGYVAPEYLLDG 328
+HRDL + N L+ K+SDFGL+ D + + KL + ++APE L DG
Sbjct: 123 -FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP--IKWMAPESLKDG 179
Query: 329 KLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
K T KSDV++FGV+L E+ LG +P ++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-51
Identities = 73/192 (38%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVCLLGYS 216
LGEGGFG VY A+ VA+K + + E E+++L ++HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++ ++V E E SL L L+ ++I L GLEYLH + +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKS 334
RDLK NILLDS KL+DFGL+ S + GT Y+APE LL G ++KS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 335 DVYAFGVVLLEL 346
D+++ GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 2e-51
Identities = 80/212 (37%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK KL VAVK L + A++ EF E ++ + HPNVV
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ +IV E ME L L + L+ + AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY--VAPEYLLDGK 329
IHRDL + N L+ K+SDFGL+ D + K G L +APE L +GK
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
T KSDV++FGV+L E+ LG +P ++ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-51
Identities = 87/282 (30%), Positives = 131/282 (46%), Gaps = 36/282 (12%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK KL VAVK L + A+++ ++F E ++ + HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLD------IQLHGPSHGSALTWHMRMKIALDTARGLEY 265
LLG ++ ++V E ME L + S L+ + A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT---LGYVAP 322
L +HRDL + N L+ K+SDFGL+ D + K +G + ++AP
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381
E L DG T KSDV++FGV+L E+ LG P L+ + + L +LP
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRKGYRLPK- 228
Query: 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P LY++ C Q +P RP ++++ L
Sbjct: 229 --PEYCPDE----LYELML---SCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 77/212 (36%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 158 ILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK L VAVK L + A++ EF E ++ + HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ IV E M L L L+ + AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY--VAPEYLLDGK 329
IHRDL + N L+ K+SDFGL+ D + G L +APE L +GK
Sbjct: 124 --FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
T KSDV++FGV+L E+ LG P ++ A+
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-50
Identities = 69/198 (34%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVCLLG 214
LGEG FG VY A+ VA+K + RE E+ +L + HPN+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+D ++V E E L L G L+ LEYLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK--KRGR-LSEDEARFYLRQILSALEYLHSKG---I 118
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
+HRDLK NILLD + KL+DFGLA K GT Y+APE LL
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGKAV 177
Query: 335 DVYAFGVVLLELLLGRRP 352
D+++ GV+L ELL G+ P
Sbjct: 178 DIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 78/206 (37%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNV 209
+ LG G FG VYKAK VAVK L ++ + + E+ +L + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V L+ D ++V E E L + GP L+ KIAL RGLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-----LSEDEAKKIALQILRGLEYLH 115
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+ +IHRDLK NILLD K++DFGLA + + GT Y+APE LL
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 328 GKL-TDKSDVYAFGVVLLELLLGRRP 352
G K DV++ GV+L ELL G+ P
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDN-LHVAVKK--LDCATQDAGREFENEVDLLSNIHHPN 208
+ +LG G FG VY A D +AVK L +++ E E+ +LS++ HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 209 VVCLLGYSAHDDTRF--IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V G ++ I E + SL L L + K GL YL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYL 117
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEY 324
H + ++HRD+K +NIL+DS KL+DFG A + D + + GT ++APE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ + +D+++ G ++E+ G+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 7/201 (3%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+GGFG VYKA+ VA+K + +++ + NE+ +L HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
D +IV E SL L S LT + + +GLEYLH + +IHR
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHSN---GIIHR 122
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
D+K++NILL S KL DFGL+ S K + GT ++APE + K+D++
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 338 AFGVVLLELLLGRRPVEKLAP 358
+ G+ +EL G+ P +L P
Sbjct: 182 SLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 84/268 (31%), Positives = 131/268 (48%), Gaps = 32/268 (11%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNV 209
+ +++G G FG VYK L+ VA+K++ ++A + E+DLL N+ HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V +G D+ +I+ E EN SL I+ GP S + ++ +GL YLH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY-----QVLQGLAYLH 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
E VIHRD+K++NIL KL+DFG+A +K++ + GT ++APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387
+ SD+++ G ++ELL G P L P + + Q D LP + P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIVQ-DDHPPLPEGISP--- 225
Query: 388 STMDLKH-LYQVAAVAVLCVQPEPSYRP 414
+LK L Q C Q +P+ RP
Sbjct: 226 ---ELKDFLMQ-------CFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 34/273 (12%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG VY + D +K++D ++ + NEV +L ++HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 216 SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
IV E + L I+ + + L+YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-FPEEQILDWFVQLCLALKYLHSR---K 123
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD 332
++HRD+K NI L S KL DFG++ + + + + GT Y++PE +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYNY 182
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDR--SKLPNIVDPVIKST 389
KSD+++ G VL EL + P E + I+ P + + S+L N+V
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS----- 237
Query: 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
+Q +P RP I +L S
Sbjct: 238 ---------------LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 156 SNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNV 209
LGEG FG V + D VAVK L+ + ++ R +FE E+++L + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 210 VCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V G + ++ E + + SL L H + + + +G++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLGYVAPE 323
IHRDL + NIL++S+ K+SDFGLA S Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 324 YLLDGKLTDKSDVYAFGVVLLELL-LGR-------RPVEKLAPAQCQSIVTWAMPQLTDR 375
L K + SDV++FGV L EL G + + AQ Q IVT + L +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
+LP ++ L + LC + EP RP
Sbjct: 243 ERLP----RPPSCPDEVYDLMK------LCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 80/287 (27%), Positives = 119/287 (41%), Gaps = 24/287 (8%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHP 207
S+ LGEG FG VY A+ D VA+K L F E+ +L+++ H P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V L + + + ++V E ++ SL+ L L+ + I LEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 268 EHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLA------ITDGSQNKNNLKLSGTLGYV 320
+IHRD+K NILLD KL DFGLA + S GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 321 APEYLLDGKL---TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
APE LL L + SD+++ G+ L ELL G P E + S T +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ-TLKIILELPTPS 234
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
L + + P + + + + +P R + L +
Sbjct: 235 LASPLSPSNPELISK----AASDLLKKLLAKDPKNRLSSSSDLSHDL 277
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 73/196 (37%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G+G FG V VAVK L A + F E +++ + HPN+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQ-KVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+ +IV E M SL L S G A +T ++ ALD G+EYL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
DL + N+L+ AK+SDFGLA + SQ +++ KL + + APE L + K + KSDV+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLA-KEASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 338 AFGVVLLELL-LGRRP 352
+FG++L E+ GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 44/276 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+GEG G VYKA VA+KK+ Q+ NE+ ++ + HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVDYYDSYL 85
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWH-MRMK------IALDTARGLEYLHEH 269
D ++V E M+ SL DI +T + +RM + + +GLEYLH
Sbjct: 86 VGDELWVVMEYMDGGSLTDI----------ITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
VIHRD+KS NILL + KL+DFG A +T +N+ + GT ++APE +
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKR 190
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPVI 386
K D+++ G++ +E+ G P + P + I T +P L + P P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN----PEKWSPEF 246
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
K ++ C+ +P RP ++L
Sbjct: 247 KDFLN------------KCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 154 HESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD----AGREFENEVDLLSNIHHPN 208
N +G G FG VY A LD +AVK++ QD +E +E+ +L + HPN
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V G H + +I E +L+ L HG L H+ L GL YLH
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPEY 324
H ++HRD+K +NI LD KL DFG A + + + + L+GT Y+APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 325 LLDGKLTDK---SDVYAFGVVLLELLLGRRPVEKL 356
+ GK +D+++ G V+LE+ G+RP +L
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 30/226 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSN 203
D+ LGEG FG V+ + +D VAVK L + A+ DA ++FE E +LL+N
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSA---------LTWHMR 252
H N+V G D +V+E ME+ L+ ++ HGP LT
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 253 MKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQN 307
++IA+ A G+ YL +H +HRDL + N L+ K+ DFG++ TD +
Sbjct: 125 LQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ L + ++ PE ++ K T +SDV++FGVVL E+ G++P
Sbjct: 181 GGHTMLP--IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG VYK L N VAVK C D R+F E ++L HPN+V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKT--CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+IV EL+ SL L + LT ++++LD A G+EYL I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG-----YVAPEYLLDGKL 330
HRDL + N L+ K+SDFG++ + +S L + APE L G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 331 TDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIV 365
T +SDV+++G++L E LG P ++ Q + +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
E+ + F LG G FG V++ + + VA+K L ++F+ EV L + H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+++ L + + +I+ ELME SL L P G L + +A A G+ YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYL 120
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEY 324
E IHRDL + NIL+ K++DFGLA I + ++ K+ + APE
Sbjct: 121 EEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEA 175
Query: 325 LLDGKLTDKSDVYAFGVVLLEL 346
G + KSDV++FG++L E+
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 95/298 (31%), Positives = 131/298 (43%), Gaps = 45/298 (15%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKL----DDN--LHVAVKKL--DCATQDAGREFENEV 198
E DS LG G FG VY+ D L VAVK L C+ QD +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEA 60
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH----GPSHGSALTWHMRMK 254
++S +H N+V L+G S RFI+ ELM L L P S+LT +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLA--ITDGSQNKN 309
A D A+G +YL E+ IHRD+ + N LL K AK++DFG+A I S +
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWA 368
+ + ++ PE LDG T K+DV++FGV+L E+ LG P P + V
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----PGRTNQEV--- 230
Query: 369 MPQLTDRSKL---PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
M +T +L PV Y++ C Q P RP +L +
Sbjct: 231 MEFVTGGGRLDPPKGCPGPV----------YRIMTD---CWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 86/277 (31%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
S E N++ G G YK K N + VK+ D +E+ + + HPN+V
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKE----INDVNSIPSSEIADMGKLQHPNIV 746
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L+G + ++++E +E ++L L L+W R KIA+ A+ L +LH C
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 271 NPAVIHRDLKSSNILLDSKFNAKL--SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+PAV+ +L I++D K L S GL TD K + YVAPE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD-------TKCFISSAYVAPETRETK 853
Query: 329 KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
+T+KSD+Y FG++L+ELL G+ P + SIV WA +D L +DP I+
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRG 911
Query: 389 TMDL--KHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ + + +V +A+ C +P+ RP DVL +L
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 82/218 (37%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 157 NILGEGGFGCVYKAKLDDNL-------HVAVKKL-DCATQDAGREFENEVDLLSNIHHPN 208
N LG G FG VY+ D L VAVK L AT +EF E L+SN +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGP----SHGSALTWHMRMKIALDTARGLE 264
+V LLG ++ ++I+ ELME L L LT + I LD A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNA-----KLSDFGLA----ITDGSQNKNNLKLSG 315
YL + IHRDL + N L+ K K+ DFGLA +D + + L
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP- 176
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ ++APE LLDGK T +SDV++FGV++ E+L LG++P
Sbjct: 177 -VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSNIHHPNVV 210
LGEG +G VYKA+ VA+KK+ ++ G RE + LL + HPN+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNIV 61
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LL + ++V+E + L L L+ ++ I RGL Y H H
Sbjct: 62 KLLDVIHTERKLYLVFEYCD-MDLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL 330
++HRDLK NIL++ KL+DFGLA G + TL Y APE LL K
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 331 TDKS-DVYAFGVVLLELLLGR 350
+ D+++ G + E++ G+
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 68/209 (32%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPNVVCLLG 214
LG+G FG V K D A+K L +E E E ++LS I+HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 215 YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--DTAR--------GL 263
Y+ + + ++V E G L H+ + + AR L
Sbjct: 60 YAFQTEEKLYLVLEYAP-------------GGELFSHLSKEGRFSEERARFYAAEIVLAL 106
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
EYLH +I+RDLK NILLD+ + KL+DFGLA S+ GT Y+APE
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
LL D ++ GV+L E+L G+ P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG V + +L + VA+K L ++ +F E ++ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G I+ E MEN SLD L + T + + A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+HRDL + NIL++S K+SDFGL+ ++ + K+ + + APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP--IRWTAPEAIAY 182
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
K T SDV++FG+V+ E++ G RP
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V++ ++ VAVK L T D ++F E ++ + HP ++ L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +IV ELM+ SL L G G AL + +A A G+ YL IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
L + N+L+ K++DFGLA D + + K + + APE L + + KSD
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSD 186
Query: 336 VYAFGVVLLELL-LGRRPVEKLAPAQCQSIVT--WAMPQ 371
V++FG++L E++ GR P + A+ V + MP
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 73/214 (34%), Positives = 104/214 (48%), Gaps = 40/214 (18%)
Query: 159 LGEGGFGCVYKA--KLDDNLHVAVKKL---------DCATQDAGREFENEVDLLSNIHHP 207
LGEG + VYKA K + VA+KK+ D A RE + LL + HP
Sbjct: 8 LGEGTYAVVYKARDKETGRI-VAIKKIKLGERKEAKDGINFTALRE----IKLLQELKHP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELME--------NRSLDIQLHGPSHGSALTWHMRMKIALDT 259
N++ LL H +V+E ME ++S+ + P+ + +M M T
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT---PADIKS---YMLM-----T 111
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
RGLEYLH + ++HRDLK +N+L+ S KL+DFGLA + GS N+ T Y
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 320 VAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRP 352
APE L + D+++ G + ELLL R P
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG VYK +L VA+K L + A +EF E +L+S++ HPN+VC
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQL--HGPSHG-----------SALTWHMRMKIALD 258
LLG + +++E + + L L + P S+L + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
A G+EYL H +HRDL + N L+ K+SDFGL+ I + K
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLEL 346
+ ++ PE +L GK T +SD+++FGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 78/275 (28%), Positives = 117/275 (42%), Gaps = 28/275 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDA-GREFENEVDLLSNIHHPN 208
+ E + LGEG G V K +L + + A+K + ++ E+++ + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 209 VVCLLG--YSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTARGLEY 265
+V G + I E E SLD I G + + KIA +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH +IHRD+K SNILL K KL DFG ++ N +GT Y+APE +
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG--VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRPVE-----KLAPAQCQS-IVTWAMPQLTDRSKLP 379
+ SDV++ G+ LLE+ R P L P + S IV P+L D
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
IK + + K + C++ +P+ RP
Sbjct: 236 ------IKWSEEFKDFIKQ------CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 64/198 (32%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ + VAVK L T F E ++ + H +V L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +IV E M SL L G L + +A A G+ YL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA--ITDGSQN-KNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
L + NIL+ K++DFGLA I D + K + + APE G+ T KSD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSD 186
Query: 336 VYAFGVVLLELL-LGRRP 352
V++FG++L E++ GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 37/213 (17%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLL 213
+GEG +G VYKA+ VA+KK+ + G E+ LL + HPN+V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 214 G--YSAHDDTRFIVYELMENRSLDIQ--LHGPSHGSALTWHMRMKIALDTAR-------- 261
S + ++V+E M++ D+ L P +K +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH---DLTGLLDSPE----------VKFTESQIKCYMKQLLE 111
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--IT-DGSQNKNNLKLSGTLG 318
GL+YLH + ++HRD+K SNIL+++ KL+DFGLA T S + N + TL
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLW 166
Query: 319 YVAPEYLLDGKLTD-KSDVYAFGVVLLELLLGR 350
Y PE LL + D+++ G +L EL LG+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNVVCLLGY 215
+GEG +G VYKA+ VA+KK+ + G E+ LL ++HPN++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
H ++V+E M+ + L + +GL + H H ++
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-DGKLTDKS 334
HRDLK N+L++++ KL+DFGLA + GS + T Y APE LL D +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 335 DVYAFGVVLLELLLGR 350
D+++ G + ELL R
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 157 NILGEGGFGCVYKAKLDDNLHV-AVK---KLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
++G+G FG V + D + A+K K C + + R NE +L ++HP +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP-FLVN 64
Query: 213 LGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L YS D+ ++V +L+ G L +H+ K+ +
Sbjct: 65 LWYSFQDEENMYLVVDLLL-------------GGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
LEYLH +IHRD+K NILLD + + ++DF +A T + + SGT GY+A
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA-TKVTPDTLTTSTSGTPGYMA 167
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
PE L + D ++ GV E L G+RP
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 37/277 (13%)
Query: 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLLGYS 216
LG+G G VYK + A+KK+ + R + E+ L + P VV G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ IV E M+ SL ++ G L IA +GL+YLH + +
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTKRH--I 121
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD 332
IHRD+K SN+L++SK K++DFG++ + + N GT+ Y++PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQGESYSY 179
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLA----PAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
+D+++ G+ LLE LG+ P Q+I P L P D +
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA- 238
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
C+Q +P RP ++L H I
Sbjct: 239 ----------------CLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 76/236 (32%), Positives = 108/236 (45%), Gaps = 49/236 (20%)
Query: 159 LGEGGFGCVYKAKLDDNLH-----------------VAVKKLDCATQDAGR-EFENEVDL 200
LGEG FG V+ + D VAVK L D R +F EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLH-----GPSHGS-ALTWHMR 252
LS + PN+ LLG D ++ E MEN L+ +Q H G + S +L++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL- 311
+ +A A G+ YL +HRDL + N L+ + K++DFG+ NL
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGM--------SRNLY 181
Query: 312 -----KLSGT----LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRR-PVEKL 356
++ G + ++A E +L GK T KSDV+AFGV L E+L L R P E L
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 76/202 (37%), Positives = 113/202 (55%), Gaps = 14/202 (6%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
I+GEG FG V + + VAVK + C + F E +++ +HH N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQ-KVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM-KIALDTARGLEYLHEHCNPAVIH 276
H+ +IV ELM +L L + G AL +++ + +LD A G+EYL + ++H
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDV 336
RDL + NIL+ AK+SDFGLA GS +N KL + + APE L K + KSDV
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDNSKLP--VKWTAPEALKHKKFSSKSDV 180
Query: 337 YAFGVVLLELL-LGRRPVEKLA 357
+++GV+L E+ GR P K++
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 7/205 (3%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE--NEVDLLSNIHHPNV 209
F N +G+G FG V+K + V A+K++D + + E +E +L+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ IV E EN L L G L + + GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
++HRD+KS N+ LD+ N K+ D G+A + GT Y++PE D
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVE 354
+KSDV+A GVVL E G+ P +
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 74/207 (35%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNV 209
F + N +GEG +G VY+A+ VA+KK+ + G + E+ LL N+ HPN+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 210 VCLLGYSA--HDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
V L H D+ F+V E E LD + + + + L RGL+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLD------NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLHE+ +IHRDLK SN+LL K K++DFGLA T G K TL Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
LL + D++A G +L ELL +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 60/287 (20%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G VYKA + VA+K + ++ +E E+ +L P +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 217 AHDDTRFIVYE---------LME--NRSLD---IQLHGPSHGSALTWHMRMKIALDTARG 262
+ +IV E +M+ N++L I I T +G
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA----------------ILYQTLKG 111
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
LEYLH + IHRD+K+ NILL+ + AKL+DFG++ +TD +N + GT ++
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWM 166
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA-QCQSIVTWAMPQLTDRSKL- 378
APE + + +K+D+++ G+ +E+ G+ P + P I P L+D K
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS 226
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
P D V K C+ +P RP +L H I
Sbjct: 227 PEFNDFVKK-----------------CLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 7e-24
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ K + VA+K + + +F E ++ + HPN+V L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
FIV E M N L L W + M D +EYL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIHRD 125
Query: 279 LKSSNILLDSKFNAKLSDFGLA-------ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
L + N L+ K+SDFGLA T K +K + PE + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA------PPEVFDYSRFS 179
Query: 332 DKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
KSDV++FGV++ E+ G+ P E+ + ++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 7e-24
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVC 211
++G+G FGCVY L D+ +H AVK L+ T + +F E ++ + HPNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 212 LLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG + + +V M++ L + +H T + L A+G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQVAKGMEYL---A 115
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS----QNKNNLKLSGTLGYVAPEY 324
+ +HRDL + N +LD F K++DFGLA I D N KL + ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWMALES 173
Query: 325 LLDGKLTDKSDVYAFGVVLLELL 347
L K T KSDV++FGV+L EL+
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 63/297 (21%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
LG+G FG VY+ K + VA+K + + A+ EF NE ++ + +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 212 LLGYSAHDDTRFIVYELM----------ENRSLDIQLHG---PSHGSALTWHMRMKIALD 258
LLG + +V ELM R G P+ + A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM------AAE 127
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
A G+ YL +HRDL + N ++ K+ DFG+ I + + K
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDR 375
+ ++APE L DG T KSDV++FGVVL E+ L +P + L+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------------- 229
Query: 376 SKLPNIVDPVIKSTMDLKHL-------YQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425
V+K +D HL ++ + +C Q P RP +++ SL
Sbjct: 230 ---------VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 62/228 (27%), Positives = 89/228 (39%), Gaps = 47/228 (20%)
Query: 158 ILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREF---ENEVD--------LLSNIH 205
I+GEG F V AK + N A+K LD + E +V L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 206 HPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HP ++ L Y+ D+ + V E N L + +L A + LE
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---------- 314
YLH +IHRDLK NILLD + K++DFG A +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 315 ----------GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT YV+PE L + SD++A G ++ ++L G+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 64/222 (28%), Positives = 91/222 (40%), Gaps = 51/222 (22%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD---------LLSNIHH 206
+G G +G V A VA+KK+ F++ +D LL ++ H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 207 PNVVCLLGYSAHDDTR-----FIVYELME---------NRSLDIQLHGPSHGSALTWHMR 252
N++ LL +IV ELME + L H + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD-----HIQYFLYQI- 112
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
RGL+YLH N VIHRDLK SNIL++S + K+ DFGLA
Sbjct: 113 -------LRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 313 LSG---TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
L+ T Y APE LL K+ D+++ G + ELL +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 79/287 (27%), Positives = 119/287 (41%), Gaps = 48/287 (16%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDL 200
Y+L+E +G G VY A L +N VA+K++D E EV
Sbjct: 3 YELIEV----------IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA 52
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHG-----SALTWHMRMK 254
+S +HPNVV D ++V + S LDI G T
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------ 106
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
+ + +GLEYLH + IHRD+K+ NILL + K++DFG++ + DG ++
Sbjct: 107 VLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 313 --LSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWA 368
GT ++APE + K+D+++FG+ +EL G P K P + +
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND 223
Query: 369 MPQL-TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
P L T KS + LC+Q +PS RP
Sbjct: 224 PPSLETGADY-----KKYSKSFRKM---------ISLCLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NE 197
+Y++LE +G+G FG V K + D + K++D +E + +E
Sbjct: 1 DYEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSE 49
Query: 198 VDLLSNIHHPNVVCLLGY--SAHDDTRFIVYELME-----NRSLDIQLHGPSHGSALTWH 250
V++L + HPN+V Y D + +Y +ME + + IQ +
Sbjct: 50 VNILRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEE 105
Query: 251 MRMKIALDTARGLEYLH--EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ 306
+I L H V+HRDLK +NI LD+ N KL DFGLA + S
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS 363
GT Y++PE L +KSD+++ G ++ EL P Q S
Sbjct: 166 FAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 85/278 (30%), Positives = 132/278 (47%), Gaps = 48/278 (17%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKL-----DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LG G FG VY+ LDD AVK++ Q+A ++ E E+ LLS + HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQL--HGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LG +D +I EL+ SL L +G + + R + GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH--- 119
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS------GTLGYVAPEY 324
+ +HRD+K +NIL+D+ KL+DFG+A K ++ S G+ ++APE
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEV 172
Query: 325 LLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
+ G +D+++ G +LE+ G+ P +L A+ ++ +LP I D
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-------AVFKIGRSKELPPIPD 225
Query: 384 PVIKSTMDLKHLYQVAAVAVL-CVQPEPSYRPLITDVL 420
HL A +L C+Q +PS RP ++L
Sbjct: 226 ----------HLSDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKA+ + L A K + +++ +F E+D+LS HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+++ +I+ E + +LD + G LT + L +LH H VIHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-----DGKLTD 332
DLK+ NILL + KL+DFG++ + S + GT ++APE + D
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLAP 358
K+D+++ G+ L+EL P +L P
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 79/249 (31%), Positives = 105/249 (42%), Gaps = 37/249 (14%)
Query: 159 LGEGGFGCVY--KAKLDDNLHV--AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG GGFG V K K + VKK +E ++L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH-MRMKIALD--TAR--------GL 263
Y D ++I Y LME G L W +R + D TAR
Sbjct: 59 YRTFKDKKYI-YMLME----------YCLGGEL-WTILRDRGLFDEYTARFYIACVVLAF 106
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
EYLH +I+RDLK N+LLDS KL DFG A S K GT YVAPE
Sbjct: 107 EYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK-TWTFCGTPEYVAPE 162
Query: 324 YLLDGKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382
+L K D S D ++ G++L ELL GR P + + + + + + PN +
Sbjct: 163 IIL-NKGYDFSVDYWSLGILLYELLTGRPPFG--EDDEDPMEIYNDILKGNGKLEFPNYI 219
Query: 383 DPVIKSTMD 391
D K +
Sbjct: 220 DKAAKDLIK 228
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFE----------NEVDLLSNIHH 206
++G+G +G VY A + +AVK+++ AGR +E++ L ++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL------DTA 260
N+V LG+ ++ I E + G S GS L + R + L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVP---------GGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
GL YLH + ++HRDLK+ N+L+D+ K+SDFG++ D N N+ + G++
Sbjct: 119 EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 319 YVAPEYL-LDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376
++APE + + + K D+++ G V+LE+ GRRP AM +L ++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKR 228
Query: 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVL--CVQPEPSYRPLITDVL 420
P I D+ A+ L C P RP ++L
Sbjct: 229 SAPPIPP-------DVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG VY +D +AVK++ D + + +E E E+ LL N+ H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
G D+T I E M S+ QL ++G ALT + K G+EYLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLK--AYG-ALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI---TDGSQNKNNLKLSGTLGYVAPEYLLDG 328
++HRD+K +NIL DS N KL DFG + T S ++GT +++PE +
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 329 KLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
K+DV++ G ++E+L + P +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 88/287 (30%), Positives = 129/287 (44%), Gaps = 40/287 (13%)
Query: 159 LGEGGFGCVYKAKLD---DNLH--VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
LG+G FG V + D DN VAVKKL +T + R+FE E+++L ++ H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 214 G--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
G YSA +V E + SL L H L + A +G+EYL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL-----SGTLGYVAPEYLL 326
+HRDL + NIL++S+ K+ DFGL Q+K K+ S Y APE L
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWY-APESLT 184
Query: 327 DGKLTDKSDVYAFGVVLLELL----LGRRP----VEKLAP-AQCQSIVTWAMPQLTDRSK 377
+ K + SDV++FGVVL EL P + + Q Q IV + L + +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244
Query: 378 LPNIVD-PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
LP P ++ A+ C +PS RP +++ +
Sbjct: 245 LPAPPGCPA-----------EIYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 159 LGEGGFGCVYKAKLD-DNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ +L DN VAVK + D +F E +L HPN+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVI 275
+IV EL++ D + G L +++ + A G+EYL +HC I
Sbjct: 63 TQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
HRDL + N L+ K K+SDFG++ DG + + APE L G+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 334 SDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIV 365
SDV++FG++L E LG P L+ Q + +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGYS 216
LG G G V K + K + ++ E+D+L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++ I E M+ SLD L + + KIA+ +GL YLHE +IH
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPEYLLDGKLTDKS 334
RD+K SNIL++S+ KL DFG++ Q N+L + GT Y+APE + + KS
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 335 DVYAFGVVLLELLLGRRPV 353
D+++ G+ L+EL GR P
Sbjct: 181 DIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 70/210 (33%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 158 ILGEGGFGCVYKAKL--DDN--LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
ILGEG FG V + +L DD L VAVK KLD T EF +E + + HPNV+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 212 LLG--YSAHDDTRF----IVYELMENRSLDIQL------HGPSHGSALTWHMRMKIALDT 259
L+G + A + ++ M++ L L P L +K +D
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---LPLQTLLKFMVDI 122
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
A G+EYL N IHRDL + N +L ++DFGL+ I G + +
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
++A E L D T KSDV+AFGV + E+
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-22
Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G+G F VYKA L D VA+KK+ + A ++ E+DLL + HPNV+ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
++ IV EL + L + H + K + LE++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
++HRD+K +N+ + + KL D GL S+ L GT Y++PE + + K
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 334 SDVYAFGVVLLELLLGRRPV--EKLAP-AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390
SD+++ G +L E+ + P +K+ + C+ I P L P +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL-----------PADHYSE 235
Query: 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+L+ L C+ P+P RP I+ VL
Sbjct: 236 ELRDLVSR------CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 75/250 (30%), Positives = 113/250 (45%), Gaps = 41/250 (16%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+GEG G V A VAVKK+D Q NEV ++ + HPN+V + YS+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM--YSS 84
Query: 218 H--DDTRFIVYELMENRSLDIQLHGPSHGSALT---WHMRMK------IALDTARGLEYL 266
+ D ++V E +E G ALT H RM + L + L +L
Sbjct: 85 YLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H VIHRD+KS +ILL S KLSDFG + L GT ++APE +
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----RSKLPNIV 382
+ D+++ G++++E++ G P P Q AM ++ D + K + V
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLPPKLKNLHKV 241
Query: 383 DPVIKSTMDL 392
P ++S +D
Sbjct: 242 SPRLRSFLDR 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 77/270 (28%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
LG+G +G VYK K L DN A+K++D +Q + NE+ +L++++HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 216 SAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ IV E L + +I + RGL+ LHE +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPEYLLDGKLTD 332
+HRDLKS+NILL + K+ D G++ K N+ + GT Y+APE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGIS----KVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392
KSD+++ G +L E+ P E + + V R K P I P I S DL
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------RGKYPPI--PPIYSQ-DL 229
Query: 393 KHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
++ + +Q +P RP +L S
Sbjct: 230 QNFIR------SMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 159 LGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE----NEVDLLSNIHHPNVVCLL 213
LG+GGFG V ++ + A KKLD + R+ E NE +L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLD-KKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYLHEHCN 271
Y+ +V LM D++ H + G R A GLE+LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
+++RDLK N+LLD N ++SD GLA+ + K +GT GY+APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAV-ELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
D +A G L E++ GR P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 70/242 (28%), Positives = 112/242 (46%), Gaps = 28/242 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH----VAVKKLDCATQDAGREFENEVDLLSNIHH 206
+ + +G G +G VYKA+ ++ VA+K + D + E+ +L H
Sbjct: 3 EDYELIQRIGSGTYGDVYKAR---DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-DI--QLHGPSHGSALTWHMRMKIALDTARGL 263
PN+V G D +IV E SL DI GP L+ + +T +GL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVA 321
YLHE IHRD+K +NILL + KL+DFG++ +T + + GT ++A
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMA 169
Query: 322 PEYL---LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT---WAMPQLTDR 375
PE G K D++A G+ +EL + P+ L P + +++ + P+L D+
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229
Query: 376 SK 377
K
Sbjct: 230 EK 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 159 LGEGGFGCVYKAKL-----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGE FG +YK L D VA+K L D EF+ E L++ +HHPN+VCL
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 213 LGYSAHDDTRFIVYE-----------LMENRSLDIQLHGPSHG---SALTWHMRMKIALD 258
LG + +++E +M + D+ G S+L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
A G+EYL H +H+DL + NIL+ + + K+SD GL+ S + ++ L
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 319 --YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
++ PE ++ GK + SD+++FGVVL E+ G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V K VA+K K ++D EF E ++ + H +V L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV E M N L L HG +++ D G+ YL IH
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
RDL + N L+D + K+SDFGL+ + D + +++ + + PE LL K + KS
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 335 DVYAFGVVLLELL-LGRRPVEKLAPAQ 360
DV+AFGV++ E+ LG+ P E+ ++
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L A++ A ++F+ E +LL+ + H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP-------SHGSA---LTWHMRMKIALDTA 260
G +V+E M + L+ ++ HGP A LT + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGT 316
G+ YL + +HRDL + N L+ K+ DFG++ TD + L
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP-- 187
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDR 375
+ ++ PE +L K T +SD+++FGVVL E+ G++P +L+ + +T +L
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP 246
Query: 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
P V +++ C Q EP R +I D+ HS
Sbjct: 247 RTCPPEVYAIMQG----------------CWQREPQQRMVIKDI-HS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLL 213
LG+G FG V + + VAVK L D +F E ++ ++ H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNP 272
G +V EL SL +L A+ A G+ YL +
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRF-- 118
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQN---KNNLKLSGTLGYVAPEYLLD 327
IHRDL + NILL S K+ DFGL A+ + + +LK+ + APE L
Sbjct: 119 --IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRT 174
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
+ SDV+ FGV L E+ G P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 36/277 (12%)
Query: 158 ILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLL 213
+LG+G FG +Y+ DD+L V K+++ R+ NE+ +LS + HPN++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--DTARGLEYLHEHCN 271
+ D+T I E +L ++ + M + + Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
++HRD+K+ NI L KL DFG++ GS+ + GT Y++PE K
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 332 DKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVT--WAMPQLTDRSKLPNIVDPVIKS 388
KSD++A G VL ELL +R + P IV + +V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-----------VVSVYSSE 228
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425
+ L H +Q +P RP +VL +
Sbjct: 229 LISLVH---------SLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-21
Identities = 84/300 (28%), Positives = 141/300 (47%), Gaps = 49/300 (16%)
Query: 159 LGEGGFGCVYKAK------LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L T A ++F+ E +LL+N+ H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP-----------SHGSALTWHMRMKIALDT 259
G D +V+E M++ L+ ++ HGP L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSG 315
A G+ YL + +HRDL + N L+ + K+ DFG++ TD + + L
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 188
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTD 374
+ ++ PE ++ K T +SDV++FGV+L E+ G++P +L+ + +T ++ +
Sbjct: 189 -IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVLE 245
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITD---VLHSLIPLVPVEL 431
R + V P K +Y + + C Q EP R I + +LH+L P+ L
Sbjct: 246 RPR----VCP--------KEVYD---IMLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 7e-21
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ + + VA+K L + F E +L+ + HP +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +I+ E MEN SL L P G LT + + +A A G+ ++ IHRD
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
L+++NIL+ K++DFGLA + + ++ + + APE + G T KSDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 338 AFGVVLLELL-LGRRP 352
+FG++L E++ GR P
Sbjct: 188 SFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 33/220 (15%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQLH---GPSHGSALTWHMRMKIALD 258
LLG H ++ E L ++R L+ S S L+ + A D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
ARG++YL + IHRDL + NIL+ + AK++DFGL+ + + T+G
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 183
Query: 319 -----YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
++A E L T SDV+++GV+L E++ LG P
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDC-ATQDAGREFENEVD 199
+ LLE +G+G FG VYKA N VA+K +D +D + + E+
Sbjct: 2 LFTLLEC----------IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ 51
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALD 258
LS P + G +I+ E S LD+ G + + + +R +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----E 106
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
GLEYLHE IHRD+K++NILL + + KL+DFG++ +T + +K N GT
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRN-TFVGT 161
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
++APE + +K+D+++ G+ +EL G P+ L P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 8e-21
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 46/221 (20%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V + +L + VA+K L T+ R+F +E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 213 LGYSAHDDTRFIVYELMENRSLD------------IQLHGPSHGSALTWHMRMKIALDTA 260
G I+ E MEN +LD IQL G G A
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG--------------IA 116
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
G++YL E +HRDL + NIL++S K+SDFGL+ + D + + + +LG
Sbjct: 117 AGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT---YTSSLG 170
Query: 319 ------YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ APE + K T SDV+++G+V+ E++ G RP
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGRE---------FENEVDLLSNIHHP 207
++G G FG VY +AVK+++ + A + E+ LL + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LG S D I E + S+ L+ ++G A + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA------ITDGSQNKNNLKLSGTLGYVA 321
N +IHRD+K +NIL+D+K K+SDFG++ N L G++ ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364
PE + T K+D+++ G +++E+L G+ P Q Q+I
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC--TQLQAI 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 41/221 (18%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+G+G FG V++A+ + VAVK L + A+ D +F+ E L++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LLGYSAHDDTRFIVYELMENRSLD--------IQLHGPSHGSA-----------LTWHMR 252
LLG A +++E M L+ SH ++ L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN---KN 309
+ IA A G+ YL E +HRDL + N L+ K++DFGL S+N +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL-----SRNIYSAD 184
Query: 310 NLKLSGT----LGYVAPEYLLDGKLTDKSDVYAFGVVLLEL 346
K S + ++ PE + + T +SDV+A+GVVL E+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 158 ILGEGGFGCVYKA-----KLDDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK + VA+K L T A +E +E +++++ HP+VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG ++ +LM L + +H + + + A+G+ YL E
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSG---TLGYVAPEYLLD 327
++HRDL + N+L+ + + K++DFGLA + D + + G + ++A E +L
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE--YHAEGGKVPIKWMALESILH 185
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRPVE 354
T KSDV+++GV + EL+ G +P E
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 70/229 (30%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L A+ +A ++F E +LL+N+ H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 213 LGYSAHDDTRFIVYELMENRSLD--IQLHGP-----SHG---SALTWHMRMKIALDTARG 262
G D +V+E M++ L+ ++ HGP + G + LT + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLG 318
+ YL + +HRDL + N L+ K+ DFG++ TD + + L +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--IR 187
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVT 366
++ PE ++ K T +SDV++ GVVL E+ G++P +L+ + +T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 74/255 (29%), Positives = 116/255 (45%), Gaps = 32/255 (12%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V++ L + VA+K L T+ ++F +E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G I+ E MEN +LD L H + + + + A G++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLSDM--- 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLLDGK 329
+HRDL + NIL++S K+SDFGL+ + SG + + APE + K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKL----------------APAQCQSIVTWAMPQ- 371
T SDV++FG+V+ E++ G RP + AP C S V M Q
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQC 246
Query: 372 -LTDRSKLPNIVDPV 385
DR++ P VD V
Sbjct: 247 WQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 32/220 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFE 195
Y+ +EK +GEG +G VYKA+ VA+KK+ T+D G RE
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE-- 48
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGS-ALTWHMRM 253
+ LL ++HPN+V LL H + + ++V+E ++ LD++ + S L +
Sbjct: 49 --ISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIK 102
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+G+ Y H H V+HRDLK N+L+D + KL+DFGLA G +
Sbjct: 103 SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159
Query: 314 SGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
TL Y APE LL + D+++ G + E++ RRP
Sbjct: 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 152 SFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI 204
+ E LG G FG V+ AK V VK L ++ EF E+D+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 205 HHPNVVCLLGYSAHDDTRFIVYE----------LMENRSLDIQLHGPSHGSALTWHMRMK 254
H NVV LLG + +++ E L +S D +L P L+ ++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP----LSTKQKVA 121
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN---KNNL 311
+ A G+++L N +HRDL + N L+ S+ K+S L+ + N
Sbjct: 122 LCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLA 357
+ L ++APE + + + KSDV++FGV++ E+ G P L+
Sbjct: 179 LIP--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 14/214 (6%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+LG+G FG V+K L D VAVK K D Q+ +F +E +L HPN+V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAV 274
+IV EL+ L L +K ALD A G+ YL ++C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAIT--DGSQNKNNLKLSGTLGYVAPEYLLDGKLTD 332
IHRDL + N L+ K+SDFG++ DG + + LK + + APE L G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-QIPIKWTAPEALNYGRYSS 173
Query: 333 KSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIV 365
+SDV+++G++L E LG P + Q + V
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 162 GGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLGYS- 216
G +G V+ AK A+K + A + + E D+LS P VV L YS
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
++V E + L L + +L + + LEYLH + +IH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSN---GIIH 116
Query: 277 RDLKSSNILLDSKFNAKLSDFGL--------AITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
RDLK NIL+DS + KL+DFGL I K + ++ GT Y+APE +L
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 329 KLTDKSDVYAFGVVLLELLLGRRP 352
+ D ++ G +L E L+G P
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 40/222 (18%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI- 204
+ E +GEG +G VYKA+ L+ VA+KK+ + G RE + LL +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQLE 56
Query: 205 --HHPNVVCLLGYSA-HDDTR----FIVYELMENRSLDIQL-HGPSHG---SALTWHMRM 253
HPN+V LL R +V+E ++ + L L P G + MR
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ RG+++LH H ++HRDLK NIL+ S K++DFGLA + L
Sbjct: 116 LL-----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEMAL 163
Query: 314 SG---TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ TL Y APE LL D+++ G + EL RRP
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-20
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 35/273 (12%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G+G FG V+K +D+ VA+K +D +D + + E+ +LS P V G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 216 SAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
D +I+ E + S LD+ GP + + +R + +GL+YLH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE---KK 122
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD 332
IHRD+K++N+LL KL+DFG+A +TD +N GT ++APE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDS 180
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392
K+D+++ G+ +EL G P +L P + V + +P+ + N P L
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP-------L 229
Query: 393 KHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
K + C+ EPS+RP ++L H I
Sbjct: 230 KEFVEA------CLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 5e-20
Identities = 67/220 (30%), Positives = 117/220 (53%), Gaps = 33/220 (15%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQ-LHGPSHGSALTWHMR--MKIALD 258
LLG H ++ E L ++R L+ ++ +A T + + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
ARG++YL + IHRDL + NIL+ + AK++DFGL+ + + T+G
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 171
Query: 319 -----YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
++A E L T SDV+++GV+L E++ LG P
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 71/220 (32%), Positives = 116/220 (52%), Gaps = 33/220 (15%)
Query: 157 NILGEGGFGCVYKA--KLDDN-LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V +A K D ++ A+K L + A+++ R+F E+++L + HHPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 212 LLGYSAHDDTRFIVYE----------LMENRSLDIQ-LHGPSHGSA--LTWHMRMKIALD 258
LLG + +I E L ++R L+ HG+A LT ++ A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
A G++YL E IHRDL + N+L+ +K++DFGL+ + + T+G
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS------RGEEVYVKKTMG 178
Query: 319 -----YVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
++A E L T KSDV++FGV+L E++ LG P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 73/237 (30%), Positives = 109/237 (45%), Gaps = 15/237 (6%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ K VAVKK+D Q NEV ++ + HH NVV +
Sbjct: 30 IGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D ++V E +E +L DI H + + + L R L YLH N VI
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH---NQGVI 140
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
HRD+KS +ILL S KLSDFG + L GT ++APE + + D
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 336 VYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392
+++ G++++E++ G P P Q + +P R K + V V++ +DL
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---RVKDSHKVSSVLRGFLDL 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 77/207 (37%), Positives = 108/207 (52%), Gaps = 26/207 (12%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKLDCATQ---DAGREFENEVDLLSNI-HHPNVVCL 212
LG+G +G V+KA +D VA+KK+ A + DA R F E+ L + HPN+V L
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 213 LG-YSAHDDTR-FIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEH 269
L A +D ++V+E ME LH H R I + L+Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEYMET-----DLHAVIRANILEDVHKRY-IMYQLLKALKYIH-- 124
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS---GTLGYVAPEY 324
+ VIHRDLK SNILL+S KL+DFGLA +++ +N N L+ T Y APE
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
LL K D+++ G +L E+LLG+
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 8e-20
Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE--FENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V+ K + VA+K ++ + A E F E ++ + HP +V L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV E MEN L L L+ M + + D G+EYL + + IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA-------ITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
RDL + N L+ S K+SDFG+ T S K +K S PE K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS------PPEVFNFSK 177
Query: 330 LTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
+ KSDV++FGV++ E+ G+ P EK + + +++ R P + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYE 232
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
M C +P RP ++L ++
Sbjct: 233 VM------------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKA+ + + A K +D +++ ++ E+D+L++ HPN+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 218 HDDTRFIVYELMENRSLD---IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+++ +I+ E ++D ++L P LT + T L YLHE+ +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP-----LTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-----DGK 329
IHRDLK+ NIL + KL+DFG++ + + GT ++APE ++ D
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
K+DV++ G+ L+E+ P +L P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 76/233 (32%), Positives = 114/233 (48%), Gaps = 36/233 (15%)
Query: 158 ILGEGGFGCVYKAK------LDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
LGEG FG V KA VAVK L + A+ R+ +E +LL ++HP+V+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLH-----GPSH-GS---------------ALTW 249
L G + D ++ E + SL L GPS+ GS ALT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ A +RG++YL E ++HRDL + N+L+ K+SDFGL+ D + +
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLS-RDVYEEDS 182
Query: 310 NLKLSG---TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAP 358
+K S + ++A E L D T +SDV++FGV+L E++ LG P +AP
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKK--LDCATQDAG----REFENEVDLLSNIHHPNVV 210
+LG+G +G VY + +AVK+ LD + A + + EVDLL ++ H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
LG D+T I E + S+ + GP + + + G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFG----LAITDGSQNKNNL--KLSGTLGYVAP 322
+C V+HRD+K +N++L KL DFG LA +N+ + GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
E + + KSD+++ G + E+ G+ P+ +
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA-GREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V N VAVK C DA + F E +++ + H N+V LLG
Sbjct: 13 TIGKGEFGDVMLGDYRGN-KVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 217 AHDD-TRFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +IV E M SL L S G S L +K +LD +EYL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
+HRDL + N+L+ AK+SDFGL + S ++ KL + + APE L + K + KS
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT-KEASSTQDTGKLP--VKWTAPEALREKKFSTKS 180
Query: 335 DVYAFGVVLLELL-LGRRPVEKLA 357
DV++FG++L E+ GR P ++
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
E +S LG G FG V+ + N VAVK L T + F E ++ + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L + + +IV E M SL L G AL + +A A G+ Y+
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYL 325
E N IHRDL+S+NIL+ K++DFGLA + + ++ + + APE
Sbjct: 119 -ERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 326 LDGKLTDKSDVYAFGVVLLELLL-GRRP 352
L G+ T KSDV++FG++L EL+ GR P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 7/192 (3%)
Query: 157 NILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L + + + + + +A + +EYL + I
Sbjct: 71 CTREPPFYIITEFMTYGNL-LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
HRDL + N L+ K++DFGL+ + G + + + APE L K + KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 335 DVYAFGVVLLEL 346
DV+AFGV+L E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHHPNVVCLL 213
LG G FG V Y K + VAVK L AG +EF E +++ + HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G + +V EL L L ++A A G+ YL E +
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYL-ESKH-- 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQNKNNLKLSGT--LGYVAPEYLLDGK 329
+HRDL + N+LL ++ AK+SDFG+ A+ GS + +G L + APE + GK
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-DYYRATTAGRWPLKWYAPECINYGK 174
Query: 330 LTDKSDVYAFGVVLLELL-LGRRP 352
+ KSDV+++GV L E G +P
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 30/215 (13%)
Query: 151 DSFHESNILGEGGFGCVYKA--KLDDNLHVAVKKLDCATQDAG------REFENEVDLLS 202
D + + N + EG +G VY+A K + VA+KKL + G RE +++L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEI-VALKKLKMEKEKEGFPITSLRE----INILL 59
Query: 203 NIHHPNVVCL----LGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIA 256
+ HPN+V + +G ++ D ++V E +E+ +SL + P S + M
Sbjct: 60 KLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM----- 112
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
L G+ +LH++ ++HRDLK+SN+LL+++ K+ DFGLA GS K +L T
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169
Query: 317 LGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGR 350
L Y APE LL K + D+++ G + ELL +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 39/226 (17%)
Query: 159 LGEGGFGCVYKAKLDD-----------------NLHVAVKKLDC-ATQDAGREFENEVDL 200
LGEG FG V+ ++ + L VAVK L A ++A +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH---------------GPSH-G 244
LS + PN++ LLG +D ++ E MEN L+ L P+H
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--IT 302
A+++ + +AL A G++YL + +HRDL + N L+ K++DFG++ +
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL 348
G + + + ++A E +L GK T SDV+AFGV L E+L+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 9e-19
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPN 208
+ +GEG FG +Y AK D+ H +K++D T+ +E E EV LL+ + HPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQL---HGP--SHGSALTWHMRMKIALDTARGL 263
+V + FIV E + L ++ G S L+W + +I+L GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISL----GL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
+++H+ ++HRD+KS NI L AKL DFG+A + GT Y++P
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
E + +K+D+++ G VL EL + P E
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212
++G G FG V +L + VA+K L T+ R+F +E ++ HPN++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G IV E MEN SLD L H T + + A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSDM--- 125
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLLDGK 329
+HRDL + NIL++S K+SDFGL+ + G + + APE + K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 330 LTDKSDVYAFGVVLLELL-LGRRP 352
T SDV+++G+V+ E++ G RP
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 34/272 (12%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEVDLLSN 203
++ D F +GEG +G VYKA+ D VA+KK+ + G E+ +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 204 IHHPNVVCL----------LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
++H N+V L L + ++V+E M++ + + G H S M
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNN 310
K L+ GL Y H +HRD+K SNILL++K KL+DFGLA ++ S+ N
Sbjct: 123 KQLLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 311 LKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELLLGRRPV----EKLAPAQCQSIV 365
+ TL Y PE LL + + DV++ G +L EL ++P+ ++LA + S +
Sbjct: 177 KVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRL 233
Query: 366 TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQ 397
+ + P+++ +TM K Y+
Sbjct: 234 CGS----PCPAVWPDVIKLPYFNTMKPKKQYR 261
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 31/286 (10%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKK-LDCATQDAGREFE-NEVDLLSNIHHPNVVCLLG 214
++GEG +G V K K + VA+KK L+ ++ E+ +L + H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
++V+E +++ LD P +G L K RG+E+ H H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYP-NG--LDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-DGKLTDK 333
IHRD+K NIL+ KL DFG A T + + T Y APE L+ D K
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 334 SDVYAFGVVLLELLLGRRPVEKLAPA-----------QCQSIVTWAMPQLTDRSKLPNIV 382
D++A G ++ E+L G E L P +C + ++ ++ L +
Sbjct: 182 VDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 383 D-PVIKSTMDLKHLY-----QVAAVAVLCVQPEPSYRPLITDVLHS 422
P +K L+ + V +A C++ +P RP + +LH
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 37/278 (13%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE------NEVDLLSNIHHPNVV 210
LG G F Y+A+ + +AVK++ + + E E+ L++ ++HP+++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHE 268
+LG + D + E M S+ L G + + + RGL YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121
Query: 269 HCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQ----NKNNLKLSGTLGYVAPE 323
+ +IHRD+K +N+L+DS +++DFG A ++ + +L GT+ ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
L + DV++ G V++E+ + P W + ++ L +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP--------------WNAEKHSNHLALIFKIA 224
Query: 384 PVIKSTMDLKHLYQ-VAAVAVLCVQPEPSYRPLITDVL 420
+ +HL + V + C++ +P RP ++L
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 76/257 (29%), Positives = 116/257 (45%), Gaps = 47/257 (18%)
Query: 159 LGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFE---NEVDLLSNIHHPNVVCLLG 214
LG G FG V + + + A+K L A ++ E NE +L +I HP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM-KIALDTAR--------GLEY 265
S DD+ +Y +ME + G G + + + AR LEY
Sbjct: 69 -SFQDDSN--LYLVME----YVP--G---GELFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPE 323
LH + +++RDLK N+LLDS K++DFG A + + L GT Y+APE
Sbjct: 117 LH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLAPE 168
Query: 324 YLLDGKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSKLPNI 381
+L K K+ D +A G+++ E+L G P P Q + I L + + P+
Sbjct: 169 IIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKVRFPSF 220
Query: 382 VDPVIKSTMDLKHLYQV 398
P K +++L QV
Sbjct: 221 FSPDAKDL--IRNLLQV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 32/231 (13%)
Query: 159 LGEGGFGCVYKAKLDDNLH---------------VAVKKLDC-ATQDAGREFENEVDLLS 202
LGEG FG V+ + + VAVK L T+ A +F E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMEN---------RSLDIQLHGPSHGSALTWHMRM 253
+ +PN++ LLG DD ++ E MEN R ++ ++ +++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+A+ A G++YL + +HRDL + N L+ + + K++DFG++ S + ++
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 314 SGTLG--YVAPEYLLDGKLTDKSDVYAFGVVLLEL--LLGRRPVEKLAPAQ 360
L ++A E +L GK T SDV+AFGV L E+ L +P L+ Q
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKK--LDCATQDAGREFENEVDLLSNIHHPN 208
+F + +GEG +G VYKA+ VA+KK LD T+ E+ LL ++HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 209 VVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
+V LL ++ ++V+E + + +D S S + + +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-----SPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H H V+HRDLK N+L++++ KL+DFGLA G + TL Y APE L
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 326 LDGKL-TDKSDVYAFGVVLLELLLGR 350
L K + D+++ G + E++ R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 74/228 (32%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI 204
L T F ++GEG +G VYKA+ VA+K +D +D E + E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKY 59
Query: 205 -HHPNVVCLLG------YSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIA 256
+HPN+ G +DD ++V EL S+ D+ G L I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSG 315
+T RGL YLHE+ VIHRD+K NILL KL DFG+ A D + + N + G
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-G 175
Query: 316 TLGYVAPE-----YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
T ++APE D +SDV++ G+ +EL G+ P+ + P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 158 ILGEGGFGCVYKA--KLDDN--LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG+G FG V +A K +D VAVK K D + EF E + HPNV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 212 LLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGS---ALTWHMRMKIALDTARG 262
L+G S + ++ M++ L L G L ++ +D A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+EYL + IHRDL + N +L+ ++DFGL+ I G + + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
A E L D T SDV+AFGV + E++ G+ P + ++ + + +R K P
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-----NRLKQP 237
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
L V + C PEP RP + L
Sbjct: 238 ------------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 73/232 (31%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 158 ILGEGGFGCVYKA------KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNV 209
LGEG FG V KA ++ VAVK L D AT+ + +E++++ I H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 210 VCLLGYSAHDDTRFIVYEL----------------MENRSLDIQLHGPSHGSALTWHMRM 253
+ LLG + ++V E E S D LT +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR---PPEETLTQKDLV 135
Query: 254 KIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
A ARG+E+L + C IHRDL + N+L+ K++DFGLA +
Sbjct: 136 SFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 313 LSGTLGY--VAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP-----VEKL 356
+G L +APE L D T +SDV++FGV+L E+ LG P VE+L
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFEN-----EVDLLSNI 204
+ +G G G VYK + HV AVK++ + G + EN ++D++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM----RRTGNKEENKRILMDLDVVLKS 70
Query: 205 HH-PNVVCLLGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
H P +V GY D FI ELM L ++ GP + + K+ + +
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-----IPEDILGKMTVAIVK 125
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
L YL E VIHRD+K SNILLD+ N KL DFG++ + D +K + +G Y
Sbjct: 126 ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAY 180
Query: 320 VAPEYLLDGKLTDK----SDVYAFGVVLLELLLGRRP 352
+APE + K +DV++ G+ L+EL G+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G G FG V+ + VA+K + + +F E ++ + HP +V L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+V+E ME+ L L + + + + LD G+ YL VIHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 279 LKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
L + N L+ K+SDFG+ + D + K + + +PE K + KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSKYSSKSD 183
Query: 336 VYAFGVVLLELLL-GRRPVE 354
V++FGV++ E+ G+ P E
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 83/243 (34%), Positives = 116/243 (47%), Gaps = 21/243 (8%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFE-NE---VDLLSNIHHPNVV 210
I+G GGFG VY K D A+K LD G NE + L+S P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 211 CLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
C+ Y+ H D + +LM D+ H HG MR A + GLE++H
Sbjct: 61 CMT-YAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH-- 114
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
N V++RDLK +NILLD + ++SD GLA D S+ K + + GT GY+APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASV-GTHGYMAPEVLQKGT 171
Query: 330 LTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
D S D ++ G +L +LL G P + I LT +LP+ P +KS
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKS 228
Query: 389 TMD 391
++
Sbjct: 229 LLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGR-EFENEVDLLS--NIHHPNV 209
LG+G FG VY+ K + VA+K ++ A R EF NE ++ N HH V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--V 71
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + ++ ELM RSL ++ + + +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+ YL+ + +HRDL + N ++ F K+ DFG+ I + + K + ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLEL-LLGRRPVEKLAPAQ 360
+PE L DG T SDV++FGVVL E+ L +P + ++ Q
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 72/242 (29%), Positives = 106/242 (43%), Gaps = 58/242 (23%)
Query: 149 ATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAG------REFENEVDLL 201
+ LGEG FG VYKA ++ VA+KK+ + G RE + +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKIL 61
Query: 202 SNIHHPNVVCLLG--YSAHDDTRF---IVYE-----------LMENRSLDIQLHGPSHGS 245
+ HPNVV L+ D ++ VY L+EN S+ + S
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT---ESQIK 118
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDG 304
M L+ G+ YLHE+ ++HRD+K++NIL+D++ K++DFGLA DG
Sbjct: 119 CY-----MLQLLE---GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 305 SQNKNNLKLSGTLG------------YVAPEYLL-DGKLTDKSDVYAFGVVLLELLLGRR 351
N K G G Y PE LL + + T D++ G V E+ RR
Sbjct: 168 --PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RR 224
Query: 352 PV 353
P+
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 46/282 (16%)
Query: 157 NILGEGGFGCVYKA-KLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
ILG G G VYKA L +AVK LD T + ++ +E+++L P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G ++ I E M+ SLD+ P H + +IA+ +GL YL +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEH-------VLGRIAVAVVKGLTYL---WSLK 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPEYLLDGKLT 331
++HRD+K SN+L++++ KL DFG++ +Q N++ + GT Y+APE + +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 332 DKSDVYAFGVVLLELLLGRRPVEKLAPAQC--------QSIVTWAMPQLTDRSKLPNIVD 383
SDV++ G+ +EL LGR P ++ Q Q IV P L V
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
+ + C++ +P RP +++ H I
Sbjct: 232 FITQ-----------------CMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G VYK + VA+KK+ +++ G E+ LL + HPN+VCL
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH-MRMKIAL-DTARGLEYLHEHCNPA 273
+ ++++E + S+D++ + S +K L +G+ + H
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTD 332
V+HRDLK N+L+D+K KL+DFGLA G + TL Y APE LL + +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 333 KSDVYAFGVVLLELLLGRRPV 353
D+++ G + E+ ++P+
Sbjct: 182 PVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 84/249 (33%), Positives = 118/249 (47%), Gaps = 23/249 (9%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFE-NE---VDLLSNIHHPNVV 210
I+G GGFG VY K D A+K LD G NE + L+S P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 211 CL-LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
C+ + D FI+ +LM D+ H HG MR A + GLE++H
Sbjct: 61 CMSYAFHTPDKLSFIL-DLMNGG--DLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMH-- 114
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
N V++RDLK +NILLD + ++SD GLA D S+ K + + GT GY+APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASV-GTHGYMAPEVLQKGV 171
Query: 330 LTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
D S D ++ G +L +LL G P + I + T +LP+ P ++S
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMAVELPDSFSPELRS 228
Query: 389 TMDLKHLYQ 397
L+ L Q
Sbjct: 229 L--LEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-18
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 9/218 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ +++ VAVK L T + F E +L+ + H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
++ +I+ E M SL + G + + + A G+ Y+ IHRD
Sbjct: 73 EEPIYIITEYMAKGSL-LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
L+++N+L+ K++DFGLA + + ++ + + APE + G T KSDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 338 AFGVVLLELL-LGRRPVEKLAPAQCQSIVT--WAMPQL 372
+FG++L E++ G+ P ++ + S + + MP++
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 69/238 (28%), Positives = 107/238 (44%), Gaps = 19/238 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ K L VAVKK+D Q NEV ++ + H NVV +
Sbjct: 28 IGEGSTGIVCIATVKSSGKL-VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D ++V E +E +L DI H + + + L + L LH VI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
HRD+KS +ILL KLSDFG + L GT ++APE + + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 336 VYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI--VDPVIKSTMD 391
+++ G++++E++ G P P + ++ +P KL N+ V P +K +D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PKLKNLHKVSPSLKGFLD 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEV 198
YK+L + +GEG G V+KAK + VA+KK+ + G + E+
Sbjct: 1 RYKILGR----------IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI 50
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-----WHMRM 253
L HP VV LL H +V E M L L L +MRM
Sbjct: 51 KALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRM 107
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLK 312
+ +G+ Y+H + ++HRDLK +N+L+ + K++DFGLA + + +
Sbjct: 108 LL-----KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
Query: 313 LSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
T Y APE L + D D++A G + ELL G
Sbjct: 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 9e-18
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 39/272 (14%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHH---P 207
+ ++G G +G VY+ K + VA+K ++ T D + + EV LLS + P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-GPSHGSALTWHMRMKIALDTARGLEYL 266
N+ G +I+ E E S+ + GP ++ +R + L+Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYI 117
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTLGYVAPE 323
H+ VIHRD+K++NIL+ + N KL DFG+A N+N+ K S GT ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSKRSTFVGTPYWMAPE 171
Query: 324 YLLDGKLTD-KSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNI 381
+ +GK D K+D+++ G+ + E+ G P + + I P+L D +
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
Query: 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR 413
+ V C+ EP R
Sbjct: 232 REFV-----------------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G V K + VA+KK + +D + EV +L + H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
++V+E +E L++ P L + + Y H H +I
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NII 122
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL-KLSGTLGYVAPEYLLDGKLTDKS 334
HRD+K NIL+ KL DFG A ++ + L T Y APE L+ K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 335 -DVYAFGVVLLELLLGR 350
DV+A G ++ ELL G
Sbjct: 183 VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 31/287 (10%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD 199
+EY E D E +LG+G +G VY A+ L + +A+K++ + E+
Sbjct: 1 LEY---EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIA 57
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH---GPSHGSALTWHMRMKIA 256
L S + H N+V LG + + I E + SL L GP + T K
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLKLSG 315
L+ GL+YLH++ ++HRD+K N+L+++ K+SDFG + N +G
Sbjct: 118 LE---GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG 171
Query: 316 TLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373
TL Y+APE + G +D+++ G ++E+ G+ P +L Q AM ++
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA------AMFKVG 225
Query: 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
P I + + + + C +P+P R D+L
Sbjct: 226 MFKIHPEIPESLSA---------EAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH-----VAVKKL-DCATQDAGREFENEVDLLSNI 204
D S++L EG FG ++ L D V VK + D A++ E LL +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 205 HHPNVVCLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGS-----ALTWHMRMKIALD 258
H N++ +L D + F++Y M +L + L G AL+ + +A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----------ITDGSQNK 308
A G+ YLH+ VIH+D+ + N ++D + K++D L+ + D N+
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD---NE 179
Query: 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAP 358
N + ++A E L++ + + SDV++FGV+L EL+ LG+ P ++ P
Sbjct: 180 NR-----PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 50/227 (22%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH-VAVKKLDCATQDAGREFEN----- 196
YK++++ LG+G FG VY A+ + VA+KK+ ++F +
Sbjct: 1 YKVIKQ----------LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECM 43
Query: 197 ---EVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR 252
EV L + HPN+V L +D + V+E ME +L QL G + +
Sbjct: 44 NLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NL-YQLMKDRKGKPFSESVI 101
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--------ITDG 304
I +GL ++H+H HRDLK N+L+ K++DFGLA TD
Sbjct: 102 RSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD- 157
Query: 305 SQNKNNLKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELLLGR 350
T Y APE LL + D++A G ++ EL R
Sbjct: 158 --------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG+G FG V+ + VA+K L T + F E ++ + H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +IV E M SL L G G L + +A A G+ Y+ E N +HRD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
L+++NIL+ K++DFGLA + + ++ + + APE L G+ T KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 338 AFGVVLLELLL-GRRP 352
+FG++L EL GR P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLLGYS 216
LG G G V K K + +A K + + + R + E+ ++ P +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPA 273
+++ + E M+ SLD + GP + + KIA+ GL YL+ H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVH---R 124
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA------ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
++HRD+K SNIL++S+ KL DFG++ I D GT Y++PE +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--------TFVGTSTYMSPERIQG 176
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRP 352
GK T KSDV++ G+ ++EL LG+ P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG+G FG VYKAK + A K ++ +++ ++ E+++L+ +HP +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
D +I+ E ++D + G LT I L+YLH + +IHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 278 DLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD----- 332
DLK+ N+LL + KL+DFG++ + + GT ++APE ++ + D
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 333 KSDVYAFGVVLLELLLGRRPVEKLAP 358
K+D+++ G+ L+E+ P +L P
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNV 209
F + +G+G FG V+K +D+ VA+K +D +D + + E+ +LS P V
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 210 VCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
G +I+ E + S LD+ GP + ++ + +GL+YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHS 119
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K++N+LL + + KL+DFG+A +TD +N GT ++APE +
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
K+D+++ G+ +EL G P + P + V + +P ++ P +
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIP----KNNPPTLTGEFS 226
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
K + C+ +PS+RP ++L H I
Sbjct: 227 KPFKEFID---------ACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLH--VAVKKLDCA-TQDAGREFENEVDLLSNIHHPNV 209
F + +G+G FG VYK +D+ VA+K +D +D + + E+ +LS P +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 210 VCLLGYSAHDDTRFIVYELMENRS-LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
G +I+ E + S LD+ GP + + +R + +GL+YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS 119
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLL 326
IHRD+K++N+LL + + KL+DFG+A +TD +N GT ++APE +
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
K+D+++ G+ +EL G P L P + ++ P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---------------- 218
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
T++ ++ C+ +P +RP ++L H I
Sbjct: 219 -PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 158 ILGEGGFGCVYKA----KLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG VY+ ++ + VAVK +C + +F E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +IV EL L L + +L + + + L YL +
Sbjct: 73 IGVIT-ENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQNKNNL-KLSGTLGYVAPEYLLDGK 329
+HRD+ + N+L+ S KL DFGL + D S K + KL + ++APE + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPESINFRR 184
Query: 330 LTDKSDVYAFGVVLLELL-LGRRP 352
T SDV+ FGV + E+L LG +P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 55/291 (18%)
Query: 159 LGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGR-EFENEVDLLS--NIHHPNV 209
LG+G FG VY+ K + VAVK ++ + R EF NE ++ HH V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + +V ELM + RSL + T +++A + A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+ YL+ +HRDL + N ++ F K+ DFG+ I + + K + ++
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLEL-LLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
APE L DG T SD+++FGVVL E+ L +P + L+ Q
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 229
Query: 380 NIVDPVIKSTMDLKHLYQ-------VAAVAVLCVQPEPSYRPLITDVLHSL 423
V+K MD +L Q V + +C Q P RP ++++ L
Sbjct: 230 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHP 207
D + + +GEG +G VYKA+ N +A+KK+ +D G E+ LL + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYL 266
N+V L + ++V+E ++ LD++ H S +K L RG+ Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H H V+HRDLK N+L+D + NA KL+DFGLA G + TL Y APE L
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 326 LDGK-LTDKSDVYAFGVVLLELLLGRRPV 353
L + + D+++ G + E ++ ++P+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAE-MVNQKPL 203
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 48/288 (16%)
Query: 159 LGEGGFGCVYKAKLDDN--LHVAVKKLDC-------ATQDAGREFENEVDLLSNI----H 205
LG G FGCVYK + +N +A+K+++ ++ + + V ++ I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSL-----DIQLHGPSHGSALTWHMRMKIALDTA 260
HPN+V +D +IV +L+E L ++ W++ +++ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTL 317
L YLH+ ++HRDL +NI+L ++DFGLA Q + KL+ GT+
Sbjct: 125 -ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA----KQKQPESKLTSVVGTI 177
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
Y PE + + +K+DV+AFG +L ++ P ++++ A
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM------CTLQPPFYSTNMLSLAT-------- 223
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425
IV+ V + + + V V C+ P+ RP I V ++I
Sbjct: 224 --KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV-SAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
+G G FG VY A+ + N VA+KK+ + + + ++++ EV L + HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ T ++V E + DI H L I +GL YLH H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL---DGKLT 331
IHRD+K+ NILL KL+DFG A N GT ++APE +L +G+
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPYWMAPEVILAMDEGQYD 192
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
K DV++ G+ +E L R+P
Sbjct: 193 GKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 41/215 (19%)
Query: 159 LGEGGFGCVYKAKLDDN---LHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLL 213
LGEG FG V + +L+ + L VAVK + A T+ +F +E + HPNV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 214 G-------------------YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
G + H D F++Y +R D + P+ M +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY----SRLGDCPQYLPTQ-------MLV 115
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNL 311
K D A G+EYL + + IHRDL + N +L+ N ++DFGL+ I +G +
Sbjct: 116 KFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLEL 346
+ ++A E L D T KSDV++FGV + E+
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPNVVC 211
LGE FG VYK L + VA+K L + RE F++E + S + HPN+VC
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 212 LLG-------------YSAHDDTRFIVYELMENRSLDIQLHGPSHG----SALTWHMRMK 254
LLG Y +H D ++E + RS + S L +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSD----LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
I A G+E+L H V+H+DL + N+L+ K N K+SD GL + + L +
Sbjct: 129 IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 315 GTLG--YVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
L +++PE ++ GK + SD++++GVVL E+
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-17
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 178 VAVKKL-DCATQDAGR--EFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVYELMENRS 233
VA+K L A ++ + F E L + ++HPN+V LL A F V+E + R+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKF 290
L L A M LD L H N ++HRDLK NI++ +
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLD---ALACAH---NQGIVHRDLKPQNIMVSQTGVRP 119
Query: 291 NAKLSDFGL-AITDGSQNKNNLKLS------GTLGYVAPEYLLDGKLTDKSDVYAFGVVL 343
+AK+ DFG+ + G ++ + L+ GT Y APE L +T SD+YA+G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 344 LELLLGRRPVEKLAPAQ 360
LE L G+R V+ + A+
Sbjct: 180 LECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 8/204 (3%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG G FG V+ A + + VAVK + + F E +++ + H +V L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +I+ E M SL + GS + + A G+ ++ + IHRD
Sbjct: 73 EPI-YIITEFMAKGSL-LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
L+++NIL+ + K++DFGLA + + ++ + + APE + G T KSDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 338 AFGVVLLELL-LGRRPVEKLAPAQ 360
+FG++L+E++ GR P ++ +
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 40/274 (14%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
++G G FG V+ + D V +K++ T+D +NE +L + HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 215 YSAHDDTRFIVYELMENRSLD--IQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEH 269
D IV E +L IQ S + L + +++ +AL H H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVH 118
Query: 270 CNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
++HRDLK+ NILLD K+ DFG++ S++K + GT Y++PE L +G
Sbjct: 119 -TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY-TVVGTPCYISPE-LCEG 175
Query: 329 K-LTDKSDVYAFGVVLLELLLGRRPVEKL-APAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
K KSD++A G VL EL +R E PA I++ ++DR P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR------YSP-- 227
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
DL+ L + + +PS RP ++ ++
Sbjct: 228 ----DLRQL------ILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 77/257 (29%), Positives = 121/257 (47%), Gaps = 31/257 (12%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLD---DNL--HVAVKKLDCAT-QDAGREFE 195
E + L++ D LGEG FG V + D DN VAVK L + + + +
Sbjct: 2 EKRFLKRIRD-------LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK 54
Query: 196 NEVDLLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSLDIQLHGPSHGSALTWHMRM 253
E+++L N++H N+V G D I + E + + SL L P + + + ++
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQL 112
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL--AI-TDGSQNKNN 310
K A+ +G++YL +HRDL + N+L++S+ K+ DFGL AI TD
Sbjct: 113 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL----GRRP----VEKLAPAQCQ 362
L + + APE L+ K SDV++FGV L ELL P ++ + P Q
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229
Query: 363 SIVTWAMPQLTDRSKLP 379
VT + L + +LP
Sbjct: 230 MTVTRLVRVLEEGKRLP 246
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 17/267 (6%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+K+++ Q NE+ ++ HPN+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + LE+LH + VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDV 336
RD+KS NILL + KL+DFG + + GT ++APE + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 337 YAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHL 395
++ G++ +E++ G P P + I T P+L + KL I + +++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 258
Query: 396 YQVAAVAVL------CVQPEPSYRPLI 416
+ +A +L +P S PLI
Sbjct: 259 KRGSAKELLQHPFLKIAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPN 208
HE +G G FG VY A N VAVKK+ + + ++++ EV L + HPN
Sbjct: 26 LHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+ G + T ++V E + D+ H L I +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-- 326
H +IHRD+K+ NILL KL+DFG A N GT ++APE +L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----SFVGTPYWMAPEVILAM 192
Query: 327 -DGKLTDKSDVYAFGVVLLELLLGRRP 352
+G+ K DV++ G+ +E L R+P
Sbjct: 193 DEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
LG+G FG V+ + VA+K L T F E ++ + H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+ +IV E M SL + G L + +A A G+ Y+ E N IHRD
Sbjct: 73 EPI-YIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN--YIHRD 127
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVY 337
L+++NIL+ K++DFGLA + + ++ + + APE L G+ T KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 338 AFGVVLLELLL-GRRP 352
+FG++L EL+ GR P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 16/272 (5%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+++++ Q NE+ ++ +PN+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + LE+LH + VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDV 336
RD+KS NILL + KL+DFG + + GT ++APE + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 337 YAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAMPQLTDRSKLPNIVDPVIKSTMDLKHL 395
++ G++ +E++ G P P + ++ T P+L + KL I + +D+
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 396 YQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427
+ +A +L Q +P L SL PL+
Sbjct: 260 KRGSAKELLQHQFLKIAKP-----LSSLTPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 43/217 (19%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---------EVDLLSNIHH 206
+ +GEG +G V A + VA+KK+ FE+ E+ +L H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKIS--------PFEHQTFCQRTLREIKILRRFKH 62
Query: 207 PNVVCLL------GYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIAL 257
N++ +L + + +D +IV ELME + + Q H +
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS--- 314
RGL+Y+H N V+HRDLK SN+LL++ + K+ DFGLA ++ + L+
Sbjct: 115 -ILRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 315 GTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
T Y APE +L+ K K+ D+++ G +L E+L R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCL-- 212
+G G +G V AK + N VA+KK+ A DA R E+ LL ++ H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 213 ----LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS-ALTWHMRMKIALDTARGLEYLH 267
A +D +IVYELM D LH S L+ RGL+Y+H
Sbjct: 72 IMPPPHREAFNDV-YIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+ V+HRDLK SN+LL++ + K+ DFGLA T + + T Y APE LL+
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 328 -GKLTDKSDVYAFGVVLLELLLGRRPV 353
+ T DV++ G + E LLGR+P+
Sbjct: 183 CSEYTTAIDVWSVGCIFAE-LLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG-REFENEVDLLSNIHHPNVVCLLGYS 216
LG+G +G VYK + +A+K++ ++ + E+D+L P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+ ++ E M+ SLD G + + +I +GL++L E N +IH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAIT-DGSQNKNNLKLSGTLGYVAPEYLLDGKLTD--- 332
RD+K +N+L++ KL DFG++ S K N+ G Y+APE + G
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGPNQNPT 183
Query: 333 ---KSDVYAFGVVLLELLLGRRPV--EKLAP--AQCQSIVTWAMPQLTD 374
+SDV++ G+ +LE+ LGR P E A AQ +IV P L
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 28/231 (12%)
Query: 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCAT-QDAGREFENEVD-LLSNIHHPNVVCLLGY 215
+G G FG V K +AVK++ + + ++D ++ + P +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 216 SAHDDTRFIVYELMENRSLD-----IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
+ +I ELM+ SLD + S + + KIA+ T + L YL E
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSV---IPEEILGKIAVATVKALNYLKEEL 127
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+IHRD+K SNILLD N KL DFG++ + ++ ++ +G Y+APE +D
Sbjct: 128 K--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMAPER-ID 180
Query: 328 GKLTD----KSDVYAFGVVLLELLLGRRPVEKLAPA--QCQSIVTWAMPQL 372
D +SDV++ G+ L E+ G+ P K Q +V P L
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 78/256 (30%), Positives = 118/256 (46%), Gaps = 30/256 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV------AVKKLDCA--TQDAGREFENEVDL-L 201
D LG G +G V K + HV AVK++ +Q+ R ++D+ +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMR-----HVPTGTIMAVKRIRATVNSQEQKRLL-MDLDISM 54
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTA 260
++ P V G + +I E+M+ SLD G + + KIA+
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
+ LEYLH + VIHRD+K SN+L++ KL DFG++ + D S K +G
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKT--IDAGCKP 168
Query: 319 YVAPEYL---LDGKLTD-KSDVYAFGVVLLELLLGRRPVE--KLAPAQCQSIVTWAMPQL 372
Y+APE + L+ K D KSDV++ G+ ++EL GR P + K Q + +V PQL
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL 228
Query: 373 TDRSKLPNIVDPVIKS 388
P D V K
Sbjct: 229 PAEKFSPEFQDFVNKC 244
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 158 ILGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNI-HHPNV 209
LG G FG V +A K D + VAVK L + RE +E+ ++S++ +H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HE 268
V LLG ++ E L L + + + A+G+ +L +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLASK 160
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPEY 324
+C IHRDL + N+LL K+ DFGLA I + S K N +L + ++APE
Sbjct: 161 NC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPES 214
Query: 325 LLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ + T +SDV+++G++L E+ LG P
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 39/216 (18%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVKKLDCATQDAGREF---ENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L D+ V V K D QD E E V L+ HP +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L D F V E + +G L +H++ D R
Sbjct: 61 LHSCFQTKDRLFFVMEYV-------------NGGDLMFHIQRSGRFDEPRARFYAAEIVL 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLG 318
GL++LHE +I+RDLK N+LLDS+ + K++DFG+ I G GT
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST---FCGTPD 161
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
Y+APE L D +A GV+L E+L G+ P E
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + V+K +KL +NL VA+K++ ++ A EV LL ++ H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + +V+E ++ D++ + G+ ++ H RGL Y H V+
Sbjct: 73 VHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-DGKLTDKS 334
HRDLK N+L++ + KL+DFGLA K TL Y P+ LL + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 335 DVYAFGVVLLELLLGR 350
D++ G + E+ GR
Sbjct: 187 DMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
+G G FG VY A+ + ++ VA+KK+ + + + ++++ EV L + HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ T ++V E + D+ H L + +GL YLH H +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL---DGKLT 331
IHRD+K+ NILL KL DFG A N GT ++APE +L +G+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----XFVGTPYWMAPEVILAMDEGQYD 192
Query: 332 DKSDVYAFGVVLLELLLGRRPV 353
K DV++ G+ +EL + P+
Sbjct: 193 GKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 152 SFHESNILGEGGFG-----------------CVYKAKLDDNLHVAVKKLDC-ATQDAGRE 193
+F E LGEG FG + + VAVK L A ++A +
Sbjct: 8 TFKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 194 FENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL--HGP------SHGS 245
F E+ ++S + PN++ LL D ++ E MEN L+ L H P +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITD 303
+++ + +A A G++YL + +HRDL + N L+ + K++DFG++ +
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
G + + + +++ E +L GK T SDV+AFGV L E+L
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPN 208
F + +G G FG VY A+ + N VA+KK+ + + + ++++ EV L I HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+ G + T ++V E + D+ H L I +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-- 326
H +IHRD+K+ NILL KL+DFG A N GT ++APE +L
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPYWMAPEVILAM 196
Query: 327 -DGKLTDKSDVYAFGVVLLELLLGRRPV 353
+G+ K DV++ G+ +EL + P+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 9e-16
Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 19/268 (7%)
Query: 159 LGEGGFGCVYKAKLDDNL--HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G G V+ A D VA+K+++ Q NE+ ++ + +PN+V L
Sbjct: 27 IGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D F+V E + SL D+ + + + + + LE+LH + VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
HRD+KS N+LL + KL+DFG + + GT ++APE + K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 336 VYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394
+++ G++ +E++ G P P + ++ T P+L + KL I + +++
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV 257
Query: 395 LYQVAAVAVL------CVQPEPSYRPLI 416
+ +A +L +P S PLI
Sbjct: 258 EKRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F + +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGESMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLE 264
VV L D +V LM D++ H G A R A + GLE
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGG--DLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
LH+ +++RDLK NILLD + ++SD GLA + +G K + GT+GY+AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 170
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
E + + + T D +A G +L E++ G+ P ++
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 162 GGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFEN----EVDLLSNIHHPNVVCLLGYS 216
G FG VY A K + A+K L + A + N ++ P V L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 217 AHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
D ++V E + I+ G L + + G+E LH+ +
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDLHQR---GI 118
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
IHRD+K N+L+D + KL+DFGL+ +G +NK K GT Y+APE +L S
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS-RNGLENK---KFVGTPDYLAPETILGVGDDKMS 174
Query: 335 DVYAFGVVLLELLLGRRPVEKLAPAQ 360
D ++ G V+ E L G P P
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG VY D +AVK++ D + + +E E E+ LL N+ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 212 LLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
G + T I E M S+ QL S+G ALT ++ K G+ YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYG-ALTENVTRKYTRQILEGVSYLHSN 125
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEYLL 326
++HRD+K +NIL DS N KL DFG + T ++GT +++PE +
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRP 352
K+D+++ G ++E+L + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCAT---QDAGREFEN 196
YK +E +G G +G V A +D VA+KK+ A A R
Sbjct: 6 RYKPIEN----------IGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLR- 53
Query: 197 EVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSA--LTWH 250
E+ +L + H N++ + A ++V +LME+ LH H H
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-----DLHHIIHSDQPLTEEH 108
Query: 251 MR--MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQN 307
+R + L RGL+Y+H VIHRDLK SN+L++ ++ DFG+A S
Sbjct: 109 IRYFLYQLL---RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 308 KNNLKLS---GTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPV 353
++ ++ T Y APE LL + T D+++ G + E +LGRR +
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCLLGY 215
+GEG +G V+KAK + + VA+K++ D G E+ LL + H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D +V+E + D++ + S + + +GL + H H V+
Sbjct: 68 LHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS- 334
HRDLK N+L++ KL+DFGLA G + TL Y P+ L KL S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 181
Query: 335 DVYAFGVVLLELLLGRRPV 353
D+++ G + EL RP+
Sbjct: 182 DMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 18/231 (7%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDL 200
I+ L F ++G G +G VYK + +A K+ T+D E + E+++
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 201 LSNI-HHPNVVCLLGY------SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
L HH N+ G HDD ++V E S+ L + G+AL
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIA 124
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLK 312
I + RGL +LH H VIHRD+K N+LL KL DFG+ A D + + N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-T 180
Query: 313 LSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
GT ++APE + D +SD+++ G+ +E+ G P+ + P
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 40/215 (18%)
Query: 159 LGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G FG VY+ + D + A+K L + +E + ++ I N+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNI---LVRTL 51
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSH---------GSALTWHMRM--KIALDTAR----- 261
D++ FIV L S G L WH++ + + D A+
Sbjct: 52 LDESPFIV-------GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAE 104
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
LE+LH++ +++RDLK NILLD+ + L DFGL+ + + NK GT
Sbjct: 105 LVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTE 161
Query: 319 YVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRP 352
Y+APE LLD K T D ++ GV++ E+ G P
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + V+K +KL +NL VA+K++ ++ A EV LL N+ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +V+E +++ D++ + + G+ ++ H RGL Y H+ ++
Sbjct: 72 IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKS 334
HRDLK N+L++ K KL+DFGLA K TL Y P+ LL + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 335 DVYAFGVVLLELLLGR 350
D++ G +L E+ GR
Sbjct: 186 DMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 21/233 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF---ENEVDLLSNIHHPNVVCLLGY 215
+G G +G VYKA+ + +A K+ + G +F + E+ ++ + H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKV--IKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 216 SAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D +I E SL H GP S + + R +T +GL YLH +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH---SKG 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL---DGKL 330
+HRD+K +NILL + KL+DFG++ + GT ++APE G
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 331 TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT---WAMPQLTDRSKLPN 380
D++A G+ +EL + P+ L P + ++T + P+L D+ K N
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 159 LGEGGFGCVYKAKLDDNLH-VAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
+G+GG+G V+ AK D VA+K++ + + R E D+L+ +V LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 215 YSAHDDTRFIVYELMEN------RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
Y+ DD +Y ME R+L L S A + M A+D L Y
Sbjct: 68 YAFQDDEY--LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY--- 122
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
IHRDLK N L+D+ + KL+DFGL+ G N + G+ Y+APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYAN-SVVGSPDYMAPEVLRGK 173
Query: 329 KLTDKSDVYAFGVVLLELLLGRRP 352
D ++ G +L E L G P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVC 211
F ++G G +G VYK + +A K+ T D E + E+++L HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 212 LLGY------SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
G DD ++V E S+ L + G+ L I + RGL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSGTLGYVAPEY 324
LH+H VIHRD+K N+LL KL DFG+ A D + + N GT ++APE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEV 182
Query: 325 LL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360
+ D KSD+++ G+ +E+ G P+ + P +
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/232 (29%), Positives = 119/232 (51%), Gaps = 24/232 (10%)
Query: 158 ILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK + VA+K L+ T A EF +E +++++ HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG + +V +LM + L +H H + + + + A+G+ YL E
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEER-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGT-LGYVAPEYLLDGK 329
++HRDL + N+L+ S + K++DFGLA + +G + + N + ++A E + K
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDR-SKLP 379
T +SDV+++GV + EL+ G +P + I T +P L ++ +LP
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIPDLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 38/274 (13%)
Query: 153 FHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCATQ-DAGREFENEVDLLSNIHH 206
F + +LG G FG VYK + VA+K+L AT A +E +E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSA--LTWHMRMKIALDTARGL 263
P+V LLG + I + LD ++ H + GS L W +++ A+G+
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 122
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT--LGYVA 321
YL E ++HRDL + N+L+ + + K++DFGLA G+ K G + ++A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380
E +L T +SDV+++GV + EL+ G +P + + ++ SI L +LP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLPQ 232
Query: 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
P I T+D V + V C + RP
Sbjct: 233 ---PPI-CTID------VYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 72/232 (31%), Positives = 113/232 (48%), Gaps = 23/232 (9%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVV- 210
+LG G FG VY D +AVK++ D +Q+ +E E E+ LL N+ H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 211 ---CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
CL + F+ E M S+ QL ++G ALT ++ + +G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFV--EYMPGGSIKDQLK--AYG-ALTENVTRRYTRQILQGVSYLH 123
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK-LSGTLGYVAPEY 324
+ ++HRD+K +NIL DS N KL DFG + I + +K ++GT +++PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGRRP-VEKLAPAQCQSIVTWAM-PQLTD 374
+ K+DV++ ++E+L + P E A A I T P L D
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 28/269 (10%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VY+A L D + VA+KK+ D A + E+DLL ++HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D+ IV EL + L + H + K + LE++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
V+HRD+K +N+ + + KL D GL S+ L GT Y++PE + + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 334 SDVYAFGVVLLELLLGRRPV--EKL-APAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390
SD+++ G +L E+ + P +K+ + C+ I P L P +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL-----------PSDHYSE 235
Query: 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDV 419
+L+ L +C+ P+P RP IT V
Sbjct: 236 ELRQLVN------MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL-DCATQDAGR-EFENEVDLLSNI 204
E D F + LG G G V K + + + +KL + A R + E+ +L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ P +V G D I E M+ SLD L + + K+++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLA 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
YL E ++HRD+K SNIL++S+ KL DFG++ + D N GT Y++P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSP 171
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPV 353
E L + +SD+++ G+ L+EL +GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 159 LGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V +A+ D + VAVK L D AT + +E++L+ I H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL------------DIQLHGP-SHGSALTWHMRMKI 255
++ LLG + +++ E +L D L++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 256 ALDTARGLEYLH-EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNN 310
A ARG+EYL C IHRDL + N+L+ K++DFGLA D + +N
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+L + ++APE L D T +SDV++FG+++ E+ LG P
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 157 NILGEGGFGCVYKAKLDDNLH------VAVKKLDCATQDAGR-EFENEVDLLSNIHHPNV 209
N +G G G VYK +H A+K + +D R + E+++L +++HPNV
Sbjct: 80 NRIGSGAGGTVYKV-----IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----GLEY 265
V H+ ++ E M+ SL+ + D AR G+ Y
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQF--LADVARQILSGIAY 183
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEY 324
LH ++HRD+K SN+L++S N K++DFG++ I + + N + GT+ Y++PE
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPER 239
Query: 325 ----LLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
L G + D+++ GV +LE LGR P
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 152 SFHESNILGEGGFGCVYKA-KLDDNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIH 205
++ +LG+G FG VY +D +A K++ D + + +E E E+ LL N+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 206 HPNVV----CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
H +V CL + T F+ Y M S+ QL ++G ALT + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEY--MPGGSVKDQLK--AYG-ALTESVTRKYTRQILE 117
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI---TDGSQNKNNLKLSGTLG 318
G+ YLH + ++HRD+K +NIL DS N KL DFG + T ++GT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+++PE + K+DV++ G ++E+L + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVD--- 199
K + + D + + +G G +G V A VA+KKL R F++ +
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKR 60
Query: 200 ------LLSNIHHPNVVCLLGYSAHDDTR------FIVYELME---NRSLDIQLHGPSHG 244
LL ++ H NV+ LL + ++V LM N + Q H
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
L + + RGL+Y+H + +IHRDLK SNI ++ K+ DFGLA
Sbjct: 121 QFLVYQI--------LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA---- 165
Query: 305 SQNKNNLKLSG---TLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGR 350
+ +++G T Y APE +L+ D+++ G ++ ELL G+
Sbjct: 166 --RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGEAMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-----GPSHGSALTWHMRMKIALDTA 260
VV L D +V LM L ++ G A+ + A +
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEIT 112
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
GLE LH +++RDLK NILLD + ++SD GLA I +G + + GT+G
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVG 166
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
Y+APE + + + T D + G ++ E++ G+ P +
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLH-VAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVC 211
+GEG +G V+K + + VA+KK + D A RE + +L + HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L+ +V+E ++ L+ +L G + H+ KI T + + + H+H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKH-- 119
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-DGKL 330
IHRD+K NIL+ + KL DFG A + T Y APE L+ D +
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 331 TDKSDVYAFGVVLLELLLG 349
DV+A G V ELL G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 159 LGEGGFGCVYK--AKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGY 215
LGEG + VYK +KL DNL VA+K++ ++ A EV LL ++ H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ + +V+E ++ D++ + G+++ H RGL Y H V+
Sbjct: 73 IHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS- 334
HRDLK N+L++ + KL+DFGLA K TL Y P+ LL TD S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS--TDYST 184
Query: 335 --DVYAFGVVLLELLLGR 350
D++ G + E+ GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 157 NILGEGGFGCVYKAKLDDNLH--VAVKKLDCATQDAGREFEN--------------EVDL 200
LGEG +G V KA D VA+KK+ + E+ +
Sbjct: 15 AHLGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIAL 257
++ I H N++ L+ D +V ++M + + +D ++ LT I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-------LTESQVKCILL 126
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----------ITDGSQ 306
GL LH +HRDL +NI ++SK K++DFGLA ++
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 307 NKNNLKLSG---TLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGR 350
+ +++ TL Y APE L+ K D+++ G + ELL G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 159 LGEGGFGCVYKAKLDDN--LHVAVKKLDCATQDAGREFEN--EVDLLSNIH---HPNVV- 210
+GEG +G V+KA+ N VA+K++ T + G EV +L ++ HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 211 ----CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
C + + + +V+E ++ P G M L RGL++L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDFL 126
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H H V+HRDLK NIL+ S KL+DFGLA Q + TL Y APE LL
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPV 353
D+++ G + E+ R+P+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPN 208
D F + LG G G V K L +A K + + A R + E+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V G D I E M+ SLD L + ++ KI++ RGL YL E
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLL 326
++HRD+K SNIL++S+ KL DFG++ + D N GT Y++PE L
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQ 171
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPV 353
T +SD+++ G+ L+E+ +GR P+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 158 ILGEGGFGCVYKAKLDD-NLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L N A+K L D +D E E V L+ HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L + F V E + +G L +H++ D AR
Sbjct: 61 LFCTFQTKEHLFFVMEYL-------------NGGDLMFHIQSSGRFDEARARFYAAEIIC 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH+ +I+RDLK N+LLD + K++DFG+ + + GT Y+A
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE L K + D ++FGV+L E+L+G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VY+A L D VA+KK+ + A ++ E+DLL ++HPNV+ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D+ IV EL + L + + + K + +E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
V+HRD+K +N+ + + KL D GL S+ L GT Y++PE + + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 334 SDVYAFGVVLLELLLGRRPV--EKLAP-AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390
SD+++ G +L E+ + P +K+ + CQ I P L P +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-----------PTEHYSE 235
Query: 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
L+ L +C+ P+P RP I V
Sbjct: 236 KLRELVS------MCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 62/224 (27%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 153 FHESNILGEGGFGCVYKAKL---DDNLHVAVKKLDCA-------TQDAGREFENEVDLLS 202
+ +G G +G VYKAK D A+KK +Q A RE + LL
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 203 NIHHPNVVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSA---------LTWHM 251
+ H NVV L+ + +++++ E+ I L W +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQN 307
L+ G+ YLH + V+HRDLK +NIL+ + K+ D GLA +
Sbjct: 118 -----LN---GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 308 KNNLKLSG---TLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELL 347
K L T+ Y APE LL + T D++A G + ELL
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 38/244 (15%)
Query: 142 EYKLLEKATDSFHESNI-----LGEGGFGCVY--------KAKLDDNLHVAVKKL-DCAT 187
EY+L E F + LGEG FG V K K + + VAVK L D AT
Sbjct: 1 EYELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 188 QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS---- 242
+ + +E++++ I H N++ LLG D +++ E +L L
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 243 ---------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+T+ + ARG+EYL + IHRDL + N+L+ K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 177
Query: 294 LSDFGLAI----TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-L 348
++DFGLA D + N +L + ++APE L D T +SDV++FGV++ E+ L
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 349 GRRP 352
G P
Sbjct: 236 GGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 67/212 (31%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 158 ILGEGGFGCVYKAKL--DDNLH-VAVKKLDCATQDAGREFE-NEVDLLSNIH-HPNVVCL 212
+LG+G FG V A+L L+ V V K D QD E E +LS HP + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG---------- 262
D F V E + +G L +H++ D AR
Sbjct: 62 YCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
L +LH+ +I+RDLK N+LLD + + KL+DFG+ K GT Y+AP
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
E L + D +A GV+L E+L G P E
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 81/293 (27%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 159 LGEGGFGCV----YKAKLDDNLH-VAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVC 211
LGEG FG V Y D VAVK L +C Q+ ++ E+++L ++H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT-SGWKKEINILKTLYHENIVK 70
Query: 212 LLGYSAH--DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
G + ++ E + SL L P H L + A G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA--QLLLFAQQICEGMAYLHSQ 126
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDG------SQNKNNLKLSGTLGYVA 321
IHRDL + N+LLD+ K+ DFGLA + +G ++ ++ + + A
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-----PVFWYA 178
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP--------VEKLAPAQCQSIVTWAMPQLT 373
E L + K + SDV++FGV L ELL E + P Q Q V + L
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426
+LP + ++ L + C + E +RP SLIP+
Sbjct: 239 RGMRLPCPKN----CPQEVYILMKN------CWETEAKFRP----TFRSLIPI 277
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 159 LGEGGFGCVYKA--KLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPNVVCLLG 214
LGEG + VYK KL L VA+K++ + G F E LL ++ H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRL-EHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYLHEHCNPA 273
T +V+E ++ D++ + G L+ H +++ L RGL Y H+
Sbjct: 71 IIHTKKTLTLVFEYLDT---DLKQYMDDCGGGLSMH-NVRLFLFQLLRGLAYCHQR---R 123
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
V+HRDLK N+L+ + KL+DFGLA +K TL Y P+ LL T+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS--TEY 181
Query: 334 S---DVYAFGVVLLELLLGR 350
S D++ G + E+ GR
Sbjct: 182 STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL-DCATQDAGR-EFENEVDLLSNI 204
E D F + + LG G G V+K + + +KL + A R + E+ +L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ P +V G D I E M+ SLD L + + K+++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
YL E ++HRD+K SNIL++S+ KL DFG++ + D N GT Y++P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSP 171
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPV 353
E L + +SD+++ G+ L+E+ +GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 17/235 (7%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYK-AKLDDNLHVAVKKLDCATQDAGREFENE 197
S + + L TD++ +G+G +G VYK D AVK LD D E E E
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAE 68
Query: 198 VDLLSNI-HHPNVVCLLGYSAHDD-----TRFIVYELMENRSLDIQLHGP-SHGSALTWH 250
++L ++ +HPNVV G D ++V EL S+ + G G L
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310
M I GL++LH N +IHRD+K +NILL ++ KL DFG++ S
Sbjct: 129 MISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 311 LKLSGTLGYVAPEYL-----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360
GT ++APE + D + DV++ G+ +EL G P+ + P +
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAGR-EFENEVDLLSNIHHPNVVCLL 213
LG G FGCV YK + + VA+K L + + R E E +++ + +P +V ++
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
G + +V E+ L+ L G +T +++ + G++YL
Sbjct: 62 GV-CEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLLDGKL 330
+HRDL + N+LL ++ AK+SDFGL+ G+ + S L + APE + K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 331 TDKSDVYAFGVVLLELL-LGRRPVEKL 356
+ +SDV+++G+ + E G++P +K+
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVD 199
+K LEK LGEG + VYK + VA+K LD A + E+
Sbjct: 2 FKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLD-AEEGTPSTAIREIS 50
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS--ALTWHMRMKIAL 257
L+ + H N+V L ++ +V+E M+ D++ + +HG AL +
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+G+ + HE+ V+HRDLK N+L++ + KL+DFGLA G TL
Sbjct: 108 QLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL 164
Query: 318 GYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
Y AP+ LL + S D+++ G ++ E++ GR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHH 206
T+ + + +G G FG V A+ +VA+KK+ +T + E+ LL ++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 207 PNVVCL--LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
N++ L + S +D F V EL+ LH L RGL+
Sbjct: 69 ENIISLSDIFISPLEDIYF-VTELLGT-----DLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVA 321
Y+H + V+HRDLK SNIL++ + K+ DFGLA Q ++G T Y A
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ------MTGYVSTRYYRA 173
Query: 322 PEYLLD-GKLTDKSDVYAFGVVLLELLLGR 350
PE +L K + D+++ G + E+L G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 159 LGEGGFGCVY--------KAKLDDNLHVAVKKLDC-ATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V K K + VAVK L AT+ + +E++++ I H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQL-----------HGPSHG--SALTWHMRMKI 255
++ LLG D +++ E +L L + P+ L++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNNL 311
A ARG+EYL + IHRDL + N+L+ K++DFGLA D + N
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+L + ++APE L D T +SDV++FGV+L E+ LG P
Sbjct: 203 RLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIH---HPNVVCL 212
+G G +G VYKA+ VA+K + T + G EV LL + HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 213 LGY--SAHDDTRFIVYELMENRSLDIQLH---GPSHGSAL-TWHMRMKIALDTARGLEYL 266
+ ++ D V + E+ D++ + P G T M+ L RGL++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDFL 124
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPE 323
H +C ++HRDLK NIL+ S KL+DFGLA Q + L+ TL Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVVTLWYRAPE 177
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRPV 353
LL D+++ G + E + R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAE-MFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLL 213
LG+GGFG + + L+ A KKL+ + +E E +L+ +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLY-ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y+ T +V +M L ++ GLE+LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
+I+RDLK N+LLD+ N ++SD GLA+ DG Q+K +GT G++APE L +
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTK-GYAGTPGFMAPELLQGEE 173
Query: 330 LTDKSDVYAFGVVLLELLLGRRP 352
D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 17/267 (6%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G+G G VY A + VA+K+++ Q NE+ ++ +PN+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 218 HDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
D ++V E + SL D+ + + + + + L++LH + VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDV 336
RD+KS NILL + KL+DFG + + GT ++APE + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 337 YAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAMPQLTDRSKLPNIVDPVIKSTMDLKHL 395
++ G++ +E++ G P P + ++ T P+L + +L + + +++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 396 YQVAAVAVL------CVQPEPSYRPLI 416
+ +A +L +P S PLI
Sbjct: 259 RRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HP 207
+D++ +G+G +G V+K + AVK LD D E E E ++L + HP
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHP 75
Query: 208 NVVCLLG-YSAHD----DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTAR 261
NVV G Y D D ++V EL S+ + G G + + I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH + IHRD+K +NILL ++ KL DFG++ S GT ++A
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 322 PEYL-----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
PE + LD + DV++ G+ +EL G P+ L P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 159 LGEGGFGCV----YKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPNVVCL 212
LG G FG V YK K + VAVK L D E E +++ + +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +V EL E L+ L H +T ++ + G++YL E
Sbjct: 62 IGI-CEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEET--- 114
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT----LGYVAPEYLLDG 328
+HRDL + N+LL ++ AK+SDFGL+ G+ ++N K + + APE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 329 KLTDKSDVYAFGVVLLELL-LGRRP 352
K + KSDV++FGV++ E G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL+YLHE+ +++RDLK N+LLD++ K++DFGL GT ++A
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE L + T D + GV++ E+L+G P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 63/245 (25%), Positives = 97/245 (39%), Gaps = 59/245 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V+ + D V A+K L D ++ E D+L++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR---- 261
P +V L Y + D + Y +ME + G G + +R + +TAR
Sbjct: 61 PWIVKL--YYSFQDEEHL-YLVME------YMPG---GDLMNLLIRKDVFPEETARFYIA 108
Query: 262 ----GLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-- 314
L+ +H+ IHRD+K NIL+D+ + KL+DFGL L+
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 315 ---------------------------GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
GT Y+APE L + D ++ GV+L E+L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 348 LGRRP 352
G P
Sbjct: 225 YGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 8/193 (4%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL- 213
++G+G +G V + D +KKL+ A++ + E E LLS + HPN+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 214 GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
+ D +IV E L +L G L + ++ + A L+YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
++HRDLK+ N+ L K+ D G+A +Q L GT Y++PE + K
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 334 SDVYAFGVVLLEL 346
SDV+A G + E+
Sbjct: 183 SDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVKKLDCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V A+L D+ + V K D QD + E + L+ HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYLHEHC 270
L D F V E + L Q+ R + A + L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE----PRSRFYAAEVTLALMFLHRH- 115
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL 330
VI+RDLK NILLD++ + KL+DFG+ GT Y+APE L + +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 331 TDKSDVYAFGVVLLELLLGRRPVE 354
D +A GV++ E++ G+ P E
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 75/281 (26%), Positives = 135/281 (48%), Gaps = 44/281 (15%)
Query: 158 ILGEGGFGCVYK---AKLDDNLH--VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG VYK +N+ VA+K L + + A +E +E +++ + P V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSA--LTWHMRMKIALDTARGLEYLHE 268
LLG + + + LD ++ + GS L W +++ A+G+ YL E
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLGYVAPEY 324
++HRDL + N+L+ S + K++DFGLA I + + + K+ + ++A E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP--IKWMALES 182
Query: 325 LLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDR-SKLPNIV 382
+L + T +SDV+++GV + EL+ G +P + + PA+ +P L ++ +LP
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAR-------EIPDLLEKGERLPQ-- 232
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P I T+D V + V C + RP +++
Sbjct: 233 -PPI-CTID------VYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F + +LG+GGFG C + + ++ A K+L+ + R+ E NE +L ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMY-ACKRLE-KKRIKKRKGESMALNEKQILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLE 264
VV L D +V +M D++ H + G+ R A + GLE
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAP 322
LH ++RDLK NILLD + ++SD GLA I +G + + GT+GY+AP
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAP 170
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
E L + + T D + G ++ E++ G+ P
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKL--DCATQDAGRE---FENEVDLLSNIHHPNVVC 211
+LG+G FG V+ A+L N A+K L D D E E V L+ HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR---------- 261
L + F V E + +G L +H++ D R
Sbjct: 61 LYCTFQTKENLFFVMEYL-------------NGGDLMFHIQSCHKFDLPRATFYAAEIIC 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
GL++LH + +++RDLK NILLD+ + K++DFG+ + + GT Y+A
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIA 164
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE LL K D ++FGV+L E+L+G+ P
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 152 SFHESNILGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFE----NEVDLLSNIH 205
+F +LG+GGFG C + + ++ A KKL+ + R+ E NE +L ++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMY-ACKKLE-KKRIKKRKGEAMALNEKRILEKVN 58
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
VV L D +V +M D++ H + G+ D R + Y
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNP---------GFDEQRAIFY 107
Query: 266 LHEHC-------NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
E C +++RDLK NILLD + + ++SD GLA I +G + + GT
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GT 164
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
+GY+APE + + K T D + G ++ E++ G+ P K
Sbjct: 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 158 ILGEGGFGCVY---KAKLDDNLHV-AVKKLDCAT---QDAGREFENEVDLLSNIHHPNVV 210
+LG+G FG V+ K D + A+K L AT +D R + E D+L+ ++HP +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 211 CLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLEYLHE 268
L Y+ + + +++ + + L +L S T +K L + A L++LH
Sbjct: 62 -KLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFT-EEDVKFYLAELALALDHLH- 115
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+ +I+RDLK NILLD + + KL+DFGL+ K GT+ Y+APE +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 329 KLTDKSDVYAFGVVLLELLLGRRP 352
T +D ++FGV++ E+L G P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 159 LGEGGFGCVYKAK---LDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIH-HPNVVC 211
LG+G +G V A+ + VA+KK+ A R E+ LL + H N+ C
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 212 LLG-----YSAHDDTRFIVYELMENRSLDIQLHGPSH-GSALT-WHMRMKIALDTARGLE 264
L ++ ++ ELME LH G LT H + I GL+
Sbjct: 67 LYDMDIVFPGNFNEL-YLYEELME-----ADLHQIIRSGQPLTDAHFQSFI-YQILCGLK 119
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSG---TLGY 319
Y+H + V+HRDLK N+L+++ K+ DFGLA ++ +N ++ T Y
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN-PGENAGFMTEYVATRWY 175
Query: 320 VAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRPVEK 355
APE +L + K+ DV++ G +L E LLGR+PV K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 158 ILGEGGFGCVYKA---KLDDNLH--VAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
+LG G FG V+K D++ VA+K + D + + +E + + + ++ H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
LLG + + LD H H +L + + A+G+ YL EH
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLD---HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLGYVAPEYLLDGK 329
++HR+L + NILL S +++DFG+A +K + + ++A E +L G+
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
T +SDV+++GV + E++ G P + P +
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 159 LGEGGFGCVY--------KAKLDDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V K K + + VAVK L D AT + +E++++ I H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHG---PSHGSA----------LTWHMRMKI 255
++ LLG D +++ E +L L P + LT+ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGSQNKNNL 311
A ARG+EYL + IHRDL + N+L+ K++DFGLA D + N
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+L + ++APE L D T +SDV++FGV+L E+ LG P
Sbjct: 197 RLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 23/240 (9%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+GEG G C+ + K VAVK +D Q NEV ++ + H NVV +
Sbjct: 29 IGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 217 AHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +++ E ++ +L DI + L + + L YLH VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSD 335
HRD+KS +ILL KLSDFG L GT ++APE + + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 336 VYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR--SKLPNI--VDPVIKSTMD 391
+++ G++++E++ G P +P Q AM +L D KL N + PV++ ++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPKLKNAHKISPVLRDFLE 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 158 ILGEGGFGCVYKAKLD----DNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
ILG G FG + + L L VA+ L + R F E L H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G +T IV E M N +LD L H L M + A G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSEM--- 126
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-KNNLKLSGTLGYVAPEYLLDGKLT 331
+H+ L + +L++S K+S F D S+ + + + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 332 DKSDVYAFGVVLLELL-LGRRP 352
SDV++FG+V+ E++ G RP
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 159 LGEGGFGCVYKAKL----DDNLHVAVKKLD-CATQDAGR-EFENEVDLLSNIHHPNVVCL 212
+GEG FG KA L +D +K+++ R E EV +LSN+ HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGP-----SHGSALTWHMRMKIALDTARGLEYLH 267
+ +IV + E L +++ L W +++ +AL H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------H 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
H + ++HRD+KS NI L KL DFG+A S + GT Y++PE +
Sbjct: 117 VH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 328 GKLTDKSDVYAFGVVLLELL 347
+KSD++A G VL E+
Sbjct: 176 RPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 23/231 (9%)
Query: 159 LGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G +G VYKA+ NLH AVK + D + E+ ++ H N+V G
Sbjct: 17 VGSGTYGDVYKAR---NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 215 YSAHDDTRFIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+ +I E SL H GP + + R +T +GL YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSK--- 125
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL---DGK 329
+HRD+K +NILL + KL+DFG+A + GT ++APE +G
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC---QSIVTWAMPQLTDRSK 377
D++A G+ +EL + P+ L P + S + P+L D++K
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 75/263 (28%), Positives = 110/263 (41%), Gaps = 49/263 (18%)
Query: 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVK---KLDCATQDAGREFENEVDLLSNIHHPN 208
F LG G FG V AK + A+K K + + E +L + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR----- 261
+V ++ S D+ R VY L+E G L H+R + D A+
Sbjct: 80 IVNMM-CSFQDENR--VYFLLEFVV----------GGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
EYLH + +I+RDLK N+LLD+K + K++DFG A + D L GT
Sbjct: 127 LVLAFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGT 178
Query: 317 LGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR 375
Y+APE ++ K K+ D + GV+L E + G P P + + L R
Sbjct: 179 PEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI------LAGR 231
Query: 376 SKLPNIVDP----VIKSTMDLKH 394
K PN D ++K + H
Sbjct: 232 LKFPNWFDGRARDLVKGLLQTDH 254
|
Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V + D H+ A+KKL + ++ E D+L+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM----------RMKIA 256
P VV L YS D+ +Y +ME L G G +T M R IA
Sbjct: 61 PWVVKLY-YSFQDENY--LYLIME------YLPG---GDMMTLLMKKDTFTEEETRFYIA 108
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---------------- 300
+T ++ +H+ IHRD+K N+LLD+K + KLSDFGL
Sbjct: 109 -ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 301 --------------------ITDGSQNKNNLKLS--GTLGYVAPEYLLDGKLTDKSDVYA 338
+N+ L S GT Y+APE L + D ++
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 339 FGVVLLELLLGRRPVEKLAPAQ-CQSIVTW 367
GV++ E+L+G P P + + I+ W
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 158 ILGEGGFG--CVYKAKLDDNLHVA----VKKLDCATQDAGREFENEVDLLSNIHHPNVVC 211
++GEG FG + + D + + K A +D+ +E LL+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE----AVLLAKMKHPNIVA 62
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
D +IV E + L +Q G ++ + G++++HE
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-- 119
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
V+HRD+KS NI L KL DFG A S GT YV PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 332 DKSDVYAFGVVLLELLLGRRPVE 354
+KSD+++ G +L EL + P +
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 159 LGEGGFG--CVYKAKLDDNLHVAVKKLDCA--TQDAGREFEN-EVDLLSNIHHPNVVCLL 213
LG+GGFG C + K ++ A KKLD + +G + E ++L ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMY-ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGS-ALTWHMRMKIALDTARGLEYLHEHCN 271
Y+ T +V LM D++ H + G L + + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGG--DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-- 114
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
+++RD+K N+LLD + N +LSD GLA+ + K + +GT GY+APE L + +
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAV-ELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
D +A G + E++ GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 158 ILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL- 212
+LG+G FG V K +KK +D E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK--IALDTAR--------G 262
+ HD F+ ME ++G L +H+ + + D AR
Sbjct: 62 YSFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFSEDRARFYGAEIVSA 107
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGY 319
L+YLH N V++RDLK N++LD + K++DFGL I DG+ K GT Y
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEY 162
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+APE L D D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 158 ILGEGGFGCVY--KAKLDDNLHVAVKKLDCATQDAGREF-----ENEVDLLSNIHHPNVV 210
+LG+G FG V + K + A+K L A E E+ V L N HP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYY-AMKILKKEVIIAKDEVAHTLTESRV--LQNTRHPFLT 58
Query: 211 CL-LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK--IALDTAR------ 261
L + HD F+ ME ++G L +H+ + + D AR
Sbjct: 59 ALKYSFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGT 316
L YLH C+ V++RDLK N++LD + K++DFGL I+DG+ K GT
Sbjct: 105 VSALGYLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGT 158
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
Y+APE L D D + GVV+ E++ GR P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKL--DCATQDAGRE---FENEVDLLS--NIHHPNV 209
+LG+G FG V A+L + AVK L D D E E V L+ N ++
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR-------- 261
C H F V E + +G L +H++ K D R
Sbjct: 62 YCTFQTKEH---LFFVMEFL-------------NGGDLMFHIQDKGRFDLYRATFYAAEI 105
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
GL++LH +I+RDLK N++LD + K++DFG+ + + GT Y
Sbjct: 106 VCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDY 162
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+APE L K T D ++FGV+L E+L+G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCL- 212
+LG+G FG V + + A+K L A E + E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM-RMKI-ALDTAR--------G 262
+ HD F+ ME ++G L +H+ R ++ + AR
Sbjct: 62 YAFQTHDRLCFV----MEY----------ANGGELFFHLSRERVFTEERARFYGAEIVSA 107
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGY 319
LEYLH V++RD+K N++LD + K++DFGL I+DG+ K GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEY 161
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+APE L D D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
D +G G FG V+ + + A+K + ++ + NE +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P ++ L + D RF+ Y LME + P G L ++R + + T
Sbjct: 61 PFIIRL--FWTEHDQRFL-YMLME--------YVP--GGELFSYLRNSGRFSNSTGLFYA 107
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS 314
LEYLH +++RDLK NILLD + + KL+DFG A + D L
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLC 159
Query: 315 GTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
GT Y+APE ++ K +K+ D +A G+++ E+L+G P
Sbjct: 160 GTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 159 LGEGGFGCVY-----KAKLDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHPNVVC 211
LG+G FG VY KA ++ L V +K++ + + E LLS + HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSH-GSALTWHMRMKIALDTARGLEYLHEHC 270
D I+ E E R LD +L H G L+ + + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL 330
++HRDLK+ NI L + K+ DFG++ +GT Y++PE L
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 331 TDKSDVYAFGVVLLEL 346
KSD+++ G +L E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 64/206 (31%), Positives = 85/206 (41%), Gaps = 23/206 (11%)
Query: 158 ILGEGGFGCVY--KAKLDDNLHVAVKKLDCATQDAGREFENEVD--------LLSNIHHP 207
++G+G FG V K K D + AVK L Q + E LL N+ HP
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFY-AVKVL----QKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTARGLEYL 266
+V L D + V + + L L R + A + A L YL
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYL 112
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +I+RDLK NILLDS+ + L+DFGL +K GT Y+APE L
Sbjct: 113 HSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRP 352
D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-12
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 9/202 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPN 208
DS+ + LGEG + VYK K N + K+ ++ G F E LL + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V L +T +V+E + D+ + H L RGL Y+H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
++HRDLK N+L+ KL+DFGLA + TL Y P+ LL
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 329 -KLTDKSDVYAFGVVLLELLLG 349
+ + D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 61/311 (19%), Positives = 116/311 (37%), Gaps = 67/311 (21%)
Query: 136 SAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG---R 192
+ I IE ++K T S ++ E +YK ++ V ++ +
Sbjct: 10 NDIKCIESDDIDKYT-----SVLIKENDQNSIYKGIFNNKE-VIIRTFKKFHKGHKVLID 63
Query: 193 EFENEVDLLSNIHHPNVVCLLGY--SAHDDTRFIVYE------------LMENRSLDIQL 238
ENE+ L I N++ + G+ DD + L + + L +
Sbjct: 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK- 122
Query: 239 HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
++ +A+D +GL L+++ N +++L S + L+ + K+ G
Sbjct: 123 ------------TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHG 168
Query: 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKL 356
L S N+ + Y + + L D + T K D+Y+ GVVL E+ G+ P E L
Sbjct: 169 LEKILSSPPFKNVN---FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
Query: 357 APAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST----MDLKHLYQVAAVAVLCVQPEPSY 412
+ I D +I + L ++ + C +
Sbjct: 226 TTKE--------------------IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265
Query: 413 RPLITDVLHSL 423
RP I ++L++L
Sbjct: 266 RPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 58/197 (29%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFE--NEVDLLSNIHHPNVVCLLGYS 216
LGEG + VYK N + K+ + G F E LL + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+T V+E M D+ + H L + RGL Y+H ++H
Sbjct: 73 HTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126
Query: 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS-- 334
RDLK N+L+ KL+DFGLA ++ TL Y P+ LL TD S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA--TDYSSA 184
Query: 335 -DVYAFGVVLLELLLGR 350
D++ G + +E+L G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 27/161 (16%)
Query: 197 EVDLLSNIHHPNVVCLLGYSAHDDTRFIV----------YELMENRSLDIQLHGPSHGSA 246
E LL N++HP+V+ + +V Y +R L I A
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPID-------QA 159
Query: 247 LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306
L I GL YLH +IHRD+K+ NI ++ + D G A
Sbjct: 160 LI------IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
L L+GT+ APE L K K+D+++ G+VL E+L
Sbjct: 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+HP +V L + F V E + D+ H H R A + + L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLHE +I+RDLK N+LLDS+ + KL+D+G+ GT Y+APE
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
L D +A GV++ E++ GR P +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 3/99 (3%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
A + A GL +LH + +I+RDLK N++LD++ + K++DFG+ + K G
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
T Y+APE + D +AFGV+L E+L G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-EV 198
I+ + S+ NI+G G FG VY+A +D + VA+KK+ QD +++N E+
Sbjct: 56 IDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDP--QYKNREL 110
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTR--------FIVYELMENRSLDIQLHGPSHGSALTWH 250
++ N++H N++ L Y + + +V E + H + AL
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKN 309
+ + R L Y+H + + HRDLK N+L+D + KL DFG A KN
Sbjct: 171 LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA-------KN 220
Query: 310 NLKLSGTLGYV------APEYLLDG-KLTDKSDVYAFGVVLLELLLG 349
L ++ Y+ APE +L T D+++ G ++ E++LG
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 47/215 (21%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y N VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80
Query: 213 LGYSAHDDTR------FIVYELME-------NRSLDIQLHGPSHGSALTWHMRMKIAL-D 258
L + ++V ELM+ LD H RM L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD--------------HERMSYLLYQ 126
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
G+++LH + +IHRDLK SNI++ S K+ DFGLA T G + ++
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVV 179
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
T Y APE +L + D+++ G ++ E++ G
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFE--NEVDLLSNIHHP 207
+ + +G+G FG V+KA+ VA+KK+ + G E+ +L + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 208 NVVCLL--------GYSAHDDTRFIVYE--------LMENRSLDIQLHGPSHGSALTWHM 251
NVV L+ Y+ + + ++V+E L+ N+++ L S +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL---SEIKKV---- 124
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----ITDGSQ 306
MK+ L+ GL Y+H + ++HRD+K++NIL+ KL+DFGLA +
Sbjct: 125 -MKMLLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 307 NKNNLKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLEL 346
N+ ++ TL Y PE LL + D++ G ++ E+
Sbjct: 178 NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 158 ILGEGGFGCVY--KAKLDDNLH---VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
++G+G FG V K KLD + V KK+ ++ LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+ + V + + L L S R A + A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ--RERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD 332
+++RDLK NILLDS+ + L+DFGL +Q+ GT Y+APE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 333 KSDVYAFGVVLLELLLGRRP 352
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 78/291 (26%), Positives = 117/291 (40%), Gaps = 51/291 (17%)
Query: 159 LGEGGFGCVYKAKLDDNLHVA---VKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V + + A VK+L AT D F EV ++HPNV+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 215 YSAHDDTRFIVYE----------LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
+V E L NR + Q+ + ++A + A GL
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--------VLQRMACEVASGLL 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAP 322
+LH+ IH DL N L + + K+ D+GLA+ ++ + L ++AP
Sbjct: 115 WLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 323 EY-------LLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTD 374
E LL T KS++++ GV + EL +P L+ Q V Q
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV--REQDI- 228
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLC-VQPEPSYRPLITDVLHSLI 424
KLP K +DLK+ + V C + PE RP +V H L+
Sbjct: 229 --KLP-------KPQLDLKYSDRWYEVMQFCWLDPET--RPTAEEV-HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL---LG 214
LG G G V+ A D + VAVKK+ + + E+ ++ + H N+V + LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 215 YSAHDDTR-----------FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTA 260
S D T +IV E ME ++ GP H + +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--------L 124
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLG- 318
RGL+Y+H + V+HRDLK +N+ ++++ K+ DFGLA + LS L
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 319 --YVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGR 350
Y +P LL T D++A G + E+L G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 39/102 (38%), Positives = 58/102 (56%), Gaps = 9/102 (8%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLK 312
A + A GL +LH + +I+RDLK N++LDS+ + K++DFG+ + DG K
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--- 160
Query: 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
GT Y+APE + D +AFGV+L E+L G+ P E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-----KNN 310
+ ARG+E+L + IHRDL + NILL K+ DFGLA D ++ K +
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPDYVRKGS 235
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ--CQSIVTW 367
+L L ++APE + D T +SDV++FGV+L E+ LG P + + CQ
Sbjct: 236 ARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----- 288
Query: 368 AMPQLTD--RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+L D R + P P I M + C Q +P RP + ++ L
Sbjct: 289 ---RLKDGTRMRAPENATPEIYRIM------------LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 42/120 (35%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 243 HGSALTWHMRMKIALDTAR----------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
+G L H++ + D +R LE LH+ VI+RDLK NILLD + +
Sbjct: 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHI 132
Query: 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
L DFGL + + GT Y+APE LL T D + GV+L E+L G P
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 28/174 (16%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
+ A+G+E+L + IHRDL + NILL K+ DFGLA D ++ + ++
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPDYVRKGD 240
Query: 316 T---LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVE--KLAPAQCQSIVTWAM 369
L ++APE + D T +SDV++FGV+L E+ LG P K+ C+ +
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----- 295
Query: 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ R + P+ P + TM + C EPS RP ++++ L
Sbjct: 296 -KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 52/225 (23%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
YK+L K +GEG F V KA+ + A+K + + +V+ L
Sbjct: 1 YKILGK----------IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-----EQVNNL 45
Query: 202 SNI-------HHPNVVCLLGYSAHDDTR----FI-------VYELMENRSLDIQLHGPSH 243
I HPN++ L+ D + +YEL++ R P
Sbjct: 46 REIQALRRLSPHPNILRLIEV-LFDRKTGRLALVFELMDMNLYELIKGR------KRPLP 98
Query: 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303
+ +M + + L+++H + + HRD+K NIL+ KL+DFG
Sbjct: 99 EKRVKSYMYQLL-----KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGI 149
Query: 304 GSQNKNNLKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELL 347
S+ +S T Y APE LL DG K D++A G V E+L
Sbjct: 150 YSKPPYTEYIS-TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 158 ILGEGGFGCVYKAKLDDNL---HVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVC 211
++G+G +G V A D VA+KK++ DA R E+ LL + HP++V
Sbjct: 7 VIGKGSYGVVCSAI--DTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 212 LLGYSAHDDTR-----FIVYELMENRSLDIQLH---------GPSHGSALTWHMRMKIAL 257
+ R ++V+ELME+ LH P H + +
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFLYQL------ 112
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLS 314
R L+Y+H V HRDLK NIL ++ K+ DFGLA D
Sbjct: 113 --LRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 315 GTLGYVAPEYL--LDGKLTDKSDVYAFGVVLLELLLGR 350
T Y APE K T D+++ G + E+L G+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD----LLSNIHHPNVVCL 212
++G+G FG V A+ + AVK L +E ++ + LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 213 -LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK----------IALDTAR 261
+ D F++ + +G L +H++ + A + A
Sbjct: 62 HFSFQTADKLYFVLDYI--------------NGGELFYHLQRERCFLEPRARFYAAEIAS 107
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
L YLH + +++RDLK NILLDS+ + L+DFGL + N GT Y+A
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE L D + G VL E+L G P
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 47/300 (15%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKK--LDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ + K K + L VAVKK LD +++ + + E+ + HPN++ +
Sbjct: 9 CFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 216 SAHDDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIAL---DTARGLEYLH-EH 269
D ++V LM + ++ H P L IA D L+Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA------IAFILKDVLNALDYIHSKG 121
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG-------TLGYVAP 322
IHR +K+S+ILL LS +++ K + L +++P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 323 EYLLDGKL---TDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378
E +L L +KSD+Y+ G+ EL G P + + Q V +P L D+S
Sbjct: 178 E-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAV---------------LCVQPEPSYRPLITDVL-HS 422
P D + +S +H +V LC+Q +P RP + +L HS
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 41/120 (34%), Positives = 63/120 (52%), Gaps = 15/120 (12%)
Query: 244 GSALTWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
G L +HM+ K+ + AR L +LHE +I+RDLK N+LLD++ + K
Sbjct: 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIK 136
Query: 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
L+D+G+ GT Y+APE +L G+ S D +A GV++ E++ GR P
Sbjct: 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCATQD---AGREFENEVDLLSNIH 205
D + + +G G +G V A LD VA+KKL Q A R + E+ LL ++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMK 72
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK---------IA 256
H NV+ LL D + +R D L P G+ L M+ + +
Sbjct: 73 HENVIGLLDVFTPDLSL--------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
+GL+Y+H +IHRDLK N+ ++ K+ DFGLA S+ ++G
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTGY 175
Query: 316 --TLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGR 350
T Y APE +L+ T D+++ G ++ E+L G+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 158 ILGEGGFGCVY----KAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLL 213
+LG+G FG V KA +KK +D E +L N HP + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 214 GYSAHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
YS R V E + L L S + + L+YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLH---SG 114
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGL---AITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
+++RDLK N++LD + K++DFGL ITD + K GT Y+APE L D
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAPEVLEDND 171
Query: 330 LTDKSDVYAFGVVLLELLLGRRP 352
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNV 209
+LG+GG+G V++ + D A+K L AT Q + E ++L + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM-RMKIAL-DTAR------ 261
V L+ Y+ + +Y ++E S G L H+ R I + DTA
Sbjct: 63 VDLI-YAFQTGGK--LYLILEYLS----------GGELFMHLEREGIFMEDTACFYLSEI 109
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
LE+LH+ +I+RDLK NILLD++ + KL+DFGL + GT+ Y
Sbjct: 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+APE L+ D ++ G ++ ++L G P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 12/103 (11%)
Query: 256 ALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
+ ARG+E+L C IHRDL + NILL K+ DFGLA D ++ + ++
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLA-RDIYKDPDYVR-K 232
Query: 315 GT----LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
G L ++APE + D T +SDV++FGV+L E+ LG P
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 29/203 (14%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y A LD N VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYSAHDDTR------FIVYELME-NRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLE 264
L + ++V ELM+ N IQ+ H RM L G++
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIK 133
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+LH + +IHRDLK SNI++ S K+ DFGLA T G+ + T Y APE
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 189
Query: 325 LLDGKLTDKSDVYAFGVVLLELL 347
+L + D+++ G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 37/178 (20%)
Query: 191 GREFENEVDLLSNIHH------------PNVVCL-LGYSAHDDTRFIVYELMENRSLDIQ 237
G+ E+D+L I H + VC+ + D F + L+
Sbjct: 130 GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLE-- 185
Query: 238 LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
A+T R+ A L YLH +IHRD+K+ NI LD NA L DF
Sbjct: 186 -------QAITIQRRLLEA------LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229
Query: 298 GLA--ITDGSQNKNNLKLSGTLGYVAPEYL-LDGKLTDKSDVYAFGVVLLELLLGRRP 352
G A + SGTL +PE L LD K+D+++ G+VL E+ +
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 13/122 (10%)
Query: 243 HGSALTWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
+G L +HM+ K+ + AR L +LHE +I+RDLK N+LLD+ +
Sbjct: 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHI 135
Query: 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
KL+D+G+ GT Y+APE L + D +A GV++ E++ GR P
Sbjct: 136 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
Query: 353 VE 354
+
Sbjct: 196 FD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCL 212
+G G G V Y A L+ +VA+KKL Q+ A R + E+ L+ ++H N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYSAHDDTR------FIVYELME-NRSLDIQLHGPSHGSALTWHMRMKIAL-DTARGLE 264
L + +IV ELM+ N IQ+ H RM L G++
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIK 140
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+LH + +IHRDLK SNI++ S K+ DFGLA T G+ + T Y APE
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 196
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGR 350
+L + D+++ G ++ E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 144 KLLEKATDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD---AGREFENEVD 199
K + + + + + +G G +G V A L VAVKKL Q A R + E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELR 68
Query: 200 LLSNIHHPNVVCLL-------GYSAHDDTRFIVYELME---NRSLDIQLHGPSHGSALTW 249
LL ++ H NV+ LL +D ++V LM N + Q H L +
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ RGL+Y+H + +IHRDLK SN+ ++ K+ DFGLA +
Sbjct: 128 QI--------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176
Query: 310 NLKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
+ T Y APE +L+ +++ D+++ G ++ ELL GR
Sbjct: 177 YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 41/116 (35%), Positives = 61/116 (52%), Gaps = 19/116 (16%)
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----------I 301
RM A +T LEYLH N ++HRDLK N+L+ S + KL+DFGL+ +
Sbjct: 104 RMYFA-ETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 302 TDGSQNKN-----NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+G K+ + ++ GT Y+APE +L D +A G++L E L+G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
A + + GL +LH +I+RDLK N++LDS+ + K++DFG+ G
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
T Y+APE + D +A+GV+L E+L G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 71/266 (26%), Positives = 106/266 (39%), Gaps = 72/266 (27%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V K+D N A+K L D ++ + E D+L+ + VV L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR--------GLEY 265
YS D +Y +M+ + P G ++ +R+ I D AR +E
Sbjct: 68 YSFQDKDN--LYFVMD--------YIPG-GDMMSLLIRLGIFEEDLARFYIAELTCAIES 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI------------------------ 301
+H IHRD+K NIL+D + KL+DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 302 --TDGSQNKNNLK-----------------LSGTLGYVAPEYLLDGKLTDKSDVYAFGVV 342
++ LK L GT Y+APE LL T D ++ GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 343 LLELLLGRRPVEKLAPAQCQ-SIVTW 367
L E+L+G+ P PA+ Q ++ W
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 159 LGEGGFGCV---YKAKLDDNLHVAVKKLDCATQDA--GREFENEVDLLSNIHHPNVVCLL 213
+G G +G V Y +L VAVKKL Q R E+ LL ++ H NV+ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 214 -----GYSAHD-DTRFIVYELME---NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
S + + ++V LM N + Q H L + + RGL+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LRGLK 132
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVA 321
Y+H + +IHRDLK SN+ ++ ++ DFGLA + + +++G T Y A
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA------RQADDEMTGYVATRWYRA 183
Query: 322 PEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
PE +L+ +++ D+++ G ++ ELL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVD----LLSNIHHPNVVCL 212
++G+G FG V AK D AVK L T +E + + LL N+ HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK----------IALDTARG 262
+ + V + + +G L +H++ + A + A
Sbjct: 62 HYSFQTAEKLYFVLDYV-------------NGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
+ YLH +I+RDLK NILLDS+ + L+DFGL + GT Y+AP
Sbjct: 109 IGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
E L D + G VL E+L G P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 153 FHESNILGEGGFGCVYKAKLDDNL--HVAVKKLDCATQD---AGREFENEVDLLSNIHHP 207
+ + +G G G V A D L +VAVKKL Q+ A R + E+ LL ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 208 NVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL-DTA 260
N++ LL + ++V ELM+ + +H H RM L
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-IHMELD------HERMSYLLYQML 133
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
G+++LH + +IHRDLK SNI++ S K+ DFGLA T N T Y
Sbjct: 134 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 189
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELLLG 349
APE +L + D+++ G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 33/81 (40%), Positives = 48/81 (59%), Gaps = 2/81 (2%)
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLGYVAPEYLLDGKLT 331
+IHRD+KS+NILL S KL DFG + + +++ GT YVAPE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
K+D+++ GV+L ELL +RP
Sbjct: 224 KKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 37/106 (34%), Positives = 64/106 (60%), Gaps = 12/106 (11%)
Query: 253 MKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQN-- 307
++ + A+G+++L ++C IHRD+ + N+LL AK+ DFGLA I + S
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
K N +L + ++APE + D T +SDV+++G++L E+ LG+ P
Sbjct: 271 KGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 46/274 (16%)
Query: 159 LGEGGFGCVYKAKLDD-----NLH---VAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LG+G F ++K + LH V +K LD + ++ F ++S + H ++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
G D +V E ++ SLD L + ++W ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 271 NPAVIHRDLKSSNILL----DSKFNA----KLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
+ H ++ + N+LL D K KLSD G++IT + L + +V P
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE----ILLERIPWVPP 173
Query: 323 EYLLDGK-LTDKSDVYAFGVVLLELLLG-RRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380
E + + + L+ +D ++FG L E+ G +P+ L + + DR +L
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYEDRHQL-- 224
Query: 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
P K T ++A + C+ EP +RP
Sbjct: 225 ---PAPKWT-------ELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 159 LGEGGFGCVYKAKLD--DNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCLL 213
+G G FG V+ D D VA+KK+ Q+ R F E+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVT-DPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 214 G--YSAHDD---TRFIVYELMENRSLDIQLH----GPSHGSALTWHMRMKIALDTARGLE 264
H D ++V ELM++ LH P S+ H+++ RGL+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-----DLHKIIVSPQPLSSD--HVKV-FLYQILRGLK 117
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
YLH + ++HRD+K N+L++S K+ DFGLA + + ++K+ + T Y APE
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 324 YLLDGK-LTDKSDVYAFGVVLLELLLGRR-------PVEKL 356
L+ + T D+++ G + E LLGRR P+++L
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAE-LLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKL-DCATQDAGREFE-NEVDLLSNIHHP 207
+ F ++GEG +G V K + + VA+KK D + +E E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V L ++V+E +E L++ P+ +R I + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYI-YQLIKAIHWCH 117
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
++ ++HRD+K N+L+ KL DFG A +++GS N N + T Y +PE L
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELL 173
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGR 350
L D+++ G +L EL G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 151 DSFHESNILGEGGFGCV-----------YKAKLDDNLHVAVKKLDCATQDAGREFENEVD 199
+ F ++G G FG V Y KL + +K+ D A F E D
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF------FWEERD 95
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL-------DIQLHGPSHGSALTWHM 251
++++ + +V L Y+ DD ++V E M L DI A +
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-----PEKWARFYTA 149
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311
+ +ALD + + IHRD+K N+LLD + KL+DFG + + N +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGM 197
Query: 312 KLS----GTLGYVAPEYLL----DGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y++PE L DG + D ++ GV L E+L+G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 15/209 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
D++ + +GEG +G VYKA+ + VA+KK + G E+ LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 208 NVVCLLGYSAHDDTR------FIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTA 260
+ L H + + ++V+E +++ + +G G L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+G+ + H+H V+HRDLK N+L+D K K++D GL K+ TL Y
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 320 VAPEYLLDGK-LTDKSDVYAFGVVLLELL 347
APE LL + D+++ G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
L++LH+ +I+RD+K NILLDS+ + L+DFGL+ + + GT+ Y+
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY-SFCGTIEYM 173
Query: 321 APEYLLDGKL--TDKSDVYAFGVVLLELLLGRRP 352
APE + G D ++ GV+ ELL G P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 57/250 (22%), Positives = 91/250 (36%), Gaps = 67/250 (26%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLD--CATQDAG-REFENEVDLLSNIHH 206
F + +LG+G G V+ +L + A+K LD + + E ++L+ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELME-------NRSLDIQLHGPSHGSALTWHMRMKIALDT 259
P + L A T + +M+ R L Q ++ +
Sbjct: 61 PFLPTLY---ASFQTETYLCLVMDYCPGGELFRLLQRQPGK-------------CLSEEV 104
Query: 260 AR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--------- 302
AR LEYLH +++RDLK NILL + LSDF L+
Sbjct: 105 ARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 303 ----DGSQNKNNLKLS----------------GTLGYVAPEYLLDGKLTDKSDVYAFGVV 342
GS+ + + GT Y+APE + D + G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 343 LLELLLGRRP 352
L E+L G P
Sbjct: 222 LYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 67/262 (25%), Positives = 103/262 (39%), Gaps = 75/262 (28%)
Query: 151 DSFHESNILGEGGFGCV-YKAKLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHH 206
+ FH ++G+G FG V K D A+K L + +D + E D+L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR---- 261
P VV L Y + D +++ Y +ME L G G +T ++ + D R
Sbjct: 61 PWVVSL--YYSFQDAQYL-YLIMEF------LPG---GDLMTMLIKYDTFSEDVTRFYMA 108
Query: 262 ----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL------------------ 299
+E +H+ IHRD+K NIL+D + KLSDFGL
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 300 --AITDGSQNKN-------NLKLS--------------------GTLGYVAPEYLLDGKL 330
+ + N+N NL +S GT Y+APE L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 331 TDKSDVYAFGVVLLELLLGRRP 352
+ D ++ G ++ E L+G P
Sbjct: 226 GQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 48/258 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHH 206
+ F ++G G FG V + D HV ++K D ++ E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
VV + YS D +++ E + + L LT +T ++
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDS 116
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI-------------------TDGS- 305
+H+ IHRD+K N+LLDSK + KLSDFGL +D +
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 306 -------------QNKNNLKLS--GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
+N+ L S GT Y+APE + D ++ GV++ E+L+G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 351 RPVEKLAPAQC-QSIVTW 367
P P + + ++ W
Sbjct: 234 PPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 65/267 (24%), Positives = 105/267 (39%), Gaps = 66/267 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHH 206
D F ++G G FG V + D H+ ++K D ++ E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL--------- 257
VV + Y + R+L + + G +T M+ K L
Sbjct: 61 AWVVKMF------------YSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYI 107
Query: 258 -DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI--------------- 301
+T ++ +H+ IHRD+K N+LLD+K + KLSDFGL
Sbjct: 108 AETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 302 ----TDGS-QN-----------KNNLKLS----GTLGYVAPEYLLDGKLTDKSDVYAFGV 341
+D S QN KN +L+ GT Y+APE + D ++ GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 342 VLLELLLGRRPVEKLAPAQC-QSIVTW 367
++ E+L+G P P + + ++ W
Sbjct: 225 IMYEMLIGYPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 154 HESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPN 208
+E +G G +G VYKAK D A+K+++ + A RE + LL + HPN
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPN 59
Query: 209 VVCLLG-YSAHDDTR-FIVYELMENRSLDI-QLHGPSHGSA----LTWHMRMKIALDTAR 261
V+ L + +H D + +++++ E+ I + H S + L M +
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAITDGSQNKNNLKLSG-- 315
G+ YLH + V+HRDLK +NIL+ + K++D G A S K L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 316 -TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELL 347
T Y APE LL + K+ D++A G + ELL
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 154 HESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPN 208
+E +G G +G VYKAK D + A+K+++ + A RE + LL + HPN
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPN 59
Query: 209 VVCLLG-YSAHDDTR-FIVYELMENRSLDI-QLHGPSHGSA----LTWHMRMKIALDTAR 261
V+ L + +H D + +++++ E+ I + H S + L M +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAITDGSQNKNNLKLSG-- 315
G+ YLH + V+HRDLK +NIL+ + K++D G A S K L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 316 -TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELL 347
T Y APE LL + K+ D++A G + ELL
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 34/241 (14%)
Query: 127 SVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKA--KLDDNLHVAVKKLD 184
++++ KK S + + + + F+ LG G FG V A K +D VA+K+ +
Sbjct: 6 NLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 185 CATQDAGREFE---NEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGP 241
+ ++ + +E +L+ I+HP V L G + ++V E +
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG---------- 115
Query: 242 SHGSALTWHMRMK---------IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292
G T+ R K A EYL + +++RDLK N+LLD
Sbjct: 116 --GEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI 170
Query: 293 KLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351
K++DFG A + D L GT Y+APE LL+ +D + G+ + E+L+G
Sbjct: 171 KMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
Query: 352 P 352
P
Sbjct: 227 P 227
|
Length = 340 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLG 318
LE+LH+ +I+RD+K NILLDS + L+DFGL+ D + + GT+
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVERAYSFCGTIE 171
Query: 319 YVAPEYLLDGKLT-DKS-DVYAFGVVLLELLLGRRP 352
Y+AP+ + G DK+ D ++ GV++ ELL G P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 66/236 (27%), Positives = 99/236 (41%), Gaps = 55/236 (23%)
Query: 158 ILGEGGFGCVYKAKLDDNL---HVAVKKLDCATQDAGR---EFENEVDLLSNIHHPNVVC 211
++G+GG G VY A D + VA+KK+ + F E + +++ HP +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 212 LLGYSAHDDTRFIVYELM----------------ENRSLDIQLH-GPSHGSALTWHMRMK 254
+ YS D VY M + SL +L S G+ L
Sbjct: 67 V--YSICSDGD-PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------S 117
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT---------DGS 305
I +EY+H V+HRDLK NILL + D+G AI D
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 306 QNKNNL---------KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
++ N+ K+ GT Y+APE LL ++ +D+YA GV+L ++L P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 29/174 (16%)
Query: 260 ARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT-- 316
ARG+E+L ++C +HRDL + N+LL K+ DFGLA D + N + T
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLA-RDIMHDSNYVSKGSTFL 301
Query: 317 -LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTD 374
+ ++APE + D T SDV+++G++L E+ LG P P +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP----------------YPGMIV 345
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL---ITDVLHSLIP 425
S N + + +V + V C EP RP ++D++ SL+P
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 159 LGEGGFGCVYKA-KLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHPNVVCLL- 213
+G G +G V A VA+KKL Q A R + E+ LL ++ H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 214 ----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
S + F Y +M D+Q G L+ + GL+Y+H
Sbjct: 82 VFTSAVSGDEFQDF--YLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHS- 135
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLL 326
+IHRDLK N+ ++ K+ DFGLA + +++G T Y APE +L
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVIL 187
Query: 327 DGKLTDKS-DVYAFGVVLLELLLGR 350
+ +++ D+++ G ++ E+L G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 146 LEKATDSFHESNILGEGGF--GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN 203
+EKA S E+ G GF C+ + HV +K A Q G E +L
Sbjct: 89 IEKAGFSILETFTPGAEGFAFACIDNKTCE---HVVIK----AGQRGGTA--TEAHILRA 139
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
I+HP+++ L G ++ ++ + D+ + + + + + I R +
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIERSVLRAI 195
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQNKNNLKLSGTLGYVA 321
+YLHE+ +IHRD+K+ NI ++ + L DFG A D + NK +GT+ A
Sbjct: 196 QYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIATNA 251
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
PE L D+++ G+VL E+
Sbjct: 252 PELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL----DIQLHGPSHGSALTWHMRMKIALDTARG 262
PN+VCL Y +D+ F+V + E L L+ P W M +ALD
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-EECVKRWAAEMVVALDA--- 100
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG--LAITDGSQNKNNLKLSGTLGYV 320
LH ++ RDL +NILLD + + +L+ F + D + + Y
Sbjct: 101 ---LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR 375
APE + T+ D ++ G +L ELL G+ VE P+ + T +P+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSE 203
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 12/99 (12%)
Query: 260 ARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQN--KNNLKLS 314
A+G+ +L ++C IHRDL + NILL K+ DFGLA I + S K N +L
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ ++APE + + T +SDV+++G++L E+ LG P
Sbjct: 280 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
L+ +H ++HRDLKS+NI L KL DFG + +D GT Y+
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360
APE + + K+D+++ GV+L ELL RP + P+Q
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFK--GPSQ 276
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-NLKLSGTLGYVA 321
LE+LH+ +++RD+K NILLDS+ + L+DFGL+ S+ K GT+ Y+A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 322 PEYLLDGKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380
PE + K+ D ++ G+++ ELL G P QS V+ + L P+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPS 232
Query: 381 IVDPV 385
+ P
Sbjct: 233 FIGPE 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 40/246 (16%)
Query: 159 LGEGGFGCVYKAKL----DDN---------LHVAVKKLDCATQDAGREFENEVDLLSNIH 205
LG G +Y L DD + V +K LD + +D F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
H ++V L G D +V E +E LD+ +H S LT + K+A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 266 LHEHCNPAVIHRDLKSSNILL-----DSKFNA--KLSDFGLAITDGSQNKNNLKLSGTLG 318
L + ++H ++ + NILL D + KLSD G+ IT S+ + ++
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP---- 173
Query: 319 YVAPEYLLDGK-LTDKSDVYAFGVVLLELLL-GRRPV--------EKLAPAQCQSIVTWA 368
++APE + D K L+ +D ++FG L E+ G P+ E+ QC +VT +
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM-LVTPS 232
Query: 369 MPQLTD 374
+L D
Sbjct: 233 CKELAD 238
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 24/195 (12%)
Query: 176 LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235
L V +K LD + +D F L+S + H ++ + G +V E +E+ LD
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--- 292
+ L + W ++ +A A L YL + ++H ++ + NILL A
Sbjct: 105 VCLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGT 159
Query: 293 ----KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLEL- 346
KLSD G++ T S+ + ++ ++APE + G L+ +D ++FG LLE+
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEIC 215
Query: 347 ------LLGRRPVEK 355
L R P EK
Sbjct: 216 FDGEVPLKERTPSEK 230
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 15/169 (8%)
Query: 186 ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS 245
A A + ENE+ L ++H N++ + R M + D L+ +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENIL-----KIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 246 ALTWHMR------MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
A W R I +EY+H+ +IHRD+K NI L+ L DFG
Sbjct: 257 AFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 300 AIT-DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347
A+ + + + GT+ +PE L + +D+++ G++LL++L
Sbjct: 314 AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENEVDLL 201
L + + ++G G FG V + V KL + R F E D++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 202 SNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQL---HGPSHGSALTWHMRMKIAL 257
+ + P VV L Y+ DD ++V E M L + L + A + + +AL
Sbjct: 98 AFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL----KL 313
D + + IHRD+K N+LLD + KL+DFG + NK +
Sbjct: 156 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTA 203
Query: 314 SGTLGYVAPEYLL----DGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y++PE L DG + D ++ GV L E+L+G P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 32/148 (21%), Positives = 52/148 (35%), Gaps = 21/148 (14%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-----PNVVCL 212
+L G VY + +K +++ G + E EV +L + P V+
Sbjct: 5 LLKGGLTNRVYLLG-TKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA- 60
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
D +++ E +E +LD IA A L LH+
Sbjct: 61 --SGESDGWSYLLMEWIEGETLD-----EVSEEEKE-----DIAEQLAELLAKLHQLPLL 108
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ H DL NIL+D + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENE 197
+ + L+ + + ++G G FG V + + V KL + R F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQL---HGPSHGSALTWHMRMK 254
D+++ + P VV L D ++V E M L + L + A + +
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVV 152
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI-TDGSQNKNNLKL 313
+ALD + +IHRD+K N+LLD + KL+DFG + D +
Sbjct: 153 LALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 314 SGTLGYVAPEYLL----DGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y++PE L DG + D ++ GV L E+L+G P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 79/299 (26%), Positives = 120/299 (40%), Gaps = 80/299 (26%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPN 208
F + LG G FG V A K+D A+K L D ++ + E D+L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 209 VVCLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI-ALDTAR----- 261
VV L YS D D + V + + G ++ +RM I D AR
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPG------------GDMMSLLIRMGIFPEDLARFYIAE 109
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI----TDGS---QNKNNL 311
+E +H+ IHRD+K NIL+D + KL+DFGL T S Q+ +++
Sbjct: 110 LTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 312 K----------------------------------------LSGTLGYVAPEYLLDGKLT 331
+ L GT Y+APE LL T
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 332 DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMP-QLTDRSKL-PNIVDPVIK 387
D ++ GV+L E+L+G+ P P + Q ++ W + ++KL P D +IK
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK 285
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 151 DSFHESNILGEGGFGCVY----KAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH 206
F +++G G FG V KA D +KK Q+ FE E D+LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENR------SLDIQLHGPSHGSALTWHM-RMKIALDT 259
P + L Y+ D +Y +ME + SL + +++ + +A+ +
Sbjct: 61 PWIPQLQ-YAFQDKDN--LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-GTLG 318
+ Y +HRD+K N+L+D + KL+DFG A + N KL GT
Sbjct: 118 VHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 319 YVAPEYLL----DGKLTD--KSDVYAFGVVLLELLLGRRPVE 354
Y+APE L DGK T + D ++ GV+ E++ GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 38/120 (31%), Positives = 65/120 (54%), Gaps = 10/120 (8%)
Query: 242 SHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+ AL++ + + A G+E+L ++C +HRDL + N+L+ K+ DFGLA
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLA 286
Query: 301 ITDGSQNKNNLKLSGT---LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKL 356
D ++ N + T L ++APE + + T SDV++FG++L E+ LG P +L
Sbjct: 287 -RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGRE----FENEVDLLSNIHH 206
+ F ++G G FG V KL + V K+ + R F E D+L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTAR 261
+ L Y+ D+ ++V + L L A + M IA+D+
Sbjct: 61 -QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG--LAITDGSQNKNNLKLSGTLGY 319
L Y +HRD+K NIL+D + +L+DFG L + + ++++ + GT Y
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 169
Query: 320 VAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRP 352
++PE L GK + D ++ GV + E+L G P
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 69/271 (25%), Positives = 109/271 (40%), Gaps = 66/271 (24%)
Query: 153 FHESNILGEGGFGCVYKA-KLDDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPN 208
F + LG G FG V A K+D + A+K L D ++ + E D+L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 209 VVCLLGYSAHD-DTRFIVYELM---ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
VV L YS D D + V + + + SL I++ A + + +A+++ +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----------------ITDGSQN 307
+ IHRD+K NIL+D + KL+DFGL I S
Sbjct: 122 F---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 308 KNNL------------------------------KLSGTLGYVAPEYLLDGKLTDKSDVY 337
++L L GT Y+APE LL T D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 338 AFGVVLLELLLGRRPVEKLAPAQCQ-SIVTW 367
+ GV+L E+L+G+ P P + Q ++ W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 159 LGEGGFGCVYKAKLDDNL---HVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V +++ V VK+L A+ +F E ++ H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTARGLEYLHEHCNP 272
+V E L L +T ++A + A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLD--- 327
IH DL N LL + K+ D+GL+ ++ +L L ++APE L+D
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE-LVDEVH 178
Query: 328 GKL-----TDKSDVYAFGVVLLELL-LGRRPVEKLAPAQ 360
G L T +S+V++ GV + EL LG +P L+ Q
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI---TDGSQNKN 309
M +A+D+ L Y +HRD+K N+LLD + +L+DFG + DG+ N
Sbjct: 111 MVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161
Query: 310 NLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y++PE L G+ + D ++ GV + E+L G P
Sbjct: 162 --VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 17/107 (15%)
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG--LAITDGSQNKNN 310
M +A+ + L Y +HRD+K N+LLD + +L+DFG L + +++
Sbjct: 111 MVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161
Query: 311 LKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRP 352
+ + GT Y++PE L GK + D ++ GV + E+L G P
Sbjct: 162 VAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 66/256 (25%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFEN----- 196
EY++++K +G G FG V+ K H ++ C + R +
Sbjct: 14 EYEVIKK----------IGNGRFGEVFLVK-----HKRTQEFFCWKAISYRGLKEREKSQ 58
Query: 197 ---EVDLLSNIHHPNVVCLLGYSAHDDTRFI------VYELME-----NRSLDIQLHGPS 242
EV+++ + H N+V + RF+ +Y LME + S +IQ
Sbjct: 59 LVIEVNVMRELKHKNIVRYI-------DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM 111
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCN----PAVIHRDLKSSNILLDSKFN------- 291
G + H + I L Y H + V+HRDLK NI L +
Sbjct: 112 FGK-IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 292 ----------AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL--DGKLTDKSDVYAF 339
AK+ DFGL+ G ++ + GT Y +PE LL DKSD++A
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAH-SCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 340 GVVLLELLLGRRPVEK 355
G ++ EL G+ P K
Sbjct: 230 GCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 162 GGFGCVYKAKLDDNLHV----AVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
G FG VY + +N + VKK D ++ + + E D L+ P +V L YS
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWH------MRMKIALDTARGLEYLHEHCN 271
VY +ME L G S L + M +K + A L+YLH H
Sbjct: 74 QSANN--VYLVME------YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH-- 123
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA 300
+IHRDLK N+L+ ++ + KL+DFGL+
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 159 LGEGGFGCVYKAKLDDNLHVA---VKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V +++ + VA VK+L A+ EF + D + HPN++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR-------MKIALDTARGLEYLH 267
+V+E E L S+ S WH R ++A + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLK------SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEY- 324
+H +H DL N L S K+ D+G+ + ++ + L ++APE
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 325 ------LLDGKLTDKSDVYAFGVVLLELL 347
L+ + T S+V+A GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 40/124 (32%), Positives = 56/124 (45%), Gaps = 20/124 (16%)
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLK 312
KI L LH+H +IH D+K N+L D +K L D+GL G+ +
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC---- 165
Query: 313 LSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP----------VEKLAPAQC 361
GTL Y +PE + G D S D +A GV+ ELL G+ P +E L Q
Sbjct: 166 YDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224
Query: 362 QSIV 365
+ +
Sbjct: 225 KKLP 228
|
Length = 267 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 52/223 (23%), Positives = 85/223 (38%), Gaps = 51/223 (22%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFEN--------EVDLLSNIHHPNV 209
++G GGFGCVY+ + + C A + EN E + +NI+ +
Sbjct: 19 LIGCGGFGCVYETQCASD--------HCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70
Query: 210 VCL-----------------LGYSAHDDT--RFIVYELMENRSLDIQLHGPSHGSALTWH 250
+ L G RFI+ E + + +I L
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI-- 128
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDG--- 304
I D LEY+HEH + H D+K NI++D + D+G+A I G
Sbjct: 129 --KNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 305 --SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLE 345
S+ + +L GTL Y + +T + D+ + G +L+
Sbjct: 184 EYSKEQKDLH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
L G GCV+++ D V K +E LL + HP V+ LL
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASSV-----HEARLLRRLSHPAVLALLDVRVV 231
Query: 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278
+V L + RS D+ + + L +A ++Y+H +IHRD
Sbjct: 232 GGLTCLV--LPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRD 285
Query: 279 LKSSNILLDSKFNAKLSDFGLA-ITDGSQNKN-NLKLSGTLGYVAPEYLLDGKLTDKSDV 336
+K+ N+L++ + L DFG A GS + + ++GT+ APE L T D+
Sbjct: 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 337 YAFGVVLLE 345
++ G+V+ E
Sbjct: 346 WSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 19/195 (9%)
Query: 178 VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQ 237
V + L+ T++ + +NEV L HPN++ +++ M S +
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN-S 88
Query: 238 LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
L ++ + I RGL YLH++ IHR++K+S+IL+ LS
Sbjct: 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS-- 143
Query: 298 GLA-----ITDGSQNKNNLKL----SGTLGYVAPEYL---LDGKLTDKSDVYAFGVVLLE 345
GL+ + +G + K + L +++PE L L G KSD+Y+ G+ E
Sbjct: 144 GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACE 202
Query: 346 LLLGRRPVEKLAPAQ 360
L GR P + + Q
Sbjct: 203 LATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.85 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.85 | |
| PLN02236 | 344 | choline kinase | 96.84 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.55 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.41 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.39 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.34 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.14 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.65 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.27 | |
| PF06679 | 163 | DUF1180: Protein of unknown function (DUF1180); In | 95.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.53 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-61 Score=474.23 Aligned_cols=291 Identities=49% Similarity=0.822 Sum_probs=256.8
Q ss_pred ccccccHHHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEE
Q 012975 137 AISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216 (452)
Q Consensus 137 ~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 216 (452)
....|++++++.+|++|...+.||+|+||.||+|.+++|..||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35678999999999999999999999999999999999999999998755433156699999999999999999999999
Q ss_pred EcCC-ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 217 AHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 217 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
.+.+ .++||||||+||+|+++|+..... .++|.+|++||.++|+||+|||+.+.|+|+|||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999974433 89999999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccCCCCCccccc-ccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 296 DFGLAITDGSQNKNNLKL-SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 296 Dfgl~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
|||+++............ .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....++.|+.+.+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999996654311111122 7999999999999999999999999999999999999999876655556699999877776
Q ss_pred CCCCCcccchhhc-ccCCH-HHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 375 RSKLPNIVDPVIK-STMDL-KHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 375 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
. .+.+++|+.+. ..... +++.++.+++.+|++.+|++||+|.||++.|+++...
T Consensus 300 ~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 G-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred c-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 5 89999999987 55554 7899999999999999999999999999999666544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=397.39 Aligned_cols=256 Identities=38% Similarity=0.578 Sum_probs=213.0
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh--hHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-ceeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~g 232 (452)
.+.||+|+||+||+|.+++...||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 5569999999999999997766999999654322 2568999999999999999999999999988 799999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEECCCC-cEEEEecCCCcccCCCCCcc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA-VIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+|..+++.. ....+++..+++++.|||+||+|||++ + |+||||||+|||++.++ ++||+|||+++.........
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM 201 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence 999999863 457899999999999999999999998 6 99999999999999997 99999999997654432333
Q ss_pred cccccccCccCccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 311 LKLSGTLGYVAPEYLL--DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~--~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
+...||..|||||++. ...|+.|+||||||++||||+||+.||......+....+. .-..+..++.
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~----~~~~Rp~~p~-------- 269 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV----VGGLRPPIPK-------- 269 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hcCCCCCCCc--------
Confidence 3467999999999999 5689999999999999999999999999887633222221 1111111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
++...+..++.+||+.||+.||++.|++..|+.+.....
T Consensus 270 ----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 ----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 244567788999999999999999999999987776444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=386.54 Aligned_cols=254 Identities=30% Similarity=0.427 Sum_probs=216.4
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChh
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 235 (452)
.+.||+|.||.||.|.++....||+|.+... .-...+|.+|+++|++|+|+|||+++|+|..++..|||||||++|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 6789999999999999999889999999754 334578999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc-ccccc
Q 012975 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-NLKLS 314 (452)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~ 314 (452)
++|.. ..+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...+.... .....
T Consensus 290 ~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 290 DYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 99986 4567899999999999999999999999 9999999999999999999999999999865443332 22233
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLK 393 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 393 (452)
-+..|.|||.+..+.++.|||||||||+||||+| |+.||...+..+....+.. ..+++ ....
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-------GyRlp----------~P~~ 428 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-------GYRLP----------RPEG 428 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-------cCcCC----------CCCC
Confidence 4668999999999999999999999999999998 9999999887664444332 22221 1123
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 394 HLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 394 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
+..++.+++..||+.+|++|||++.+...|+++...+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 55677889999999999999999999999988876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=363.29 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=204.8
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-eeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-RFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~~g 232 (452)
.+.||+|..|+|||++++ ++..+|+|.+... .....+++.+|++++++.+|||||.++|.|..++. ..|+||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 788999999999999987 5788999999544 45567889999999999999999999999999995 99999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
||++.+.. .+.+++...-+|+.++++||.|||+ + +|+||||||+|||++..|++||+|||.+...... ...
T Consensus 164 SLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~ 235 (364)
T KOG0581|consen 164 SLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IAN 235 (364)
T ss_pred CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcc
Confidence 99998853 3679999999999999999999996 5 9999999999999999999999999999655333 445
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--hhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ .....+..+... .....+++ .
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~lP~--------~ 305 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPRLPE--------G 305 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCCCCc--------c
Confidence 67899999999999999999999999999999999999999987521 122223322211 01111111 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....++..++..||++||.+||+++|+++.
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 244577889999999999999999999953
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.06 Aligned_cols=247 Identities=29% Similarity=0.471 Sum_probs=216.8
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..|...++||+|||++||.++. ..|..||+|.+... .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4678899999999999999998 78999999999643 3455677899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|+|++|+|..++. ....+++.+++.+..||+.||.|||++ +|+|||||..|+|++++.++||+|||||......
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999988874 467899999999999999999999999 9999999999999999999999999999888777
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
..+..+.+||+.|+|||++.....+..+||||+||+||-|+.|++||+..+-.+....+... +...+.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------~Y~~P~------ 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------EYSMPS------ 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------Cccccc------
Confidence 77888999999999999999999999999999999999999999999987665544433311 111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....+..++|..+|+.||.+|||+++|+.
T Consensus 240 ------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 ------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22345668999999999999999999994
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=397.02 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=224.5
Q ss_pred CCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..+.++||.|.||.||+|+++- ...||||.++.. ++...++|+.|+.+|.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4457899999999999999762 467999999744 45667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||+||+|+.+|+. +.+.+++.+...++.+||.||.||-+. ++|||||.++|||++.+..+|++|||+++...++.
T Consensus 711 yMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999984 456799999999999999999999999 99999999999999999999999999998765544
Q ss_pred Ccccccc---cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 308 KNNLKLS---GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 308 ~~~~~~~---gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
....+.. -..+|.|||.+..++++.+|||||||++|||.++ |++||.+++.++..+.+. +..+++.-
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------~gyRLPpP-- 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------QGYRLPPP-- 856 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-------hccCCCCC--
Confidence 3222222 2468999999999999999999999999999996 999999998876544443 23333332
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCccccCCCC
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRVAPSG 441 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~ 441 (452)
.++...+.+|++.|||+|-.+||++.+++..|+++++. ..+++.....
T Consensus 857 --------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn--P~SLk~~~~~ 904 (996)
T KOG0196|consen 857 --------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN--PNSLKTIAPE 904 (996)
T ss_pred --------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC--chhhcccCCC
Confidence 24677888999999999999999999999999999987 4445444443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=395.27 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=217.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
.+.+....+.||+|.||+||+|... +.+.||||.++..... ...+|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445555788999999999999753 3567999999866555 77899999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCC-------CCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPS-------HGS----ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~-------~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
.+||+|||..|+|.++|.... .+. +|+..+.+.||.|||.||+||-++ .+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 999999999999999986321 122 389999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhh
Q 012975 291 NAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 291 ~~kl~Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~ 367 (452)
.+||+|||+++...+.+.. .....-..+||+||.++.++++++||||||||+|||+++ |+.||.+...++....+..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 9999999999765433322 112234679999999999999999999999999999998 9999999988775544432
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
..- +. ....+..++.+|+..||+.+|++||+++||-.+|+.....+
T Consensus 721 g~l-L~----------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 721 GQL-LS----------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred CCc-cc----------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 111 11 12255678888999999999999999999999997765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=358.65 Aligned_cols=207 Identities=28% Similarity=0.453 Sum_probs=185.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|...+.||+|.||+||+|+++ ++.+||||.+... .+...+.+..|+.+|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356777888999999999999976 5899999999766 5566677899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC------CcEEEEecCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK------FNAKLSDFGLA 300 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~------~~~kl~Dfgl~ 300 (452)
|||.+|+|..+++. .+.+++..+..++.|+|.||++||++ +|+||||||.||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999974 34799999999999999999999999 99999999999999765 45899999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS 363 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~ 363 (452)
+.... .....+.+|++-|||||+++.++|+.|+|+||.|+++|++++|+.||+..+..+...
T Consensus 163 R~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 163 RFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 88753 334456899999999999999999999999999999999999999999877765433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=344.39 Aligned_cols=256 Identities=26% Similarity=0.368 Sum_probs=209.3
Q ss_pred CCCccCeEeecCcEEEEEEE-eCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEE-EEcC-Cceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGY-SAHD-DTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~-~~~~lV~ 226 (452)
+|++.++||+|.||+|||+. +.+|..+|.|.+... +....++...|+.+|++|+|||||++++. +.++ +..+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45667789999999999997 458999999998633 45566779999999999999999999983 3333 4589999
Q ss_pred eecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
|||..|+|..++.. .+....+++..+++++.|++.||.++|+. .+. |+||||||.||+|+.+|.+||+|||+++..
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999888754 34456799999999999999999999994 224 999999999999999999999999999988
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.+........+||+.||+||.+.+..|+.||||||+||++|||..-+.||.+.+-.+....+.. .+.+.+-|
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q--------gd~~~~p~ 250 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ--------GDYPPLPD 250 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc--------CCCCCCcH
Confidence 7777777788999999999999999999999999999999999999999998754332222221 12211111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.-+...+.++|..|+..||+.||+.-.+++.+.
T Consensus 251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 245567888999999999999999655555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=355.91 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=203.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
..+.|...+.||+|+||.|-+|... +|+.||||.+.... ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456777899999999999999764 79999999985321 112233579999999999999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEec
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDF 297 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~Df 297 (452)
..|||||||++|.|.+.+-. ++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998864 44577778889999999999999999 99999999999999766 78999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCC--C-CchhhHHHHHHHHHHHHcCCCCCCCCChhh-hhhhhhhhccccc
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK--L-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLT 373 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~ 373 (452)
|+|+..+ ......+.|||+.|.|||++.+.. + ..+.|+||+||+||-+++|.+||.+..... ....+..
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~------ 396 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK------ 396 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc------
Confidence 9998876 344556789999999999997754 2 348899999999999999999998765432 1111111
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+.. +.| ....+..++..++|.+||..||++|||+.|+++
T Consensus 397 G~y~----f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYA----FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccc----ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 111 112245678889999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.50 Aligned_cols=265 Identities=29% Similarity=0.467 Sum_probs=213.7
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
++++...+.+.....||+|.||+||+|++.+ .||||.+.... .+..+.|++|+..+++-+|.||+-+.|||.+++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4455555666778999999999999999986 49999997653 4567889999999999999999999999999887
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.||+.+|++.+|+.++|.. ...++..+.+.|+.|+|.|+.|||.+ +|+|||||+.||++.+++++||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999964 36799999999999999999999999 99999999999999999999999999985
Q ss_pred ccCC--CCCcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 302 TDGS--QNKNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 302 ~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
.... .........|...|||||++.. .+|+..+||||||+++|||+||..||.....+++ -|. .....
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifm---VGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFM---VGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEE---ecccc
Confidence 4221 1122223457889999999865 4689999999999999999999999994333221 111 11111
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
-.++... ...++..++.+|+..||..++++||.+.+|+.+|+++++.
T Consensus 610 l~pd~s~------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMPDLSK------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCccchh------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111111 1114456778899999999999999999999999999886
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=345.06 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=206.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..++||+|+||+||.++.. +++.+|+|.++.. .....+...+|..+|.+++||.||+++-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467888999999999999999865 5889999998643 234567789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+||+.||.|+.+|.. ...+++..+.-++..|+.||.|||+. +|+||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999953 46699999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
......+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+.......+.... ....+..+
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----~~~~p~~l--- 249 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----LPLPPGYL--- 249 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----CCCCCccC---
Confidence 6666677899999999999999999999999999999999999999999877554433332111 01111112
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 414 (452)
..+..+++...++.||++|-
T Consensus 250 ---------s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 ---------SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---------CHHHHHHHHHHhccCHHHhc
Confidence 23456788999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=335.84 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=211.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+.|+...++|+|+||.|||++++ +|+.||||++.... +.-.+-.++|+.+|++++|+|+|+++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35666788999999999999987 59999999995433 3345668999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||+..-|.++-+ ....++.....+++.|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+|+......
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998876665543 234588899999999999999999999 99999999999999999999999999999887677
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc--------ccccC---
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--------QLTDR--- 375 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~~--- 375 (452)
...+..+.|.+|.|||.+.+ .+|+...||||.||++.||++|++-|.+.+..+...++..... .+..+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 77778889999999999887 7899999999999999999999999988776543322221111 11111
Q ss_pred --CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 376 --SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 376 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
-.+++.-++.-....-+....-+++++..|++.||.+|++.+|++
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 122222222111111123445788999999999999999999988
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.36 Aligned_cols=266 Identities=30% Similarity=0.463 Sum_probs=215.8
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeCC--C---cEEEEEEecC---cChhhHHHHHHHHHHHHcCCCCceeeeEEEEE
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLDD--N---LHVAVKKLDC---ATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 217 (452)
++...++....++||+|+||.||+|++.. + ..||||.... .......+|.+|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445566667999999999999998653 2 2289999874 44777889999999999999999999999999
Q ss_pred cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 218 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
.++..|+|||+|+||+|.++|.. +...++..++++++.+.|+||+|||++ +++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999974 334799999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
|+++.............-+.+|+|||.+....++.++|||||||++||+++ |..||.+....+....+... ..+.
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~----~~r~ 382 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN----GYRM 382 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc----CccC
Confidence 998665422221112235679999999999999999999999999999998 99999998876544333110 0001
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccC
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~ 432 (452)
..+. .....+..++..||..||++||+|.++.+.|+.+......
T Consensus 383 ~~~~------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIPS------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCC------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111 2234556677799999999999999999999888776553
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=350.10 Aligned_cols=265 Identities=28% Similarity=0.380 Sum_probs=213.2
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
-+.....+.+.||+|-||.|..+....+..||||+++..... ..++|.+|+++|.+++||||+.|+|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 344556678999999999999999999999999999766544 4589999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|..++.... ...+.-....+|+.|||.||+||.+. +++||||.++|+|+|.++++||+|||+++.....
T Consensus 615 EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999996432 12245666788999999999999998 9999999999999999999999999999754333
Q ss_pred C--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHH--cCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 307 N--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL--LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 307 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ell--tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
. ......+-+.+|||+|.+..++++.+||||+||+++||++ +.+.||......+.. ..+...+.+...--...
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQVVLS 767 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcceecc
Confidence 2 2333445678999999999999999999999999999987 489999987754422 11111122111111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
...-+...+.+++.+||..|.++||+++++...|.+.
T Consensus 768 -------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 -------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223456777899999999999999999999888764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.93 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
...|.....||+|..|.||.++. .+++.||||++....+...+-+.+|+.+|+..+|+|||++++.+..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34677778999999999999974 46889999999887777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
|++|+|.+.+. ...+++.++..|+.+++.||+|||.+ +|+|||||++|||++.+|.+||+|||++........
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999988875 34599999999999999999999999 999999999999999999999999999976655555
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhh-hhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT-WAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~ 387 (452)
...+.+||+.|||||++....|++|.||||||++++||+-|++||-..++-....++. ...+.+.. ++
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~----~~------- 493 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN----PE------- 493 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC----cc-------
Confidence 6667899999999999999999999999999999999999999998765543222222 11111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.|+++|++++|+|+
T Consensus 494 -----klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 -----KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22345667888999999999999999995
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=350.46 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=204.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|+..+.||+|+||.||+|.+ .++..||||++.... ......+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 235679999986433 33456799999999999 8999999999987654
Q ss_pred -ceeeeeeecCCCChhhhccCCCC--------------------------------------------------------
Q 012975 221 -TRFIVYELMENRSLDIQLHGPSH-------------------------------------------------------- 243 (452)
Q Consensus 221 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 243 (452)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--CcccccccccC
Q 012975 244 ---GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLG 318 (452)
Q Consensus 244 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~ 318 (452)
...+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13588999999999999999999998 99999999999999999999999999996542221 11222346678
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHH
Q 012975 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQ 397 (452)
Q Consensus 319 y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 397 (452)
|+|||++.+..++.++|||||||++|||++ |..||......+. ... ......... ... .....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~~~~------~~~----~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGTRMR------APE----NATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCCCCC------CCC----CCCHH
Confidence 999999999999999999999999999997 9999987543221 111 001110000 001 12345
Q ss_pred HHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 398 VAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 398 l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 77899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=388.47 Aligned_cols=269 Identities=29% Similarity=0.508 Sum_probs=218.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
...|...++||+|+||.||+|+. .++..||||++...... ..+|++.+++++||||++++|+|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677788999999999999987 47889999998643322 23568899999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.++++ .++|.++.+++.|+|+||+|||+.+.++++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999985 28999999999999999999998777799999999999999999988875 665433211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....+|..|+|||++.+..++.++|||||||++|||+||+.||+.... .....+.|+..... ......++|+.+..
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDMWIDPSIRG 911 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhheeCccccC
Confidence 1123578999999999999999999999999999999999999964332 22445556543322 23344566666643
Q ss_pred --cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCcc
Q 012975 389 --TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTL 435 (452)
Q Consensus 389 --~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~ 435 (452)
..+.++..++.+++.+||+.||++||||+||++.|+++.+.....+.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~ 960 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccccc
Confidence 23457788899999999999999999999999999998886665554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=339.62 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=199.1
Q ss_pred CCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC--ceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~ 228 (452)
++...+.||+|.||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34557889999999999998765 8899999997654333677899999999999999999999855544 68999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCC--
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGS-- 305 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~-- 305 (452)
+++|+|.+++... +..+++..+.+++.|+++||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999742 22799999999999999999999999 9999999999999999 79999999999865542
Q ss_pred -CCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC-ChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 -QNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKL-APAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 -~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.........||+.|||||++.++ ....++|||||||++.||+||+.||... ...+ .+... ......+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~--~~~~i-----g~~~~~P~-- 243 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE--ALLLI-----GREDSLPE-- 243 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH--HHHHH-----hccCCCCC--
Confidence 22234457899999999999864 3345999999999999999999999873 2111 11111 11111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
+.. ....+..+++..|++.||++|||+.++++..
T Consensus 244 ---ip~----~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 244 ---IPD----SLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111 1223566789999999999999999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=379.04 Aligned_cols=263 Identities=29% Similarity=0.436 Sum_probs=215.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC--C----cEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD--N----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
.+....+.||+|+||.||.|...+ | ..||+|.+... +.....+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344457889999999999998653 3 34999999654 4566788999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 224 IVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
|++|||++|+|..+|...+ ....++..+.+.++.|||+|+.||+++ ++|||||.++|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998531 245799999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccc--cccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 300 AITDGSQNKNNLK--LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 300 ~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
|+........... ..-..+|||||.+.++.++.|+|||||||+|||++| |..||...+..+....+.. .+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-------gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-------GG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-------CC
Confidence 9844332222111 123468999999999999999999999999999998 9999998887654432221 11
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
++. ....+...+.+|+..||+.+|++||++..+++++..++....+.
T Consensus 922 RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 922 RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 111 11234556778999999999999999999999887776654443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=336.52 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=199.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhh---HHHHHHHHHHHHcCCCCceeeeEEEEEc----CCceeeeeee
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA---GREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVYEL 228 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~ 228 (452)
...||+|++|.||+|.+ +|..||||.+....... .+.|.+|+.+|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 57799999987543322 4678899999999999999999999876 3467899999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++.. ...+++..+++++.+++.||.|||+.. +++||||||+||++++++.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999964 346899999999999999999999732 67899999999999999999999999986543222
Q ss_pred cccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 NNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+. .......
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~~------- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII------NKNNSLK------- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcCCCCC-------
Confidence 23457899999999876 688999999999999999999999998766443222211 0001100
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.+......+.+++.+||+.||++|||++|+++.|+++
T Consensus 243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0112344677899999999999999999999999765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=343.71 Aligned_cols=267 Identities=28% Similarity=0.380 Sum_probs=209.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Ccee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (452)
..+.|+..++||+|.||.|||++. .+|..||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345667788899999999999985 578999999997655 34456678999999999999999999988776 6899
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||+|||+. +|.-++. ..+-.++..++..++.|++.||+|||++ +|+|||||.+|||||++|.+||+|||||+..
T Consensus 195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999986 5655555 2345799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC-CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc----CCC
Q 012975 304 GSQN-KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----RSK 377 (452)
Q Consensus 304 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~~ 377 (452)
.... ...+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.+..+....+.-......+ ..+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 4443 335567789999999999885 7999999999999999999999999998876544433322111110 111
Q ss_pred CC--cccch------hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LP--NIVDP------VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~--~~~d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
++ ..+.+ .+... -.......++|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 11111 11111 11233567789999999999999999999853
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=353.55 Aligned_cols=239 Identities=28% Similarity=0.493 Sum_probs=201.7
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
+.+-||.|+.|.||+|++.+ ..||||+++... +.+|+.|++|+|+||+.+.|+|.....+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 36779999999999999974 589999985322 3578899999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+.|.. +..++......+..+||.|+.|||.+ .|||||||+-||||..+..+||+|||-++...+. ...+.++
T Consensus 200 ~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFA 272 (904)
T ss_pred HHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhh
Confidence 999953 56789999999999999999999999 9999999999999999999999999988765443 5556789
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
||..|||||++.+.+.++|.||||||||||||+||+.||.+.+... +-|.... .. +.-.....+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGs----Ns--------L~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGS----NS--------LHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEeccC----Cc--------ccccCcccC
Confidence 9999999999999999999999999999999999999998866432 2232111 11 111122244
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
..-+.-|++.||+..|.+||++++++..|+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 556667899999999999999999998885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=334.20 Aligned_cols=267 Identities=28% Similarity=0.418 Sum_probs=202.1
Q ss_pred CccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHc--CCCCceeeeEEEEEcCC----ceeeeee
Q 012975 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHDD----TRFIVYE 227 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E 227 (452)
+..++||+|+||.||||++.+ +.||||++. ....+.|.+|-++.+. ++|+||++++++-+... .++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 336779999999999999976 699999986 4556678888877665 58999999999987766 7899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
|.++|+|.++|. ...++|....+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999996 34699999999999999999999964 46899999999999999999999999999996
Q ss_pred ccC--CCCCcccccccccCccCcccccCCC-CC-----chhhHHHHHHHHHHHHcCCCCCC--------CCChhhhhh--
Q 012975 302 TDG--SQNKNNLKLSGTLGYVAPEYLLDGK-LT-----DKSDVYAFGVVLLELLLGRRPVE--------KLAPAQCQS-- 363 (452)
Q Consensus 302 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~s~Gvll~elltG~~P~~--------~~~~~~~~~-- 363 (452)
... ........-+||.+|||||++.+.- +. .+.||||+|.+||||+++..-++ ..-..+.+.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 543 2222223457999999999987642 22 36899999999999998654332 111111110
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccC
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~ 432 (452)
-+.........+...+.+-|...+. ..+..+++.+..||..|++-|-|+.=|.+++.++..-...
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 0000111122223334444444443 3467788999999999999999999999888877766554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=334.34 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=208.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.+.|+..++||.|..++||+|+. ..+..||||++.... ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 45788889999999999999985 467899999997543 3346889999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||.+||+.+.+... ....+++..+..|..++++||.|||++ |.+|||||+.||||+++|.+||+|||.+-...+..
T Consensus 105 fMa~GS~ldIik~~-~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY-YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHH-ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999888642 234599999999999999999999999 99999999999999999999999999874322221
Q ss_pred ---Ccc-cccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 308 ---KNN-LKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 308 ---~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
... ....||++|||||+++. .-|+.|+||||||++..||.+|..||....+....... +.. ..+..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t------Lqn--~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT------LQN--DPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH------hcC--CCCCc
Confidence 112 45689999999999654 46899999999999999999999999998775432211 111 11111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.-..+..+.+......+.+++..||+.||++|||+.++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1112222223344457888999999999999999999983
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.47 Aligned_cols=249 Identities=28% Similarity=0.388 Sum_probs=208.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc----Ch-hhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA----TQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 221 (452)
..+.|...+.||+|.||+|+.|+.. ++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567888999999999999999765 6899999976543 11 23456778999999998 9999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLA 300 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~ 300 (452)
.++||||+.+|+|.+++.. ...+.+.++.+++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999964 56788999999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGK-LT-DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
...........+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++......... .......+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k------i~~~~~~~ 242 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK------IRKGEFKI 242 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH------HhcCCccC
Confidence 77643344455779999999999999977 76 789999999999999999999998554322211 22333444
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
+.++. ..++..++.+|+..||.+|+|+.|++
T Consensus 243 p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 PSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 44442 23566799999999999999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.99 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=202.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-----------------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-----------------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCL 212 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 212 (452)
++|...+.||+|+||.||++.+++ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997542 3469999986543 3445679999999999999999999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPS----------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H 276 (452)
++++.+.+..++||||+++|+|.+++.... ....++|..+++++.|++.||+|||+. +++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999998875311 123578999999999999999999999 9999
Q ss_pred CCCCCCCEEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 012975 277 RDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL--GRRP 352 (452)
Q Consensus 277 ~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt--G~~P 352 (452)
|||||+|||+++++.+||+|||++........ ......++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999865422211 1122345788999999998899999999999999999986 6778
Q ss_pred CCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 353 VEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
|......+...... ............. ....+...+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAG---EFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHH---HHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 87665433211111 1111000000000 001223567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=328.42 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=204.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+|.+. .+..||+|.+.... ......|.+|+.++++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999763 36789999987543 33456799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999864 235789999999999999999999999 999999999999999999999999998754322
Q ss_pred CCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 306 QNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 306 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....+. +....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~~~---- 228 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGFRLP---- 228 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCCCC----
Confidence 211 1112235678999999999999999999999999999875 999998765433211111 111100
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
........+.+++..||+.+|++||+++|+.+.|.++
T Consensus 229 ------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112334677899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.83 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=213.5
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+..++|...+.||+|+||.||+|...++..+++|.+.........++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888899999999999999998899999999976666567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++... .+..+++.++++++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999753 345789999999999999999999998 99999999999999999999999999986554332
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+...... . ....
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~----~~~~-------- 223 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A----GYRM-------- 223 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h----CCcC--------
Confidence 22223346678999999988899999999999999999998 899998765433222111 0 0000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.....+...+.+++.+||+.||++|||++++++.|+.+
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00112335678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.08 Aligned_cols=247 Identities=35% Similarity=0.557 Sum_probs=195.1
Q ss_pred cCeEeecCcEEEEEEEeC-----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 156 SNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+.||.|.||.||+|.+. .+..|+||.+... .....+.|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 568999999999999877 3678999999654 3445788999999999999999999999999888899999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-- 307 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-- 307 (452)
++|+|.++|+.. ....+++.++++|+.|+++||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999853 246799999999999999999999999 99999999999999999999999999997652211
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..... ...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-----~~~-------- 226 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-----LPI-------- 226 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-----TTS--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cee--------
Confidence 11223346788999999999999999999999999999999 7899987755442222221110 000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.......+.+++..||+.||++|||+.++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001234577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.50 Aligned_cols=264 Identities=27% Similarity=0.371 Sum_probs=211.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh--hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.+|+|.||.||+|+.. +|+.||+|++...... ......+|++.|+.++|+||+.+++++-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4666788999999999999854 7999999999654322 245678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
|+ .+|+..+.+ +...++..++..++.++.+||+|||++ .|+||||||+|+|++++|.+||+|||+++..+..+.
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 488888863 456799999999999999999999999 999999999999999999999999999999887777
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-----cccCCCCCccc
Q 012975 309 NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ-----LTDRSKLPNIV 382 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 382 (452)
.....+-|..|.|||.+.+ +.|+...|+||.||++.||+.|.+-|.+.+.-+....+-.+... +.+-..+++.+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 6666678999999999887 57999999999999999999999888877665543333322211 11111122211
Q ss_pred ch------hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DP------VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+- .+.. .-.......++++..++..||.+|.++.|++++
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111 112344566899999999999999999999953
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.68 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=198.5
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
+.||+|+||.||+++.. +|..||+|.+... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 6889999998643 2334456889999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99988863 35689999999999999999999999 9999999999999999999999999998654333333345
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+. .....++.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~p~------------ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEEIRFPR------------ 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH------cCCCCCCC------------
Confidence 679999999999999999999999999999999999999998755433222111 11111111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
....++.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1234567899999999999999 7999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=330.00 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=199.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
|+..+.||+|+||+||++... ++..||+|.+.... ......+.+|++++++++|+|++++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 68899999986432 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|..++... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999998877532 234689999999999999999999999 99999999999999999999999999986543221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.... ......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~----------- 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV--KEDQEE----------- 223 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh--hccccc-----------
Confidence 2234468999999999999999999999999999999999999998754322111111000 000000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
...+....+.+++.+||+.||++||+ ++|+++
T Consensus 224 -~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 -YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11122346778999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.10 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=205.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888999999999999999876 57889999886543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.. +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999863 345899999999999999999999852 6999999999999999999999999998654322
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc-------
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN------- 380 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 380 (452)
......||..|+|||.+.+..++.++|||||||++|||++|+.||......+........ ..........
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP--VVDGEEGEPHSISPRPR 234 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc--ccccccCCccccCcccc
Confidence 122346899999999999999999999999999999999999999766543322221110 0000000000
Q ss_pred ---------------------ccchhhc----ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 381 ---------------------IVDPVIK----STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 381 ---------------------~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..+-... ..........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00001234568899999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=322.88 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=203.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||.||++++.++..+|+|.+... .....+|.+|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357778899999999999999988889999988633 2335678999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-c
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 309 (452)
+|+|.++++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........ .
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988742 24689999999999999999999998 999999999999999999999999999865432211 1
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... ... ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~-----~~~~--- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRL-----YRPK--- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCC-----CCCC---
Confidence 122235668999999998889999999999999999999 99999876543322221110 000 0011
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.....+.+++.+||+.||++||+++|+++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=331.93 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999876 68899999986432 234566889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 34689999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.. ....++..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~------~~~~~~~~----- 220 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA------GKLEFPRH----- 220 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCcCCCcc-----
Confidence 2235689999999999998999999999999999999999999987654332221111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 422 (452)
....+.+++.+||+.||.+||+ ++|+++.
T Consensus 221 -------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 -------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1235678999999999999995 8888855
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=341.23 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=202.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 221 (452)
.++|+..+.||+|+||.||+|+. +++..||||.+.... ....+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999963 246689999986432 33456789999999999 89999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCC-----------------------------------------------------------
Q 012975 222 RFIVYELMENRSLDIQLHGPS----------------------------------------------------------- 242 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 242 (452)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988885321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 243 -------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 243 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
....++|..+++++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112578999999999999999999998 9999999999999999999999999998654332211
Q ss_pred --ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 310 --NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 310 --~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .......... ....+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~--~~~~~~------ 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGY--RMLSPE------ 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCc--cCCCCC------
Confidence 112235667999999999999999999999999999998 999997654322 1111111000 000000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
....++.+++.+||+.||++||++.||++.|++.
T Consensus 341 ------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.34 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=201.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999876 68899999986433 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++ +|.+++.. .+..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 88887753 234688999999999999999999999 999999999999999999999999999865433333
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc--------cccccCCCCC
Q 012975 309 NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM--------PQLTDRSKLP 379 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 379 (452)
......++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+......... +.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3334568999999998865 568999999999999999999999998766543222211110 0111111111
Q ss_pred cccchhhccc----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKST----MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....+..... .......+..+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111110000 00012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=312.10 Aligned_cols=236 Identities=27% Similarity=0.370 Sum_probs=201.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||.|.||+|..++.+ +|..+|+|.++... ....+...+|..+|+.+.||+++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777899999999999999976 58889999996543 234556789999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|.|+.+|+. .++++...++-+|.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999964 45799999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
..+.|||+.|+|||.+....++.++|.|||||++|||+.|..||...++......+- ..+-+.+..+++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~------~~~v~fP~~fs~-- 266 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL------EGKVKFPSYFSS-- 266 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH------hCcccCCcccCH--
Confidence 567899999999999999999999999999999999999999999887754433322 233344444444
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCC
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYR 413 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~R 413 (452)
.+.+|+...++.|-.+|
T Consensus 267 ----------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 ----------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------HHHHHHHHHHhhhhHhh
Confidence 34457777888888887
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=327.28 Aligned_cols=280 Identities=27% Similarity=0.374 Sum_probs=207.6
Q ss_pred ccCCCccccccHHHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHc--CCCCce
Q 012975 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNV 209 (452)
Q Consensus 132 ~~~~~~~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~ni 209 (452)
++.|++.+.+-...+ ..+....+.||+|.||+||+|++++ ..||||.+... +++.+.+|.++.+. |+|+||
T Consensus 195 SGSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSR---DERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred CCCCCCchhHhHHhh---hheeEEEEEecCccccceeeccccC-CceEEEEeccc---chhhhhhHHHHHHHHHhccchh
Confidence 345555555544443 3466778999999999999999985 48999999632 34556667666664 599999
Q ss_pred eeeEEEEEcCC----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeCCCC
Q 012975 210 VCLLGYSAHDD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-----HCNPAVIHRDLK 280 (452)
Q Consensus 210 v~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~i~H~Dlk 280 (452)
+.+++.-..++ .++||++|.++|||+++|.. ..++....++++..+|.||+|||. +.+|.|.|||||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 99999876554 57999999999999999963 569999999999999999999994 468999999999
Q ss_pred CCCEEECCCCcEEEEecCCCcccCCC----CCcccccccccCccCcccccCCCC------CchhhHHHHHHHHHHHHcC-
Q 012975 281 SSNILLDSKFNAKLSDFGLAITDGSQ----NKNNLKLSGTLGYVAPEYLLDGKL------TDKSDVYAFGVVLLELLLG- 349 (452)
Q Consensus 281 ~~NIll~~~~~~kl~Dfgl~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDv~s~Gvll~elltG- 349 (452)
+.|||+.+++++.|+|+|||...... .......+||.+|||||++...-. -..+||||||+++||+..+
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999543222 223345679999999999865321 2368999999999999632
Q ss_pred ---------CCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 350 ---------RRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 350 ---------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
+.||.+..+.+-.... +....-..++...++... .+.+.+..+.++++.||..+|.-|-|+--+-
T Consensus 424 ~~ggi~eey~~Pyyd~Vp~DPs~ee---MrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVPSDPSFEE---MRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hcCCEehhhcCCcccCCCCCCCHHH---HhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 4577655432210000 001111122222222222 2347788999999999999999999998888
Q ss_pred HhccccCc
Q 012975 421 HSLIPLVP 428 (452)
Q Consensus 421 ~~L~~l~~ 428 (452)
..|.++..
T Consensus 498 Ktl~~l~~ 505 (513)
T KOG2052|consen 498 KTLAKLSN 505 (513)
T ss_pred HHHHHHhc
Confidence 88877764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.13 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=207.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5678889999999999999998888899999986433 345688999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-c
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 309 (452)
+|+|.++++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999998642 345689999999999999999999998 999999999999999999999999999976433221 1
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++..|+|||.+....++.++||||||+++|||+| |+.||......+....... ....+ .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-------~~~~~-----~~-~ 227 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-------GYRMP-----RM-E 227 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------CCCCC-----CC-C
Confidence 122345678999999988889999999999999999998 9999987654332221110 00000 00 0
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.....+.+++.+|++.+|++||+++++.+.|+++
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.82 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=205.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
..++|.+.+.||+|.|++|++|+.. .+.++|||++... .+...+....|-++|.+| .||.|++|+-.+.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4568889999999999999999865 6899999998533 223345577889999999 8999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+|+||++||+|.++++. -+.+++.....++.+|+.||+|||++ |||||||||+|||||+|+++||+|||-|+..
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999974 36699999999999999999999999 9999999999999999999999999999653
Q ss_pred CCC-------------CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 304 GSQ-------------NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 304 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
... ......++||..|.+||++.+...+..+|+|+|||+||+|+.|.+||.+.++--.-..+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~---- 300 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ---- 300 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH----
Confidence 221 111145789999999999999999999999999999999999999999876432211111
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+++ .....+.+|+.+.|..||++|+|..|+-+
T Consensus 301 --~l~y~fp~------------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 301 --ALDYEFPE------------GFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --HhcccCCC------------CCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11122222 22246678999999999999999988874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=341.66 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=204.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888999999999999998742 34579999996543 33456788999999999 8999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCC----------------------------------------------------------
Q 012975 221 TRFIVYELMENRSLDIQLHGPS---------------------------------------------------------- 242 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 242 (452)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999998875311
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC--ccc
Q 012975 243 ---------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNL 311 (452)
Q Consensus 243 ---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~ 311 (452)
....+++.++++++.|++.||+|||++ +++||||||+|||+++++.+||+|||++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 113578999999999999999999998 999999999999999999999999999865422211 111
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhh-hhhhhhhccccccCCCCCcccchhhccc
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
...++..|+|||++.+..++.++|||||||++|||++ |+.||........ ....... .....+..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~-------- 339 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----YQMSRPDF-------- 339 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----cCccCCCC--------
Confidence 2235668999999999999999999999999999997 9999976543221 1111100 00001111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
...++.+++.+||+.||++|||+.+|++.|+++++
T Consensus 340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~~ 374 (374)
T cd05106 340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQLG 374 (374)
T ss_pred ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHhC
Confidence 12457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.07 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=205.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.+|+..+.||+|+||.||+|++. ++. .||+|.+.... ....+++.+|+.+++.++|+||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999986443 34567899999999999999999999999864 5789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||+++|+|.+++.. ....+++..+++++.|++.||+|||+. +++||||||+|||+++++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999874 234689999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~~- 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLPQ- 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-------CCCCCC-
Confidence 32221 112234678999999999999999999999999999997 9999987654432222211 111100
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
+ . .+...+.+++.+||+.||.+||++.+++..|.++.....
T Consensus 233 --~---~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 233 --P---P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --C---C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0 0 122356789999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.03 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=206.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58899999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999863 34689999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~ 385 (452)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .|. .... .+...++.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQ----RPVYDDPR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-cccc----CCCCCccc
Confidence 223456999999999999999999999999999999999999999877654432222 221 1110 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....++.+++.+||+.+|++||+++|+++.
T Consensus 227 ------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 ------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1234467789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=334.87 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=210.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhH-HHHHHHHHHHHcCC-CCceeeeEEEEEcCC-ceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAG-REFENEVDLLSNIH-HPNVVCLLGYSAHDD-TRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 225 (452)
.++|...+.||.|.||+||+|+.. +|..||||+++..-.... ..=.+|+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 356777888999999999999854 688899999865433322 23478999999998 999999999999888 99999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||+ .+|+.++.. ++..++...+..|+.||+.||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+...+
T Consensus 89 fE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99996 588888874 377899999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc----------
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD---------- 374 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------- 374 (452)
... .+..+.|.+|.|||++.. .-|+.+.|+||+||+++|+.+-++-|.+.+..+....+..+......
T Consensus 163 kpP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 443 345678999999998765 67899999999999999999999999888765433333222111110
Q ss_pred ---CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 375 ---RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 375 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
+-.++......+..... ....+..+++.+|+++||.+|||+.|.++.-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11122222222222222 3567888999999999999999999999753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=334.95 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=197.3
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
+.||+|+||.||+++.. +|..||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 6889999998643 2334566788999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
+|..++.. ...+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99888853 34689999999999999999999999 9999999999999999999999999998653333233334
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
..||..|+|||.+.+..++.++|||||||++|||++|+.||...+......... .....++.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~~~~~p~------------ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEEIRFPR------------ 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCCCCCC------------
Confidence 569999999999999999999999999999999999999998765433222111 11111111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223567899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=321.39 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=208.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..+.||+|++|.||+|...++..||+|.+.... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688899999999999999998888889999986443 3356789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.... +..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999986422 45789999999999999999999998 999999999999999999999999999876542221
Q ss_pred c-ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 N-NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+. ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~------- 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGYRMP------- 224 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC-------
Confidence 1 111223457999999999899999999999999999999 999998765433221111 110100
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
........+.+++.+|++.||++||+++++++.|+++
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0012235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.43 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=198.3
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 6889999998643 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
+|..++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99888853 34689999999999999999999999 9999999999999999999999999998653332223334
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....++.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~~~~~~p~------------ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEDIKFPR------------ 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------cCCccCCC------------
Confidence 579999999999999999999999999999999999999998755433222111 11111111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
.....+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223567899999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.62 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=201.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999976 5789999998533 2234467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998863 34688999999999999999999999 9999999999999999999999999999654322
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .....++..++
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------~~~~~~p~~~~--- 239 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL------AGRLKFPNWFD--- 239 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh------cCCcCCCCCCC---
Confidence 224579999999999999999999999999999999999999998765433221111 11112222222
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~ 422 (452)
..+.+++.+||+.||++||+ ++|+++.
T Consensus 240 ---------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 240 ---------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 24568999999999999997 6887743
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=325.61 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=202.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||+||+++.. ++..||+|++.... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 57889999986432 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++++++..+.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765543 234689999999999999999999998 99999999999999999999999999996643222
Q ss_pred -CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc--------cccCCCC
Q 012975 308 -KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ--------LTDRSKL 378 (452)
Q Consensus 308 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 378 (452)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+........... .......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1222356899999999999989999999999999999999999999876543211111110000 0000000
Q ss_pred Ccccchhhcc------cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 379 PNIVDPVIKS------TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 379 ~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.... .........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=333.03 Aligned_cols=239 Identities=24% Similarity=0.324 Sum_probs=195.0
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||.||+++.. ++..||+|.+... .......+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 5788999998532 234456788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++..............
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 998863 34689999999999999999999999 999999999999999999999999999875433333334457
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..... ......++. ..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~------~~~~~~~~~------------~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI------LQEPLRFPD------------GF 216 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCCCCCC------------cC
Confidence 999999999999999999999999999999999999999875543321111 111111111 12
Q ss_pred HHHHHHHHHHhcCCCCCCCCC---hHHHHH
Q 012975 395 LYQVAAVAVLCVQPEPSYRPL---ITDVLH 421 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs---~~evl~ 421 (452)
...+.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 235678999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.50 Aligned_cols=256 Identities=31% Similarity=0.499 Sum_probs=206.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|+..+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367778999999999999998643 2579999986443 334567999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 224 IVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999988864211 14588999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhh
Q 012975 291 NAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 291 ~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~ 367 (452)
.+||+|||++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999986543222 11223356788999999998899999999999999999998 9999987665443222211
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
..... .......++.+++.+||+.||.+||+++||++.|+.+
T Consensus 242 --------~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 242 --------RQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --------CCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 01111 1113446788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.91 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=206.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|...+.||+|+||.||+|++.. ...||+|.+.... .....+|.+|+.++++++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999998742 4579999886443 33456799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ....+++..+++++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999864 234789999999999999999999998 999999999999999999999999999976542
Q ss_pred CCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 QNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+...... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~-- 229 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-------DGYRLPP-- 229 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCCCCC--
Confidence 111 1112235678999999998899999999999999999998 999997765433222111 0000000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
..+....+.+++.+||+.+|++||+++||++.|.+++
T Consensus 230 --------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 230 --------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=331.77 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=209.0
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.|...+.||+|.||.||||.+. .++.||+|.+... ..+...++++|+.+|.+++++||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555688999999999999875 5788999999755 3556688999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
.+|++.+.|.. +..+++....-|..++..||.|||++ +.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999988853 44557778888899999999999999 9999999999999999999999999999776666666
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
..+++||+.|||||++....|+.|+||||||++.+||.+|.+|+.+..+....-++ +.-..|.+.+
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk~~PP~L~~- 233 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PKSAPPRLDG- 233 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cCCCCCcccc-
Confidence 67889999999999999889999999999999999999999999988763321111 1111233333
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++..||++||+.||++.++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23345778899999999999999999983
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=333.24 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=193.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+|+..+.||+|+||+||+|++. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445788999999999999875 68899999986443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.... ..++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.........
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999986432 356778889999999999999999 9999999999999999999999999999765433222
Q ss_pred ccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 310 NLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||......+......... .......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~------ 296 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQPPEA------ 296 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccCCCCC------
Confidence 334579999999998743 233568999999999999999999998433222211111110 0000000
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......++.+++.+||+.||++||++.|+++.
T Consensus 297 ------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 ------PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223467789999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.01 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=206.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
..++|+...+||+|+||.||.++.+ +|..+|+|++.... ....+..+.|-++|...++++||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5678999999999999999999865 68899999997553 4456678999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||++||++..+|. +.+.|+...+..++.+++.|++-||+. |++||||||+|+|||..|++||+||||+.-..
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999985 356799999999999999999999999 99999999999999999999999999983110
Q ss_pred C------------------------CCC----cc-------------------cccccccCccCcccccCCCCCchhhHH
Q 012975 305 S------------------------QNK----NN-------------------LKLSGTLGYVAPEYLLDGKLTDKSDVY 337 (452)
Q Consensus 305 ~------------------------~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDv~ 337 (452)
. ... .. ...+||+.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 000 00 124599999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChhh-hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-
Q 012975 338 AFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL- 415 (452)
Q Consensus 338 s~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs- 415 (452)
|+|||+|||+.|-+||...++.+ ...++.|... +..... .+...+..++|.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999998877 4666666422 111111 1122567789999999 9999965
Q ss_pred --hHHHH
Q 012975 416 --ITDVL 420 (452)
Q Consensus 416 --~~evl 420 (452)
++||-
T Consensus 437 ~G~~EIK 443 (550)
T KOG0605|consen 437 KGAEEIK 443 (550)
T ss_pred ccHHHHh
Confidence 44444
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.58 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=198.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999976 688999999864332 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++ ++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577666653 345688999999999999999999999 99999999999999999999999999986543333
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccc-----cCCCCCc
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLT-----DRSKLPN 380 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~ 380 (452)
.......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ............ .....+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 33334568999999998865 4578899999999999999999999986543211 111110000000 0000000
Q ss_pred cc--------chhhcccC-CHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 IV--------DPVIKSTM-DLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 ~~--------d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. ...+.... .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00000000 0011245678999999999999999999995
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=322.74 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=205.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|...+.||+|+||.||+|+..+ +..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 478999998755444 4678999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 224 IVYELMENRSLDIQLHGPS-----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
+||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986421 234588999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhc
Q 012975 293 KLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~ 369 (452)
||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence 999999986432221 11223345778999999999999999999999999999998 999997765433221111
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
....... .......+.+++.+||+.||++||+++||++.|++
T Consensus 239 -----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 -----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0111000 01223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.64 Aligned_cols=246 Identities=30% Similarity=0.430 Sum_probs=209.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.... ..+.+.+.+|+++++.++|||||.++++++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778889999999999999866 57889999986543 3456779999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+.+ +|..+|.. .+.+.+..+..++.+++.||.|||+. +|.|||+||.|||++.++++|++|||+|+......
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 99999953 56799999999999999999999999 99999999999999999999999999998877766
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.....+.||+-|||||.+.++.|+..+|.||+||++||+++|++||....-.+ ++. ....+..+.+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~---Lv~---~I~~d~v~~p~------- 221 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ---LVK---SILKDPVKPPS------- 221 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH---HHH---HHhcCCCCCcc-------
Confidence 66677889999999999999999999999999999999999999998644222 222 12222222222
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+....+..++...+++||.+|.|-.+++.
T Consensus 222 -----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 -----TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22335667888899999999999988874
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=318.43 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=208.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+++++.++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999865 6889999987532 3344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++|+|.+++.... ....++...++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875322 234588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........|+..|+|||.+.+..++.++|+||||+++|||++|+.||....... ....... .. ...+..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----~~-~~~~~~---- 228 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----EQ-CDYPPL---- 228 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----hc-CCCCCC----
Confidence 3332334568889999999998889999999999999999999999986543211 1111111 00 001110
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
........+.+++.+||+.+|++||++++|++.|+++
T Consensus 229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0112345678899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=323.79 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=209.0
Q ss_pred cCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|...+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999974 2345689999876666667789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 225 VYELMENRSLDIQLHGPS----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999998886321 123589999999999999999999998 9999999999999999999999
Q ss_pred EecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 295 SDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence 99999865432211 1222345778999999998899999999999999999998 9999977654332111110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
..... ... .....+.+++.+||+.||.+|||++||...|+++...
T Consensus 238 ----~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 ----GRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----CCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 001 1224578899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=337.44 Aligned_cols=263 Identities=26% Similarity=0.371 Sum_probs=206.7
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEc
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAH 218 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 218 (452)
+...++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|++++++++ ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 334567888999999999999999853 23469999996443 334567999999999996 9999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCC--------------------------------------------------------
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPS-------------------------------------------------------- 242 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------- 242 (452)
.+..+|||||+++|+|.++++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998876421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 243 -------------------------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 243 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
....+++..+++++.|++.||+|||+. +++||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 013588899999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~ 362 (452)
+++++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999865432211 1222346788999999999999999999999999999997 99999765432211
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
... ........ ........+.+++.+||+.||++||++.+|.+.|+++++
T Consensus 350 --~~~----~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 --YNK----IKSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHH----HhcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 00000000 011223567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=321.13 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=203.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
..++|+..+.||+|+||.||+|... ++..||+|++.... .....+|.+|+.+++.++|+||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999753 35679999885432 3345678999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 222 RFIVYELMENRSLDIQLHGPSH-------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999998864221 23468899999999999999999998 9999999999999999999999
Q ss_pred EecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 295 SDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~---- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME---- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence 99999864432211 1112345778999999998899999999999999999999 7899987654332211110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
...... .......+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ----GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000000 01123467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=328.96 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=195.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHH---HcCCCCceeeeEEEEEcCCceeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLL---SNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++ +.++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999875 58899999986432 23345566676655 567899999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..+++. ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888753 4699999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.. .....+.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~p~----- 222 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN------DEVRYPR----- 222 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCC-----
Confidence 33333456799999999999999999999999999999999999999987654332221111 1111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| ++.++++
T Consensus 223 -------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 -------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1123567899999999999999 5677665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=329.68 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=196.0
Q ss_pred CeEeecCcEEEEEEEe----CCCcEEEEEEecCc----ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKL----DDNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+.||+|+||.||+++. .+++.||+|.+... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35788999998642 123345678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999988853 34688889999999999999999999 999999999999999999999999999865433333
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+. .....++..+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~------~~~~~~~~~~------ 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------KGKLNLPPYL------ 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCCCCCCC------
Confidence 3344579999999999998889999999999999999999999998765432211111 1111122111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
...+.+++.+||+.||++|| ++.++++
T Consensus 224 ------~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 ------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ------CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 23567899999999999999 7888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=328.37 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=202.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888999999999999999876 5778889887654 23345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 346889999999999999999999742 6999999999999999999999999998644222
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc-ccccC---CCCC----
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP-QLTDR---SKLP---- 379 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~---~~~~---- 379 (452)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||................. ..... ....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 12234689999999999988999999999999999999999999986554322211110000 00000 0000
Q ss_pred ----------------cccchhhccc----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 ----------------NIVDPVIKST----MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ----------------~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+...... .......++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000000 00012345788999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=316.43 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=202.3
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+|...+.||+|+||.||+|+..++..+|+|.+.... ....+|.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466788999999999999998877789999986433 2346789999999999999999999999998999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc-c
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-N 310 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 310 (452)
|+|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+......... .
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999988642 33689999999999999999999998 9999999999999999999999999998654332211 1
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~--------- 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPH--------- 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCC---------
Confidence 12235678999999988889999999999999999998 99999876543321111110 0000000
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.....+.+++.+||+.||.+||++.++++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12356788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=331.45 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=201.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC--CcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD--NLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.++|+..+.||+|+||.||+|++.+ +..||+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468888999999999999998643 368999998532 23345678899999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999863 34689999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. ......+..+
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------~~~~~~p~~~-- 251 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------EGIIYFPKFL-- 251 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh------cCCCCCCCCC--
Confidence 22 234579999999999999889999999999999999999999998765433222111 1111111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
...+.+++.+|++.||++|+ +++|+++.
T Consensus 252 ----------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 ----------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 23456799999999999995 89988864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=302.72 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=209.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+.++|+..+.||+|.||.||.|+.+ ++..||+|.+.... ..-..++.+|+++-+.|+||||+++++++.++...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567889999999999999999876 57789999986432 2335679999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||.++|+++..|.. .....++......+..|+|.||.|+|.. +++||||||+|+|++.++..|++|||.+....
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999975 3456789999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....+.+||..|.+||...+...+...|+|++|++.||++.|..||+.....+....+.-. +- .+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------~~-----~~p 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------DL-----KFP 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------cc-----cCC
Confidence 34456789999999999999999999999999999999999999999876644322222211 11 111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .......++|.+|+..+|.+|.+..||+.
T Consensus 243 ---~----~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ---S----TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---c----ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 11235668999999999999999999985
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.76 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=212.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEE-eCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----ce
Q 012975 149 ATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TR 222 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 222 (452)
..++|.+.+.+|+|||+-||.++ ..++..+|+|++.+...++.+..++|++..++++|||++++++++..+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999998 4578899999999988888899999999999999999999999876544 48
Q ss_pred eeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 223 FIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
||+++|...|+|.+.+... .++..+++.+.+.|+.++++||++||+. .|+++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999888653 3455899999999999999999999997 4569999999999999999999999999985
Q ss_pred ccCCCCCc---------ccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc
Q 012975 302 TDGSQNKN---------NLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 302 ~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~ 369 (452)
...-.... ...-..|..|.|||.+. +...++++|||||||+||+|+.|..||+..-... +++. .+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSla-LA- 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLA-LA- 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEE-Ee-
Confidence 43221111 11234788999999875 3467889999999999999999999998654321 1111 11
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
+..+.+.-..+....+.+.+++.+|++.||.+||++.+++..++.++
T Consensus 255 -----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 -----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00111111111235678899999999999999999999999998775
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.33 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=197.4
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
+.||+|+||.||+++.. ++..||+|.+... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6889999998643 2334566788999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
+|..++.. ...+++..+..++.|++.||+|||+ . +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99988853 3468999999999999999999997 6 899999999999999999999999999865333333333
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~------~~~~~p~~---------- 218 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EEIRFPRT---------- 218 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc------CCCCCCCC----------
Confidence 45699999999999999999999999999999999999999987654332222211 11111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 --LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 123567899999999999996 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=322.80 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=209.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35667889999999999999743 356689999876666666789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 225 VYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
||||+++++|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986421 124589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhh
Q 012975 292 AKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~ 368 (452)
++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-- 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-- 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--
Confidence 9999999986543322 11223446788999999999999999999999999999998 999997765533221111
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....... .......+.+++.+||+.||++||++++|++.|+++...
T Consensus 240 ------~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 ------QGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ------CCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0111100 001234677899999999999999999999999888553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.43 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=195.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC--CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcC---CCCceeeeEEEEEc-----
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCAT--QDAGREFENEVDLLSNI---HHPNVVCLLGYSAH----- 218 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 218 (452)
++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999886432 22334566777777665 69999999999853
Q ss_pred CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
....++||||++ ++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346799999996 6888887642 234589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSK 377 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~ 377 (452)
++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+. ..+....... ....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~--~~~~ 232 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP--GEED 232 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC--Chhh
Confidence 98654332 222345689999999999988999999999999999999999999987654332 1222111000 0000
Q ss_pred CCc-------ccchhhc---ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 LPN-------IVDPVIK---STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ~~~-------~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
++. .+.+... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 0000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.08 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=203.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-C-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-D-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.|...+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3777899999999999999754 3 5778888876555556667889999999999999999999999999999999999
Q ss_pred CCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 230 ENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 230 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887532 2245689999999999999999999999 999999999999999999999999999975433221
Q ss_pred --cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 --NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 --~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ......+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~------ 293 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-----GKYDPFPC------ 293 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCCc------
Confidence 23345699999999999999999999999999999999999999987654332211111 00001111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++||++.++++
T Consensus 294 ------~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 ------PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12235778999999999999999999874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.62 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=204.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+|+..+.||+|+||.||+|+.. ....+++|.+.... .....++.+|+.+++.++||||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667889999999999999753 23568888876443 3345679999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 012975 225 VYELMENRSLDIQLHGPS---------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~N 283 (452)
++||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999998875321 123588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhh
Q 012975 284 ILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQ 360 (452)
Q Consensus 284 Ill~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~ 360 (452)
|++++++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999864322211 1122345678999999988899999999999999999998 999998765443
Q ss_pred hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...... ... .... .......+.+++.+||+.||++||+++|+++.|++++..
T Consensus 238 ~~~~~~---~~~--~~~~------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLK---TGY--RMER------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHh---CCC--CCCC------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 222211 000 0000 012234677899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.92 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=198.3
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
+.||+|+||.||+|++. ++..+|+|.+... ..+....+.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 6888999987543 344557799999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc--ccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--NLK 312 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--~~~ 312 (452)
.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......... ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999863 345689999999999999999999999 9999999999999999999999999998643321111 111
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
..++..|+|||.+.+..++.++||||||+++|||++ |..||............... ..... .
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----~~~~~------------~ 218 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----VRLPC------------P 218 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCC------------c
Confidence 123457999999999899999999999999999997 99999766543322222110 00001 0
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
......+.+++.+|++.||++|||+.||++.|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=315.75 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=203.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|+..+.||+|+||.||+|+.. ++..||+|.+..........+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999974 67889999987655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.++++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999998863 34689999999999999999999998 9999999999999999999999999998755433332
Q ss_pred ccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 310 NLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....|+..|+|||.+. ...++.++||||||+++|||++|+.||....+.+... .+. ...... +..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~----~~~~~~-----~~~ 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS----KSNFQP-----PKL 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee----cCCCCC-----CCC
Confidence 33456889999999874 3457889999999999999999999997554322110 000 000000 101
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.. .......+.+++.+||+.||++||+++++++.|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 011235678899999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.19 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=206.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..++||+|+||.||+|...++..||+|.+.... ....++.+|++++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788899999999999999999889999999986443 33467899999999999999999999874 4678999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN- 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~- 307 (452)
+++++|.+++... .+..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988642 345789999999999999999999998 99999999999999999999999999986543221
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......++..|+|||.+....++.++||||||+++||+++ |+.||......+...... .....+ .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~------~ 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYRMP------R 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCCCC------C
Confidence 12223345678999999988889999999999999999998 999998665433211111 000000 0
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.. ....++.+++.+|++.+|++||+++++.+.|+.+
T Consensus 225 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 225 PD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 01 1234688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.95 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=205.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|++|.||+|+.. ++..|++|.+... .......+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4667789999999999999875 5888999988643 345567899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.++++.. ....+++..+++++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998752 245799999999999999999999998 999999999999999999999999999876544333
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......|+..|+|||+..+..++.++|+||||+++|||++|+.||......... .... ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~-----~~~~~~-------- 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---LKII-----RGVFPP-------- 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-----cCCCCC--------
Confidence 333456889999999999999999999999999999999999999876533211 1110 000110
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 001233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.12 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=206.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
+-|+.++.||.|+.|.|-.|++. +|+.+|||.+.... ......+.+|+-+|+-+.|||++.+++++++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34566788999999999999875 79999999996542 333456899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|-|++++.. .+++...++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|... ..
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-VP 164 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-cC
Confidence 99999999999963 46799999999999999999999999 9999999999999999999999999999553 23
Q ss_pred CCcccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLT-DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
+....+.||.+.|.|||++.+.+|. .++||||.||+||.|+||+.||++.+-......+... ...++..+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G------~f~MPs~I--- 235 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG------VFEMPSNI--- 235 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC------cccCCCcC---
Confidence 3444567999999999999999985 6899999999999999999999976544333333321 11222222
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..+..+|+.+|+..||++|.|++||++.
T Consensus 236 ---------s~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 ---------SSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------CHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2355678999999999999999999975
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.91 Aligned_cols=241 Identities=27% Similarity=0.353 Sum_probs=195.4
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+++.. ++..||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5789999998632 233456678888888876 699999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+. ......+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~~~~---------- 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDEVVYPTW---------- 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh------cCCCCCCCC----------
Confidence 4579999999999999999999999999999999999999998766443222111 111111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCh------HHHHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLI------TDVLH 421 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 421 (452)
....+.+++.+||+.||++||++ +++++
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 219 --LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred --CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 12356789999999999999998 66653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.66 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=209.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|... +|..||+|.+... .......+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 7889999987532 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++|+|..++... .....+++.+++.++.+++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888542 2245689999999999999999999998 999999999999999999999999999865543
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ... ......
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~-~~~~~~---- 228 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK----IEK-CDYPPL---- 228 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhh----hhc-CCCCCC----
Confidence 3333334568889999999998889999999999999999999999996543211 111110 000 001000
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
........+.+++.+||+.+|++|||+.+|++.|+++-
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01133456788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.74 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=202.7
Q ss_pred cCCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||.||+|++ .++..+++|.+.... ......+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999984 246789999986433 3344678999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 225 VYELMENRSLDIQLHGPS--------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
||||+++++|.+++.... ....+++.+.+.++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 123588999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhh
Q 012975 291 NAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 291 ~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~ 367 (452)
.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999996543221 11223345678999999988889999999999999999998 9999977554332222211
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
.. ... ... .....+.+++.+||+.||.+||++.++.+.|+.
T Consensus 242 -------~~-~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 -------RQ-LLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------CC-cCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 000 001 123457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.88 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=205.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+|...+.||+|+||.||+|... .+..||+|.+... .....++.+|+++++.++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35677889999999999999875 4788999988643 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988642 235689999999999999999999998 9999999999999999999999999998654332211
Q ss_pred -ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 310 -NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 310 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....... .. ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~--~~~~--------- 226 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---GY--RMER--------- 226 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CC--CCCC---------
Confidence 112234568999999999999999999999999999998 9999987554332111110 00 0000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
......++.+++.+||+.||++||++.|+++.|+++.
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 1112356788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.83 Aligned_cols=240 Identities=26% Similarity=0.393 Sum_probs=192.1
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||+|+.. ++..||+|.+.... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 57789999986432 23344566677777654 899999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999988853 34689999999999999999999998 999999999999999999999999999965433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~~~~~~~---------- 218 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRW---------- 218 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCCCCCCCC----------
Confidence 5679999999999999999999999999999999999999998766433222211 111111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChH-HHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLIT-DVL 420 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 420 (452)
....+.+++.+||+.||++||++. +++
T Consensus 219 --~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 --ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123456789999999999999986 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.09 Aligned_cols=253 Identities=29% Similarity=0.426 Sum_probs=203.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346778899999999999999988888999999865333 3467899999999999999999999885 45689999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 308 (452)
++++|.++++.. ....+++..++.++.+++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998742 234689999999999999999999999 999999999999999999999999999965433221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...... .....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~-------- 223 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-------RGYRMP-------- 223 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC--------
Confidence 1112235668999999988899999999999999999999 999997755433221111 000000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
...+....+.+++.+|++.||++|||++++.+.|++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 --CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.19 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=196.5
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
++||+|+||.||+|+.. +++.||+|.+... .......+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 4789999998643 233445678899998876 799999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999888853 34689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||......+....+. ......+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~------~~~~~~p~~---------- 218 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL------HDDVLYPVW---------- 218 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCCCCCCC----------
Confidence 5579999999999999999999999999999999999999998766543221111 111111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-------ChHHHHHh
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRP-------LITDVLHS 422 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RP-------s~~evl~~ 422 (452)
...++.+++..||+.||++|| +++++++.
T Consensus 219 --~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 --LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 123567899999999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.48 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=197.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCC-CceeeeEEEEEcCCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 226 (452)
+|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999876 4678999998643 23345678889999999976 56888999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988853 34689999999999999999999999 9999999999999999999999999998643322
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
........||..|+|||++.+..++.++|||||||++|||+||+.||......+....+. .....++..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~~~~~~~~----- 223 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM------EHNVSYPKS----- 223 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCCCCCCCC-----
Confidence 233334579999999999999999999999999999999999999998765433221111 111111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 421 (452)
....+.+++.+||+.||++|++. +++++
T Consensus 224 -------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 224 -------LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12356789999999999999987 56553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.94 Aligned_cols=241 Identities=27% Similarity=0.398 Sum_probs=193.9
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+|+.. ++..||+|.+.... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 47889999986431 23345567788888764 899999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865332223334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||++.+..++.++|||||||++|||++|+.||......+....+... ....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~---------- 218 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRW---------- 218 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCcc----------
Confidence 457999999999999999999999999999999999999999876544322222111 1111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChH-HHHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLIT-DVLH 421 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 421 (452)
....+.+++.+||+.||++||++. ++.+
T Consensus 219 --~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 --LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 123466889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.99 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=204.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+|++.. + ..+|+|.+... .....+.+.+|++++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778999999999999998752 2 36899988654 334456799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999863 335689999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCcc---cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 306 QNKNN---LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 306 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-------~~~~~~~- 231 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------DGFRLPA- 231 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-------cCCCCCC-
Confidence 22111 11123457999999988889999999999999999997 999997655432211111 1111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
..+....+.+++.+||+.||++||++.+|++.|++++
T Consensus 232 ---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 232 ---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=333.36 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=204.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999976 68899999986432 244567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999864 25689999999999999999999998 9999999999999999999999999998654332
Q ss_pred C-----------------------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 307 N-----------------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 307 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
. .......||..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12233568999999999999999999999999999999999999998776
Q ss_pred hhhhhhh-hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHh
Q 012975 358 PAQCQSI-VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-ITDVLHS 422 (452)
Q Consensus 358 ~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~ 422 (452)
..+.... ..|. ....++... .....+.+++.+|++ ||.+||+ ++|+++.
T Consensus 235 ~~~~~~~i~~~~-----~~~~~p~~~----------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYNKIINWK-----ESLRFPPDP----------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHHhccC-----CcccCCCCC----------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4432221 1111 111111100 023456788999998 9999999 9999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=317.69 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=201.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||.||+|++. ++. .+++|.+.... .....++..|+..+++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45677899999999999999874 343 47788875332 3344678889999999999999999998854 56789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||+++|+|.++++. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999873 345689999999999999999999998 99999999999999999999999999996543
Q ss_pred CCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+.- .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-------GERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCcCC--
Confidence 221 11223456778999999998899999999999999999998 9999987665443222211 01100
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.+.. +...+.+++.+||+.||++|||+.|+++.|..+.+.
T Consensus 232 -~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 -QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0111 123456789999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.51 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+++. .++..++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999986 47889999987542 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++++|.+++... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887632 2345689999999999999999999999 999999999999999999999999999865543
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........|+..|+|||.+.+..++.++|+||||+++|||++|..||....... ........ .... +.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-----~~~~-----~~ 227 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-----QCDY-----PP 227 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhh-----cCCC-----CC
Confidence 3332334468899999999998889999999999999999999999997543211 11111000 0000 00
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.. .......+.+++.+||+.||++|||+.+|++.++++-
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 0123456788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=320.72 Aligned_cols=263 Identities=27% Similarity=0.361 Sum_probs=201.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-----CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Ccee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (452)
++|+..+.||+|+||.||++..+ ++..||+|++........+.+.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777899999999999999743 5788999999776666678899999999999999999999987543 4678
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 304 GSQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
...... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR--------MMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh--------hccccccccc
Confidence 322211 11112345699999999889999999999999999999988776443211000 0000000000
Q ss_pred cc-------chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 381 IV-------DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 381 ~~-------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.. ...............+.+++.+||+.+|++|||++||++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00000001112345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.46 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=201.1
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+|...+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999998877789999886432 2345688999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc-c
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-N 310 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 310 (452)
++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......... .
T Consensus 84 ~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999863 234689999999999999999999999 9999999999999999999999999998654322111 1
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... . .... +
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~--~~~~-----~----- 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---Y--RLYR-----P----- 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC---C--cCCC-----C-----
Confidence 11224457999999998999999999999999999998 89999876543322211100 0 0000 0
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.....++.+++.+||+.+|++|||+.|+++.|
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 --KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11234678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.15 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=203.4
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+.+++++.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445667777789999999999999865 5778999998776666777899999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGPSHGSAL--TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~ 302 (452)
+||+++++|.+++... ...+ ++..+..++.|++.||+|||+. +++||||||+||+++. ++.++|+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 84 MEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999998742 2334 7888999999999999999998 9999999999999976 67999999999865
Q ss_pred cCCCCCcccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
............|+..|+|||.+.+.. ++.++||||||+++|||++|+.||........ ..+..........++
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~- 234 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKIHPEIP- 234 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhccCCCCC-
Confidence 433333333345889999999986643 78899999999999999999999976432211 111111111111111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....++.+++.+||+.+|++|||+.|+++.
T Consensus 235 -----------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 -----------ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----------cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1223456788999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=332.16 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=203.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC-C
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD-D 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 220 (452)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888999999999999999642 24689999986443 33446788999999999 899999999988754 4
Q ss_pred ceeeeeeecCCCChhhhccCCCC---------------------------------------------------------
Q 012975 221 TRFIVYELMENRSLDIQLHGPSH--------------------------------------------------------- 243 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 243 (452)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988753211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--CcccccccccCcc
Q 012975 244 -GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYV 320 (452)
Q Consensus 244 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~ 320 (452)
...++|..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999998 99999999999999999999999999996542221 1122334677899
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHH
Q 012975 321 APEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVA 399 (452)
Q Consensus 321 aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 399 (452)
|||++.+..++.++|||||||++|||++ |+.||......+. .... +..... .. ........+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~----~~~~~~--~~--------~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR----LKEGTR--MR--------APEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH----HhccCC--CC--------CCccCCHHHH
Confidence 9999999999999999999999999997 9999976443221 1000 000000 00 0112234678
Q ss_pred HHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 400 AVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 400 ~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
+++.+||+.+|++||++.|+++.|.+++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=313.74 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=204.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++|...+.||+|+||.||+|++.++..||+|.+..... ....|.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 346888899999999999999988777899999874332 34578999999999999999999998754 5679999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998642 234689999999999999999999998 9999999999999999999999999998654332211
Q ss_pred -ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 310 -NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 310 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.....++..|+|||...+..++.++||||||+++|||+| |+.||......+....... ....+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------~~~~~-------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GYRMP-------- 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-------CCCCC--------
Confidence 112346678999999988899999999999999999999 8889977654332211110 00000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
...+....+.+++.+|++.||++||++.++++.|++..
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11133456789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.62 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=194.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----cee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (452)
+|+..+.||+|+||.||+|+.. ++..||+|++... .......+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999865 6889999998642 2234457889999999999999999999886433 479
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688887753 34699999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCC---CcccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc-----
Q 012975 304 GSQN---KNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT----- 373 (452)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~----- 373 (452)
.... .......||..|+|||.+.+ ..++.++|||||||++|||+||+.||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 11234568999999998866 6789999999999999999999999976553221111110000000
Q ss_pred --cCCCCCcccch-------hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 --DRSKLPNIVDP-------VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 --~~~~~~~~~d~-------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........++. ...... ......+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 000000 0112456789999999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.82 Aligned_cols=242 Identities=27% Similarity=0.343 Sum_probs=196.6
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+++.. ++..||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 4788999998643 233455678899999888 799999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999888853 34699999999999999999999999 999999999999999999999999999865333333333
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...........+. ......+.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~------~~~~~~~~----------- 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL------EDEVRYPR----------- 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCCCCC-----------
Confidence 4568999999999999999999999999999999999999998765433211111 11111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHh
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLHS 422 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~ 422 (452)
.....+.+++.+||+.||++||++ .++++.
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 -WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 122456789999999999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.39 Aligned_cols=243 Identities=27% Similarity=0.390 Sum_probs=207.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
..++|....+||+|.||+|+++..+ ++..+|||.++.. ..++.+..+.|..++... +||.+++++.++..++..|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999876 5778999998644 355677788888888877 5999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
.||||+.+|++..+.+ ...++...+.-++..++.||+|||++ +||+||||.+|||||.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999554433 46799999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
-.......+++||+.|||||++.+..|+.+.|.|||||+||||+.|+.||.+.+.++.-+-+ +.++...+-
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d~~~yP~--- 589 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VNDEVRYPR--- 589 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcCCCCCCC---
Confidence 65666778899999999999999999999999999999999999999999988766532222 122222222
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
....+...++++++..+|++|--+
T Consensus 590 ---------~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ---------FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------cccHHHHHHHHHHhccCcccccCC
Confidence 233467789999999999999877
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.57 Aligned_cols=246 Identities=25% Similarity=0.309 Sum_probs=197.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 226 (452)
+|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999876 57789999986432 22344567788888877 5899999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|..++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988853 34689999999999999999999999 9999999999999999999999999998654333
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
........||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+. ......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~~~~~~p~------ 222 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNVAYPK------ 222 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCCC------
Confidence 333345679999999999999999999999999999999999999998766543222111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 421 (452)
....++.+++.+|++.||++|++. .++.+
T Consensus 223 ------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 223 ------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 123456789999999999999985 56653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.37 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=207.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 222 (452)
.++|...+.||+|+||.||+|.+.+ +..|++|++... .......+.+|+.++++++|+|++++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998765 688999988643 34456778999999999999999999999876 4678
Q ss_pred eeeeeecCCCChhhhccCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 223 FIVYELMENRSLDIQLHGPSHG-----SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
++++||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643222 5699999999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccccc
Q 012975 298 GLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 298 gl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
|+++....... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....+.+...... .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-------D 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------c
Confidence 99864322111 1122345778999999998889999999999999999998 999998765533222111 1
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
...+.. .......+.+++.+||+.||++|||+.|+++.|.++..
T Consensus 235 ~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111100 00123467889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.00 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=210.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCC-cEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEE-EEcC------C
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDN-LHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGY-SAHD------D 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~~------~ 220 (452)
..++.+.+.|.+|||+.||.+++..+ .++|+|++...++...+...+|+++|++|+ |+|||.+++. .... -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34566788999999999999998766 999999998888888999999999999996 9999999993 2221 2
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
+.+|.||||.+|.|-+++..... ..|++.++++|+.++++|+++||.. .|+|||||||-+||||..+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 56899999999999998875333 3499999999999999999999985 889999999999999999999999999998
Q ss_pred cccCCCCCc---------ccccccccCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh
Q 012975 301 ITDGSQNKN---------NLKLSGTLGYVAPEYL---LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 301 ~~~~~~~~~---------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~ 368 (452)
...-..... .....-|+.|+|||++ .+...++|+|||+|||+||-|+....||++.....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 543221111 1123368999999987 45678999999999999999999999999754322
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.+..+..++.. ..+...+..||+.||+.||++||++-+|+..+.++....
T Consensus 266 --Ilng~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 --ILNGNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --EEeccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12222222221 367788999999999999999999999999887766543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.81 Aligned_cols=265 Identities=27% Similarity=0.334 Sum_probs=208.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhh--HHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA--GREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 225 (452)
+.|+..+.|++|.||.||+|++. ++..||+|+++...... --...+||.+|.+.+|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45666889999999999999976 68899999997554221 23458999999999999999998876543 478999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||+. +|...++.. .+++...++..+..|+++|++|||.. .|+|||||++|+|+++.|.+||+|||+|+..++
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 788888743 36899999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc-----CCCCC
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-----RSKLP 379 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 379 (452)
..+..+..+-|.+|.|||.+.+. .|+++.|+||+||++.||+++++-|.+....+..+.+-.......+ -..++
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 88888888899999999999875 6899999999999999999999999887764433333222111110 01111
Q ss_pred --------cccchhhcccCCH-HHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 --------NIVDPVIKSTMDL-KHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 --------~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..-...++..+.. ...++-++++...+..||.+|-|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111111111111 12356678999999999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.64 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=215.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-eeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-RFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 226 (452)
++|...+.+|+|+||.++..+.+ ++..+++|++.... ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777899999999999999765 57789999986553 3344578999999999999999999999999988 99999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
+|++||++.+.+.. .++..++..++.+++.|++.|++|||+. .|+|||||+.||+++.++.+||+|||+++..+..
T Consensus 84 ~Y~eGg~l~~~i~~-~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE-QKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHH-HhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999998876 3367799999999999999999999988 9999999999999999999999999999988777
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....+..||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+.......+.... ++|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~------------~~P-- 225 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL------------YSP-- 225 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc------------CCC--
Confidence 656677899999999999999999999999999999999999999999877654322222110 111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+..++..++..|++.+|..||++.+++.+
T Consensus 226 ---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222455677889999999999999999999976
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=317.01 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=195.2
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999875 68899999986432 22335678899999999999999999999999999999999999999
Q ss_pred hhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccccc
Q 012975 235 DIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313 (452)
Q Consensus 235 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 313 (452)
..++... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 8877532 2345699999999999999999999999 99999999999999999999999999986554333333345
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 314 ~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
.||..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ....... ...
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~------------~~~ 222 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---ILNDSVT------------YPD 222 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---hcccCCC------------Ccc
Confidence 789999999999999999999999999999999999999976542211 111110 0111000 111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345677899999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.82 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=193.1
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||+|+.. +|..||+|.+.... ......+..|..++... +|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 57889999986432 23345567788888764 899999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999988853 34689999999999999999999999 999999999999999999999999999864322223334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.. .....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~---------- 218 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------DTPHYPRW---------- 218 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCC----------
Confidence 56799999999999999999999999999999999999999987654332221111 11111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChH-HHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLIT-DVL 420 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 420 (452)
...++.+++.+||+.||++||++. +++
T Consensus 219 --~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 --ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123566799999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=332.52 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=199.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+++.. +++.||||.+.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999876 58899999986432 234456889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999864 34689999999999999999999999 9999999999999999999999999998543211
Q ss_pred CC--------------------------------------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 012975 307 NK--------------------------------------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL 348 (452)
Q Consensus 307 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt 348 (452)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 00 0112459999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhh-hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHH
Q 012975 349 GRRPVEKLAPAQCQS-IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL---ITDVLH 421 (452)
Q Consensus 349 G~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 421 (452)
|+.||......+... ...|... ...+.. ......+.+++.+|+. +|.+|++ ++|+++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~----------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKET-----LQFPDE----------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCc-----cCCCCC----------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999998766543221 2122100 001000 0112355678888886 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.24 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=176.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+++.. +++.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 58899999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999863 35699999999999999999999999 9999999999999999999999999998643211
Q ss_pred C-----------------------------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 012975 307 N-----------------------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 307 ~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0 00123579999999999999999999999999999999999999
Q ss_pred CCCCCChhh
Q 012975 352 PVEKLAPAQ 360 (452)
Q Consensus 352 P~~~~~~~~ 360 (452)
||......+
T Consensus 235 Pf~~~~~~~ 243 (363)
T cd05628 235 PFCSETPQE 243 (363)
T ss_pred CCCCCCHHH
Confidence 998766544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.73 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+|+..+.||+|+||+||++... ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999875 68899999986432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887642 235689999999999999999999999 99999999999999999999999999986543222
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.... ......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~---------- 223 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV--KEDQEE---------- 223 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh--hhcccc----------
Confidence 2223468999999999999899999999999999999999999998754322111111100 000000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
........+.+++..||+.||++|| +++++++.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 --YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112344677899999999999999 78888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=327.13 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=194.0
Q ss_pred CeEeecCcEEEEEEEe----CCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 157 NILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
+.||+|+||.||+++. .+|..+|+|.+.... ......+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999986432 2234567889999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999998853 34689999999999999999999999 99999999999999999999999999987654433333
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
....||..|+|||.+.+..++.++|||||||++|||++|+.||......+....+. .....++..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~------~~~~~~p~~--------- 220 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL------KAKLGMPQF--------- 220 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH------cCCCCCCCC---------
Confidence 45679999999999998889999999999999999999999998765433221111 111111111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChHH
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLITD 418 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~~e 418 (452)
....+.+++.+||+.||++||++.+
T Consensus 221 ---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 ---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1235667999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.74 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=207.2
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
...++|+..+.||+|+||.||++... +...+|+|.+... ......++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34557888899999999999999864 2367899988643 233456789999999999 899999999999999
Q ss_pred CceeeeeeecCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 220 DTRFIVYELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+..+++|||+++|+|..+++.. .....+++..+++++.|++.||+|||+. +++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999988632 2245789999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhh
Q 012975 287 DSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQS 363 (452)
Q Consensus 287 ~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~ 363 (452)
++++.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999865432211 1112235678999999988899999999999999999997 999998765433222
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
... ..... . ........+.+++.+|++.||++|||++|+++.|+.++
T Consensus 246 ~~~-------~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLK-------EGYRM-E---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH-------cCCcC-C---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 00000 0 01122346778999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=312.88 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=198.2
Q ss_pred CccCeEeecCcEEEEEEEeCCCc---EEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------Cce
Q 012975 154 HESNILGEGGFGCVYKAKLDDNL---HVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------DTR 222 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 222 (452)
...+.||+|+||.||+|++.++. .+|+|.+... .....+.+.+|+++++.++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 35678999999999999876432 5899987643 344567899999999999999999999988542 246
Q ss_pred eeeeeecCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 223 FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
+++|||+++|+|..++... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998876321 1234589999999999999999999998 999999999999999999999999999
Q ss_pred CcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 300 AITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 300 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
+........ ......++..|+|||...+..++.++||||||+++|||++ |+.||......+....+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCC
Confidence 865432221 1122245678999999999999999999999999999999 899997755433211111 111
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.... .......+.+++.+||+.||++|||+.|+++.|++++
T Consensus 232 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 232 RLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1000 0112345778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.80 Aligned_cols=237 Identities=28% Similarity=0.356 Sum_probs=190.3
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+|+.. +|+.||+|.+.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 68899999986432 223344555555 56789999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999988853 34689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~~~~~----~------- 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL------NKPLRLK----P------- 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH------cCCCCCC----C-------
Confidence 5579999999999999999999999999999999999999998765433211111 1111111 1
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLIT 417 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 417 (452)
.....+.+++.+||+.||++||+++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1134567899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.58 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=193.6
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 5788999998643 233445678899988877 899999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999888753 34689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--hhhhhhhccc-cccCCCCCcccchhhcc
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QSIVTWAMPQ-LTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~d~~l~~ 388 (452)
...||..|+|||++.+..++.++|||||||++|||++|+.||........ .....+.... ......++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-------- 226 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-------- 226 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--------
Confidence 56799999999999999999999999999999999999999964321110 0001111000 111111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPL------ITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~ 421 (452)
.....+.+++.+||+.||++||+ +.++++
T Consensus 227 ----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 227 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 12345678999999999999998 467654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.55 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=194.8
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
++||+|+||.||+++.. ++..||+|.+... .....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 5788999998643 223445688999999998 799999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++...........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999888753 35699999999999999999999999 999999999999999999999999999865332333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh--hhhhhhhhccc-cccCCCCCcccchhhcc
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ--CQSIVTWAMPQ-LTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~d~~l~~ 388 (452)
...||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+.... ......++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-------- 226 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR-------- 226 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--------
Confidence 5679999999999999999999999999999999999999997432211 00011111000 011111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPL------ITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~ 421 (452)
.....+.+++.+||+.||++||+ ++|+++
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12235678999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=315.86 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666889999999999999642 356799999887777777889999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 225 VYELMENRSLDIQLHGPSH------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
+|||+++|+|.++++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998864221 13589999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhc
Q 012975 293 KLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~ 369 (452)
||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999864422211 1112235678999999999999999999999999999998 999997665433222111100
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
....+ . .....+.+++.+||+.||++||+++||++.|+
T Consensus 242 -----~~~~~--------~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 -----ELERP--------R----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----cCCCC--------C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 0 12245678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=315.30 Aligned_cols=256 Identities=32% Similarity=0.419 Sum_probs=202.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|...+.||+|+||.||+|.+.+ +..|++|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999998753 5678899886443 33456799999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEE
Q 012975 223 FIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLS 295 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~---~~kl~ 295 (452)
++||||+++++|.++++... ....+++..+++++.|++.||+|||+. +++||||||+||++++++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999886432 123689999999999999999999999 999999999999998765 59999
Q ss_pred ecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccc
Q 012975 296 DFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 296 Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
|||++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...........+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----- 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG----- 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----
Confidence 99998654222111 112223567999999999999999999999999999997 9999987654432222110
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
..... ........+.+++.+|++.||++||++.+|++.|.+
T Consensus 237 --~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 --GGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred --CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00000 001123467789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.18 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=200.6
Q ss_pred CccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeee
Q 012975 154 HESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 225 (452)
+..+.||+|+||+||+++. .++..||+|.+.... ......|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6788999999999988653 357789999986543 23456788999999999999999999998764 357899
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 3599999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 QNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+....... .....+..... ....+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-TVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-chhhhhhhh
Confidence 2111 112235667999999988899999999999999999999999986543211 11111111000 000111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
+.............++.+++..||+.||++|||++++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111123346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=309.86 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=205.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999876 67899999976544 56789999999999999999999999999899999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999986422 23699999999999999999999999 999999999999999999999999999865522211
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+.. .. ....+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~--~~~~~---------- 221 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GY--RMEAP---------- 221 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CC--CCCCc----------
Confidence 2235668999999988899999999999999999997 9999987654332221110 00 00000
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
......+.+++.+||+.+|++||+++|++.+|+.+
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 --EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11235677899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=317.13 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=206.5
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
...++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34578888999999999999999753 24579999876433 233456889999999999999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 012975 221 TRFIVYELMENRSLDIQLHGPS-------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~k 293 (452)
..++||||+++|+|.+++.... ....+++..+.+++.|++.||.|||++ +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999986421 123467888999999999999999998 999999999999999999999
Q ss_pred EEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcc
Q 012975 294 LSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~ 370 (452)
|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM---- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999865432211 1122235678999999998899999999999999999998 899998765433221111
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
..... . ........+.+++.+|++.||++|||+.|+++.|++.+..
T Consensus 236 ---~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 236 ---DGGYL-D---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred ---cCCCC-C---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 00000 0 0011235788899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=319.21 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=203.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-C--cEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-N--LHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
++|++.+.||+|+||.||+|...+ + ..+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998754 3 34788887642 334456789999999999 799999999999999999999
Q ss_pred eeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
+||+++|+|.++++... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986421 123588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+...... ..
T Consensus 159 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~---~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP---QG 234 (297)
T ss_pred EECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---cC
Confidence 999999985432111 1111223567999999988889999999999999999997 999998765433211110 00
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
. ....+ ......+.+++.+||+.||.+||++.++++.|++++..
T Consensus 235 ~--~~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 235 Y--RMEKP------------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred C--CCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00011 11234677899999999999999999999999877754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.13 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+|++. ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999864 23479999886433 33456899999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ....+++.++++++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999874 335689999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCcc---cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 306 QNKNN---LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 306 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......+...... +....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~~~~- 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-------EGYRLPA- 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-------CCCcCCC-
Confidence 22111 11223568999999998899999999999999999886 999998765433211111 0001100
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.......+.+++.+|++.+|++||++.++++.|++++
T Consensus 231 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 231 ---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred ---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 0112345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=315.14 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|++. ++. .||+|.+... .......+.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46777899999999999999854 343 4899998644 34456778999999999999999999999975 45789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||+++|+|.++++. ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++....
T Consensus 86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999863 235689999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... .....++..|+|||...+..++.++||||||+++|||++ |..||...........+. . ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~----~~~~~~- 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---K----GERLPQ- 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C----CCcCCC-
Confidence 22211 112234678999999999999999999999999999998 999997655433222111 1 000000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011234577899999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=310.51 Aligned_cols=245 Identities=25% Similarity=0.423 Sum_probs=195.6
Q ss_pred EeecCcEEEEEEEeC---CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD---DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 45679999886543 334567999999999999999999999886 4578999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc---cc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN---NL 311 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~---~~ 311 (452)
.+++.. ....+++..+++++.|++.||+|||++ +++||||||+||++++++.+||+|||++......... ..
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 998863 245689999999999999999999998 9999999999999999999999999998644322211 11
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
...++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+... .....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~------------ 219 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-----KRLDC------------ 219 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCCC------------
Confidence 1223578999999988889999999999999999996 99999876554322222110 00000
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
+..+..++.+++.+||+.||++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112245677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.44 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=198.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--------------hhHHHHHHHHHHHHcCCCCceeeeE
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------------DAGREFENEVDLLSNIHHPNVVCLL 213 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 213 (452)
..++|.....||+|.||.|-+|+.. ++..||+|.+..... ...+...+|+.+|++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578888999999999999999865 688999999853221 1235788999999999999999999
Q ss_pred EEEEcC--CceeeeeeecCCCChhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 214 GYSAHD--DTRFIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 214 g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
++..+. +..|||+|||..|.+... ..... ++..++++++.++..||+|||.+ +|+||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 998765 478999999999988533 22334 99999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCcccCCC-----CCcccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChhhh
Q 012975 291 NAKLSDFGLAITDGSQ-----NKNNLKLSGTLGYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC 361 (452)
Q Consensus 291 ~~kl~Dfgl~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~ 361 (452)
++||+|||.+...... ........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998654211 11122367999999999987733 24578999999999999999999988654443
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
...+. .+ .+.-...+++...+.+|+.++|++||++|.++.+|....
T Consensus 328 ~~KIv------n~----------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 FDKIV------ND----------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHh------cC----------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 22221 11 111111224456677899999999999999999987543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.78 Aligned_cols=246 Identities=30% Similarity=0.432 Sum_probs=199.0
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChh
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 235 (452)
++||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999986543 334457899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc-ccccc
Q 012975 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN-NLKLS 314 (452)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~ 314 (452)
+++.. ....+++..++.++.|++.+|.|||+. +++||||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 98863 234689999999999999999999998 9999999999999999999999999998643222111 11223
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLK 393 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 393 (452)
++..|+|||++.+..++.++||||||+++||+++ |..||...........+.. .. .... ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---~~--~~~~------------~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---GY--RMSC------------PQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---CC--CCCC------------CCC
Confidence 4567999999998899999999999999999998 9999987654332211110 00 0000 011
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 394 HLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 394 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=309.77 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=202.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|...+.||+|++|.||++.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999998877789999876432 33467899999999999999999999875 456899999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-c
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 309 (452)
+|+|.++++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999998742 244689999999999999999999998 999999999999999999999999999965432221 1
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++..|+|||...+..++.++||||||+++|||+| |+.||......+...... .....+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~--------- 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------RGYRMP--------- 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC---------
Confidence 122346678999999988899999999999999999999 999998765433211111 000000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
........+.+++.+||+.||++||++++|++.|++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=312.43 Aligned_cols=255 Identities=29% Similarity=0.427 Sum_probs=201.4
Q ss_pred CCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-----
Q 012975 153 FHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 221 (452)
|...+.||+|+||.||+|++.. +..||+|++... .......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 367999998643 23445679999999999999999999999876554
Q ss_pred -eeeeeeecCCCChhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 222 -RFIVYELMENRSLDIQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 222 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
.++++||+++|+|..++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 699999999999998885422 234689999999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccccc
Q 012975 298 GLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 298 gl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
|+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~---~~--~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR---HG--N 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC--C
Confidence 998654322211 112235678999999988889999999999999999999 999997755433211111 00 0
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
....+ .....++.+++.+||+.||++||++.|+++.|++++
T Consensus 233 ~~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 233 RLKQP------------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCCC------------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 00011 123446788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=317.02 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=205.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|...+.||+|+||.||+++. ..+..||+|.+.... ....+.+.+|+++++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345788899999999999999974 235679999886543 33456789999999999 7999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+++|+|.++++... ...+++.+++.++.|++.||+|||++ +++|+||||+||++++++.+|++|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999987422 34489999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 301 ITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 301 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. ........ ...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~~~~--~~~ 264 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIKEGY--RMA 264 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHHcCC--cCC
Confidence 65432221 1112345678999999999999999999999999999998 99999765533211 11110000 000
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.+ . ....++.+++.+|++.+|++|||+.|+++.|++++
T Consensus 265 ~~--------~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 265 QP--------E----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CC--------C----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 00 0 11246788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.88 Aligned_cols=254 Identities=28% Similarity=0.391 Sum_probs=201.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+|...+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3455778999999999999864 257899999975443 234668999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 225 VYELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
++||+++++|.+++... .....+++..+++++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999887521 1123588999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhh
Q 012975 292 AKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~ 368 (452)
+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~- 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN- 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999865432221 1122345778999999988889999999999999999998 8889987655432222211
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
. .... ...+....+.+++..||+.+|++||++++|+..|+.
T Consensus 242 ------~-~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 ------R-QVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------C-CcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 0000 011234457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=314.44 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=200.9
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
|+..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+|++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999976 4778889988766666677899999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
++|..+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999888763 235699999999999999999999998 999999999999999999999999999865433333333
Q ss_pred ccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 312 KLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
...++..|+|||.+. +..++.++|||||||++|||++|+.||......+.. ..... ... .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~----~~~--~~~~~~-- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK----SEP--PTLAQP-- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh----cCC--CCCCCc--
Confidence 456899999999874 345778999999999999999999999875543211 11100 000 000001
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+||+.||.+||++.++++.
T Consensus 232 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 -----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123467789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.61 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=196.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|...+.||+|+||+||+|+.. ++..||+|.+... .......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5777899999999999999865 5789999998643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998863 34688999999999999999999998 99999999999999999999999999874321000
Q ss_pred -----------------------------------------------CcccccccccCccCcccccCCCCCchhhHHHHH
Q 012975 308 -----------------------------------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFG 340 (452)
Q Consensus 308 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G 340 (452)
.......||..|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001234699999999999998999999999999
Q ss_pred HHHHHHHcCCCCCCCCChhhhhh-hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHH--hcCCCCCCCCChH
Q 012975 341 VVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVL--CVQPEPSYRPLIT 417 (452)
Q Consensus 341 vll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~ 417 (452)
|++|||++|+.||......+... ...|.. ....+.. . ....++.+++.+ |+..++..||++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~------~----~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWEN-----TLHIPPQ------V----KLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccc-----ccCCCCC------C----CCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999998766443221 222110 0111110 0 112344556666 5666777799999
Q ss_pred HHHHh
Q 012975 418 DVLHS 422 (452)
Q Consensus 418 evl~~ 422 (452)
|+++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.97 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=191.7
Q ss_pred CeEeecCcEEEEEEEeCC-------------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 157 NILGEGGFGCVYKAKLDD-------------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998542 2358889887655556678899999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-------EEEEe
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-------AKLSD 296 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~-------~kl~D 296 (452)
+||||+++|+|..+++. ....+++..+++++.|+++||+|||+. +++||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988863 345689999999999999999999998 9999999999999987664 89999
Q ss_pred cCCCcccCCCCCcccccccccCccCccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 297 fgl~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gvll~ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+...... .
T Consensus 156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~ 224 (262)
T cd05077 156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-------G 224 (262)
T ss_pred CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-------c
Confidence 9998654322 1235788999999886 467899999999999999998 5899987654332211110 0
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.. .... .....+.+++.+||+.||++||+++++++.|.
T Consensus 225 ~~---~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QC---MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Cc---cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 0000 11245778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=323.83 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=196.1
Q ss_pred CCCccCeEeecCcEEEEEEEe----CCCcEEEEEEecCc----ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCce
Q 012975 152 SFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCA----TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (452)
+|+..+.||+|+||.||+++. .++..||+|.+... .....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467789999999999999975 35789999998532 122345688999999999 599999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998853 34689999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 303 DGSQN-KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 303 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
..... .......||..|+|||.+.+. .++.++|||||||++|||+||+.||...........+... .......++.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--ILKCDPPFPS 232 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--HhcCCCCCCC
Confidence 43222 223345799999999998865 4788999999999999999999999754322111111100 0111111111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| +++++++
T Consensus 233 ------------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 233 ------------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1223566789999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=316.83 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=204.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+|...+.||+|+||.||+|... ++..|++|.+..........+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46778889999999999999864 68899999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999998853 3589999999999999999999999 9999999999999999999999999998654333222
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+... ...+.. .. .+..-.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~----~~--~~~~~~------ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT----NG--TPELQN------ 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc----CC--CCCCCC------
Confidence 2334688999999999988899999999999999999999999976654221 111110 00 000000
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..+....+.+++.+||+.||++||++.|+++.
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 -PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11223457789999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=320.26 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=201.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC---------------CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEE
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD---------------NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
++|+..+.||+|+||.||+++..+ ...||+|.+... .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987642 235899998654 3344567999999999999999999999
Q ss_pred EEEcCCceeeeeeecCCCChhhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 215 YSAHDDTRFIVYELMENRSLDIQLHGPS---------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 215 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
++..++..++||||+++++|.+++.... ....+++..+++++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999998885421 112478999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL--GRRPVEKLAPAQC 361 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt--G~~P~~~~~~~~~ 361 (452)
+++++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999865332211 1122335678999999998899999999999999999998 6778876654332
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
...... ............. .......+.+++.+|++.||++||++++|++.|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGE---FFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHH---hhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111 0000000000000 00123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.56 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=200.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999876 57789999986443 22344678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++ +|..++.. .+..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 77777653 234689999999999999999999998 999999999999999999999999999865433333
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc--------ccccCCC--
Q 012975 309 NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--------QLTDRSK-- 377 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~~~~-- 377 (452)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+.......... .+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3333467899999998865 4688999999999999999999999987665432222211110 0000000
Q ss_pred ---CCccc-chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 ---LPNIV-DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ---~~~~~-d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+... .+... .......++.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLIN--HAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhh--hccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 00112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=310.60 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=206.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|...+.||+|+||.||++.+++++.+|+|.+.... ....++.+|+.++++++|+|++++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456788899999999999999998888899999987433 3456789999999999999999999999998999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++... .+..+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998752 235689999999999999999999999 999999999999999999999999999865432111
Q ss_pred -cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 -NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||............. ... ....+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~~--~~~~~------- 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE---RGY--RMPRP------- 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC--CCCCC-------
Confidence 1112234568999999998889999999999999999998 999997655432111111 000 00000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
.+....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0113467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=309.29 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=204.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|+..+.||+|+||.||+|+..+ +..+++|.+..... ..++.+|++++++++|+|++++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999999875 78999999864432 678999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ....+++..++.++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 99999999863 345789999999999999999999998 9999999999999999999999999998765443323
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||............. ...... +.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~-----~~-- 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------NKPPPT-----LS-- 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--------cCCCCC-----CC--
Confidence 334458889999999999899999999999999999999999998654432111100 000000 00
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........+.+++.+||+.||++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01122346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=339.62 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=203.6
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC----
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD---- 220 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 220 (452)
...++|...+.||+|+||+||+++.. +|+.||||.+... +......+.+|+..+..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999864 6899999998643 3445567899999999999999999888765432
Q ss_pred ----ceeeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 221 ----TRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 221 ----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 357999999999999988642 2345689999999999999999999999 99999999999999999999999
Q ss_pred ecCCCcccCCC--CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 296 DFGLAITDGSQ--NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 296 Dfgl~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
|||+++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-----~ 260 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-----G 260 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----C
Confidence 99998654322 1122345799999999999999999999999999999999999999987654332111110 0
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....++ .....++.+++.+||+.||++||++.++++.
T Consensus 261 ~~~~~~------------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLP------------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCC------------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000111 1223467789999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.53 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=205.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4577888999999999999998643 4689999986443 34456789999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 223 FIVYELMENRSLDIQLHGPS-------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
++||||+++|+|.+++.... ....++|..++.++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999886422 123578999999999999999999998 99999999999999999999999
Q ss_pred ecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccc
Q 012975 296 DFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 296 Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
|||++....... .......++..|+|||.+.+..++.++||||||+++||++| |+.||...+..+.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----- 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID----- 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-----
Confidence 999986543221 11223346789999999988889999999999999999998 9999987665443222210
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
......+. .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLDLPE------------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCC------------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00001111 113467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=329.07 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=204.9
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCC-CCceeeeEEEEEcC
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAHD 219 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 219 (452)
...++|...+.||+|+||.||+|++. .+..||+|++..... ...+.+.+|+.++.++. ||||++++++|..+
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456777899999999999999864 346799999975432 33457899999999997 99999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCC---------------------------------------------------------
Q 012975 220 DTRFIVYELMENRSLDIQLHGPS--------------------------------------------------------- 242 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 242 (452)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886421
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 012975 243 --------------------------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (452)
Q Consensus 243 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NI 284 (452)
....+++..+++++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112478888999999999999999998 999999999999
Q ss_pred EECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhh
Q 012975 285 LLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQC 361 (452)
Q Consensus 285 ll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~ 361 (452)
|+++++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999986542211 11122356788999999998889999999999999999998 9999976543221
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.... . ....... .+ ......+.+++.+||+.+|.+||+++||++.|++++
T Consensus 351 ~~~~--~----~~~~~~~---~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNA--I----KRGYRMA---KP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHH--H----HcCCCCC---CC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1100 0 0000000 00 012346788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=309.17 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=196.1
Q ss_pred eEeecCcEEEEEEEeC---CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 158 ILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
.||+|+||.||+|.++ ++..+|+|.+.... ....+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 57889999886443 334567999999999999999999999985 45679999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc---
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--- 309 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 309 (452)
+|.+++.. ...+++..+++++.|++.||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998853 34689999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+....+... .....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~-------- 221 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-----ERMECPQ-------- 221 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-----CCCCCCC--------
Confidence 112234578999999988889999999999999999998 99999876554332222210 0011111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
....++.+++.+||+.||++||++.+|.+.|++.
T Consensus 222 ----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1234567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=308.98 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=203.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+|+..+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|+.+++.++|+|++++++++..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999876 6889999988543 3445567889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ..+..++...++.++.|++.||.|||+. +++|+||||+||++++++.++++|||++.........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999888764 2345689999999999999999999999 9999999999999999999999999998655443333
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. .....++.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~--------- 222 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-----GSYKPLPS--------- 222 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-----CCCCCCCc---------
Confidence 3345688999999999988899999999999999999999999986553321111110 00011111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+.+++.+||+.||++||++.|++.+
T Consensus 223 ---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 ---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.04 Aligned_cols=240 Identities=26% Similarity=0.337 Sum_probs=191.4
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHH-HHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+++.. +|+.+|+|.+... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 6889999998543 2233345566655 46778999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999888753 45689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. ..... +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~~~~~----~~~------- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------HKPLV----LRP------- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------cCCcc----CCC-------
Confidence 5679999999999999999999999999999999999999998765433211111 10000 011
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
.....+.+++.+|++.||.+||++++.+
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1223566889999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.68 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=203.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+.|+..+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778889999999999999876 47889999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|..++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 99999887753 234689999999999999999999998 9999999999999999999999999998654333222
Q ss_pred ccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 310 NLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||......... .... .. ..+....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~----~~--~~~~~~~- 237 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA----KS--EPPTLSQ- 237 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHHh----cC--CCccCCC-
Confidence 33456888999999885 345678999999999999999999999775543211 1110 00 0000000
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.+++.+||+.||++||+++|+++.
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11223457789999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.34 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=200.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
..++|+..+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999876 5889999998532 22334557899999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998863 3478888999999999999999999 99999999999999999999999999986543
Q ss_pred CCCC-cccccccccCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 305 SQNK-NNLKLSGTLGYVAPEYLLDG----KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 305 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ......+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~ 269 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH----KNSLTFP 269 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----CCcCCCC
Confidence 2221 22345699999999998653 4788999999999999999999999876543221111100 0000011
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 422 (452)
. .......+.+++.+||+.+|++ ||++.|+++.
T Consensus 270 ~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 D----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0112346678999999999987 9999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=330.49 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=197.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||+||+++.. ++..||+|.+... .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999865 6889999998532 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998863 35688999999999999999999999 9999999999999999999999999998522110
Q ss_pred CC-----------------------------------------------cccccccccCccCcccccCCCCCchhhHHHH
Q 012975 307 NK-----------------------------------------------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAF 339 (452)
Q Consensus 307 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~ 339 (452)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChhhhh-hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC---CC
Q 012975 340 GVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR---PL 415 (452)
Q Consensus 340 Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps 415 (452)
||++|||++|+.||......+.. .+..|.. ...+++. ......+.+++.+|++ +|.+| ++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~p~~----------~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRE-----TLYFPDD----------IHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----ccCCCCC----------CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999876543321 1222211 1111110 0112356678889997 66665 69
Q ss_pred hHHHHHh
Q 012975 416 ITDVLHS 422 (452)
Q Consensus 416 ~~evl~~ 422 (452)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.85 Aligned_cols=251 Identities=24% Similarity=0.275 Sum_probs=200.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||+||+++.. ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999875 68899999986432 234566889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999864 235699999999999999999999999 9999999999999999999999999999654332
Q ss_pred CC-cccccccccCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 307 NK-NNLKLSGTLGYVAPEYLL------DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
.. ......||..|+|||++. ...++.++|||||||++|||++|+.||...........+... ......+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~ 231 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF----QRFLKFP 231 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC----CCccCCC
Confidence 22 222346899999999986 456788999999999999999999999876543321111100 0000000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .......+.+++..|++ ||++||+++++++
T Consensus 232 ~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 01123456778889998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=319.06 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=207.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+... ......++.+|+++++++ +|+||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888999999999999999753 2356999998754 234456788999999999 799999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 220 DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+..++||||+++|+|.+++.... ....+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999986422 123589999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhh
Q 012975 287 DSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQS 363 (452)
Q Consensus 287 ~~~~~~kl~Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~ 363 (452)
++++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 99999999999998654322111 111234568999999998899999999999999999998 899997655433222
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
..... . ..+ .......++.+++.+||+.+|++||++.||++.|++++...
T Consensus 254 ~~~~~-------~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 254 LLKEG-------H-RMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHcC-------C-CCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 22110 0 000 01122346778999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.06 Aligned_cols=239 Identities=26% Similarity=0.432 Sum_probs=190.0
Q ss_pred eEeecCcEEEEEEEeCC-------------------------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeee
Q 012975 158 ILGEGGFGCVYKAKLDD-------------------------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 212 (452)
.||+|+||.||+|++.. ...|++|.+..........|.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 24588898865555556678999999999999999999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC--
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-- 290 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-- 290 (452)
+++|.+++..++||||+++|+|..++.. ....+++..+++++.|+++||+|||++ +++||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988863 345689999999999999999999998 999999999999997654
Q ss_pred -----cEEEEecCCCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCChhhhhh
Q 012975 291 -----NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQS 363 (452)
Q Consensus 291 -----~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~ell-tG~~P~~~~~~~~~~~ 363 (452)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987543221 12346788999998865 56899999999999999995 6999998765433221
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
... .....+.. ....+.+++.+||+.+|++|||++++++.|.
T Consensus 233 ~~~-------~~~~~~~~------------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FYE-------KKHRLPEP------------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH-------hccCCCCC------------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 01111110 1125778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=318.05 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=208.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 218 (452)
..++|...+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3456778899999999999999741 3457999988643 234557799999999999 89999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
.+..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999986421 124588999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~ 362 (452)
+++++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999655332211 122345678999999998889999999999999999998 88898776544322
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
..+.. .... . ........+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 250 ~~~~~-------~~~~-~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KLLKE-------GHRM-D---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHc-------CCcC-C---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 22210 0000 0 0012345677899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=314.20 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=199.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|++|.||+|+.. ++..||+|++.... ......+.+|+.++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 68899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++ ++|.+++.....+..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888876544446799999999999999999999998 999999999999999999999999999865443332
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhcccccc----C-------
Q 012975 309 NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTD----R------- 375 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~----~------- 375 (452)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||......... ............ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 22334578899999988654 5788999999999999999999999865432211 110000000000 0
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+.+........ ......++.+++.+||+.||++|||+++|++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 0012346678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=321.33 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=194.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 226 (452)
+|+..+.||+|+||+||+++.. +|..||+|.+... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 5889999998643 2234456788999998885 577888999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|..++.. ...+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988853 34699999999999999999999999 9999999999999999999999999998654333
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
........||..|+|||++.+..++.++|||||||++|||++|+.||...........+. ......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~~~~~p~------ 222 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM------EHNVSYPK------ 222 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCCc------
Confidence 333334569999999999999999999999999999999999999998765433211111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
.....+.+++.+||+.||.+|++.
T Consensus 223 ------~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ------SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------cCCHHHHHHHHHHcccCHhhCCCC
Confidence 112356789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.52 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=202.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-----------------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-----------------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCL 212 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 212 (452)
++|+..+.||+|+||.||++... ++..+|+|.+... ......+|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 2446899998654 33445789999999999999999999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPS--------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NI 284 (452)
++++..++..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999886421 123578899999999999999999999 999999999999
Q ss_pred EECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChhh
Q 012975 285 LLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL--GRRPVEKLAPAQ 360 (452)
Q Consensus 285 ll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt--G~~P~~~~~~~~ 360 (452)
++++++.++|+|||++........ ......++..|++||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999865422211 1112234678999999888889999999999999999998 788987665433
Q ss_pred hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
....... ........ . ..+ ....+...+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~~~~~---~~~~~~~~-~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGE---FFRDQGRQ-V-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHH---HHhhcccc-c-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2111110 00000000 0 000 001123567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.26 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=202.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999876 57788888886543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999864 356899999999999999999999732 89999999999999999999999999985442221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC----------
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL---------- 378 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 378 (452)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.....................
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 223468899999999988889999999999999999999999997654332221111110000000000
Q ss_pred ------Ccccchhhc----ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 379 ------PNIVDPVIK----STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 379 ------~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.+..+.... ..........+.+++.+||+.||++|||++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000123457899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=314.91 Aligned_cols=256 Identities=28% Similarity=0.412 Sum_probs=204.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++++++|+||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 46789999986543 34456799999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 012975 223 FIVYELMENRSLDIQLHGPS-------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~N 283 (452)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999998886321 113578999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhh
Q 012975 284 ILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQ 360 (452)
Q Consensus 284 Ill~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~ 360 (452)
|++++++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986432221 11112234667999999998899999999999999999997 889997665443
Q ss_pred hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
....+.. ..... .......++.+++.+||+.||++|||+.|+++.|++
T Consensus 241 ~~~~~~~--------~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRD--------GNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhc--------CCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2211111 11100 001123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=327.98 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=195.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++..++..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999875 57889999753 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-C
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ-N 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~-~ 307 (452)
+. ++|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 688877753 34689999999999999999999999 9999999999999999999999999998643221 2
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh--------hhhhhhhhccccccCCC--
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ--------CQSIVTWAMPQLTDRSK-- 377 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~--------~~~~~~~~~~~~~~~~~-- 377 (452)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ...++..... ......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~-~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT-HPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC-ChhhcCcc
Confidence 22334579999999999999999999999999999999999998875432110 0001100000 000000
Q ss_pred ----CCccc---------chhhccc--CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 ----LPNIV---------DPVIKST--MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ----~~~~~---------d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+.... .+..... ...+....+.+++.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0000000 00123456788999999999999999999995
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=319.53 Aligned_cols=260 Identities=29% Similarity=0.459 Sum_probs=203.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc--EEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999875 343 4677777543 344556789999999999 899999999999999999999
Q ss_pred eeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
|||+++|+|.++++... ....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999886421 123689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |..||......+......
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----- 237 (303)
T cd05088 164 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP----- 237 (303)
T ss_pred EeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-----
Confidence 999999985322111 1111234668999999988889999999999999999998 999997655433211110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
....... .......+.+++.+||+.+|++||++.++++.|.+++....
T Consensus 238 --~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 --QGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0000000 00122356789999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=316.11 Aligned_cols=263 Identities=29% Similarity=0.410 Sum_probs=204.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-----------------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-----------------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVC 211 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 211 (452)
.++|+..+.||+|+||.||+++..+ +..||+|.+.... ......+.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997643 2458999986543 345678999999999999999999
Q ss_pred eEEEEEcCCceeeeeeecCCCChhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 012975 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPS--------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSN 283 (452)
Q Consensus 212 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~N 283 (452)
+++++..++..+++|||+++++|..++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999886422 123689999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChh
Q 012975 284 ILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL--GRRPVEKLAPA 359 (452)
Q Consensus 284 Ill~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt--G~~P~~~~~~~ 359 (452)
|++++++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999986532221 11223346778999999988889999999999999999998 77888765433
Q ss_pred hhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 360 QCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
+. ............. ....+ .......++.+++.+||+.||++|||+.||++.|++
T Consensus 241 ~~---~~~~~~~~~~~~~-~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QV---IENAGHFFRDDGR-QIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HH---HHHHHhccccccc-cccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22 1111111111000 00000 011123568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.93 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=202.2
Q ss_pred CCCccCeEeecCcEEEEEEEeCC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.|+..+.||+|+||.||+|.+.. + ..||+|.+... ......+|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999998753 2 36999998654 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999998864 235689999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCc---ccccc--cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 307 NKN---NLKLS--GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 ~~~---~~~~~--gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||...........+. . ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~----~~~~~~ 232 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---Q----DYRLPP 232 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CCcCCC
Confidence 111 11111 2357999999999999999999999999999886 999998765433222111 0 011110
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
..+....+.+++.+||+.+|++||++++++..|+++
T Consensus 233 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 012234577899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=311.55 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=200.6
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC------
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD------ 219 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 219 (452)
.+.+.|+..+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999875 57889999986443 3446788999999998 799999999998753
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
...+++|||+++|+|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999988742 245689999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+..............|+..|+|||++. +..++.++|||||||++|||++|+.||.............
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-------- 229 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------- 229 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh--------
Confidence 875543333334456899999999886 3457889999999999999999999997654432211110
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000001111 112345778999999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.76 Aligned_cols=250 Identities=29% Similarity=0.465 Sum_probs=196.8
Q ss_pred CeEeecCcEEEEEEEeCC-Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLDD-NL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
++||+|+||.||+|++.+ +. .+++|.+... .......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998764 33 4688887643 344556789999999999 899999999999999999999999999
Q ss_pred CChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 232 RSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 232 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
|+|.++++... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999886421 123588999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+...... ....
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~ 229 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------QGYR 229 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-------CCCC
Confidence 985322111 1112234567999999988889999999999999999997 999997654332111111 0000
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.. ... .....+.+++.+|++.||.+|||+.|++..|++++
T Consensus 230 ~~------~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE------KPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC------CCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 000 12245778999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=313.69 Aligned_cols=253 Identities=29% Similarity=0.434 Sum_probs=205.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|+..+.||+|+||.||+|+.. ++..+|+|.+..........|.+|++++++++|+|++++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356777888999999999999875 5889999998776666777899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|..++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998863 234699999999999999999999999 999999999999999999999999999865544333
Q ss_pred cccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 309 NNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
......++..|+|||.+. ...++.++||||||+++|||++|+.||.......... .+.. ...+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~------~~~~~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL--KILK------SEPPTLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH--HHhc------CCCCCcCC
Confidence 334456899999999875 3456779999999999999999999998765433211 1110 00000000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.+++..||+.||.+||++.++++.
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 -------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01122356789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=305.24 Aligned_cols=248 Identities=32% Similarity=0.499 Sum_probs=203.4
Q ss_pred CeEeecCcEEEEEEEeCC----CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||++...+ +..+++|.+...... ..+.+.+|++.++.++|+|++++++++..++..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 788999998755433 367899999999999999999999999999999999999999
Q ss_pred CChhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 232 RSLDIQLHGPSH------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 232 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
++|.+++..... ...+++.+++.++.|++.||+|||++ +++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999875311 36799999999999999999999998 999999999999999999999999999976543
Q ss_pred CC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 QN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||......+....... ......+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~--- 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKP--- 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCC---
Confidence 32 22234457889999999988889999999999999999998 6999988754332221110 0000011
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.....++.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 ---------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=322.86 Aligned_cols=237 Identities=27% Similarity=0.343 Sum_probs=188.9
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
++||+|+||.||+|+.. ++..||+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57889999985332 223344555554 57889999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...++...+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999888753 34688899999999999999999998 999999999999999999999999999865333333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+. .....++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~~~~~------------ 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL------HKPLQLP------------ 216 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh------cCCCCCC------------
Confidence 4578999999999999899999999999999999999999998765432211111 1111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLIT 417 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 417 (452)
......+.+++.+||+.||.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11234677899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.39 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=199.8
Q ss_pred CeEeecCcEEEEEEEeCC--C--cEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLDD--N--LHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998653 2 3689999976655 566789999999999999999999999988 888999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC---
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--- 308 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--- 308 (452)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999875322 5689999999999999999999999 999999999999999999999999999866533211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....... ...... .+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~~~~---~~--- 223 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGERLE---RP--- 223 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCCcCC---CC---
Confidence 1112346788999999999899999999999999999998 9999976654432221111 000000 00
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
......+.+++.+|++.+|++||++.|+++.|.
T Consensus 224 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 ----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=332.49 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--------
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-------- 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 219 (452)
..++|...+.||+|+||.||+|... ++..||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999875 57899999985332 2345799999999999999999876432
Q ss_pred CceeeeeeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEec
Q 012975 220 DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDF 297 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Df 297 (452)
...++||||+++ +|.+++.. ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135789999985 56555432 23356799999999999999999999999 999999999999999664 7999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc---
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT--- 373 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~--- 373 (452)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+.............
T Consensus 216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9997543222 22345689999999988764 689999999999999999999999987654332111111000000
Q ss_pred --------cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 --------DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 --------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++......+...+......++.+++.+||+.||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000011111111111111122356889999999999999999999984
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.25 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||.||+++.. +|..+|+|.+.... ......+..|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 58899999985322 22344567799999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
..++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 8887542 234589999999999999999999998 99999999999999999999999999986543322 222346
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
|+..|+|||++.+..++.++|||||||++|||++|+.||...........+. ....... ... .. ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~--~~~-----~~----~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLEDE--VKF-----EH----QNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--HHhhccc--ccc-----cc----ccC
Confidence 8999999999999889999999999999999999999997643211111110 0011100 000 00 012
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
..++.+++..||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 345788999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=320.83 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=190.8
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+++.. +++.+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999986432 23445688999999888 699999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999888753 34699999999999999999999999 999999999999999999999999999865333333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc-ccCCCCCcccchhhcccC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL-TDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~l~~~~ 390 (452)
...||..|+|||.+.+..++.++|||||||++|||++|+.||.............+..... .....++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--------- 225 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--------- 225 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC---------
Confidence 5679999999999999999999999999999999999999996533221111111110000 111111111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
....+.+++.+||+.||++|+++
T Consensus 226 ---~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 ---LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCC
Confidence 12345689999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=322.86 Aligned_cols=242 Identities=27% Similarity=0.346 Sum_probs=190.7
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHH-HHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+++.. ++..||+|.+.... ......+..|.. +++.++|+||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 56789999986432 222334444544 56788999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+....+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999988863 34578888899999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ...... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~~~~----~~------- 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKPLQL----KP------- 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH------hCCcCC----CC-------
Confidence 5679999999999999999999999999999999999999998765433211111 000011 11
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+....+.+++.+|++.||.+||++.+.+..
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 -NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 122356788999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.67 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=206.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 57789999987666666788999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ....++..++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999998863 235689999999999999999999998 9999999999999999999999999998654433323
Q ss_pred ccccccccCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 310 NLKLSGTLGYVAPEYLLDG---KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||............. .... .. +.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~----~~-----~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNF----PP-----PKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC----CC-----ccc
Confidence 3345688899999998776 78999999999999999999999998765433211111 0000 00 000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. ........+.+++.+||+.||.+|||+.+|+.
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 11233456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=313.96 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=204.4
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+|+..+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999986 468899999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|..++.. ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998853 3589999999999999999999999 9999999999999999999999999998654433322
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...+.......... .. .+....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~------~~--~~~~~~~----- 238 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------NG--TPELQNP----- 238 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------cC--CcccCCc-----
Confidence 3344688999999999988899999999999999999999999987654332111110 00 0000000
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+||+.||++||++.++++
T Consensus 239 --~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 --EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 012235667899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.93 Aligned_cols=250 Identities=29% Similarity=0.504 Sum_probs=193.8
Q ss_pred CeEeecCcEEEEEEEeC----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCceeeeeeecC
Q 012975 157 NILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIVYELME 230 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 230 (452)
+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++|||++++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998543 33456788999999999999999999998764 456799999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC---
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--- 307 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~--- 307 (452)
+|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998642 34578888999999999999999998 99999999999999999999999999986432211
Q ss_pred -CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 308 -KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ..... ....... +
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~~~----~~~~~~~---~- 224 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI---TVYLL----QGRRLLQ---P- 224 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHh----cCCCCCC---C-
Confidence 11112345678999999988899999999999999999999 5666765443221 11110 0000000 0
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
. .....+.+++..||+.+|++||++.||++.|+++..
T Consensus 225 --~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 225 --E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 112357789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=347.09 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=206.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|+.. +++.||+|++... .....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999876 5889999998643 2234567999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 227 ELMENRSLDIQLHGP--------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 227 E~~~~gsL~~~l~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
||+++|+|.+++... .....+++..+++++.|+++||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999887531 1123567888999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCC------------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 299 LAITDGSQN------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 299 l~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 996541110 01112469999999999999999999999999999999999999997643321
Q ss_pred hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC-CChHHHHHhccccCccccC
Q 012975 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR-PLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~~l~~~~~~ 432 (452)
.... ......... .+ ..+....+.+++.+|++.||++| ++++++.+.|++.+....+
T Consensus 239 i~~~-----~~i~~P~~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYR-----DVILSPIEV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhh-----hhccChhhc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 1100 000000000 00 01223456789999999999999 5677888888777665443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=329.10 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=193.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|...+.||+|+||+||+|+.. ++..+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999875 57889999986432 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998863 34688999999999999999999999 9999999999999999999999999997421100
Q ss_pred ----------------------------------------------CCcccccccccCccCcccccCCCCCchhhHHHHH
Q 012975 307 ----------------------------------------------NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFG 340 (452)
Q Consensus 307 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~G 340 (452)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001134689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCChhhhhh-hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC---h
Q 012975 341 VVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL---I 416 (452)
Q Consensus 341 vll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~ 416 (452)
|++|||++|+.||....+.+... ...|.. ....+. .... ..+..+++.+|+ .+|++|++ +
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~p~------~~~~----s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQT-----SLHIPP------QAKL----SPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCC-----CcCCCC------cccC----CHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999998766543222 122111 001110 0011 223445565655 49999987 8
Q ss_pred HHHHH
Q 012975 417 TDVLH 421 (452)
Q Consensus 417 ~evl~ 421 (452)
.|+++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 88774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.59 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=208.4
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+|++.+.||+|.||.|-+++. ..|+.||||.+... ++.+.-.+++|+++|+.|+||||+.++.+|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3567778899999999999986 57999999998643 4455567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||..+|.|++++. ..+.|++.++.+++.||..|+.|+|.+ +++|||||.+|||+|+|+++||+|||++....+.
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999995 466799999999999999999999999 9999999999999999999999999999766443
Q ss_pred CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
....+++|++-|.+||.+.+.+| ++..|-|||||+||-|+.|..||++.+-.. ++... . ++.. ..|
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQI----s-~GaY---rEP- 273 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQI----S-RGAY---REP- 273 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHHh----h-cccc---cCC-
Confidence 34457899999999999999888 478999999999999999999999876432 22221 1 1111 111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
+......-+|+|||..+|++|-|+.+|....
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1223455699999999999999999998764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.91 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=205.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..+.||+|+||.||++...++..+++|.+... ......+.+|++++++++|+|++++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34678889999999999999999888888999988643 3345678999999999999999999999887 778999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++... .+..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999998652 245689999999999999999999998 999999999999999999999999999865432211
Q ss_pred -cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 -NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......++..|+|||++....++.++|+||||+++||++| |+.||............. .....+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~------- 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMP------- 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCCC-------
Confidence 1112335677999999998889999999999999999998 999998765432211111 000000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.......++.+++.+|++.+|++||++.++.+.|+++
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0012234678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.73 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=196.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+|+..+.||+|+||.||+++.. ++..||+|.+.... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 58899999985322 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
|+++|+|.+++.. ...++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999864 34688899999999999999999999 9999999999999999999999999997421100
Q ss_pred ------------------------------------------CCcccccccccCccCcccccCCCCCchhhHHHHHHHHH
Q 012975 307 ------------------------------------------NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLL 344 (452)
Q Consensus 307 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ 344 (452)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChhhhhhh-hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC---ChHHHH
Q 012975 345 ELLLGRRPVEKLAPAQCQSI-VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP---LITDVL 420 (452)
Q Consensus 345 elltG~~P~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl 420 (452)
||++|+.||......+.... ..|... ...+. .. +....+.+++.+|+ .+|.+|+ ++.|++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~------~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETT-----LHIPS------QA----KLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCcc-----ccCCC------CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999987765432221 111100 00000 01 11234456666765 4999999 889998
Q ss_pred Hh
Q 012975 421 HS 422 (452)
Q Consensus 421 ~~ 422 (452)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=305.37 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=200.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|...+.||+|++|.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68899999875332 2234578999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 34588999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCcc---cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKNN---LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||............. .......++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~-- 229 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNPQLP-- 229 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----ccCCCCCCC--
Confidence 221111 23457889999999999889999999999999999999999997654322111100 000111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+||+.+|++|||++|+++.
T Consensus 230 ----------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 ----------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1223456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.59 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=197.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||.||+|... ++..||+|.+... ......++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999864 6788999998644 344456799999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 368888999999999999999999 9999999999999999999999999998654322
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... ...... .+.+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~------~~~~~ 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED------PPVLP 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC------CCCCC
Confidence 1223468999999999999999999999999999999999999997643221110 000000 000000 00000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......++.+++.+|++.||++||+++|+++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01123457789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.07 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=204.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..+|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 357888999999999999999864 6889999999766555667789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998853 3589999999999999999999998 999999999999999999999999999865433332
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ .. ...+....+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~--~~~~~~~~~---- 238 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT--NGTPELQNP---- 238 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------cc--CCCCCCCCc----
Confidence 223446888999999999988999999999999999999999999765432211000 00 000000011
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+||+.||++||+++++++
T Consensus 239 ---~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ---ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112345678999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=306.16 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=196.4
Q ss_pred CeEeecCcEEEEEEEeCC----CcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||+|++.. +..+|+|.+..... ...+++.+|++++++++|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899999865443 35567999999999999999999999876 4567999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc-
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN- 310 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~- 310 (452)
|+|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999964 23689999999999999999999998 99999999999999999999999999986543322211
Q ss_pred --cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 311 --LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 311 --~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.... ....+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~-------- 220 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-----RLPRP-------- 220 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----cCCCC--------
Confidence 11223567999999998999999999999999999998 999998765433222221100 00000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
......+.+++.+||+.||++||++.++++.|+++
T Consensus 221 ----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 ----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11234677899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.33 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=199.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEE-cCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA-HDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 229 (452)
++|+..+.||+|+||.||++... |..+|+|..... ...+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46777899999999999999876 668999988543 23567899999999999999999999765 445789999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998642 234589999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .. ......
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~~--~~~~~~--------- 221 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG--YKMDAP--------- 221 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cC--CCCCCC---------
Confidence 12235668999999998899999999999999999997 999997654332211111 00 000000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
......+.+++.+|++.||++|||+.++++.|+++
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 ---DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12234677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=308.70 Aligned_cols=252 Identities=33% Similarity=0.491 Sum_probs=201.6
Q ss_pred CCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHH--HHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGR--EFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|+..+.||+|+||+||+++... +..+|+|.+......... ...+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999875 568999999766543332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++. ....+++..++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999886 345689999999999999999999999 9999999999999999999999999998653233333
Q ss_pred ccccccccCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc-ccccCCCCCcccchhhc
Q 012975 310 NLKLSGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP-QLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~-~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~ 387 (452)
.....++..|+|||.+. +...+.++||||+|+++|+|++|..||................. .... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------SSQQ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------cccc
Confidence 44556899999999998 78899999999999999999999999997632221111111100 0000 0000
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. ......+.+++.+||+.||++||++.++++.
T Consensus 226 ~---~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 S---REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp H---TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c---chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0012678899999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.53 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=203.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||.|++|.||+|+.. ++..||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999876 58899999986543 44556789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999863 2789999999999999999999998 999999999999999999999999999976554433
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......++..|+|||.+.+..++.++||||||+++|||+||+.||....+......... ... +.+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~~~-----~~~~~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK--------NNP-----PSLEG 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh--------cCC-----CCCcc
Confidence 33445688899999999998899999999999999999999999976553321111110 000 11111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .....+.+++.+||+.||++|||++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 02345778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.88 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=216.9
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+|-...+....++||-|.||.||.|.|+. ...||||.++... -...+|++|+.+|+.++|||+|+|+|+|..+..+||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33333455567899999999999999875 6789999997543 356789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|+|||.+|+|.++|.. -+...++-...+.++.||+.|++||..+ ++|||||.++|+|+.++..+|++|||+++...
T Consensus 341 iTEfM~yGNLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999986 3345678888899999999999999998 99999999999999999999999999998764
Q ss_pred CCCCcc-cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 305 SQNKNN-LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 305 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.+.... ....-...|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+-.+...+..-
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk--------------- 481 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK--------------- 481 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc---------------
Confidence 333221 12224568999999999999999999999999999998 9999998775544333321
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
..+-...+.|...+.+|++.||+++|.+||++.|+-+.++.++..+
T Consensus 482 --gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 482 --GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred --cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1111123356778899999999999999999999999988776543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.71 Aligned_cols=261 Identities=29% Similarity=0.403 Sum_probs=201.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC-C
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD-D 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 220 (452)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788899999999999999973 346789999996543 33456788999999999 789999999988655 4
Q ss_pred ceeeeeeecCCCChhhhccCCCC---------------------------------------------------------
Q 012975 221 TRFIVYELMENRSLDIQLHGPSH--------------------------------------------------------- 243 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 243 (452)
..+++|||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999988863210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC--cccccc
Q 012975 244 -------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLS 314 (452)
Q Consensus 244 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~ 314 (452)
...+++..+.+++.|++.||+|||++ +++||||||+||++++++.+||+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12478899999999999999999999 999999999999999999999999999865422211 112234
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLK 393 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 393 (452)
++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ....... ......+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~--~~~~~~~~~~----------- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKE--GTRMRAPDYT----------- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHhc--cCCCCCCCCC-----------
Confidence 5678999999998899999999999999999996 9999976543211 1100000 0011111111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 394 HLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 394 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...+.+++..||+.||++|||+.|+++.|++++..
T Consensus 308 -~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 -TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 13567889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=306.32 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=191.9
Q ss_pred eEeecCcEEEEEEEeCC---CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 158 ILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 4578999886543 3344578999999999999999999999999999999999999999
Q ss_pred hhhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC--c
Q 012975 234 LDIQLHGPS--HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--N 309 (452)
Q Consensus 234 L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~ 309 (452)
|.++++... .....++..++.++.|++.||+|||+. +++||||||+||+++.++++||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986422 123567888889999999999999998 999999999999999999999999999865332221 1
Q ss_pred ccccccccCccCcccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 310 NLKLSGTLGYVAPEYLLDG-------KLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+...... . ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~-------~~~~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-R-------EQQLKL 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-h-------cccCCC
Confidence 1234567889999988642 35789999999999999996 999998765433211110 0 000111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.++.+.... ...+.+++..|+ .+|++|||++||+..|.
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122222111 234567888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.92 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=199.8
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChh
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 235 (452)
++||+|+||.||++.+.++..|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877999999998755433 5678999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc--cccc
Q 012975 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--NLKL 313 (452)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--~~~~ 313 (452)
+++.. ....+++..++.++.+++.||+|||++ +++||||+|+||++++++.+||+|||++......... ....
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99864 234688999999999999999999999 9999999999999999999999999998654321111 1112
Q ss_pred ccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 314 ~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
.++..|+|||.+.+..++.++|+||||+++|||+| |..||.............. ..... ...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------~~~~~----------~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------GYRMP----------APQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------CCCCC----------CCc
Confidence 23567999999988899999999999999999999 8999977654332222111 00000 011
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
....++.+++.+|++.+|++||++.||++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 22346888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.85 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=202.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
.+|+..+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3566788999999999999998778899999886432 234578999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc-
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN- 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 309 (452)
+++|.+++.. ....+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999998863 234689999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+...... ... ....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---~~~~~~~-- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AGF---RLYKPRL-- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CCC---CCCCCCC--
Confidence 112235678999999998899999999999999999998 999998655432211111 000 0011111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1346788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=305.81 Aligned_cols=238 Identities=29% Similarity=0.467 Sum_probs=191.0
Q ss_pred CeEeecCcEEEEEEEeCCCc-----------EEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 157 NILGEGGFGCVYKAKLDDNL-----------HVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999886432 4777876543333 6789999999999999999999999988 778999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-------cEEEEecC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-------NAKLSDFG 298 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-------~~kl~Dfg 298 (452)
|||+++|+|++++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998742 23689999999999999999999998 999999999999999888 79999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDR 375 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 375 (452)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......+...... ..
T Consensus 154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~~ 222 (259)
T cd05037 154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------DQ 222 (259)
T ss_pred ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------cC
Confidence 9865433 1223467789999998876 78999999999999999999 688887664332211111 00
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
...+. + ....+.+++.+||+.+|.+|||+.||++.|+
T Consensus 223 ~~~~~---~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLPM---P---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCC---C---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0 0157788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.19 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=205.7
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||.++.. ++..+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777899999999999999864 5888999988644 345567789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987422 45689999999999999999999998 999999999999999999999999999866543332
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+...... . .......
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~------~--~~~~~~~------ 222 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV------Q--GNYTPVV------ 222 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------c--CCCCCCc------
Confidence 3334568999999999988889999999999999999999999998755433211111 0 1111100
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
......+.+++.+||+.+|++||+++|+++.+
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ---SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 12234577899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.95 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=198.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----cee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (452)
+|+..+.||+|+||.||++... ++..||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677899999999999999874 6889999998643 2334567899999999999999999999998776 789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 577766643 35699999999999999999999999 9999999999999999999999999999654
Q ss_pred CCCC-CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc------------
Q 012975 304 GSQN-KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM------------ 369 (452)
Q Consensus 304 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~------------ 369 (452)
.... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3222 122234578999999998774 47899999999999999999999998766543222211100
Q ss_pred ----cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 370 ----PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 370 ----~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..+............ +. ....+...++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPV-LY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHH-hc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 00 0011124567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.86 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=201.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|...+.||+|+||.||+|+.. ++..||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666788999999999999865 58889999987665555567889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999998853 34689999999999999999999999 9999999999999999999999999998654433333
Q ss_pred ccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 310 NLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||....+......... .... +.. .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------~~~~-~~~----~ 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------SNFQ-PPK----L 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------cCCC-CCc----c
Confidence 33456899999999874 45688899999999999999999999876543221111110 0000 000 0
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.... .....+.+++.+|++.||++||+++++++.
T Consensus 232 ~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 122356789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=310.47 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=198.3
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
|...+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556788999999999999875 68899999986432 22345578899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888642 234699999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||................ .......
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~--~~~~~~~---------- 224 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV--LETEEVY---------- 224 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh--hcccccc----------
Confidence 1223468999999999999999999999999999999999999998765432211111110 0000011
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
..+....+.+++..|++.||++||+ ++++++
T Consensus 225 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 --SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1112335678999999999999999 566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.11 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=202.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++|+|++++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999986 58899999885432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999998877643 34589999999999999999999998 99999999999999999999999999997654433
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh-ccc-------cccCCCC
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA-MPQ-------LTDRSKL 378 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~-~~~-------~~~~~~~ 378 (452)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+........ ... .....-.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 22333457889999999876 45788999999999999999999999876543321111100 000 0000000
Q ss_pred CcccchhhcccCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 379 PNIVDPVIKSTMD-----LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 379 ~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+....... ......+.+++.+||+.||++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 0123567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=325.51 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=198.8
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
...++|+..+.||+|+||.||+++.. ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999976 5788999988532 2234456889999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998853 3478899999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCC-cccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 304 GSQNK-NNLKLSGTLGYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
..... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+... .....+
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~----~~~~~~ 268 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH----KNSLNF 268 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CcccCC
Confidence 32221 223456999999999987643 778999999999999999999999876543321111100 000011
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHh
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLHS 422 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 422 (452)
+. +......+.+++..|++.++.+ |+++.|+++.
T Consensus 269 p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 0112334567788888755543 8999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=313.78 Aligned_cols=264 Identities=24% Similarity=0.368 Sum_probs=199.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999876 57889999986433 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++ ++|..++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588887763 234688999999999999999999998 999999999999999999999999999865433332
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc--------cccccCCC--
Q 012975 309 NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM--------PQLTDRSK-- 377 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~--------~~~~~~~~-- 377 (452)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..+......... +.......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22334578899999988654 57889999999999999999999998765433211111000 00000000
Q ss_pred ---CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 ---LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ---~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+......+. .........+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 000112345678999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=308.25 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|...+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998643 3468999886554 4556789999999999999999999999875 557899
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ....+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999864 234689999999999999999999998 999999999999999999999999999865433
Q ss_pred CCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 306 QNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 306 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
... ......++..|+|||.+....++.++||||||+++||+++ |..||......+....... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-------~~~~~---- 228 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-------GERLP---- 228 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------CCcCC----
Confidence 221 1122234568999999988889999999999999999986 9999987654332221111 01110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...+....+.+++.+|+..+|++|||+.++++.|.++...
T Consensus 229 ------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 ------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0012234677899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.28 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=200.0
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+|...+.||+|+||+||+|...++..+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366788999999999999998889999999886432 22345689999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 24588999999999999999999998 999999999999999999999999999864321
Q ss_pred C------CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 306 Q------NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 306 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
. ........|+..|+|||.+.+..++.++||||||+++|||++|+.||...+......... ......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG------AHRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh------hccCCCC
Confidence 1 111123458899999999998889999999999999999999999997654322111100 0000011
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. +.. .....+.+++.+||+.+|++||++.|+++
T Consensus 229 ~-----~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R-----LPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 111 22345678999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.87 Aligned_cols=266 Identities=25% Similarity=0.338 Sum_probs=203.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh--hHHHHHHHHHHHHcCCCCc-eeeeEEEEEcCC------c
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPN-VVCLLGYSAHDD------T 221 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 221 (452)
.|+..++||+|.||+||+|+.. +|+.||+|++.....+ .-....+|+.+|++++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3444667999999999999865 6889999999755432 2345689999999999999 999999998877 7
Q ss_pred eeeeeeecCCCChhhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
.++||||++ .+|..++...... ..++...+..+..|+++||+|||++ +|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999995 5888887643221 4577788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+...-.....+...+|..|.|||++.+. .|+...||||+||+++||++++.-|.+....+....+-...... ....++
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP-~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP-NEKDWP 246 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC-CccCCC
Confidence 8765444445566799999999999987 78999999999999999999999998877644222222111110 011111
Q ss_pred c-------------ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 N-------------IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~-------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. +-.+...............+++.+|++.+|.+|.|++..++.
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 110100000001111467789999999999999999999975
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=314.11 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=200.9
Q ss_pred CCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Ccee
Q 012975 152 SFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (452)
.|+..+.||+|+||.||+++. .++..||+|.+.... ......+.+|+.++++++|+|++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456788999999999999974 357889999986443 34456799999999999999999999999875 5679
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999863 234689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--------hhhhhhhcccc
Q 012975 304 GSQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--------QSIVTWAMPQL 372 (452)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--------~~~~~~~~~~~ 372 (452)
..... ......++..|+|||.+.+..++.++||||||+++|||+|++.|......... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 33221 11234467789999999888899999999999999999998876543211000 00000000000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
...... .........+.+++.+||+.||++||+++++++.|++++
T Consensus 240 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 240 EEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 000000 011123457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=313.52 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=202.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC-----CCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCcee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 223 (452)
.|+..+.||+|+||.||++++. ++..+|+|.+...... ....|.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999864 3678999999755443 56789999999999999999999999987 55789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
++|||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999974 233699999999999999999999998 9999999999999999999999999998665
Q ss_pred CCCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh--------hhhhhhcccc
Q 012975 304 GSQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ--------SIVTWAMPQL 372 (452)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~--------~~~~~~~~~~ 372 (452)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 422111 11223456799999998889999999999999999999999998654321100 0000000000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.... .......+..++.+++.+||+.+|++|||+.||+++|+++
T Consensus 240 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 0001112335788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=307.14 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=203.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566788999999999999875 58899999886442 445677999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998853 3588999999999999999999998 9999999999999999999999999999655433333
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||....+........ .... ..
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~--------~~~~---------~~ 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP--------KNNP---------PT 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh--------cCCC---------CC
Confidence 334467889999999988889999999999999999999999998655432111110 0000 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+||+.+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 222445678899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.98 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=200.3
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
|...+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445677999999999999865 57789999886443 3445679999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++..........
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999988752 4589999999999999999999998 99999999999999999999999999986554333223
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....+..... + ... .. .+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~-~~-----~~~~---- 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPK-NS-----PPTL---- 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhc-CC-----CCCC----
Confidence 33457889999999999899999999999999999999999997654322111 0 000 00 0111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234567789999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=315.46 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=205.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
.++|...+.||+|+||.||+++.. ....+|+|.+... .......+.+|+++++++ +|+||++++++|..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 2456899988643 234456789999999999 699999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 220 DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+..+++|||+++|+|.+++.... ....+++..+++++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999886421 124589999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhh
Q 012975 287 DSKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQS 363 (452)
Q Consensus 287 ~~~~~~kl~Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~ 363 (452)
++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999654322211 111234467999999998899999999999999999999 999997765433222
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
... .... .+. ......++.+++.+||+.||++||++.|+++.|.++...
T Consensus 248 ~~~-------~~~~-~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 LLR-------EGHR-MDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHH-------cCCC-CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 211 0000 000 011234667899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=305.95 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|.....||+|+||.||+|+.. +...+++|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999864 3457899988654433 4577999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 224 IVYELMENRSLDIQLHGPSHG------SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998753322 2689999999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCC-CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccC
Q 012975 298 GLAITDGSQN-KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDR 375 (452)
Q Consensus 298 gl~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 375 (452)
|++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||............. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~--------~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------A 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--------c
Confidence 9985432211 11223346778999999988889999999999999999998 889997654322111111 0
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
....... .......+.+++.+||+.||++||++.|++..|.+
T Consensus 234 ~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0000000 01123467789999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.00 Aligned_cols=240 Identities=25% Similarity=0.420 Sum_probs=191.8
Q ss_pred CeEeecCcEEEEEEEeCC--------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 359999999999998642 234888888655555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------EEEEecCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--------AKLSDFGLA 300 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~--------~kl~Dfgl~ 300 (452)
+++|+|..+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998742 34689999999999999999999999 9999999999999988765 699999988
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLG-RRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++| ..|+............. ....+
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------~~~~~ 224 (258)
T cd05078 156 ITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-------DRHQL 224 (258)
T ss_pred cccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-------ccccC
Confidence 54322 123457889999999876 4578999999999999999998 56666544432211111 11111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
+. ....++.+++.+||+.||++|||++++++.|.
T Consensus 225 ~~------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 PA------------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CC------------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 11245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.34 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=207.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
.+|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999742 23468999886433 33457899999999999 7999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 012975 221 TRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~ 287 (452)
..++++||+++|+|.+++.... ....++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999886421 124589999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCCcccCCCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhh
Q 012975 288 SKFNAKLSDFGLAITDGSQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSI 364 (452)
Q Consensus 288 ~~~~~kl~Dfgl~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~ 364 (452)
+++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999998654332211 112234567999999999999999999999999999998 8999977654332222
Q ss_pred hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccC
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~ 432 (452)
+. .... .+. ......++.+++.+||+.+|++||++.|+++.|+++......
T Consensus 249 ~~-------~~~~-~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 249 LK-------EGHR-MDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HH-------cCCC-CCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 11 0000 000 012234677899999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.20 Aligned_cols=245 Identities=30% Similarity=0.403 Sum_probs=199.9
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
...||+|+||.||++... ++..||+|.+........+.+.+|+..++.++|+|++++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 466999999999999875 5889999998766556667799999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..............
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 988742 3589999999999999999999999 999999999999999999999999999865433333333456
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
|+..|+|||.+.+..++.++||||||+++|||++|+.||............... . . +.... ....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~------~----~~~~~--~~~~ 244 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---L------P----PRVKD--SHKV 244 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---C------C----Ccccc--cccc
Confidence 889999999998888999999999999999999999999865543321111110 0 0 00000 0012
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3356678999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=302.21 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=201.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-Cceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 227 (452)
+|+..+.||+|++|.||+++.. ++..+|+|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777899999999999999875 5788999998643 234456789999999999999999999987644 46789999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++... ....+++.+++.++.+++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888642 245689999999999999999999999 99999999999999999999999999987654433
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......++..|+|||.+.+..++.++||||||++++||++|+.||...+......... . ...+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~------~--~~~~~------- 221 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------E--GKLPP------- 221 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------h--cCCCC-------
Confidence 33344568899999999999999999999999999999999999998654322111110 0 11111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......++.+++.+|++.||++||++.|+++.
T Consensus 222 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 --MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=307.89 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-C----cEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-N----LHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||.||+|.+.+ | ..+|+|.+.... ......+.+|+.++++++|+|+++++++|.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778999999999999998653 3 258899876543 3445678999999999999999999999987 78899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999874 344599999999999999999999998 99999999999999999999999999996543
Q ss_pred CCCCcc--cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKNN--LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||......+....+.. ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~~~- 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-------GERLPQ- 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-------CCCCCC-
Confidence 222111 11223568999999988889999999999999999998 9999987665443222211 000000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
+. .+...+.+++.+||..||++||++.++++.|+++...
T Consensus 233 --~~-------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 233 --PP-------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 1123567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=307.75 Aligned_cols=260 Identities=25% Similarity=0.335 Sum_probs=197.0
Q ss_pred CCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----ceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 225 (452)
.|...+++|.|.||.||+|.+.+ +..||||++-...+ --.+|+++|++++|||||+|.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45567899999999999999764 68999999854332 2257999999999999999998876432 34689
Q ss_pred eeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCccc
Q 012975 226 YELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITD 303 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~~~ 303 (452)
||||+. +|...++. ...+..++...+.-+..|+++||.|||+. +|+||||||.|+|+|.+ |.+||+|||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 77666653 12356688888889999999999999998 99999999999999976 99999999999776
Q ss_pred CCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc--------
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-------- 374 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-------- 374 (452)
.... .+.....|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+....+-.......+
T Consensus 177 ~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 177 VKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred ccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 4433 33556789999999999874 7999999999999999999999999987654432222211111100
Q ss_pred ---CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 375 ---RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 375 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
+.+.+.+...............+.++++.++++.+|.+|.++.|++
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 1112222222211112234456788999999999999999999998
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=309.77 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=198.2
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+|++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999876 68899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888542 234589999999999999999999998 99999999999999999999999999986543222
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.................... ...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~---------- 224 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--EEY---------- 224 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--hhc----------
Confidence 11234689999999999999999999999999999999999999986532211111110000000 000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
.......+.+++..||+.||++||| ++|+++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112345678999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.59 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=201.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46778899999999999999986 58899999875332 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|..+... ...+++.+++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887653 33589999999999999999999998 99999999999999999999999999986544333
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc------------
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD------------ 374 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------ 374 (452)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...........+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 33334457889999998875 44788999999999999999999999765432211111111000000
Q ss_pred -CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 -RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 -~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....++.................+.+++.+||+.||++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000011234668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=302.97 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=203.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.+|+++.. +|+.+|+|.+... .....+++.+|+.++++++|+||+++++++..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777899999999999999865 6789999998643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. .....+++.++++++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988864 2234588999999999999999999998 999999999999999999999999999865543332
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......|+..|+|||.+.+...+.++|+||||++++||++|+.||......+...... .. ..+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~------~~--~~~~-------- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII------RG--SYPP-------- 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh------cC--CCCC--------
Confidence 2233458889999999998899999999999999999999999997654432211110 00 0000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+||+.+|++||+++||++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 -VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=304.02 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=197.6
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh---------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
|.....||+|++|.||+|... ++..+|+|.+..... ...+.+.+|++++++++|+||+++++++.+++..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999865 578899998854321 1235688999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
+++|||+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999853 35689999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 303 DGSQN------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 303 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
..... .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......... . . .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-~----~~-~ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--K-I----GE-N 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH--H-H----hc-c
Confidence 43211 11122457889999999998889999999999999999999999998754322110 0 0 00 0
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+.+ .......+.+++.+||+.||++||++.|+++
T Consensus 228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111 1122346778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.45 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+++.. ++..||+|.+... .......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999876 5889999998632 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999863 35689999999999999999999999 9999999999999999999999999998543211
Q ss_pred C-----------------------------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 012975 307 N-----------------------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 307 ~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0 00123469999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhh-hhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHH
Q 012975 352 PVEKLAPAQCQSIV-TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL---ITDVLH 421 (452)
Q Consensus 352 P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 421 (452)
||...........+ .|.. ....+. .. ....++.+++.+|+. ||.+|++ +.|+++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~-----~~~~p~----~~------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQETYRKVMNWKE-----TLVFPP----EV------PISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHHHHHHHcCCC-----ceecCC----CC------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99877654432221 1110 000110 00 012345566666664 9999985 566664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=314.00 Aligned_cols=262 Identities=20% Similarity=0.271 Sum_probs=193.8
Q ss_pred cCeEeec--CcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 156 SNILGEG--GFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 156 ~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
.++||+| +|++||+++.. +|..||+|++... .....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 5679999 78999999875 6889999998644 23345668889999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC--
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-- 308 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 308 (452)
+|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999988532 134589999999999999999999998 999999999999999999999999986533211110
Q ss_pred -----cccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhccccccC-----
Q 012975 309 -----NNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDR----- 375 (452)
Q Consensus 309 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~----- 375 (452)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .......+...+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0112346778999999876 45889999999999999999999999865432210 0000000000000
Q ss_pred -------------CCCCcc---------cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 -------------SKLPNI---------VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 -------------~~~~~~---------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....+. ................+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 0000000111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=315.62 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=195.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+++.. ++..||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999876 5889999998532 2234456889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999863 245689999999999999999999999 9999999999999999999999999998654332
Q ss_pred CC-cccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 307 NK-NNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+.. ......++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~ 231 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----HKEHFQFPP 231 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc----CCCcccCCC
Confidence 22 1223468999999999863 4578899999999999999999999987654332111110 000011111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCC--CCCCCChHHHHHh
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPE--PSYRPLITDVLHS 422 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~d--P~~RPs~~evl~~ 422 (452)
. .. .....+.+++.+|+..+ +..||+++++++.
T Consensus 232 ~-----~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 D-----VT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c-----cC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00 12234566777766543 3448899999865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.59 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=188.8
Q ss_pred eEeecCcEEEEEEEeCC---CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 158 ILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.||+|+||.||+|+..+ ...+++|.+.... ......|.+|+.+++.++|+||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568888775433 3345678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC--c
Q 012975 234 LDIQLHGPSH--GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--N 309 (452)
Q Consensus 234 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~ 309 (452)
|.+++..... ....++...+.++.|++.||+|||+. +++||||||+|||+++++++||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865321 23456888899999999999999999 999999999999999999999999999854322211 1
Q ss_pred ccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 310 NLKLSGTLGYVAPEYLLD-------GKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+....... ... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-----~~~---~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR-----EQD---IKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh-----ccC---ccC
Confidence 122345678999998643 356789999999999999998 8889977654331111110 000 011
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.++.+.. .....+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1121221 22344556778888 49999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=312.30 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=201.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||.||+|++. ++. .+|+|.+.... .....++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45667889999999999999864 343 47888876443 23345789999999999999999999998754 4679
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999863 344689999999999999999999998 99999999999999999999999999996543
Q ss_pred CCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~~- 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-------GERLPQ- 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------CCCCCC-
Confidence 2221 1122335678999999998999999999999999999997 9999977654332222211 111100
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
+ . .+...+.+++..||..+|++||+++++++.|+++...
T Consensus 233 --~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 --P---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --C---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0 1224577899999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=309.73 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=202.5
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEE----
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSA---- 217 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---- 217 (452)
..+..+.++|+..+.||+|+||.||++... ++..+|+|.+... .....++.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344557789999999999999999999875 5788999987643 22345688999999999 6999999999884
Q ss_pred -cCCceeeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 218 -HDDTRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 218 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
.++..++||||+++++|.++++.. .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999998877532 2345689999999999999999999998 99999999999999999999999
Q ss_pred ecCCCcccCCCCCcccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 296 Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
|||++..............|+..|+|||.+.. ..++.++|||||||++|||++|+.||......... ...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~~--- 241 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FKI--- 241 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hhc---
Confidence 99998655433323334468999999998753 45788999999999999999999999865432211 110
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.. .......++. .....+.+++.+||+.||++|||++|+++.+
T Consensus 242 --~~-~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 --PR-NPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --cc-cCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0001111111 1123577899999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=321.90 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=200.7
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
.++...++|+..+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445688999999999999999999876 5788999998532 2233456889999999999999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+++|+|..++.. ..++...+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999988853 3478888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-cccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccC
Q 012975 301 ITDGSQNK-NNLKLSGTLGYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR 375 (452)
Q Consensus 301 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 375 (452)
........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+. ...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~ 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------NHK 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC
Confidence 65433221 223456999999999987543 7889999999999999999999998765432211111 000
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHhc
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLHSL 423 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~L 423 (452)
..+ .+.+ ..+....+.+++..|++.++.+ ||++.|+++..
T Consensus 264 ~~~-~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NSL-TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred Ccc-cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 0000 0122345667889999844443 78999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=307.83 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=200.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35777889999999999999986 6889999988654 334456799999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|..++........+++..+..++.+++.||.|||+.+ +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988875333457999999999999999999999632 89999999999999999999999999986543221
Q ss_pred cccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 309 NNLKLSGTLGYVAPEYLLDG------KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.....++..|+|||.+.+. .++.++|+|||||++|||++|+.||.............. ... .....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~-~~~~~-- 229 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA----IVD-GDPPT-- 229 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH----Hhh-cCCCC--
Confidence 2234578899999988554 347899999999999999999999976443221111110 000 00000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+....+.+++.+||+.+|++||+++++++.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 -------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111234567789999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=309.02 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=205.5
Q ss_pred ccHHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc
Q 012975 141 IEYKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (452)
Q Consensus 141 ~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 218 (452)
+....+..++++|...+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556667889999999999999999999875 67889999886432 2345678899999999 89999999999875
Q ss_pred CC-----ceeeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 219 DD-----TRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 219 ~~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
.+ ..++||||+++|+|.++++.. .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999887532 2345689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-----KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~ 367 (452)
||+|||++..............|+..|+|||.+... .++.++|||||||++|||++|+.||........ +..+
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKI 245 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHH
Confidence 999999986544333222334688999999987543 368899999999999999999999987654221 1111
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. .....+.++ .+....+.+++.+||+.||++||++.|+++.
T Consensus 246 ~~------~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PR------NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hc------CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 001111111 1223467889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.13 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=201.5
Q ss_pred CCCccCeEeecCcEEEEEEEeCC--CcEEEEEEecCc----------ChhhHHHHHHHHHHHHc-CCCCceeeeEEEEEc
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD--NLHVAVKKLDCA----------TQDAGREFENEVDLLSN-IHHPNVVCLLGYSAH 218 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 218 (452)
+|+..+.||+|+||.||+|.... +..+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999999765 678999987532 22334567788988875 799999999999999
Q ss_pred CCceeeeeeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 219 DDTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
++..+++|||+++++|.+++.. ......+++..+++++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999887743 123456899999999999999999999631 8999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+. . ..
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~------~--~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV------E--AV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh------h--cc
Confidence 9996644332 2334568899999999998889999999999999999999999997654332111111 0 00
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
.... .. ......+.+++.+||+.||++||++.||..++++
T Consensus 230 ~~~~----~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YEPL----PE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCcC----Cc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0000 00 0123467789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.62 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=198.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----- 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 220 (452)
..++|+..+.||+|+||.||++... .+..||+|++... .......+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568989999999999999999865 5889999998643 3344567889999999999999999999886543
Q ss_pred -ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 221 -TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 221 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||++ +++||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999975 5555553 2488999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hh-----------
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TW----------- 367 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~----------- 367 (452)
+....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+..... ..
T Consensus 166 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 166 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 97543322 222346899999999999999999999999999999999999999876532211100 00
Q ss_pred ----hccccccCCCCCcccchh-----hc---ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 368 ----AMPQLTDRSKLPNIVDPV-----IK---STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 368 ----~~~~~~~~~~~~~~~d~~-----l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
................+. +. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000000 00 00111123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=330.31 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=209.6
Q ss_pred cCeEeecCcEEEEEEEeC-C----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 156 SNILGEGGFGCVYKAKLD-D----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++||+|+||+||||.+- + ..+||+|.+... ......++.+|+-+|.+++|||+++|+|+|..+. ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 678999999999999753 3 356899988543 4556788999999999999999999999998866 89999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
+.|+|.++++ .+.+.+--...+.|..|||+||.|||.+ .++||||..+|||+.+-..+||.|||+++........
T Consensus 780 P~G~LlDyvr--~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVR--EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999998 4567788999999999999999999999 9999999999999999999999999999876554433
Q ss_pred ccc--cccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 310 NLK--LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 310 ~~~--~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
... ..-.+.|||-|.+....++.++|||||||++||++| |..||++....++.+++... .+++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-------eRLs------- 920 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-------ERLS------- 920 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-------ccCC-------
Confidence 322 223567999999999999999999999999999998 99999998877765555422 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
..+-+...+..++.+||..|++.||+++++..++.++.+.
T Consensus 921 ---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 ---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1223445677789999999999999999999888766554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=308.38 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=197.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|++|.||+|+.. ++..||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999876 678999999864432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++ +|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 984 89888763 234689999999999999999999999 999999999999999999999999999865432222
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChh-hhhhhhhhhccc--------cccCCC-
Q 012975 309 NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA-QCQSIVTWAMPQ--------LTDRSK- 377 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~--------~~~~~~- 377 (452)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +........... ......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2223346889999998875 45789999999999999999999999765421 111111000000 000000
Q ss_pred ----CCcccchhhccc-CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 ----LPNIVDPVIKST-MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ----~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........+... ........+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000 00111256678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.93 Aligned_cols=264 Identities=25% Similarity=0.308 Sum_probs=197.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----- 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 220 (452)
..++|+..+.||+|+||.||++... +|..||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468889999999999999999875 5889999998543 3344567889999999999999999999986543
Q ss_pred -ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 221 -TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 221 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
..++||||+++ +|...++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 4555543 2478899999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhh------------
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVT------------ 366 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~------------ 366 (452)
+...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+...... ...
T Consensus 170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 8654322 22233568999999999999999999999999999999999999998765322100 000
Q ss_pred ---hhccccccCCCC-----Ccccchhhc---ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 367 ---WAMPQLTDRSKL-----PNIVDPVIK---STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 367 ---~~~~~~~~~~~~-----~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
............ .+....... ...+......+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 000000000 00011123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.83 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=193.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcC---CCCceeeeEEEEEcC-----C
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNI---HHPNVVCLLGYSAHD-----D 220 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 220 (452)
+|+..+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+++++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999876 58899999886432 12233456777777665 799999999988653 3
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..+++|||++ ++|..++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999997 4787777642 234589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhccc----cccC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQ----LTDR 375 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~----~~~~ 375 (452)
....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ......... +...
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 6543222 222346889999999999989999999999999999999999999766543321 111111000 0000
Q ss_pred CCC-Ccccchhhc---ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 SKL-PNIVDPVIK---STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~~~-~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... .....+... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000 0001123346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=299.57 Aligned_cols=247 Identities=29% Similarity=0.468 Sum_probs=200.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+|...+.||+|+||.||+|... ++..|++|.+.... +...+.+.+|+++++.++|+|++++++++.+++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999987 78899999885432 33557799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999863 34589999999999999999999998 999999999999999999999999999865433
Q ss_pred CCCcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||............. ........+.
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~---- 225 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG----RSKELPPIPD---- 225 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----hcccCCCcCC----
Confidence 32 223446888999999987776 8999999999999999999999997755322111111 0001111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.+|++||++.++++
T Consensus 226 --------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 --------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12345667899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=304.82 Aligned_cols=249 Identities=35% Similarity=0.514 Sum_probs=197.2
Q ss_pred CeEeecCcEEEEEEEeCC-------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDD-------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999875432 34566789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-----cEEEEecCC
Q 012975 229 MENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-----NAKLSDFGL 299 (452)
Q Consensus 229 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-----~~kl~Dfgl 299 (452)
+++++|.+++.... ....+++.+++.++.|++.||+|||+. +++|+||||+||++++++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986421 224588999999999999999999998 999999999999999887 899999999
Q ss_pred CcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 300 AITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 300 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
+....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-------AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-------cCC
Confidence 86432211 11112345678999999999999999999999999999998 999997655433221111 000
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
... ........+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 011223567889999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=308.00 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=203.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||.||+|++. ++..||+|.+... .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999876 5788999988643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++++.+..+... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998887766532 34589999999999999999999999 99999999999999999999999999986654433
Q ss_pred C-cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc--------ccc---
Q 012975 308 K-NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ--------LTD--- 374 (452)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~--- 374 (452)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+........... ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 22335678899999999888 8899999999999999999999999865433211111110000 000
Q ss_pred --CCCCCcccchh-hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 --RSKLPNIVDPV-IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 --~~~~~~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+..++. ...........++.+++++||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00111111111 001111122567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=310.88 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=199.5
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
...||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
..++.. ..+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..............
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 887742 4589999999999999999999999 999999999999999999999999999865433332233456
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....... ... ... .. ....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-----~~~-----~~--~~~~ 243 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-----PKL-----KN--AHKI 243 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-----CCc-----cc--cCCC
Confidence 89999999999988999999999999999999999999986554332111110 000 000 00 0012
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+.+++.+|++.+|++||+++|+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2356789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.55 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=188.6
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC---CCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI---HHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
||+|+||+||+|+.. ++..||+|.+.... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 58899999985322 22334456677777665 699999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999988853 45689999999999999999999999 999999999999999999999999999865433333334
Q ss_pred ccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 312 KLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
...||..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.. ....++. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------~~~~~~~-------~-- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------GKVRFPK-------N-- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------CCCCCCC-------c--
Confidence 56799999999998765 478999999999999999999999987654332222111 0111110 0
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCC----ChHHHHH
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRP----LITDVLH 421 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RP----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| ++.|+++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123556799999999999998 5666664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.63 Aligned_cols=192 Identities=27% Similarity=0.332 Sum_probs=163.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
...+|...+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999876 4678888875322 23568999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+. ++|..++.. ....+++..+++++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 678777753 345799999999999999999999999 9999999999999999999999999998643222
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPV 353 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~ 353 (452)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999855554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.30 Aligned_cols=267 Identities=18% Similarity=0.255 Sum_probs=195.4
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC------CceeeeEEEEE
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHH------PNVVCLLGYSA 217 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~ 217 (452)
+++...++|++.+.||+|+||+||+|... .+..||||++.... ...+.+..|+.++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999875 57789999986432 233455667777766654 45889999887
Q ss_pred cC-CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC------
Q 012975 218 HD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF------ 290 (452)
Q Consensus 218 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~------ 290 (452)
.+ +..++|||++ +++|.+++.. ...+++..+..|+.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 65 4678999988 6778777753 356999999999999999999999732 899999999999998765
Q ss_pred ----------cEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 291 ----------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 291 ----------~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999875422 22234679999999999999999999999999999999999999998766543
Q ss_pred hhhhhhhhcccc-----------------ccCCCCCcccchh-hc---c---cCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 361 CQSIVTWAMPQL-----------------TDRSKLPNIVDPV-IK---S---TMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 361 ~~~~~~~~~~~~-----------------~~~~~~~~~~d~~-l~---~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
....+......+ .....+....++. +. . ..+.-....+++++.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 222221111100 0000000011110 00 0 0000113457799999999999999999
Q ss_pred HHHHH
Q 012975 417 TDVLH 421 (452)
Q Consensus 417 ~evl~ 421 (452)
+|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99996
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.66 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=209.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-----CcEEEEEEecC-cChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+.....++||.|-||.||+|.+.+ .-.||||..+. .+.+..+.|+.|+.+|++++|||||+++|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344456889999999999997532 34588888765 345667889999999999999999999999986 56799
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|||.++-|.|..+|.. +...|+......++.|++.+|+|||+. .++||||..+|||+....-+||+|||+++...
T Consensus 468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999984 456788899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 305 SQNKN-NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 305 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
++... .....-+..|||||.+.-++++.+||||-|||.+||++. |..||.+....+.. ..+....+++
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeRlP--- 612 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGERLP--- 612 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCCCC---
Confidence 54432 223334568999999999999999999999999999996 99999987654321 1222222221
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
..+.+...+..++.+||..||.+||++.|+...|.+++..+.
T Consensus 613 -------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 613 -------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred -------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 122444566678999999999999999999988887776443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=324.79 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=194.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46888999999999999999876 47889999643 234578999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 308 (452)
. ++|..++.. ....++|.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5 788877753 234699999999999999999999999 999999999999999999999999999865432211
Q ss_pred -cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--------hhhhhhhhhhccccccCCCCC
Q 012975 309 -NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--------AQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 379 (452)
......||..|+|||++.+..++.++|||||||++|||++|..|+..... .+....+.+...... .++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~---~~~ 393 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD---EFP 393 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc---cCC
Confidence 12235699999999999999999999999999999999998876543221 111222222111100 000
Q ss_pred cccchhhcc------------cCC-------HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKS------------TMD-------LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~------------~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.. ... ......+.+++.+||+.||++|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 000 0112356789999999999999999999964
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.83 Aligned_cols=247 Identities=31% Similarity=0.492 Sum_probs=198.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|...+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.++++++|+|++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577789999999999999975 56689999986432 345789999999999999999999998764 5799999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998642 234689999999999999999999998 99999999999999999999999999986532211
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+....... .... ++
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~----~~----- 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYRM----EP----- 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------CCCC----CC-----
Confidence 12234568999999988899999999999999999997 9999987665432222111 0000 00
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
.......+.+++.+||+.+|++||+++++++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01223567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=299.46 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=207.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|++|.||+++..+ +..|++|++..... .....+.+|++.+.+++|+|++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367788999999999999999874 88999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
+++++|.+++.. ...+++..++.++.|+++||+|||+ . +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999863 2568999999999999999999999 8 99999999999999999999999999987654433
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||.............+... ..... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~-----~- 223 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-----GPPPS-----L- 223 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-----CCCCC-----C-
Confidence 333345688999999999998999999999999999999999999987653121222222110 00000 0
Q ss_pred ccCCHH-HHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLK-HLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
... ....+.+++.+||+.+|++||++.|+++.
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34577889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.01 Aligned_cols=264 Identities=24% Similarity=0.304 Sum_probs=198.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 219 (452)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3467888999999999999999865 5788999998643 234456788999999999999999999987543
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356999999975 5655553 2478899999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc----------
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM---------- 369 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~---------- 369 (452)
+....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 173 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 97543322 1223468999999999999999999999999999999999999998765433211111000
Q ss_pred ------cccccCCCCCc-----ccchhh---cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 370 ------PQLTDRSKLPN-----IVDPVI---KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 370 ------~~~~~~~~~~~-----~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+...... ...... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 000000 000111123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=308.25 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=195.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||+|+.. +|..+|+|.+.... ......+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999876 68899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++ ++|.+++.. ....+++..++.++.|+++||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 577776653 235699999999999999999999999 999999999999999999999999999865443322
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-hhh-hhhh-------hccccc---cC
Q 012975 309 NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQS-IVTW-------AMPQLT---DR 375 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~-~~~-~~~~-------~~~~~~---~~ 375 (452)
......++..|+|||.+.+. .++.++|||||||++|||+||..|+......+ ... +... ..+... ..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334578899999988765 46899999999999999999999865433211 100 0000 000000 00
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......................+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000011123456778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=300.24 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||.|+||+||+|... ++..+++|.+.... ....+.+.+|++.++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 67889999986432 23567899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++........+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999987533335689999999999999999999998 999999999999999999999999999854433221
Q ss_pred ----cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 309 ----NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 309 ----~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
......|+..|+|||.+... .++.++|+||||+++|||++|+.||........ ....... ....+....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~~~~~~~~~- 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---DPPSLETGA- 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---CCCCcCCcc-
Confidence 12334688999999998776 788999999999999999999999987654321 1111100 000010000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........+.+++.+||+.||++||+++|+++
T Consensus 232 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 ------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01133456788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.72 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=203.1
Q ss_pred cHHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc-
Q 012975 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH- 218 (452)
Q Consensus 142 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 218 (452)
+...+..+.+.|+..+.||+|+||.||+|+.. ++..+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556788899999999999999999875 57889999886443 3446788999999998 79999999999853
Q ss_pred -----CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 012975 219 -----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (452)
Q Consensus 219 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~k 293 (452)
.+..+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45779999999999999888642 245688999999999999999999999 999999999999999999999
Q ss_pred EEecCCCcccCCCCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh
Q 012975 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~ 368 (452)
|+|||++..............|+..|+|||.+. +..++.++|||||||++|||++|+.||....+........+
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~- 240 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 240 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-
Confidence 999999865433222233456899999999875 34678899999999999999999999976543321111110
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... ....+....+.+++.+||+.||.+||++.|+++
T Consensus 241 -------~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 -------NPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------CCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 001123456888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.90 Aligned_cols=267 Identities=26% Similarity=0.341 Sum_probs=197.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++++|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888999999999999999865 688999999864432 22346788999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+. ++|..++.. ....+.+.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 666655542 234578889999999999999999998 9999999999999999999999999998654333
Q ss_pred CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccC------CCCC
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR------SKLP 379 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 379 (452)
........++..|+|||.+.+. .++.++||||||+++|||++|+.||.............|........ ...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3223334578899999988764 57889999999999999999999998655422111111110000000 0000
Q ss_pred cccchhh----ccc-----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVI----KST-----MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l----~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....... ... ........+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 000 00012346678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=306.47 Aligned_cols=264 Identities=28% Similarity=0.336 Sum_probs=200.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh-----hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+|+..+.||+|+||.||+|... ++..||+|++...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999875 6889999998654322 345678899999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+ +|+|.+++... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999998642 23699999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccc----cccCCCCC
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQ----LTDRSKLP 379 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~----~~~~~~~~ 379 (452)
.........++..|+|||.+.+ ..++.++|||||||++|||++|..||......+... ........ ........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 3333333356788999998865 467899999999999999999988887655322111 11100000 00000011
Q ss_pred cccchhhcccC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTM-----DLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........... .......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11110000000 1123467789999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.29 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=201.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++|+|++++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 344578999999999999864 6889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++...........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999998863 4589999999999999999999999 999999999999999999999999998865433322223
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||...++.+......... ... ... .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~-----~~~--~ 238 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--------PPK-----LKN--L 238 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--------CCC-----Ccc--c
Confidence 3468899999999988889999999999999999999999997755433222111110 000 000 0
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 012346788999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=307.09 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=201.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||++...+ +..+|+|.+..... ...+.+.+|+++++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999998764 88999999865432 24567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+.+++|.+++.. ..+..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998864 2346799999999999999999999998 9999999999999999999999999998543211
Q ss_pred CC-----------------------------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 307 NK-----------------------------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 307 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
.. ......||..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 1112357889999999999889999999999999999999999998665
Q ss_pred hhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC----hHHHHH
Q 012975 358 PAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL----ITDVLH 421 (452)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 421 (452)
......... ......+. .......+.+++.+||+.||++||+ ++|+++
T Consensus 237 ~~~~~~~~~------~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDETFSNIL------KKEVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHHHHh------cCCccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 432111110 11111110 0013457888999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.56 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=202.1
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 226 (452)
+|+..+.||.|+||.||++... ++..+|+|.+... .....+++.+|++++++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999865 6788999988543 34445678999999999999999999998764 34679999
Q ss_pred eecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHC--NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||+++++|.+++... .....+++..++.++.|++.||.|||..+ +.+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888642 22467999999999999999999999332 239999999999999999999999999999765
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
...........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~--- 229 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------EGKFRR--- 229 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh--------cCCCCC---
Confidence 544332334568999999999999889999999999999999999999998765322111110 011100
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+|++.+|++||++++|++.
T Consensus 230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.19 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||+||++... ++..||+|.+.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666788999999999999875 57889999876443 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|..++.. .+.+++..+..++.+++.||.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988853 346899999999999999999999732 7999999999999999999999999998543221
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-----hhhhhhhhccccccCCCCCcccc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-----CQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ ......+........ ...
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--- 232 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPR--- 232 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCC---
Confidence 1123468999999999988899999999999999999999999998654321 011111111111100 000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
+ ...+....+.+++.+|++.||++|||+.|+++..
T Consensus 233 --~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 --L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0112345678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=300.79 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=201.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3566788999999999999865 67899999876432 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999988853 3589999999999999999999998 9999999999999999999999999998655433322
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....++..|+|||.+.+..++.++|+||||+++|||++|..||...........+. . ... +.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~-~~~-----~~~--- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------K-NNP-----PTL--- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-------c-CCC-----CCC---
Confidence 333468889999999988889999999999999999999999997654322111110 0 000 001
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.+++.+|++.+|.+||++.++++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11233457789999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.77 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=195.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+++.. ++..+|+|.+... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999876 4678999998532 2233455889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999963 234689999999999999999999999 9999999999999999999999999998654322
Q ss_pred CC-cccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 307 NK-NNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+... ..+...+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~~~p~ 231 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH----KERFQFPA 231 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----CccccCCC
Confidence 22 222346999999999886 346788999999999999999999999876543322111100 00011111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCC--CCCChHHHHHh
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPS--YRPLITDVLHS 422 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~--~RPs~~evl~~ 422 (452)
.. . .....+.+++.+|+..+++ .|++++|+++.
T Consensus 232 ~~-----~----~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 QV-----T----DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----c----cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 1 1233556677887755444 47899999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.33 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=197.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||+||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999876 5778999998532 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|..++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999863 235689999999999999999999999 9999999999999999999999999998654332
Q ss_pred CC-cccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 307 NK-NNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. ......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.. ...+..++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~~~p~ 231 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----HEERFQFPS 231 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc----CCCcccCCC
Confidence 22 1223469999999998875 4678899999999999999999999987654332111110 000111111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHh
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLHS 422 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 422 (452)
.+. +....+.+++.+|++.++++ |++++++++.
T Consensus 232 ~~~---------~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 HIT---------DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccc---------cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 110 12345677888888866544 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.61 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=193.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cce
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (452)
.+|+..+.||+|+||.||+|... ++..|++|++.... ......+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 58899999885332 23345689999999999999999999988753 567
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998863 34589999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCC---CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 303 DGSQN---KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 303 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||............. .......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~ 231 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA----TQPTNPQLP 231 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh----cCCCCCCCc
Confidence 32211 11122457889999999999889999999999999999999999998654322111100 000011111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .....+..++ .||..+|++||+++||++
T Consensus 232 --------~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 232 --------S----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --------h----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 1112333444 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=300.64 Aligned_cols=262 Identities=25% Similarity=0.331 Sum_probs=203.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEec--CcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-----CCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-----DDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 221 (452)
...|...+.||+|+||.|+++... +|..||+|++. .......++-.+|+.+|+.++|+||+.+++.... -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999875 68999999997 4566677888999999999999999999998865 246
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+|+|+| ..+|...++. +..|+......+..|+++||.|+|+. +++||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 79999999 5688877753 44599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC--CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-------
Q 012975 302 TDGSQ--NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ------- 371 (452)
Q Consensus 302 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~------- 371 (452)
..... ....+..+.|..|.|||.+.. ..|+...||||.||++.||++|+.-|.+.+......++....+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 76432 223345678999999998755 68999999999999999999999999887754433333222111
Q ss_pred ----------cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 ----------LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 ----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+......+..--..+-. ......++++.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp----~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP----NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC----CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11100000000000001 222456789999999999999999999853
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.39 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=199.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 225 (452)
++|+..+.||+|+||.||+|+.. ++..+++|.+..... .....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999986 578899999864432 2234577899999999999999999998877 789999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||++ ++|.+.+.. ....+++.+++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 588887763 234689999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hhhc-------c---ccc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAM-------P---QLT 373 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~~~-------~---~~~ 373 (452)
.........++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+ .... + .+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 33333334578899999988764 4688999999999999999999999876543322111 1000 0 000
Q ss_pred --cCCCCCcccchhhcccCCHH-HHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 --DRSKLPNIVDPVIKSTMDLK-HLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
............+....... ....+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111111111 2456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=300.01 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=189.4
Q ss_pred eEeecCcEEEEEEEeCCC---cEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 158 ILGEGGFGCVYKAKLDDN---LHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 345667665432 3456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--Ccc
Q 012975 234 LDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNN 310 (452)
Q Consensus 234 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~ 310 (452)
|.++++... .....++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987532 224567778889999999999999998 99999999999999999999999999975422111 122
Q ss_pred cccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 311 LKLSGTLGYVAPEYLLD-------GKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+....+. ........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI--------KDQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hhcccccC
Confidence 23467889999998743 245789999999999999997 677887655433211111 01111222
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
++.+....+ ..+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333332222 35666888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=304.13 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=198.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|++|.||+|+.. ++..||+|++.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777899999999999999875 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+. ++|..++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888887642 245689999999999999999999998 999999999999999999999999999865543333
Q ss_pred cccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccc-------c----C
Q 012975 309 NNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLT-------D----R 375 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~-------~----~ 375 (452)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ .....+...... . .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 223345788999999887644 58899999999999999999999976543221 111111100000 0 0
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+.+........ .......+.+++.+|++.||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 0012245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.89 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=203.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++|||++++++++..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57788899999999999999864 67889999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++++|.+++.. ..+++.++..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998853 3578999999999999999999999 9999999999999999999999999988654433333
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....++..|+|||.+.+..++.++|+||||+++||+++|+.||............ ... . .+...
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~-~-~~~~~------- 236 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN-G-TPELQ------- 236 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcC-C-CCCCC-------
Confidence 33446888999999998888999999999999999999999999765432211000 000 0 00000
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123457789999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=302.80 Aligned_cols=264 Identities=25% Similarity=0.290 Sum_probs=201.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||+|+.. +|..||+|++.... ......+.+|+.++++++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999875 68899999986543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+ +++|.+++... ...+++.+++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988632 35699999999999999999999998 999999999999999999999999999865543321
Q ss_pred -cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh-hhhh-------ccccccCCCC
Q 012975 309 -NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI-VTWA-------MPQLTDRSKL 378 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~-~~~~-------~~~~~~~~~~ 378 (452)
......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........... .... ++....-...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 12234688999999988654 468899999999999999999888876543221111 1100 0000000000
Q ss_pred Ccccch-----hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 379 PNIVDP-----VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 379 ~~~~d~-----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+ .+.. ...+....+.+++.+|++.||++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000 011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=297.84 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=200.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 688999999865543 3677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999864 34588999999999999999999999 999999999999999999999999999865433322
Q ss_pred cc----cccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 309 NN----LKLSGTLGYVAPEYLLDGK---LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 309 ~~----~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.. ....++..|+|||.+.+.. .+.++||||||+++||+++|+.||........ ..... .. .....++..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~-~~-~~~~~~~~~ 230 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHV-GA-GHKPPIPDS 230 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHH-hc-CCCCCCCcc
Confidence 11 1245788999999998766 88999999999999999999999976532211 11000 00 111111110
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+||+.||++||++.|++.
T Consensus 231 ----------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 ----------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 012345668999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.38 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=201.7
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC-----
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD----- 220 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 220 (452)
.++++|+..+.||+|++|.||+|... +++.+++|.+..... ...++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999985 577899998865433 446799999999999 7999999999997654
Q ss_pred -ceeeeeeecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 221 -TRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 221 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999998876422 246789999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
++..............|+..|+|||.+.. ..++.++||||||+++|||++|+.||........ .... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~-----~ 231 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI-----P 231 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh-----h
Confidence 98654433333334568899999998754 3467899999999999999999999976543221 1110 0
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.. .......+.+++.+||..||++|||+.|+++
T Consensus 232 -~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000111111 1123456778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.65 Aligned_cols=249 Identities=32% Similarity=0.484 Sum_probs=199.9
Q ss_pred CccCeEeecCcEEEEEEEeCC-----CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 154 HESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+..+.||.|+||.||+++..+ +..||+|.+...... ..+.+..|+..++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999998764 478999999655433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999986422 12289999999999999999999999 99999999999999999999999999986543321
Q ss_pred Cccc-ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 308 KNNL-KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 ~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.... ...++..|+|||.+.+..++.++||||+|++++||++ |+.||...........+.. .. .... +
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-------~~-~~~~--~- 226 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-------GY-RLPK--P- 226 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------CC-CCCC--C-
Confidence 1111 2236789999999988889999999999999999998 8899876544332211110 00 0000 0
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
. ....++.+++.+|++.||++|||+.|+++.|
T Consensus 227 --~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 --E----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --C----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 1234677899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=312.43 Aligned_cols=252 Identities=27% Similarity=0.311 Sum_probs=211.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 223 (452)
..+.|+..+.||+|.||.||+++.+. |..+|+|.+..... .....+.+|+.+|+++. |||||.+.+++++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45577888999999999999999775 99999999965433 24468999999999998 999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEecCC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFGL 299 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~----~~~kl~Dfgl 299 (452)
+|||++.+|.|.+.+... .++..++..++.|++.+++|||+. +++||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998743 399999999999999999999998 99999999999999643 4799999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...+..+....+.....
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--------- 255 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--------- 255 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---------
Confidence 988766 5566678999999999999999999999999999999999999999998875543332221111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
++-++ .-......+-+++..|+..||.+|+|+.++++.
T Consensus 256 ~f~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 111234567789999999999999999999984
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=305.64 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=200.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46788899999999999999876 47889999886443 234457889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999853 34689999999999999999999998 9999999999999999999999999988531100
Q ss_pred C---------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 307 N---------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 307 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~--- 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--- 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---
Confidence 0 0111235788999999998888999999999999999999999999865543321111110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.... +.... .....+.+++.+||+.||++||++.++.+.|..-
T Consensus 232 ---~~~~-----~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 232 ---DIEW-----PEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ---ccCC-----CCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 0000 00000 1234567899999999999999976666665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=306.96 Aligned_cols=196 Identities=29% Similarity=0.400 Sum_probs=159.2
Q ss_pred cCeEeecCcEEEEEEEeC---CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceeeeeeecC
Q 012975 156 SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVYELME 230 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 230 (452)
.+.||+|+||+||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 23457889999999999999999998854 346789999986
Q ss_pred CCChhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEecCCC
Q 012975 231 NRSLDIQLHGP------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA 300 (452)
Q Consensus 231 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll----~~~~~~kl~Dfgl~ 300 (452)
+ +|..++... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 776665321 1123589999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCC---CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 301 ITDGSQN---KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 301 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
....... .......||..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6543322 122345689999999998774 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=301.02 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=200.8
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+|+..+.||+|++|.||+|+.. +|..||+|.+..... .....+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 588999999865432 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++ +|.+++........+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 7877776433345689999999999999999999998 9999999999999999999999999998654332222
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccc-------cccC----C
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQ-------LTDR----S 376 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~-------~~~~----~ 376 (452)
.....++..|++||.+.+. .++.++||||||+++|||++|+.||...+..+... ........ +... .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2334578899999988664 56889999999999999999999998765433211 11110000 0000 0
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+...+... ..........+.+++.+|++.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 1111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=299.55 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=199.7
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 226 (452)
.|+..+.||+|+||.||+|.+. ++..+|+|.+... ......++.+|+.++++++ |+|++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667788999999999999964 6889999988644 3344567889999999996 999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988753 3689999999999999999999999 9999999999999999999999999998765444
Q ss_pred CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
........|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||............ .. ... +.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~-~~~-----~~ 221 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK-SKP-----PR 221 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc-CCC-----CC
Confidence 3333445688999999988654 4688999999999999999999999865432211100 00 001 11
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+... ....++.+++.+||+.||++||++.|+++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1110 13346778999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=299.71 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=198.3
Q ss_pred CCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 153 FHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
|...+.||+|+||.||+|.+. ++..||+|.+... .....+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3688999988643 3345667899999999999999999999886543
Q ss_pred ceeeeeeecCCCChhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 221 TRFIVYELMENRSLDIQLHGPS---HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
..++++||+++|+|..++.... ....+++...++++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999987764321 223588999999999999999999998 9999999999999999999999999
Q ss_pred CCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccccc
Q 012975 298 GLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 298 gl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
|++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||......+...... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-------K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-------c
Confidence 99865432211 1122335678999999998889999999999999999999 899997665433211111 0
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
...... .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011000 012335788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=302.24 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=205.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..+.|+..+.||+|++|.||+|..+ ++..+++|.+..... ....+.+|++.++.++|+|++++++++..++..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566777889999999999999987 688999999975544 56778999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999742 24799999999999999999999998 99999999999999999999999999885543332
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......++..|++||.+.+..++.++|+||||+++|||++|+.||....+....... .. .......++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~------~~~~~~~~~--- 239 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TT------KGIPPLKNP--- 239 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh------cCCCCCcch---
Confidence 2223345788999999998888999999999999999999999999865543211111 00 001111110
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+|++.+|.+||++.++++
T Consensus 240 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 ----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 012345778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=306.38 Aligned_cols=196 Identities=29% Similarity=0.404 Sum_probs=158.6
Q ss_pred cCeEeecCcEEEEEEEeC---CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceeeeeeecC
Q 012975 156 SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVYELME 230 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 230 (452)
...||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999865 35789999986432 23467889999999999999999998854 457799999997
Q ss_pred CCChhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEecCCC
Q 012975 231 NRSLDIQLHG------PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA 300 (452)
Q Consensus 231 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll----~~~~~~kl~Dfgl~ 300 (452)
+ +|.+++.. ......+++..+..++.|++.||+|||+. +++||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 66555431 11223588999999999999999999999 99999999999999 56779999999999
Q ss_pred cccCCCCC---cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 301 ITDGSQNK---NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 301 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
........ ......||..|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 75433221 1223468999999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=297.89 Aligned_cols=253 Identities=24% Similarity=0.428 Sum_probs=198.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh----------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ----------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
+|...+.||+|+||.||+|... +|..+|+|.+..... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3556789999999999999865 688999998753211 12346888999999999999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999864 25689999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCC--CcccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 301 ITDGSQN--KNNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 301 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
....... .......|+..|+|||.+.... ++.++|+||||+++||+++|..||......+. ..... . .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~----~--~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG----N--K 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh----c--c
Confidence 6543221 1123345888999999987654 78999999999999999999999975443221 11100 0 0
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....++.. ...+....+.+++.+||+.||++||+++||++.
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 001111111 111234577889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=295.67 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.7
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677899999999999999874 6788999998644 234467799999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~~ 307 (452)
+++++|.+++... .+..+++..++.++.+++.||+|||++ +++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998742 245689999999999999999999998 99999999999999865 468999999997654332
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......... .....+++
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~------- 223 (256)
T cd08220 157 K-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-----GTFAPISD------- 223 (256)
T ss_pred c-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-----cCCCCCCC-------
Confidence 2 2234688899999999988899999999999999999999999977554321111100 00001111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+.+++.+||+.||++|||++|+++.
T Consensus 224 -----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.29 Aligned_cols=244 Identities=28% Similarity=0.442 Sum_probs=205.1
Q ss_pred CeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChh
Q 012975 157 NILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 235 (452)
-+||+|.||+||-|++.+ ...+|||.+........+-+..|+.+-++++|+|||+++|.|.+++..-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999764 6679999998777777778999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCCCCCcccc
Q 012975 236 IQLHGPSHGSAL--TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 236 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
.+|. ..-+++ ++...-.+..||++||.|||++ .|+|||||-+|||++. .|.+||+|||-++....-+....+
T Consensus 661 sLLr--skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 661 SLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHH--hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9997 345566 6777788899999999999999 9999999999999965 799999999999776666666677
Q ss_pred cccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCCCcccchhhccc
Q 012975 313 LSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
+.||..|||||++..+ .|+.++|||||||++.||.||++||-.....+. .-.+. -..-.. .
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG----myKvHP------------~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG----MYKVHP------------P 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc----ceecCC------------C
Confidence 8899999999999765 478899999999999999999999987654331 11111 111111 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+..+...+...++.+|+.+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 33355677888999999999999999999984
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.07 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=196.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC---CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..+|...+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457889999999999999999754 3578999987532 23568999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+. ++|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 67877773 345799999999999999999999999 9999999999999999999999999998654332
Q ss_pred C--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc-C--------
Q 012975 307 N--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-R-------- 375 (452)
Q Consensus 307 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~-------- 375 (452)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||..................+.. .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2 1223456999999999999999999999999999999999999999765432211111100000000 0
Q ss_pred -------------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 376 -------------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 376 -------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+.. ......+.+++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000001110 0112456678999999999999999999965
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.97 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=196.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
+.|...+.||+|+||+||+|+.. ++..||+|.+.... ....+++.+|+++++.++|||++++.++|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999875 68899999885332 334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||++ |++.+.+.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566665542 234689999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 307 NKNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
....++..|+|||.+. ...++.++||||||+++|||+||+.||.............+ ...+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~-- 234 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NDSPTL-- 234 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--------CCCCCC--
Confidence 2345788999999874 45688899999999999999999999976654322111111 000000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+||+.||++||++.+++..
T Consensus 235 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 ------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.20 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=195.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cce
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (452)
++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999875 58899999875321 23346788999999999999999999988764 467
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
+++|||+++++|.+++.. ...+++...++++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 24588999999999999999999999 999999999999999999999999999864
Q ss_pred cCCC---CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 303 DGSQ---NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 303 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
.... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||............. .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~------~~-~~-- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------TQ-PT-- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh------cC-CC--
Confidence 3221 111223458889999999988889999999999999999999999997654322111110 00 00
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.+ .........+.+++.+|+. +|++||+++|+++.
T Consensus 227 ---~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 0112334566778888985 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=311.23 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=195.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 219 (452)
..++|...+.||+|+||.||+|... ++..||||++.... ......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 67889999986432 23345678999999999999999999987543
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
...++++|++ +++|..++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 788887764 24599999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccc------
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQ------ 371 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~------ 371 (452)
+...... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ........
T Consensus 165 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 165 ARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9654322 234468999999999877 568899999999999999999999997654322111 10000000
Q ss_pred -cccC------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 -LTDR------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 -~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+... ..++..-...+.... ......+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000000000 0112346789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=287.76 Aligned_cols=253 Identities=27% Similarity=0.372 Sum_probs=202.1
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcC-CCCceeeeEEEEE
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNI-HHPNVVCLLGYSA 217 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 217 (452)
...+.|...++||.|..+.|-++..+ +|.+.|+|++.... ....+.-.+|+++|+++ .||||+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567788899999999999988765 68899999985321 11234457899999998 6999999999999
Q ss_pred cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 218 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
.+...++|+|.|+.|.|+++|.. .-.+++....+|+.|+.+|++|||.. +|+||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999964 34699999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLD------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
|+++.... .......+||++|+|||.+.- ..|+...|+|++||+||-|+.|.+||.-....-....+....-+
T Consensus 168 GFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 168 GFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred ceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 99977643 334457899999999998743 34778999999999999999999999754322211111111001
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+ .-++| .+....+.+++.+||+.||.+|-|++|++.
T Consensus 247 F----~speW----------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 F----RSPEW----------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c----CCcch----------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 11111 133456778999999999999999999984
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.69 Aligned_cols=258 Identities=28% Similarity=0.373 Sum_probs=200.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 226 (452)
++|...+.||.|++|.||++... ++..+|+|.+.... .....++.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999985 57889999886433 24457789999999999999999999998654 3689999
Q ss_pred eecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++++|.+++... .....++...+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876531 2345689999999999999999999998 999999999999999999999999999854332
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--hhhhhhhhhhccccccCCCCCcccc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........+.... ..+...+
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 230 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPELKD 230 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----Cchhhcc
Confidence 211 234578899999999999999999999999999999999999986532 1111122221110 0001000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. . ..+......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0 001123456789999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.15 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=198.3
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|+..+.||+|++|.||+|... +|..||+|++.... ......+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999875 68899999986443 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
+ ++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68988886422 24689999999999999999999998 9999999999999999999999999998654332222
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccc-------c----CC
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLT-------D----RS 376 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~-------~----~~ 376 (452)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.... .....+...... . ..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2233568899999987664 568899999999999999999999987654221 111111000000 0 00
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
............ ........+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 011223567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.30 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=198.2
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cc
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DT 221 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 221 (452)
+...++|.+.+.||+|+||+||+++.. ++..+|+|.+... .......|..|+.++++++||||+++++++.+. +.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999876 4677888887543 334556789999999999999999999988543 46
Q ss_pred eeeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeeCCCCCCCEEECCC-------
Q 012975 222 RFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCN----PAVIHRDLKSSNILLDSK------- 289 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~i~H~Dlk~~NIll~~~------- 289 (452)
.||||||+++|+|..+|... .....+++..++.|+.||+.||+|||+... .+|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988642 223569999999999999999999998521 259999999999999642
Q ss_pred ----------CcEEEEecCCCcccCCCCCcccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 290 ----------FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 290 ----------~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999996543322 2234569999999999864 458899999999999999999999997644
Q ss_pred hhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 358 PAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... .+... +.....++ + . .....+.+++..||+.+|.+||++.|++.
T Consensus 248 ~~~--qli~~----lk~~p~lp------i-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS--QLISE----LKRGPDLP------I-K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH--HHHHH----HhcCCCCC------c-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 321 11110 11111110 0 0 11345778999999999999999999983
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.81 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=205.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
+|...+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 688899999976655567789999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 99999988642 25689999999999999999999998 999999999999999999999999999866544332 2
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
....++..|++||.+.+..++.++||||||+++++|++|+.||...+.......... .......++
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~------ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGPPGLRNP------ 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCCCCcCcc------
Confidence 345688999999999888899999999999999999999999987643322111110 001111111
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+||+.||++|||+.|+++.
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0113467789999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.95 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=205.7
Q ss_pred cCeEeecCcEEEEEEEeC--C--CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 156 SNILGEGGFGCVYKAKLD--D--NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
.+.||+|.||.|++|.|. + ...||||.+...... ...+|.+|+.+|.+|+|+|+++|||+..+ ...+||||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 577999999999999876 2 356899999765544 56789999999999999999999999988 77899999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
.|+|.+.|+. .....+-......+++|||.||.||.++ ++|||||..+|+|+-....+||+||||.+..+......
T Consensus 194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999987 4566788889999999999999999999 99999999999999999999999999998765433222
Q ss_pred c---ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 311 L---KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 311 ~---~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ...-...|+|||.+....++.+||||+|||+||||+| |+.||.+....++...++ . +..+
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~------~erL-------- 334 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-A------GERL-------- 334 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-c------cccC--------
Confidence 1 1224567999999999999999999999999999998 999999887665444433 1 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.-.+.+.+.+.+++..||..+|.+|||+..+.+.+
T Consensus 335 --pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 --PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 12235677888999999999999999999997444
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=296.90 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=200.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999876 57889999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~ 307 (452)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988642 234689999999999999999999998 999999999999999886 46999999986554333
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......|+..|+|||...+..++.++|+||||+++|||++|+.||......+... .. .. ...... .
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~----~~--~~~~~~-~---- 223 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL--KI----CQ--GYFAPI-S---- 223 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--HH----hc--ccCCCC-C----
Confidence 22233458889999999988889999999999999999999999997654322111 00 00 001110 1
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+|++.+|++|||++|++..
T Consensus 224 ----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 ----PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=298.03 Aligned_cols=252 Identities=29% Similarity=0.407 Sum_probs=200.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+|+..+.||+|++|.||++.+. +++.+++|.+.... .....++.+|++++++++|+||+++++++..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667788999999999999886 58889999986543 345567899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++++|.+++... ...++...+.+++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999998642 2578999999999999999999999 7 999999999999999999999999999855432211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ............. . . +.+..
T Consensus 157 ~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~-~-----~~~~~ 226 (265)
T cd06605 157 K--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE-P-P-----PRLPS 226 (265)
T ss_pred h--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC-C-C-----CCCCh
Confidence 1 2568889999999999999999999999999999999999997653111 0011111000000 0 0 00000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++..||+.||++|||+.|++.
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 ---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 013445778999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=300.74 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=200.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999876 58899999885332 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999864 35689999999999999999999998 9999999999999999999999999998665433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....++..|+|||.+.+...+.++||||||+++|||++|+.||............. .....++..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~----- 220 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------EGKVRFPSF----- 220 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCccCCcc-----
Confidence 234468899999999988888999999999999999999999997665322111111 111111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
....+.+++.+||+.||.+|+ +++|+++
T Consensus 221 -------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 -------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -------CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 124566799999999999999 7788774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.56 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=199.1
Q ss_pred CCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+|+..+.||+|++|.||+++. .++..+|+|.+.... ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999986 468899999886432 1234678999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~ 303 (452)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 34689999999999999999999999 999999999999998776 5999999998654
Q ss_pred CCCCC----cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 304 GSQNK----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 304 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
..... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||............... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--- 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI-ASATTAP--- 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH-hccCCCC---
Confidence 33211 112345788999999998888999999999999999999999999754432211111100 0000001
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.........+.+++.+|++.+|.+||++.|+++
T Consensus 231 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111233456778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=301.23 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=196.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCc-----
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 221 (452)
++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999876 68899999875432 223457888999999994 6999999999887665
Q ss_pred eeeeeeecCCCChhhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecC
Q 012975 222 RFIVYELMENRSLDIQLHGPSH--GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFG 298 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfg 298 (452)
.++||||+++ +|..++..... ...+++..++.++.|++.||+|||+. +++||||+|+||++++ ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78777754221 35689999999999999999999999 9999999999999998 8999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhcc-c---c
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMP-Q---L 372 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~-~---~ 372 (452)
++..............++..|+|||.+.+ ..++.++||||||+++|||++|..||......... ........ . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98654332222223356888999998865 45789999999999999999999999865443211 11111000 0 0
Q ss_pred ccCCC------CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 373 TDRSK------LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 373 ~~~~~------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... .+......+.. ..+....++.+++.+||+.||.+||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000000000 01123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=301.21 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=192.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHH-HHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDL-LSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||.||+++.. +|..||+|++.... .....++..|+.. ++.++|+|++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46788899999999999999876 58899999986542 2334456666665 566789999999999999999999999
Q ss_pred ecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 228 LMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|++ |+|..++.. ......+++..++.++.|++.||+|||+++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 678766643 223457999999999999999999999853 7999999999999999999999999998654322
Q ss_pred CCcccccccccCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 307 NKNNLKLSGTLGYVAPEYLLD----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+.... . .......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~----~--~~~~~~~ 229 (283)
T cd06617 158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVV----E--EPSPQLP 229 (283)
T ss_pred c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHH----h--cCCCCCC
Confidence 1 1122457889999998865 456889999999999999999999997533211 1111100 0 0000000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.......+.+++.+||+.+|++||+++++++
T Consensus 230 --------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 --------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112346778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.79 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=199.8
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVYE 227 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 227 (452)
|+..+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999876 47899999997553 33456788999999999999999999999988 78999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++ +|..++... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888777532 25799999999999999999999998 99999999999999999999999999986554332
Q ss_pred C-cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc--cCCCC-----
Q 012975 308 K-NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT--DRSKL----- 378 (452)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~----- 378 (452)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+........ .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1 1223356788999998765 4578999999999999999999999987664332221111100000 00000
Q ss_pred ------CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 379 ------PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 379 ------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.......+...+.+++.+||+.||++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00001111111111125678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.60 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=196.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|++|.||+|+.. ++..||+|.+..... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999876 688999999864332 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~ 306 (452)
|++ ++|.+++.. .....+++..+..++.|++.||+|||++ +++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577776643 2233468888999999999999999998 9999999999999985 567999999999654333
Q ss_pred CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh-hhhhccccc----cCCCCCc
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI-VTWAMPQLT----DRSKLPN 380 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~ 380 (452)
........++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+.... ......... ....+++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 2222334578899999988664 578999999999999999999999987654322111 111000000 0000000
Q ss_pred c-------cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 I-------VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 ~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. ....+.. .......++.+++.+|++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLAT-VVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHH-hCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000 01122345788999999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.41 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=193.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcC--Cceeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHD--DTRFIVYE 227 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 227 (452)
|+..+.||+|+||.||+|+.. ++..+|+|++.... ........+|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999865 68899999886432 222334567899999885 99999999999987 88999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++ |+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||+|+||++++ +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 577777653 235689999999999999999999999 9999999999999999 999999999996543322
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc--------ccc----c
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--------QLT----D 374 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~----~ 374 (452)
. .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+.......... ... .
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2 123457889999997654 5578899999999999999999999987654321111100000 000 0
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+......+.. ........+.+++.+||+.||++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00011111111100 011345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=290.69 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=200.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+.|+..+.||+|.|+.||+.... +|+.+|+|.++.. +....+++.+|+.+.+.|+||||++|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456666788999999999998654 6889999887532 3446678999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~~~~ 303 (452)
|+|++++|..-+-. ..-.++..+-.++.||+++|.|+|.+ +|+|||+||+|+++-+ .-.+||+|||++...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999655532 23467778889999999999999999 9999999999999953 345999999999877
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
. .........||++|||||++...+|+..+|||+.||+||-|+.|..||.+.+.......+.. ...+ ++
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~------g~yd----~~ 232 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA------GAYD----YP 232 (355)
T ss_pred C-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc------cccC----CC
Confidence 6 45556677899999999999999999999999999999999999999998654332111110 0001 11
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
+.--. ...++..+++++||..||.+|.|+.|.+
T Consensus 233 ~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 SPEWD----TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CcccC----cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 10111 1123556799999999999999998887
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=312.87 Aligned_cols=244 Identities=28% Similarity=0.424 Sum_probs=199.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh---hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|...+.||.|.||.||.+++. +...||||++.-..+ ....++.+|+..|++++|||.|.+.|++..+.+.|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555778999999999999875 577899999975543 334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||- |+-.+.+. -...++...++..|+.+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.+.....
T Consensus 107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 67666665 2346789999999999999999999999 999999999999999999999999999855432
Q ss_pred CcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 308 KNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
...++||+.|||||++. .+.|+-++||||||++..||...++|+..++.......+.. ++ .|
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-----Ne--------sP 243 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NE--------SP 243 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----cC--------CC
Confidence 34578999999999985 47899999999999999999999999887764332111111 11 12
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+. ..+-...++.++..||++-|.+|||..+++.
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 222 1244567788999999999999999988874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.17 Aligned_cols=243 Identities=27% Similarity=0.372 Sum_probs=197.6
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChh
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD 235 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 235 (452)
..||+|+||.||++... ++..||+|++..........+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999875 68899999987655556677999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccccccc
Q 012975 236 IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315 (452)
Q Consensus 236 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~g 315 (452)
+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..............|
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 87742 3589999999999999999999999 9999999999999999999999999988654333222233468
Q ss_pred ccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHH
Q 012975 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHL 395 (452)
Q Consensus 316 t~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 395 (452)
+..|+|||.+.+..++.++|+||||+++|||++|..||............... .. ..+.. + . ...
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~--~~~~~-----~-~----~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP--PKLKN-----L-H----KVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---CC--cccCC-----c-c----cCC
Confidence 89999999998888999999999999999999999999865443222111110 00 00000 0 0 122
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 396 YQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 396 ~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 34667899999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.34 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=207.5
Q ss_pred CCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
|+++..||.|+||.|||+..++ +...|.|.+...+.....+|.-|+++|..++||+||+|++.++.++.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4456779999999999998875 444567888877888889999999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|-.+..+. .-+..|+..++..++.|++.||.|||++ .|+|||||+.|||++-+|.++|+|||.+-..........
T Consensus 114 GAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred chHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99988776 3456799999999999999999999999 999999999999999999999999999855544445556
Q ss_pred ccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 312 KLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.+.||++|||||+++ +.+|+.++||||||++|.||..+.+|-...++......+.- ...+.++-|.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--------SePPTLlqPS- 259 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------SEPPTLLQPS- 259 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh--------cCCCcccCcc-
Confidence 788999999999874 57899999999999999999999999988877543332221 1122222221
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.-...+.+++.+||.+||..||++.++++
T Consensus 260 ------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 ------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12345667889999999999999999884
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.39 Aligned_cols=267 Identities=24% Similarity=0.310 Sum_probs=195.3
Q ss_pred CCCccCeEeecCcEEEEEEEeCC---CcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Ccee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 223 (452)
+|+..+.||+|+||.||+|+... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999998754 7899999987532 33446678899999999999999999999988 7899
Q ss_pred eeeeecCCCChhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEEec
Q 012975 224 IVYELMENRSLDIQLHGP--SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDF 297 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~----~~~~kl~Df 297 (452)
+||||+++ +|...+... .....++...++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 555544321 1223689999999999999999999999 9999999999999999 999999999
Q ss_pred CCCcccCCCCC---cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhh----------hhh
Q 012975 298 GLAITDGSQNK---NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ----------CQS 363 (452)
Q Consensus 298 gl~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~----------~~~ 363 (452)
|++........ ......++..|+|||.+.+. .++.++||||||++++||++|+.||....... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99865433222 22234678899999988764 57899999999999999999999997654322 000
Q ss_pred hhhhhccc----cccCCCCCcccc------------hhhcccCCH--HHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 364 IVTWAMPQ----LTDRSKLPNIVD------------PVIKSTMDL--KHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 364 ~~~~~~~~----~~~~~~~~~~~d------------~~l~~~~~~--~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
++...... .......++..+ ..+....+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 000000000000 000000000 233567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=298.78 Aligned_cols=248 Identities=29% Similarity=0.432 Sum_probs=196.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|...+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4667889999999999999865 6889999998633 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++ |+|.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 577666642 245689999999999999999999998 9999999999999999999999999988543321
Q ss_pred CcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 308 KNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
....|+..|+|||.+. .+.++.++||||||+++|||++|+.||............ .. ... ...
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~-----~~~-~~~--- 244 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ-----NES-PTL--- 244 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--Hh-----ccC-CCC---
Confidence 2345888999999874 456889999999999999999999998765432211111 10 000 000
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
........+.+++.+||+.+|.+||++.++++.+.-
T Consensus 245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 011223457789999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=297.99 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=208.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
|.+..+||+|.||.|||+.++ .|+.+|+|++... .+.+++.+|+.+|++.+.|++|++||.+.....+++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455778999999999999876 6999999998653 4667899999999999999999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+..+.++ .++.+|+..++..++...++||+|||.. .=+|||||+.|||++.+|.+||+|||.+-...+.-....
T Consensus 113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999987 4567899999999999999999999998 789999999999999999999999999966555544555
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
++.||+.|||||++..-.|+.++||||||+...||..|++||.+..+....- .......+.+-.|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------MIPT~PPPTF~KP------- 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------MIPTKPPPTFKKP------- 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------eccCCCCCCCCCh-------
Confidence 7789999999999999999999999999999999999999998866532110 1111122222222
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+.-..++.++++.||-+.|++|-|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 223456778999999999999999998875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=300.20 Aligned_cols=265 Identities=30% Similarity=0.367 Sum_probs=197.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 224 (452)
.++|+..+.||+|+||.||+|... +|..||+|.+..... .....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999975 588999999864332 2233567899999999999999999998765 46899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++ +|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 77777753 235689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc-c-------cccC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP-Q-------LTDR 375 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-~-------~~~~ 375 (452)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+..... . ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 33222223346788999998865 4578999999999999999999999987665432221111100 0 0000
Q ss_pred C-----CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 S-----KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~-----~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .........+... .......+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000000 0012445678999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=287.61 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=203.1
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVY 226 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 226 (452)
+|...+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|++.+++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999987 68899999986544 24567899999999999999999999999988 8899999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999864 23799999999999999999999998 9999999999999999999999999998665443
Q ss_pred CC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 NK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......++..|+|||.+.+...+.++||||||+++++|++|+.||....... . ..+..........++
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~--~~~~~~~~~~~~~~~----- 226 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-A--ALYKIGSSGEPPEIP----- 226 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-H--HHHhccccCCCcCCC-----
Confidence 32 1234568889999999988889999999999999999999999998765111 1 111100000111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+|++.||++||++.|+++.
T Consensus 227 -------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 -------EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -------cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1224567789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.74 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999976 58899999986432 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999863 25789999999999999999999998 99999999999999999999999999986543332
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||............... .......+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~------- 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---ETADVLYPA------- 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh---ccccccCcc-------
Confidence 223346888999999999888999999999999999999999999876532111111110 001111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCCh--HHHH
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLI--TDVL 420 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl 420 (452)
.....+.+++.+||+.||.+||++ +|++
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 -----TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122567789999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=295.06 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=202.2
Q ss_pred CCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|+..+.||.|.-|+||++.+++ +...|+|.++... .+...+.+.|-+||+.++||.+..|++.++.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34446779999999999999875 5889999996543 4445677889999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC---
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG--- 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~--- 304 (452)
||+||+|...++. +.+..++...+.-++..++.||+|||-. |||.|||||+||||.++|++-|+||.|+....
T Consensus 158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999988876 5577899999999999999999999999 99999999999999999999999999873110
Q ss_pred ----C--------------------------C-C----------------------CcccccccccCccCcccccCCCCC
Q 012975 305 ----S--------------------------Q-N----------------------KNNLKLSGTLGYVAPEYLLDGKLT 331 (452)
Q Consensus 305 ----~--------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 331 (452)
. . . .....++||-.|+|||++.+.-.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 111235699999999999999999
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCC
Q 012975 332 DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPS 411 (452)
Q Consensus 332 ~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~ 411 (452)
.+.|+|+|||++|||+.|..||.+.+..+...-+-. ..+.-.........+.+||++.|.+||+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------QPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------CCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999998776543222111 1111111113446778899999999999
Q ss_pred CCCC----hHHHH
Q 012975 412 YRPL----ITDVL 420 (452)
Q Consensus 412 ~RPs----~~evl 420 (452)
+|-. +.||-
T Consensus 378 kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 378 KRLGSKRGAAEIK 390 (459)
T ss_pred hhhccccchHHhh
Confidence 9988 55554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=286.06 Aligned_cols=247 Identities=30% Similarity=0.504 Sum_probs=202.9
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|++|.||+++.. ++..+++|.+..... .....+.+|++++++++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667889999999999999876 578899999865543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998853 25699999999999999999999998 999999999999999999999999999976554443
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......++..|+|||...+..++.++||||+|+++|+|++|+.||......... +.... ......+.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~-------- 221 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FRIVQ-DDHPPLPE-------- 221 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHhc-cCCCCCCC--------
Confidence 333456889999999998888899999999999999999999999765432211 11000 11111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.+|++||++.|++.
T Consensus 222 ----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 ----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11345678999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=303.84 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=198.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----- 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 220 (452)
..++|+..+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4567999999999999999999875 6889999998532 3334566788999999999999999999886443
Q ss_pred -ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 221 -TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 221 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
..++||||+. ++|...+.. .++...+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4699999996 577776642 288999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhh----------
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWA---------- 368 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~---------- 368 (452)
+........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... .....
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 976543222 223457889999999999999999999999999999999999997654322111 10000
Q ss_pred -----ccccccC-----CCCCcccchhh----cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 369 -----MPQLTDR-----SKLPNIVDPVI----KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 369 -----~~~~~~~-----~~~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....... ..+.......+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00111111110 000011234567899999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.27 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=193.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999876 57899999986433 345567899999999996 99999999999999999999999
Q ss_pred cCCCChhhh---ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 229 MENRSLDIQ---LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 229 ~~~gsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+.. ++..+ +.. .....+++..+..++.+++.||+|||+.. +++||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 44332 222 22356999999999999999999999742 899999999999999999999999999865432
Q ss_pred CCCcccccccccCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDG---KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..... ... ...
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~----~~~--~~~---- 228 (288)
T cd06616 161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQ----VVK--GDP---- 228 (288)
T ss_pred CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhh----hcC--CCC----
Confidence 221 1233588899999998776 68899999999999999999999997644110 01000 000 000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+.+..........++.+++.+||+.||++|||++||+..
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112344578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=296.92 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=195.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 221 (452)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||++++++|...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999876 58899999885432 2233456789999999999999999999876543
Q ss_pred ---eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 222 ---RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 222 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
.++||||+.+ +|...+.. ....+++.+++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999974 77776653 234689999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCC----cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 299 LAITDGSQNK----NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 299 l~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
++........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9865432211 11233577889999988664 468899999999999999999999987654432222221111000
Q ss_pred c-----CC------------CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 D-----RS------------KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 ~-----~~------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .. .........+... .....+.+++.+||+.||.+|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00 0000000000000 012356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.57 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=214.3
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecC-cChhhHHHHHHHHHHHHcCCCCceeeeEEEEE
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 217 (452)
++.....+++...++-+|.||.||+|.+. +.+.|-||.++. .++-....+..|.-.+..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34445567888889999999999999554 445677887753 45556778999999999999999999999987
Q ss_pred cC-CceeeeeeecCCCChhhhcc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 218 HD-DTRFIVYELMENRSLDIQLH-----GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 218 ~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
++ +..+.+|.++.-|+|..+|. +....+.++..+...++.|++.|++|||.+ +++|.||..+|++||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence 65 47799999999999999998 556667899999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCcccC--CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhh
Q 012975 292 AKLSDFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 292 ~kl~Dfgl~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~ 368 (452)
+||+|-.+++..- +.+.....-..+..||+||.+.+..|+.++|||||||+||||+| |+.||.+.++.+......
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-- 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-- 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh--
Confidence 9999999986532 22222222235678999999999999999999999999999998 999999988877544332
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
+..++. ...++..+++.++.-||..+|++||+++|++.-|.+.
T Consensus 513 -----dGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 -----DGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -----ccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222221 1224567888899999999999999999999887653
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=296.32 Aligned_cols=269 Identities=25% Similarity=0.324 Sum_probs=198.3
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC---
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--- 220 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 220 (452)
+...++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678889999999999999999986 57899999986432 223456788999999999999999999987655
Q ss_pred -------ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 012975 221 -------TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (452)
Q Consensus 221 -------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~k 293 (452)
..++|+||+++ ++...+.. ....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 66565543 234689999999999999999999999 999999999999999999999
Q ss_pred EEecCCCcccCCCCC-cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc-c
Q 012975 294 LSDFGLAITDGSQNK-NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM-P 370 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~-~ 370 (452)
|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.... .
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999865433221 1122346778999998765 457889999999999999999999998655432211111110 0
Q ss_pred cccc-CC---CCCcc--cc------hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 371 QLTD-RS---KLPNI--VD------PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 371 ~~~~-~~---~~~~~--~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.... .. ..+.. .+ ........ .....+.+++..||+.||++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00 00000 00 00000000 123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=288.07 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=205.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|...+.||+|+||.||++... ++..+++|++..... .....+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999976 588999999875433 5567789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
+++++|.+++.... .+..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886421 246799999999999999999999999 99999999999999999999999999997654443
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......|+..|+|||...+..++.++|+||+|+++++|++|+.||......+...... . .....++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~---~~~~~~~~------- 225 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL--K---GQYPPIPS------- 225 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--c---CCCCCCCC-------
Confidence 23334568899999999988889999999999999999999999997765332111110 0 00111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+.+++.+||+.+|++|||+.|+++.
T Consensus 226 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=291.22 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=195.8
Q ss_pred EeecCcEEEEEEEeCC-CcEEEEEEecCcCh---hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||.||+++..+ |..+++|.+..... .....+.+|++++++++|+|++++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 88999999864432 4556789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC------
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK------ 308 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~------ 308 (452)
.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988642 3689999999999999999999998 999999999999999999999999999865432211
Q ss_pred --cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 --NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 --~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......++..|++||...+...+.++||||||+++|||++|+.||......+....... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~---- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------GKIEWPEDV---- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CCcCCCccc----
Confidence 22334578899999999888899999999999999999999999987654332111110 011111100
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 225 ------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 ------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01356778999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=293.57 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=200.4
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++++++++|+|++++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 688899999864432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++ +|..++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 78777753 235799999999999999999999999 9999999999999999999999999998665443322
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hhh-ccccccCCCCCc------
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWA-MPQLTDRSKLPN------ 380 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~------ 380 (452)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+..... ... .+.........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578889999998876 7899999999999999999999999776543221111 100 000000000000
Q ss_pred -----ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 -----IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 -----~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+... .....+...++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=303.69 Aligned_cols=270 Identities=24% Similarity=0.323 Sum_probs=198.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----ce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 222 (452)
.++|+..+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|+.++++++|+||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467889999999999999999865 68899999986432 334566889999999999999999999876543 47
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++|+||+++ +|..++. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7776664 24699999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCC---cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 303 DGSQNK---NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
...... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||................... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHH
Confidence 432211 1123468899999998755 568899999999999999999999997654322111100000000 00000
Q ss_pred Ccccchhh---------cccC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--ccccCc
Q 012975 379 PNIVDPVI---------KSTM-----DLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIPLVP 428 (452)
Q Consensus 379 ~~~~d~~l---------~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~l~~ 428 (452)
....+... .... ......++.+++.+||+.||++|||+.|+++. +++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000000 0000 01124567899999999999999999999976 555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.06 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=192.5
Q ss_pred eEeec--CcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 158 ILGEG--GFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 158 ~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
.||+| +||+||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999875 68999999986432 334567899999999999999999999999999999999999999
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc---
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN--- 309 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--- 309 (452)
+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9998886422 24589999999999999999999998 9999999999999999999999999865322111000
Q ss_pred ----ccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhc--c----ccc---
Q 012975 310 ----NLKLSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAM--P----QLT--- 373 (452)
Q Consensus 310 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~--~----~~~--- 373 (452)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......+.. ....... + ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112346679999998764 4788999999999999999999999876532211 0000000 0 000
Q ss_pred -------------------cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 -------------------DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 -------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.........+..+.......+...+.+++++||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000111111122223345678899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.48 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=194.7
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||.|++|.||+++.. ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 47899999985432 23456799999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 999864 24589999999999999999999998 99999999999999999999999999986654332 223346
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
++..|++||.+.+..++.++|+||||+++|||++|..||............... ........+. ..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~------------~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL--KGNGKLEFPN------------YI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh--ccCCCCCCCc------------cc
Confidence 888999999998888999999999999999999999999876521111110000 0001111111 11
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 395 LYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
..++.+++.+||+.||++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 346788999999999999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=288.05 Aligned_cols=249 Identities=28% Similarity=0.377 Sum_probs=203.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+|+..+.||+|+||.||+++.. ++..+++|.+... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999765 6788999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
+++++|..++... .....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999887541 1235689999999999999999999998 9999999999999999999999999998665433
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......++..|++||.+.+..++.++|+||||+++|||++|+.||...+..+...... ....+.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~------- 220 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------RGKYPP------- 220 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------cCCCCC-------
Confidence 2223457889999999999999999999999999999999999998765433211111 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........+.+++.+|++.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111334568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=302.39 Aligned_cols=268 Identities=26% Similarity=0.352 Sum_probs=200.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (452)
.++|...+.||+|+||+||+++.. ++..||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999865 6889999998643 233445678899999999999999999987654 24
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688877753 35699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.............++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+................ ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS-EEDLGF 235 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC-hHHhhh
Confidence 55433222233467889999998865 4688999999999999999999999976543221111110000000 000000
Q ss_pred cc---------------chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--cccc
Q 012975 381 IV---------------DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIPL 426 (452)
Q Consensus 381 ~~---------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~l 426 (452)
.. ++.... ...+....+.+++.+||+.||++|||++|+++. +..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 000000 011234567899999999999999999999976 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=301.70 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=196.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC--ce
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD--TR 222 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~ 222 (452)
..++|...+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888899999999999999876 5788999988532 233445678899999999 9999999999986543 67
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||++ ++|..++.. ..++|..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888753 2689999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC-----CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccC-
Q 012975 303 DGSQN-----KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR- 375 (452)
Q Consensus 303 ~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~- 375 (452)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 43222 12223458899999998765 457889999999999999999999997655432211111110000000
Q ss_pred ------CCCCcccc-------hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 376 ------SKLPNIVD-------PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 376 ------~~~~~~~d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+++ ..... ...+...++.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 00000 001134567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=289.82 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=195.7
Q ss_pred CCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh--hhHHHHHHHHHHHHcC---CCCceeeeEEEEEcCCc-----
Q 012975 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 221 (452)
|++.+.||+|+||.||+|+... +..+|+|.+..... .....+.+|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5567899999999999999874 88999999864322 2234566788777665 69999999999988776
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+++|||++ ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 47888776422 24689999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hhhcccccc------
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAMPQLTD------ 374 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~~~~~~~~------ 374 (452)
....... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+....+ .........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 6433222 12335788999999999999999999999999999999999999876543321111 110000000
Q ss_pred ---CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 ---RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
............ .....+....+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 1111133466788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.96 Aligned_cols=244 Identities=27% Similarity=0.342 Sum_probs=191.7
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||+||++... +|..+|+|.+.... ......+.+|+++++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999885432 22345678899999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 99886422 24689999999999999999999998 9999999999999999999999999998654321 1222345
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
++..|+|||.+.+..++.++||||||+++|+|++|+.||............... ........+ ...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~------------~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLEMAVEYP------------DKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--cccccccCC------------ccC
Confidence 788999999998888999999999999999999999999765432111111100 001111111 112
Q ss_pred HHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 395 LYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
...+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34567899999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.32 Aligned_cols=242 Identities=28% Similarity=0.340 Sum_probs=186.3
Q ss_pred eEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHH---cCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLS---NIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
+||+|+||.||++... ++..+|+|.+.... ......+.+|..+++ ..+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999885432 122233445544433 4479999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999988853 34699999999999999999999999 999999999999999999999999999865432221
Q ss_pred cccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ......+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~----------- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVEL----------- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCC-----------
Confidence 23468999999998864 56889999999999999999999999765432211111110 0001111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
.......+.+++.+||+.||++|| +++|+++.
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112334677899999999999999 69999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=306.16 Aligned_cols=200 Identities=28% Similarity=0.361 Sum_probs=174.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-C-----CceeeeEEEEEcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-H-----PNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 224 (452)
+|.+.++||+|.||.|.|+.+. +++.||||.++. .+...++-..|+.+|..++ | -|+|++++|+...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999865 589999999974 3455677789999999996 4 389999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CcEEEEecCCCcc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLAIT 302 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~--~~~kl~Dfgl~~~ 302 (452)
|+|.+ .-+|++++.... ...++...+..++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 569999997643 45699999999999999999999998 99999999999999754 4699999999977
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
...... ...-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 654433 4467889999999999999999999999999999999988888877544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=292.23 Aligned_cols=244 Identities=30% Similarity=0.441 Sum_probs=193.2
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
|...+.||+|+||+||+|+.. ++..|++|.+... .......+.+|+++++.++|+|++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445678999999999999875 5788999998643 233446788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+. |++.+.+.. ....+++.+++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 567666642 245689999999999999999999998 999999999999999999999999998854322
Q ss_pred cccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 309 NNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.....|+..|+|||.+. ...++.++||||||+++|||++|..||.............. ...+....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~-- 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NDSPTLQS-- 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------cCCCCCCc--
Confidence 12346888999999874 45688899999999999999999999977654322111110 00111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+||+.+|.+||++.++++.
T Consensus 243 ------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122356789999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.36 Aligned_cols=242 Identities=28% Similarity=0.431 Sum_probs=194.5
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEec--C--cChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc--eeeeeee
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLD--C--ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT--RFIVYEL 228 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E~ 228 (452)
..+||+|.|-+||||.+. +|.+||--.++ . .+....+.|..|+.+|+.|+|+||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 567999999999999876 58888743332 1 234455889999999999999999999999987765 6789999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~ 307 (452)
|..|+|..|+.. ...++......|+.||++||.|||++ .|+|+|||||-+||+|+. .|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999853 45689999999999999999999997 899999999999999975 5899999999997754433
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL-APAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ..+.||+.|||||+.. ..|++..||||||++|+||+|+..||..= .+.++...+.-. .....+..+-||
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG----iKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG----IKPAALSKVKDP-- 271 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC----CCHHHhhccCCH--
Confidence 3 3478999999999665 88999999999999999999999999743 334444333321 111122222233
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
++.++|.+|+.. .++|||+.|+|.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 566789999999 999999999994
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.84 Aligned_cols=261 Identities=24% Similarity=0.310 Sum_probs=192.0
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
+.+|.|+++.||+++. ++..||+|++... .....+.+.+|+++++.++|+||+++++++.+++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455555666666655 6889999998654 345567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC------
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK------ 308 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~------ 308 (452)
.+++... ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+........
T Consensus 87 ~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9998742 234688999999999999999999999 999999999999999999999999998854321111
Q ss_pred -cccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhccccccCCC-------
Q 012975 309 -NNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDRSK------- 377 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~------- 377 (452)
......++..|+|||.+.. ..++.++|+||||+++|||++|+.||......... .......+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1122346778999999876 35788999999999999999999999875433211 000000000000000
Q ss_pred CC----cccchhhc----ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LP----NIVDPVIK----STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~----~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. ...++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 01111111 11122334578889999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=299.99 Aligned_cols=264 Identities=26% Similarity=0.327 Sum_probs=202.0
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-----cee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-----TRF 223 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 223 (452)
+|+..+.||+|++|.||+|+.. ++..+|+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677899999999999999976 48899999986543 445567999999999999999999999988775 789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
++|||++ ++|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 578888753 33799999999999999999999999 9999999999999999999999999999655
Q ss_pred CCCC---CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc-----
Q 012975 304 GSQN---KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----- 374 (452)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 374 (452)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 4332 122334578899999999887 7899999999999999999999999877654322221111000000
Q ss_pred --CCCCCcccchhh-c-----ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 --RSKLPNIVDPVI-K-----STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 --~~~~~~~~d~~l-~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.... . .....+....+.+++.+||+.||++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000000 0 00011134567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.34 Aligned_cols=264 Identities=27% Similarity=0.447 Sum_probs=208.7
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEE
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGY 215 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 215 (452)
+|...++....+.+|+|.||.|++|... ....||||.+... ...+.+.+..|+++|+.+ +|+||++++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555556679999999999999743 1567999998644 345678899999999999 69999999999
Q ss_pred EEcCCceeeeeeecCCCChhhhccCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012975 216 SAHDDTRFIVYELMENRSLDIQLHGPS-------H----G--SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSS 282 (452)
Q Consensus 216 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~ 282 (452)
|..++..++|+||+..|+|.++|...+ . . ..++..+.+.++.|||.|++||++. +++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999997543 0 0 2499999999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEEecCCCcccCCCCCcc-cccc--cccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 012975 283 NILLDSKFNAKLSDFGLAITDGSQNKNN-LKLS--GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAP 358 (452)
Q Consensus 283 NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~ 358 (452)
|||++++..+||+|||+++......... .... -...|||||.+....++.+|||||||++|||++| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999997543332221 1112 2456999999999999999999999999999998 9999987431
Q ss_pred hhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 359 AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.+ .+..+. .+..++ .....+..++.++++.||+.+|++||++.|+.+.+..++.
T Consensus 528 ~~--~l~~~l----~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TE--ELLEFL----KEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH--HHHHHH----hcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 112211 111111 1111234567789999999999999999999999988654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=296.91 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=206.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+-|...+.||+|.|..|-.+++- +|..||||.++...- -....+.+|+..|+.++|||||+||++......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345666778999999999999754 789999999975543 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~~~~~ 305 (452)
|.-++|+|++++- .+...+.+..+.+++.||..|+.|+|+. .++||||||+||.+. +-|-+||.|||++....
T Consensus 97 ELGD~GDl~DyIm--KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIM--KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EecCCchHHHHHH--hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 9999999999996 4456799999999999999999999999 999999999998875 46889999999996543
Q ss_pred CCCcccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLT-DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
......+.+|...|-|||++.+..|+ ++.|||||||+||.|++|+.||+..+..+....+. .....++.
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm------DCKYtvPs---- 240 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM------DCKYTVPS---- 240 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh------cccccCch----
Confidence 33444567999999999999999987 57899999999999999999999877655333221 11222222
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+..++|..||..||++|.+.+|+...
T Consensus 241 --------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 241 --------HVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --------hhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 234466789999999999999999999853
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.59 Aligned_cols=263 Identities=25% Similarity=0.271 Sum_probs=195.0
Q ss_pred cCCC-ccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhh--------------HHHHHHHHHHHHcCCCCceeeeEE
Q 012975 151 DSFH-ESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA--------------GREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 151 ~~f~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
++|. ..+.||+|+||+||+|... ++..||+|.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 3467999999999999865 68899999885432211 125778999999999999999999
Q ss_pred EEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 215 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888753 34589999999999999999999998 9999999999999999999999
Q ss_pred EecCCCcccCC--------------CCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 012975 295 SDFGLAITDGS--------------QNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPA 359 (452)
Q Consensus 295 ~Dfgl~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~ 359 (452)
+|||++..... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999865431 11111223467889999998764 4688999999999999999999999876643
Q ss_pred hhhh-hhhhhcccc----ccCCCC------CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 360 QCQS-IVTWAMPQL----TDRSKL------PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 360 ~~~~-~~~~~~~~~----~~~~~~------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+... +........ .....+ .....+..... .......+.+++.+||+.||++||+++|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3211 111110000 000000 00000111110 0122456788999999999999999999996
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=286.41 Aligned_cols=243 Identities=24% Similarity=0.305 Sum_probs=188.9
Q ss_pred CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHH-HcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLL-SNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 57899999986432 22233445555544 445899999999999999999999999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
++|..++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 999998853 34689999999999999999999998 999999999999999999999999999865432 22
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
...++..|+|||.+.+..++.++||||||+++|||++|..||.............. .....+.. ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~----~~---- 217 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS------RRINWPEE----VK---- 217 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------cccCCCCc----cc----
Confidence 34588899999999888889999999999999999999999987654332111110 00000000 00
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 392 LKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 392 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
......+.+++.+||+.||++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 12234678899999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.62 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=196.7
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|...+.||+|++|+||+|+.. ++..|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999986 478899999864422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
+|+|.+++.... ...+++.+++.++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988886422 35789999999999999999999998 999999999999999999999999999865433221
Q ss_pred ccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccccc----c--------C
Q 012975 310 NLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLT----D--------R 375 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~----~--------~ 375 (452)
.....++..|+|||.+.. ..++.++|+||||+++|||++|+.||.......... ...+...... . .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 557899999999999999999999997665432111 1110000000 0 0
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..++......+..... .....+.+++.+||+.||++|||++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000010110001 113568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.11 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=193.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||.||+|..++ +..||||.+.... ......+..|+.++.+.+ |+||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567778999999999999999875 8899999986443 234456777888777775 999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++ ++...+.. ....+++..+..++.|++.||+|||+.. +++||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99854 66555542 2347899999999999999999999732 8999999999999999999999999998654332
Q ss_pred CCcccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..+...... .....+.
T Consensus 169 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~---~~~~~~~-- 241 (296)
T cd06618 169 KAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQE---EPPSLPP-- 241 (296)
T ss_pred Ccc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcC---CCCCCCC--
Confidence 221 2235788999999987654 7889999999999999999999997543211 111111100 0000100
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .....++.+++.+||+.||++||+++++++.
T Consensus 242 -~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -N-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -C-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0123467889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.01 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=195.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|...+.||+|+||.||+|+.. ++..+|+|.+... ......++.+|+++++.++|+|++++++++..++..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556788999999999999975 5778999988532 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+. |++.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 577666642 234689999999999999999999998 9999999999999999999999999998654322
Q ss_pred CcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 308 KNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......+...... . ...+...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~------~~~~~~~-- 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--Q------NESPALQ-- 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh--h------cCCCCcC--
Confidence 2345788999999874 3567889999999999999999999987654332111111 0 0000000
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
.......+.+++.+||+.+|++||++.++++.-..
T Consensus 236 ------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11233557789999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=284.38 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=196.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cce
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (452)
.+|...+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999875 5889999987422 233456789999999999999999999998764 357
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++++||+++++|.+++.. ...+++....+++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988853 34588999999999999999999999 999999999999999999999999999865
Q ss_pred cCCC---CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 303 DGSQ---NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 303 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
.... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......... ..... ......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~--~~~~~~~- 230 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FKIAT--QPTKPML- 230 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HHHHc--CCCCCCC-
Confidence 4221 11112345889999999999888999999999999999999999999865432211 11100 0001111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......+.+++.+|++ +|..||+..++++.
T Consensus 231 -----------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 -----------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -----------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11233467788999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.44 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=199.3
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|+..+.||+|++|.||+|+.. ++..+|+|.+.... ......+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999976 48899999987543 333467889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
+ ++|.+++... ...+++..+++++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 5899888642 24699999999999999999999999 9999999999999999999999999998665443322
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhc-------ccccc----CC
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAM-------PQLTD----RS 376 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~-------~~~~~----~~ 376 (452)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+... ...... ..... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2333467789999998776 78999999999999999999999997755322111 111000 00000 00
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+......... ........+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011100000000 00112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=315.63 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=187.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC--CcEEEEE------------------EecCcChhhHHHHHHHHHHHHcCCCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD--NLHVAVK------------------KLDCATQDAGREFENEVDLLSNIHHPN 208 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 208 (452)
..++|+..+.||+|+||+||++.++. +...+.| ++. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 12234456889999999999999
Q ss_pred eeeeEEEEEcCCceeeeeeecCCCChhhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS--HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 209 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
|+++++++...+..++|+|++. ++|..++.... ........++..++.|++.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 56666554311 112334566788999999999999999 99999999999999
Q ss_pred CCCCcEEEEecCCCcccCCCCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCChhhhhhh
Q 012975 287 DSKFNAKLSDFGLAITDGSQNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR-PVEKLAPAQCQSI 364 (452)
Q Consensus 287 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~-P~~~~~~~~~~~~ 364 (452)
+.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999976543222 2234579999999999999999999999999999999999875 4443322111111
Q ss_pred hhhhccccccCCCCCc-------------------ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 365 VTWAMPQLTDRSKLPN-------------------IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~-------------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.............+++ .+.+.+... .....+.+++.+||+.||++|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1110000000000110 011111110 012345677899999999999999999863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.04 Aligned_cols=265 Identities=26% Similarity=0.327 Sum_probs=194.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|...+.||+|+||.||+|+.. ++..+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999876 578999998854322 22345778999999999999999999875443
Q ss_pred --ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 221 --TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 221 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
..++|+||+.+ +|...+.. ....+++.++..++.|+++||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56666553 245699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCC-----------cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhh
Q 012975 299 LAITDGSQNK-----------NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT 366 (452)
Q Consensus 299 l~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~ 366 (452)
++........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9864322111 11223567889999987654 57899999999999999999999998765433222211
Q ss_pred hhccc-----cccCCCCCccc--------chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 367 WAMPQ-----LTDRSKLPNIV--------DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 367 ~~~~~-----~~~~~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... ......++... .+.+.... ......+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11000 00000111111 11111000 112256789999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.37 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=204.9
Q ss_pred cHHHHHH---hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEE
Q 012975 142 EYKLLEK---ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 142 ~~~~l~~---~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
.++.+|. ..+.|..-++||+||||.||-++.. +|.-+|.|++... .+..+...++|-.+|.+++.+.||.+--
T Consensus 173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 3444444 3466888899999999999999765 6888999988543 2334556789999999999999999999
Q ss_pred EEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 215 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
.++..+.+++|+..|++|+|.-||.... +..+++..++-++.+|+.||++||.. .|+.||+||+|||+|+.|+++|
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 9999999999999999999999987533 35799999999999999999999999 9999999999999999999999
Q ss_pred EecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+|+|+|........ ....+||.+|||||++.+..|+...|.||+||+||||+.|+.||...........+. +..+.+
T Consensus 329 SDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~~ 405 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLED 405 (591)
T ss_pred eccceEEecCCCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhcc
Confidence 99999977644332 233489999999999999999999999999999999999999997654322111111 111222
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChH
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLIT 417 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 417 (452)
...++ .....+...+....|++||++|--.+
T Consensus 406 ~~ey~------------~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 PEEYS------------DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhcc------------cccCHHHHHHHHHHHccCHHHhccCC
Confidence 22222 23445566677889999999996654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.64 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=200.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 225 (452)
++|...+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999876 6889999988542 2334567889999999998 99999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998864 34699999999999999999999998 999999999999999999999999999865433
Q ss_pred CC--------------------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh
Q 012975 306 QN--------------------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV 365 (452)
Q Consensus 306 ~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~ 365 (452)
.. .......++..|+|||.+.+..++.++|+||||++++++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 22 1122345788999999998888999999999999999999999999876532211111
Q ss_pred hhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh----HHHHH
Q 012975 366 TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI----TDVLH 421 (452)
Q Consensus 366 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 421 (452)
. .....++. .....+.+++.+||+.||++||++ +|+++
T Consensus 235 ~------~~~~~~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 L------KLEYSFPP------------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H------hcCCCCCC------------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 11111111 113457789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.20 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=197.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 223 (452)
++|+..+.||+|+||.||+|+.. +|..||+|++.... ......+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999865 58899999986432 2345667889999999999999999998753 34679
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+. |+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 688888753 34599999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCC----cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc----c-
Q 012975 304 GSQNK----NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL----T- 373 (452)
Q Consensus 304 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~----~- 373 (452)
..... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32211 1123468889999998765 468899999999999999999999997765432111111000000 0
Q ss_pred --cCCCCCcccc------hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 --DRSKLPNIVD------PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 --~~~~~~~~~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+....+ +........+....+.+++.+||+.||++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 000000011235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=288.93 Aligned_cols=255 Identities=18% Similarity=0.242 Sum_probs=181.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCC----cEEEEEEecCcChhh-----------HHHHHHHHHHHHcCCCCceeeeEE
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDN----LHVAVKKLDCATQDA-----------GREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
.++|...+.||+|+||+||+|...++ ..+|+|......... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788899999999999999987653 445555433222111 011233445566778999999999
Q ss_pred EEEcCC----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 215 YSAHDD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 215 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +++||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 876554 34677777643 45444432 23357888999999999999999998 999999999999999999
Q ss_pred cEEEEecCCCcccCCCC-------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-hh
Q 012975 291 NAKLSDFGLAITDGSQN-------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQ 362 (452)
Q Consensus 291 ~~kl~Dfgl~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~-~~ 362 (452)
.++|+|||++....... .......||+.|+|||...+..++.++|||||||++|||++|+.||....... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999986542211 11123469999999999999999999999999999999999999998763221 11
Q ss_pred hh--hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 363 SI--VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 363 ~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
.. ..+. ..+... .. .. ......+.+++..|++.+|++||++.++.+.|+
T Consensus 244 ~~~~~~~~-~~~~~~-~~--------~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFI-KRLHEG-KI--------KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHH-HHhhhh-hh--------cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10 1110 111110 00 00 012346778999999999999999999998763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.60 Aligned_cols=255 Identities=32% Similarity=0.470 Sum_probs=190.5
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD----- 219 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 219 (452)
.+..++|++..+||+||||.|||++++ ||+.+|||++.... ......+.+|+.+|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678889999999999999999987 89999999997553 34456688999999999999999986543110
Q ss_pred --------------------------------------------------------------------------------
Q 012975 220 -------------------------------------------------------------------------------- 219 (452)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (452)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 012975 220 ----------------------------------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265 (452)
Q Consensus 220 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 265 (452)
-.+||-||||+..+|+++++...... .-...++++.+|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 01377888888888888876432211 456788999999999999
Q ss_pred HHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc------------------CCCCCcccccccccCccCcccccC
Q 012975 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD------------------GSQNKNNLKLSGTLGYVAPEYLLD 327 (452)
Q Consensus 266 LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~ 327 (452)
+|++ ++|||||||.||++|+++.+||+|||++... +......+..+||.-|+|||.+.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 9999999999999999999999999999651 011112345679999999999876
Q ss_pred C---CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHH
Q 012975 328 G---KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVL 404 (452)
Q Consensus 328 ~---~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~ 404 (452)
. .|+.|+|+||+|++++||+. ||... .+....+...+ ...++.- ..+..+....=.++|++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-----~g~iP~~------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-----KGSIPEP------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-----cCCCCCC------cccccccchHHHHHHHH
Confidence 5 49999999999999999984 45432 22222222111 2222221 11111223334579999
Q ss_pred hcCCCCCCCCChHHHHHh
Q 012975 405 CVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 405 Cl~~dP~~RPs~~evl~~ 422 (452)
+++.||.+|||+.|+++.
T Consensus 854 Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HhcCCCccCCCHHHHhhc
Confidence 999999999999999964
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=301.23 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=204.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
...|.....||+|.|+.|..+++. ++..||+|.++... ....+.+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456778899999999999999865 68899999987543 233455899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+.+|.+++++.. .+.+....+..++.|+.++++|||++ .|+|||||++||||+.+.++||+|||++.... .
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y 207 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-c
Confidence 99999999999964 44566688999999999999999999 99999999999999999999999999997765 3
Q ss_pred CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.....+.+|++.|.|||.+.+.+| ++++|+||+|+++|-|+.|..||++..-.+ ...+.+..+..++..+..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------Lr~rvl~gk~rIp~~ms~- 280 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------LRPRVLRGKYRIPFYMSC- 280 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------ccchheeeeecccceeec-
Confidence 344456799999999999999876 579999999999999999999998744322 112222223333332222
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+.-+++++++-.+|.+|++++++.+-
T Consensus 281 -----------dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 281 -----------DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -----------hhHHHHHHhhccCccccCCHHHhhhh
Confidence 23357888999999999999999853
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.20 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=194.4
Q ss_pred CCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecC---c--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDC---A--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
+|...+.||+|+||.||+++... +..+++|.+.. . ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999999999998754 33455554432 1 223345677899999999999999999999999999999
Q ss_pred eeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|||+++++|..++... .....+++.+++.++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887531 2345799999999999999999999998 9999999999999975 569999999986543
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
..........|+..|+|||...+..++.++|+||||+++|+|++|..||............ .. ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~--~~~~~---- 224 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VE--GPTPS---- 224 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hc--CCCCC----
Confidence 3333333456888999999998888899999999999999999999999754432211110 00 11111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.......++.+++.+||+.||++||++.|+++.
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112334577889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=295.71 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=197.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|...+.||+|+||.||+|+.. +|..||+|++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999865 6889999998643 2233456889999999999999999999987543
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++|+||+.. +|..++ +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 665554 23589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc-------
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL------- 372 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~------- 372 (452)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||................+..
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 654221 223457889999999876 468899999999999999999999998765322111111100000
Q ss_pred -ccC------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--ccccCccc
Q 012975 373 -TDR------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIPLVPVE 430 (452)
Q Consensus 373 -~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~l~~~~ 430 (452)
.+. ...+......+.... ......+.+++.+||+.||++||++.|++.. ++......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000 000000000000000 0123457789999999999999999999954 65554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=287.48 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=194.6
Q ss_pred CCCccCeEeecCcEEEEEEEe----CCCcEEEEEEecCcC----hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCce
Q 012975 152 SFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (452)
+|+..+.||+|+||.||+++. .+|..||+|.+.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366788999999999999986 368889999986432 22346688999999999 699999999999998999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999863 34688999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCC
Q 012975 303 DGSQN-KNNLKLSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 303 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~ 378 (452)
..... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKSEPPY 231 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---hhccCCCC
Confidence 43322 122235688999999998753 467899999999999999999999974332111 111111 11111111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
+. .....+.+++.+|++.||++|| ++++++..
T Consensus 232 ~~------------~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 PQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred Cc------------cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 1234566899999999999997 77777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.82 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=194.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecC--cChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 227 (452)
..|+..+.||.||.+.||++...+.+.+|+|++.. .+.....-|.+|+..|.+|+ |.+||.|++|...++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45677889999999999999999888999998743 34555678999999999995 9999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
|- +-+|..+|... ......| .++.+..||+.++.++|++ +|||.||||.|+|+- .|.+||+|||.|.....+
T Consensus 441 ~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 75 56898888742 2233445 7778999999999999999 999999999999985 468999999999654332
Q ss_pred -CCcccccccccCccCcccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 307 -NKNNLKLSGTLGYVAPEYLLDGK-----------LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 307 -~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
......-+||..||+||.+.... .+.+|||||+||+||+|+.|+.||...... |+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~a------ 580 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------IA------ 580 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------HH------
Confidence 22233457999999999986532 457899999999999999999999754321 11
Q ss_pred CCCCCcccchhhcccCC-HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVDPVIKSTMD-LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
++..+.||.-.-++. .....++.+++..||+.||++|||+.|+|+.
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112222332111111 0112238899999999999999999999963
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=281.48 Aligned_cols=244 Identities=21% Similarity=0.247 Sum_probs=187.3
Q ss_pred hhcCCCccCeE--eecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNIL--GEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (452)
..++|...+.+ |+|+||.||+++.. ++..+|+|.+....... .|+.....+ +|+|++++++++..++..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666666 99999999999865 57788888875432111 122222222 79999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~ 303 (452)
||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999863 23799999999999999999999999 999999999999999998 9999999998654
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.... ...++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.... .......
T Consensus 161 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~---- 230 (267)
T PHA03390 161 GTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QKKLPFI---- 230 (267)
T ss_pred CCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cccCCcc----
Confidence 3221 2358899999999999899999999999999999999999998544322 1111111111 1000000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-ITDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 421 (452)
......+.+++.+||+.||.+||+ ++|+++
T Consensus 231 --------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 --------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 123346778999999999999996 688874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=287.82 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=198.0
Q ss_pred CCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcC----hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCce
Q 012975 152 SFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (452)
+|+..+.||+|++|.||+++.. ++..||||.+.... ......+.+|++++.++ +|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999753 56789999886432 22345688999999999 699999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988863 34689999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCC
Q 012975 303 DGSQN-KNNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 303 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~ 378 (452)
..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ ..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RILKSKPPF 231 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HHHccCCCC
Confidence 43222 1222345889999999987665 78899999999999999999999964322110 11111 011111111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
+.. ....+.+++.+||+.||++|||++++.+.|+...
T Consensus 232 ~~~------------~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 232 PKT------------MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred Ccc------------cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 111 1234667899999999999999998887776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.73 Aligned_cols=241 Identities=28% Similarity=0.345 Sum_probs=185.8
Q ss_pred eEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHH---HHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 158 ILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVD---LLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
+||+|+||.||++... +++.||+|.+.... ......+..|.. .++..+|+|++.+++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 57899999886432 112222344433 4455689999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+|+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 9999988853 35699999999999999999999998 99999999999999999999999999986543222 2
Q ss_pred cccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ ... ......+ ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~--------~~- 220 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMT--LTMAVEL--------PD- 220 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHh--hccCCCC--------CC-
Confidence 234689999999998754 6889999999999999999999999865322111110 000 0000111 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+|++.||.+|| ++.|+++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234677899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.55 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=197.1
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC--
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-- 220 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 220 (452)
+....++|+..+.||+|+||.||++... ++..||||++... .......+.+|++++++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999865 6889999998532 2333456889999999999999999999987654
Q ss_pred ----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 221 ----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 221 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
..++||||+ +++|..++. ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 348999999 678887764 24689999999999999999999998 999999999999999999999999
Q ss_pred cCCCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhcc----
Q 012975 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMP---- 370 (452)
Q Consensus 297 fgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~---- 370 (452)
||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ........
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 162 FGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998654322 223457889999998876 45889999999999999999999999865432211 11100000
Q ss_pred ---ccccC------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 371 ---QLTDR------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 371 ---~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+... ..++......+.. ........+.+++.+|++.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000000000 00122345778999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=292.33 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=197.0
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCcee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRF 223 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 223 (452)
.++++|+..+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+++++.++|||++++++++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 36778999999999999999999865 7889999987532 23345678899999999999999999998866 45789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+++||+ +++|..++. ...+++.....++.|+++||+|||+. +++||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568887775 23578888999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc--------ccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ--------LTD 374 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~ 374 (452)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.................. ...
T Consensus 159 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 159 DP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 22 1123457889999998766 56899999999999999999999999766542211111100000 000
Q ss_pred CCCCCcccchh-hcccCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVDPV-IKSTMD-----LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~-l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.... +++... ...... ......+.+++.+|++.+|++||++.+++..
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTL-RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhH-HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000 000000 1123578889999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.14 Aligned_cols=236 Identities=28% Similarity=0.355 Sum_probs=192.5
Q ss_pred EeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 159 LGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
||+|+||.||++... ++..+++|.+.... ......+..|++++++++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 48899999886432 23456789999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 314 (452)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..............
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 999864 23689999999999999999999998 999999999999999999999999999866543322333456
Q ss_pred cccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 315 gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
++..|++||...+...+.++|+||||+++||+++|+.||...+.......+. .....++...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~------------ 216 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL------KDPLRFPEFL------------ 216 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh------cCCCCCCCCC------------
Confidence 8889999999988888999999999999999999999997655322111111 1111121111
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHH
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITD 418 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~e 418 (452)
...+.+++.+||+.||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 345678999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=290.54 Aligned_cols=269 Identities=24% Similarity=0.300 Sum_probs=198.7
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
..++....++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4456667899999999999999999999864 68899999986432 23346688999999999999999999988643
Q ss_pred ------CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 012975 220 ------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (452)
Q Consensus 220 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~k 293 (452)
...+++++++ +++|..++.. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3467888887 7888877642 3589999999999999999999999 999999999999999999999
Q ss_pred EEecCCCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccc
Q 012975 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQ 371 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~ 371 (452)
|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 161 l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 161 ILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred Eeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998654322 223467889999998866 567889999999999999999999997654322111 11100000
Q ss_pred c-ccCCCCCcccc----hhh----cccCC---HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 L-TDRSKLPNIVD----PVI----KSTMD---LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 ~-~~~~~~~~~~d----~~l----~~~~~---~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .....+..... ..+ ..... ......+.+++.+|++.||.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000000000 000 00000 0123457789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.43 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=194.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC----------
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD---------- 219 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 219 (452)
.+|...+.||.|+||.||+|... ++..||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999875 5889999998766656667889999999999999999999876544
Q ss_pred ----CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEE
Q 012975 220 ----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKL 294 (452)
Q Consensus 220 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~kl 294 (452)
...++||||++ ++|..++. ...+++..++.++.|++.||+|||+. +++||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 58877764 23589999999999999999999998 999999999999997 4567899
Q ss_pred EecCCCcccCCCCC---cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 295 SDFGLAITDGSQNK---NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.........+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999865422111 1112357889999998754 5678899999999999999999999987654332221111110
Q ss_pred cccc--CCCCCcccchhhc-----c-----cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 371 QLTD--RSKLPNIVDPVIK-----S-----TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 371 ~~~~--~~~~~~~~d~~l~-----~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... ...........+. . ........++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000000000000 0 000112356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=289.34 Aligned_cols=262 Identities=25% Similarity=0.328 Sum_probs=190.7
Q ss_pred CCCccCeEeecCcEEEEEEEeC-C--CcEEEEEEecCc--ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC----Cc
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-D--NLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD----DT 221 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 221 (452)
+|...+.||+|+||.||+++.. + +..||+|++... .....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667889999999999999875 3 678999998643 223356788999999999 599999999976433 35
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++++||+. ++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 688888753 45689999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCC----cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-----
Q 012975 302 TDGSQNK----NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ----- 371 (452)
Q Consensus 302 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~----- 371 (452)
....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5432111 1123468999999998765 46889999999999999999999999865432211110000000
Q ss_pred ---cccCC------CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 ---LTDRS------KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ---~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+.... .....-...+.. ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 000000000000 00012346788999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.33 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=196.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc----
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT---- 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 221 (452)
..++|...+.||+|++|.||+|+.. ++..||+|++... .......+.+|+.++++++|+|++++++++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888999999999999999986 5788999988643 23344667889999999999999999988766554
Q ss_pred --eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 222 --RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 222 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 5689888753 4699999999999999999999998 999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhc---ccccc
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAM---PQLTD 374 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~---~~~~~ 374 (452)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... +..... +.+..
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 8654332 223457889999998865 367889999999999999999999997655432111 111100 00000
Q ss_pred CC---CCCcccchhhcc-cCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 RS---KLPNIVDPVIKS-TMD-----LKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 ~~---~~~~~~d~~l~~-~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+. ....++...... ... ......+.+++.+||+.||++|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000000000000 000 012457889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=276.75 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=200.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
..++|+..++||+|.||.|..++-+ +++-+|+|.++.. .++....-..|-.+|+..+||.+..|.-.+...+.+|.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4567888999999999999999865 6889999998644 34455566789999999999999999888999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+.+|.|+-+|.. ...++.....-+...|+.||.|||++ +|+.||||.+|.|+|.||++||+|||+++..-
T Consensus 246 VMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999998853 45688888888999999999999999 99999999999999999999999999998766
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.......+++||+.|+|||++.+..|+.+.|.|.+||++|||++|+.||...+....-.++. ...-+.+.-+.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~ed~kFPr~ls- 392 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------MEDLKFPRTLS- 392 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------hhhccCCccCC-
Confidence 66667778999999999999999999999999999999999999999998765432222221 11122222111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCC
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 414 (452)
.+...+....|.+||.+|.
T Consensus 393 -----------~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 393 -----------PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----------HHHHHHHHHHhhcChHhhc
Confidence 2344567778999999994
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=299.95 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=175.3
Q ss_pred CccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------ceeee
Q 012975 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TRFIV 225 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV 225 (452)
...+.||+|+||.||+|+++ +|+.||||.+.... ....+...+|+++|++++|+|||++++.-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 33577999999999999965 79999999986543 344566889999999999999999999876554 45799
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCc--EEEEecCCCc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFN--AKLSDFGLAI 301 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~--~~~~--~kl~Dfgl~~ 301 (452)
||||.+|||+..|..+++...|+..+.+.+..+++.||.|||++ +|+||||||.||++- .+|+ -||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999999999999999999999999999999999998 999999999999984 3344 6999999998
Q ss_pred ccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~ 358 (452)
...+. .......||..|++||.+.. +.|+..+|.|||||++||.+||..||.....
T Consensus 173 el~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 173 ELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 76544 35567889999999999985 7889999999999999999999999976543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=262.76 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=190.5
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
...||.|..|.|++++.. .|..+|||.+.... ....++++..++++.+-+ +|+||+-+||+..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 566999999999999876 58899999997554 445577888888877765 99999999999999999999999843
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
-++.++.. -..++++..+-++...++.||.||-+++ +|+|||+||+|||+|+.|++|++|||.+-...+. ...+.
T Consensus 176 C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtr 250 (391)
T KOG0983|consen 176 CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHTR 250 (391)
T ss_pred HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-ccccc
Confidence 44455542 2345888888889999999999998765 9999999999999999999999999998443222 22334
Q ss_pred cccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChh-hhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 313 LSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA-QCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
..|.+.|||||.+.- ..|+-++||||||+.++||.||+.||..-..+ +....+. .+ .+..++....
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl------n~---ePP~L~~~~g- 320 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL------NE---EPPLLPGHMG- 320 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH------hc---CCCCCCcccC-
Confidence 568999999999864 46888999999999999999999999874432 1111111 11 1122222221
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+.+++..||++|+.+||...++++.
T Consensus 321 -----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 -----FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 34567788999999999999999998853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.17 Aligned_cols=145 Identities=29% Similarity=0.415 Sum_probs=130.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|.+.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.++..++|+||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999976 6889999998643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999864 24588999999999999999999998 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.02 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=197.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.+-+++..+.||.|.||.||.+... +|.-.|+|-+.... ........+|+.++..++|||+|+++|+-.+.+..+|-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3456777899999999999999754 68888999875433 33345678999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||++|+|.+.+. .+...++.....+..|++.|+.|||++ +||||||||.||+|+.+|.+|++|||.|.....
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999884 355577777778889999999999999 999999999999999999999999999966533
Q ss_pred CC----CcccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChhh-hhhhhhhhccccccCCC
Q 012975 306 QN----KNNLKLSGTLGYVAPEYLLDGK---LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 306 ~~----~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~ 377 (452)
.. .......||+.|||||++.+.. ...++||||+|||+.||+||++||...+..- +...+.. .....
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-----gh~Pq 1461 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-----GHKPQ 1461 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-----cCCCC
Confidence 21 1122456999999999997743 4568999999999999999999998776421 2222211 11222
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+++ ....+=.+++.+|++.||++|-++.|+++
T Consensus 1462 ~P~------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPE------------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred Cch------------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222 22334457888999999999988887775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=270.51 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=191.7
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
...||.|.||+|+|-.++ .|+.+|||++..... .+.++++.|.+...+- ++||||+++|.+..++..|+.||.|+ -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 567999999999999876 699999999976543 5667889999876555 79999999999999999999999995 4
Q ss_pred Chhhh---ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 233 SLDIQ---LHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 233 sL~~~---l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
||+.+ .+. .+...+++.-.-.|+...+.||.||-... .|+|||+||+|||++..|.+||+|||.+-...... .
T Consensus 148 SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-A 223 (361)
T ss_pred hHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-H
Confidence 55433 332 23456888888889999999999998764 89999999999999999999999999985432221 1
Q ss_pred ccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 310 NLKLSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.+...|...|||||.+... -|+-+|||||||++|+|+.||+.||...+..- ..+... .. +..+.+..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-eql~~V----v~--gdpp~l~~---- 292 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-EQLCQV----VI--GDPPILLF---- 292 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-HHHHHH----Hc--CCCCeecC----
Confidence 2234688899999998653 48889999999999999999999998876421 111111 11 11111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+....+..++..|+-+|-++||...++.+.
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11113456678889999999999999999998854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=267.68 Aligned_cols=220 Identities=22% Similarity=0.219 Sum_probs=174.5
Q ss_pred cCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhhhccC
Q 012975 162 GGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG 240 (452)
Q Consensus 162 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 240 (452)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 67899999986432 233455555566799999999999999999999999999999988853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCcc
Q 012975 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320 (452)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~ 320 (452)
...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||.+....... ....++..|+
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~ 149 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYC 149 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcccc
Confidence 23589999999999999999999998 99999999999999999999999999875443321 1234567899
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHH
Q 012975 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAA 400 (452)
Q Consensus 321 aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 400 (452)
|||...+..++.++||||+|+++|||++|+.|+....... . ......++. .....+.+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~---------~~~~~~~~~------------~~~~~~~~ 207 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N---------THTTLNIPE------------WVSEEARS 207 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c---------cccccCCcc------------cCCHHHHH
Confidence 9999988889999999999999999999998875422110 0 000001111 12245678
Q ss_pred HHHHhcCCCCCCCCChH
Q 012975 401 VAVLCVQPEPSYRPLIT 417 (452)
Q Consensus 401 li~~Cl~~dP~~RPs~~ 417 (452)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=244.45 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=199.5
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh--hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD--AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
|...++||+|.||+||||+.. ++..||+|++.....+ --....+|+.+|+.++|+|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444567999999999999876 4778999998654332 2356789999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
. .+|..+.. +-++.++...+..++.|+.+||.++|++ ++.|||+||.|.||+.+|++|++|||+++..+-....
T Consensus 84 d-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 84 D-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 5 46766665 3456799999999999999999999999 9999999999999999999999999999887766555
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc---ccch
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN---IVDP 384 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~ 384 (452)
.....-|..|.+|.++.+. -|+...|+||-||++.|+.. |++-|.+.+..+....+-|....... +.++. +-|-
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e-d~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE-DQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc-ccCCccccCCCC
Confidence 4455679999999999886 47889999999999999996 88778877765544444443322111 11111 1111
Q ss_pred hhc---------ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIK---------STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~---------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... ...-++....=.++.+..+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 000 0011122222345677788889999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.16 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=204.3
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
+.+....++|.+.++||+|+||.|..++.+ ++..+|+|++... .......|..|-++|..-+.+-|+.+.-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 445556789999999999999999999976 5788999998652 344556799999999999999999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
.++|+|||||+||+|-.++.. ...++..++..++..|+-||.-||+. |+|||||||+|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999988853 33799999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCC-cccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 300 AITDGSQNK-NNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 300 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
+......+. .....+|||.|++||++.. +.|+..+|.||+||++|||+.|..||...+-.+....+..- .
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h----k 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH----K 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----h
Confidence 865543333 3345679999999999853 57899999999999999999999999876554432222211 1
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL---ITDVLH 421 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 421 (452)
+.-.+|+.. +-..+..++|++.+. +|+.|-. +.++-.
T Consensus 298 ~~l~FP~~~----------~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 ESLSFPDET----------DVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhcCCCccc----------ccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 112222111 123455567777665 6777777 777763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.29 Aligned_cols=238 Identities=29% Similarity=0.371 Sum_probs=192.2
Q ss_pred CcEEEEEEEeCC-CcEEEEEEecCcChhh-HHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhhhccC
Q 012975 163 GFGCVYKAKLDD-NLHVAVKKLDCATQDA-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG 240 (452)
Q Consensus 163 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 240 (452)
+||.||+|+..+ +..+++|.+....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8899999997655444 67899999999999999999999999999999999999999999998864
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCcc
Q 012975 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320 (452)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~ 320 (452)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 2 2389999999999999999999999 99999999999999999999999999997654332 222345788999
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHH
Q 012975 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAA 400 (452)
Q Consensus 321 aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 400 (452)
+||.+.+..++.++||||||+++++|++|..||......+ .......... ...... .......+.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~~~---~~~~~~---------~~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGKPK---PPFPPP---------EWKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhccC---CCCccc---------cccCCHHHHH
Confidence 9999988889999999999999999999999997632211 1111111000 000000 0002346788
Q ss_pred HHHHhcCCCCCCCCChHHHHH
Q 012975 401 VAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 401 li~~Cl~~dP~~RPs~~evl~ 421 (452)
++.+|++.+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=285.00 Aligned_cols=241 Identities=26% Similarity=0.329 Sum_probs=192.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++.|.....+|.|.|+.|-++... +++..+||.+.... .+-.+|+.++... +|+|++++.+.+.++...|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888888999999999988754 68899999996542 2335677666665 7999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL-DSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll-~~~~~~kl~Dfgl~~~~~~ 305 (452)
|++.++-+.+.+.... ... .++..|+.+|+.++.|||++ +++||||||+|||+ ++.++++|+|||.+.....
T Consensus 396 e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877765322 233 77788999999999999999 99999999999999 6999999999999976544
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||.....+. .+... + ...+
T Consensus 469 ~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~~~----i-~~~~-------- 530 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIHTR----I-QMPK-------- 530 (612)
T ss_pred h---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHHHh----h-cCCc--------
Confidence 3 234467889999999999999999999999999999999999998755431 11110 0 0111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+...-.....+|+.+||+.||.+||+|.++...
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 112334566789999999999999999999853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.65 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=215.3
Q ss_pred cccHHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEE
Q 012975 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSA 217 (452)
Q Consensus 140 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 217 (452)
.+.++.+...++.|++.++||+|.+|.||+++.. +++.+|+|.+... .+...+++.|.++|+.+ +|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3455666667888999999999999999999865 6788888888643 44456778899999988 6999999999985
Q ss_pred c-----CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 218 H-----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 218 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
. ++.+|||||||.+||..+++.... +..+.|..+..|+..++.||.+||.. .++|||||-.|||+++++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 4 458899999999999999988755 78899999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~ 367 (452)
||.|||.+........+..+..||+.|||||++.- ..|+..+|+||||++..||--|.+|+.++.+...
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------ 236 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 236 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence 99999999776666666667889999999999854 3467799999999999999999999998766431
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.-.+.. .+.+.+.. ...-..++.++|..||.+|-.+||++.++++
T Consensus 237 -LF~IpR-NPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 -LFLIPR-NPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hccCCC-CCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111221 22222211 2234567888999999999999999999884
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=260.11 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--------Cc
Q 012975 153 FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--------DT 221 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~ 221 (452)
|+...+||+|.||.||+++.. +|+.||+|++.... ...-....+|+++|..++|+|++++++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444677999999999999865 57788998874432 22334568999999999999999999988543 34
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+||++|+. +|.-.|.. ....++...+.++..++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 7999999975 66666642 235689999999999999999999999 99999999999999999999999999995
Q ss_pred ccCCC----CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 302 TDGSQ----NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 302 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
..... ....+..+-|..|.+||.+.+ ++|+++.|||.-||++.||+||.+-+++........++......+.. +
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk-e 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK-E 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc-c
Confidence 43221 122334557999999999887 57999999999999999999999999888766544444433222211 1
Q ss_pred CCCcccchhh----------cccCC--HHHH------HHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 377 KLPNIVDPVI----------KSTMD--LKHL------YQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 377 ~~~~~~d~~l----------~~~~~--~~~~------~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.++++..-.+ ++.+. ++.+ .+.++++..++..||.+|+++.++++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1222111111 11000 1112 25678899999999999999999884
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=262.13 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=195.6
Q ss_pred cCeEeecCcEEEEEEE-eCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 156 SNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.+.||+|+++.|-.+. +.+|.++|||.++........+..+|++++.+.+ |+||+.|++++++++..|||||-|.+|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3579999999999886 5689999999998776677788999999999995 9999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecCCCcccCC-----
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITDGS----- 305 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfgl~~~~~~----- 305 (452)
|..+++. ...+++.++.++..+|+.||.|||.+ +|.|||+||+|||..+... +||+||.+..-...
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999964 45699999999999999999999999 9999999999999976544 89999998732111
Q ss_pred --CCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 306 --QNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 306 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
......+.+|+..|||||++. ...|+.++|.|||||+||-|++|-.||.+....++ .|-+...= +.--
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~C-r~CQ 311 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVC-RVCQ 311 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCcc-HHHH
Confidence 111223467888999999863 24588899999999999999999999987654332 12110000 0000
Q ss_pred Ccccchhhcc--cCCHH----HHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 379 PNIVDPVIKS--TMDLK----HLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 379 ~~~~d~~l~~--~~~~~----~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..++.....+ ++..+ ...+..+++...+..|+.+|-++.++++
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0011111111 11112 2345567888889999999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.44 Aligned_cols=203 Identities=30% Similarity=0.402 Sum_probs=166.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC---C--CcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCce
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD---D--NLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTR 222 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 222 (452)
..|+....||+|.||.|||+.-. + +..+|+|+++.... .-.....+|+.+++.++|+|++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46778899999999999999532 2 34799999965422 223457899999999999999999998877 7789
Q ss_pred eeeeeecCCCChhhhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEe
Q 012975 223 FIVYELMENRSLDIQLH--GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSD 296 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~----~~~kl~D 296 (452)
+|++||.+. +|...++ .......++-..+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 4544443 334456799999999999999999999999 89999999999999887 8999999
Q ss_pred cCCCcccCCCCC---cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 297 FGLAITDGSQNK---NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 297 fgl~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
+|+++.....-. ....++-|..|.|||.+.+. .||.+.|||+.||++.||+|-++-|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999987654432 22346689999999999885 68999999999999999999888776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=258.18 Aligned_cols=246 Identities=25% Similarity=0.304 Sum_probs=192.2
Q ss_pred hcCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC----Cce
Q 012975 150 TDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD----DTR 222 (452)
Q Consensus 150 ~~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 222 (452)
+++|.+. ++||-|-.|.|-.+..+ ++..+|+|.+... ...++|+++--.. .|+|||.+++++++. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455543 57999999999998765 6888999998532 2346788765544 699999999988653 466
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl 299 (452)
.+|||.|++|.|+..+.+ .....+++.++-.|..||+.|+.|||+. +|.||||||+|+|.+. |-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999998875 3356799999999999999999999999 9999999999999965 45699999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
|+..... ....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|-+||....... ++
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------------is 272 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------------IS 272 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------------CC
Confidence 9765432 33446688999999999999999999999999999999999999997643211 11
Q ss_pred cccchhhc---ccCC----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIK---STMD----LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~---~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.-+...++ ..+. ..-.+...++|+.+|..+|.+|-|+.|+++.
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111111 0011 1234566789999999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=281.07 Aligned_cols=260 Identities=21% Similarity=0.315 Sum_probs=181.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe-----------------CCCcEEEEEEecCcChhhHHHH--------------HHH
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL-----------------DDNLHVAVKKLDCATQDAGREF--------------ENE 197 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 197 (452)
..++|...++||+|+||.||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999875543333333 346
Q ss_pred HHHHHcCCCCce-----eeeEEEEEc--------CCceeeeeeecCCCChhhhccCCCC---------------------
Q 012975 198 VDLLSNIHHPNV-----VCLLGYSAH--------DDTRFIVYELMENRSLDIQLHGPSH--------------------- 243 (452)
Q Consensus 198 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 243 (452)
+..+.+++|.|+ ++++++|.. .+..+|||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677888754 3567999999999999998874210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-cccccccccCccCc
Q 012975 244 GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-NNLKLSGTLGYVAP 322 (452)
Q Consensus 244 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~gt~~y~aP 322 (452)
...++|..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........ ......+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357888999999999999999998 999999999999999999999999999865332211 11122357899999
Q ss_pred ccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCChhh------hhhhhhhhccccc
Q 012975 323 EYLLDGKL----------------------TDKSDVYAFGVVLLELLLGRR-PVEKLAPAQ------CQSIVTWAMPQLT 373 (452)
Q Consensus 323 E~~~~~~~----------------------~~~sDv~s~Gvll~elltG~~-P~~~~~~~~------~~~~~~~~~~~~~ 373 (452)
|.+..... ..+.||||+||+++||++|.. |+....... ......|.. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence 98754321 124699999999999999876 775432111 011111211 000
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCC---CCCCChHHHHHh
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEP---SYRPLITDVLHS 422 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~~ 422 (452)
....+. .. ........+++.+++..+| .+|+|++|+++.
T Consensus 459 ~~~~~~------~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFS------LL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcc------cc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000010 00 1123456678888998766 689999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.76 Aligned_cols=260 Identities=20% Similarity=0.215 Sum_probs=168.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-C----CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEE------EE
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-D----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY------SA 217 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 217 (452)
..++|...+.||+|+||.||+|++. + +..||+|++...... +.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999875 4 689999997543221 111111 1222222222222111 24
Q ss_pred cCCceeeeeeecCCCChhhhccCCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012975 218 HDDTRFIVYELMENRSLDIQLHGPSH-----------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (452)
Q Consensus 218 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk 280 (452)
.++..++||||+++++|.++++.... +.......+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 56688999999999999988864211 01112334567999999999999998 99999999
Q ss_pred CCCEEECC-CCcEEEEecCCCcccCC-CCCcccccccccCccCcccccCC----------------------CCCchhhH
Q 012975 281 SSNILLDS-KFNAKLSDFGLAITDGS-QNKNNLKLSGTLGYVAPEYLLDG----------------------KLTDKSDV 336 (452)
Q Consensus 281 ~~NIll~~-~~~~kl~Dfgl~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv 336 (452)
|+|||+++ ++.+||+|||++..... .........++++|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 68999999999965322 12223345789999999965322 23456799
Q ss_pred HHHHHHHHHHHcCCCCCCCCChhhh-------hhhhhhhccccccCCCCCcccchhhcccCC--HHHHHHHHHHHHHhcC
Q 012975 337 YAFGVVLLELLLGRRPVEKLAPAQC-------QSIVTWAMPQLTDRSKLPNIVDPVIKSTMD--LKHLYQVAAVAVLCVQ 407 (452)
Q Consensus 337 ~s~Gvll~elltG~~P~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~ 407 (452)
|||||++|||+++..|++.....-. .....|.... . ....+.+...++ ........+++.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-E------PRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-c------cccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999998777543211100 0111111000 0 000000000000 0011234479999999
Q ss_pred CCCCCCCChHHHHHh
Q 012975 408 PEPSYRPLITDVLHS 422 (452)
Q Consensus 408 ~dP~~RPs~~evl~~ 422 (452)
.||++|||++|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=268.59 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=192.2
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC-------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCc
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT-------QDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDT 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 221 (452)
++|-..++||+|||+.|||+.+ ...+-||||.-.... ....+...+|.++-+.|+||.||++++|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3455678899999999999975 457778888764221 1223457899999999999999999999864 468
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFG 298 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfg 298 (452)
+|-|+|||++.+|+-+|. ....+++.++..|++||+.||.||.+. +|+|+|-||||.|||+-+ -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999985 356799999999999999999999886 789999999999999954 4789999999
Q ss_pred CCcccCCCCCc-------ccccccccCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh
Q 012975 299 LAITDGSQNKN-------NLKLSGTLGYVAPEYLLDG----KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW 367 (452)
Q Consensus 299 l~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~ 367 (452)
+++........ .....||.+|++||.+.-+ +.+.|.||||.||++|..+.|+.||....... +++..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhh
Confidence 99765433222 2235699999999987543 56889999999999999999999998765432 11110
Q ss_pred hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 368 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
- ..+. ...+.--..|. ...+...+|++||+..-++|-...++..
T Consensus 697 N-TIlk-AtEVqFP~KPv--------VsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 N-TILK-ATEVQFPPKPV--------VSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred h-chhc-ceeccCCCCCc--------cCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 0000 00000001111 1234557899999999999998888763
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.82 Aligned_cols=243 Identities=28% Similarity=0.360 Sum_probs=193.4
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
.++||+|.||+||-|+.+ +|+.||||.++.. ....+.++++|+.+|++++||.||++--.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999876 6999999998643 3445578999999999999999999999999999999999999554
Q ss_pred ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEecCCCcccCCCCCc
Q 012975 233 SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 233 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~Dfgl~~~~~~~~~~ 309 (452)
-| +++.. ++.+.|+.....-+..||+.||.|||.+ +|+|+||||+|||+.+. -++||+|||+|+..+...-+
T Consensus 649 ML-EMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 ML-EMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HH-HHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 44 44443 4456788888888999999999999999 99999999999999653 46999999999988755433
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
..++||+.|+|||++.++-|+..-|+||.||++|--++|..||...... .+.+..+. -+..+.-..
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAa----------FMyPp~PW~- 789 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAA----------FMYPPNPWS- 789 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccc----------cccCCCchh-
Confidence 4578999999999999999999999999999999999999999875421 11111110 011111111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
+.....+++|...||..-++|-+...-+
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2234566788888888888888887654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=263.61 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=194.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
.+|+...+||+|.||.|-.+..+ +...+|||.++... .++.+--+.|-++|... +-|.++.+..++..-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999765 45679999886432 22233345677777766 578899999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+.+|+|-.++.. -+.+.+..+.-+|..||-||-+||++ +|+.||||.+|||+|.+|++||+|||+++..-.
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888753 45577788899999999999999999 999999999999999999999999999977655
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
......+.+||+.|+|||.+..++|+...|.|||||+||||+.|+.||++.+..+.-..+. ..+-.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~------ehnvs-------- 568 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM------EHNVS-------- 568 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------HccCc--------
Confidence 6666678899999999999999999999999999999999999999999987655322111 11111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 415 (452)
+......+...++...+.+.|.+|..
T Consensus 569 ----yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 ----YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----CcccccHHHHHHHHHHhhcCCccccC
Confidence 12223345667788889999999843
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=260.84 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCC--C----ceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHH--P----NVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~ 221 (452)
.+++|.+...+|+|.||.|-.+.+.. +..||||.++.- ....+..+-|+++|+++.+ | .+|.+.+++.-.+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36788899999999999999997654 688999998643 2334556789999999932 3 37788889999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------------
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS------------- 288 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~------------- 288 (452)
.|||+|.+ +-|++++|..+ +-.+++...+..++.|++++++|||+. +++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 56899999753 235688899999999999999999999 9999999999999932
Q ss_pred -------CCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh
Q 012975 289 -------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC 361 (452)
Q Consensus 289 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~ 361 (452)
+..+||+|||.|+...... ..++.|..|.|||++.+-.++.++||||+||+|.|+.||..-|+.-+..+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3458999999997765443 456789999999999999999999999999999999999999987765442
Q ss_pred hhhhhhhcccc----ccCC---------C-----------CCcccchh--h--cccCCHHHHHHHHHHHHHhcCCCCCCC
Q 012975 362 QSIVTWAMPQL----TDRS---------K-----------LPNIVDPV--I--KSTMDLKHLYQVAAVAVLCVQPEPSYR 413 (452)
Q Consensus 362 ~~~~~~~~~~~----~~~~---------~-----------~~~~~d~~--l--~~~~~~~~~~~l~~li~~Cl~~dP~~R 413 (452)
..........+ ..+. . .....++. + ....+..+..++++|+..+|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 21111111111 0000 0 01111110 0 011223566789999999999999999
Q ss_pred CChHHHHH
Q 012975 414 PLITDVLH 421 (452)
Q Consensus 414 Ps~~evl~ 421 (452)
+|++|+++
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=267.79 Aligned_cols=207 Identities=27% Similarity=0.367 Sum_probs=174.8
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.-|..++.||-|+||+|.+++. ++...+|.|.+...+ .........|-+||..-+.+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3466788999999999999964 456678999886543 344556789999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc---
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD--- 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~--- 303 (452)
||+++|++-.+|.. .+.+.+..+..++..+++|+++.|.. |+|||||||+|||||.+|++||.||||+.-.
T Consensus 709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999887753 45688888888999999999999999 9999999999999999999999999998311
Q ss_pred ------C--CCCC-------------------------------cccccccccCccCcccccCCCCCchhhHHHHHHHHH
Q 012975 304 ------G--SQNK-------------------------------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLL 344 (452)
Q Consensus 304 ------~--~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ 344 (452)
. +... .....+||..|+|||++....++..+|.||.||+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0000 001235999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChhhhhh
Q 012975 345 ELLLGRRPVEKLAPAQCQS 363 (452)
Q Consensus 345 elltG~~P~~~~~~~~~~~ 363 (452)
||+.|+.||-...+.+.+.
T Consensus 863 em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHhhCCCCccCCCCCccee
Confidence 9999999999888766433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=237.83 Aligned_cols=205 Identities=28% Similarity=0.411 Sum_probs=166.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
..++......||+|++|.|-+.++. +|..+|+|++...- .+..++..+|+++..+. .+|.+|.++|....+...++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3344445677999999999988864 79999999996543 33456678888876665 799999999999999999999
Q ss_pred eeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 226 YELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||.|. .||+.+-.. ..++..+++.-.=+|+..+.+||.|||++. .++|||+||+|||++.+|++|++|||.+-...
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99995 467654322 245678999999999999999999999986 89999999999999999999999999986543
Q ss_pred CCCCcccccccccCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLD----GKLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
+.-.. +...|...|||||.+.. ..|+-+|||||||+.+.||.+++.||+...
T Consensus 201 dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 32221 12357889999998754 368889999999999999999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=267.14 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=199.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCc-EEEEEEec---CcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNL-HVAVKKLD---CATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+++....||-||||.|=.++.+... .+|+|.++ .......+....|-.+|...+.+.||++|-.+.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556778999999999999876543 36776664 334555667889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|-|-+|.|...|.+ .+.++.....-++..+.+|++|||++ +|+.|||||+|.++|.+|-+||.|||+|+..+..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999964 45688888889999999999999999 9999999999999999999999999999887655
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.+ +.+++||+.|.|||++.++-.+.++|.||||+++|||++|.+||...++....+++--....+.
T Consensus 574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------- 639 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------- 639 (732)
T ss_pred Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-------------
Confidence 44 4578999999999999999999999999999999999999999999887665444432211111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 415 (452)
+.........+++++.+..+|.+|-.
T Consensus 640 ---~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ---FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---cccccchhHHHHHHHHHhcCcHhhhc
Confidence 11122234567888888899999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.90 Aligned_cols=243 Identities=29% Similarity=0.396 Sum_probs=185.5
Q ss_pred CCccCeEeecCcEE-EEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecC
Q 012975 153 FHESNILGEGGFGC-VYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 153 f~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
|...+++|.|..|+ ||+|... |++||||++-. +...-..+|+..|+.- +|||||++++...+++..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44457899998875 6999886 66999999853 3334567899999988 6999999999999999999999999
Q ss_pred CCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---C--CcEEEEecCCCcccC
Q 012975 231 NRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---K--FNAKLSDFGLAITDG 304 (452)
Q Consensus 231 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~--~~~kl~Dfgl~~~~~ 304 (452)
..+|++++... .......-...+.+..|++.||++||+. +|+||||||.||||+. + ..++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 46999998753 1111111134567889999999999997 9999999999999975 3 569999999997643
Q ss_pred CC---CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQ---NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. -.......||.+|+|||.+....-+.+.||||+||++|+.++ |.+||.+.-..+ .+++. ....+-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~-------~~~~L~- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT-------GNYTLV- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc-------Ccccee-
Confidence 22 223445679999999999999888889999999999999998 699998754332 12211 111110
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
.+... .++ +..++|.+|+++||..||++.+|+
T Consensus 734 ----~L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 ----HLEPL--PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----eeccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 01111 112 677899999999999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=235.01 Aligned_cols=211 Identities=37% Similarity=0.569 Sum_probs=183.7
Q ss_pred EeecCcEEEEEEEeCC-CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhh
Q 012975 159 LGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 236 (452)
||+|.+|.||+++..+ +..+++|.+...... ....+.+|++.++.++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 889999998755432 45679999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCCCCCccccccc
Q 012975 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNKNNLKLSG 315 (452)
Q Consensus 237 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~g 315 (452)
++... ...+++..+..++.++++++++||+. +++|+||+|.||++++ ++.++|+|||.+..............+
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 88642 14689999999999999999999999 9999999999999999 899999999999665443222233457
Q ss_pred ccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHH
Q 012975 316 TLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394 (452)
Q Consensus 316 t~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 394 (452)
...|++||..... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999998877 788999999999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 395 LYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 395 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
..+.+++..|++.||++||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=244.50 Aligned_cols=201 Identities=24% Similarity=0.389 Sum_probs=176.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (452)
.++|...++||+|.|..|..+++. +.+.+|+|.++.. ..++....+.|-.+..+. +||.+|-+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999876 5778899887532 233445566777777666 79999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|.||+++|+|--++. +...+++..+.-+...|.-||.|||++ +|+.||||.+|||+|..|.+||.|+|+++..-
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999976664 345689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL 356 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~ 356 (452)
.......+++||+.|.|||.+.+..|....|.|++||+++||+.|+.||+-.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 6677777899999999999999999999999999999999999999999743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=238.14 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=193.4
Q ss_pred CccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cceeee
Q 012975 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DTRFIV 225 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 225 (452)
+..+.||-|+||.||.+++. +|+.||.|++...- -...+.+.+|+.+|..++|.|++..++.-.-. ++.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999875 79999999986433 23457788999999999999999988876543 356899
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+|.|. .+|.+.+-.+ +.++-..+.-+..||++||.|||+. +|.||||||.|.|+++|..+||+|||+++....
T Consensus 136 TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 99995 4777766543 4588888888899999999999999 999999999999999999999999999976544
Q ss_pred CCCc-ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh---------------
Q 012975 306 QNKN-NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA--------------- 368 (452)
Q Consensus 306 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~--------------- 368 (452)
.... .+..+-|..|.|||.+++. .|+.+.||||.||++.||+..+.-|....+.+...++...
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 3332 3334578899999999884 6899999999999999999999989877765533333211
Q ss_pred -ccccccCCCCCcccchhhcccCC-HHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 369 -MPQLTDRSKLPNIVDPVIKSTMD-LKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 369 -~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
...+-+...-..- -+.+..... ...-.+...+.+.++.+||++|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps-~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPD-TQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCC-ccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111100000 011111000 12223445667778999999999998887554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=229.64 Aligned_cols=198 Identities=34% Similarity=0.447 Sum_probs=171.8
Q ss_pred CCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 153 FHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
|...+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4557889999999999999875 889999999765544 67789999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-Cc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-KN 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~ 309 (452)
+++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+++||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999986422 1289999999999999999999998 99999999999999999999999999986654332 11
Q ss_pred ccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 310 NLKLSGTLGYVAPEYL-LDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
.....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2234578889999988 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=262.32 Aligned_cols=258 Identities=28% Similarity=0.396 Sum_probs=212.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..++|+....+|.|.+|.|||+++. ++...|+|.++....+...-..+|+-+++..+|+||+.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4567888899999999999999865 688899999988777777888999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||.+|+|++.-|. ..++++.++...+....+||+|||++ +=+|||||-.|||+++.|.+|++|||.+-..+...
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999988774 45799999999999999999999999 88999999999999999999999999986665555
Q ss_pred CcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh---hccccccCCCCCcc
Q 012975 308 KNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW---AMPQLTDRSKLPNI 381 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 381 (452)
.....+.||+.|||||+.. .+-|...+|||+.|+...|+---+.|..+..+.....+..- ..+.+.+..+
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k---- 242 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK---- 242 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc----
Confidence 5566788999999999863 45689999999999999999888888777665543222221 1111222211
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
-...+.++++.|+.++|++||+++.+++ .+.+...
T Consensus 243 ------------ws~~fh~fvK~altknpKkRptaeklL~--h~fvs~~ 277 (829)
T KOG0576|consen 243 ------------WSEFFHNFVKGALTKNPKKRPTAEKLLQ--HPFVSQT 277 (829)
T ss_pred ------------chHHHHHHHHHHhcCCCccCCChhhhee--ceeeccc
Confidence 1234567888999999999999998876 4444444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=222.54 Aligned_cols=256 Identities=18% Similarity=0.287 Sum_probs=191.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCC--ceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDD--TRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 224 (452)
..++|+..+.+|+|.+++||.|.. .++.+++||.++ +...+.+.+|+.+|..|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 346778889999999999999974 567789999986 345567899999999997 999999999988765 6689
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~~~ 303 (452)
|+||++|.+....- ..++...+..++.+++.||.|+|+. ||.|||+||.|++||.. ..++|+|+|+|...
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998775443 3588888999999999999999999 99999999999999964 56999999999776
Q ss_pred CCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChh--hhh---------hhhhhhccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA--QCQ---------SIVTWAMPQ 371 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~--~~~---------~~~~~~~~~ 371 (452)
.....-+ ..+.+..|--||.+-+ +.|+..-|+|||||++.+|+..+.||...... +.. .+..+...+
T Consensus 184 Hp~~eYn-VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 184 HPGKEYN-VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred CCCceee-eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 4433222 3346777899998765 56788899999999999999999998644321 111 111111110
Q ss_pred -ccc------------CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 -LTD------------RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 -~~~------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+.- +..+..++.+.-.... ..+.++++...|..|-.+|+|++|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 1111111111111111 246778899999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=229.73 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=189.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------ce
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TR 222 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 222 (452)
+|.....+|.|.- .|..+.+. .++.||+|++... .....++..+|..++..++|+|+++++.++.-.. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888877 55555433 5789999987432 3344566789999999999999999999986543 56
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
|+||||| ..+|...++ -.++-.....|..|+++|++|||+. +|+||||||+||++..+..+||.|||+++.
T Consensus 97 y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 9999999 467776665 2366777889999999999999999 999999999999999999999999999977
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhh---------------
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVT--------------- 366 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~--------------- 366 (452)
.... -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+. ...+.
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 5544 445567789999999999998899999999999999999999998876543211 11111
Q ss_pred hhccccccC-----CCCCcccchhh-cc--cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 367 WAMPQLTDR-----SKLPNIVDPVI-KS--TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 367 ~~~~~~~~~-----~~~~~~~d~~l-~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
-+.-+.... ....+.+...+ .. +.+.-......+++.+||-.||++|-+++++++.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 00111111100 00 0111223456678999999999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.68 Aligned_cols=275 Identities=20% Similarity=0.228 Sum_probs=212.2
Q ss_pred cccHHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC------CCceeee
Q 012975 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH------HPNVVCL 212 (452)
Q Consensus 140 ~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l 212 (452)
++.+..-|...+.|.+....|+|-|++|.+|... .|..||||.+.. ++...+.=++|+++|++|+ --+.++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 5556666777789999999999999999999876 478999999974 3444555678999999995 2478999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-Cc
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FN 291 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~ 291 (452)
+..|...+++|||||-+ .-+|.+.|.....+-.|....+..++.|+.-||..|-.. +|+|.||||+|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999977 568888887766667788999999999999999999887 99999999999999875 56
Q ss_pred EEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+||||||.|...+.... +...-+..|.|||++.+-.|+...|+||.||+||||.||+.-|.+........+..-....
T Consensus 576 LKLCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 89999999866543322 1223456799999999999999999999999999999999999988765543333221111
Q ss_pred cccC-----------------------CCCC--------cccch------hhcc-----cCCHHHHHHHHHHHHHhcCCC
Q 012975 372 LTDR-----------------------SKLP--------NIVDP------VIKS-----TMDLKHLYQVAAVAVLCVQPE 409 (452)
Q Consensus 372 ~~~~-----------------------~~~~--------~~~d~------~l~~-----~~~~~~~~~l~~li~~Cl~~d 409 (452)
+... ..+. ..+.| .+.. .-+...+.++.+|+..|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 1100 0000 01111 1111 122355678889999999999
Q ss_pred CCCCCChHHHHH
Q 012975 410 PSYRPLITDVLH 421 (452)
Q Consensus 410 P~~RPs~~evl~ 421 (452)
|++|-|..+.|.
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=231.30 Aligned_cols=131 Identities=30% Similarity=0.421 Sum_probs=109.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-----C---CceeeeEEEEEcC--
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----H---PNVVCLLGYSAHD-- 219 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~-- 219 (452)
++|.+.++||-|.|++||++.+. +.+.||+|+.+. .+...+....||.+|++++ | ..||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999764 677899999863 3445566789999999883 3 3699999999764
Q ss_pred --CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 220 --DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 220 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
.+.|||+|+. +.+|..++.. .+-..++...+..|+.||+.||.|||.+| +|+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4789999999 5566666654 33456889999999999999999999998 99999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=240.01 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=164.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh---h-----hHHHHHHHHHHHHcCC---CCceeeeEEEEEc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ---D-----AGREFENEVDLLSNIH---HPNVVCLLGYSAH 218 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 218 (452)
.+|...+.+|+|+||.|+.+.++. ..+|++|.+....- . ..-..-.|+.+|..++ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357788999999999999998874 56788887753210 0 1112457999999997 9999999999999
Q ss_pred CCceeeeeeec-CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 219 DDTRFIVYELM-ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 219 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
++.+||+||-. ++-+|++++. ....+++.++..|+.|++.|+++||++ +|+|||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 99999999975 4457888885 346699999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
|.+-+..+. ....++||.+|.|||++.+.+| +..-|||++|++||-++..+.||..
T Consensus 715 gsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998554322 2235689999999999999877 4568999999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=221.76 Aligned_cols=246 Identities=22% Similarity=0.397 Sum_probs=195.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecC--cChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
..+|.+...|+.|+|+++++ .+++|.+.. .+....++|..|.-.|+-+.||||++++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45688999999999999976 456666643 234455789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE--ecCCCcccCCCCCccc
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS--DFGLAITDGSQNKNNL 311 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~ 311 (452)
|+..||. ..+-.++-.++.+++.++|+|++|||+. .|-|.---|.+..|++|++.+++|+ |--++... .
T Consensus 274 lynvlhe-~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe-------~ 344 (448)
T KOG0195|consen 274 LYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------V 344 (448)
T ss_pred HHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-------c
Confidence 9999996 3345678889999999999999999996 5556666799999999999999885 33332111 1
Q ss_pred ccccccCccCcccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 312 KLSGTLGYVAPEYLLDGKLT---DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~---~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
...-.+.||+||.++..+.+ .++|+|||++++|||.|.+.||.+..+.+++..+... . + +-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----g----l--------rv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----G----L--------RV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----c----c--------cc
Confidence 12235789999999876543 4799999999999999999999999998887766431 1 1 11
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.+.+.....+.+++.-|++.||.+||.+..|+-.|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 122233446778888999999999999999998887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=261.09 Aligned_cols=194 Identities=22% Similarity=0.282 Sum_probs=138.3
Q ss_pred cCCC-CceeeeEEEE-------EcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012975 203 NIHH-PNVVCLLGYS-------AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (452)
Q Consensus 203 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 274 (452)
.++| .||++++++| .+.+..+.++||+ +++|.++|... ...+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3455 5888888877 2334667888987 66999999742 35699999999999999999999999 99
Q ss_pred eeCCCCCCCEEECCCC-------------------cEEEEecCCCcccCCCC----------------CcccccccccCc
Q 012975 275 IHRDLKSSNILLDSKF-------------------NAKLSDFGLAITDGSQN----------------KNNLKLSGTLGY 319 (452)
Q Consensus 275 ~H~Dlk~~NIll~~~~-------------------~~kl~Dfgl~~~~~~~~----------------~~~~~~~gt~~y 319 (452)
+||||||+||||+..+ .+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45566666654211000 000113478889
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHH
Q 012975 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVA 399 (452)
Q Consensus 320 ~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 399 (452)
||||++.+..++.++|||||||+||||++|..|+...... ...+.. .. ..+.. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-~~~~~~---~~----------~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-MSSLRH---RV----------LPPQI-----LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-HHHHHH---hh----------cChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999887542211 000100 00 00100 01123345
Q ss_pred HHHHHhcCCCCCCCCChHHHHH
Q 012975 400 AVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 400 ~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.++.+||++||.+||+|.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7788999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=214.31 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=183.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEE-EEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY-SAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 226 (452)
.+.|.+.+.+|+|.||.+-.+.++ +...+++|-+. ......++|.+|...--.| .|.||+.-++. ++..+....++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 457888899999999999999887 46778888875 3345568899998776666 58999987764 56667888999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEecCCCcccC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFGLAITDG 304 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~--~~~~~kl~Dfgl~~~~~ 304 (452)
||++.|+|..-+.. ..+-+....+++.|++.|+.|||++ +++|||||.+||||- +...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999876643 4577888899999999999999999 999999999999994 34579999999986554
Q ss_pred CCCCcccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDG-----KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
..-.. ..-+..|.+||..... ...+.+|||.||++++.++||+.|++.....+ .....|..-.-.....++
T Consensus 175 ~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 TTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccCccCc
Confidence 43221 2245679999976542 34678999999999999999999998543322 222222111111112233
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
..+.+ ....+.++-++-+.+++++|=-+.++-.+.
T Consensus 251 ~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 251 KKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 32222 223455667778889999885555554433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=206.73 Aligned_cols=168 Identities=23% Similarity=0.202 Sum_probs=125.5
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
|+|.++++. .+..+++.+++.++.|++.||+|||++ + ||+|||+++++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888863 345699999999999999999999998 4 999999999999999 99986543322
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMD 391 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 391 (452)
..||+.|+|||++.+..++.++|||||||++|||+||+.||........ ....... ...... +.. ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~-~~~~~~-------~~~-~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLN-GMPADD-------PRD-RSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHH-HhccCC-------ccc-cccH
Confidence 2588999999999999999999999999999999999999976543211 1111100 000000 000 0001
Q ss_pred HHHH--HHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 392 LKHL--YQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 392 ~~~~--~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.... .++.+++.+||+.||++||++.|+++.+..+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1112 25889999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=216.42 Aligned_cols=200 Identities=30% Similarity=0.414 Sum_probs=165.4
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCc
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 221 (452)
....+.|...++||+|.|++||++++. ....||+|.+...+. -....+|++.|..+ -+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567888999999999999999754 467899999965433 34578999999999 48999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLA 300 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~ 300 (452)
..+|+||++.....++... ++..++..++..+..||+++|++ ||+||||||+|+|.+. .+.-.|.|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 9999999999988887752 77889999999999999999999 9999999999999975 567899999998
Q ss_pred c-ccCCC------------CC-------------------------------cccccccccCccCcccccCC-CCCchhh
Q 012975 301 I-TDGSQ------------NK-------------------------------NNLKLSGTLGYVAPEYLLDG-KLTDKSD 335 (452)
Q Consensus 301 ~-~~~~~------------~~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sD 335 (452)
. ..... .. ......||+||.|||++... ..+++.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 5 10000 00 00123499999999998764 5688999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC
Q 012975 336 VYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 336 v~s~Gvll~elltG~~P~~~~~ 357 (452)
|||.||+++-+++++.||....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeeccceeehhhccccccccCc
Confidence 9999999999999999997553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=210.86 Aligned_cols=164 Identities=22% Similarity=0.179 Sum_probs=127.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
..++|...+.||+|+||+||+|++. +++.||||++... .......|.+|+++|++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4567999999999999999999875 5777899987532 22335669999999999999999853322 246
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEEecCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL-KSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dl-k~~NIll~~~~~~kl~Dfgl~ 300 (452)
.++||||+++++|... . .. . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||++
T Consensus 93 ~~LVmE~~~G~~L~~~-~--~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R--PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-C--cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 7999999999999632 1 11 1 146788999999999999 9999999 999999999999999999999
Q ss_pred cccCCCCCc--------ccccccccCccCcccccCC
Q 012975 301 ITDGSQNKN--------NLKLSGTLGYVAPEYLLDG 328 (452)
Q Consensus 301 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 328 (452)
......... -....++..|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 754332211 1245688889999988654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=203.44 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=192.3
Q ss_pred CCCccCeEeecCcEEEEEEEeCCC--cEEEEEEecCcChhhHHHHHHHHHHHHcCCC----CceeeeEEEE-EcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDN--LHVAVKKLDCATQDAGREFENEVDLLSNIHH----PNVVCLLGYS-AHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 224 (452)
+|...+.||+|+||.||++...+. ..+|+|.-..........+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999997653 4677777654333222267788888888863 5888888888 47778899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEEecCC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-----FNAKLSDFGL 299 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-----~~~kl~Dfgl 299 (452)
||+.+ +.+|.++..... ...++....++|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 778988764323 57899999999999999999999999 99999999999999865 4699999999
Q ss_pred Cc--ccC-CCC-----C-c-ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc
Q 012975 300 AI--TDG-SQN-----K-N-NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 300 ~~--~~~-~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~ 369 (452)
++ ... ..+ . . .....||.+|.++....+.+.+.+.|+||++.++.|+..|..|+...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 97 311 111 1 1 223559999999999999999999999999999999999999997655322111111110
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.. .... . ..... ..++.++...+-..+...+|....+...|+++....
T Consensus 254 ~~----~~~~----~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RK----LLTD----R--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hh----hccc----c--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 0000 0 01111 233444444555589999999999999887776664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-22 Score=193.26 Aligned_cols=256 Identities=30% Similarity=0.396 Sum_probs=195.3
Q ss_pred CCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh---hHHHHHHHHHHHHcCCCC-ceeeeEEEEEcCCceeeeeee
Q 012975 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD---AGREFENEVDLLSNIHHP-NVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 228 (452)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ |++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456778999999999999987 67899988644322 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~ 307 (452)
+.++++.+++........++......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999996664321113688999999999999999999999 899999999999999988 79999999986443322
Q ss_pred C------cccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----hhhhhhhhhhcccccc
Q 012975 308 K------NNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP----AQCQSIVTWAMPQLTD 374 (452)
Q Consensus 308 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~----~~~~~~~~~~~~~~~~ 374 (452)
. ......|+..|+|||.+.+ .......|+||+|++++++++|..|+..... ......+... ...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL---PTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc---CCc
Confidence 1 2345679999999999987 5788999999999999999999999776553 1111111110 000
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........... ......+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 2234567788999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=215.22 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=181.3
Q ss_pred ccCeEeecCcEEEEEEEeC-CCcEEEEEEec-----CcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 155 ESNILGEGGFGCVYKAKLD-DNLHVAVKKLD-----CATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..+++|.|.+|.|+..... .....+.|... ..... ....+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977777543 22223333221 11111 12226678888889999999887777766665556699
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||++ +|+.++.. ...++..++..++.|+..|++|||+. ++.|||+|++|++++.+|.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99988853 34688999999999999999999999 99999999999999999999999999985543222
Q ss_pred ----CcccccccccCccCcccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 308 ----KNNLKLSGTLGYVAPEYLLDGKLTD-KSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 308 ----~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
......+|+..|+|||.+.+.+|++ ..||||.|+++..|++|+.||......+...... ..........
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~~~~~~~~~~ 548 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------NYSDQRNIFE 548 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------cccccccccc
Confidence 2345678999999999999999987 5799999999999999999997655432211000 0000000000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+ .............++.++|+.||.+|-|+++|++
T Consensus 549 ~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Ch---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 0011133445667899999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=181.50 Aligned_cols=171 Identities=13% Similarity=0.152 Sum_probs=132.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHH---H------HHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGR---E------FENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
..++|...+++|+|+||.||.... ++..+|+|.+........+ . +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999755 5668999999644322222 2 68999999999999999998886533
Q ss_pred --------CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 220 --------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 220 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
+..+|+|||+++.+|.++.. ++. ....+++.+|..||+. +++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999976632 222 2455899999999999 999999999999999998
Q ss_pred EEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 012975 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL 347 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ell 347 (452)
++|+|||........... ..++....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987544221111 11344556778999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=176.80 Aligned_cols=139 Identities=15% Similarity=0.185 Sum_probs=107.5
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh--h------------------------HHHHHHHHHHHHcCCCCce
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--A------------------------GREFENEVDLLSNIHHPNV 209 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 209 (452)
...||+|+||.||+|...+|..||||.+...... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999888999999998643211 0 1122459999999987776
Q ss_pred eeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEECC
Q 012975 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 210 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~i~H~Dlk~~NIll~~ 288 (452)
.....+.. ...+|||||++++++..... ....++......++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 43333222 23389999999887754432 134688999999999999999999 677 999999999999998
Q ss_pred CCcEEEEecCCCccc
Q 012975 289 KFNAKLSDFGLAITD 303 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~ 303 (452)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-23 Score=212.76 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=178.0
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC-hhhHHHHHHHHHH--HHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT-QDAGREFENEVDL--LSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++...+.||++.|=+|.++++++|. |+||.+-... .-..+.|.++++- ...++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666888999999999999999996 8888874433 2233444433333 4556899999988776777778999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc--ccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI--TDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~--~~~~~ 306 (452)
..+ +|++.+. .+.-+...+..-|+.|++.||..+|.. +|+|||||.+||||+...-+.|+||..-+ +...+
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 7887773 345578888889999999999999999 99999999999999999999999998653 22222
Q ss_pred CCcc-cc----cccccCccCcccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhc
Q 012975 307 NKNN-LK----LSGTLGYVAPEYLLDG----------K-LTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 307 ~~~~-~~----~~gt~~y~aPE~~~~~----------~-~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~ 369 (452)
+... .. ...-..|+|||.+... . .+++.||||+||+++||++ |++||.-.+ +..+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhc
Confidence 2111 11 1233469999987541 2 5778999999999999997 888886422 222211
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
.. .......+....+ ..+..++..|++.||++|-++++.++.-
T Consensus 250 ~~-------~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 250 GN-------ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred cC-------ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 10 1111111222111 1466789999999999999999999873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=194.69 Aligned_cols=217 Identities=26% Similarity=0.397 Sum_probs=165.1
Q ss_pred HHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCCC
Q 012975 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV-IHRDL 279 (452)
Q Consensus 201 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-~H~Dl 279 (452)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...+..+++.||+|||.. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4568999999999999999999999999999999999974 356799999999999999999999986 44 99999
Q ss_pred CCCCEEECCCCcEEEEecCCCcccCC--CCCcccccccccCccCcccccCC-------CCCchhhHHHHHHHHHHHHcCC
Q 012975 280 KSSNILLDSKFNAKLSDFGLAITDGS--QNKNNLKLSGTLGYVAPEYLLDG-------KLTDKSDVYAFGVVLLELLLGR 350 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~s~Gvll~elltG~ 350 (452)
+++|+++|....+||+|||+...... .........-..-|.|||.+.+. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999855432 11111112234569999988763 1467899999999999999999
Q ss_pred CCCCCCChhhh-hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 351 RPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 351 ~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.||........ ..++..... .....+-|.+.... +....+..++..||..+|.+||++++|-..++.+.+.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99987543221 222222111 01111222222111 2333688899999999999999999999999888776
Q ss_pred c
Q 012975 430 E 430 (452)
Q Consensus 430 ~ 430 (452)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 4
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=169.97 Aligned_cols=140 Identities=18% Similarity=0.146 Sum_probs=110.2
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh--------------------------hHHHHHHHHHHHHcCCCCce
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--------------------------AGREFENEVDLLSNIHHPNV 209 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 209 (452)
...||+|++|.||+|++.+|+.||||.+...... ....+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998643211 01224678999999999987
Q ss_pred eeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECC
Q 012975 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 210 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~ 288 (452)
.....+... ..+|||||++++++..... ....++..+..+++.+++.++.+||+ . +++||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544443332 2489999999886543321 12357788899999999999999999 8 999999999999998
Q ss_pred CCcEEEEecCCCcccC
Q 012975 289 KFNAKLSDFGLAITDG 304 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~~ 304 (452)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=165.01 Aligned_cols=186 Identities=18% Similarity=0.117 Sum_probs=139.3
Q ss_pred CccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh----hHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeee
Q 012975 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD----AGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.+...|++|+||+||.+.. ++.+++.+.+.....- ....|.+|+++|++++ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 6778888887654331 1235889999999995 5889999886 446999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL-KSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dl-k~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
+++.+|...+.. ....++.|++.+|+++|++ +|+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998644310 1135678999999999999 9999999 7999999999999999999997543322
Q ss_pred Cc-------------ccccccccCccCcccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 308 KN-------------NLKLSGTLGYVAPEYLLDG-KLT-DKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 308 ~~-------------~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
.. ......++.|++|+...-- ..+ ...+.++-|.-+|.++||+.+.....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0012256778888754321 223 56799999999999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=173.69 Aligned_cols=230 Identities=20% Similarity=0.263 Sum_probs=147.9
Q ss_pred ccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCC-----------CceeeeEEE----
Q 012975 155 ESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHH-----------PNVVCLLGY---- 215 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-----------~niv~l~g~---- 215 (452)
..+.||.|+++.||.+++.+ |+++|||.+.... ....+++.+|.-....+.+ .-++++--.
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 46789999999999999874 8999999874332 3345667777655554432 112222111
Q ss_pred ----EEcCC--------ceeeeeeecCCCChhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 012975 216 ----SAHDD--------TRFIVYELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL 279 (452)
Q Consensus 216 ----~~~~~--------~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dl 279 (452)
..... +.+++|+-+ .++|.+.+.. ......+....++.+..|+++.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11111 236677777 5677665431 11123456677888889999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccC--------CCCCchhhHHHHHHHHHHHHcCCC
Q 012975 280 KSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD--------GKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999987655433221 234578999997643 247889999999999999999999
Q ss_pred CCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC
Q 012975 352 PVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR 413 (452)
Q Consensus 352 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 413 (452)
||....+...... ... ... +..+.+..+|..+|+.||.+|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9987654321110 111 122 456677889999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=171.45 Aligned_cols=200 Identities=23% Similarity=0.346 Sum_probs=166.1
Q ss_pred CCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeec
Q 012975 152 SFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.|.+.++||+|.||.++.|+. -++..||||--...+ ..-++..|....+.| ..++|..++-|-.++-.-.||+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 678899999999999999974 478899999754333 345677888888877 4688988888878887889999988
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEEecCCCcccC
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-----FNAKLSDFGLAITDG 304 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-----~~~kl~Dfgl~~~~~ 304 (452)
+-||+++.. --+..++...+.-+|.|++.-++|+|++ .+|.|||||+|.||..- ..+.++|||+|+...
T Consensus 107 -GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 678877764 2356799999999999999999999999 99999999999999643 458999999997643
Q ss_pred CCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 012975 305 SQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA 359 (452)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~ 359 (452)
+... ......||.+||+--...+++.+.+.|.=|+|-++.+++-|..||++....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 3221 223456999999999999999999999999999999999999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-21 Score=167.96 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=165.0
Q ss_pred hcCCCccCeEeecCcEEEEEEE-eCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC-CceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|...+.||.|.||.+|.|. ..+|.+||+|.-.... ...++.-|..+.+.+++ ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578889999999999999997 4579999999864332 23456778888888875 567777778888888899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~Dfgl~~~~~ 304 (452)
.. +-||++...- -...++...++-++-|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+++...
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 7788877652 234688999999999999999999999 99999999999998643 468999999996543
Q ss_pred CCC-------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 305 SQN-------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 305 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
+.. .......||.+|.+--...+.+.+.+.|+-|+|.+|.++--|..||++.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 221 22334669999999888888888899999999999999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=161.69 Aligned_cols=135 Identities=15% Similarity=0.173 Sum_probs=105.5
Q ss_pred CccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-----CCCceeeeEEEEEcCC---c-eee
Q 012975 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-----HHPNVVCLLGYSAHDD---T-RFI 224 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 224 (452)
...+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ +||||++++|+++++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 433333479988765444567899999999999 5799999999998874 3 337
Q ss_pred eeee--cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEEec
Q 012975 225 VYEL--MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL-EYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDF 297 (452)
Q Consensus 225 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~i~H~Dlk~~NIll~~----~~~~kl~Df 297 (452)
|+|| +.+|+|.+++.. ..++.. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 568999999953 235554 35577888777 999999 9999999999999974 347999995
Q ss_pred CC
Q 012975 298 GL 299 (452)
Q Consensus 298 gl 299 (452)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-20 Score=185.91 Aligned_cols=186 Identities=27% Similarity=0.350 Sum_probs=153.6
Q ss_pred eEeecCcEEEEEEE----eCCCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecC
Q 012975 158 ILGEGGFGCVYKAK----LDDNLHVAVKKLDCATQ--DAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+|.||.|+.++ .+.|.-+|.|.+...+. ........|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999874 23466778877654321 11124566788888886 9999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
+|.|...+.. ....+......+...++-+++++|+. +++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999888743 34567777777788889999999999 9999999999999999999999999999765433322
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
+||.-|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999987 567899999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=190.48 Aligned_cols=197 Identities=21% Similarity=0.253 Sum_probs=155.8
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCce
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 222 (452)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|.=.....- +|--=.+++.+|+ -+-|+++..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 44456778889999999999999999988999999986543321 1111122333333 23455555555666778
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------CCcEEEE
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-------KFNAKLS 295 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-------~~~~kl~ 295 (452)
+||+||.+.|+|.+++. ..+.++|...+.++.|+++.+++||.. +|||+||||+|.||.. ...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999986 456799999999999999999999999 9999999999999953 3458999
Q ss_pred ecCCCcccC--CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 012975 296 DFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 296 Dfgl~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
|||.+.... .........++|-.+-.+|+..++.++...|.|.++.+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999985432 22233345678889999999999999999999999999999999885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=160.38 Aligned_cols=141 Identities=17% Similarity=0.131 Sum_probs=110.4
Q ss_pred CCCccCeEeecCcEEEEEEE--eCCCcEEEEEEecCcChh------------------------hHHHHHHHHHHHHcCC
Q 012975 152 SFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQD------------------------AGREFENEVDLLSNIH 205 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 205 (452)
.|...+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999988643210 1134678999999997
Q ss_pred CCc--eeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCC
Q 012975 206 HPN--VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA-VIHRDLKSS 282 (452)
Q Consensus 206 H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-i~H~Dlk~~ 282 (452)
+.+ +.+++++ ...++||||+++++|...... ...+...+...++.|++.++++||+. + ++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 533 3344443 235899999999888665421 23456667789999999999999999 8 999999999
Q ss_pred CEEECCCCcEEEEecCCCccc
Q 012975 283 NILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 283 NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999988543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=156.17 Aligned_cols=134 Identities=21% Similarity=0.257 Sum_probs=112.4
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcCh--------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
+.||+|++|.||+|.. .|..+++|....... .....+.+|++++..++|+|+.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 566889997643221 1224578999999999999988777777777888999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
+++++|.+.+... .+ .+..++.+++.+|.+||+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887531 12 7889999999999999999 999999999999999 78999999998744
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-18 Score=153.67 Aligned_cols=144 Identities=19% Similarity=0.134 Sum_probs=111.2
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh----------------------hhHHHHHHHHHHHHc
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ----------------------DAGREFENEVDLLSN 203 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~ 203 (452)
+-.....|...+.||+|+||.||++...+|+.||||.+..... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999998653221 011236788999999
Q ss_pred CCCCc--eeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 012975 204 IHHPN--VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281 (452)
Q Consensus 204 l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~ 281 (452)
+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+. +++||||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 98774 4444432 455899999999998755320 23567889999999999998 999999999
Q ss_pred CCEEECCCCcEEEEecCCCcccCC
Q 012975 282 SNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 282 ~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999855433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-18 Score=160.70 Aligned_cols=192 Identities=24% Similarity=0.308 Sum_probs=132.8
Q ss_pred CCCceeeeEEEEEcC---------------------------CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHH
Q 012975 205 HHPNVVCLLGYSAHD---------------------------DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257 (452)
Q Consensus 205 ~H~niv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 257 (452)
+|||||++.+++.++ .++|+||.-.+ -+|..++.. ...+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 599999999877542 24577877653 477777753 3466667777889
Q ss_pred HHHHHHHHHHhcCCCCeeeCCCCCCCEEE--CCCC--cEEEEecCCCcccCCC------CCcccccccccCccCcccccC
Q 012975 258 DTARGLEYLHEHCNPAVIHRDLKSSNILL--DSKF--NAKLSDFGLAITDGSQ------NKNNLKLSGTLGYVAPEYLLD 327 (452)
Q Consensus 258 ~ia~~L~~LH~~~~~~i~H~Dlk~~NIll--~~~~--~~kl~Dfgl~~~~~~~------~~~~~~~~gt~~y~aPE~~~~ 327 (452)
|+++|+.|||++ ++.|||+|++|||+ |+|+ .+.|+|||++...... .......-|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999998 4444 4788999998543221 122234457788999998765
Q ss_pred CC------CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHH
Q 012975 328 GK------LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAV 401 (452)
Q Consensus 328 ~~------~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 401 (452)
.+ .-.|+|.|+.|.+.||+++...||......- .+.-.+...+ -..+++- ....+.++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~q---LPalp~~------------vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQ---LPALPSR------------VPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhh---CCCCccc------------CChHHHHH
Confidence 32 2358999999999999999999998733211 0111111111 1122222 22345678
Q ss_pred HHHhcCCCCCCCCChHHHH
Q 012975 402 AVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 402 i~~Cl~~dP~~RPs~~evl 420 (452)
+...|+.||++|++.+-..
T Consensus 490 V~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred HHHHhcCCccccCCccHHH
Confidence 8889999999999875443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.1e-18 Score=176.49 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=112.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEE-ecCc-C------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKK-LDCA-T------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
...|...+.||+|+||+||+|.+.+.. +++|+ +... . ......+.+|+++++.++|+|++....++...+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999886554 34443 2211 1 1123568899999999999999988888887778
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988774 3577899999999999999 99999999999999 67899999999985
Q ss_pred c
Q 012975 302 T 302 (452)
Q Consensus 302 ~ 302 (452)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=151.61 Aligned_cols=130 Identities=24% Similarity=0.333 Sum_probs=105.3
Q ss_pred eEeecCcEEEEEEEeCCCcEEEEEEecCcCh--------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.||+|+||.||+|.+ ++..+++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 467899998643211 12356788999999999887665555566667789999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++++|.+.+.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988774311 0 7899999999999999 999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.7e-19 Score=171.62 Aligned_cols=173 Identities=28% Similarity=0.470 Sum_probs=130.5
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..|+.|++|...+|.++|.........+|...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877778889999999999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccc
Q 012975 301 ITDGSQN------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 301 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
....... ...+.-.||..||+||.+.++.|+.|+||||||++|+||+. -..+++... .... .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----t~~d------~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----TLTD------I 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----hhhh------h
Confidence 6543322 12334569999999999999999999999999999999986 333332111 0000 1
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDV 419 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 419 (452)
+.+.++ |....... .=..++.+++.+.|.+||++.++
T Consensus 473 r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 111121 11111111 11357778999999999955444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-17 Score=173.46 Aligned_cols=209 Identities=26% Similarity=0.393 Sum_probs=141.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
-++|+.++.|..|++|.||..+++. .+..|. +++..+- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee------------------
Confidence 3578889999999999999998874 455666 4321110 1110 22222333332
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC--
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ-- 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~-- 306 (452)
|+=...+. +-+.+.... +.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+.+.....
T Consensus 136 ---gDc~tllk---~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222232 222333222 7789999998 9999999999999999999999999998532110
Q ss_pred -------------CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 307 -------------NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 307 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
.-....++||+.|.|||++..+-|....|+|++|+++||.+-|+.||.+..+.+....+- .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h
Confidence 011124579999999999999999999999999999999999999999988765322221 1
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
+...+++- +.....+..+++.+.|+.+|..|--.
T Consensus 273 d~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 273 DDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhcccccc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 22222222 11223456678888999999988433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=136.91 Aligned_cols=134 Identities=25% Similarity=0.226 Sum_probs=114.1
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.+.||+|.++.||+++..+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 5679999999999999866 6899998864433 5678999999999976 588899998888888999999999887
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
+..+ +......++.+++++|++||.....+++|+|++|+||++++++.+++.|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7532 5667788899999999999986555799999999999999999999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=140.10 Aligned_cols=136 Identities=20% Similarity=0.173 Sum_probs=97.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh--hHHH----------------------HHHHHHHHHcCCCCc--e
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD--AGRE----------------------FENEVDLLSNIHHPN--V 209 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 209 (452)
.+.||+|+||+||+|...+++.||||.+...... .... ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 1111 135566666654332 3
Q ss_pred eeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECC
Q 012975 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 210 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~ 288 (452)
.+.+++ ...++||||++++.+........ ... .+...++.+++.++.++|+ . +++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 344433 34689999999965432111100 011 5678899999999999999 7 999999999999999
Q ss_pred CCcEEEEecCCCccc
Q 012975 289 KFNAKLSDFGLAITD 303 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~ 303 (452)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4e-15 Score=138.86 Aligned_cols=135 Identities=19% Similarity=0.197 Sum_probs=104.9
Q ss_pred cCeEe-ecCcEEEEEEEeCCCcEEEEEEecCcC-------------hhhHHHHHHHHHHHHcCCCCce--eeeEEEEEcC
Q 012975 156 SNILG-EGGFGCVYKAKLDDNLHVAVKKLDCAT-------------QDAGREFENEVDLLSNIHHPNV--VCLLGYSAHD 219 (452)
Q Consensus 156 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 219 (452)
...|| .||.|+||++... +..++||.+.... ......+.+|++++.+++|+++ ...+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999886 5578998774211 1233567889999999998875 6677765443
Q ss_pred Cc----eeeeeeecCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 220 DT----RFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 220 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
.. .++||||+++ .+|.+++.. ..++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688887753 234443 356889999999999 9999999999999999999999
Q ss_pred EecCCCcc
Q 012975 295 SDFGLAIT 302 (452)
Q Consensus 295 ~Dfgl~~~ 302 (452)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-16 Score=165.93 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=184.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC--CcEEEEEEecCcC--hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD--NLHVAVKKLDCAT--QDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 225 (452)
..|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345667779999999998887643 4456666665443 333344556777777776 99999999999999999999
Q ss_pred eeecCCCChhhhc-cCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcc
Q 012975 226 YELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~ 302 (452)
.+|..++++.+-+ +. .....+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999998887 42 2224566667788999999999999 76 999999999999999999 999999999965
Q ss_pred cCC-C--CCccccccc-ccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 303 DGS-Q--NKNNLKLSG-TLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 303 ~~~-~--~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
... . .......+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++...... .....|.... ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~----~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK----GR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc----cc
Confidence 443 2 122234568 9999999998884 45678899999999999999999998765433 1112221110 00
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
. ...... .......++...++..+|..|.+.+++.
T Consensus 250 ~----~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 F----TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c----ccCccc----cCChhhhhcccccccCCchhcccccccc
Confidence 0 000011 1122445566778889999999999876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-14 Score=134.70 Aligned_cols=203 Identities=23% Similarity=0.310 Sum_probs=139.1
Q ss_pred HHHHHHcCCCCceeeeEEEEEcCC-----ceeeeeeecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012975 197 EVDLLSNIHHPNVVCLLGYSAHDD-----TRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHC 270 (452)
Q Consensus 197 E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 270 (452)
-.+-|-++-|.|||++..|+.+.. ...++.|||..|++..+|.... ....+......+++.||..||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 344556667999999999986543 4578999999999999997643 34467777788999999999999999 6
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC----CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHH
Q 012975 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN----KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLEL 346 (452)
Q Consensus 271 ~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~el 346 (452)
.|+++|+++.-+.|++..+|-+|+.---........+ .....-.+-++|.+||+=.....+.++|||+||...+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999999988885322111100000 001112366899999987777778899999999999999
Q ss_pred HcCCCC-CCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 347 LLGRRP-VEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 347 ltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.-|+.- -...+..+...-...+ .+ ..-++.-+ ..+..|++..|..||+|++++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~--i~-------~len~lqr------------~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANV--II-------GLENGLQR------------GSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhhh--ee-------eccCcccc------------CcCcccccCCCCCCcchhhhhc
Confidence 877653 2221111111000000 00 00111111 2455699999999999999873
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=7e-14 Score=141.59 Aligned_cols=140 Identities=21% Similarity=0.187 Sum_probs=98.9
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhh----------------------------------------HHHHH
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA----------------------------------------GREFE 195 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 195 (452)
.+.||.|++|.||+|++.+|+.||||......... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999975431110 01255
Q ss_pred HHHHHHHcCC----CCceeeeEEEE-EcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 012975 196 NEVDLLSNIH----HPNVVCLLGYS-AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR-GLEYLHEH 269 (452)
Q Consensus 196 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~ 269 (452)
+|+..+.+++ |.+-+.+-.++ ...+..+|||||+++++|.+....... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666555552 33223332222 234567999999999999877542111 12 23456666665 46788888
Q ss_pred CCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 270 ~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+++|+|++|.||++++++.+++.|||++...
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.6e-14 Score=143.16 Aligned_cols=245 Identities=27% Similarity=0.274 Sum_probs=176.7
Q ss_pred CCCccCeEee--cCcEEEEEEEe--C-CCcEEEEEEec--CcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 152 SFHESNILGE--GGFGCVYKAKL--D-DNLHVAVKKLD--CATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 152 ~f~~~~~ig~--G~~g~Vy~~~~--~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
.|.....+|. |.+|.+|.++. . ++..+|+|+-. .........=.+|+....++ .|+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999987 3 67889999843 22223333345677777777 4999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFG 298 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfg 298 (452)
+-+|++. .+|..+-+.. ...+.....+.+..+... ||.++|+. +++|-|+||.||++.++ ..+++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 9999985 7787777642 334666677777777777 99999999 99999999999999999 889999999
Q ss_pred CCcccCCCCCcccc-----cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 299 LAITDGSQNKNNLK-----LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 299 l~~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
+....+..+-.... ..|...|++||.. ...++..+|+|++|.++.|-.+|-......- ...|. ++.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~--~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWS--QLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CCCcc--ccc
Confidence 98766555432222 2577889999955 4567899999999999999998776554321 11111 111
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
....+ .++...-..++..++..+++.+|..|++.+.++
T Consensus 340 ------~~~ip---~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 340 ------QGYIP---LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ------cccCc---hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11110 111111122334478889999999999998877
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-12 Score=114.22 Aligned_cols=130 Identities=22% Similarity=0.151 Sum_probs=95.6
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceee-eEEEEEcCCceeeeeeecCCCCh
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
.+.++.|.++.||+++.. +..+++|....... ....+.+|+..++.+.+.++++ ++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999876 66899998754322 2335678999999886655554 44433 3345899999999887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC--NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.... . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5320 0 11345678999999999872 12369999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.3e-12 Score=128.59 Aligned_cols=166 Identities=19% Similarity=0.260 Sum_probs=125.2
Q ss_pred eCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHH
Q 012975 172 LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251 (452)
Q Consensus 172 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 251 (452)
..++.+|.|...+..+........+-++.|+.++||||++++...+.++..|||+|-+. .|..++.. ++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44678888888876666445567778889999999999999999999999999999874 45545532 33455
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCC
Q 012975 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331 (452)
Q Consensus 252 ~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 331 (452)
....+.||+.||.|||..| +++|++|.-+.|+++..|..||++|.++......+.......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 6667889999999999776 899999999999999999999999998754332221111111223466666443322
Q ss_pred chhhHHHHHHHHHHHHcC
Q 012975 332 DKSDVYAFGVVLLELLLG 349 (452)
Q Consensus 332 ~~sDv~s~Gvll~elltG 349 (452)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=133.63 Aligned_cols=143 Identities=17% Similarity=0.143 Sum_probs=91.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcCh----------------------------------hhHH--
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQ----------------------------------DAGR-- 192 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------------------------------~~~~-- 192 (452)
...|+. +.||+|++|.||+|++.+ |+.||||.....-. +..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345765 789999999999999987 99999999863310 0111
Q ss_pred ----HHHHHHHHHHcCC----CCceeeeEEEEEc-CCceeeeeeecCCCChhhhccCCCCCC---CCCHHHHHHHHHHHH
Q 012975 193 ----EFENEVDLLSNIH----HPNVVCLLGYSAH-DDTRFIVYELMENRSLDIQLHGPSHGS---ALTWHMRMKIALDTA 260 (452)
Q Consensus 193 ----~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~---~l~~~~~~~i~~~ia 260 (452)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-...+. .+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 2444554444442 3333333333322 456789999999999976421101111 1222222222333
Q ss_pred HHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEecCCCccc
Q 012975 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFGLAITD 303 (452)
Q Consensus 261 ~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Dfgl~~~~ 303 (452)
+... +++|+|+||.||+++.++ .+++.|||++...
T Consensus 276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3345 999999999999999988 9999999998554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=7e-11 Score=108.79 Aligned_cols=141 Identities=21% Similarity=0.245 Sum_probs=110.2
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCC---ceeeeeeecC
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHH--PNVVCLLGYSAHDD---TRFIVYELME 230 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 230 (452)
+.|+.|.++.+|++...+|..+++|....... .....+..|+++++.+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998754322 134578999999999975 34566777776543 5689999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC---------------------------------------- 270 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 270 (452)
++++...+.. ..++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765531 34777888888999999999998521
Q ss_pred -------------CCCeeeCCCCCCCEEECC--CCcEEEEecCCCc
Q 012975 271 -------------NPAVIHRDLKSSNILLDS--KFNAKLSDFGLAI 301 (452)
Q Consensus 271 -------------~~~i~H~Dlk~~NIll~~--~~~~kl~Dfgl~~ 301 (452)
...++|+|+++.||+++. ++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 6678999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-10 Score=103.63 Aligned_cols=136 Identities=14% Similarity=0.166 Sum_probs=97.8
Q ss_pred CeEeecCcEEEEEEEeCC-------CcEEEEEEecCcC----------------------hhhHHHH----HHHHHHHHc
Q 012975 157 NILGEGGFGCVYKAKLDD-------NLHVAVKKLDCAT----------------------QDAGREF----ENEVDLLSN 203 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~ 203 (452)
..||.|--+.||.|...+ +..+|||...... ....+.+ ++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999997653 4789999763111 0112233 389999999
Q ss_pred CCC--CceeeeEEEEEcCCceeeeeeecCCCChhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCC
Q 012975 204 IHH--PNVVCLLGYSAHDDTRFIVYELMENRSLDI-QLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDL 279 (452)
Q Consensus 204 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~i~H~Dl 279 (452)
+.. -++...+++ ..-+|||||+.++.+.. .+. ...++..+...+..+++.+|..| |.. +++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 455556654 45689999998754422 121 12344556677889999999999 777 9999999
Q ss_pred CCCCEEECCCCcEEEEecCCCcccC
Q 012975 280 KSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++.||+++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-11 Score=124.76 Aligned_cols=245 Identities=20% Similarity=0.194 Sum_probs=170.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--CCcEEEEEEecCcChhhH--HHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCATQDAG--REFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
.+.+|..+..||.|.|+.|++...+ ++..+++|.+........ ..-..|+.+...+ .|.+++.....+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999998644 678899998754332222 2234566666666 4888888877777778888
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCcc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAIT 302 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~~ 302 (452)
+--||++++++..... ....++...++++..|++.++.++|+. .++|+|+||+||++.++ +..+++|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 9999999999876652 234477788899999999999999988 99999999999999886 8899999998854
Q ss_pred cCCCCCcccccccccCcc--CcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 303 DGSQNKNNLKLSGTLGYV--APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
..... .......+++ +++......+..+.|+||||.-+.|.++|..--.... .|... ..+..
T Consensus 417 ~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i---~~~~~-- 480 (524)
T KOG0601|consen 417 LAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTI---RSGDT-- 480 (524)
T ss_pred cceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceee---ecccc--
Confidence 21111 1122333444 4555555678889999999999999998875322211 11100 00101
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 423 (452)
+.+.. ...++..+...+..+++..||.+.++....
T Consensus 481 ---p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 481 ---PNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ---cCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 11111 113444566678899999999998877544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.2e-09 Score=102.93 Aligned_cols=170 Identities=19% Similarity=0.210 Sum_probs=125.7
Q ss_pred CcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEE----cCCceeeeeeecCC-CChhh
Q 012975 163 GFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA----HDDTRFIVYELMEN-RSLDI 236 (452)
Q Consensus 163 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~ 236 (452)
...+.||+... ||..|++|++.............-++.++++.|.|+|++.+++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 45688999754 78899999994332222223345688899999999999988775 34477999999986 45644
Q ss_pred hccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 237 QLHG------------PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 237 ~l~~------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
.-.. ...+...++...|.++.|++.||.++|+. |+.-+-|.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 3322 12334577889999999999999999999 99999999999999999899998888764332
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P 352 (452)
.+.. |-+.. -.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 2210 11111 2367888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-09 Score=92.49 Aligned_cols=130 Identities=23% Similarity=0.304 Sum_probs=95.6
Q ss_pred eEeecCcEEEEEEEeCCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.+++|+-+.+|.+.+-+. ++++|.-..+. +-....-.+|+.++.+++--.|---.-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999976543 46666432221 112244678999999886444443344556777888999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++-.|.+.+... +..++..+-+-+.-||.. +|+|+||.++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888532 245666677778889999 999999999999998765 99999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.2e-11 Score=123.98 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=163.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecC---cChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDC---ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
..+.|...+-+-+|.++.++.++-.. |...+.|.... ......+....+-.++-..+||-++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45667777788899999998775432 32223332211 112222333344444433455666654444444567899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
+++|..+++|...||.. ...+..........+...++|||.. .+.|+|++|.|.+...++..+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999988753 2455555666677788899999998 79999999999999999999999998431100
Q ss_pred -------C----------------------CC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 012975 305 -------S----------------------QN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPV 353 (452)
Q Consensus 305 -------~----------------------~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~ 353 (452)
. .. .......||+.|.+||...+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 00 1122345899999999999999999999999999999999999999
Q ss_pred CCCChhhhh-hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChH
Q 012975 354 EKLAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLIT 417 (452)
Q Consensus 354 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 417 (452)
....++... ++..... .++. ...+..++..+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~-------~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDI-------PWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCC-------CCCC---------CccccChhhhhhhhhhhccCchhccCcc
Confidence 988765431 1111111 1100 0111223344566667788888886665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5e-09 Score=90.69 Aligned_cols=143 Identities=19% Similarity=0.179 Sum_probs=99.7
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
...+|-+|+-+.|+++.+. |+...||.-.... +-..++..+|+..|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999986 4455666432211 223456788999999886444433333455666678999
Q ss_pred eecCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecCCCcc
Q 012975 227 ELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAIT 302 (452)
Q Consensus 227 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfgl~~~ 302 (452)
||+++ .++.+++...-... ........++..+-+.+.-||.. +++|+||..+||++..++. +.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 36666665322211 22222356788888889999999 9999999999999976553 58999999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-08 Score=94.20 Aligned_cols=141 Identities=14% Similarity=0.094 Sum_probs=101.4
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhh-H----------HHHHHHHHHHHcCCCC--ceeeeEEEEEcC---
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA-G----------REFENEVDLLSNIHHP--NVVCLLGYSAHD--- 219 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~--niv~l~g~~~~~--- 219 (452)
.+.+-+.....|+++.+ +|+.+.||+........ . ..+.+|...+.++... .....+++.+..
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35566666666778766 46689999875433211 1 1477899988888433 334455555432
Q ss_pred --CceeeeeeecCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------C
Q 012975 220 --DTRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-------K 289 (452)
Q Consensus 220 --~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-------~ 289 (452)
...+||+|++++. +|.+++.... ....+...+..++.+++..+.-||.. +++|+|++++|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 2468999999986 7888774211 23455667788999999999999999 9999999999999975 4
Q ss_pred CcEEEEecCCCc
Q 012975 290 FNAKLSDFGLAI 301 (452)
Q Consensus 290 ~~~kl~Dfgl~~ 301 (452)
+.+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.8e-09 Score=91.96 Aligned_cols=126 Identities=23% Similarity=0.226 Sum_probs=82.4
Q ss_pred EEEEEEeCCCcEEEEEEecCcC--------------------------hhhHHHHHHHHHHHHcCCCC--ceeeeEEEEE
Q 012975 166 CVYKAKLDDNLHVAVKKLDCAT--------------------------QDAGREFENEVDLLSNIHHP--NVVCLLGYSA 217 (452)
Q Consensus 166 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 217 (452)
.||.|...+|..+|||...... ........+|++.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999999999999863210 00124467899999999765 455565542
Q ss_pred cCCceeeeeeecC--CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 218 HDDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL-HEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 218 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
.-.|||||++ +..+..+... .++......++.+++..+..+ |.. +++|+||.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999998 5555433321 112334556777777766654 666 99999999999999988 9999
Q ss_pred EecCCCcccC
Q 012975 295 SDFGLAITDG 304 (452)
Q Consensus 295 ~Dfgl~~~~~ 304 (452)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.7e-08 Score=92.77 Aligned_cols=193 Identities=17% Similarity=0.261 Sum_probs=124.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEE------EEcCC-ceeeeee
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY------SAHDD-TRFIVYE 227 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~------~~~~~-~~~lV~E 227 (452)
.+.||+|+-+.+|-.---.+ .+.|...........+ .+..|.+. .||-+-.-+.+ --+.+ ..-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 57799999999996532222 2345554333322222 23333333 45533221111 01112 2456666
Q ss_pred ecCCCCh-hhhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 228 LMENRSL-DIQLH---GPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 228 ~~~~gsL-~~~l~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
.+++--- ..++. ..+.-...+|.-.++.+..+|.+.+-||.. |.+-+|++++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 6655321 11111 112234579999999999999999999999 9999999999999999999999986533221
Q ss_pred CCCCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLL-GRRPVEKLA 357 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~ 357 (452)
.........+|...|++||.-. +-..+...|-|.+|+++++++. |++||.+..
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 2222233456888999999654 3355778999999999999998 599998653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.5e-08 Score=89.14 Aligned_cols=136 Identities=20% Similarity=0.128 Sum_probs=96.7
Q ss_pred CCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC----------------------hhhHHHHHHHHHHHHcCCCC--c
Q 012975 153 FHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT----------------------QDAGREFENEVDLLSNIHHP--N 208 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 208 (452)
....+.||.|--+.||.|...+|.++|||--..-. .......++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34578999999999999999999999999642110 01233467899999999654 5
Q ss_pred eeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 012975 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 209 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~ 288 (452)
+.+.+++ +.-.+||||+++-.|...- ++....-.++..|.+-+.-+-.. |++|+|++.-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 5555554 3447999999986664321 12233334444444444444455 9999999999999999
Q ss_pred CCcEEEEecCCCccc
Q 012975 289 KFNAKLSDFGLAITD 303 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~ 303 (452)
||.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.7e-09 Score=106.17 Aligned_cols=149 Identities=21% Similarity=0.310 Sum_probs=99.4
Q ss_pred HHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc---------cccccccCccCcccccC
Q 012975 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN---------LKLSGTLGYVAPEYLLD 327 (452)
Q Consensus 257 ~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~---------~~~~gt~~y~aPE~~~~ 327 (452)
.+++.||.|+|.. ++++|++|.|++|.++.++..||+.|+++.......... .-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999976 589999999999999999999999999985433211100 01124457999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhc
Q 012975 328 GKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCV 406 (452)
Q Consensus 328 ~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl 406 (452)
...+.++|+||+|+++|-+.. |+.-+.............. .++ .-...+..+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-----~~~---------~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-----LLN---------AGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-----ccc---------cccccccccCcHHHHHHHHHHh
Confidence 888999999999999999995 4443433222111111110 000 0000011233345666677799
Q ss_pred CCCCCCCCChHHHHH
Q 012975 407 QPEPSYRPLITDVLH 421 (452)
Q Consensus 407 ~~dP~~RPs~~evl~ 421 (452)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877763
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.3e-07 Score=79.61 Aligned_cols=137 Identities=14% Similarity=0.093 Sum_probs=101.6
Q ss_pred EeecCcEEEEEEEeCCCcEEEEEEecCcC------hhhHHHHHHHHHHHHcCCC--CceeeeEEEEE-cCC----ceeee
Q 012975 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHH--PNVVCLLGYSA-HDD----TRFIV 225 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~-~~~----~~~lV 225 (452)
-|+||-+.|++....+. .+-+|+-.... +.....|.+|+..|.++.. -.+.+.. ++. ... .-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45689999999877655 68899865221 3356789999999999853 2344444 332 211 34799
Q ss_pred eeecCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEEecCCCc
Q 012975 226 YELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAI 301 (452)
Q Consensus 226 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~--~kl~Dfgl~~ 301 (452)
+|-+++ -+|.+++... .-.+.+...+..+..+++..+.-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5787777432 123567788889999999999999999 9999999999999986667 9999998663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.6e-07 Score=82.68 Aligned_cols=105 Identities=21% Similarity=0.207 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHcCCC--CceeeeEEEEEcCC----ceeeeeeecCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 012975 192 REFENEVDLLSNIHH--PNVVCLLGYSAHDD----TRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264 (452)
Q Consensus 192 ~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~ 264 (452)
....+|...+..+.. -...+.+++.+... ..++|+|++++. +|.+++... ...+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 457788888777743 33455666665532 348999999884 788887531 12666778889999999999
Q ss_pred HHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEecCCCcc
Q 012975 265 YLHEHCNPAVIHRDLKSSNILLDSKF---NAKLSDFGLAIT 302 (452)
Q Consensus 265 ~LH~~~~~~i~H~Dlk~~NIll~~~~---~~kl~Dfgl~~~ 302 (452)
-||.. +++|+|+++.|||++.+. .+.++||+-+..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.2e-07 Score=92.47 Aligned_cols=144 Identities=20% Similarity=0.220 Sum_probs=93.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh----------------------------------------h
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD----------------------------------------A 190 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~ 190 (452)
..|+ .+.|+.++-|.||+|++++|+.||||.....-.. .
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3453 3689999999999999999999999986422110 1
Q ss_pred HHHHHHHHHHHHcCC-----CCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHH-HH
Q 012975 191 GREFENEVDLLSNIH-----HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG-LE 264 (452)
Q Consensus 191 ~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~ 264 (452)
+-++.+|+.-+.+++ .+++.=-.=|.+-.+...|+|||++|-.+.+...-.. ..++.. .++..++++ ++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHH
Confidence 112455655555542 3333211222333467789999999988877743212 234422 233333322 22
Q ss_pred HHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 265 ~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
.+=.. ++.|.|.+|.||+++.+|...+.|||+....
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 22234 8999999999999999999999999998543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-06 Score=80.05 Aligned_cols=138 Identities=18% Similarity=0.216 Sum_probs=84.2
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeEEEEEcCCceeeeeeecCCCC-
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRS- 233 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 233 (452)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24467778765422 2345688999998886433 4567788877777889999999863
Q ss_pred hhhh---------------------ccCCCCCCCCCHHHHH-HHHH----------HHH-HHHHHHHhc-CCCCeeeCCC
Q 012975 234 LDIQ---------------------LHGPSHGSALTWHMRM-KIAL----------DTA-RGLEYLHEH-CNPAVIHRDL 279 (452)
Q Consensus 234 L~~~---------------------l~~~~~~~~l~~~~~~-~i~~----------~ia-~~L~~LH~~-~~~~i~H~Dl 279 (452)
+... +|.... ......... ++.. .+. ....+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 222100 001111000 0000 001 112222211 1346789999
Q ss_pred CCCCEEECCCCcEEEEecCCCc
Q 012975 280 KSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|.||++++++ +.+.||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999773
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.5e-06 Score=73.45 Aligned_cols=137 Identities=13% Similarity=0.151 Sum_probs=90.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHH---------HHHHHHHHcCC---CCceeeeEEEE
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF---------ENEVDLLSNIH---HPNVVCLLGYS 216 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~g~~ 216 (452)
..++|...+++-......|.+-..++ ..+++|..........+.| .+++..+.+++ -.....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34677777778777777777766654 5788998765443333332 23444444442 23333433333
Q ss_pred EcC-----CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 217 AHD-----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 217 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
+.. ...+|+|||++|..|.+... ++. .++..+..++.-||+. |+.|+|.+|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence 322 34568999999988865432 222 2445677789999999 999999999999998665
Q ss_pred EEEEecCCCc
Q 012975 292 AKLSDFGLAI 301 (452)
Q Consensus 292 ~kl~Dfgl~~ 301 (452)
+++.||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.1e-06 Score=75.81 Aligned_cols=143 Identities=26% Similarity=0.269 Sum_probs=85.8
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC--ceeeeEEEEEcC---CceeeeeeecC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLLGYSAHD---DTRFIVYELME 230 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~ 230 (452)
.+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999988 48999997543 4566788899998888533 345666655333 34689999999
Q ss_pred CCChhh-------------------hccCC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 012975 231 NRSLDI-------------------QLHGP-SHGSALTWHMR---------MKI------------ALDTAR-GLEYLHE 268 (452)
Q Consensus 231 ~gsL~~-------------------~l~~~-~~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH~ 268 (452)
+..+.. .+|.. .......+... ... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988766 11111 01111111110 000 111222 3334432
Q ss_pred c----CCCCeeeCCCCCCCEEEC-CCCcEEEEecCCCc
Q 012975 269 H----CNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAI 301 (452)
Q Consensus 269 ~----~~~~i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~ 301 (452)
. ....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234799999999999999 66666899999763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=9.5e-06 Score=74.28 Aligned_cols=154 Identities=19% Similarity=0.146 Sum_probs=99.1
Q ss_pred ccHHHHHHhhcCCCccC---eEeecCcEEEEEEEeCCCcEEEEEEecCcChhh------------------------HHH
Q 012975 141 IEYKLLEKATDSFHESN---ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA------------------------GRE 193 (452)
Q Consensus 141 ~~~~~l~~~~~~f~~~~---~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~ 193 (452)
.+.+.+....+...... .|+.|--+.||+|...++..+|||+........ ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34555555554444443 466777889999998889999999985432211 112
Q ss_pred HHHHHHHHHcCC--CCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012975 194 FENEVDLLSNIH--HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271 (452)
Q Consensus 194 ~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 271 (452)
..+|+.-|.++. +-.+.+-+++. .-.|||||+.......-. ...-.+...+...+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 345666666663 23333333332 236999999765221111 11122333367777888888888887633
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 272 ~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
+++|+||+.=|||+. ++.+.++|+|-+....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 8899999999886543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.2e-06 Score=75.73 Aligned_cols=104 Identities=27% Similarity=0.185 Sum_probs=82.6
Q ss_pred HHHHHHHHcCCC-CceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012975 195 ENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273 (452)
Q Consensus 195 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 273 (452)
..|.-+++.+++ +++.+++|+|- .+++.||...+++...-....+-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 69999999994 3789999988766422100011234789999999999999999999854446
Q ss_pred eeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 274 VIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 274 i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
+.-.|++++|+-+++++++|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987743
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.8e-06 Score=76.59 Aligned_cols=138 Identities=18% Similarity=0.193 Sum_probs=84.7
Q ss_pred EeecCc-EEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecCCCChhh
Q 012975 159 LGEGGF-GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSLDI 236 (452)
Q Consensus 159 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 236 (452)
|..|.+ ..||+...++ ..+.+|...... ..++.+|+++++.+. +--+.+++++...++..++|||++++.++..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 7889997654 678888875432 345678888888873 4445567777777667899999999987753
Q ss_pred h-------------------ccCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 012975 237 Q-------------------LHGPSH-GSALT--WHMRMKIAL--------------------DTARGLEYLHEH----C 270 (452)
Q Consensus 237 ~-------------------l~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~~LH~~----~ 270 (452)
. +|.... ..... ....+.... .+...++.|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 3 121110 00111 001110000 011112222111 2
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 271 ~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
.+.++|+|+.|.|||+++++...|+||+.+
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 356899999999999999888899999976
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.4e-08 Score=97.30 Aligned_cols=186 Identities=20% Similarity=0.172 Sum_probs=133.7
Q ss_pred CccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc-eeeeEEEEEcCCceeeeeeecCCC
Q 012975 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
...+-+++++++.++|.+-...+...++.+... ....-++++|.+++||| .+..++-+..++..+++++++..+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 334557899999999988554444445555322 34456889999999999 777777777777889999999887
Q ss_pred -ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccc
Q 012975 233 -SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL 311 (452)
Q Consensus 233 -sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 311 (452)
+-..... .....+...+...+...-+++++|||+. .=+|+| ||+..+ +..|..||+......... ...
T Consensus 320 rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~ 388 (829)
T KOG0576|consen 320 RSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR 388 (829)
T ss_pred ccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence 2221111 1112344445566677778899999987 558888 776655 678999999875543332 234
Q ss_pred ccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 312 ~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
...+|+.|+|||+.....+..+.|+|++|+--.++--|..|-..
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 56799999999999999999999999999877777777776543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1e-05 Score=82.90 Aligned_cols=146 Identities=17% Similarity=0.211 Sum_probs=90.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh-------------------------------------hHH
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-------------------------------------AGR 192 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~ 192 (452)
...|. .+.||.-..|.||+|++++|..||||.-+..-+. .+-
T Consensus 161 f~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 161 FSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred HHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 34443 3689999999999999999999999985322111 111
Q ss_pred HHHHHHHHHHcC----CCCceee---eEE-EEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 012975 193 EFENEVDLLSNI----HHPNVVC---LLG-YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264 (452)
Q Consensus 193 ~~~~E~~~l~~l----~H~niv~---l~g-~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~ 264 (452)
+|.+|++-..+. .|-++.. +=. |..-...+.|+||||+|..+.+...- ....++-..+..-+.+ +
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~---~-- 312 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVE---A-- 312 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHH---H--
Confidence 244555433333 3444111 111 12233578999999999888765331 1223454443333333 2
Q ss_pred HHHhcCCCCeeeCCCCCCCEEECC----CCcEEEEecCCCccc
Q 012975 265 YLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDFGLAITD 303 (452)
Q Consensus 265 ~LH~~~~~~i~H~Dlk~~NIll~~----~~~~kl~Dfgl~~~~ 303 (452)
|++.-...|++|+|=+|.||+++. ++.+.+-|||+....
T Consensus 313 ~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 313 YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 222222338999999999999984 678999999998654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.8e-05 Score=84.58 Aligned_cols=79 Identities=16% Similarity=0.273 Sum_probs=58.0
Q ss_pred cCeEeecCcEEEEEEEeCCC---cEEEEEEecCcC-hhhHHHHHHHHHHHHcCC-CCce--eeeEEEEEcC---Cceeee
Q 012975 156 SNILGEGGFGCVYKAKLDDN---LHVAVKKLDCAT-QDAGREFENEVDLLSNIH-HPNV--VCLLGYSAHD---DTRFIV 225 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 225 (452)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46688899999999887654 367777764322 123456889999999995 6664 7788888765 467899
Q ss_pred eeecCCCCh
Q 012975 226 YELMENRSL 234 (452)
Q Consensus 226 ~E~~~~gsL 234 (452)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00012 Score=70.83 Aligned_cols=78 Identities=10% Similarity=0.101 Sum_probs=58.0
Q ss_pred CccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC---CceeeeEEEEEcC---Cceeeeee
Q 012975 154 HESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH---PNVVCLLGYSAHD---DTRFIVYE 227 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E 227 (452)
...+.||.|..+.||+....++ .+++|..+. ......|..|++.|+.+.- -.+.+++++|..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999987766 466666432 1133578999999998853 3677888888654 56799999
Q ss_pred ecCCCCh
Q 012975 228 LMENRSL 234 (452)
Q Consensus 228 ~~~~gsL 234 (452)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=9.9e-05 Score=68.73 Aligned_cols=73 Identities=15% Similarity=0.216 Sum_probs=45.2
Q ss_pred CeEeecCcE-EEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC---ceeeeEEEEEcCC---ceeeeeeec
Q 012975 157 NILGEGGFG-CVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP---NVVCLLGYSAHDD---TRFIVYELM 229 (452)
Q Consensus 157 ~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~E~~ 229 (452)
+.|+.|+.. .||+.. ..+++|.... ......+.+|++.+..+... -+..+++.+...+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 588752 2466776432 22345788999999887532 2334444443322 348899999
Q ss_pred CCCChh
Q 012975 230 ENRSLD 235 (452)
Q Consensus 230 ~~gsL~ 235 (452)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00011 Score=63.92 Aligned_cols=128 Identities=20% Similarity=0.208 Sum_probs=86.0
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceee-eEEEEEcCCceeeeeeecCCCC
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gs 233 (452)
..+.|++|.+|.||+|.+.++ .+|+|.-... .....+..|+++|..++--++-+ ++.|-. -++.|||+.+..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 356799999999999998866 7888886533 34567899999999998766554 344422 245599999988
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCCEEECCCCcEEEEecCCCcc
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK-SSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk-~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
|.+.-.. .+-...+ .+++.---|... +|-|+.|. |...++.+++.+.|+||.-|..
T Consensus 99 L~~~~~~------~~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------GDRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------ccHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8655421 1222333 333332233333 89999887 4444454555999999998853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.2e-05 Score=70.62 Aligned_cols=137 Identities=16% Similarity=0.228 Sum_probs=78.0
Q ss_pred EeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCcee-eeEEEEEcCCceeeeeeecCCCChhhh
Q 012975 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMENRSLDIQ 237 (452)
Q Consensus 159 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~~ 237 (452)
+..|-.+.+|+... ++..+++|..............+|..+++.+....+. ++++.+. .++||||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677889998874 4557888875432222112357788888888643333 3343332 3689999998776421
Q ss_pred -----------------ccCCCC-CCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCCeeeCCCCCCCE
Q 012975 238 -----------------LHGPSH-GSALTWHMRM-KIALD---------TARGLEYLHEH-----CNPAVIHRDLKSSNI 284 (452)
Q Consensus 238 -----------------l~~~~~-~~~l~~~~~~-~i~~~---------ia~~L~~LH~~-----~~~~i~H~Dlk~~NI 284 (452)
+|.... +.+++..... .+..+ +...+..+-.. ..+.++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 232111 1222322211 11111 11112222111 123689999999999
Q ss_pred EECCCCcEEEEecCCCc
Q 012975 285 LLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 285 ll~~~~~~kl~Dfgl~~ 301 (452)
++++++ +.+.||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999887 7899999873
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00021 Score=77.87 Aligned_cols=199 Identities=20% Similarity=0.188 Sum_probs=135.0
Q ss_pred HHHHHHHHHHHcCCCCceeeeEEEEEcCCce----eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012975 192 REFENEVDLLSNIHHPNVVCLLGYSAHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267 (452)
Q Consensus 192 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 267 (452)
....-|.+.+.+..|+|++.+++|..+.... .+..|++...++...+. .-..++....+.+..+..+||.|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence 3445677788889999999999998766543 34567888888877764 3456888888889999999999999
Q ss_pred hcCCCCeeeCCCCCC---CEEECCCCcEEEE--ecCCCcccCCCCCcccccccccCccCcccccCCCCCc--hhhHHHHH
Q 012975 268 EHCNPAVIHRDLKSS---NILLDSKFNAKLS--DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTD--KSDVYAFG 340 (452)
Q Consensus 268 ~~~~~~i~H~Dlk~~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDv~s~G 340 (452)
+. ...|.-+..+ +--.+.++....+ ||+............ ...-+..|.++|......+.. ..|+|++|
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccccchhhhhhHHHHHH
Confidence 98 5666655555 5555666777777 888776554333222 223445677888776655544 47999999
Q ss_pred HHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 341 VVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 341 vll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
.....+..|..+-..... ..+.+..... .........|+..++++|++..+++
T Consensus 380 ll~~~~~~~~~i~~~~~~-----------------------~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-----------------------PVSLLDVLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccccc-----------------------hhhhhccccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 999999887764322110 0011111111 0334456679999999999999999
Q ss_pred Hhcc
Q 012975 421 HSLI 424 (452)
Q Consensus 421 ~~L~ 424 (452)
...-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 6553
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00016 Score=67.22 Aligned_cols=140 Identities=19% Similarity=0.198 Sum_probs=80.7
Q ss_pred CeEeecCcEEEEEEEeCC--CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeeeeecCCCC
Q 012975 157 NILGEGGFGCVYKAKLDD--NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
+.|..|-...+|+....+ +..+++|....... ......+|+.+++.+...++ .++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 66788887643222 11233578888888854333 34444332 248999999877
Q ss_pred hhhh-----------------ccCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 012975 234 LDIQ-----------------LHGPSHG--------SALT-WHMRMKIAL----------------------DTARGLEY 265 (452)
Q Consensus 234 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~~ 265 (452)
+... +|..... .... |.....+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6311 1221111 1111 222111111 11111122
Q ss_pred H----Hhc-CCCCeeeCCCCCCCEEECC-CCcEEEEecCCCc
Q 012975 266 L----HEH-CNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAI 301 (452)
Q Consensus 266 L----H~~-~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~ 301 (452)
| ... ....++|+|+.+.|||+++ ++.+.+.||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 2 111 2346999999999999998 5789999999773
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=61.95 Aligned_cols=129 Identities=20% Similarity=0.279 Sum_probs=88.3
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC----------------hhhHHHHHHHHHHHHcCC------CCceeee
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT----------------QDAGREFENEVDLLSNIH------HPNVVCL 212 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 212 (452)
....||+|+.-.||.--. +....||...... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~HP~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECCC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999996543 3446777765443 223456677777666555 7889999
Q ss_pred EEEEEcCCceeeeeeecCC--C----ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 213 LGYSAHDDTRFIVYELMEN--R----SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+|+.+.+...-+|+|.+.+ | +|.+++. ...++. ...+ .+-+-.+||-+. .|+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 9999999999999998754 2 3555553 223444 3333 333445677777 89999999999999
Q ss_pred CCC--C--cEEEEe
Q 012975 287 DSK--F--NAKLSD 296 (452)
Q Consensus 287 ~~~--~--~~kl~D 296 (452)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 643 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0011 Score=64.68 Aligned_cols=141 Identities=16% Similarity=0.188 Sum_probs=77.5
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeEE------EEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLG------YSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~E~ 228 (452)
+.|+.|...++|+...++| .+++|...... ......|+..+..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999987766 68888875212 223334555555543111 222222 12234567899999
Q ss_pred cCCCChhh--------------hccCCCC--------CCCCCH-HHHHHHH-------------HHHHHHHHHHHhc---
Q 012975 229 MENRSLDI--------------QLHGPSH--------GSALTW-HMRMKIA-------------LDTARGLEYLHEH--- 269 (452)
Q Consensus 229 ~~~gsL~~--------------~l~~~~~--------~~~l~~-~~~~~i~-------------~~ia~~L~~LH~~--- 269 (452)
++|..+.. .+|.... ...+.| .....-. ..+...++.+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1221110 011222 2211111 1111222333211
Q ss_pred -CCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 270 -CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 270 -~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
...+++|+|+.+.||+++++...-|.||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 34589999999999999977666899999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00066 Score=65.47 Aligned_cols=142 Identities=19% Similarity=0.169 Sum_probs=86.4
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeEEE------EEcCCceeeeee
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGY------SAHDDTRFIVYE 227 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 227 (452)
.+.|..|....+|+....++ .+++|.... ........|++++..+++.+ +.+.+.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677787789999877655 688888753 22345667888877774332 3444331 123445689999
Q ss_pred ecCCCChhh--------------hccCCC--------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----cCC
Q 012975 228 LMENRSLDI--------------QLHGPS--------HGSALTWHMRMK----------IALDTARGLEYLHE----HCN 271 (452)
Q Consensus 228 ~~~~gsL~~--------------~l~~~~--------~~~~l~~~~~~~----------i~~~ia~~L~~LH~----~~~ 271 (452)
|++|..+.. .+|... ......|..... ....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 112100 001123332211 11123344555543 223
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 272 ~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+++|+|+.|.||++++++...|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999999873
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00082 Score=67.13 Aligned_cols=76 Identities=16% Similarity=0.152 Sum_probs=53.8
Q ss_pred cCeEeecCcEEEEEEEeCCC-cEEEEEEecCc------C-hhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceee
Q 012975 156 SNILGEGGFGCVYKAKLDDN-LHVAVKKLDCA------T-QDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 224 (452)
.+.||.|.+..||++...+| +.++||.-... . .-...++..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999999877 48999985311 1 123456777888888763 2345666666 4466789
Q ss_pred eeeecCCCC
Q 012975 225 VYELMENRS 233 (452)
Q Consensus 225 V~E~~~~gs 233 (452)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0015 Score=63.40 Aligned_cols=143 Identities=18% Similarity=0.213 Sum_probs=82.5
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeEEEE------EcCCceeeeee
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGYS------AHDDTRFIVYE 227 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 227 (452)
.+.++.|....+|+...++| .+++|...... .......|.+++..|.... +.+.+... ..++..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45566777789999887666 57788764321 1234456667776664222 33333321 22345689999
Q ss_pred ecCCCChhh--------------hccCCCCC---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 012975 228 LMENRSLDI--------------QLHGPSHG---------SALTWHMRMK------------IALDTARGLEYLHE---- 268 (452)
Q Consensus 228 ~~~~gsL~~--------------~l~~~~~~---------~~l~~~~~~~------------i~~~ia~~L~~LH~---- 268 (452)
|++|..+.. .+|....+ ..-.|..... ....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 12221110 0112221110 01123334555543
Q ss_pred cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 269 ~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
....+++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999998877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.002 Score=57.86 Aligned_cols=125 Identities=25% Similarity=0.375 Sum_probs=87.7
Q ss_pred cCCCccCeEeecCc-EEEEEEEeCCCcEEEEEEecC---cCh------------------hhHHHHHHHHHHHHcCC---
Q 012975 151 DSFHESNILGEGGF-GCVYKAKLDDNLHVAVKKLDC---ATQ------------------DAGREFENEVDLLSNIH--- 205 (452)
Q Consensus 151 ~~f~~~~~ig~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 205 (452)
.+++..+.||.|.- |.|||++..+ +.+|+|.+.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57777899999999 9999999875 4999999321 000 11235788888888774
Q ss_pred CCce--eeeEEEEEcCC------------------ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 012975 206 HPNV--VCLLGYSAHDD------------------TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265 (452)
Q Consensus 206 H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 265 (452)
+.++ |+.+||..-.. ...||.||++... .++.. -+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence 4466 88888873221 1256777776433 12222 34556667788
Q ss_pred HHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 266 LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 9988 9999999999975 4589999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.002 Score=62.38 Aligned_cols=140 Identities=24% Similarity=0.280 Sum_probs=82.1
Q ss_pred CeEeecCcEEEEEEEeCC-------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCcee-eeEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDD-------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~ 228 (452)
+.+..|-...+|+....+ +..+++|...... ....+..+|..++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 445667777999988765 4678888865432 2223457788888877533333 4455543 2 358999
Q ss_pred cCCCChhhh-----------------ccCCCCCC------C--CCHHHHHHH--------------------------HH
Q 012975 229 MENRSLDIQ-----------------LHGPSHGS------A--LTWHMRMKI--------------------------AL 257 (452)
Q Consensus 229 ~~~gsL~~~-----------------l~~~~~~~------~--l~~~~~~~i--------------------------~~ 257 (452)
++|..+... +|...... . .-|....++ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776421 22211110 0 111111110 11
Q ss_pred HHHHHHHHHHh------cCCCCeeeCCCCCCCEEECCC----CcEEEEecCCCc
Q 012975 258 DTARGLEYLHE------HCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAI 301 (452)
Q Consensus 258 ~ia~~L~~LH~------~~~~~i~H~Dlk~~NIll~~~----~~~kl~Dfgl~~ 301 (452)
.+..-+++|-. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 12222334432 134578999999999999985 889999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=5.1e-05 Score=84.33 Aligned_cols=164 Identities=15% Similarity=-0.030 Sum_probs=116.7
Q ss_pred HHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceeeeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012975 191 GREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLH 267 (452)
Q Consensus 191 ~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH 267 (452)
.+....|.+.++...|+++.....-... +.+.+.+++|+..|.++..+-.. ++...++..-+...-.+......-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3445566667777889998765543332 33668999999999998887542 23334444444433333345555555
Q ss_pred hcCCC--CeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHH
Q 012975 268 EHCNP--AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLE 345 (452)
Q Consensus 268 ~~~~~--~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~e 345 (452)
+..+. --+|+++|+-|.+|..+.++|++++|+.+.............+++.|+.|+....-+++.++|+|..|+.+|+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 54332 3589999999999999999999999999743333333334567888999998888889999999999999999
Q ss_pred HHcCCCCCC
Q 012975 346 LLLGRRPVE 354 (452)
Q Consensus 346 lltG~~P~~ 354 (452)
..-|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 988887763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00051 Score=65.39 Aligned_cols=136 Identities=16% Similarity=0.142 Sum_probs=90.5
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--------Chh--------------hHHHHHHHHHHHHcCCC-C-
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--------TQD--------------AGREFENEVDLLSNIHH-P- 207 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~--------------~~~~~~~E~~~l~~l~H-~- 207 (452)
-+.+.+.||-|--+-+|.+...+|.+.++|.-..- ... ..-...+|...|+.|.- -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35678999999999999999999999998853210 000 11224577778887742 2
Q ss_pred ceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 012975 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (452)
Q Consensus 208 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~ 287 (452)
-+.+.+++ +.-++|||++.+-.|...-+. .+..... ..+..-+.-|..+ |+||+|+.--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHHHc---CceecccchheeEEe
Confidence 13333433 344799999998888543321 2222222 2222334445556 999999999999999
Q ss_pred CCCcEEEEecCCCccc
Q 012975 288 SKFNAKLSDFGLAITD 303 (452)
Q Consensus 288 ~~~~~kl~Dfgl~~~~ 303 (452)
+++.++++||--+...
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999866443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0037 Score=59.88 Aligned_cols=140 Identities=24% Similarity=0.314 Sum_probs=74.3
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceeeeeeecCC
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
..+.++-|....+|+.. .++..+.||.-. ......|..|++-|+.|. --.+.+++++...++..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678888899999988 566789999875 333456888888888873 44577888888877778999999988
Q ss_pred CChh-----------hhccC-CC------------------CCCCCCHHH-----HHHHHHHHH-----------HHHHH
Q 012975 232 RSLD-----------IQLHG-PS------------------HGSALTWHM-----RMKIALDTA-----------RGLEY 265 (452)
Q Consensus 232 gsL~-----------~~l~~-~~------------------~~~~l~~~~-----~~~i~~~ia-----------~~L~~ 265 (452)
+... ..||. .. +.-.-+|.. |+.-..+.+ +.++-
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 7211 12333 10 001123432 111111111 11222
Q ss_pred HHhc-----CCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 266 LHEH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 266 LH~~-----~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
+.+. ..|.++|+||-+.|++.+.+|.+.|.|=.
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 2221 25689999999999999999989998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.012 Score=56.95 Aligned_cols=128 Identities=18% Similarity=0.206 Sum_probs=78.8
Q ss_pred EEEEEEEeCCCcEEEEEEec--CcChhhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCC--ceeeeeeecCCCChhhhc
Q 012975 165 GCVYKAKLDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDD--TRFIVYELMENRSLDIQL 238 (452)
Q Consensus 165 g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l 238 (452)
-.+|..... ++++++. .. ...........+|..+++.+.- --+-..+++|.++. ..+.||+|+++..+...+
T Consensus 39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 344444433 6677777 32 1223334556678888877742 23445678887776 779999999985554333
Q ss_pred cCCCCCCCCCHHHHHHHH-HHHHHHHHHHH--------------------------------------------------
Q 012975 239 HGPSHGSALTWHMRMKIA-LDTARGLEYLH-------------------------------------------------- 267 (452)
Q Consensus 239 ~~~~~~~~l~~~~~~~i~-~~ia~~L~~LH-------------------------------------------------- 267 (452)
..... . .+++ ..+++.|.-||
T Consensus 117 ~~~~~----~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 117 PPESL----G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred Ccccc----h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 21110 0 1111 24444444444
Q ss_pred hc-----CCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 268 EH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 268 ~~-----~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
.+ ..+.++|+|+.+.|+++++++-+=+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 134789999999999999998899999999854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.015 Score=55.41 Aligned_cols=31 Identities=29% Similarity=0.453 Sum_probs=25.5
Q ss_pred CCeeeCCCCCCCEEECCCCc-EEEEecCCCcc
Q 012975 272 PAVIHRDLKSSNILLDSKFN-AKLSDFGLAIT 302 (452)
Q Consensus 272 ~~i~H~Dlk~~NIll~~~~~-~kl~Dfgl~~~ 302 (452)
+.++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.014 Score=56.88 Aligned_cols=140 Identities=16% Similarity=0.235 Sum_probs=95.8
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCc-----C--------------------hhh-HHHHHHHHHHHHcCCCCce
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCA-----T--------------------QDA-GREFENEVDLLSNIHHPNV 209 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~-~~~~~~E~~~l~~l~H~ni 209 (452)
...|..|--+.||.++..+|..+|||..+-+ . ... .....+|+.-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4578899999999999999999999976311 0 001 1234567777777754432
Q ss_pred eeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 012975 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK 289 (452)
Q Consensus 210 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~ 289 (452)
.-- .-..- ..-.|||+|+....... .....-.++...+..+-.+++.-+.-|-+.| .+||.||.--|+|+. +
T Consensus 229 P~P-ePIlL-k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCP-EPILL-KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCC-Cceee-ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 100 00000 12368999996433221 1123445777788888899999999998888 899999999999985 5
Q ss_pred CcEEEEecCCCccc
Q 012975 290 FNAKLSDFGLAITD 303 (452)
Q Consensus 290 ~~~kl~Dfgl~~~~ 303 (452)
|.+.++|.+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68999999877543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.013 Score=57.81 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=79.2
Q ss_pred eEeecCcEEEEEEEeCC-----CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCcee-eeEEEEEcCCceeeeeeecCC
Q 012975 158 ILGEGGFGCVYKAKLDD-----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 231 (452)
.+..|-...+|+....+ +..+++|.......... .-.+|..+++.+...++. ++++++.. + .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 44456677888887542 35788887654332222 236788888887544443 44555432 2 58999988
Q ss_pred CChhhh-----------------ccCCCC-CC--CCCHHHHHHHHHH-----------------HHHHHHHHHh-----c
Q 012975 232 RSLDIQ-----------------LHGPSH-GS--ALTWHMRMKIALD-----------------TARGLEYLHE-----H 269 (452)
Q Consensus 232 gsL~~~-----------------l~~~~~-~~--~l~~~~~~~i~~~-----------------ia~~L~~LH~-----~ 269 (452)
.++... +|.... .. ..-|.+..++..+ +...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 232110 11 1223333233211 1122222221 1
Q ss_pred CCCCeeeCCCCCCCEEECC-CCcEEEEecCCCc
Q 012975 270 CNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAI 301 (452)
Q Consensus 270 ~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~ 301 (452)
....++|+|+++.||++++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2336899999999999986 4789999999874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.01 Score=53.69 Aligned_cols=152 Identities=18% Similarity=0.168 Sum_probs=93.2
Q ss_pred cCcEEEEEEEeCCCcEEEEEEecCcChh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCChhhhccC
Q 012975 162 GGFGCVYKAKLDDNLHVAVKKLDCATQD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG 240 (452)
Q Consensus 162 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 240 (452)
++..+.-+|+..-| ...+|++....-. ...-|..+.+++++++ .|+++.. .+.-..-++.|+|-.-..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------
Confidence 44555555554444 5667777533322 3345788899998885 4666651 122245688998843111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCcc
Q 012975 241 PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320 (452)
Q Consensus 241 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~ 320 (452)
.. .-.|..+ ...|.-.|+. +++.+|+|..|+||+-|.+|.+||.|=+..... +.-|.
T Consensus 142 ------~~---~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~------------~V~~v 198 (308)
T PF07387_consen 142 ------NF---SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN------------QVNMV 198 (308)
T ss_pred ------ch---hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh------------eeeEE
Confidence 11 1112222 3667788865 568999999999999999999999998754211 11122
Q ss_pred CcccccCCCCCchhhHHHHHHHHHHHHcCC
Q 012975 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGR 350 (452)
Q Consensus 321 aPE~~~~~~~~~~sDv~s~Gvll~elltG~ 350 (452)
--| ....++++.+-+|=.-++++....
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 211 133477888888877777777533
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.024 Score=54.91 Aligned_cols=30 Identities=27% Similarity=0.333 Sum_probs=25.8
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 271 ~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999987 578899999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.051 Score=49.61 Aligned_cols=75 Identities=19% Similarity=0.211 Sum_probs=52.8
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
+.+.-|.--..|...+ +..++.||.- .......|..|+.-|..+. --++.+++.+-.+.+..|+|+||.+-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444445555543 3457888874 3445577888988777763 4567788888888899999999999887
Q ss_pred hh
Q 012975 234 LD 235 (452)
Q Consensus 234 L~ 235 (452)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.046 Score=53.09 Aligned_cols=32 Identities=22% Similarity=0.281 Sum_probs=28.4
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 271 ~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
..+++|+|+.++|+++++++.+.+.||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999998744
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.039 Score=54.25 Aligned_cols=73 Identities=15% Similarity=0.147 Sum_probs=47.1
Q ss_pred eEeecCcEEEEEEEeCCC-cEEEEEEec----Cc--C-hhhHHHHHHHHHHHHcCC--CCceee-eEEEEEcCCceeeee
Q 012975 158 ILGEGGFGCVYKAKLDDN-LHVAVKKLD----CA--T-QDAGREFENEVDLLSNIH--HPNVVC-LLGYSAHDDTRFIVY 226 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~~-~~vavK~~~----~~--~-~~~~~~~~~E~~~l~~l~--H~niv~-l~g~~~~~~~~~lV~ 226 (452)
.||-|....||++..++| ..|+||.-. .. + +-...+..-|.+.|+... -|..++ ++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478999999999998754 579999742 11 1 223344556777776653 354443 433 3556667999
Q ss_pred eecCCC
Q 012975 227 ELMENR 232 (452)
Q Consensus 227 E~~~~g 232 (452)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.022 Score=56.94 Aligned_cols=73 Identities=14% Similarity=0.092 Sum_probs=48.9
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCc----Ch---hhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceeee
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCA----TQ---DAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 225 (452)
.+.||-|....||+.... +..++||+-... +. ....+-..|++.|+.+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998875 446889975411 11 12233344566666553 246777888877 446789
Q ss_pred eeecCC
Q 012975 226 YELMEN 231 (452)
Q Consensus 226 ~E~~~~ 231 (452)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.018 Score=56.54 Aligned_cols=139 Identities=19% Similarity=0.250 Sum_probs=77.3
Q ss_pred CeEeecCcEEEEEEEeCC----CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCcee-eeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLDD----NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.|..|=...+|+....+ +..|++|.....+. ..-.-.+|..+++.+...++- ++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345446677888886543 23677887643322 222235788888888655543 4555542 22 58999987
Q ss_pred CChhh-----------------hccCCC-C--CCCCCHHHHHHHHHHH----------------------HHHHHHHHhc
Q 012975 232 RSLDI-----------------QLHGPS-H--GSALTWHMRMKIALDT----------------------ARGLEYLHEH 269 (452)
Q Consensus 232 gsL~~-----------------~l~~~~-~--~~~l~~~~~~~i~~~i----------------------a~~L~~LH~~ 269 (452)
.++.. .+|... . ...--|....++..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76631 123211 0 1111233332222221 1112222211
Q ss_pred -----CCCCeeeCCCCCCCEEECC-CCcEEEEecCCC
Q 012975 270 -----CNPAVIHRDLKSSNILLDS-KFNAKLSDFGLA 300 (452)
Q Consensus 270 -----~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~ 300 (452)
...-++|+|+.+.||++++ ++.++++||..+
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 1224799999999999975 578999999987
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.06 Score=52.55 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=82.2
Q ss_pred eEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc---eee---eEE----EEEcCCceeeeee
Q 012975 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN---VVC---LLG----YSAHDDTRFIVYE 227 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n---iv~---l~g----~~~~~~~~~lV~E 227 (452)
.|.+ .-..+|+....+|.. ++|..... ....+...|...|..+.-.. .++ +=| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 567899999888865 77777654 34455666777777773211 112 111 1111125678999
Q ss_pred ecCCCChhh-h--------------ccC---------CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 012975 228 LMENRSLDI-Q--------------LHG---------PSHGSALTWHM-------------RMKIALDTARGLEYLHEHC 270 (452)
Q Consensus 228 ~~~~gsL~~-~--------------l~~---------~~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~~~ 270 (452)
|++|..+.. . +|. +.......|.. ......++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988762 1 111 01111344431 0112333444455554331
Q ss_pred ----CCC---eeeCCCCCCCEEECCCCc-EEEEecCCCcc
Q 012975 271 ----NPA---VIHRDLKSSNILLDSKFN-AKLSDFGLAIT 302 (452)
Q Consensus 271 ----~~~---i~H~Dlk~~NIll~~~~~-~kl~Dfgl~~~ 302 (452)
... +||+|+.+.||+++.+.. +-+.||+.+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 223 899999999999999885 89999998743
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.03 Score=54.47 Aligned_cols=102 Identities=20% Similarity=0.195 Sum_probs=68.5
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..|++|++- ++++.. .....|.+.+.++.+.+..+.-+.... +.-|||+.-.||||+ +|++.|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 445666654 444421 233679999999999988888887654 889999999999999 999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHH
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAF 339 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~ 339 (452)
+....++... ..+.--|-.+.|.. +..=|||-+
T Consensus 369 Rl~~~q~~is-----y~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 369 RLSYSQGIIS-----YNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred ecccCCceee-----ccccCchhhhcCcc-ceeeeHHHH
Confidence 7543332211 11223344444332 556667653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.16 Score=49.64 Aligned_cols=73 Identities=19% Similarity=0.186 Sum_probs=45.0
Q ss_pred ecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC--ceeeeE---E--EEEcCCceeeeeeecCCCC
Q 012975 161 EGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLL---G--YSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 161 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~E~~~~gs 233 (452)
.+.-..||+....++..+++|..... .....+...|.+.+..+... .++... | +...++..+.++++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 45567899999888888888876422 22345566777777766321 122211 1 1223456788999998765
Q ss_pred h
Q 012975 234 L 234 (452)
Q Consensus 234 L 234 (452)
.
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 4
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.07 Score=53.36 Aligned_cols=74 Identities=19% Similarity=0.234 Sum_probs=44.0
Q ss_pred CeEeecCcEEEEEEEeCCC--cE-----EEEEEecCcChhhHHHHHHHHHHHHcCCCCceee-eEEEEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDDN--LH-----VAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC-LLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~ 228 (452)
+.|..|-...+|++...++ .. |.++... ......-+-.+|+.+++.+...++-+ +++.+. -.+++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 3455577889999876543 12 3333321 11111122356888999887665554 444443 2599999
Q ss_pred cCCCChh
Q 012975 229 MENRSLD 235 (452)
Q Consensus 229 ~~~gsL~ 235 (452)
+++.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9998774
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.042 Score=54.72 Aligned_cols=74 Identities=19% Similarity=0.240 Sum_probs=48.4
Q ss_pred cCeEeecCcEEEEEEEeCC-CcEEEEEEecCc-----C-hhhHHHHHHHHHHHHcCC--CCceee-eEEEEEcCCceeee
Q 012975 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDCA-----T-QDAGREFENEVDLLSNIH--HPNVVC-LLGYSAHDDTRFIV 225 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--H~niv~-l~g~~~~~~~~~lV 225 (452)
.+.||-|.-..||++.+.+ +..|+||.-... + +-...+..-|.+.|+... .|..++ ++. .+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999999853 567999974211 1 223455566777777663 454443 443 345566789
Q ss_pred eeecCC
Q 012975 226 YELMEN 231 (452)
Q Consensus 226 ~E~~~~ 231 (452)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998865
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.019 Score=52.33 Aligned_cols=29 Identities=38% Similarity=0.496 Sum_probs=21.0
Q ss_pred CeeeCCCCCCCEEE-CCCCcEEEEecCCCc
Q 012975 273 AVIHRDLKSSNILL-DSKFNAKLSDFGLAI 301 (452)
Q Consensus 273 ~i~H~Dlk~~NIll-~~~~~~kl~Dfgl~~ 301 (452)
.++|+|+.+.|||+ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 67999999999999 889999999999873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.25 Score=55.92 Aligned_cols=143 Identities=20% Similarity=0.257 Sum_probs=78.2
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-------CCCceeeeE-----EEEEc-CC--c
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-------HHPNVVCLL-----GYSAH-DD--T 221 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~-----g~~~~-~~--~ 221 (452)
+.|+ |..-.+|+.+..+|..+++|..+... .......|...|..| .-|.+++-. ..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 45678899988888889999986432 223334455555444 233444321 11111 22 3
Q ss_pred eeeeeeecCCCChhhh-----------------ccC-------CCCCCCCCHHH-----------------HHHHHHHHH
Q 012975 222 RFIVYELMENRSLDIQ-----------------LHG-------PSHGSALTWHM-----------------RMKIALDTA 260 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~-----------------l~~-------~~~~~~l~~~~-----------------~~~i~~~ia 260 (452)
.+-+++|+++..+.+. +|. +.....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 4668999998776541 110 01112233421 112222222
Q ss_pred HHHHH----HHhcCCCCeeeCCCCCCCEEECCCC--cEE-EEecCCCcc
Q 012975 261 RGLEY----LHEHCNPAVIHRDLKSSNILLDSKF--NAK-LSDFGLAIT 302 (452)
Q Consensus 261 ~~L~~----LH~~~~~~i~H~Dlk~~NIll~~~~--~~k-l~Dfgl~~~ 302 (452)
...+- .-.....++||+|+.+.|||++.++ .+. |.|||.+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22211 1122345799999999999999875 454 999998743
|
|
| >PF06679 DUF1180: Protein of unknown function (DUF1180); InterPro: IPR009565 This entry consists of several hypothetical eukaryotic proteins thought to be membrane proteins | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.25 Score=42.62 Aligned_cols=8 Identities=13% Similarity=0.439 Sum_probs=3.0
Q ss_pred HHHHhhhc
Q 012975 91 LWLYHLKY 98 (452)
Q Consensus 91 ~~~~~~~~ 98 (452)
+-.+|.|+
T Consensus 114 ir~~R~r~ 121 (163)
T PF06679_consen 114 IRTFRLRR 121 (163)
T ss_pred HHHHhhcc
Confidence 33343333
|
Their function is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.046 Score=55.50 Aligned_cols=47 Identities=21% Similarity=0.287 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHcCCCCceeeeEEEEEcCC-ceeeeeeecCCCChhhhcc
Q 012975 192 REFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYELMENRSLDIQLH 239 (452)
Q Consensus 192 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~ 239 (452)
.++......++.++|+|+...+.+....- ...+|+|++ +.||++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 45667788899999999999888876543 457889988 568877764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 452 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-28 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-132
Identities = 113/286 (39%), Positives = 169/286 (59%), Gaps = 6/286 (2%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA-TQDAGREFENEVDLL 201
+ L+ A+D+F NILG GGFG VYK +L D VAVK+L TQ +F+ EV+++
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHG-SALTWHMRMKIALDTA 260
S H N++ L G+ R +VY M N S+ L L W R +IAL +A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGY 319
RGL YLH+HC+P +IHRD+K++NILLD +F A + DFGLA + D + GT+G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE--KLAPAQCQSIVTWAMPQLTDRSK 377
+APEYL GK ++K+DV+ +GV+LLEL+ G+R + +LA ++ W L ++ K
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-K 260
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
L +VD ++ + + Q+ VA+LC Q P RP +++V+ L
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-129
Identities = 116/324 (35%), Positives = 180/324 (55%), Gaps = 18/324 (5%)
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEG 162
+K +K+ +S N + SS+L F S R + ++ LE+AT++F ++G G
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYR--------VPLVD---LEEATNNFDHKFLIGHG 50
Query: 163 GFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222
FG VYK L D VA+K+ + EFE E++ LS HP++V L+G+ +
Sbjct: 51 VFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110
Query: 223 FIVYELMENRSLDIQLHGPSHGSA-LTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281
++Y+ MEN +L L+G + ++W R++I + ARGL YLH A+IHRD+KS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKS 167
Query: 282 SNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAF 339
NILLD F K++DFG++ T+ Q + + GTLGY+ PEY + G+LT+KSDVY+F
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 340 GVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVA 399
GVVL E+L R + + P + ++ WA+ + +L IVDP + + + L +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLEQIVDPNLADKIRPESLRKFG 286
Query: 400 AVAVLCVQPEPSYRPLITDVLHSL 423
AV C+ RP + DVL L
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-127
Identities = 104/297 (35%), Positives = 157/297 (52%), Gaps = 20/297 (6%)
Query: 143 YKLLEKATDSFHE------SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG----R 192
+ L+ T++F E N +GEGGFG VYK +++ VAVKKL +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQ 75
Query: 193 EFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR 252
+F+ E+ +++ H N+V LLG+S+ D +VY M N SL +L L+WHMR
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNN 310
KIA A G+ +LHE+ IHRD+KS+NILLD F AK+SDFGLA +Q
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370
++ GT Y+APE L G++T KSD+Y+FGVVLLE++ G V++ Q ++
Sbjct: 193 SRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEE 249
Query: 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427
+ + + +D + D + + +VA C+ + + RP I V L +
Sbjct: 250 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 8e-80
Identities = 75/311 (24%), Positives = 117/311 (37%), Gaps = 29/311 (9%)
Query: 139 SFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEV 198
+ + L + + G FGCV+KA+L + +VAVK + E EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFP-IQDKQSWQNEYEV 69
Query: 199 DLLSNIHHPNVVCLLGYSAHDDT----RFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
L + H N++ +G + +++ E SL L ++W+
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125
Query: 255 IALDTARGLEYLHEH-------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--DGS 305
IA ARGL YLHE PA+ HRD+KS N+LL + A ++DFGLA+ G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 306 QNKNNLKLSGTLGYVAPEYL-----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360
+ GT Y+APE L + D+YA G+VL EL +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 361 CQSI--VTWAMPQLTDRSKL--PNIVDPVIKSTMD-LKHLYQVAAVAVLCVQPEPSYRPL 415
P L D ++ PV++ + + C + R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 416 ITDVLHSLIPL 426
V + +
Sbjct: 306 AGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-71
Identities = 87/269 (32%), Positives = 131/269 (48%), Gaps = 20/269 (7%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G FG V++A+ VAVK L + EF EV ++ + HPN+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
IV E + SL LH L R+ +A D A+G+ YLH + NP +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
+HR+LKS N+L+D K+ K+ DFGL+ S ++ +GT ++APE L D +KS
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 335 DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKH 394
DVY+FGV+L EL ++P L PAQ V A+ R ++P ++P + + +
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKCKRLEIPRNLNPQVAAII---- 272
Query: 395 LYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
C EP RP ++ L
Sbjct: 273 --------EGCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-65
Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 28/276 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
++G G FG V KAK VA+K+++ ++ + F E+ LS ++HPN+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G A + +V E E SL LHG T M L ++G+ YLH
Sbjct: 65 KLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 271 NPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKNNLKLS--GTLGYVAPEYLLD 327
A+IHRDLK N+LL + K+ DFG + + + G+ ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387
++K DV+++G++L E++ R+P +++ + + WA+ R L + I+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN-GTRPPLIKNLPKPIE 234
Query: 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
S M C +PS RP + +++ +
Sbjct: 235 SLM------------TRCWSKDPSQRPSMEEIVKIM 258
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-63
Identities = 77/289 (26%), Positives = 140/289 (48%), Gaps = 39/289 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL-------DCATQDAGREFENEVDLLS 202
+ +G+GGFG V+K + + D VA+K L + + +EF+ EV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
N++HPN+V L G + +V E + L +L +H + W +++++ LD A G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSK-----FNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+EY+ + NP ++HRDL+S NI L S AK++DFGL+ + L G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNF 190
Query: 318 GYVAPEYLLDGKL---TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374
++APE + + T+K+D Y+F ++L +L G P ++ + + + I + +
Sbjct: 191 QWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--NMIREEGL 247
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
R +P P +++ + LC +P RP + ++ L
Sbjct: 248 RPTIPEDCPPRLRNVI------------ELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-62
Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 33/281 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPN 208
+ L E G ++K + N + VK L + R+F E L HPN
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 209 VVCLLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
V+ +LG S ++ M SL LH + + +K ALD ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFL 127
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H P + L S ++++D A++S + + S + +VAPE L
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPE-AL 180
Query: 327 DGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382
K +D+++F V+L EL+ P L+ + + + R +P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGMKVALEGLRPTIPPGI 236
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P + M +C+ +P+ RP ++ L
Sbjct: 237 SPHVSKLMK------------ICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-62
Identities = 77/280 (27%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKL----DCATQDAGREFENEVDLLSNIHHPNVVCL 212
I+G GGFG VY+A VAVK D E L + + HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
G + +V E L+ L G + + + A+ ARG+ YLH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 273 AVIHRDLKSSNILLDSKF--------NAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPE 323
+IHRDLKSSNIL+ K K++DFGLA + + +G ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA---AGAYAWMAPE 184
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
+ + SDV+++GV+L ELL G P + V + + +P+
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAYGVAMNKLALPIPSTCP 240
Query: 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
M C P+P RP T++L L
Sbjct: 241 EPFAKLM------------EDCWNPDPHSRPSFTNILDQL 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 6e-61
Identities = 71/321 (22%), Positives = 115/321 (35%), Gaps = 50/321 (15%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVD--LLSN 203
D+ ++G G +G VYK LD+ VAVK + F NE + +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFS---FANRQNFINEKNIYRVPL 63
Query: 204 IHHPNVVCLLGYSAHDDTR-----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+ H N+ + +V E N SL L + W ++A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHS 119
Query: 259 TARGLEYLHE------HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT--------DG 304
RGL YLH H PA+ HRDL S N+L+ + +SDFGL++ G
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 305 SQNKNNLKLSGTLGYVAPEYL-------LDGKLTDKSDVYAFGVVLLELLLG---RRPVE 354
++ + GT+ Y+APE L + D+YA G++ E+ + P E
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 355 KLAPAQ-CQSIVTWAMPQLTDRSKL-------PNIVDPVIKSTMDLKHLYQVAAVAVLCV 406
+ Q P D L P + ++++ ++ L C
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL---KETIEDCW 296
Query: 407 QPEPSYRPLITDVLHSLIPLV 427
+ R + L+
Sbjct: 297 DQDAEARLTAQXAEERMAELM 317
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-60
Identities = 63/283 (22%), Positives = 110/283 (38%), Gaps = 40/283 (14%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLG 214
++G+G FG VY + VA++ +D +D + F+ EV H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
I+ L + R+L + L + +IA + +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLS-GTLGYVAPEYLLDGK 329
+H+DLKS N+ D+ ++DFGL + + ++ L++ G L ++APE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 330 L---------TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380
+ SDV+A G + EL P + + W M +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNLSQI 266
Query: 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ I + + C E RP T ++ L
Sbjct: 267 GMGKEISDIL------------LFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-59
Identities = 86/278 (30%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG VYK K VAVK L T + F+NEV +L H N++ +GYS
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
IV + E SL LH + + IA TARG++YLH ++IH
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIH 143
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLD---GKLT 331
RDLKS+NI L K+ DFGLA + S + +LSG++ ++APE + +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 332 DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA------MPQLTDRSKLPNIVDPV 385
+SDVYAFG+VL EL+ G+ P + + P L SK+ +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDL---SKVRSNCPKR 257
Query: 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+K M C++ + RP +L +
Sbjct: 258 MKRLM------------AECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 35/282 (12%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+LG+G FG K + + +K+L ++ R F EV ++ + HPNV+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + E ++ +L + S S W R+ A D A G+ YLH +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA--------------ITDGSQNKNNLKLSGTLGYVA 321
HRDL S N L+ N ++DFGLA K + G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381
PE + +K DV++FG+VL E++ P + + P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---RGFLDRYCPPN 247
Query: 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P + V C +P RP + H L
Sbjct: 248 CPP------------SFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 68/297 (22%), Positives = 116/297 (39%), Gaps = 37/297 (12%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G +G V+ K VAVK T++A E E+ + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWRGE-KVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
+++ + EN SL L + L +K+A + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS-----GTLGYVAP 322
PA+ HRDLKS NIL+ ++D GLA+ + N + + GT Y+ P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNEVDIPPNTRVGTKRYMPP 215
Query: 323 EYLLDGKL-------TDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTD 374
E +LD L +D+Y+FG++L E+ + Q + + P D
Sbjct: 216 E-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 375 RSKLPNIVD----PVIKSTMDLKH-LYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426
++ + P + L Q+ + C P+ R V +L +
Sbjct: 275 MREI--VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G +G V++ +VAVK + + E E+ + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
+++ E SL L + L ++I L A GL +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAPE 323
PA+ HRDLKS NIL+ ++D GLA + S N+ ++ + GT Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 324 YLLDGKL-------TDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360
+LD + + D++AFG+VL E+ + +
Sbjct: 188 -VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-52
Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 35/296 (11%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V++ K VAVK + ++ E E+ + H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 217 AHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE---- 268
D+ ++V + E+ SL L+ + +T +K+AL TA GL +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 269 -HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAPE 323
PA+ HRDLKS NIL+ ++D GLA D + + ++ + GT Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 324 YLLDGKL-------TDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDR 375
+LD + ++D+YA G+V E+ Q + + P + +
Sbjct: 222 -VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 376 SKLPNIVD----PVI-KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426
K+ + + P I + L +A + C + R + +L L
Sbjct: 281 RKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 70/204 (34%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 159 LGEGGFGCVYKAKL-DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ +L DN VAVK + D +F E +L HPN+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+IV EL++ L + G+ L +++ D A G+EYL C IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV-----APEYLLDGK 329
RDL + N L+ K K+SDFG++ DG SG L V APE L G+
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-----SGGLRQVPVKWTAPEALNYGR 291
Query: 330 LTDKSDVYAFGVVLLELL-LGRRP 352
+ +SDV++FG++L E LG P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-44
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG+G FG VY+ + VA+K + + A+ EF NE ++ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 210 VCLLGYSAHDDTRFIVYELMEN-------RSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
V LLG + ++ ELM RSL + + + +++A + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 263 LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
+ YL+ +HRDL + N ++ F K+ DFG+ I + + G G
Sbjct: 151 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGL 201
Query: 320 V-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ +PE L DG T SDV++FGVVL E+ L +P
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FGCVY L DN +H AVK L +F E ++ + HPNV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 212 LLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-H 269
LLG + + +V M++ L + + T + L A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL--GYVAPEYL 325
+HRDL + N +LD KF K++DFGLA + D + K L ++A E L
Sbjct: 149 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 326 LDGKLTDKSDVYAFGVVLLELL-LGRRP 352
K T KSDV++FGV+L EL+ G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
+G G F VYK + + VA + T+ + F+ E ++L + HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 215 Y----SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V ELM + +L ++ + + +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHT 147
Query: 269 HCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
P +IHRDLK NI + + K+ D GLA + + GT ++APE +
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEM-YE 203
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP-AQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
K + DVYAFG+ +LE+ P + AQ VT + + + P +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----FDKVAIPEV 259
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
K ++ C++ R I D+L H+
Sbjct: 260 KEIIE------------GCIRQNKDERYSIKDLLNHAFF 286
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 48/300 (16%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
+ + ++ F E ++G GGFG V+KAK D +K++ + A E EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKA 57
Query: 201 LSNIHHPNVVCLLGY----------------SAHDDTRFIVYELMENRSLDIQLHGPSHG 244
L+ + H N+V G + FI E + +L+ Q G
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRG 116
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
L + +++ +G++Y+H +I+RDLK SNI L K+ DFGL +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364
+ K + GTL Y++PE + + D+YA G++L ELL +
Sbjct: 174 NDGKRT-RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF 227
Query: 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
T + +I D K L Q + +P RP +++L +L
Sbjct: 228 FTDLR-----DGIISDIFDK------KEKTLLQ------KLLSKKPEDRPNTSEILRTLT 270
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 154 HESNILGEGGFGCVYKAKLDD----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPN 208
H ++G+G FG VY + D + A+K L F E L+ ++HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 209 VVCLLGYSAHDD-TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V+ L+G + ++ M + L + S T + L ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 268 E-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL--GYVAP 322
E +HRDL + N +LD F K++DFGLA I D L + A
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
E L + T KSDV++FGV+L ELL G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 157 NILGEGGFGCVYKAKLDD----NLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVV 210
ILGEG FG V + L +L VAVK KLD ++Q EF +E + + HPNV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 211 CLLGYSAHDDTR-----FIVYELMENRSLD--IQLHGP-SHGSALTWHMRMKIALDTARG 262
LLG ++ ++ M+ L + + + +K +D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
+EYL +HRDL + N +L ++DFGL+ I G + + V
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---QGRIAKMPV 213
Query: 321 ---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
A E L D T KSDV+AFGV + E+ G P
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FGCVY L DN +H AVK L +F E ++ + HPNV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 212 LLGYSAHDDT-RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-H 269
LLG + +V M++ L + + T + L A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEY 324
+HRDL + N +LD KF K++DFGLA + D + +G V A E
Sbjct: 213 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-VHNKTGAKLPVKWMALES 267
Query: 325 LLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
L K T KSDV++FGV+L EL+ G P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-42
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 159 LGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LGEG FG V+ A+ D + VAVK L T A ++F+ E +LL+N+ H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 213 LGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMKIALDT 259
G D +V+E M++ L + L + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
A G+ YL +HRDL + N L+ + K+ DFG++ + + G
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VGGH 194
Query: 318 GYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ PE ++ K T +SDV++FGV+L E+ G++P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-42
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
LG G FG V K VAVK + + EF E + + HP +V G +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 218 HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHR 277
+ +IV E + N L L SHG L +++ D G+ +L H IHR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 278 DLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLDGKLTD 332
DL + N L+D K+SDFG+ + D + GT V APE K +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYSS 184
Query: 333 KSDVYAFGVVLLELL-LGRRP 352
KSDV+AFG+++ E+ LG+ P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-42
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LGEG FG V+ A+ D + VAVK L A++ A ++F+ E +LL+ + H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD--IQLHGP----------SHGSALTWHMRMKIALD 258
G +V+E M + L+ ++ HGP L + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGT 316
A G+ YL +HRDL + N L+ K+ DFG++ I + G
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGG 218
Query: 317 LGYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ PE +L K T +SDV++FGVVL E+ G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-42
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LGE FG VYK L + VA+K L D A EF +E L + + HPNV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD-------------IQLHGPSHGSALTWHMRMKIA 256
VCLLG D +++ + L + SAL + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 257 LDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
A G+EYL H +H+DL + N+L+ K N K+SD GL + K L
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---LL 187
Query: 314 SGTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+L + APE ++ GK + SD++++GVVL E+ G +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 64/290 (22%), Positives = 109/290 (37%), Gaps = 42/290 (14%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC 211
+ LGEGGF V + L D A+K++ C Q E + E D+ +HPN++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 212 LLGYSAHDDTR----FIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
L+ Y + +++ + +L + G+ LT + + L RGLE +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---------GTL 317
H HRDLK +NILL + L D G + + + T+
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 318 GYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373
Y APE L + + +++DV++ G VL ++ G P + + +
Sbjct: 208 SYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV-----------FQKGDS 255
Query: 374 DRSKLPNIVDPVIKSTM--DLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
+ N + L L + +P RP I +L
Sbjct: 256 VALAVQNQLSIPQSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLS 299
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 68/298 (22%), Positives = 113/298 (37%), Gaps = 48/298 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIHHPN 208
F LG GGFG V++AK D+ + A+K++ ++ RE EV L+ + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 209 VVCLLGYSAHDDTR------------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIA 256
+V +T +I +L +L ++G + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA------------ITDG 304
L A +E+LH ++HRDLK SNI K+ DFGL +T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364
+ GT Y++PE + + K D+++ G++L EL L P Q
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---------LYPFSTQME 232
Query: 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
+ + K P + K + Q + P P RP +++ +
Sbjct: 233 RVRTLTDVR-NLKFPPL--FTQKYP-CEYVMVQ------DMLSPSPMERPEAINIIEN 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 157 NILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
+LG G FG VYK + VA+K+L + + A +E +E +++++ +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG T ++ +LM L + H + + + A+G+ YL +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPEYLL 326
++HRDL + N+L+ + + K++DFGLA + + + K+ + ++A E +L
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALESIL 192
Query: 327 DGKLTDKSDVYAFGVVLLELL-LGRRP 352
T +SDV+++GV + EL+ G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 66/220 (30%), Positives = 111/220 (50%), Gaps = 33/220 (15%)
Query: 157 NILGEGGFGCVYKAKLDDN---LHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPNVVC 211
+++GEG FG V KA++ + + A+K++ + A++D R+F E+++L + HHPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 212 LLGYSAHDDTRFIVYELMENRSLD-------------IQLHGPSHGSALTWHMRMKIALD 258
LLG H ++ E + +L S S L+ + A D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG 318
ARG++YL + IHRDL + NIL+ + AK++DFGL+ + + T+G
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 201
Query: 319 YV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ A E L T SDV+++GV+L E++ LG P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 71/219 (32%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG G FG VY+ ++ L VAVK L + ++ +F E ++S +H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQL----HGPSHGSALTWHMRMKIALDTARGLEY 265
V +G S RFI+ ELM L L PS S+L + +A D A G +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 266 LHE-HCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
L E H IHRD+ + N LL AK+ DFG+A I S + G
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-----KGGCAM 206
Query: 320 V-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ PE ++G T K+D ++FGV+L E+ LG P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 27/279 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +GEG FG K +D +K+++ + + E EV +L+N+ HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V + + +IV + E L + G + + L+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+ ++HRD+KS NI L +L DFG+A S + GT Y++PE +
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSKLPNIVDPVI 386
+KSD++A G VL EL + E + I++ + P +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------PVSLHYSY-- 251
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
DL+ L + P RP + +L I
Sbjct: 252 ----DLRSLVS------QLFKRNPRDRPSVNSILEKGFI 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G FG V+ + VA+K + +F E +++ + HP +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+V E ME+ L L + + + LD G+ YL E C VIH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLDGKLT 331
RDL + N L+ K+SDFG+ + D + +GT V +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----TGTKFPVKWASPEVFSFSRYS 183
Query: 332 DKSDVYAFGVVLLELL-LGRRP 352
KSDV++FGV++ E+ G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 70/219 (31%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LG G FG VY+ ++ L VAVK L + ++ +F E ++S +H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQL----HGPSHGSALTWHMRMKIALDTARGLEY 265
V +G S RFI+ ELM L L PS S+L + +A D A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 266 LHE-HCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
L E H IHRD+ + N LL AK+ DFG+A I + G
Sbjct: 197 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCAM 247
Query: 320 V-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ PE ++G T K+D ++FGV+L E+ LG P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-41
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LG G FG V K VA+K + + EF E ++ N+ H +V L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
FI+ E M N L L +++ D +EYL +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 277 RDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLDGKLT 331
RDL + N L++ + K+SDFGL+ + D + G+ V PE L+ K +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 199
Query: 332 DKSDVYAFGVVLLELL-LGRRP 352
KSD++AFGV++ E+ LG+ P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
+F +G G F VY+A L D + VA+KK+ + E+DLL ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLE 264
PNV+ D+ IV EL + L I+ + K + LE
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALE 150
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
++H V+HRD+K +N+ + + KL D GL S+ L GT Y++PE
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLA---PAQCQSIVTWAMPQLTDRSKLPNI 381
+ + KSD+++ G +L E+ + P + C+ I P L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--------- 258
Query: 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
P + +L+ L +C+ P+P RP +T V
Sbjct: 259 --PSDHYSEELRQLVN------MCINPDPEKRPDVTYVY 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 157 NILGEGGFGCVYKAKLDDN----LHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVV 210
+LG+G FG V +A+L + VAVK K D EF E + HP+V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 211 CLLGYSAHDDTR------FIVYELMENRSLD--IQLHGPSH-GSALTWHMRMKIALDTAR 261
L+G S + ++ M++ L + L ++ +D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 262 GLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
G+EYL + IHRDL + N +L ++DFGL+ I G + + +
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR---QGCASKL 201
Query: 319 YV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
V A E L D T SDV+AFGV + E++ G+ P
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG V +L + VA+K L T+ R+F E ++ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G IV E MEN SLD L H + T + + A G++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDG 328
+HRDL + NIL++S K+SDFGL + G + +PE +
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 329 KLTDKSDVYAFGVVLLELL-LGRRP 352
K T SDV+++G+VL E++ G RP
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 157 NILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
I+G G G V +L ++ VA+K L T+ R+F +E ++ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G IV E MEN SLD L +H T + + G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDG 328
+HRDL + N+L+DS K+SDFGL+ +G + APE +
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 329 KLTDKSDVYAFGVVLLELL-LGRRP 352
+ SDV++FGVV+ E+L G RP
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKLD-----DNLHVAVKKL-DCATQDAGREFENEVDLLSNI 204
LGEG FG V + D VAVK L + + + + E+++L N+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 205 HHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+H N+V G + ++ E + + SL L P + + + ++K A+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 263 LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
++YL +HRDL + N+L++S+ K+ DFGL I + Y
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-----------YY 183
Query: 320 V------------APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
APE L+ K SDV++FGV L ELL
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L L + ++ + + +A + +EYL + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLDGKL 330
HRDL + N L+ K++DFGL+ +T + + +G + APE L K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNKF 189
Query: 331 TDKSDVYAFGVVLLELL-LGRRP 352
+ KSDV+AFGV+L E+ G P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-40
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A D L VAVK L A D +E+ ++S++ H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 209 VVCLLGYSAHDDTRFIVYELMEN-----------RSLDIQLHGPSHGSALTWHMRMKIAL 257
+V LLG H ++ E R L+ S + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 258 DTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS 314
A+G+ +L +C IHRD+ + N+LL + AK+ DFGLA I + S N +
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKG 224
Query: 315 GTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
V APE + D T +SDV+++G++L E+ LG P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 46/233 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
LGEG FG V KA VAVK L + A+ R+ +E ++L ++HP+V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VCLLGYSAHDDTRFIVYELMENRSL---------------------DIQLHGPSHGSALT 248
+ L G + D ++ E + SL + ALT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ A ++G++YL E +HRDL + NIL+ K+SDFGL+ +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDV---- 200
Query: 306 QNKNNLKLSGTLGYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ + + + G + A E L D T +SDV++FGV+L E++ LG P
Sbjct: 201 -YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-40
Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 46/233 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNV 209
+GEG FG V++A+ + VAVK L + A+ D +F+ E L++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 210 VCLLGYSAHDDTRFIVYELMENRSL---------------------DIQLHGPSHGSALT 248
V LLG A +++E M L L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
++ IA A G+ YL E +HRDL + N L+ K++DFGL+ I
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 306 QNKNNLKLSGTLGYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
K + + PE + + T +SDV+A+GVVL E+ G +P
Sbjct: 229 YYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 158 ILGEGGFGCVYKAKL-----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVC 211
++G G FG VYK L + VA+K L T+ +F E ++ H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 212 LLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
L G + I+ E MEN +LD L + + + A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDG 328
+HRDL + NIL++S K+SDFGL+ + SG + APE +
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 329 KLTDKSDVYAFGVVLLELL-LGRRP 352
K T SDV++FG+V+ E++ G RP
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 31/215 (14%)
Query: 158 ILGEGGFGCVYKAKL--------DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
LG+G F ++K V +K LD A ++ F ++S + H ++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V G D +V E ++ SLD L + + + ++++A A + +L E+
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 270 CNPAVIHRDLKSSNILLDSKFN--------AKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
+IH ++ + NILL + + KLSD G++ + + + +
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------W 183
Query: 320 VAPEYLLDGKL-TDKSDVYAFGVVLLELL-LGRRP 352
V PE + + K +D ++FG L E+ G +P
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG G FG V+ A + + VAVK + + F E +++ + H +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + +I+ E M SL L GS + + A G+ ++ +
Sbjct: 247 KLHAVVTKEPI-YIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYL 325
IHRDL+++NIL+ + K++DFGLA I D G + APE +
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR----EGAKFPIKWTAPEAI 357
Query: 326 LDGKLTDKSDVYAFGVVLLELL-LGRRP 352
G T KSDV++FG++L+E++ GR P
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 157 NILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVV 210
+LG G FG VYK + VA+K+L + + A +E +E +++++ +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LLG T ++ +LM L + H + + + A+G+ YL +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ--NKNNLKLSGTLGYVAPEYLL 326
++HRDL + N+L+ + + K++DFGLA + + + K+ + ++A E +L
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALESIL 192
Query: 327 DGKLTDKSDVYAFGVVLLELL-LGRRP 352
T +SDV+++GV + EL+ G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 157 NILGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HH 206
LGEG FG V A+ + + VAVK L D AT+ + +E++++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRM 253
N++ LLG D +++ E +L +T+ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
ARG+EYL C IHRDL + N+L+ K++DFGLA D + K
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKK 215
Query: 313 LSGTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ V APE L D T +SDV++FGV++ E+ LG P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVKKL +T++ R+FE E+++L
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
++ H N+V G YSA ++ E + SL L H + ++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQIC 124
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+G+EYL IHRDL + NIL++++ K+ DFGL + +
Sbjct: 125 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----------- 169
Query: 318 GYV------------APEYLLDGKLTDKSDVYAFGVVLLELL 347
+ APE L + K + SDV++FGVVL EL
Sbjct: 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY- 215
+G+G FG V N VAVK + + F E +++ + H N+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+IV E M SL L S L +K +LD +EYL + +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDGKLTD 332
HRDL + N+L+ AK+SDFGL + S ++ KL V APE L + K +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT-KEASSTQDTGKLP-----VKWTAPEALREKKFST 193
Query: 333 KSDVYAFGVVLLELL-LGRRP 352
KSDV++FG++L E+ GR P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 159 LGEGGFGCVYKAKL---DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + + VA+K L + E E ++ + +P +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +V E+ L L G + ++ + G++YL E
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---F 131
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDGKLT 331
+HRDL + N+LL ++ AK+SDFGL+ G+ + S + APE + K +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 332 DKSDVYAFGVVLLELL-LGRRP 352
+SDV+++GV + E L G++P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG V++ + L VA+K +C + +F E + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L +L + A + L YL
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLD 327
+HRD+ + N+L+ S KL DFGL+ + D + K S + APE +
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWMAPESINF 191
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
+ T SDV+ FGV + E+L G +P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 157 NILGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HH 206
LGEG FG V A+ + + VAVK L D AT+ + +E++++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRM 253
N++ LLG D +++ E +L +T+ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
ARG+EYL C IHRDL + N+L+ K++DFGLA D + K
Sbjct: 207 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKK 261
Query: 313 LSGTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ V APE L D T +SDV++FGV++ E+ LG P
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 8/199 (4%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+ LG G +G VY+ +L VAVK L T + EF E ++ I HPN+V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ +I+ E M +L L + ++ + + +A + +EYL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
HR+L + N L+ K++DFGL+ + G + + + APE L K + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 335 DVYAFGVVLLELL-LGRRP 352
DV+AFGV+L E+ G P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 68/240 (28%), Positives = 96/240 (40%), Gaps = 50/240 (20%)
Query: 144 KLLEKATDS--FHESNI-----LGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDA 190
L + D FH+ + LGEG FG V D VAVK L A
Sbjct: 17 VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH 76
Query: 191 GREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
++ E+D+L ++H +++ G A + +V E + SL L S +
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IG 132
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ A G+ YLH H IHRDL + N+LLD+ K+ DFGLA + +G
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
Query: 306 QNKNNLKLSGTLGYV------------APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ Y APE L + K SDV++FGV L ELL
Sbjct: 189 E-----------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVKKL +T++ R+FE E+++L
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
++ H N+V G YSA ++ E + SL L H + ++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQIC 155
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+G+EYL IHRDL + NIL++++ K+ DFGL + +
Sbjct: 156 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----------- 200
Query: 318 GYV------------APEYLLDGKLTDKSDVYAFGVVLLELL 347
Y APE L + K + SDV++FGVVL EL
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
++ LG G FG V+ + + VAVK L + F E +L+ + H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + +I+ E MEN SL L PS G LT + + +A A G+ ++ E
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS-QNKNNLKLSGTLGYV---APEY 324
IHRDL+++NIL+ + K++DFGLA I D + K + APE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTAPEA 181
Query: 325 LLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ G T KSDV++FG++L E++ GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
ILGEG FG VY+ + ++VAVK T D +F +E ++ N+ HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L + ++L + +L + + YL
Sbjct: 79 IGIIE-EEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV---APEYLLD 327
+HRD+ NIL+ S KL DFGL+ I D K S T + +PE +
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA----SVTRLPIKWMSPESINF 188
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
+ T SDV+ F V + E+L G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 69/227 (30%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A VAVK L + AT R +E+ +L +I HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 209 VVCLLGY-SAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMK 254
VV LLG + ++ E + +L + LT +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 255 IALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNL 311
+ A+G+E+L C IHRDL + NILL K K+ DFGLA I K+
Sbjct: 153 YSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI-----YKDPD 203
Query: 312 KLSGTLGYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ + APE + D T +SDV++FGV+L E+ LG P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 153 FHESNI-----LGEGGFGCVYKAKLD-----DNLHVAVKKLDCATQDAGREFENEVDLLS 202
F E ++ LG+G FG V + D VAVK+L + D R+F+ E+ +L
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 203 NIHHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+H +V G Y + +V E + + L L H + L + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQIC 137
Query: 261 RGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+G+EYL C +HRDL + NIL++S+ + K++DFGLA +
Sbjct: 138 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----------- 182
Query: 318 GYV------------APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
YV APE L D + +SDV++FGVVL EL +
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LG G FG V +A D + VAVK L A +E+ +LS + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL---------------DIQLHGPSHGSALTWHMRM 253
+V LLG ++ E L AL +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 254 KIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
+ A+G+ +L +C IHRDL + NILL K+ DFGLA D + N +
Sbjct: 149 SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA-RDIKNDSNYVV 203
Query: 313 LSGTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
V APE + + T +SDV+++G+ L EL LG P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 46/233 (19%)
Query: 157 NILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
+LG G FG V A ++ VAVK L + A +E+ +++ + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL--------------------DIQLHGPSHGSALT 248
+V LLG ++++E L +L + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 249 WHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ + A A+G+E+L C +HRDL + N+L+ K+ DFGLA I
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDI---- 222
Query: 306 QNKNNLKLSGTLGYV-----APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
++ + + APE L +G T KSDV+++G++L E+ LG P
Sbjct: 223 -MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 74/319 (23%), Positives = 119/319 (37%), Gaps = 52/319 (16%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYS 216
L EGGF VY+A+ + A+K+L ++ R EV + + HPN+V +
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 217 AH-----DDTRFIVYELME--NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ D + L E L L L+ +KI T R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS------------GTL 317
P +IHRDLK N+LL ++ KL DFG A T + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 318 GYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373
Y PE ++D + +K D++A G +L L + P E A + + +++P
Sbjct: 215 MYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-GKYSIPPHD 272
Query: 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433
+ L + +Q P R I +V+H L E+
Sbjct: 273 TQYT-------------VFHSLIRA------MLQVNPEERLSIAEVVHQLQ-----EIAA 308
Query: 434 TLRVAPSGPPADSTIPSGH 452
V P P + +G
Sbjct: 309 ARNVNPKSPITELLEQNGG 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG+G FG V+ + VA+K L T F E ++ + H +V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L ++ +IV E M SL L G + G L + +A A G+ Y+
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS-QNKNNLKLSGTLGYVAPEYLLD 327
+HRDL+++NIL+ K++DFGLA I D + K + + APE L
Sbjct: 301 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALY 355
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
G+ T KSDV++FG++L EL GR P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
F E +LG+G FG V KA+ D+ + A+KK+ T++ +EV LL++++H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 209 VVCLLG-------------YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRM 253
VV T FI E EN +L I + W +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-----------IT 302
+I L Y+H +IHRDLK NI +D N K+ DFGLA +
Sbjct: 124 QILE----ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 303 DGSQNKNNLKLS---GTLGYVAPEYLLDGKLTD--KSDVYAFGVVLLELL 347
+ ++ L+ GT YVA E +LDG K D+Y+ G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 20/242 (8%)
Query: 159 LGEGGFGCVYKAKLDDNLH--VAVKKL--DCATQDAGRE-FENEVDLLSNIHHPNVVCLL 213
+G GG G VY+A+ D VA+K + ++ R + E + P+VV +
Sbjct: 42 VGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 214 GYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
+ D ++ L+ L ++ GP L + I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
HRD+K NIL+ + A L DFG+A TD + + GTL Y+APE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-RSKLPNIVDPVIKS 388
T ++D+YA VL E L G P + + + + A+P+ + R +P D VI
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271
Query: 389 TM 390
M
Sbjct: 272 GM 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 32/279 (11%)
Query: 151 DSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNI-HH 206
SF + LG G +G V+K +D AVK+ + EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P V L ++ EL +Q H + G++L DT L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP---SLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H ++H D+K +NI L + KL DFGL + G+ G Y+APE LL
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQEGDPRYMAPE-LL 228
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
G +DV++ G+ +LE+ P + QL P +
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL-----PHGGEG-----WQQLRQGYLPPEFTAGL- 277
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
+ +L+ + + ++P+P R +L ++
Sbjct: 278 --SSELRSVLV------MMLEPDPKLRATAEALLALPVL 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 12/226 (5%)
Query: 131 VSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDA 190
+ E +S LG+G FG V+ + VA+K L T
Sbjct: 247 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP 306
Query: 191 GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH 250
F E ++ + H +V L ++ +IV E M SL L G + G L
Sbjct: 307 -EAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLP 363
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS-QN 307
+ +A A G+ Y+ +HRDL+++NIL+ K++DFGLA I D
Sbjct: 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
+ K + + APE L G+ T KSDV++FG++L EL GR P
Sbjct: 421 RQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKL-DCATQDAGREFENEVDLLSNI 204
+ +LG G FG V+K + V +K + D + + + + + + + ++
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H ++V LLG + +V + + SL + H AL + + + A+G+
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQIAKGMY 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV-- 320
YL EH ++HR+L + N+LL S +++DFG+A + + S +
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAKTPIKW 183
Query: 321 -APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
A E + GK T +SDV+++GV + EL+ G P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 66/312 (21%), Positives = 111/312 (35%), Gaps = 43/312 (13%)
Query: 159 LGEGGFGCVYKAKLDDNLH---VAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLG 214
+ GG G +Y A D N++ V +K L + +A E L+ + HP++V +
Sbjct: 88 IAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 215 YSAHDDTR-----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+ H D +IV E + +SL L + L+ L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+++ DLK NI+L + KL D G I L GT G+ APE ++
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPE-IVR 250
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387
T +D+Y G L L L +P+ K + +++
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRLLR 302
Query: 388 STM--DLKHLYQVA---AVAVLCVQPEPSYRPLITDV--LHSLIPLVPVELGGTLRVAPS 440
+ D + + A + + V E + L ++ G L VA +
Sbjct: 303 RAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHT 362
Query: 441 GPPADSTIPSGH 452
D + +
Sbjct: 363 DVYLDGQVHAEK 374
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 37/285 (12%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +G G +G K + D + K+LD + + +EV+LL + HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 208 NVVCLLG--YSAHDDTRFIVYELMENRSLDIQL-HGPSHGSALTWHMRMKIALDTARGLE 264
N+V + T +IV E E L + G L +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 265 YLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
H + V+HRDLK +N+ LD K N KL DFGLA GT Y++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR------S 376
E + +KSD+++ G +L EL P ++ +L +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----------AFSQKELAGKIREGKFR 234
Query: 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
++P +L + + + +RP + ++L
Sbjct: 235 RIPYRYSD------ELNEIIT------RMLNLKDYHRPSVEEILE 267
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G+G FG V N VAVK + + F E +++ + H N+V LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 217 AHDDTRF-IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
+ IV E M SL L S L +K +LD +EYL + +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY--VAPEYLLDGKLTDK 333
HRDL + N+L+ AK+SDFGL + ++ + +G L APE L + K + K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 334 SDVYAFGVVLLELL-LGRRP 352
SDV++FG++L E+ GR P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP 386
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 159 LGEGGFGCVYKAKL--------DDNLHVAVKKL-DCATQDAGREFENEVDLLSNI-HHPN 208
LGEG FG V A+ + VAVK L AT+ + +E++++ I H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-------------DIQLHGPSHGSALTWHMRMKI 255
++ LLG D +++ E +L + L+ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 256 ALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS 314
A ARG+EYL C IHRDL + N+L+ K++DFGLA D K +
Sbjct: 197 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA-RDIHHIDYYKKTT 251
Query: 315 GTLGYV---APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
V APE L D T +SDV++FGV+L E+ LG P
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVK--KLDCAT-QDAGREFENE 197
YK+++K LG GG VY A+ D L+ VA+K + ++ + FE E
Sbjct: 13 YKIVDK----------LGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFERE 61
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
V S + H N+V ++ DD ++V E +E +L I+ HGP L+ +
Sbjct: 62 VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINF 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
G+++ H+ ++HRD+K NIL+DS K+ DFG+A +++ S + N L
Sbjct: 117 TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT+ Y +PE + +D+Y+ G+VL E+L+G P
Sbjct: 174 -GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL---DCATQDAGREFENEVDLLSNIHHPNVV 210
LG+G FG V + + + VAVK L + +A +F EV+ + ++ H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G +V EL SL +L H + A+ A G+ YL
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT---LGYVAPEYLLD 327
IHRDL + N+LL ++ K+ DFGL + + + + APE L
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
+ SD + FGV L E+ G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-37
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 158 ILGEGGFGCVYKAKL----DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCL 212
+GEG FG V++ + + VA+K +C + +F E + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +I+ EL L L +L + A + L YL
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDG---SQNKNNLKLSGTLGYVAPEYLLD 327
+HRD+ + N+L+ S KL DFGL+ + D +K L + APE +
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINF 566
Query: 328 GKLTDKSDVYAFGVVLLELL-LGRRP 352
+ T SDV+ FGV + E+L G +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 158 ILGEGGFGCVYKAKL---DDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPNVVCL 212
LG G FG V K VAVK K + E E +++ + +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
+G ++ +V E+ E L+ L + +++ + G++YL E
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 273 AVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT---LGYVAPEYLLDGK 329
+HRDL + N+LL ++ AK+SDFGL+ + + + + APE + K
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 330 LTDKSDVYAFGVVLLELL-LGRRP 352
+ KSDV++FGV++ E G++P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+LG+G +G VY + L + + +A+K++ + E+ L ++ H N+V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+ + I E + SL L GL+YLH++ ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 277 RDLKSSNILLDSKF-NAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKL--T 331
RD+K N+L+++ K+SDFG + + + GTL Y+APE + G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGPRGYG 203
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
+D+++ G ++E+ G+ P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G F VY+A+ + L VA+K +D + +NEV + + HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 215 YSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
Y D ++V E+ N ++ L + + + G+ YLH H
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAPEYLLDGKLT 331
++HRDL SN+LL N K++DFGLA + + L GT Y++PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQ--LKMPHEKHYTLCGTPNYISPE-IATRSAH 189
Query: 332 D-KSDVYAFGVVLLELLLGRRP 352
+SDV++ G + LL+GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVV 210
SF ++LG G G + + DN VAVK++ + + EV LL HPNV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81
Query: 211 CLLGYSAHDDTRFIVYELMENRSLD-IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
++I EL + ++ +H + + T GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLHSL 137
Query: 270 CNPAVIHRDLKSSNILL-----DSKFNAKLSDFGLA--ITDGSQNKNNLK-LSGTLGYVA 321
++HRDLK NIL+ K A +SDFGL + G + + + GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 322 PEYLLD---GKLTDKSDVYAFGVVLLELLLGRRP 352
PE L + T D+++ G V ++
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 58/301 (19%), Positives = 120/301 (39%), Gaps = 58/301 (19%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVD 199
Y +L++ +G GG V++ + A+K L+ A + NE+
Sbjct: 10 IYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 200 LLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
L+ + + ++ L Y D ++V E N L+ ++ + R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-----IDPWERKSY 113
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ + +H+H ++H DLK +N L+ KL DFG+A + + +
Sbjct: 114 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 314 SGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQ 360
GT+ Y+ PE + D K++ KSDV++ G +L + G+ P +++ ++
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+I+ + P+I + ++ + C++ +P R I ++L
Sbjct: 230 LHAIIDPNHEI-----EFPDIPEKDLQDVLK------------CCLKRDPKQRISIPELL 272
Query: 421 H 421
Sbjct: 273 A 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 66/343 (19%), Positives = 131/343 (38%), Gaps = 60/343 (17%)
Query: 102 SSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISF--IEYKLLEKATDSFHESNIL 159
S K + E + S LG + S IS Y +L++ +
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ----------I 64
Query: 160 GEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGY 215
G GG V++ + A+K L+ A + NE+ L+ + + ++ L Y
Sbjct: 65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 216 SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA 273
D ++V E N L+ ++ + R + + +H+H
Sbjct: 125 EITDQYIYMVME-CGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 274 VIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLD---- 327
++H DLK +N L+ KL DFG+A + + + G + Y+ PE + D
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 328 -------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQCQSIVTWAMPQLTDRSKL 378
K++ KSDV++ G +L + G+ P +++ ++ +I+ +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-----IEF 289
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
P+I + ++ + C++ +P R I ++L
Sbjct: 290 PDIPEKDLQDVLK------------CCLKRDPKQRISIPELLA 320
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 159 LGEGGFGCVYKAKL---DDNLHVAVKKL-DCATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + + VA+K L + E E ++ + +P +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
+ +V E+ L L + ++ + G++YL E
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV---APEYLLDGKLT 331
+HR+L + N+LL ++ AK+SDFGL+ G+ + S + APE + K +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 332 DKSDVYAFGVVLLELL-LGRRP 352
+SDV+++GV + E L G++P
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 58/301 (19%), Positives = 120/301 (39%), Gaps = 58/301 (19%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVK--KLDCATQDAGREFENEVD 199
Y +L++ +G GG V++ + A+K L+ A + NE+
Sbjct: 29 IYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 200 LLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKI 255
L+ + + ++ L Y D ++V E N L+ ++ + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-----IDPWERKSY 132
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ + +H+H ++H DLK +N L+ KL DFG+A + + +
Sbjct: 133 WKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 314 SGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQ 360
GT+ Y+ PE + D K++ KSDV++ G +L + G+ P +++ ++
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+I+ + P+I + ++ + C++ +P R I ++L
Sbjct: 249 LHAIIDPNHE-----IEFPDIPEKDLQDVLK------------CCLKRDPKQRISIPELL 291
Query: 421 H 421
Sbjct: 292 A 292
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+GGF ++ D A K + + + E+ + ++ H +VV G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ +D F+V EL RSL + + AR G +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQ 155
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAP 322
YLH + VIHRDLK N+ L+ K+ DFGLA + K L GT Y+AP
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAP 210
Query: 323 EYLLDGKLTD-KSDVYAFGVVLLELLLGRRP 352
E +L K + DV++ G ++ LL+G+ P
Sbjct: 211 E-VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 62/266 (23%), Positives = 100/266 (37%), Gaps = 35/266 (13%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGY 215
+G G FG V++ K AVKK+ E+ + + P +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 216 SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
I EL+E SL + L + GLEYLH ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 276 HRDLKSSNILLDSK-FNAKLSDFGLA--ITDGSQNKNNLK---LSGTLGYVAPEYLLDGK 329
H D+K+ N+LL S A L DFG A + K+ L + GT ++APE ++
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
K D+++ ++L +L G P + C I + P ++P P+
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----EIPPSCAPLTAQ 288
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRP 414
+ ++ EP +R
Sbjct: 289 AIQ------------EGLRKEPVHRA 302
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+GGF ++ D A K + + + E+ + ++ H +VV G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ +D F+V EL RSL + + AR G +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQ 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK--LSGTLGYVAP 322
YLH + VIHRDLK N+ L+ K+ DFGLA + K L GT Y+AP
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKVLCGTPNYIAP 184
Query: 323 EYLLDGKLTD-KSDVYAFGVVLLELLLGRRP 352
E +L K + DV++ G ++ LL+G+ P
Sbjct: 185 E-VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 62/302 (20%), Positives = 104/302 (34%), Gaps = 55/302 (18%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKK--LDCATQDAGREFENEVDLLSNI-H 205
T FHE +G G FG V+K K D A+K+ A + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H +VV A DD I E SL D S + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 265 YLHEHCNPAVIHRDLKSSNILLD-------------------SKFNAKLSDFGLAITDGS 305
Y+H +++H D+K SNI + +K K+ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----T 182
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364
+ + G ++A E L + K+D++A + ++ I
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--HEI 240
Query: 365 VTWAMPQLTDR-SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HS 422
+P++ S+ + L + + + P+P RP ++ HS
Sbjct: 241 RQGRLPRIPQVLSQ-------------EFTELLK------VMIHPDPERRPSAMALVKHS 281
Query: 423 LI 424
++
Sbjct: 282 VL 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGRE--FENEVDLLSNIHHPNVVCLLG 214
LG+G FG VY A+ +A+K L + AG E EV++ S++ HPN++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 215 YSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y HD TR +++ E ++ ++Q + A L Y H
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSK-- 128
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
VIHRD+K N+LL S K++DFG ++ + + L GTL Y+ PE +++G++
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPE-MIEGRMH 184
Query: 332 DKS-DVYAFGVVLLELLLGRRP 352
D+ D+++ GV+ E L+G+ P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 15/234 (6%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+GEG G V A+ VAVK +D Q NEV ++ + H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
VV + + +++ E ++ +L DI L + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH 158
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
VIHRD+KS +ILL KLSDFG I+ + + L GT ++APE +
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVI 213
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378
+ D+++ G++++E++ G P +P Q + + P+L + K+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 37/298 (12%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVD 199
+Y+L E +G G V A VA+K+++ Q + E E+
Sbjct: 16 DYELQEV----------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMR-MKIAL 257
+S HHPN+V D ++V +L+ S+ DI H + G + + IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 258 ---DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
+ GLEYLH++ IHRD+K+ NILL + +++DFG++ + G N
Sbjct: 126 ILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 313 LS---GTLGYVAPEYLLDGKLTD-KSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTW 367
GT ++APE + + D K+D+++FG+ +EL G P K P + +
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 368 AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
P L + ++ KS + ++ LC+Q +P RP ++L H
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKM-----IS----LCLQKDPEKRPTAAELLRHKFF 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 15/234 (6%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ +G+G G VY A + VA+++++ Q NE+ ++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V L D ++V E + SL D+ + + + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLH 133
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
+ VIHRD+KS NILL + KL+DFG IT ++ + GT ++APE +
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378
K D+++ G++ +E++ G P P + I T P+L + KL
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLD-----------------CATQDAGREFENEVDLL 201
L +G F + + DN A+KK + + + +F+NE+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 202 SNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGP---SHGSALTWHMRMKI 255
++I + + G + +I+YE MEN S+ + ++ + + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS- 314
Y+H N + HRD+K SNIL+D KLSDFG S+ + K+
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE-----SEYMVDKKIKG 209
Query: 315 --GTLGYVAPEYLLDGKLT---DKSDVYAFGVVLLELLLGRRP 352
GT ++ PE + + K D+++ G+ L + P
Sbjct: 210 SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 74/332 (22%), Positives = 128/332 (38%), Gaps = 71/332 (21%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVK--KLDCAT-QDAGREFENE 197
Y+L E LG GG V+ A+ D H VAVK + D A F E
Sbjct: 14 YELGEI----------LGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 198 VDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHM 251
+ ++HP +V + + +IV E ++ +L + GP +T
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKR 117
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---------IT 302
+++ D + L + H++ +IHRD+K +NI++ + K+ DFG+A +T
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ 362
+ + GT Y++PE + +SDVY+ G VL E+L G P +P
Sbjct: 175 QTAA------VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---- 224
Query: 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LIT 417
V+ A + + P+ + + +D AV + + P R +
Sbjct: 225 --VSVAYQHVREDPIPPSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRA 274
Query: 418 DVLHSLIPLVPVELGGTLRVAPSGPPADSTIP 449
D++ P A+ T
Sbjct: 275 DLVRVHNGEPPEA-------PKVLTDAERTSL 299
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 19/221 (8%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSNI 204
+ + LG GGFG V + D VA+K+ RE + E+ ++ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 205 HHPNVVCLL------GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
+HPNVV A +D + E E L L+ + L + D
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLA--ITDGSQNKNNLKL 313
+ L YLHE+ +IHRDLK NI+L K+ D G A + G +
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---EF 183
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
GTL Y+APE L K T D ++FG + E + G RP
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 35/317 (11%), Positives = 72/317 (22%), Gaps = 51/317 (16%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC---ATQDAGREFENEVDLLSNIHHPNVVCLL 213
L G V+ + ++ A+K ++ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 214 GY-----------------------SAHDDTRFIVYELMENRSLDIQLHG------PSHG 244
D LM S+D++L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304
+ R L ++H N+ + L D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 305 SQNKNNLKLSGTLGYVAPEYLLDGKL--TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ 362
++ S + Y E+L T + + G+ + + P + P
Sbjct: 246 TRGPA---SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-H 421
+W P L +K L + + R L + +
Sbjct: 303 ---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTL-----IGRFL-NFDRRRRLLPLEAMET 353
Query: 422 SLIPLVPVELGGTLRVA 438
+ E+ +L
Sbjct: 354 PEFLQLQNEISSSLSTG 370
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 11/224 (4%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDA 190
K+ A + K+ E D F + + LG G G V+K L +A K + + A
Sbjct: 14 RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73
Query: 191 GREF-ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTW 249
R E+ +L + P +V G D I E M+ SLD L +
Sbjct: 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPE 130
Query: 250 HMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNK 308
+ K+++ +GL YL E ++HRD+K SNIL++S+ KL DFG++ S
Sbjct: 131 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188
Query: 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ + GT Y++PE L + +SD+++ G+ L+E+ +GR P
Sbjct: 189 SFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 60/232 (25%), Positives = 90/232 (38%), Gaps = 37/232 (15%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLS-NIHHPNV 209
+ ILG G G V VAVK++ D E+ LL+ + HPNV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMR--MKIALDTARGLEY 265
+ D +I EL +L ++ S + + + A G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 266 LHEHCNPAVIHRDLKSSNILLDSK-------------FNAKLSDFGLA-ITDGSQNKNNL 311
LH +IHRDLK NIL+ + +SDFGL D Q+
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 312 KLS---GTLGYVAPEYLLDG-------KLTDKSDVYAFGVVLLELL-LGRRP 352
L+ GT G+ APE L + +LT D+++ G V +L G+ P
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 55/266 (20%), Positives = 97/266 (36%), Gaps = 37/266 (13%)
Query: 143 YKLLEKATDSFHESNILGEG--GFGCVYKAK-LDDNLHVAVKK--LDCATQDAGREFENE 197
Y+LL +G+G V A+ +V V++ L+ + + + E
Sbjct: 27 YELLTV----------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIA 256
+ + +HPN+V D+ ++V M S D+ G IA
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IA 131
Query: 257 L---DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNL 311
+ L+Y+H +HR +K+S+IL+ LS + Q + +
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 312 KLS-----GTLGYVAPEYLLDGKL--TDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QS 363
L +++PE L KSD+Y+ G+ EL G P + + Q
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 364 IVTWAMPQLTDRSKLPNIVDPVIKST 389
+ +P L D S +P + S
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSR 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 40/228 (17%), Positives = 73/228 (32%), Gaps = 24/228 (10%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLDCATQDAGREFENEVD 199
+ + + ++LGEG F VY+A D +K A ++
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLD--IQLHGPSHGSALTWHMRMKIAL 257
L + + +V EL +L I L+ + + + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILL-----------DSKFNAKLSDFGLAITDGSQ 306
+E +H+ +IH D+K N +L D L D G +I
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 307 NKNNL--KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
K + T G+ E L + + D + + +L G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 24/220 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
+ S+ILG+G V++ + A+K + + E ++L ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 209 VVCLLGY--SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L + ++ E SL L PS+ L + + D G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 267 HEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
E+ ++HR++K NI+ D + KL+DFG A + D Q L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182
Query: 321 APEYLLDGKLTD--------KSDVYAFGVVLLELLLGRRP 352
P+ L D+++ GV G P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G FG VY A+ + +A+K L + + + E+++ S++ HPN++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 215 YSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
Y HD R +++ E L ++Q HG + A L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSATFMEELADALHYCHERK- 134
Query: 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAI-TDGSQNKNNLKLSGTLGYVAPEYLLDGKL 330
VIHRD+K N+L+ K K++DFG ++ + + + GTL Y+ PE +++GK
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLDYLPPE-MIEGKT 188
Query: 331 TDKS-DVYAFGVVLLELLLGRRP 352
D+ D++ GV+ E L+G P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 18/239 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ + LG+G FG VYKAK + A K ++ +++ ++ E+++L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V LLG HD +I+ E ++ I L LT + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
+IHRDLK+ N+L+ + + +L+DFG++ Q +++ GT ++APE +
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVV 189
Query: 326 LDGKLTD-----KSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378
+ + D K+D+++ G+ L+E+ P +L P + I P L SK
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 24/220 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
+ S+ILG+G V++ + A+K + + E ++L ++H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 209 VVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
+V L TR ++ E SL L PS+ L + + D G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 267 HEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYV 320
E+ ++HR++K NI+ D + KL+DFG A + D Q L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182
Query: 321 APEYLLDGKLTD--------KSDVYAFGVVLLELLLGRRP 352
P+ L D+++ GV G P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 18/257 (7%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDA 190
S K + I + + + +G G G V+K + +AVK++ +
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 191 GRE-FENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
+ ++D +L + P +V G + FI ELM + ++ +
Sbjct: 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR---MQGPIP 122
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQN 307
+ K+ + + L YL E VIHRD+K SNILLD + KL DFG+ +
Sbjct: 123 ERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTD-----KSDVYAFGVVLLELLLGRRPVEKLAP--AQ 360
K+ +G Y+APE + T ++DV++ G+ L+EL G+ P +
Sbjct: 181 KDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
Query: 361 CQSIVTWAMPQLTDRSK 377
++ P L
Sbjct: 239 LTKVLQEEPPLLPGHMG 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC-ATQDAGREFENEVDL 200
+ LEK +G+G FG V+K VA+K +D +D + + E+ +
Sbjct: 24 FTKLEK----------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDT 259
LS P V G D +I+ E + S D+ GP L I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREI 128
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+GL+YLH IHRD+K++N+LL KL+DFG+A +TD +N GT
Sbjct: 129 LKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTP 183
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
++APE + K+D+++ G+ +EL G P +L P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 23/221 (10%)
Query: 145 LLEKATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVK---KLDCATQDAGREFEN 196
++ +T F + +LG+G FG V K AVK K +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 197 EVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
EV LL + HPN++ L + ++V E+ L +I + +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-----FSEVDAAR 130
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNL 311
I G+ Y+H++ ++HRDLK N+LL+SK N ++ DFGL+ +K
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMK 186
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y+APE +L G +K DV++ GV+L LL G P
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 41/241 (17%), Positives = 78/241 (32%), Gaps = 54/241 (22%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE----------------------- 193
+LG+ +A + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 194 -----FENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVYELMENRSLD----IQLHGPS 242
F DL+ + ++ + +RF +Y M++ + H +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302
H S L H R+++ L R L LH + ++H L+ +I+LD + L+ F +
Sbjct: 200 HKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 303 DGSQNKNNLKLSGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRR 351
DG+ + S + G+ PE +T D +A G+V+ +
Sbjct: 256 DGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 352 P 352
P
Sbjct: 312 P 312
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 15/234 (6%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
+ F LGEG +G VYKA + VA+K++ + +E E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
VV G + +IV E S+ DI LT I T +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
IHRD+K+ NILL+++ +AKL+DFG+A +TD +N + GT ++APE +
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKL 378
+ +D+++ G+ +E+ G+ P + P + I T P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 17/257 (6%)
Query: 130 MVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQ 188
M + + + + + + +G G +G V K +AVK++
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60
Query: 189 DAGRE-FENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI-QLHGPSHGS 245
+ ++ ++D ++ + P +V G + +I ELM +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 246 ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITD 303
+ + KI L T + L +L E+ +IHRD+K SNILLD N KL DFG++ + D
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTD----KSDVYAFGVVLLELLLGRRPVEKLAP- 358
+ G Y+APE + +SDV++ G+ L EL GR P K
Sbjct: 179 SIAKTRDA---GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 359 -AQCQSIVTWAMPQLTD 374
Q +V PQL++
Sbjct: 236 FDQLTQVVKGDPPQLSN 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + +GEG +G V+KAK + + VA+K++ D G RE + LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKE 57
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ H N+V L D +V+E + D++ + S L + +GL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ H V+HRDLK N+L++ KL++FGLA G + TL Y P+
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 324 YLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
L KL S D+++ G + EL RP
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 63/446 (14%), Positives = 131/446 (29%), Gaps = 102/446 (22%)
Query: 60 HHHHMDAHHKLLIALIIACSALCLIILALLCLWLYHLKYSFKSSNKNAKSKDSENGVVLS 119
HHHH L ++I L + + + + + +V +
Sbjct: 4 HHHHSSGRENLYFQGFRGTDPGDVVIEELF-----NRIPQANVRTTSEYMQSAADSLVST 58
Query: 120 SFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHV 178
S R+ S+ G + L + +LG+ +A +
Sbjct: 59 SLWNTGQPFRVESELGE-----RPRTLVRG-------TVLGQEDPYAYLEATDQETGESF 106
Query: 179 AVK---KLDCATQDAGREFENEV-------------------------DLLSNIHHPNVV 210
V + +A ++ + EV DL+ + ++
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 211 CLLGYSAHDD--TRFIVYELMENRSLD----IQLHGPSHGSALTWHMRMKIALDTARGLE 264
+ +RF +Y M++ + H +H S L H R+++ L R L
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIRLLA 225
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
LH + ++H L+ +I+LD + L+ F + DG+ + G+ PE
Sbjct: 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIGRGFAPPET 278
Query: 325 L----------LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374
+T D + G+ + + P + + +
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD------DAALGGSEWIFRS 332
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL---------HSLIP 425
+P V +++ ++ R L + L
Sbjct: 333 CKNIPQPVRALLEG----------------FLRYPKEDRLLPLQAMETPEYEQLRTELSA 376
Query: 426 LVPVELG-GTLRVAPSGPPADSTIPS 450
+P+ G PP+ ++ P
Sbjct: 377 ALPLYQTDGEPTREGGAPPSGTSQPD 402
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 145 LLEKATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENE 197
+ E LG G +G V + ++ A+K + + + + E
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE 86
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
V +L + HPN++ L + ++V E + L +I I
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVI 141
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLK 312
G+ YLH+H ++HRDLK N+LL+SK K+ DFGL+ +Q K +
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK-E 197
Query: 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y+APE +L K +K DV++ GV+L LL G P
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 72/207 (34%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-----EVDLLSNI 204
+ + + LGEG F VYKA+ + N VA+KK+ + ++ N E+ LL +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HPN++ LL H +V++ ME D+++ + LT L T +GLE
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
YLH+H ++HRDLK +N+LLD KL+DFGLA + GS N+ T Y APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
L ++ D++A G +L ELLL
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI 204
+ + + +GEG +G VYKAK VA+K++ +D G RE + LL +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKEL 76
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
HHPN+V L+ + +V+E ME D++ + + L RG+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
+ H+H ++HRDLK N+L++S KL+DFGLA G ++ TL Y AP+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
L+ K S D+++ G + E++ G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 14/239 (5%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVD-LLS 202
+E D LG G +G V K + + +AVK++ ++ ++D +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+ P V G + +I ELM+ G + + KIA+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLSGTLGYVA 321
LE+LH + VIHRD+K SN+L+++ K+ DFG+ K+ +G Y+A
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDAGCKPYMA 177
Query: 322 PE----YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP--AQCQSIVTWAMPQLTD 374
PE L + KSD+++ G+ ++EL + R P + Q + +V PQL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG------REFENEVDLLSNI 204
+ +H +GEG +G VYKA+ + A+KK+ +D G RE + +L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKEL 57
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H N+V L +V+E ++ D++ L L G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
Y H+ V+HRDLK N+L++ + K++DFGLA G + TL Y AP+
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
L+ K + D+++ G + E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 33/231 (14%)
Query: 145 LLEKATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVKKLD-------------CA 186
+ K E LG G +G V K + + A+K +
Sbjct: 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 187 TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHG 244
+ E NE+ LL ++ HPN++ L ++V E E L I
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--- 142
Query: 245 SALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAI 301
I G+ YLH+H ++HRD+K NILL++K N K+ DFGL+
Sbjct: 143 --FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
K GT Y+APE +L K +K DV++ GV++ LL G P
Sbjct: 198 FFSKDYKLR-DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHH 206
+ ++ +LG+G FG V K K AVK ++ A EV+LL + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN++ L + +IV EL L +I + H +I G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGIT 135
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
Y+H+H ++HRDLK NILL+SK + K+ DFGL+ K GT Y+A
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-DRIGTAYYIA 191
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE +L G +K DV++ GV+L LL G P
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIH 205
F + +G G FG VY A+ + ++ VA+KK+ + + + +++ EV L +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HPN + G + T ++V E + D+ H L + +GL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH H +IHRD+K+ NILL KL DFG A N GT ++APE +
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPAN-SFVGTPYWMAPEVI 222
Query: 326 LDGKLTD---KSDVYAFGVVLLELLLGRRPVEKLAP 358
L K DV++ G+ +EL + P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 56/272 (20%), Positives = 86/272 (31%), Gaps = 54/272 (19%)
Query: 132 SKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDC 185
G + + L + +H +G+G +G V A A+K K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 186 ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSH 243
+ EV L+ +HHPN+ L + +V EL L + +
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 244 GSALTWHMRMKIALDTAR-----------------------------------GLEYLHE 268
+ L YLH
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 269 HCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA-ITDGSQNKNNLKLS---GTLGYVAP 322
+ HRD+K N L + + KL DFGL+ N ++ GT +VAP
Sbjct: 187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 323 EYLLDG--KLTDKSDVYAFGVVLLELLLGRRP 352
E L K D ++ GV+L LL+G P
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN--EVDLLSNIHHP 207
+ + + +GEG +G V+K + D VA+KK + D + E+ +L + HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LL +V+E ++ + + + H+ I T + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH---TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+H IHRD+K NIL+ KL DFG A + T Y +PE L+
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 328 GKLTDKS-DVYAFGVVLLELLLGR 350
DV+A G V ELL G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 48/310 (15%), Positives = 83/310 (26%), Gaps = 63/310 (20%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLH--VAVKKLD---CATQDAGREFENE 197
Y+LL G ++A D L VA+ +D D +E +
Sbjct: 33 YRLLIF----------HGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSR 81
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
LS I P V +L +V E + SL + ++
Sbjct: 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQ 136
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
A + H V S + + + L+
Sbjct: 137 SLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP-------------------- 173
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
+ + D+ G L LL+ R P+ + S + A +
Sbjct: 174 ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDTAGQPI 223
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTLRV 437
P +D I + AVA VQ + R + +L+ + V +
Sbjct: 224 EPADIDRDIPFQIS--------AVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLG 274
Query: 438 APSGPPADST 447
P +
Sbjct: 275 PIDEAPVSAA 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGREFENEVDLLSNIHHPNVVC 211
++G+G F V + + AVK K + + + + E + + HP++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 212 LLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
LL + D ++V+E M+ L +I G + + L Y H++
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 270 CNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
+IHRD+K +LL SK N+ KL FG+AI G GT ++APE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRP 352
DV+ GV+L LL G P
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 149 ATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQD-----AGREFENEVDLLS 202
++ F + LG G + VYK ++VA+K++ +++ A RE + L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMEN--RSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N+V L ++ +V+E M+N + + L ++
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
+GL + HE+ ++HRDLK N+L++ + KL DFGLA G TL Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 321 APEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
AP+ L+ + S D+++ G +L E++ G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 151 DSFHESNILGEGGFGCVYKA-KLDDNLHVAVK---KLDCATQDAGREFENEVDLLSNIHH 206
D F +G+G FG V K D A+K K C ++ R E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMR--MKIALDTAR-- 261
P +V L YS D+ F+V +L+ G L +H++ + +T +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLL-------------GGDLRYHLQQNVHFKEETVKLF 120
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
L+YL +IHRD+K NILLD + ++DF +A + ++G
Sbjct: 121 ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMAG 176
Query: 316 TLGYVAPEYLLDGKLT--DKS-DVYAFGVVLLELLLGRRP 352
T Y+APE K + D ++ GV ELL GRRP
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQD-----AGREFENEVDLLSNI 204
+++ + + LGEG + VYK K + VA+K++ ++ A RE V LL ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE 264
H N+V L + + +V+E ++ D++ + G+ + H RGL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEY 324
Y H V+HRDLK N+L++ + KL+DFGLA K TL Y P+
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGR 350
LL D++ G + E+ GR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 39/212 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE--FENEVDLLSNIHHPNVVCLLGY 215
+G+G F V A+ + VA+K +D + EV ++ ++HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 216 SAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEY 265
+ T +++ E + D + HG RMK AR ++Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-----------RMKE--KEARSKFRQIVSAVQY 129
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVAP 322
H+ ++HRDLK+ N+LLD+ N K++DFG + T G + L G Y AP
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----LDAFCGAPPYAAP 182
Query: 323 EYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
E L GK D + DV++ GV+L L+ G P
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 44/253 (17%)
Query: 187 TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL----DIQLHGPS 242
+ ++ + N V L S+ +I +L +L + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302
+ H+ ++IA +E+LH ++HRDLK SNI K+ DFGL
Sbjct: 161 REHGVCLHIFIQIAE----AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 303 DGSQNKNNLKLS------------GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
+ L+ GT Y++PE + + K D+++ G++L ELL
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--- 270
Query: 351 RPVEKLAPAQCQSIVTWAMPQLTDRSK-LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPE 409
++ +R + + ++ + K+ Q + + P
Sbjct: 271 ----------------YSFSTQMERVRIITDVRNLKFPLLFTQKY-PQEHMMVQDMLSPS 313
Query: 410 PSYRPLITDVLHS 422
P+ RP TD++ +
Sbjct: 314 PTERPEATDIIEN 326
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDL 200
D + S LG G G V A VA++ + D E E+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 201 LSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGP---SHGSALTWHMRMK 254
L ++HP ++ + + D +IV ELME L + + + + M
Sbjct: 194 LKKLNHPCIIKI--KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--- 248
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKN 309
++YLHE+ +IHRDLK N+LL S+ K++DFG + + + S +
Sbjct: 249 -----LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR- 299
Query: 310 NLKLSGTLGYVAPEYLLDGKL---TDKSDVYAFGVVLLELLLGRRP 352
L GT Y+APE L+ D ++ GV+L L G P
Sbjct: 300 --TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + ++GEG +G V K + D VA+KK + D RE + LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQ 80
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ H N+V LL ++V+E +++ I + L + + K G+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH---TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
+ H H +IHRD+K NIL+ KL DFG A T + + T Y APE
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 324 YLLDGKLTDKS-DVYAFGVVLLELLLGR 350
L+ K+ DV+A G ++ E+ +G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 52/222 (23%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDLLSNIHHPNV 209
LG G FG V+ A + N V VK + + E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA------LTWHMRMKIALDTAR-- 261
+ + ++ EN+ QL HGS + H R+ A
Sbjct: 92 IKV-------------LDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDE--PLASYI 135
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+ YL +IHRD+K NI++ F KL DFG A + G
Sbjct: 136 FRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYT 188
Query: 314 S-GTLGYVAPEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
GT+ Y APE +L G + ++++ GV L L+ P
Sbjct: 189 FCGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHH 206
+ ++ +LG+G FG V K K AVK ++ A EV+LL + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN++ L + +IV EL L +I + H +I G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGIT 135
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
Y+H+H ++HRDLK NILL+SK + K+ DFGL+ K GT Y+A
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-DRIGTAYYIA 191
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
PE +L G +K DV++ GV+L LL G P
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G V A VAVK +D D + E+ + ++H NVV G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 217 AHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYL 266
+ +++ E L D I+ M A+ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI-----------GMPE--PDAQRFFHQLMAGVVYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLGYVAPEY 324
H + HRD+K N+LLD + N K+SDFGL + + + L GTL YVAPE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 325 LLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
LL + DV++ G+VL +L G P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 72/280 (25%), Positives = 110/280 (39%), Gaps = 62/280 (22%)
Query: 99 SFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNI 158
SF S K + + + +S +V+ G S+ ++ +
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR-------PQEVSYTDTKV 61
Query: 159 LGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN-EVDLLSNIHHPNVVCLLG-- 214
+G G FG VY+AKL D VA+KK+ QD F+N E+ ++ + H N+V L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV---LQDK--RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 215 YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD----------TA 260
YS+ + +V + + ++ + R K L
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-----TVY-----RVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLA--ITDGSQNKNNLKLSGTL 317
R L Y+H + HRD+K N+LLD KL DFG A + G N
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--------- 214
Query: 318 GYV------APEYLLDGKL-TDKSDVYAFGVVLLELLLGR 350
Y+ APE + T DV++ G VL ELLLG+
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHP 207
D F LG G FG V+ + L +K ++ +Q + E E+++L ++ HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 208 NVVCLLGYSAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGL 263
N++ + + +D +IV E E L I + L+ ++ L
Sbjct: 81 NIIKI--FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNAL 137
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLG 318
Y H V+H+DLK NIL K+ DFGLA + N GT
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
Y+APE + +T K D+++ GVV+ LL G P
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 50/216 (23%), Positives = 79/216 (36%), Gaps = 38/216 (17%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD----CATQDAGREFENEVDLLSNIHHPNVVCLL 213
LGEG +G V + + AVK L + + E+ LL + H NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 214 G--YSAHDDTRFIVYELMENRS---LDIQLHGPSHGSALTWHMRMKIALDTAR------- 261
Y+ ++V E LD R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPV--CQAHGYFCQLI 119
Query: 262 -GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLG 318
GLEYLH ++H+D+K N+LL + K+S G+ + + S G+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 319 YVAPEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
+ PE K D+++ GV L + G P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLD--CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG+G F V + + A ++ + ++ E E + + HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 215 YSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHE 268
+ + +++++L+ L DI + A + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128
Query: 269 HCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
V+HR+LK N+LL SK KL+DFGLAI + + +GT GY++PE L
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRP 352
D++A GV+L LL+G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+LG G F V+ K A+K + + ENE+ +L I H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 217 AHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274
++V +L+ L I G T + ++YLHE+ +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN---GI 127
Query: 275 IHRDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
+HRDLK N+L + ++DFGL+ + + + GT GYVAPE L +
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS--TACGTPGYVAPEVLAQKPYS 185
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
D ++ GV+ LL G P
Sbjct: 186 KAVDCWSIGVITYILLCGYPP 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
++L+E +G G +G VYK + + A+K +D + E + E+++L
Sbjct: 26 FELVEL----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINML 74
Query: 202 SNI-HHPNVVCLLG------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
HH N+ G DD ++V E S+ L + G+ L
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAY 133
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
I + RGL +LH+H VIHRD+K N+LL KL DFG++ + +N
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188
Query: 313 LSGTLGYVAPEYLLDGKLTD-----KSDVYAFGVVLLELLLGRRPVEKLAP 358
GT ++APE + + D KSD+++ G+ +E+ G P+ + P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 38/223 (17%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFEN-EVDLLSNIH 205
E+ ++ ++G G FG V++AKL ++ VA+KK+ QD F+N E+ ++ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV---LQDK--RFKNRELQIMRIVK 90
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
HPNVV L YS D +V E + ++ A + ++K +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVY-----RASRHYAKLKQTMPM 140
Query: 260 A----------RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNK 308
R L Y+H + HRD+K N+LLD KL DFG A +
Sbjct: 141 LLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 309 NNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGR 350
N + + Y APE + T D+++ G V+ EL+ G+
Sbjct: 198 NVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 41/230 (17%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENE 197
+ D + S LG G G V A VA+K + D E E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
+++L ++HP ++ + + D +IV ELME L + + ++
Sbjct: 66 IEILKKLNHPCIIKI--KNFFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEA 114
Query: 255 IALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGS 305
++YLHE+ +IHRDLK N+LL S+ K++DFG + + + S
Sbjct: 115 TCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKL---TDKSDVYAFGVVLLELLLGRRP 352
+ L GT Y+APE L+ D ++ GV+L L G P
Sbjct: 172 LMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 55/223 (24%), Positives = 87/223 (39%), Gaps = 31/223 (13%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH 205
K D F + G+G FG V K + VA+KK+ + RE + + L+ +H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 206 HPNVVCLL------GYSAHDDTRF-IVYELME---NRSLDIQLHGPSHGSALTWHMRMKI 255
HPN+V L G D +V E + +R + A +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR---NYYRRQVAPPPILIKVF 134
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLS 314
R + LH V HRD+K N+L++ + KL DFG A N
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----- 188
Query: 315 GTLGYV------APEYLLDGKL-TDKSDVYAFGVVLLELLLGR 350
+ Y+ APE + + T D+++ G + E++LG
Sbjct: 189 --VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 23/237 (9%)
Query: 129 RMVSKKGSAISFIEYKLLEKATDSFHES----NILGEGGFGCVYKA-KLDDNLHVAVK-- 181
M S G + + A+ F ++ LG+G F V + L A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 182 -KLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQL 238
+ +D ++ E E + + HPN+V L + ++V++L+ L DI
Sbjct: 63 NTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 239 HGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLS 295
+ + Y H + ++HR+LK N+LL SK KL+
Sbjct: 122 RE-----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
DFGLAI + +GT GY++PE L + D++A GV+L LL+G P
Sbjct: 174 DFGLAIEVNDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
+G G +G V A + A KK+ + F+ E++++ ++ HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 217 AHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GLEYLHEHC 270
+ ++V EL L + R A + + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKL- 125
Query: 271 NPAVIHRDLKSSNILLDSK---FNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYL 325
V HRDLK N L + KL DFGLA G + GT YV+P+ +
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQ-V 179
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRP 352
L+G + D ++ GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 67/240 (27%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGREFEN---------------- 196
+G+G +G V A +DN + A+K KL R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 197 -----EVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSL-DIQLHGPSHGSA 246
E+ +L + HPNVV L ++D ++V+EL+ + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132
Query: 247 LTWHMRMKIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298
+ D AR G+EYLH +IHRD+K SN+L+ + K++DFG
Sbjct: 133 -----PLSE--DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 299 LAITDGSQNKNNLKLS---GTLGYVAPEYLLDGKLT---DKSDVYAFGVVLLELLLGRRP 352
++ ++ LS GT ++APE L + + DV+A GV L + G+ P
Sbjct: 183 VS---NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 39/264 (14%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
K K K ++ K+ + K+GS + Y +LE+ LG
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEE----------LG 60
Query: 161 EGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219
G FG V++ K ++ +NE+ +++ +HHP ++ L + A +
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL--HDAFE 118
Query: 220 DTRFI--VYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNP 272
D + + E + +R ++ + GL+++HEH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAA-------EDYKMSEAEVINYMRQACEGLKHMHEH--- 168
Query: 273 AVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
+++H D+K NI+ ++K + K+ DFGLA + K T + APE +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 225
Query: 329 KLTDKSDVYAFGVVLLELLLGRRP 352
+ +D++A GV+ LL G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 21/213 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKA-KLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHH 206
+D++ LG+G F V + L A K ++ + ++ E E + + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLE 264
PN+V L + ++V++L+ L DI + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIA 119
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
Y H + ++HR+LK N+LL SK KL+DFGLA + D +GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 173
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
++PE L + D++A GV+L LL+G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHPNVVCLLGYS 216
LGEG +G V A VAVK +D D + E+ + ++H NVV G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 217 AHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYL 266
+ +++ E L D I+ M A+ G+ YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI-----------GMPE--PDAQRFFHQLMAGVVYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL-AITDGSQNKNNLKLS-GTLGYVAPEY 324
H + HRD+K N+LLD + N K+SDFGL + + + L GTL YVAPE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 325 LLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
LL + DV++ G+VL +L G P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 144 KLLEKATDSFHE----SNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEV 198
+ L + + F + +G G + + N+ AVK +D + +D E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMK 254
LL HPN++ L +DD + ++V ELM+ L I +
Sbjct: 69 -LLRYGQHPNIITL--KDVYDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASA 120
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQNKNN 310
+ + +EYLH V+HRDLK SNIL + ++ DFG A ++N
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
+ T +VAPE +L+ + D + D+++ GV+L +L G P
Sbjct: 178 MTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 40/213 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHHPNVVCLLG 214
LG G FG V + VAVK L+ + D + + E+ L HP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 215 YSAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ F+V E + L D I HG R++ AR ++
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEE--MEARRLFQQILSAVD 125
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVA 321
Y H H V+HRDLK N+LLD+ NAK++DFGL+ ++DG L+ S G+ Y A
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAA 178
Query: 322 PEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
PE ++ G+L + D+++ GV+L LL G P
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 39/235 (16%)
Query: 140 FIEYKLLEKAT---DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE 195
F+++K LE D F + +LG GGFG V+ ++ + A KKL+ + ++
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 196 ---NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHM 251
E +L+ +H +V L Y+ T +V +M +G + +H+
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIM-------------NGGDIRYHI 276
Query: 252 RM------KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
A GLE+LH+ +I+RDLK N+LLD N ++SD
Sbjct: 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333
Query: 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GLA+ + +GT G++APE LL + D +A GV L E++ R P
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
D + LGEG +G VYKA N VA+K++ ++ G RE V LL
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKE 89
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMEN---RSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N++ L H+ +++E EN + +D ++ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSFLYQLI 142
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-----KLSDFGLAITDGSQNKNNLKLSG 315
G+ + H +HRDLK N+LL + K+ DFGLA G +
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 316 TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
TL Y PE LL + S D+++ + E+L+
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 44/234 (18%)
Query: 148 KATDSFHE----SNILGEGGFGCVYKAK-LDDNLHVAVKKLD---------CATQDAGRE 193
+T F+E ILG G V + AVK +D Q+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 194 FENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWH 250
EVD+L + HPN++ L + F+V++LM+ L +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------T 120
Query: 251 MRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDG 304
+ K R + LH+ ++HRDLK NILLD N KL+DFG + + G
Sbjct: 121 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKS------DVYAFGVVLLELLLGRRP 352
+ + + GT Y+APE + + D+++ GV++ LL G P
Sbjct: 178 EKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 63/223 (28%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN-----EVDLL 201
AT + +G G +G VYKA+ VA+K + G EV LL
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 202 ---SNIHHPNVVCLL----GYSAHDDTR-FIVYELMEN---RSLDIQLHGPSHGSALTWH 250
HPNVV L+ + + +V+E ++ LD +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310
MR RGL++LH +C ++HRDLK NIL+ S KL+DFGLA
Sbjct: 126 MRQ-----FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----Q 173
Query: 311 LKLSG---TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
+ L+ TL Y APE LL D+++ G + E+ +
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 39/216 (18%), Positives = 81/216 (37%), Gaps = 24/216 (11%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH 205
++ + + + LG G FG V++ K + D + E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59
Query: 206 HPNVVCLLGYSAHDDTRFIVYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
H N++ L + +++E + R L +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINT-------SAFELNEREIVSYVHQVC 112
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGT 316
L++LH H + H D++ NI+ ++ ++ K+ +FG A + G +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TA 166
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
Y APE ++ +D+++ G ++ LL G P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE---NEVDLLSNIHH 206
+ F ILGEG F V A+ A+K L+ + E D++S + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR-- 261
P V L ++ DD + + + L ++R R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAK-------------NGELLKYIRKIGSFDETCTRFY 135
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
LEYLH +IHRDLK NILL+ + +++DFG A ++ S+
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 314 SGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
GT YV+PE LL K KS D++A G ++ +L+ G P
Sbjct: 193 VGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 42/235 (17%)
Query: 140 FIEYKLLEKAT---DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREFE 195
F+++K LE+ ++F + +LG+GGFG V ++ + A KKL+ +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA 229
Query: 196 ---NEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHM 251
NE +L ++ VV L Y+ +V LM +G L +H+
Sbjct: 230 MALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLM-------------NGGDLKFHI 275
Query: 252 ----RMKIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299
+ A GLE LH +++RDLK NILLD + ++SD GL
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 300 A--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
A + +G K GT+GY+APE + + + T D +A G +L E++ G+ P
Sbjct: 333 AVHVPEGQTIKG---RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 152 SFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+ ++ ILG G FG V+K + L +A K + E +NE+ +++ + H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 211 CLLGYSAHDDTRFI--VYELME-----NRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
L Y A + I V E ++ +R +D LT + G+
Sbjct: 150 QL--YDAFESKNDIVLVMEYVDGGELFDRIID-------ESYNLTELDTILFMKQICEGI 200
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
++H+ ++H DLK NIL ++ K+ DFGLA + K N GT +
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEF 254
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+APE + ++ +D+++ GV+ LL G P
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 28/225 (12%)
Query: 147 EKATDSFH-ESNILGEGGFGCVYKAKLDDNL---HVAVKKLDCATQDAGREFEN--EVDL 200
E+ D F E +G G +G VYKAK D A+K++ + G E+ L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIAL 71
Query: 201 LSNIHHPNVVCLLG--YSAHDDTRFIVYELMEN---RSLDIQLHGPSH--GSALTWHMRM 253
L + HPNV+ L S D +++++ E+ + ++ L M
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLAITDGSQNKN 309
+ G+ YLH + V+HRDLK +NIL+ + K++D G A S K
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 310 NLKLSG---TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
L T Y APE LL + K+ D++A G + ELL
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG------REFENEVDLLSN 203
+ + +G+G FG V+KA+ VA+KK+ + G RE + +L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQL 72
Query: 204 IHHPNVVCLLG--------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
+ H NVV L+ Y+ + ++V++ E+ D+ + T ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRV 129
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT-DGSQNKNNLKLS 314
GL Y+H + ++HRD+K++N+L+ KL+DFGLA ++N + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 315 G---TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
TL Y PE LL + D++ G ++ E+
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 32/261 (12%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
+ K S N + K + V K + Y + E+ LG
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEE----------LG 166
Query: 161 EGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219
G FG V++ + A K + + E+ +S + HP +V L + A +
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL--HDAFE 224
Query: 220 DTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275
D + +YE M L + + ++ ++ +GL ++HE+ +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 276 HRDLKSSNILLDSKFNA--KLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT 331
H DLK NI+ +K + KL DFGL + K GT + APE +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVG 334
Query: 332 DKSDVYAFGVVLLELLLGRRP 352
+D+++ GV+ LL G P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 48/220 (21%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD------CATQDAGREFENEVDLLSNIHH--PNV 209
LG GGFG VY + DNL VA+K ++ G EV LL + V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 210 VCLLGYSAHDDTRFIVYELMENRS--LD-IQLHGPSHGSALTWHMRMKIALDTAR----- 261
+ LL + D+ ++ E E D I G ++ + AR
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----------ALQ--EELARSFFWQ 157
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLA--ITDGSQNKNNLKLS- 314
+ + H V+HRD+K NIL+D + KL DFG + D
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFD 209
Query: 315 GTLGYVAPEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
GT Y PE++ + V++ G++L +++ G P
Sbjct: 210 GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 59/222 (26%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
LGEG FG V A VA+K + E+ L + HP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 215 YSAHDDTRFIVYELMENRSLDIQL-----------HGPSHGSALTWHMRMKIALDTAR-- 261
Y+++ + DI + + RM D R
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKK-------RMTE--DEGRRF 113
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKL 313
+EY H H ++HRDLK N+LLD N K++DFGL+ +TDG+ LK
Sbjct: 114 FQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKT 166
Query: 314 S-GTLGYVAPEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
S G+ Y APE +++GKL + DV++ G+VL +L+GR P
Sbjct: 167 SCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHHPNVVCLLG 214
LG G FG V K VAVK L+ + E+ L HP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 215 YSAHDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLE 264
+ F+V E + L D I +G R+ +R G++
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDE--KESRRLFQQILSGVD 130
Query: 265 YLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVA 321
Y H H V+HRDLK N+LLD+ NAK++DFGL+ ++DG L+ S G+ Y A
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAA 183
Query: 322 PEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
PE ++ G+L + D+++ GV+L LL G P
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/259 (23%), Positives = 100/259 (38%), Gaps = 22/259 (8%)
Query: 104 NKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHE----SNIL 159
+ + S + G + + +SV + G+A +Y + D+ + + L
Sbjct: 3 HHHHHSSGVDLGT-ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 160 GEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
G G VY+ K A+K L + E+ +L + HPN++ L
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 219 DDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIH 276
+V EL+ L I G + + YLHE+ ++H
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVH 171
Query: 277 RDLKSSNILLDSKFNA---KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDK 333
RDLK N+L + K++DFGL+ Q + GT GY APE L +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-TVCGTPGYCAPEILRGCAYGPE 230
Query: 334 SDVYAFGVVLLELLLGRRP 352
D+++ G++ LL G P
Sbjct: 231 VDMWSVGIITYILLCGFEP 249
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 52/223 (23%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLD------CATQDAGREFENEVDLLSNIH----HP 207
LG+GGFG V+ L D L VA+K + + EV LL + HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSAL----TWHMRMKIALDTAR-- 261
V+ LL + + +V E P L T + +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYITEKGPLG--EGPSRCF 144
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLA--ITDGSQNKNNLK 312
+++ H V+HRD+K NIL+D + KL DFG + D
Sbjct: 145 FGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYT 196
Query: 313 LS-GTLGYVAPEYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
GT Y PE++ + V++ G++L +++ G P
Sbjct: 197 DFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHH 206
+ + +GEG +G V A + + VA+KK+ R E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 207 PNVVCLLG-YSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRMKIALD 258
N++ + A + IV +LME + L Q H + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------- 137
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
RGL+Y+H N V+HRDLK SN+LL++ + K+ DFGLA + + L+
Sbjct: 138 -LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 316 TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
T Y APE +L+ K KS D+++ G +L E+L R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 48/222 (21%)
Query: 158 ILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVD---------LLSNIHH 206
+ G +G V + + VA+K++ D + LL++ HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 207 PNVVCLLG-YSAHDDTRF----IVYELMEN------RSLDIQLHGPSHGSALTWHMRMKI 255
PN++ L + ++ +V ELM I + P H +H+
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYFMYHI---- 143
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
GL LHE V+HRDL NILL + + DF LA D +
Sbjct: 144 ----LLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN------- 189
Query: 316 TLGYV------APEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
YV APE ++ K K D+++ G V+ E+ +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 158 ILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGY 215
LGEG F K N AVK + + + E+ L HPN+V L +
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN---TQKEITALKLCEGHPNIVKL--H 72
Query: 216 SAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCN 271
D F+V EL+ L I+ + I + ++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 272 PAVIHRDLKSSNILLDSKF-NA--KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
V+HRDLK N+L + N K+ DFG A N+ TL Y APE LL+
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQ 183
Query: 329 KLTDKS-DVYAFGVVLLELLLGRRP 352
D+S D+++ GV+L +L G+ P
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 36/240 (15%)
Query: 130 MVSKKGSAISFIEYKLLEKA---TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC 185
M S+ +F ++ + + +G G G V A +VA+KKL
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 186 A---TQDAGREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRF----IVYELME---NRS 233
A R + E+ L+ ++H N++ LL F IV ELM+ +
Sbjct: 61 PFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+ ++L S L + M G+++LH + +IHRDLK SNI++ S K
Sbjct: 120 IQMELD-HERMSYLLYQM--------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167
Query: 294 LSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
+ DFGLA T G+ ++ T Y APE +L + D+++ G ++ E++ G
Sbjct: 168 ILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQDAG------REFENEVD 199
+A + +GEG +G V+KA+ + VA+K++ T + G RE V
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VA 63
Query: 200 LL---SNIHHPNVVCLL----GYSAHDDTR-FIVYELMEN---RSLDIQLHGPSHGSALT 248
+L HPNVV L +T+ +V+E ++ LD +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
M RGL++LH H V+HRDLK NIL+ S KL+DFGLA
Sbjct: 124 DMMFQ-----LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 172
Query: 309 NNLKLSG---TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
+ L+ TL Y APE LL D+++ G + E+ +
Sbjct: 173 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 72/236 (30%), Positives = 107/236 (45%), Gaps = 42/236 (17%)
Query: 140 FIEYKLLEKAT----DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGREF 194
F ++K +E + F I+G GGFG VY + D + A+K LD +
Sbjct: 174 FCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 195 E---NEVDLLSNIH---HPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSAL 247
NE +LS + P +VC+ Y+ H + + +LM G L
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMN-------------GGDL 279
Query: 248 TWHMRM--KIALDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
+H+ + R GLE++H V++RDLK +NILLD + ++SD
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL 336
Query: 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
GLA D S+ K + GT GY+APE L G D S D ++ G +L +LL G P
Sbjct: 337 GLAC-DFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 33/230 (14%)
Query: 141 IEYKLLEKATDSFHE-----SNILGEGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREF 194
+ ++ E + + +LG G G V + A+K L + A +E
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV 72
Query: 195 ENEVDLLSNIHHPNVVCLLGY----SAHDDTRFIVYELMENRSL--DIQLHGPSHGSALT 248
++ P++VC+L I+ E ME L IQ G T
Sbjct: 73 DH---HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FT 126
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NA--KLSDFGLAITDGS 305
+I D +++LH H + HRD+K N+L SK +A KL+DFG A
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 306 QNKNNLKLS---GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
L T YVAPE L K D+++ GV++ LL G P
Sbjct: 184 N-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 43/221 (19%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLD--------CATQDAGREFENEVDLLSNIH-HP 207
++G G V + AVK ++ ++ E +L + HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 208 NVVCLLGYSAHDDTR--FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR-- 261
+++ L +++ + F+V++LM L + + K R
Sbjct: 161 HIITL--IDSYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSL 209
Query: 262 --GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTL 317
+ +LH + ++HRDLK NILLD +LSDFG + + G + + +L GT
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTP 263
Query: 318 GYVAPEYLLDGKLTD------KSDVYAFGVVLLELLLGRRP 352
GY+APE L + D++A GV+L LL G P
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 35/241 (14%)
Query: 133 KKGSAISFIEYKLLEKATDSFHE-----SNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA 186
S + L ++ ++F+ S LG G F V + A K L
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65
Query: 187 --TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI--VYELME-----NRSLDI 236
QD E +E+ +L P V+ L + +++T I + E + L
Sbjct: 66 RRGQDCRAEILHEIAVLELAKSCPRVINL--HEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 237 QLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAK 293
S + +K L+ G+ YLH++ ++H DLK NILL S + + K
Sbjct: 124 LAEMVSENDVIRL---IKQILE---GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174
Query: 294 LSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351
+ DFG++ I + + + GT Y+APE L +T +D++ G++ LL
Sbjct: 175 IVDFGMSRKIGHACELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
Query: 352 P 352
P
Sbjct: 232 P 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 49/244 (20%)
Query: 130 MVSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KL 183
M + K + Y + E+ LG G F V K + L A K +
Sbjct: 2 METFKQQKVE-DFYDIGEE----------LGSGQFAIVKKCREKSTGLEYAAKFIKKRQS 50
Query: 184 DCATQDAGRE-FENEVDLLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQL 238
+ + RE E EV +L + HPN++ L + +++ + + EL+ L +
Sbjct: 51 RASRRGVCREEIEREVSILRQVLHPNIITL--HDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 239 HGPSHGSALTWHMRMKIALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK----F 290
+ + A + G+ YLH + H DLK NI+L K
Sbjct: 109 KE---------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156
Query: 291 NAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL 348
+ KL DFGLA I DG + KN GT +VAPE + L ++D+++ GV+ LL
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 349 GRRP 352
G P
Sbjct: 214 GASP 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL- 213
+LGEG +G V A VA+KK++ A R E+ +L + H N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 214 -----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALDTARGLEYLH 267
+ ++ +I+ ELM+ D LH L+ H++ T R ++ LH
Sbjct: 77 IQRPDSFENFNEV-YIIQELMQT---D--LHRVISTQMLSDDHIQY-FIYQTLRAVKVLH 129
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLG----YV--- 320
N VIHRDLK SN+L++S + K+ DFGLA +N + +G +V
Sbjct: 130 G-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 321 ---APEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
APE +L ++ DV++ G +L EL L R
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVD 199
+K D + LG G F V K + L A K + + + RE E EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
+L + H NV+ L + +++ + + EL+ L + + +
Sbjct: 68 ILRQVLHHNVITL--HDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEE 116
Query: 256 ALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLA--ITDGS 305
A + G+ YLH + H DLK NI+L K + KL DFGLA I DG
Sbjct: 117 ATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ KN GT +VAPE + L ++D+++ GV+ LL G P
Sbjct: 174 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 65/268 (24%), Positives = 102/268 (38%), Gaps = 43/268 (16%)
Query: 101 KSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKATDSFHESNILG 160
+ ++ +F + K +AI +YK+ + +LG
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI-IDDYKVTSQ---------VLG 71
Query: 161 EGGFGCVYKA-KLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218
G G V + A+K L A RE V+L P++V + +
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRI--VDVY 124
Query: 219 DDTR------FIVYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
++ IV E ++ L IQ G T +I ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSI- 180
Query: 271 NPAVIHRDLKSSNILLDSKF-NA--KLSDFGLAITDGSQNKNNLKLS---GTLGYVAPEY 324
+ HRD+K N+L SK NA KL+DFG A + ++ L+ T YVAPE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFA----KETTSHNSLTTPCYTPYYVAPEV 234
Query: 325 LLDGKLTDKSDVYAFGVVLLELLLGRRP 352
L K D+++ GV++ LL G P
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 34/277 (12%)
Query: 91 LWLYHLKYSFKSSNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKA- 149
+ L+ L Y + + G + +SK F ++ +
Sbjct: 1 MSLHFLYYCSEPTLD--VKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTF 58
Query: 150 --TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSN 203
+ +G G G V A + +VA+KKL A R + E+ L+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117
Query: 204 IHHPNVVCLL-------GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIA 256
++H N++ LL D ++V ELM D L M +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDV-YLVMELM-----DANLCQVIQMELDHERMSY-LL 170
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
G+++LH + +IHRDLK SNI++ S K+ DFGLA T G+ ++
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY 223
Query: 316 --TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
T Y APE +L + D+++ G ++ E++ +
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 36/232 (15%)
Query: 149 ATDSFHES---------NILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV 198
+TDSF ++LGEG V L + AVK ++ EV
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 199 DLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
++L H NV+ L+ + +D ++V+E M S+ I +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVV 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA---KLSDFGLAI----TDGSQNK 308
D A L++LH + HRDLK NIL + K+ DF L
Sbjct: 117 VQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 309 NNLKLS---GTLGYVAPEYLLDGKLTDKS-----DVYAFGVVLLELLLGRRP 352
+ +L G+ Y+APE + D+++ GV+L LL G P
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVDLLSNIHHPNVVC 211
LG G F V K + A K +L + + RE E EV++L I HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 212 LLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKIALDTAR----GL 263
L + ++ + + EL+ L + + A + G+
Sbjct: 73 L--HDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGV 121
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLA--ITDGSQNKNNLKLSGTL 317
YLH + H DLK NI+L K KL DFG+A I G++ KN GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTP 175
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+VAPE + L ++D+++ GV+ LL G P
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVK-----KLDCATQDAGRE-FENEVD 199
E D + LG G F V K + L A K + + + RE E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFI--VYELMENRSL--DIQLHGPSHGSALTWHMRMKI 255
+L I HPNV+ L + +++ + + EL+ L + + +
Sbjct: 67 ILKEIQHPNVITL--HEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEE 115
Query: 256 ALDTAR----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA----KLSDFGLA--ITDGS 305
A + + G+ YLH + H DLK NI+L + K+ DFGLA I G+
Sbjct: 116 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ KN GT +VAPE + L ++D+++ GV+ LL G P
Sbjct: 173 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
++ +G G +G V A VA+KKL A R + E+ LL ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRMKIA 256
H NV+ LL A F +V M+ + + ++ L + M
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF-SEEKIQYLVYQM----- 135
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG- 315
+GL+Y+H + V+HRDLK N+ ++ K+ DFGLA ++ ++G
Sbjct: 136 ---LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGY 183
Query: 316 --TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
T Y APE +L +++ D+++ G ++ E+L G+
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
D F LG G FG V K + H A+K LD ++ E NE +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P +V L +S D++ +Y +ME + G + H+R + + AR
Sbjct: 101 PFLVKLE-FSFKDNSN--LYMVMEYVA----------GGEMFSHLRRIGRFSEPHARFYA 147
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
EYLH +I+RDLK N+L+D + +++DFG A + L GT
Sbjct: 148 AQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGT 201
Query: 317 LGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
+APE ++ K +K+ D +A GV++ E+ G P
Sbjct: 202 PEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 36/222 (16%)
Query: 153 FHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVV 210
+ + LG GG G V+ A D + VA+KK+ E+ ++ + H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 211 CLL----------GYSAHDDTRF----IVYELME---NRSLDIQLHGPSHGSALTWHMRM 253
+ T IV E ME L+ H + +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL-- 129
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNKNNLK 312
RGL+Y+H + V+HRDLK +N+ ++++ K+ DFGLA +
Sbjct: 130 ------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 313 LSG---TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
LS T Y +P LL K+ D++A G + E+L G+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 38/241 (15%)
Query: 130 MVSKKGSAISFIEYKLLEKA---TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC 185
M S + F ++ + A + + +G G +G V A VA+KKL
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 186 A---TQDAGREFENEVDLLSNIHHPNVVCLLG--YSAHDDTRF----IVYELME---NRS 233
A R + E+ LL ++ H NV+ LL F +V M +
Sbjct: 61 PFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL 119
Query: 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+ + G L + M +GL Y+H +IHRDLK N+ ++ K
Sbjct: 120 MKHEKLGEDRIQFLVYQM--------LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 168
Query: 294 LSDFGLAITDGSQNKNNLKLSG---TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLG 349
+ DFGLA S+ ++G T Y APE +L+ ++ D+++ G ++ E++ G
Sbjct: 169 ILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 350 R 350
+
Sbjct: 223 K 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 57/212 (26%), Positives = 81/212 (38%), Gaps = 40/212 (18%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA 217
+G G FG + VAVK ++ + E+ ++ HPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 218 HDDTRFIVYELMENRSL-D-IQLHGPSHGSALTWHMRMKIALDTAR--------GLEYLH 267
I+ E L + I G R D AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAG-----------RFSE--DEARFFFQQLLSGVSYCH 133
Query: 268 EHCNPAVIHRDLKSSNILLDSKF--NAKLSDFGLA--ITDGSQNKNNLKLS-GTLGYVAP 322
+ HRDLK N LLD K+ DFG + SQ K + GT Y+AP
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAP 186
Query: 323 EYLLDGKLTD--KSDVYAFGVVLLELLLGRRP 352
E +L + D +DV++ GV L +L+G P
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
+ + + +G G +G V A L VAVKKL A R + E+ LL ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 206 HPNVVCLLG--YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALD 258
H NV+ LL A F +V LM D L+ LT H++ +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQF-LIYQ 140
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG--- 315
RGL+Y+H + +IHRDLK SN+ ++ K+ DFGLA + ++G
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVA 191
Query: 316 TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
T Y APE +L+ +++ D+++ G ++ ELL GR
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 77/248 (31%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVD---------LLSNIHHP 207
++G G +G V +A + VA+KK+ R FE+ +D +L+ ++H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHD 112
Query: 208 NVVCLL-----GYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA-- 260
+VV +L D ++V E+ + D R + L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKK---------LFRTPVYLTELHI 158
Query: 261 --------RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
G++Y+H ++HRDLK +N L++ + K+ DFGLA T N +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 313 LSGTL---------------------GYV------APEYLLDGKLTDKS-DVYAFGVVLL 344
L + G+V APE +L + ++ DV++ G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 345 ELLLGRRP 352
ELL +
Sbjct: 276 ELLNMIKE 283
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 40/224 (17%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH-HPNVVC 211
LG+G +G V+K+ VAVKK+ A + DA R F E+ +L+ + H N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 212 LLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-WHMRMKIALDTARGLEYLHE 268
LL + +D ++V++ ME D LH + L H + + + ++YLH
Sbjct: 74 LLNVLRADNDRDVYLVFDYMET---D--LHAVIRANILEPVHKQY-VVYQLIKVIKYLHS 127
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL----------- 317
++HRD+K SNILL+++ + K++DFGL+ + + + + ++
Sbjct: 128 -GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 318 ----GYV------APEYLLDGKLTDKS-DVYAFGVVLLELLLGR 350
YV APE LL K D+++ G +L E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 61/252 (24%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI 204
LE ++ + LG G FG V + ++ A+KK+ QD + E+D++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKNR-ELDIMKVL 57
Query: 205 HHPNVVCLLG--YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT-------------- 248
H N++ L+ Y+ D+ ++ L + +G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 249 --------------WHMRMKIALD--------TARGLEYLHEHCNPAVIHRDLKSSNILL 286
I ++ R + ++H + HRD+K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174
Query: 287 DSKFNA-KLSDFGLAITDGSQNKNNLKLSGTLGYV------APEYLLDGKL-TDKSDVYA 338
+SK N KL DFG A K + ++ Y+ APE +L T D+++
Sbjct: 175 NSKDNTLKLCDFGSA-------KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 339 FGVVLLELLLGR 350
G V EL+LG+
Sbjct: 228 IGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y+L+ K LG G + V++A + +N V VK L ++ + E+ +L
Sbjct: 38 YQLVRK----------LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKIL 84
Query: 202 SNI-HHPNVVCLLGYSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALT-WHMR--M 253
N+ PN++ L D + + D + + LT + +R M
Sbjct: 85 ENLRGGPNIITLADI-VKDPVSRTPALVFEHVNNT---DFKQLYQT----LTDYDIRFYM 136
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA-KLSDFGLAITDGSQNKNNLK 312
L + L+Y H ++HRD+K N+++D + +L D+GLA + N++
Sbjct: 137 YEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 313 LSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
++ + + PE L+D ++ D S D+++ G +L ++ + P
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFE---NEVDLLSNIHH 206
F LG G FG V+ + + + A+K L ++ E +E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR-- 261
P ++ + + D + F++ + +E G L +R + A+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIE-------------GGELFSLLRKSQRFPNPVAKFY 111
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
LEYLH +I+RDLK NILLD + K++DFG A L G
Sbjct: 112 AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCG 165
Query: 316 TLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
T Y+APE ++ K +KS D ++FG+++ E+L G P
Sbjct: 166 TPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 60/237 (25%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLL 213
++G G +G VY A + +VA+KK++ D R E+ +L+ + ++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLY 91
Query: 214 G-YSAHDDTRF----IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA-------- 260
D +F IV E+ ++ D L L + I L
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS---D--LK------KL---FKTPIFLTEEHIKTILYN 137
Query: 261 --RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL- 317
G ++HE +IHRDLK +N LL+ + K+ DFGLA T S+ N+
Sbjct: 138 LLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 318 ---------------GYV------APEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
+V APE +L + KS D+++ G + ELL +
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 53/225 (23%), Positives = 86/225 (38%), Gaps = 39/225 (17%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
D F ++G G F V K+ V A+K + D + F E D+L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMR---MKIALDTAR-- 261
+ L ++ D+ +Y +ME G L + +I + AR
Sbjct: 121 RWITQLH-FAFQDENY--LYLVMEYYV----------GGDLLTLLSKFGERIPAEMARFY 167
Query: 262 ------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS- 314
++ +H +HRD+K NILLD + +L+DFG + + ++
Sbjct: 168 LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 315 GTLGYVAPEYLLDGKLTDKSDVY-------AFGVVLLELLLGRRP 352
GT Y++PE L + Y A GV E+ G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 43/226 (19%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKLDCATQDAGRE---FENEVDLLSNIHH 206
+ F ++G G FG V KL + V A+K L+ E F E D+L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 207 PNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMR---MKIALDTAR- 261
+ L Y+ DD ++V + G L + ++ + AR
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYV-------------GGDLLTLLSKFEDRLPEEMARF 179
Query: 262 -------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNL 311
++ +H+ +HRD+K NIL+D + +L+DFG + DG+ +
Sbjct: 180 YLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV- 235
Query: 312 KLSGTLGYVAPEYLLDGKLTDKS-----DVYAFGVVLLELLLGRRP 352
GT Y++PE L + D ++ GV + E+L G P
Sbjct: 236 -AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL---DCATQDAGREFENEVDLLSNIHH 206
+ + ++G G FG V + V A+K L + + F E D+++ +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR----- 261
P VV L Y+ DD +Y +ME + G G + + AR
Sbjct: 129 PWVVQLF-YAFQDDRY--LYMVME------YMPG---GDLVNLMSNYDVPEKWARFYTAE 176
Query: 262 ---GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSG 315
L+ +H IHRD+K N+LLD + KL+DFG +G + G
Sbjct: 177 VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVG 231
Query: 316 TLGYVAPEYLL----DGKLTDKSDVYAFGVVLLELLLGRRP 352
T Y++PE L DG + D ++ GV L E+L+G P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 64/216 (29%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHH 206
+ F +LG+G FG V K + A+K L A E + E +L N H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P + L YS R + +ME + G L +H+ + D AR
Sbjct: 208 PFLTALK-YSFQTHDR--LCFVMEYAN----------GGELFFHLSRERVFSEDRARFYG 254
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGT 316
L+YLH N V++RDLK N++LD + K++DFGL GT
Sbjct: 255 AEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
Y+APE L D D + GVV+ E++ GR P
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 62/275 (22%), Positives = 97/275 (35%), Gaps = 74/275 (26%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKL-DCATQDAGREFENEVDLLSN 203
D LG G FG V +A VAVK L + AT R +E+ +L +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 204 I-HHPNVVCLLGY-SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTW------------ 249
I HH NVV LLG + ++ E + +L L +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 250 ----HMRMKIALDT--------------ARGLEYLHEHCNPAVIHRDLKSSNILL----- 286
+ +K LD+ + L + E P +++D + L+
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 287 -------------------------DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV- 320
K K+ DFGLA D ++ + ++ +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPDYVRKGDARLPLK 260
Query: 321 --APEYLLDGKLTDKSDVYAFGVVLLELL-LGRRP 352
APE + D T +SDV++FGV+L E+ LG P
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFEN---EVDLLSNIHH 206
+ F +LG+G FG V + + A+K L A E + E +L N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR--- 261
P + L Y+ R + +ME + G L +H+ + AR
Sbjct: 65 PFLTALK-YAFQTHDR--LCFVMEYAN----------GGELFFHLSRERVFTEERARFYG 111
Query: 262 -----GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKL 313
LEYLH V++RD+K N++LD + K++DFGL I+DG+ K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---F 165
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y+APE L D D + GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 147 EKAT-DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKL--DCATQDAGREFENEVD 199
EKA F +LG+G FG V+ K D A+K L + E D
Sbjct: 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
+L ++HP +V L Y+ + + +Y +++ G L +
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGK--LYLILDFLR----------GGDLFTRLSKEVMFTE 125
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
+ + L++LH +I+RDLK NILLD + + KL+DFGL+ K
Sbjct: 126 EDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 310 NLKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
GT+ Y+APE +++ + +S D ++FGV++ E+L G P
Sbjct: 183 AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 51/227 (22%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
+ F +LG+G FG V+ A+ N A+K L D D ++V+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD------DDVECTMVEKRV 70
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
L HP + + + F V E + G L +H++ K
Sbjct: 71 LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLN-------------GGDLMYHIQSCHKFD 116
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
L A GL++LH +++RDLK NILLD + K++DFG+ + +
Sbjct: 117 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ GT Y+APE LL K D ++FGV+L E+L+G+ P
Sbjct: 174 KTNT---FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 57/230 (24%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
FH ++G+G FG V A+ + + AVK L + E
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK------KEEKHIMSERNV 91
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
LL N+ HP +V L +S + +Y +++ + G L +H++
Sbjct: 92 LLKNVKHPFLVGLH-FSFQTADK--LYFVLDYIN----------GGELFYHLQRERCFLE 138
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309
AR L YLH +++RDLK NILLDS+ + L+DFGL K
Sbjct: 139 PRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC-------KE 188
Query: 310 NLKLS-------GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
N++ + GT Y+APE L D + G VL E+L G P
Sbjct: 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F+ +LG+G FG V ++ + AVK L D QD ++V+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD------DDVECTMVEKRV 394
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
L P + L R +Y +ME + G L +H++ +
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDR--LYFVMEYVN----------GGDLMYHIQQVGRFKE 441
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
A GL +L +I+RDLK N++LDS+ + K++DFG+ I DG
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
K GT Y+APE + D +AFGV+L E+L G+ P
Sbjct: 499 TKT---FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 53/228 (23%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F ++G G + V +L + A+K + + D ++D
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD------EDIDWVQTEKHV 62
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
+HP +V L ++R F V E + G L +HM+ K+
Sbjct: 63 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVN-------------GGDLMFHMQRQRKLP 108
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
+ AR L YLHE +I+RDLK N+LLDS+ + KL+D+G+ + G
Sbjct: 109 EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKS-DVYAFGVVLLELLLGRRP 352
GT Y+APE +L G+ S D +A GV++ E++ GR P
Sbjct: 166 TTST---FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 47/277 (16%)
Query: 103 SNKNAKSKDSENGVVLSSFLGKFTSVRMVSKKGSAISFIEYKLLEKAT-DSFHESNILGE 161
+ + + S G +S G ++++ K + EK ++F +LG
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64
Query: 162 GGFGCVYKAKL----DDNLHVAVK---KLDCATQDAGRE---FENEVDLLSNIHHPNVVC 211
G +G V+ + D A+K K + E E +V L P +V
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVT 123
Query: 212 LLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDTAR------- 261
L Y+ +T+ ++ + + G L H+ + +
Sbjct: 124 LH-YAFQTETKLHLILDYIN-------------GGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 262 -GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTL 317
LE+LH+ +I+RD+K NILLDS + L+DFGL+ + D ++ + GT+
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTI 224
Query: 318 GYVAPEYLLDGKL-TDKS-DVYAFGVVLLELLLGRRP 352
Y+AP+ + G DK+ D ++ GV++ ELL G P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
F+ +LG+G FG V ++ + AVK L D QD ++V+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD------DDVECTMVEKRV 73
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
L P + L R +Y +ME + G L +H++ +
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDR--LYFVMEYVN----------GGDLMYHIQQVGRFKE 120
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
A GL +L +I+RDLK N++LDS+ + K++DFG+ I DG
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
K GT Y+APE + D +AFGV+L E+L G+ P
Sbjct: 178 TKT---FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 57/233 (24%), Positives = 85/233 (36%), Gaps = 59/233 (25%)
Query: 133 KKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG 191
KK + I +YK+ + +LG G G V + A+K L A
Sbjct: 11 KKNAIID--DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR 58
Query: 192 REFENEVDLLSNI-HHPNVVCLLGYSAHDDTR------FIVYELMENRSL--DIQLHGPS 242
RE V+L P++V + +++ IV E ++ L IQ G
Sbjct: 59 RE----VELHWRASQCPHIVRI--VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NA--KLSDFGL 299
T +I ++YLH + HRD+K N+L SK NA KL+DFG
Sbjct: 113 A---FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
A E K D+++ GV++ LL G P
Sbjct: 167 ---------------------AKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKL--DCATQDAGREFEN---EVDLL 201
+ F +LG+GG+G V++ + + A+K L ++A ++ + E ++L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA-KDTAHTKAERNIL 75
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIALDT 259
+ HP +V L+ Y+ + +Y ++E S G L + DT
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGK--LYLILEYLS----------GGELFMQLEREGIFMEDT 122
Query: 260 AR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNK 308
A L +LH+ +I+RDLK NI+L+ + + KL+DFGL I DG+
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT+ Y+APE L+ D ++ G ++ ++L G P
Sbjct: 180 T---FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHV-AVKKL--DCATQDAGREFENEVD-------- 199
F ++G G + V +L + A++ + + D ++D
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD------EDIDWVQTEKHV 105
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIAL 257
+HP +V L ++R ++ ++E + G L +HM+ K+
Sbjct: 106 FEQASNHPFLVGLH-SCFQTESR--LFFVIEYVN----------GGDLMFHMQRQRKLPE 152
Query: 258 DTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQ 306
+ AR L YLHE +I+RDLK N+LLDS+ + KL+D+G+ + G
Sbjct: 153 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y+APE L D +A GV++ E++ GR P
Sbjct: 210 TST---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 51/227 (22%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKL--DCATQDAGREFENEVD-------- 199
D+F +LG+G FG V A++ + AVK L D QD ++V+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD------DDVECTMTEKRI 76
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM--KIA 256
L +HP + L R F V E + G L +H++ +
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVN-------------GGDLMFHIQKSRRFD 122
Query: 257 LDTAR--------GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGS 305
AR L +LH+ +I+RDLK N+LLD + + KL+DFG+ I +G
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
GT Y+APE L + D +A GV+L E+L G P
Sbjct: 180 TTAT---FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIH--------- 205
LG G F V+ AK + +N HVA+K + D +A + E+ LL ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 206 --HPNVVCLLGYSAHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
+++ LL + H +V+E++ L + G L +++ +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI-YVK-QISKQL 140
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLD------SKFNAKLSDFGLAITDGSQNKNNLKL 313
GL+Y+H C +IH D+K N+L++ + K++D G A N+++
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR 350
T Y +PE LL +D+++ ++ EL+ G
Sbjct: 198 --TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 53/258 (20%), Positives = 86/258 (33%), Gaps = 74/258 (28%)
Query: 159 LGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI-----HHPN-- 208
LG G F V+ + + VA+K K + +E+ LL ++ + PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101
Query: 209 -VVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
VV LL + +V+E++ + L + G L KI +GL
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGL 159
Query: 264 EYLHEHCNPAVIHRDLKSSNILL------------------------------------- 286
+YLH C +IH D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 287 ------------DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKS 334
K K++D G A +K+ + T Y + E L+ +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 335 DVYAFGVVLLELLLGRRP 352
D+++ + EL G
Sbjct: 275 DIWSTACMAFELATGDYL 292
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 39/240 (16%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
++ L +K +G GGFG +Y A + A + Q+ G F +E+
Sbjct: 38 QWVLGKK----------IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKF 86
Query: 201 LSNIHHPNVVCLLGYSAHDDT----RFIVYELMENRSLD-----IQLHGPSHGSALTWHM 251
+ + + D F L E + ++ G +
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG 146
Query: 252 RM------KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK--LSDFGLA--I 301
++ + LEY+HE+ +H D+K++N+LL K + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 302 TDGSQNK-----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL 356
+K +GT+ + + + L+ +SDV G +L L G+ P E+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 43/244 (17%), Positives = 86/244 (35%), Gaps = 44/244 (18%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK---------LDDNLHVAVK----------K 182
++KL G +Y+A ++K +
Sbjct: 43 QWKLKSF----------QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNE 92
Query: 183 LDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT-RFIVYELMENRSLDIQLHGP 241
+ + A N+ L + + +G+ H D RF+V + RSL
Sbjct: 93 QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDV 150
Query: 242 SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK--LSDFGL 299
S L+ +++A LE+LHE+ +H ++ + NI +D + ++ L+ +G
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 300 A---ITDGS----QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
A G + G L +++ + + +SD+ + G +L+ L G P
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
Query: 353 VEKL 356
Sbjct: 268 WTNC 271
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 50/232 (21%), Positives = 84/232 (36%), Gaps = 48/232 (20%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV--D 199
+++ +K +G G FG + K L N +VA+K ++ E
Sbjct: 11 FRVGKK----------IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
L S P V + +V ++L GPS +
Sbjct: 61 LGSGDGIPQV---YYFGPCGKYNAMV----------LELLGPSLEDLFDLCDRTFSLKTV 107
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK-----LSDFGLAI--TDGS 305
+ IA+ +EY+H +I+RD+K N L+ N + DF LA D
Sbjct: 108 LMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164
Query: 306 QNK-----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
K + L+GT Y++ L + + + D+ A G + + L G P
Sbjct: 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 51/230 (22%), Positives = 84/230 (36%), Gaps = 46/230 (20%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV-DL 200
Y+L K +G G FG +Y + VA+K T+ E+++ +
Sbjct: 11 YRLGRK----------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM 60
Query: 201 LSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
+ P + A D +V ++L GPS +
Sbjct: 61 MQGGVGIPTI---RWCGAEGDYNVMV----------MELLGPSLEDLFNFCSRKFSLKTV 107
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK---LSDFGLAI--TDGSQN 307
+ +A +EY+H IHRD+K N L+ + DFGLA D +
Sbjct: 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 308 K-----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
+ N L+GT Y + L + + + D+ + G VL+ LG P
Sbjct: 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 46/234 (19%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV-DL 200
++L K +G G FG +Y + N VA+K + T+ +E+++ +
Sbjct: 9 FRLGRK----------IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI 58
Query: 201 LSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
L PNV + D +V + L GPS L+
Sbjct: 59 LQGGTGIPNV---RWFGVEGDYNVLV----------MDLLGPSLEDLFNFCSRKLSLKTV 105
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK---LSDFGLAI--TDGSQN 307
+ +A +E++H +HRD+K N L+ A + DFGLA D S +
Sbjct: 106 LMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
Query: 308 -----KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL 356
+ N L+GT Y + L + + + D+ + G VL+ L G P + L
Sbjct: 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 48/248 (19%), Positives = 90/248 (36%), Gaps = 60/248 (24%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVK-----KLDCATQD------- 189
+K+ +G+GGFGC+Y A ++ + V K++ +
Sbjct: 36 AWKVGLP----------IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELK 85
Query: 190 -----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----RFIVYELMENRSLDIQLHG 240
A E + + + V G HD RF++ + G
Sbjct: 86 FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI----------MDRFG 135
Query: 241 PSHGSALTWHMR-------MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293
+ + ++++L LEY+HEH +H D+K+SN+LL+ K +
Sbjct: 136 SDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQ 192
Query: 294 --LSDFGLA---ITDGSQN----KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLL 344
L D+GLA +G GT+ + + + + + D+ G ++
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMI 252
Query: 345 ELLLGRRP 352
+ L G P
Sbjct: 253 QWLTGHLP 260
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 51/236 (21%), Positives = 84/236 (35%), Gaps = 48/236 (20%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEV-DL 200
YK+ + +GEG FG +++ L +N VA+K + E L
Sbjct: 12 YKVGRR----------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 201 LSNIHH-PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMR 252
L+ PNV + +V I L GPS G +
Sbjct: 62 LAGCTGIPNV---YYFGQEGLHNVLV----------IDLLGPSLEDLLDLCGRKFSVKTV 108
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK-----LSDFGLAI--TDGS 305
A ++ +HE +++RD+K N L+ + + DFG+ D
Sbjct: 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165
Query: 306 QNK-----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL 356
+ LSGT Y++ L + + + D+ A G V + L G P + L
Sbjct: 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI--HHP---- 207
+++G+G FG V KA + VA+K K A + + EV LL + H
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKY 116
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
+V L + + +V+E++ D+ + G +L R K A L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN-LTR-KFAQQMCTALLFLA 174
Query: 268 EHCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
++IH DLK NILL + K+ DFG + G + ++ + Y +PE L
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SRFYRSPEVL 230
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGR 350
L D+++ G +L+E+ G
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 9e-11
Identities = 42/250 (16%), Positives = 66/250 (26%), Gaps = 68/250 (27%)
Query: 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKL--------DCATQDAGREFENEVDL 200
T+ +GEG FG V++ D+ VA+K + + + Q E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 201 LSNIH---------HPNVVCLLG------------------------------YSAHDDT 221
+ + L DD
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKS 281
FIV E Q+ + I L HRDL
Sbjct: 137 LFIVLEFEFGGIDLEQM----RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 282 SNILLDSKFNAKLSD-----------FGLAITDGSQNKNNLKLSGTLGY---VAPEYLLD 327
N+LL KL GL ++ + L+ G + + E L
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250
Query: 328 GKLTDKSDVY 337
G + D+Y
Sbjct: 251 GDGDYQFDIY 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI------HHPN 208
++G+G FG V KA + HVA+K + + E E+ +L ++ + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMN 160
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
V+ +L + + +EL+ ++ G +L +R K A + L+ LH+
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP-LVR-KFAHSILQCLDALHK 218
Query: 269 HCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
+ +IH DLK NILL + K+ DFG + + ++ + Y APE +L
Sbjct: 219 N---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYIQSRFYRAPEVIL 272
Query: 327 DGKLTDKSDVYAFGVVLLELLLGR 350
+ D+++ G +L ELL G
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 68/459 (14%), Positives = 131/459 (28%), Gaps = 138/459 (30%)
Query: 60 HHHHMD-----AHHK-------LLIALI--------------IACSALCLIIL------- 86
HHHHMD ++ A + I I+
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 87 -ALLCLWLYHLK----------------YSFKSSNKNAKSKD-SENGVVLSSFLGKFTSV 128
L W K Y F S + + S + + +
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 129 RMVSKKGSAISFIEYKLLEKATDSF-HESNIL--GEGGFGCVYKAKLDDNLHVAVKKLDC 185
V K + Y L +A N+L G G G K + A+ C
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDV--C 171
Query: 186 ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDI---QLHGPS 242
+ + + ++ L+ L +T V E+++ I
Sbjct: 172 LSYKVQCKMDFKIFWLN----------LKNCNSPET---VLEMLQKLLYQIDPNWTSRSD 218
Query: 243 HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG---L 299
H S + +R+ R L + N ++ +++++ + F + L
Sbjct: 219 HSSNIK--LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF-----NLSCKIL 269
Query: 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL---LGRRPVEKL 356
T Q + L + T +++ ++ D+ LL L RP + L
Sbjct: 270 LTTRFKQVTDFLS-AATTTHISLDHHSMTLTPDEV---------KSLLLKYLDCRP-QDL 318
Query: 357 APAQCQ------SIV---------TWAMPQLTDRSKLPNIVDPVIK--STMDLKHLYQVA 399
SI+ TW + + KL I++ + + + ++
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 400 AV---------AVLCV---QPEPSYRPLITDVLH--SLI 424
+V +L + S ++ + LH SL+
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 48/220 (21%), Positives = 80/220 (36%), Gaps = 38/220 (17%)
Query: 158 ILGEGGFGCVYKA--KLDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI--------H 205
LGEG FG V + VA+K + ++A R E+++L I
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
V + + I +EL+ + + L H+R +A L +
Sbjct: 83 L--CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP-HVR-HMAYQLCHALRF 138
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL----SGTLG--- 318
LHE+ + H DLK NIL + L + + + S ++++ S T
Sbjct: 139 LHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 319 ---------YVAPEYLLDGKLTDKSDVYAFGVVLLELLLG 349
Y PE +L+ DV++ G +L E G
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 38/222 (17%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNI-----HHPNV 209
+G+G FG V + +D+ + AVK + + + E D+L I ++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V G + D +++E + +I +G + ++ ++ + L YL +
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIE-DIK-LYCIEILKALNYLRKM 156
Query: 270 CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ------NKNNLKL----SGTLG- 318
+ H DLK NILLD + K +TDG + +KL T
Sbjct: 157 S---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 319 -----------YVAPEYLLDGKLTDKSDVYAFGVVLLELLLG 349
Y APE +L+ SD+++FG VL EL G
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 36/219 (16%)
Query: 158 ILGEGGFGCVYKAK--LDDNLHVAVK--KLDCATQDAGREFENEVDLLSNIHHP------ 207
LGEG FG V + HVAVK K +A R E+ +L +++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSL-DIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
V +L + H IV+EL+ S D L H+R K+A + + +L
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLG-LSTYDFIKENGFLPFRLD-HIR-KMAYQICKSVNFL 134
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL----SGTLG---- 318
H + + H DLK NIL + + + + + ++K+ S T
Sbjct: 135 HSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 319 --------YVAPEYLLDGKLTDKSDVYAFGVVLLELLLG 349
Y APE +L + DV++ G +L+E LG
Sbjct: 192 STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.4 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.26 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.33 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.04 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.21 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.9 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=444.87 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=215.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|...+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999864 478899999987777778899999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 225 VYELMENRSLDIQLHGP----------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
|||||++|+|.++|+.. .....++|.++++|+.|+|.||+|||++ +|+||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 1235799999999999999999999999 9999999999999999999999
Q ss_pred EecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 295 SDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+|||+++....... ......||++|||||++.+..++.++|||||||++|||+| |+.||...+..+....+....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-- 247 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-- 247 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 99999975433222 2233569999999999999999999999999999999998 999999877655433332110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....+. .+..++.+++.+||+.||++|||++||.+.|+++...
T Consensus 248 ---~~~~p~------------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 248 ---VLQRPR------------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---CCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCc------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111 1234677899999999999999999999999877544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=444.76 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=209.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|...+.||+|+||+||+|++. ++..||||++...+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666788999999999999864 478899999987777778899999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 225 VYELMENRSLDIQLHGPS------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
|||||++|+|.++++... ...+++|.++++|+.|+|.||+|||++ +|+||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999987532 124699999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhc
Q 012975 293 KLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~ 369 (452)
||+|||+++...... .......||++|||||++.+..++.++|||||||+||||+| |+.||......+....+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g- 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG- 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999997543322 22334679999999999999999999999999999999999 99999987765533333211
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.+...+. .+..++.+++.+||+.||++||||+||++.|+.+..
T Consensus 277 ----~~~~~p~------------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 277 ----RELERPR------------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ----CCCCCCT------------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCcc------------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111111 123467789999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=439.58 Aligned_cols=256 Identities=30% Similarity=0.398 Sum_probs=210.1
Q ss_pred CCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+++..+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4455788999999999999863 46789999996443 3446789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 225 VYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
|||||++|+|.++|+... ....++|.++++|+.|+|+||+|||++ +|+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996422 124699999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhh
Q 012975 292 AKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~ 368 (452)
+||+|||+++...... .......||++|||||++.++.++.++|||||||+||||+| |+.||.+.+..+....+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999997543222 22334679999999999999999999999999999999998 99999987765433322210
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.....+ .++...+.+++.+||+.||++||||+||++.|+...
T Consensus 264 -----~~~~~p------------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 264 -----QVLPCP------------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -----CCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCCc------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 001111 123346778999999999999999999999997653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=432.84 Aligned_cols=257 Identities=31% Similarity=0.484 Sum_probs=203.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..+++...+.||+|+||+||+|++++ .||||.++.. +....+.|.+|+++|++++|||||+++|+|.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34577788999999999999999765 5899988643 34556789999999999999999999999865 5689999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|.++|+. ....++|.++++|+.|+|.||+|||++ +|+||||||+||||++++++||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999974 345799999999999999999999999 9999999999999999999999999999764322
Q ss_pred --CCcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhccccccCCCCCc
Q 012975 307 --NKNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 --~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 380 (452)
.......+||+.|||||++.+ ..++.++|||||||+||||+||+.||...+..... ..+.. .. ....+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~---~~-~~p~~~~ 261 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR---GY-ASPDLSK 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT---TC-CCCCSTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc---CC-CCCCccc
Confidence 222345679999999999864 45899999999999999999999999876543211 11110 00 0011111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
...++...+.+++.+||+.||++||||.||++.|+.+
T Consensus 262 ---------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 ---------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ---------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ---------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112345677899999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=431.89 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=211.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+.|+..+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999976 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999998863 3599999999999999999999999 9999999999999999999999999999876655555
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... .. ..+.. . .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~--~~~~~---~---~- 294 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP--PRLKN---L---H- 294 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SC--CCCSC---G---G-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CC--CCCCc---c---c-
Confidence 56778999999999999999999999999999999999999999887655433322211 00 00100 0 0
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++.+++.+||+.||++|||+.|+++
T Consensus 295 ---~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 ---KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12245678999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-56 Score=432.53 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=205.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 367899999999999999999875 6899999999643 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|.+++.. ..+..+++.+++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 103 Ey~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999964 2345689999999999999999999999 9999999999999999999999999999765443
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+....+... ....++.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----~~~~~~~------ 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-----SFPPVSL------ 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----CCCCCCT------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCCCc------
Confidence 33344567999999999999999999999999999999999999999887654432222110 0001111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++.+++.+||+.||++|||++|+++
T Consensus 248 ------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 ------HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12245778999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=433.45 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=213.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356889999999999999999976 6899999999766555566789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
|++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||||+.+|.+||+|||+|........
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998863 3599999999999999999999999 999999999999999999999999999987665555
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+.... . ..+.. ..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---~--~~~~~------~~ 371 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---P--PRLKN------LH 371 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---C--CCCSC------TT
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC---C--CCCcc------cc
Confidence 5567789999999999999999999999999999999999999998876554333322110 0 00000 00
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++.+++.+||+.||++|||+.|+++
T Consensus 372 ----~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 ----KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ----SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11235678999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=430.43 Aligned_cols=269 Identities=28% Similarity=0.376 Sum_probs=217.2
Q ss_pred cHHHHHHhhcCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCC-CceeeeE
Q 012975 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHH-PNVVCLL 213 (452)
Q Consensus 142 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~ 213 (452)
+...+|...++|+..+.||+|+||+||+|++.+ ++.||||++.... ....++|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345566677899999999999999999998642 3679999996543 4456789999999999965 8999999
Q ss_pred EEEEcC-CceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 012975 214 GYSAHD-DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL 279 (452)
Q Consensus 214 g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dl 279 (452)
|+|.++ +..+||||||++|+|.++|+... ....++|.+++.++.|||+||+|||++ +|+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999765 56899999999999999996421 134599999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012975 280 KSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKL 356 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~ 356 (452)
||+|||+++++++||+|||+|+...... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997653322 22335679999999999999999999999999999999998 99999876
Q ss_pred Chhh-hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 357 APAQ-CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 357 ~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
...+ ....+.. ..+...++. ...++.+++.+||+.||++|||+.||++.|++++..+
T Consensus 292 ~~~~~~~~~i~~-----g~~~~~p~~------------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 292 KIDEEFCRRLKE-----GTRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCSHHHHHHHHH-----TCCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHc-----CCCCCCCcc------------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 5432 1111111 011112211 2235678999999999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=421.25 Aligned_cols=267 Identities=27% Similarity=0.313 Sum_probs=199.4
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC----ceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 227 (452)
+|...+.||+|+||+||+|+++ |+.||||++.... .....++.|+..+.+++|||||+++|+|.+++ ..|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4566789999999999999984 7899999996432 22223445666667889999999999998764 4799999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
||++|+|.++|+. ..++|..+++++.|++.||+|||++ .+++|+||||||+|||+++++++||+|||+++.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999974 3599999999999999999999986 256899999999999999999999999999975
Q ss_pred cCCCCC----cccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--hh------h
Q 012975 303 DGSQNK----NNLKLSGTLGYVAPEYLLDG------KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QS------I 364 (452)
Q Consensus 303 ~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--~~------~ 364 (452)
...... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+. .. .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 433221 22345799999999998764 467899999999999999999887654322110 00 0
Q ss_pred hhhhccccccCCCCCcccchhhc-ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIK-STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.......... .. .+|.+. .....+....+.+++.+||+.||++||||.||++.|+++...
T Consensus 238 ~~~~~~~~~~-~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTT-SC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhc-cc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000000 11 111111 111235677888999999999999999999999999887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=420.75 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=206.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+.|...+.||+|+||+||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45677788999999999999975 689999999964322 247999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcccCCCCC
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~ 308 (452)
++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||||+.+| .+||+|||+++.......
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999963 35699999999999999999999999 999999999999999988 599999999976533221
Q ss_pred -----cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 309 -----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 309 -----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||......+....+....+... .+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~----- 278 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR---EI----- 278 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG---GS-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch---hc-----
Confidence 12345799999999999999999999999999999999999999987665443222221110000 01
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.......+.+++.+||+.||++|||+.|+++.|.+.+..
T Consensus 279 -------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 279 -------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 112234677899999999999999999999988777654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=414.55 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=208.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+.. +|+.||||.+... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999875 6899999999643 2334577999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999963 35699999999999999999999999 9999999999999999999999999999765432
Q ss_pred --CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 --NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 --~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....+.+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+....+.. ....+++.+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------~~~~~p~~~-- 257 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK------LEYDFPEKF-- 257 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TCCCCCTTC--
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCccc--
Confidence 2334567899999999999999999999999999999999999999988765443222221 111222211
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
..++.+++.+||+.||++|||++|++
T Consensus 258 ----------s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 ----------FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----------CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----------CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 23567899999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=407.96 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=196.5
Q ss_pred CccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCceeeee
Q 012975 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVY 226 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 226 (452)
+..+.||+|+||+||+|++. ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999876 5889999998543 34456789999999999999999999999865 34579999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~ 305 (452)
|||++|+|.+++.. ...+++..+..++.|++.||+|||++ +++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999963 45699999999999999999999998 223999999999999984 79999999999976433
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...... +.... .. ...+...+
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i----~~-~~~~~~~~-- 252 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV----TS-GVKPASFD-- 252 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH----TT-TCCCGGGG--
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHH----Hc-CCCCCCCC--
Confidence 23345689999999998865 699999999999999999999999976543221 11111 11 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... ..++.+++.+||+.||++|||++|+++
T Consensus 253 --~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 --KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 235678999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=401.03 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=192.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+.. +|+.||+|.+.... ......+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 68999999986432 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+ +|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899888853 35699999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+..+....+.. ....++..+
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~------~~~~~p~~~--- 235 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN------GVYTLPKFL--- 235 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TCCCCCTTS---
T ss_pred C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc------CCCCCCCCC---
Confidence 2 2335689999999999998876 5799999999999999999999987665443222221 111222222
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..++.+++.+||+.||++|||++|+++
T Consensus 236 ---------s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 ---------SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 235668999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=412.67 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=199.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 46789999986432 2233468899999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|||||++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999963 35699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.........+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+....+.. .....+..+
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~~~~~p~~~-- 249 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------AKLGMPQFL-- 249 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTS--
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc------CCCCCCCcC--
Confidence 444455567899999999999999999999999999999999999999998776543332221 111222222
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 421 (452)
..++.+++.+||+.||++|||+ +|+++
T Consensus 250 ----------s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 250 ----------SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----------CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2356789999999999999984 67774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=396.07 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=190.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-------
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT------- 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------- 221 (452)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999875 68999999986543 3445679999999999999999999999876543
Q ss_pred -----eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 222 -----RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 222 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
.|+|||||++|+|.+++.........++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 689999999999999997644445577888999999999999999999 999999999999999999999999
Q ss_pred cCCCcccCCCCC------------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh
Q 012975 297 FGLAITDGSQNK------------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364 (452)
Q Consensus 297 fgl~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~ 364 (452)
||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence 999975433211 1234579999999999999999999999999999999996 7754221 1111
Q ss_pred hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... .....+... .+......+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~-----~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDV-----RNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-----HTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-----hcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 111111111 122234567999999999999999999997
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=393.73 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=202.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------Cc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------DT 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 221 (452)
++|+..+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56888999999999999999975 6899999999643 234456789999999999999999999997643 57
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|||||||+ |+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 779888863 45799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC----CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc--
Q 012975 302 TDGSQ----NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-- 374 (452)
Q Consensus 302 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-- 374 (452)
..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 54322 2233457899999999998875 4689999999999999999999999887655433322211110000
Q ss_pred CCCCCc-ccchhhc-----ccCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 RSKLPN-IVDPVIK-----STMD-----LKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 ~~~~~~-~~d~~l~-----~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...... .....+. .... .....++.+++.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000000 0000 011246778999999999999999999996
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=384.50 Aligned_cols=281 Identities=37% Similarity=0.663 Sum_probs=241.2
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+++.++++|+..+.||+|+||+||+|++.++..||||++........+.+.+|+.++++++||||+++++++.+++..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34457789999999999999999999988899999999877666677889999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||||+++|+|.+++.... ....++|.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999987532 224699999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 304 GSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 304 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||....+.+......|.... .....+...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 268 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQI 268 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHHh
Confidence 3222 2223456899999999999999999999999999999999999999877665555555554332 233456667
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
+++.+......+....+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777777777788999999999999999999999999999999887654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=380.00 Aligned_cols=288 Identities=38% Similarity=0.638 Sum_probs=240.9
Q ss_pred cccccHHHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEE
Q 012975 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYS 216 (452)
Q Consensus 138 ~~~~~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 216 (452)
...++..+++...++|...+.||+|+||+||+|+..++..||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345678899999999999999999999999999988899999999865432 2234689999999999999999999999
Q ss_pred EcCCceeeeeeecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 217 AHDDTRFIVYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 217 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
.+++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+.++++||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999987533 33469999999999999999999999888899999999999999999999999
Q ss_pred ecCCCcccCCCC-CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh--hhhhhhhhhcccc
Q 012975 296 DFGLAITDGSQN-KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPA--QCQSIVTWAMPQL 372 (452)
Q Consensus 296 Dfgl~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~--~~~~~~~~~~~~~ 372 (452)
|||++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......|....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL- 255 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT-
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH-
Confidence 999997654332 2233455999999999999989999999999999999999999999632211 112233343332
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.....+....+..+......++...+.+++.+||+.||++|||+.||++.|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 334556677777777778888999999999999999999999999999999763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=401.77 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=212.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|++.+.||+|+||+||+|+.. +|+.||+|.+........+.+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999875 6899999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~--~~~kl~Dfgl~~~~~~~ 306 (452)
|++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998863 345799999999999999999999999 99999999999999864 89999999999876433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+... ....+. ..
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~------~~~~~~----~~ 379 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWNMDD----SA 379 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CCCCCS----GG
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC------CCCCCc----cc
Confidence 2 334568999999999999999999999999999999999999999987765433322211 111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 235678999999999999999999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=381.13 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=171.1
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCce
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (452)
...+.|+..+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35678999999999999999999753 47889999986433 345688999999998 699999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAI 301 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~ 301 (452)
||||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999884 389999999999999999999999 99999999999999876 799999999996
Q ss_pred ccCCCC----------------------------CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCC
Q 012975 302 TDGSQN----------------------------KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRP 352 (452)
Q Consensus 302 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P 352 (452)
...... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 543211 112235799999999999876 489999999999999999999999
Q ss_pred CCCCC
Q 012975 353 VEKLA 357 (452)
Q Consensus 353 ~~~~~ 357 (452)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=369.90 Aligned_cols=262 Identities=34% Similarity=0.504 Sum_probs=207.6
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
...++|+..+.||+|+||+||+|+. +|..||||.+.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788899999999999999987 47789999986543 44456799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
|||+++|+|.+++........+++..++.++.|++.||+|||+. + ++||||||+|||+++++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999997533233599999999999999999999998 7 999999999999999999999999999765
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ......+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~--- 262 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----CKRLEIPR--- 262 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----CCCCCCCT---
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCCCCCCc---
Confidence 44433344567999999999999999999999999999999999999999887655433322211 11111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....++.+++.+||+.||++|||+.|+++.|++++..
T Consensus 263 ---------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 263 ---------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1223577899999999999999999999999988765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=367.64 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=212.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|...+.||+|+||+||+|++. ++..||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999976 58899999997777777889999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999974 245699999999999999999999999 9999999999999999999999999999654332211
Q ss_pred --------------ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccC
Q 012975 310 --------------NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR 375 (452)
Q Consensus 310 --------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 375 (452)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------------ 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------------ 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------------
Confidence 114569999999999999999999999999999999999999987644322100
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...................+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 233 ---GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000000001112223577899999999999999999999999887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=394.95 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=199.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhh---HHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDA---GREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|+..++||+|+||+||+|+.. +|+.||+|.+.... ... ......++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999876 68999999985321 111 22334456777888999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
|||||||++|+|..+|.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999963 35699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||..........+.... ......++..
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~~~~~~p~~ 416 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDS 416 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HHCCCCCCTT
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cCCCCCCCcc
Confidence 5432 2345689999999999975 57999999999999999999999999764432221111111 1111222222
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
+ ..++.+++.+||+.||++|++ ++||++
T Consensus 417 ~------------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 F------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp S------------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C------------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 2 235678999999999999998 577763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.54 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=210.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|+..+.||+|+||+||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999986 46889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999863 3589999999999999999999999 999999999999999999999999999976655444
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||................ .... ..+
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----~~~~---~~~---- 239 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-----TPEL---QNP---- 239 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-----SCCC---SCG----
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCC---CCc----
Confidence 4555679999999999999999999999999999999999999998766543222211110 0000 000
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
......+.+++.+||+.||++|||++|+++
T Consensus 240 ---~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 ---EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112345778999999999999999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=359.40 Aligned_cols=283 Identities=37% Similarity=0.582 Sum_probs=227.5
Q ss_pred cccccHHHHHHhhcCCCcc------CeEeecCcEEEEEEEeCCCcEEEEEEecCc----ChhhHHHHHHHHHHHHcCCCC
Q 012975 138 ISFIEYKLLEKATDSFHES------NILGEGGFGCVYKAKLDDNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHHP 207 (452)
Q Consensus 138 ~~~~~~~~l~~~~~~f~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ 207 (452)
...+.+.+++.++++|... +.||+|+||.||+|+. ++..||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3557789999999999887 8999999999999987 5779999998542 234567899999999999999
Q ss_pred ceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 012975 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (452)
Q Consensus 208 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~ 287 (452)
||+++++++.+++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999987544456799999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh
Q 012975 288 SKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV 365 (452)
Q Consensus 288 ~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~ 365 (452)
+++.+||+|||++........ ......||..|+|||.+.+ .++.++||||||+++|||++|+.||............
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999976543221 1233568999999998765 5899999999999999999999999876543211111
Q ss_pred hhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 366 TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 366 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
..........+.+.+++.+. .........+.+++.+||+.||++|||++||++.|+++..
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 --KEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --HHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 00011111222223333222 2345677889999999999999999999999999988753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.21 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=215.2
Q ss_pred cccHHHHHHhhcC----------CCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc
Q 012975 140 FIEYKLLEKATDS----------FHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208 (452)
Q Consensus 140 ~~~~~~l~~~~~~----------f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n 208 (452)
.++.++++.+++. |...+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3556666666654 566779999999999999987 68999999997666666778999999999999999
Q ss_pred eeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 012975 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 209 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~ 288 (452)
|+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 99999999999999999999999999998863 3599999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh
Q 012975 289 KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~ 368 (452)
++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 256 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999976554443444567999999999999999999999999999999999999999876654322211110
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .+.... .. .....+.+++.+||+.||++|||+.|+++.
T Consensus 257 ---~-----~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 257 ---P-----PPKLKN---SH----KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---S-----CCCCTT---GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---C-----CCCcCc---cc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 00 112356789999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=371.78 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=203.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.++|...+.||+|+||.||+|++. ++..||||.+... .....++|.+|+.++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999999999999865 5778999999754 34456789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.++++. ....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999973 345799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .. ..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---~~--~~--- 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---YR--LP--- 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---EE--CC---
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CC--CC---
Confidence 32211 112235778999999999999999999999999999998 99999877654432222111 00 00
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...+....+.+++.+||+.||++||++.||++.|++++..
T Consensus 271 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 271 ---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0112235678899999999999999999999999988764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=363.62 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=211.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.++|...+.||+|+||+||+|++. .+..||||.+... .....+.|.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999975 3556999999754 44556789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999963 345799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
..... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .....+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~- 276 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----YRLPAP- 276 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CCCCCC-
Confidence 33221 222346778999999999999999999999999999999 99999887654432222211 000011
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
......+.+++.+||+.||++|||+.||++.|+.++..
T Consensus 277 -----------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 277 -----------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 12234677899999999999999999999999988765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=369.15 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=213.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEe--------CCCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL--------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
.++|...+.||+|+||+||+|++ .++..||||.+... .....+.+.+|+++++++ +||||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 45788889999999999999985 24567999999654 334567899999999999 899999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 220 DTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999986422 124589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhh
Q 012975 287 DSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQS 363 (452)
Q Consensus 287 ~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~ 363 (452)
+.++.+||+|||++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999997544322 12233457889999999999999999999999999999999 999998766544322
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.+... .....+ ......+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 317 ~~~~~-----~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 LLKEG-----HRMDKP------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHTT-----CCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcC-----CCCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 22111 001111 122346778999999999999999999999999887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.69 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=208.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|...+.||+|+||.||+|++ .+|..||||++... .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788899999999999999997 47899999998643 3445677899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999853 34699999999999999999999999 9999999999999999999999999999655332
Q ss_pred CCcccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLT-DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. .....+||+.|+|||.+.+..++ .++|||||||++|||++|+.||......+....+.. .....+..+
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~~~~p~~~--- 237 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------GKYRIPFYM--- 237 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTS---
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCC---
Confidence 2 23456799999999999988775 799999999999999999999988765443332221 111222211
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+.+++.+||+.||++|||++|+++.
T Consensus 238 ---------s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 ---------STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---------CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---------CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2356689999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=351.87 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=212.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||+||+|++.++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5678889999999999999999888899999997543 234679999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-Cc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-KN 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~ 309 (452)
+|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... ..
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999963 345699999999999999999999999 99999999999999999999999999996543322 12
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.... ....+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~-------- 230 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----RLYKPR-------- 230 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----CCCCCT--------
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----cCCCCC--------
Confidence 223456788999999999999999999999999999999 999998876544322221110 000111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 231 ----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1123577899999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.98 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=204.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..++|+..+.||+|+||+||+|+..+|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 456788899999999999999999889999999986443 233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 77777753 345699999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc-----
Q 012975 307 NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN----- 380 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 380 (452)
........||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... ....+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-NPREWPQVQELP 251 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC-CTTTSGGGTTSH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC-ChHHhhhhhccc
Confidence 444445578999999999876 568999999999999999999999998766543222211100000 0000000
Q ss_pred --------ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 --------IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 --------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+.............++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000112346788999999999999999999997
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.36 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=212.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++|+..+.||+|+||.||+|++.++..||+|.+.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45788899999999999999999998899999997543 23467899999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 308 (452)
++++|.+++.. .+..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999863 234699999999999999999999999 999999999999999999999999999975543322
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+......... ....+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~------ 229 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----RLYRPHL------ 229 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTT------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----CCCCCCc------
Confidence 2223446778999999999899999999999999999999 999998776544322222111 0011111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 230 ------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 230 ------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1235778999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=357.99 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=208.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||+||+++.. +|+.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999876 6889999998643 233456789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988863 34689999999999999999999999 999999999999999999999999999976444
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
........+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.. ....++..
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~---- 227 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EEIRFPRT---- 227 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTT----
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCCC----
Confidence 44444567899999999999999999999999999999999999999987665433222211 11112211
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
....+.+++.+||+.||++|| +++|+++.
T Consensus 228 --------~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 --------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 123567899999999999999 89999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=369.47 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=211.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..++|...+.||+|+||.||+|++. ++..||||.+.... .....+|.+|++++++++||||++++++|.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457888899999999999999986 68899999986442 344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. .+..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++......
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999863 344699999999999999999999999 9999999999999999999999999999754332
Q ss_pred CCcc--cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 307 NKNN--LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 307 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.... ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... .....+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~--- 338 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-----GRLPCPE--- 338 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-----CCCCCCT---
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC---
Confidence 1111 12235778999999999999999999999999999998 99999887654433222211 0111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.....+.+++.+||+.||++|||++++++.|+++..
T Consensus 339 ---------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 339 ---------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 123467789999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=363.62 Aligned_cols=269 Identities=26% Similarity=0.353 Sum_probs=206.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc----eeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----RFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV 225 (452)
.++|+..+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888999999999999999886 6899999996443 334556779999999999999999999987553 6999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-------NPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ +++|+||||||+|||+++++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999963 34999999999999999999999762 3489999999999999999999999999
Q ss_pred CCcccCCCCC--cccccccccCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh----
Q 012975 299 LAITDGSQNK--NNLKLSGTLGYVAPEYLLDG-----KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW---- 367 (452)
Q Consensus 299 l~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~---- 367 (452)
++........ ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||..............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9965433222 22335799999999998873 556789999999999999999999976543211100000
Q ss_pred -----hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 368 -----AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 368 -----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
....... ........... ........+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 257 ~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 257 PSLEDMQEVVVH-KKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCHHHHHHHHTT-SCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cchhhhhhhhhc-ccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000 11111111111 112456678999999999999999999999999988754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.63 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=198.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--------------------------hhHHHHHHHHHHHH
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------------------------DAGREFENEVDLLS 202 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 202 (452)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999875 688999999854321 12356899999999
Q ss_pred cCCCCceeeeEEEEEc--CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012975 203 NIHHPNVVCLLGYSAH--DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (452)
Q Consensus 203 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk 280 (452)
+++||||+++++++.+ ++..++||||+++|+|.+++. ...+++.+++.++.|++.||+|||++ +++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 567899999999999987653 34699999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 281 SSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK---LTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 281 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
|+|||++.++.+||+|||++..............||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999976554443344567999999999987765 3778999999999999999999998765
Q ss_pred hhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 358 PAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.......+... ....+. .. +....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~------~~~~~~------~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLHSKIKSQ------ALEFPD------QP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHHC------CCCCCS------SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhcc------cCCCCC------cc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43322222111 001110 01 12245778999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.23 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=203.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|++. ++. +||+|.+... .....+.|.+|+.++++++||||++++++|.+++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46788899999999999999864 333 4688887533 2345678999999999999999999999998754 789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++....
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999874 345799999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+.... ....+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----~~~~~-- 241 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----RLPQP-- 241 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----CCCCC--
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----CCCCC--
Confidence 3222 2223456889999999999999999999999999999999 999998876554333332111 00111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
......+.+++.+||+.||++||+++|+++.|+++...
T Consensus 242 ----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 242 ----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11234677899999999999999999999999887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=348.11 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=201.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||+||+|+..+|..||+|++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 56888999999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 88888763 235699999999999999999999999 999999999999999999999999999976544333
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc-----cc
Q 012975 309 NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN-----IV 382 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 382 (452)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+............ ....++. ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC-Chhhchhhhccccc
Confidence 33445789999999998764 58999999999999999999999998776543221111100000 0000000 00
Q ss_pred chhh-------cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVI-------KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
++.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00001122346778999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=349.63 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=209.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 457888999999999999999875 6889999998533 334457899999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999863 34699999999999999999999999 999999999999999999999999999976533
Q ss_pred CC-CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 306 QN-KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... .. ...+. ...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~--~~~~~-~~~ 234 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH------IQ--DSVPN-VTT 234 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH------HS--SCCCC-HHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hh--ccCCC-cch
Confidence 22 2223456999999999999999999999999999999999999999876643321110 00 01111 001
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHhccccCcccc
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-LITDVLHSLIPLVPVEL 431 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~l~~~~~ 431 (452)
.... +....+.+++.+||+.||++|| +++++.+.|..++....
T Consensus 235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1111 2234677899999999999998 99999999998877643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=350.66 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=211.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..+.||+|+||+||++++.++..||+|.+..... ..+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3457888899999999999999999998999999975432 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN- 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~- 307 (452)
+++|+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999874 235699999999999999999999999 99999999999999999999999999996543321
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+.... ....+..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~----- 245 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RLYRPHL----- 245 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTT-----
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----CCCCCCc-----
Confidence 11223346788999999998999999999999999999998 999998876544333222110 0111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....+.+++.+||+.||++|||++|+++.|++++..+
T Consensus 246 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1235778999999999999999999999999887653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=359.75 Aligned_cols=265 Identities=26% Similarity=0.351 Sum_probs=207.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (452)
.++|+..+.||+|+||+||+|++ .++..||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788899999999999999984 36889999999877777778899999999999999999999999654 468
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999874 234699999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCC---CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh---------hhhhhcc
Q 012975 303 DGSQN---KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS---------IVTWAMP 370 (452)
Q Consensus 303 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~---------~~~~~~~ 370 (452)
..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 43322 11223447778999999999999999999999999999999999987543211000 0000000
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
........ ........++.+++.+||+.||++|||++|+++.|+++...
T Consensus 244 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccCcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111110 01112335678899999999999999999999999887643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=374.11 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=215.6
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
+...++|...+.||+|+||+||+|+++++..||||.+.... ...+.|.+|+.+|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34556788899999999999999999988999999997543 34678999999999999999999999986 56789999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999742 123689999999999999999999999 9999999999999999999999999999765332
Q ss_pred CC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 NK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......+|..|+|||.+....++.++||||||+++|||+| |+.||......+....+... ...+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------~~~~~---- 406 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------YRMPR---- 406 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-------CCCCC----
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------CCCCC----
Confidence 11 1123346788999999998999999999999999999999 99999887654433222211 01100
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccC
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~ 432 (452)
.......+.+++.+||+.||++|||+++|++.|+++......
T Consensus 407 ------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 407 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 012234677899999999999999999999999998876443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=362.61 Aligned_cols=268 Identities=29% Similarity=0.393 Sum_probs=214.4
Q ss_pred cHHHHHHhhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeE
Q 012975 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLL 213 (452)
Q Consensus 142 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~ 213 (452)
....++...++|...+.||+|+||.||+|++ .+++.||||.+... .....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3555666778999999999999999999973 34688999999754 344557799999999999 799999999
Q ss_pred EEEEcCCc-eeeeeeecCCCChhhhccCCCC-------------------------------------------------
Q 012975 214 GYSAHDDT-RFIVYELMENRSLDIQLHGPSH------------------------------------------------- 243 (452)
Q Consensus 214 g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 243 (452)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99988654 8999999999999999875321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--
Q 012975 244 --------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-- 307 (452)
Q Consensus 244 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-- 307 (452)
...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12289999999999999999999999 99999999999999999999999999997543222
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh-hhhhhhccccccCCCCCcccchh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.......||..|+|||.+.+..++.++||||||+++|||+| |+.||......+.. ..... ......+..
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~---- 320 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-----GTRMRAPDY---- 320 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-----TCCCCCCTT----
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-----CCCCCCCCC----
Confidence 22334568899999999999999999999999999999998 99999876533211 11110 001111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...++.+++.+||+.||++|||+.|+++.|++++..
T Consensus 321 --------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 321 --------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 123577899999999999999999999999887654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.85 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=200.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHc--CCCCceeeeEEEEEcC----Ccee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHD----DTRF 223 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 223 (452)
.++|+..+.||+|+||+||+|+. ++..||||.+... ....+..|.+++.. ++||||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999998 5789999998643 34556667777666 7999999999987553 4579
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--------EHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
+||||+++|+|.+++.. ..+++..+++++.|++.||+||| +. +++||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999953 46999999999999999999999 66 99999999999999999999999
Q ss_pred ecCCCcccCCCCCc----ccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 012975 296 DFGLAITDGSQNKN----NLKLSGTLGYVAPEYLLDG------KLTDKSDVYAFGVVLLELLLG----------RRPVEK 355 (452)
Q Consensus 296 Dfgl~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gvll~elltG----------~~P~~~ 355 (452)
|||++......... .....||+.|+|||.+.+. .++.++||||||+++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999654322211 2234799999999999876 455799999999999999999 888865
Q ss_pred CChhhhh-hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 356 LAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 356 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
....... ....... ......+..-. ..........+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVV---CVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHH---TTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHH---hccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4332211 1111000 00111111111 111225677899999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=355.53 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=205.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcE----EEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLH----VAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|++. ++.. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999865 3433 7888875332 233456788999999999999999999986 467899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999874 245799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+.... ....+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 241 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-----RLAQPQI 241 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-----BCCCCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----CCCCCCc
Confidence 3322 2234567889999999999999999999999999999999 999998876544333332211 1111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.. ..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 242 ~~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 242 CT------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp BC------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred Cc------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 13556899999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=351.55 Aligned_cols=261 Identities=28% Similarity=0.480 Sum_probs=202.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||+||+|+.. +..||+|.+.. ....+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46778899999999999999986 67899999863 345678999999999999999999999887 45799999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-EEEEecCCCcccCCCCCc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~-~kl~Dfgl~~~~~~~~~~ 309 (452)
+|+|.+++........+++..++.++.|++.||+|||+....+++||||||+||++++++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975443345889999999999999999999942238999999999999998886 799999998654322
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.... ...... ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~----~~~~~~-----~~- 227 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN----GTRPPL-----IK- 227 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHHT----TCCCCC-----BT-
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHhc----CCCCCc-----cc-
Confidence 12346899999999999999999999999999999999999999865432211 1111100 001111 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGT 434 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~ 434 (452)
.....+.+++.+||+.||++|||++|+++.|+++...-.+..
T Consensus 228 ---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 228 ---NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 122357789999999999999999999999998877655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=357.04 Aligned_cols=264 Identities=28% Similarity=0.408 Sum_probs=213.9
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
+...++|...+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999874 3578999999754 344567899999999999999999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSH---------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRD 278 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~D 278 (452)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 999999999999999999864211 25799999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 012975 279 LKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEK 355 (452)
Q Consensus 279 lk~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~ 355 (452)
|||+|||+++++.+||+|||++....... .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999986543221 12233468899999999999999999999999999999999 9999987
Q ss_pred CChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 356 LAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....+....+... .....+. .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 280 ~~~~~~~~~~~~~-----~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAHEEVIYYVRDG-----NILACPE------------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCHHHHHHHHHTT-----CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CChHHHHHHHhCC-----CcCCCCC------------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7654432222110 0001111 12346778999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.36 Aligned_cols=267 Identities=28% Similarity=0.401 Sum_probs=217.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 218 (452)
..++|...+.||+|+||+||+|+.. ++..||||++... .......+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567888999999999999999852 3467999999654 344557899999999999 99999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999864221 24699999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~ 362 (452)
+++++.+||+|||++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997554322 22233457889999999999999999999999999999999 99999877654433
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCcc
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTL 435 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~ 435 (452)
..+.... ....+ . ....++.+++.+||+.||++|||++||++.|++++.....+..
T Consensus 304 ~~~~~~~-----~~~~~--------~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 304 KLLKEGH-----RMDKP--------S----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHHHTTC-----CCCCC--------S----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHHHcCC-----CCCCC--------c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 2222110 01111 1 1234677899999999999999999999999999877655544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=358.22 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=202.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
..++|+..+.||+|+||+||+|+.. ++..||+|.+... .......+.+|..+++.+ +||||+++++++.+++..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 5889999998643 233456688999999988 7999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999863 35699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. .....+..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~-- 246 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------DEVVYPTW-- 246 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTT--
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCC--
Confidence 4444445567899999999999998999999999999999999999999988765443222211 11112221
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI------TDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 421 (452)
....+.+++.+||+.||++||++ +|+++
T Consensus 247 ----------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 ----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12356789999999999999998 77774
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=341.87 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=196.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh----hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ----DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||+||+|++. +..||||.+..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999976 77899999864322 2346789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--------CCcEEEEec
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--------KFNAKLSDF 297 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~--------~~~~kl~Df 297 (452)
|||+++++|.+++. ...+++..++.++.|++.||+|||++...+++||||||+||++++ ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999885 346999999999999999999999982223999999999999986 778999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
|++........ ....||..|+|||.+.+..++.++||||||+++|||++|+.||............... .....
T Consensus 161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~ 234 (271)
T 3dtc_A 161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----KLALP 234 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----CCCCC
T ss_pred Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----CCCCC
Confidence 99965433222 2446899999999999999999999999999999999999999876644322211110 00011
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.+ . .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 235 ~~--------~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 IP--------S----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC--------T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC--------c----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 1 1234677899999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=340.39 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 226 (452)
++|...+.||+|+||+||+|+++ +..||||.+... .....+.|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56788899999999999999986 778999998654 344567799999999999999999999999887 6789999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||+++|+|.+++... ....+++..++.++.|++.||+|||+. + ++||||||+||++++++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999752 234699999999999999999999998 6 9999999999999999999999999875432
Q ss_pred CCCCcccccccccCccCcccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTD---KSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+........ ......+.
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~- 234 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE----GLRPTIPP- 234 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS----CCCCCCCT-
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc----CCCCCCCC-
Confidence 2 2346899999999998766554 899999999999999999999877654422211110 00111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.....+.+++..||+.||++|||++|+++.|+++..
T Consensus 235 -----------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 235 -----------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 122357789999999999999999999999988753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=361.82 Aligned_cols=270 Identities=26% Similarity=0.336 Sum_probs=209.6
Q ss_pred cCCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 223 (452)
++|+..+.||+|+||.||++++ .++..||||++........+.+.+|++++++++|+||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678899999999999999984 3688999999987777777889999999999999999999999874 45689
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999863 234699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh--------hhhcccc
Q 012975 304 GSQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV--------TWAMPQL 372 (452)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~--------~~~~~~~ 372 (452)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||............ .......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43322 222345788899999999999999999999999999999999998754322100000 0000000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCcc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGTL 435 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~ 435 (452)
.... ...........+.+++.+||+.||++|||++|+++.|+.+.........
T Consensus 258 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 258 EEGQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred hccc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 0000 0011122345678899999999999999999999999999887766554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=355.12 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=207.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh------hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD------AGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
..+.|...+.||+|+||.||+++.. +|..||+|.+...... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467888999999999999999976 5889999998644321 35679999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEec
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDF 297 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Df 297 (452)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999853 45699999999999999999999999 999999999999998877 7999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
|++....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||......+....+... ...
T Consensus 164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------~~~ 236 (361)
T 2yab_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------SYD 236 (361)
T ss_dssp SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CCC
T ss_pred CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------CCC
Confidence 9997654322 233457999999999999999999999999999999999999999886654432222110 001
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 237 ----~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ----FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111 245778999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=344.69 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=201.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999986 58899999986432 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|++++.+..+.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 998654444332 245699999999999999999999999 99999999999999999999999999997765444
Q ss_pred CcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC-ChhhhhhhhhhhccccccCCCCCccc---
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKL-APAQCQSIVTWAMPQLTDRSKLPNIV--- 382 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--- 382 (452)
.......||..|+|||.+.+.. ++.++||||||+++|||++|..|+... ...+....+....... ....+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGGGST
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhhhhhcccc
Confidence 4445567899999999998766 799999999999999999988885443 3222111111100000 000000000
Q ss_pred ---------chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 ---------DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 ---------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..........+....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000111123456778999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=348.28 Aligned_cols=271 Identities=18% Similarity=0.260 Sum_probs=211.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC--ceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 226 (452)
++|...+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999986 48899999986433 334567889999999999999999999998765 679999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEecCCCcc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAIT 302 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll----~~~~~~kl~Dfgl~~~ 302 (452)
||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997644445599999999999999999999999 99999999999999 7888899999999976
Q ss_pred cCCCCCcccccccccCccCccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhcc-c-
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLL--------DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMP-Q- 371 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~-~- 371 (452)
...... .....||..|+|||.+. +..++.++|||||||++|||++|+.||........ ......... .
T Consensus 166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred cCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 544332 23456999999999886 57889999999999999999999999975443221 111110000 0
Q ss_pred ------cccCCCCCcccch--hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 372 ------LTDRSKLPNIVDP--VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 372 ------~~~~~~~~~~~d~--~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
...........++ .............+.+++.+||+.||++|||++|+++...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 0000000000000 11123445777888999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.81 Aligned_cols=255 Identities=28% Similarity=0.382 Sum_probs=208.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC-ceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD-TRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 227 (452)
..++|+..+.||+|+||.||+|++. |..||||.+.... ..+.|.+|+.+|++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888899999999999999986 6699999997543 4567999999999999999999999987765 7899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999742 233479999999999999999999999 99999999999999999999999999997543222
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... .+...+
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~p------- 408 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAP------- 408 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-----CCCCCC-------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCC-------
Confidence 12357889999999999999999999999999999998 99999876654432222110 001111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
......+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 409 -----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 409 -----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 122346778999999999999999999999998876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=351.34 Aligned_cols=251 Identities=18% Similarity=0.217 Sum_probs=207.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||+||+++.. ++..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999976 5788999998744 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~ 306 (452)
+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999863 345699999999999999999999999 9999999999999987 789999999999765432
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... .... +...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------~~~~----~~~~ 226 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------EYTF----DEEA 226 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCC----CHHH
T ss_pred C-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC------CCCC----Chhh
Confidence 2 233456999999999999988999999999999999999999999886654432222111 0000 1111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... ...++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1346778999999999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=363.88 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=208.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
..++|+..+.||+|+||+||++... +|..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567889999999999999999875 68899999986543 33456789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~---~~~~~kl~Dfgl~~~ 302 (452)
|||+++|+|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999988864 35699999999999999999999999 999999999999998 568899999999976
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
............||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..... ..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------~~~~-- 234 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY------DFPS-- 234 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------CCCT--
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC------CCCc--
Confidence 65544444556899999999999999999999999999999999999999987765443322221110 0000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+.. . .....+.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~-~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 -PEW-D----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -TTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -ccc-c----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 1 112357789999999999999999999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=349.08 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=202.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||+||+|+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999876 688999999864432 334668999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999863 35699999999999999999999999 9999999999999999999999999999654221
Q ss_pred -CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 -NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+... .... .+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----~~~~----~~ 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KTYL----NP 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----CTTS----TT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----cccC----Cc
Confidence 122234579999999999988775 779999999999999999999998655422 111111110 0000 00
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 231 --~~----~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --WK----KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cc----cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01 122456789999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=356.30 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=208.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|+..+.||+|+||.||+|+.. +|..||+|.+..........+.+|++++++++||||+++++++.+++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457888999999999999999876 6889999999766666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~ 306 (452)
+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998863 345699999999999999999999999 9999999999999974 577999999999765433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .. .. ++..
T Consensus 205 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~----~~----~~~~ 273 (387)
T 1kob_A 205 EI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--DW----EF----DEDA 273 (387)
T ss_dssp SC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--CC----CC----CSST
T ss_pred cc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----CC----Cccc
Confidence 22 23457999999999999999999999999999999999999999876654322221110 00 00 0001
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. ....++.+++.+||+.||++|||+.|+++.
T Consensus 274 ~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 122457789999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=357.17 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=204.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
.+.|+..+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999875 68899999985321 124577999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecCC
Q 012975 224 IVYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGL 299 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfgl 299 (452)
+||||+++|+|.+++... ..+..+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777532 2234589999999999999999999999 9999999999999987655 99999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+..............||+.|+|||.+.+..++.++|||||||++|||++|+.||............. ....
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~-------~~~~-- 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK-------GKYK-- 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH-------TCCC--
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc-------CCCC--
Confidence 9776554444445679999999999999999999999999999999999999998753221111111 0000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 251 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111 1246778999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=374.96 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=213.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..++|...+.||+|+||.||+|++.. +..||||.+.... ...++|.+|+.+|++++||||++++++|.+++..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34567778899999999999999875 7899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999742 235699999999999999999999999 99999999999999999999999999997653322
Q ss_pred -CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 308 -KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... . +...
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~--~~~~------- 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---Y--RMER------- 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---C--CCCC-------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---C--CCCC-------
Confidence 11223346788999999999999999999999999999999 99999877654432222110 0 0001
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.......+.+++.+||+.||++|||+.||++.|+++...
T Consensus 441 -----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112234677899999999999999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=353.64 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=206.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
..++|...+.||+|+||.||+|... +|..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467899999999999999999876 5889999999643 334557799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~Dfgl~~~ 302 (452)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988863 35699999999999999999999999 99999999999999865 4599999999976
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... ....+.
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------~~~~~~-- 251 (362)
T 2bdw_A 181 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------AYDYPS-- 251 (362)
T ss_dssp CTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCT--
T ss_pred ecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCCc--
Confidence 54322 223457999999999999999999999999999999999999999876654322222111 001100
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+. .. .....+.+++.+||+.||++|||+.|+++.
T Consensus 252 -~~-~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 -PE-WD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TG-GG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cc-cc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 01 112457789999999999999999999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=349.34 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=212.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
..++|...+.||+|+||.||+|+. .++..||+|.+... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346788889999999999999986 34578999998654 34456789999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSH---------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk 280 (452)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999874321 23489999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 012975 281 SSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLA 357 (452)
Q Consensus 281 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~ 357 (452)
|+||++++++.+||+|||++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976543322 1223457788999999999999999999999999999999 999998776
Q ss_pred hhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 358 PAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.......+.... ....+ . .....+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 258 ~~~~~~~~~~~~-----~~~~~--------~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERLFNLLKTGH-----RMERP--------D----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGHHHHHHTTC-----CCCCC--------T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCC-----cCCCC--------c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 544332222110 00111 1 123467789999999999999999999999988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.12 Aligned_cols=268 Identities=23% Similarity=0.347 Sum_probs=193.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||+||+|+.. +|..||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999875 58899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|++ |+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6888877531 1224589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc--------cccC
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ--------LTDR 375 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~--------~~~~ 375 (452)
..........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... ....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 43333345578999999999876 46899999999999999999999999887654432222111000 0000
Q ss_pred CC----C----CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 SK----L----PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ~~----~----~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. . ...+...+...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0 0000001111111112346789999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=349.22 Aligned_cols=251 Identities=26% Similarity=0.310 Sum_probs=206.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
+.|...+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999976 588999999864322 13577999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEecCC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFGL 299 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Dfgl 299 (452)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+|||+++++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999853 45699999999999999999999999 999999999999999887 899999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ....
T Consensus 165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------~~~~- 236 (326)
T 2y0a_A 165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYEF- 236 (326)
T ss_dssp CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT------CCCC-
T ss_pred CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc------CCCc-
Confidence 97654322 223457999999999999999999999999999999999999999876654322222111 0001
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....... ....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 ---EDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---CHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---Ccccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 12456789999999999999999999963
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.01 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=209.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|...+.||+|+||.||+|++.++..||||.+.... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788889999999999999999988889999997543 235679999999999999999999999876 678999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN- 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~- 307 (452)
+++|+|.+++... .+..+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999631 234589999999999999999999999 99999999999999999999999999997543322
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .+...+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~------- 403 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCP------- 403 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCC-------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCC-------
Confidence 11223456789999999999999999999999999999999 99999887654432222111 000111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
......+.+++.+||+.||++|||++++++.|+++.....
T Consensus 404 -----~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 404 -----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1223467789999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.02 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=206.4
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCce
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 222 (452)
...++|...+.||+|+||+||+|+.. +|+.||+|.+.... ......+..|..++..+ +||||+++++++.+++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999986 58899999986432 23456678899999877 999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999863 34699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
...........+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.. ....++..+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~~ 241 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------DNPFYPRWL 241 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTS
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------CCCCCCccc
Confidence 44333444567899999999999999999999999999999999999999987765443222221 111122111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChH-HHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLIT-DVL 420 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 420 (452)
...+.+++.+||+.||++||++. |++
T Consensus 242 ------------s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 242 ------------EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------------CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------------CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 23567899999999999999997 665
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.91 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=211.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|...+.||+|+||.||+++..++..||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56778899999999999999998888999999975433 34679999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-Cc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-KN 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~ 309 (452)
+++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....... ..
T Consensus 87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999863 235689999999999999999999999 99999999999999999999999999986543221 11
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... . ....+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~---~--~~~~~~-------- 228 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---F--RLYKPR-------- 228 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---C--CCCCCT--------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC---C--cCCCCc--------
Confidence 223457788999999998899999999999999999999 99999876654322222110 0 000111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 229 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1124577899999999999999999999999887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.26 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=205.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|...+.||+|+||+||+|++.. +..||+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678899999999999998643 346999998654 33455679999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999863 345799999999999999999999999 99999999999999999999999999996543
Q ss_pred CCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. ....+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-------~~~~~~ 271 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------GFRLPT 271 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------TCCCCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-------CCcCCC
Confidence 3221 1122346788999999999999999999999999999999 9999987665433222211 111100
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.......+.+++.+||+.||++||++.|+++.|++++...
T Consensus 272 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 272 ----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0012346778999999999999999999999999887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=344.72 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=205.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-C-------cEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-N-------LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
.++|...+.||+|+||+||+|+... + ..||+|.+........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3567888999999999999998653 2 5799999977666777889999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------EE
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--------AK 293 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~--------~k 293 (452)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999974 234599999999999999999999999 9999999999999998887 99
Q ss_pred EEecCCCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhhhhhhhhhhccc
Q 012975 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLG-RRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
|+|||++..... .....||..|+|||.+.+ ..++.++||||||+++|||++| ..|+.............
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~----- 232 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE----- 232 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-----
Confidence 999999854422 223468899999999987 6789999999999999999995 55555544332221111
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+... ...+.+++.+||+.||++|||+.|+++.|+++..-
T Consensus 233 --~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 --DRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --TTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --ccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111111111 12356789999999999999999999999998873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=352.05 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=198.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCC----cEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDN----LHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
..++|...+.||+|+||+||+|++... ..||||.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 346788999999999999999987643 27999998644 345567899999999999999999999999887655
Q ss_pred ------eeeeeecCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 012975 223 ------FIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAK 293 (452)
Q Consensus 223 ------~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~k 293 (452)
++||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 9999999999999888532 1223699999999999999999999999 999999999999999999999
Q ss_pred EEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcc
Q 012975 294 LSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 294 l~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~ 370 (452)
|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.........
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~- 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN- 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence 99999996543322 12223456788999999999999999999999999999999 999998776544322221110
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....+ ......+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 257 ----~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 257 ----RLKQP------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----CCCCC------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----CCCCC------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000 112346778999999999999999999999999887653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=341.96 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=202.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhh-------HHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA-------GREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
.++|+..+.||+|+||+||+|++. ++..||+|.+....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 357888999999999999999975 68899999985433211 167899999999999999999999986654
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCc-----EEE
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFN-----AKL 294 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~~~~~-----~kl 294 (452)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ + ++||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999888863 345799999999999999999999998 7 999999999999988876 999
Q ss_pred EecCCCcccCCCCCcccccccccCccCcccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYL--LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
+|||++..... ......||..|+|||.+ ....++.++||||||+++|||++|+.||..................
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 246 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG- 246 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-
Confidence 99999964432 23345799999999998 3456789999999999999999999999876543321111111000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
.....+. .....+.+++.+||+.||++|||++|+++.|+++
T Consensus 247 -~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 -LRPTIPE------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CCCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CCCCCCc------------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111111 2234677899999999999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=361.57 Aligned_cols=260 Identities=29% Similarity=0.392 Sum_probs=210.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|...+.||+|+||+||+|++. ++..||||++... ......++.+|+.++++++||||+++++++.+++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999853 4678999998643 445566799999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEE
Q 012975 223 FIVYELMENRSLDIQLHGP----SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLS 295 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~---~~kl~ 295 (452)
++||||+++|+|.+++... .....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999998642 1234699999999999999999999999 999999999999999555 59999
Q ss_pred ecCCCcccC--CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhcccc
Q 012975 296 DFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 296 Dfgl~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
|||++.... ..........||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~--- 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 999996431 11122234568899999999999999999999999999999998 999998876544332222110
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....+ ......+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 304 --~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 --RMDPP------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --CCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCCC------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00011 11223577899999999999999999999999877654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=357.29 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=202.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (452)
.++|+..++||+|+||+||+++.. +++.||+|.+.... ....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457888999999999999999976 57889999986432 22334578899999887 89999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998863 34699999999999999999999999 99999999999999999999999999997644
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--hhhhhhh-ccccccCCCCCcc
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QSIVTWA-MPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~ 381 (452)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....... .........++..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 444445567899999999999999999999999999999999999999975432110 0000000 0011111122211
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI------TDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 421 (452)
...++.+++.+||+.||++||++ .|+++
T Consensus 285 ------------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 285 ------------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ------------SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ------------CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 22356789999999999999996 56663
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=349.39 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=195.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEe----CCCcEEEEEEecCcC----hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
.++|+..+.||+|+||.||+++. .++..||+|.+.... ......+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999987 478899999986432 2334568899999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998863 34689999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.............||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. ....++..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------~~~~~p~~ 243 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------CKLNLPPY 243 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------TCCCCCTT
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------CCCCCCCC
Confidence 543333333456799999999999999999999999999999999999999987665432222111 11111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
....+.+++.+||+.||++|| ++.|+++
T Consensus 244 ------------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 244 ------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 123567899999999999999 7788875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=352.25 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=208.3
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
...++|...+.||+|+||+||+|+. .++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++..+
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457888999999999999999986 246789999996432 33456799999999999 899999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSH--------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDL 279 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dl 279 (452)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 999999999999999999875321 13489999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012975 280 KSSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKL 356 (452)
Q Consensus 280 k~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~ 356 (452)
||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999965432221 2233457889999999999999999999999999999998 99999876
Q ss_pred ChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 357 APAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
....... ....... ....+. .....+.+++.+||+.||++|||+.|+++.|+.++....+.
T Consensus 279 ~~~~~~~--~~~~~~~--~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 279 PVDANFY--KLIQNGF--KMDQPF------------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp CCSHHHH--HHHHTTC--CCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred CcHHHHH--HHHhcCC--CCCCCC------------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 5432111 1110000 001111 12346778999999999999999999999999988765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=346.37 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=212.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|...+.||+|+||+||+|++ .++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788899999999999999985 357889999997543 34557799999999999 9999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 221 TRFIVYELMENRSLDIQLHGPSH---------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999864321 22589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhh-
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQC- 361 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~- 361 (452)
+++++.+||+|||++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999976543322 1223457889999999999999999999999999999999 9999987653321
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....... . ....+ ......+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus 258 ~~~~~~~---~--~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 YKMIKEG---F--RMLSP------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHT---C--CCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhccC---C--CCCCc------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111110 0 00000 112346778999999999999999999999999887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=350.28 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=200.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT------ 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 221 (452)
.++|+..+.||+|+||.||+|++. +|..||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999987 78999999986443 3456789999999999999999999999866442
Q ss_pred ---------------------------------------------------eeeeeeecCCCChhhhccCCCCCCCCCHH
Q 012975 222 ---------------------------------------------------RFIVYELMENRSLDIQLHGPSHGSALTWH 250 (452)
Q Consensus 222 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 250 (452)
.++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999865555667888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC------------CcccccccccC
Q 012975 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN------------KNNLKLSGTLG 318 (452)
Q Consensus 251 ~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~------------~~~~~~~gt~~ 318 (452)
.++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 99999999999999999999999999997654332 12233569999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHH
Q 012975 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQV 398 (452)
Q Consensus 319 y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 398 (452)
|+|||.+.+..++.++||||||+++|||++|..|+.... ...... .....+. . .......+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~-----~~~~~~~-----~----~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDV-----RNLKFPL-----L----FTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHH-----HTTCCCH-----H----HHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHh-----hccCCCc-----c----cccCChhH
Confidence 999999999999999999999999999999877643211 111100 0011111 0 01233456
Q ss_pred HHHHHHhcCCCCCCCCChHHHHHh
Q 012975 399 AAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 399 ~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.+++.+||+.||++|||++|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 789999999999999999999963
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=344.28 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||+||+|+.. +|..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 58899999985443 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888753 34599999999999999999999999 99999999999999999999999999997655444
Q ss_pred CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc-------------ccc
Q 012975 308 KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP-------------QLT 373 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~-------------~~~ 373 (452)
.......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 33445578999999999876 5689999999999999999999999988765443222211100 000
Q ss_pred cCCCCCc--ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 DRSKLPN--IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 ~~~~~~~--~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+. ...+.... ..+....+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELK--FPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHH--CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhh--cccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0011110 00000000 01223457889999999999999999999953
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.35 Aligned_cols=259 Identities=32% Similarity=0.519 Sum_probs=197.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..++|...+.||+|+||+||+|++.+ .||+|.+... .....+.|.+|++++++++|+||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45678889999999999999998754 5999998644 344567899999999999999999999976 456689999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999863 345799999999999999999999999 9999999999999999999999999998654321
Q ss_pred --CCcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCCCc
Q 012975 307 --NKNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 307 --~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 380 (452)
........||..|+|||.+. +..++.++||||||+++|||++|+.||......+. ...+... .. ...+..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~--~~~~~~ 249 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG--SL--SPDLSK 249 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT--SC--CCCTTS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc--cc--Ccchhh
Confidence 12223456899999999986 56788899999999999999999999987554321 1111100 00 001110
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
+.. +....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 250 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 -----VRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----ccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011 223567889999999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=343.17 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=199.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
..++|+..+.||+|+||.||+|++.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678889999999999999998753 457999998653 3445577999999999999999999999984 46789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999873 234699999999999999999999999 9999999999999999999999999999654
Q ss_pred CCCCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 304 GSQNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-----~~~~~~-- 239 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMP-- 239 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCC--
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-----CCCCCC--
Confidence 33221 2223456788999999998999999999999999999997 99999876654322222110 001111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
......+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 240 ----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 240 ----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12234677899999999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=349.33 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=202.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|..++.++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999976 5889999998643 334456788999999988 899999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999998863 34699999999999999999999999 999999999999999999999999999976444
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh--hhhhhhc-cccccCCCCCccc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ--SIVTWAM-PQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~ 382 (452)
........+||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ....... ........++.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-- 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-- 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--
Confidence 444445668999999999999999999999999999999999999999753211100 0000000 00111111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI------TDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 421 (452)
.....+.+++.+||+.||++||++ .|+++
T Consensus 241 ----------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 241 ----------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ----------TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ----------CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 122356789999999999999996 56663
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=351.13 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=206.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
..++|+..+.||+|+||+||+|+... ++.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35689999999999999999999874 7889999986431 23456788999999988 8999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999863 34699999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
..........+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.. .....+..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~-- 243 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HNVAYPKS-- 243 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTT--
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------CCCCCCCC--
Confidence 4444444567899999999999999999999999999999999999999987765443222211 11112111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
....+.+++.+||+.||++||+ ++|+++
T Consensus 244 ----------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 244 ----------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----------SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1235778999999999999996 477764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.33 Aligned_cols=245 Identities=25% Similarity=0.335 Sum_probs=205.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||+||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999976 68899999986432 23456788999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999864 34699999999999999999999999 999999999999999999999999999976533
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. ....+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. ......+..
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~~~~p~~---- 225 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------NAELRFPPF---- 225 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HCCCCCCTT----
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCCCC----
Confidence 2 234579999999999999999999999999999999999999998766543222111 111112211
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
....+.+++.+||+.||++|| +++|+++
T Consensus 226 --------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 --------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 123567899999999999999 8999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=349.62 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=213.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 218 (452)
..++|...+.||+|+||+||+|++. ++..||+|.+... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3467888999999999999999863 4678999999654 344567799999999999 89999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999875321 23589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~ 362 (452)
++.++.+||+|||++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999976543322 1223457788999999999899999999999999999999 99999877654432
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
..+.... ....+ ......+.+++.+||+.||.+|||+.|+++.|++++......
T Consensus 270 ~~~~~~~-----~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 270 KLLKEGH-----RMDKP------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHHHHTC-----CCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHhcCC-----CCCCC------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 2221110 00111 112346778999999999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=365.99 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||.||+++.. +|..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999875 6889999998643 333456788999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|||+++|+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988863 3469999999999999999999998 7 99999999999999999999999999997644
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....++..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~--- 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EEIRFPRT--- 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTT---
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CCCCCCcc---
Confidence 444444556899999999999999999999999999999999999999987765443222221 11112211
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
....+.+++.+||+.||++|| +++|+++
T Consensus 372 ---------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 ---------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 123567899999999999999 9999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=361.25 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=209.7
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 218 (452)
.+.++...++|+..++||+|+||+||+|++.+ ++.||+|++.... ......+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999874 7889999986321 1122348899999999999999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
++..++|||||++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999974 245699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCC-cccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 299 LAITDGSQNK-NNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 299 l~~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
+++....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+......
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~- 299 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER- 299 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-
Confidence 9966543322 233467999999999987 567899999999999999999999999887655432222111000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHH
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLH 421 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 421 (452)
...+... . +....+.+++.+||+.+|++ ||+++|+++
T Consensus 300 ---~~~p~~~-----~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 ---FQFPTQV-----T----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---CCCCSSC-----C----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---ccCCccc-----c----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111110 0 11235677899999988888 999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=340.63 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=211.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..+.||+|+||+||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 346788899999999999999999988899999996443 345679999999999999999999999864 568999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++++|.+++... .+..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998631 123699999999999999999999999 999999999999999999999999999976543321
Q ss_pred -cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 -NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... . ....+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~--~~~~~------- 232 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---Y--RMVRP------- 232 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---C--CCCCC-------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc---c--CCCCc-------
Confidence 1223456789999999998899999999999999999999 99999876654322222110 0 00000
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
. .....+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 233 -~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 233 -D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -c----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 1 123467789999999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=351.33 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=200.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+|+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999997 468899999985321 12235789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+ +|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7888888753 34699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. .....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...........+. ......++.
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~------~~~~~~p~~--- 230 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN------SCVYVMPDF--- 230 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC------SSCCCCCTT---
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH------cCCCCCccc---
Confidence 32 2234579999999999988776 689999999999999999999998654322111000 001111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....+.+++.+||+.||.+|||++|+++
T Consensus 231 ---------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 ---------LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---------SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---------CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1235678999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.09 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=183.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 356888999999999999999974 78899999985332 12246789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999873 345799999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... .......+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~------ 232 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VLADYEMP------ 232 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CSSCCCCC------
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hhcccCCc------
Confidence 333334567899999999999989999999999999999999999999865432211100 00011111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .....+.+++.+||+.||++|||++|+++
T Consensus 233 --~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 --S----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --T----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --c----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 12235678999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=352.13 Aligned_cols=275 Identities=19% Similarity=0.263 Sum_probs=205.7
Q ss_pred hcCCCccCeEeec--CcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEG--GFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.++|+..+.||+| +||+||+++.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568889999999 99999999986 68999999986442 4455778999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998642 235699999999999999999999999 99999999999999999999999999885421
Q ss_pred CC-------CCcccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhcccccc
Q 012975 305 SQ-------NKNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLTD 374 (452)
Q Consensus 305 ~~-------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~ 374 (452)
.. ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ......+...+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 111223468999999999987 678999999999999999999999998755432111 11000000000
Q ss_pred CCCC------------------Ccccch---------hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--ccc
Q 012975 375 RSKL------------------PNIVDP---------VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIP 425 (452)
Q Consensus 375 ~~~~------------------~~~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~ 425 (452)
.... .+.... .............+.+++.+||+.||++|||+.|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0000 000000 00000111233568889999999999999999999954 554
Q ss_pred cCc
Q 012975 426 LVP 428 (452)
Q Consensus 426 l~~ 428 (452)
+..
T Consensus 340 ~~~ 342 (389)
T 3gni_B 340 IKR 342 (389)
T ss_dssp C--
T ss_pred Hhh
Confidence 443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.34 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=198.5
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
.+.||+|+||.||+|+.. +|..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999875 6889999999876666778899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--CCCCcEEEEecCCCcccCCCCCcccc
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL--DSKFNAKLSDFGLAITDGSQNKNNLK 312 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll--~~~~~~kl~Dfgl~~~~~~~~~~~~~ 312 (452)
.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||++........ ...
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~~~ 247 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKV 247 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-CCC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-ccc
Confidence 888863 234699999999999999999999999 99999999999999 6678999999999976543322 233
Q ss_pred cccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCH
Q 012975 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDL 392 (452)
Q Consensus 313 ~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 392 (452)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+... ...... . ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------~~~~~~---~-~~~---- 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------RWDLED---E-EFQ---- 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCSCS---G-GGT----
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCCCCh---h-hhc----
Confidence 46999999999999999999999999999999999999999877654322211110 011100 0 011
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 393 KHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 393 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12346778999999999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=352.03 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=209.5
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeCC-C-----cEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcC
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLDD-N-----LHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHD 219 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 219 (452)
...++|...+.||+|+||+||+|+... + ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345788899999999999999998753 2 479999986543 34567799999999999 899999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPS-----------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~ 288 (452)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+|||+++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 99999999999999999886321 134689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh-hh
Q 012975 289 KFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ-SI 364 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~-~~ 364 (452)
++.+||+|||++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |..||......... ..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999965422211 1223457889999999999999999999999999999998 99999875433211 11
Q ss_pred hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.... . ....+. .....+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 280 ~~~~---~--~~~~~~------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VKDG---Y--QMAQPA------------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHT---C--CCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcC---C--CCCCCC------------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1110 0 000111 1124577899999999999999999999999877543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.48 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=214.9
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 218 (452)
++...++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3445678999999999999999999764 36789999986443 3445679999999999999999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPS-------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence 999999999999999999886311 124579999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhh
Q 012975 292 AKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWA 368 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~ 368 (452)
+||+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME- 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT-
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc-
Confidence 99999999965432221 1223457889999999999999999999999999999999 8999987665432222211
Q ss_pred ccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 369 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
...... .......+.+++.+||+.||++|||+.|+++.|++++....
T Consensus 256 -------~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 256 -------GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp -------TCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred -------CCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 000000 01123457789999999999999999999999999877544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.96 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=211.5
Q ss_pred cCCCccC-eEeecCcEEEEEEEeC---CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESN-ILGEGGFGCVYKAKLD---DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|...+ .||+|+||.||+|.+. ++..||+|.+... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 5788999999754 344567899999999999999999999999 45678999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999863 345699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 306 QNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 306 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .....+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-----~~~~~~-- 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECP-- 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCC--
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-----CcCCCC--
Confidence 322 1223346889999999998899999999999999999998 99999876654332222110 001111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCCc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGGT 434 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~~ 434 (452)
......+.+++..||+.||++||++.|+++.|+++......++
T Consensus 236 ----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 236 ----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ----------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 1223467789999999999999999999999999877655543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=348.17 Aligned_cols=260 Identities=18% Similarity=0.206 Sum_probs=208.4
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||+||+|+. .+++.||||.+..... ...+.+|+++++++ +|+||+++++++.+++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788899999999999999996 4788999999864332 34688999999999 999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----EEEEecCCCccc
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-----AKLSDFGLAITD 303 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~-----~kl~Dfgl~~~~ 303 (452)
+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 99999998742 45799999999999999999999999 9999999999999999887 999999999754
Q ss_pred CCCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 304 GSQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 304 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-AT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cC
Confidence 33221 12356799999999999999999999999999999999999999987654332221111100000 00
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
. ...+.. ... ++.+++..||+.||.+||++++|.+.|+++...
T Consensus 240 ~-----~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 240 P-----IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp C-----HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-----HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 000111 112 788899999999999999999999999877654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=372.65 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=211.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++|...+.||+|+||.||+|++.++..||||++.... ...++|.+|+++|++++|+||+++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34566678899999999999999988899999997543 235679999999999999999999999876 6789999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK- 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 308 (452)
++|+|.+++... .+..+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++........
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999631 234589999999999999999999999 999999999999999999999999999975432211
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .+...+
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~-------- 486 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCP-------- 486 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----CCCCCC--------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCC--------
Confidence 1122346788999999999999999999999999999999 99999887654432222111 000111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
......+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 487 ----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 ----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1223467789999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=348.56 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=202.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|++. ++. +||+|.+... .....+.+.+|+.++++++||||+++++++..++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999865 343 3578877533 3445678999999999999999999999998754 789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999873 345699999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.... ....+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~- 242 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----RLPQPP- 242 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----CCCCCT-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----CCCCCc-
Confidence 3221 2223446788999999999999999999999999999999 999998876554333322110 011111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 243 -----------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 243 -----------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1223577899999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.04 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=203.8
Q ss_pred cCCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cce
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTR 222 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 222 (452)
+.|+..+.||+|+||.||+|++ .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577789999999999999984 368899999986432 33457899999999999999999999999877 568
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999853 235699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--------hhhhhhhccc
Q 012975 303 DGSQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--------QSIVTWAMPQ 371 (452)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--------~~~~~~~~~~ 371 (452)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 543321 22344588889999999999999999999999999999999998643211000 0000000000
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
....... .........+.+++.+||+.||++|||+.|+++.|++++
T Consensus 256 ~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000 011122356788999999999999999999999998765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.50 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=200.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+|... +|..||+|++... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 356888999999999999999874 6889999998642 344567799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
|||+++|+|.+++... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999888531 1245689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
..........|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ....+....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-----~~~~~~~~~- 260 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-----QCDYPPLPS- 260 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHH-----TTCSCCCCT-
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhh-----cccCCCCcc-
Confidence 43333344568999999999999999999999999999999999999997643221 11111110 011111100
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
. .....+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 261 ---~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 261 ---D----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---c----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1 12246778999999999999999999999998887654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.57 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=205.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+++.. +|..||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 68899999985432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999863 34599999999999999999999999 9999999999999999999999999999765332
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
....+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.. ....++..
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~p~~----- 260 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------GKVRFPSH----- 260 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTT-----
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc------CCCCCCCC-----
Confidence 2345799999999999999999999999999999999999999987765443222211 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
....+.+++.+||+.||++||+ ++|+++
T Consensus 261 -------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 -------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1235678999999999999998 888885
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=336.07 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=200.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|....+||+|+||.||+|+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555679999999999999974 68899999997666666778999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCCCcccCCCCC
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999987543345678999999999999999999999 9999999999999987 89999999999976544333
Q ss_pred cccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 309 NNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......||..|+|||.+.+.. ++.++||||||+++|||++|+.||.......... ... ........++.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~--~~~~~~~~~~~------ 249 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FKV--GMFKVHPEIPE------ 249 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HHH--HHHCCCCCCCT------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hhh--ccccccccccc------
Confidence 334557899999999987643 7899999999999999999999997543322111 000 00111111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++||++.|+++
T Consensus 250 ------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 ------SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12245678999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=338.04 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=207.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999986 4778999988543 234567789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988753 34699999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........||..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. ....++..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~---- 237 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------NEYSIPKH---- 237 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTT----
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------ccCCCccc----
Confidence 43334456799999999999998999999999999999999999999987664432221111 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+.+++.+||+.||++|||++|+++.
T Consensus 238 --------~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 --------INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --------SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 12356789999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.59 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=203.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999876 57889999985322 23456789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999864 45699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. .....+.
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~p~-- 241 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---TVVTYPS-- 241 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---CCCCCCT--
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---cccCCCC--
Confidence 2 23345679999999999874 4589999999999999999999999986544332222221111 1111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-ITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 421 (452)
.....+.+++.+||+.||++||+ ++++++
T Consensus 242 ----------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 ----------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11246778999999999999999 777764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=345.70 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=190.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..++|+..+.||+|+||+||+|+.. +++.||||.+.... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567888999999999999999987 57889999986432 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~~~~~ 304 (452)
|+++|+|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999864 35699999999999999999999999 9999999999999975 8899999999997543
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ..... ....... ..+
T Consensus 203 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i---~~~~~~~---~~~ 273 (349)
T 2w4o_A 203 HQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI---LNCEYYF---ISP 273 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH---HTTCCCC---CTT
T ss_pred ccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH---HhCCCcc---CCc
Confidence 322 22345699999999999999999999999999999999999999976554321 11100 0000000 001
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .. +....+.+++.+||+.||++|||+.|+++.
T Consensus 274 ~-~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 W-WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-hh----hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01 123467789999999999999999999973
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.46 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=206.3
Q ss_pred CCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce-eee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR-FIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 225 (452)
.|...+.||+|+||+||+|++.+ +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456889999999999998532 3379999986543 34567899999999999999999999999877655 999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+.+|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999974 346789999999999999999999999 999999999999999999999999999965432
Q ss_pred CC----CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 306 QN----KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP-VEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 306 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. .......+|..|+|||.+.+..++.++||||||+++|||++|..| |......+......... ....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 251 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-----RLPQPE 251 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-----CCCCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-----CCCCCc
Confidence 21 122334678899999999999999999999999999999995554 55444333222222111 001111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
.....+.+++.+||+.||++|||++|+++.|++++......
T Consensus 252 ------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 252 ------------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ------------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11246778999999999999999999999999988765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=354.41 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=199.6
Q ss_pred CCCccCeEeecCcEEEEEEEeC--C--CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCceeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD--D--NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFIV 225 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 225 (452)
.|...+.||+|+||+||+|++. + +..||+|.+... .....++|.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999863 2 346899998643 34556789999999999999999999999865 4578999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999973 345689999999999999999999999 999999999999999999999999999965432
Q ss_pred CCC----cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 306 QNK----NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 306 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
... ......+|..|+|||.+.+..++.++||||||+++|||+| |..||......+....+.... ....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-----~~~~p~ 319 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----RLLQPE 319 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-----CCCCCT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-----CCCCCC
Confidence 211 1223457788999999999999999999999999999999 788887665433222211110 000111
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
.....+.+++.+||+.||++|||+.|+++.|++++..-.+.
T Consensus 320 ------------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 320 ------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 12245778999999999999999999999999888765544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=343.27 Aligned_cols=262 Identities=16% Similarity=0.184 Sum_probs=209.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+|+.+++.+ +|+|++++++++.+++..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35788899999999999999996 578999999985432 334678899999999 79999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----EEEEecCCCcc
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-----AKLSDFGLAIT 302 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~-----~kl~Dfgl~~~ 302 (452)
|+ +++|.+++.. .+..+++..++.++.|++.||+|||++ +++||||||+||+++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999874 234699999999999999999999999 9999999999999987776 99999999975
Q ss_pred cCCCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccC
Q 012975 303 DGSQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDR 375 (452)
Q Consensus 303 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 375 (452)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.................... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-S 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-H
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-C
Confidence 433221 12345699999999999999999999999999999999999999987543221111111100000 0
Q ss_pred CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 376 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.. .+.+.. .....+.+++.+||+.||++||++++|++.|++++..
T Consensus 240 ~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 240 TP-----LRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SC-----HHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cc-----HHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 00 011111 1234678899999999999999999999999988765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=347.08 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=199.5
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
+.|...+.||+|+||+||+|+. .++..||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 478899999986432 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 677777652 235699999999999999999999999 9999999999999999999999999999654322
Q ss_pred CCcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 307 NKNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
....||+.|+|||.+. +..++.++|||||||++|||++|+.||...........+.. .. .+....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~------~~--~~~~~~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NE--SPALQS 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------SC--CCCCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------cC--CCCCCC
Confidence 2357999999999984 56789999999999999999999999987654332111110 00 001000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. .....+.+++.+||+.||++|||++|+++.
T Consensus 276 ----~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 ----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----C----CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 112356789999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=355.61 Aligned_cols=268 Identities=20% Similarity=0.284 Sum_probs=204.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCcChhhH-----------HHHHHHHHHHHcCCCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCATQDAG-----------REFENEVDLLSNIHHPNVVC 211 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~ 211 (452)
..++|...+.||+|+||+||+|++.+ +..||||.+........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999998865 47899999865442211 12445666778889999999
Q ss_pred eEEEEEcC----CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 012975 212 LLGYSAHD----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD 287 (452)
Q Consensus 212 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~ 287 (452)
+++++... ...+|||||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998775 3579999999 9999999874 345799999999999999999999999 999999999999999
Q ss_pred --CCCcEEEEecCCCcccCCCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 012975 288 --SKFNAKLSDFGLAITDGSQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP 358 (452)
Q Consensus 288 --~~~~~kl~Dfgl~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~ 358 (452)
.++.+||+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999965432211 11234599999999999999999999999999999999999999985432
Q ss_pred hhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 359 AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
... ......... ...+..++++.+... ....++.+++..||+.||++||++.++++.|++++..
T Consensus 267 ~~~--~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPK--YVRDSKIRY--RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHH--HHHHHHHHH--HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHHHh--hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 211 111110000 111222233322111 1235677899999999999999999999999888764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.80 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=193.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|++. +|+.||||++... .......+..|+..+.++ +|+||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999987 7899999998543 233444556666666555 8999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+ +++|.+++.. .+..++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 6788888763 245699999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ..+ .. .. ..+..
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~--------~~-~~----~~~~~ 273 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQL--------RQ-GY----LPPEF 273 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HHH--------TT-TC----CCHHH
T ss_pred C-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH--------hc-cC----CCccc
Confidence 2 2234569999999998876 7899999999999999999997776542211 111 00 00 11111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... ....+.+++.+||+.||++|||++|+++
T Consensus 274 ~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 121 2346788999999999999999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=333.22 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=206.3
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
..++|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3568889999999999999999876 5889999998543 344557789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfgl~~~ 302 (452)
|||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888753 34699999999999999999999999 9999999999999987655 99999999966
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+...... .+.
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~~~-- 228 (284)
T 3kk8_A 158 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------YPS-- 228 (284)
T ss_dssp CCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------CCT--
T ss_pred cccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc------CCc--
Confidence 54332 223457999999999999999999999999999999999999999877654432222211100 000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 229 -~~-~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 -PE-WD----TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -TT-TT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hh-hc----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 01 11235778999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.38 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=202.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||.||+|+.. +|..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457888999999999999999986 48899999985433 334566889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887653 34599999999999999999999999 9999999999999999999999999999765444
Q ss_pred CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh-------------cccc
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA-------------MPQL 372 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~-------------~~~~ 372 (452)
........||..|+|||.+.+. .++.++||||||+++|||++|+.||......+........ ....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 4444455799999999998875 7899999999999999999999999887654321111100 0000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....++..................+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111000001123457889999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.55 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=205.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||+||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457888999999999999999976 4778999999765555677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcccCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~~~ 305 (452)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999988853 34589999999999999999999999 99999999999999 7889999999999976543
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+....+... ....+ ..
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~----~~ 229 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG------TFTFP----EK 229 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCC----HH
T ss_pred cc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------CCCCC----ch
Confidence 32 22345699999999987654 899999999999999999999999886654432222111 00110 00
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11346778999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=340.77 Aligned_cols=260 Identities=27% Similarity=0.382 Sum_probs=215.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..++|...+.||+|+||+||+|++.+ +..||+|.+... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999874 788999999743 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998642 345699999999999999999999999 99999999999999999999999999997654332
Q ss_pred C-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 308 K-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||................ ....+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~------ 234 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----RMERP------ 234 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----CCCCC------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-----CCCCC------
Confidence 2 2233457889999999999999999999999999999999 999998766544332222110 00011
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 235 ------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 235 ------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112346778999999999999999999999998887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=348.13 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=197.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhh-HHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDA-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||+||+|+.. ++..||+|.+....... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999986 68899999986443221 22456899999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
++ |+|.+++.. .+..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588887763 345699999999999999999999999 999999999999999999999999999976544433
Q ss_pred cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... ....++...+....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhh
Confidence 3445578999999999876 568999999999999999999999998876554322222111110 01111111110000
Q ss_pred ---------c----cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 388 ---------S----TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 388 ---------~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 000112346778999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.00 Aligned_cols=276 Identities=18% Similarity=0.245 Sum_probs=214.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC--ceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 226 (452)
++|...+.||+|+||+||+|++. +|..||||.+.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999986 48899999996433 334567889999999999999999999998765 679999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEecCCCcc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKLSDFGLAIT 302 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll----~~~~~~kl~Dfgl~~~ 302 (452)
||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997644444599999999999999999999999 99999999999999 7788899999999976
Q ss_pred cCCCCCcccccccccCccCcccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhc-ccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLD--------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAM-PQL 372 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~-~~~ 372 (452)
..... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........ ...
T Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 54332 2234569999999998865 5678899999999999999999999975432211 11111000 000
Q ss_pred -------ccCCCCCcccch--hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 373 -------TDRSKLPNIVDP--VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 373 -------~~~~~~~~~~d~--~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.........+.. .............+.+++.+||+.||++||+++|+++.+++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000000000000 0112334567788889999999999999999999999998887754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.86 Aligned_cols=270 Identities=23% Similarity=0.300 Sum_probs=208.5
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-----CCceeeeEEEE
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----HPNVVCLLGYS 216 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~ 216 (452)
++......++|...+.||+|+||+||+|+.. ++..||||.+.. .....+.+..|+++++.++ ||||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3333445678999999999999999999974 688999999863 3445567888999999996 99999999999
Q ss_pred EcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--------
Q 012975 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-------- 288 (452)
Q Consensus 217 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-------- 288 (452)
...+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 9999999999999 99999998752 234599999999999999999999999 9999999999999975
Q ss_pred -----------------CCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 012975 289 -----------------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 289 -----------------~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
++.+||+|||++....... ....||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 7899999999997643322 34578999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhhhccccc----------------cCCC----CCcccch-----hhcccCC---HHHHHHHHHHHH
Q 012975 352 PVEKLAPAQCQSIVTWAMPQLT----------------DRSK----LPNIVDP-----VIKSTMD---LKHLYQVAAVAV 403 (452)
Q Consensus 352 P~~~~~~~~~~~~~~~~~~~~~----------------~~~~----~~~~~d~-----~l~~~~~---~~~~~~l~~li~ 403 (452)
||......+....+........ .... ++..... .+..... ......+.+++.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9987765443222221111000 0000 0000000 0000000 001156779999
Q ss_pred HhcCCCCCCCCChHHHHH
Q 012975 404 LCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 404 ~Cl~~dP~~RPs~~evl~ 421 (452)
+||+.||++|||++|+++
T Consensus 338 ~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCSSGGGSCCHHHHTT
T ss_pred HHhcCChhhCCCHHHHhc
Confidence 999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=344.55 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=206.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356778899999999999999986 4778999998543 334567799999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988753 35699999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........||..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. ....++..+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~--- 264 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------NEYSIPKHI--- 264 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTS---
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------CCCCCCccC---
Confidence 43334456799999999999999999999999999999999999999987654432221111 111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+.+++.+||+.||++|||++|+++
T Consensus 265 ---------~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 ---------NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 235677999999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=346.19 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=199.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce---
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR--- 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 222 (452)
.++|+..+.||+|+||.||+++. .+++.||||.+... .......+.+|+.++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45788899999999999999997 47889999999654 234456789999999999999999999998776544
Q ss_pred -eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 223 -FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 223 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999863 34699999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCCC---CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 302 TDGSQN---KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 302 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...... .. ...
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~------~~-~~~ 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------RE-DPI 237 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HC-CCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------cC-CCC
Confidence 543321 12233568999999999999999999999999999999999999998766543211111 00 000
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH-HhccccCcc
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLIPLVPV 429 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl-~~L~~l~~~ 429 (452)
. ...... .....+.+++.+||+.||++||++.+++ +.|.++...
T Consensus 238 ~---~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 P---PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp C---HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred C---cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 001111 1234577899999999999999766655 555554433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=354.20 Aligned_cols=244 Identities=27% Similarity=0.337 Sum_probs=193.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHH-HHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDL-LSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||+||+++.. ++..||+|.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999986 57889999986432 2334556777776 5678999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999998863 34689999999999999999999999 999999999999999999999999999976444
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....++..
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~~~~~~---- 261 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------KPLQLKPN---- 261 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH------SCCCCCSS----
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------cccCCCCC----
Confidence 44444567899999999999999999999999999999999999999987665443222211 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITD 418 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 418 (452)
....+.+++.+||+.||++||++.+
T Consensus 262 --------~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 --------ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --------SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --------CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1235678999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.47 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=178.7
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.+.||+|+||+||+++.. +++.||||.+.. .....+.+|+.+++.++ ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 588999999853 34567789999999997 9999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEecCCCcccCCCCCcc
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---NAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~---~~kl~Dfgl~~~~~~~~~~~ 310 (452)
|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++..........
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9999864 35699999999999999999999999 999999999999998765 89999999997655444444
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccC
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTM 390 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 390 (452)
....||..|+|||.+.+..++.++||||||+++|||++|+.||..................+.. ... .. .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~-~~~-~~-~~~~~--- 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-GDF-SF-EGEAW--- 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-TCC-CC-CSHHH---
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-CCC-CC-Ccccc---
Confidence 5567899999999999999999999999999999999999999865432110000000001110 000 00 00000
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 391 DLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 391 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....++.+++.+||+.||++|||+.|+++
T Consensus 241 -~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 -KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112346788999999999999999999884
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=358.37 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=207.6
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
..++...++|+..+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 334456688999999999999999999986 58899999985321 12234578999999999999999999999999
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
+..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998863 3589999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCCC-cccccccccCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 300 AITDGSQNK-NNLKLSGTLGYVAPEYLLDGK----LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 300 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+......+
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-- 292 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-- 292 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--
Confidence 976543322 233567999999999998765 7899999999999999999999998876544322221110000
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHh
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSY--RPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 422 (452)
..+.. . .....+.+++.+||+.+|++ ||+++||++.
T Consensus 293 --~~p~~------~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 --TFPDD------N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --CCCTT------C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --cCCCc------c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 01100 0 11235678999999999988 9999999953
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=347.87 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=196.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
..++|...+.||+|+||+||+|+.. ++..||+|++..... .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999865 688999999864432 2345688999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-----CCCCcEEEEecCCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL-----DSKFNAKLSDFGLA 300 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll-----~~~~~~kl~Dfgl~ 300 (452)
|||++ |+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 599888863 34599999999999999999999999 99999999999999 45566999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc-----
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----- 374 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 374 (452)
..............||..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.........
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 7654444444455789999999999874 4899999999999999999999999877654322211111000000
Q ss_pred -------CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 -------RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 -------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....+......+..........++.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00011111111111111112356788999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.35 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=204.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc-CCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH-DDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 224 (452)
..|+..+.||+|+||+||+|++.+ ...+|+|.+... .....+.+.+|+.++++++||||++++++|.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998643 235899998653 34456789999999999999999999999754 457899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999973 345689999999999999999999999 99999999999999999999999999996543
Q ss_pred CCC----CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 305 SQN----KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 305 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+......... ....+
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 254 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----RLLQP 254 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-----CCCCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-----CCCCC
Confidence 322 12223457889999999999999999999999999999999 666676654433221111100 00011
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
. .....+.+++.+||+.||++|||++|+++.|++++....
T Consensus 255 ~------------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 255 E------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp T------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred c------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 112357789999999999999999999999998876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.03 Aligned_cols=268 Identities=29% Similarity=0.394 Sum_probs=213.4
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEE
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLG 214 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g 214 (452)
...++...++|...+.||+|+||+||+|++ .++..||||.+.... ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445667899999999999999999974 357889999996543 34456799999999999 7999999999
Q ss_pred EEEcCC-ceeeeeeecCCCChhhhccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012975 215 YSAHDD-TRFIVYELMENRSLDIQLHGPSH-------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (452)
Q Consensus 215 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk 280 (452)
++...+ ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 998765 58999999999999999975322 12389999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 012975 281 SSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLA 357 (452)
Q Consensus 281 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~ 357 (452)
|+||+++.++.+||+|||++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999965433221 2234557889999999999999999999999999999998 999998755
Q ss_pred hhhhh-hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 358 PAQCQ-SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 358 ~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
..+.. ...... .....+.. ....+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus 256 ~~~~~~~~~~~~-----~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 256 IDEEFCRRLKEG-----TRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CSHHHHHHHHHT-----CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHhccC-----ccCCCCCC------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 32211 111100 00111111 1235778999999999999999999999999887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=341.02 Aligned_cols=269 Identities=24% Similarity=0.326 Sum_probs=203.8
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC--CCCceeeeEEEEEcC----
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI--HHPNVVCLLGYSAHD---- 219 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~---- 219 (452)
.....++|+..+.||+|+||.||+|+.. +..||||.+... ....+..|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3345578999999999999999999986 789999998532 234455566666655 899999999999887
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCcEEE
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-----NPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
+..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++++||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 678999999999999999963 35999999999999999999999762 448999999999999999999999
Q ss_pred EecCCCcccCCCCCc----ccccccccCccCcccccCCCCCch------hhHHHHHHHHHHHHcC----------CCCCC
Q 012975 295 SDFGLAITDGSQNKN----NLKLSGTLGYVAPEYLLDGKLTDK------SDVYAFGVVLLELLLG----------RRPVE 354 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------sDv~s~Gvll~elltG----------~~P~~ 354 (452)
+|||++......... .....||..|+|||.+.+...+.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999654332221 124569999999999988766654 9999999999999999 66665
Q ss_pred CCChhhhh-hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 355 KLAPAQCQ-SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 355 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
........ ....... ............ ....+...++.+++.+||+.||++|||+.||++.|+++...
T Consensus 264 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIV----CIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSCCHHHHHHHH----TTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCCchhhhHHHH----hhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 54322110 0000000 000111111111 11125677899999999999999999999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=348.41 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=193.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||+||+++.. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888999999999999999986 68899999996433 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~--~kl~Dfgl~~~~~~~ 306 (452)
+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++......
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998853 34699999999999999999999999 9999999999999988766 999999998643222
Q ss_pred CCcccccccccCccCcccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCCCcccch
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDK-SDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........ ....... .......+..
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~--- 244 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---LSVKYSIPDD--- 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH---HTTCCCCCTT---
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH---hcCCCCCCCc---
Confidence 22234569999999999988887665 8999999999999999999987543221 1111111 0111111110
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.+++.+||+.||++|||+.|+++.
T Consensus 245 -------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 -------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0112456789999999999999999999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.66 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=202.3
Q ss_pred eEeecCcEEEEEEEeC---CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 158 ILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 158 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.||+|+||.||+|.+. ++..||||.+.... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 56789999997543 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC---cc
Q 012975 234 LDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK---NN 310 (452)
Q Consensus 234 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~---~~ 310 (452)
|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999973 356799999999999999999999999 999999999999999999999999999976533221 11
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
....+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+... .+...+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p---------- 561 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECP---------- 561 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-----CCCCCC----------
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCC----------
Confidence 22345689999999999999999999999999999998 99999887654433222211 001111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
......+.+++..||+.||++||++.+|++.|+++....
T Consensus 562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 123356778999999999999999999999998876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=346.68 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=206.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 224 (452)
.++|...+.||+|+||.||+++. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999997 5788999999876666777889999999999999999999999873 347799
Q ss_pred eeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||||+++|+|.+++... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999888641 2346799999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCc---------ccccccccCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 304 GSQNKN---------NLKLSGTLGYVAPEYLLDGK---LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 304 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
...... .....||..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~-- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ-- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhh--
Confidence 321110 11234799999999987654 68899999999999999999999964221110 0000000
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
.....+. .......+.+++.+||+.||++|||++|+++.|+.+....+.+
T Consensus 262 --~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 262 --NQLSIPQ----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp --CC--CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred --ccCCCCc----------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0000100 0112346778999999999999999999999998876554433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=346.45 Aligned_cols=258 Identities=24% Similarity=0.267 Sum_probs=200.6
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-----ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-----TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
....++|+..+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|++++++++||||+++++++.+++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345668999999999999999999875 6788999998532 3345678999999999999999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 012975 221 TRFIVYELMENRSLDIQLHGPS-------------------------------------HGSALTWHMRMKIALDTARGL 263 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~L 263 (452)
..++||||+++|+|.+++.... ....+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999998885200 011246777889999999999
Q ss_pred HHHHhcCCCCeeeCCCCCCCEEECCCC--cEEEEecCCCcccCCCC----CcccccccccCccCcccccC--CCCCchhh
Q 012975 264 EYLHEHCNPAVIHRDLKSSNILLDSKF--NAKLSDFGLAITDGSQN----KNNLKLSGTLGYVAPEYLLD--GKLTDKSD 335 (452)
Q Consensus 264 ~~LH~~~~~~i~H~Dlk~~NIll~~~~--~~kl~Dfgl~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 335 (452)
+|||+. +++||||||+||+++.++ .+||+|||++....... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999996532211 12234569999999999875 67899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 012975 336 VYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415 (452)
Q Consensus 336 v~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 415 (452)
|||||+++|||++|+.||......+....+... ..... .+.. . .....+.+++.+||+.||++|||
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~------~~~~~---~~~~-~----~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK------KLCFE---NPNY-N----VLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCTT---SGGG-G----GSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------ccccC---Cccc-c----cCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999887654422221111 10000 0110 1 11245778999999999999999
Q ss_pred hHHHHH
Q 012975 416 ITDVLH 421 (452)
Q Consensus 416 ~~evl~ 421 (452)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.17 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=206.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
..++|...+.||+|+||+||+|++.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998542 346999998654 34456789999999999999999999999865 4568
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999863 345689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 304 GSQNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 304 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+........ .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~- 237 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPD- 237 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-----CCCCCCT-
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-----CCCCCCC-
Confidence 33221 2223457889999999998999999999999999999998 99999876554332222111 0111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.....+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 238 -----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 238 -----------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 11245778999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=335.66 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=202.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+.++|+..+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567888999999999999999876 56789999985332 2235678999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999988853 34689999999999999999999998 99999999999999999999999999885443
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ....+..
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~--- 229 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDF--- 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTT---
T ss_pred cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC------CCCCCCc---
Confidence 22 223457899999999999999999999999999999999999999877654433222211 1111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+.+++.+||+.||++|||++|+++.
T Consensus 230 ---------~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ---------VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---------SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---------CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12356689999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.88 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=208.0
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 218 (452)
.++.+...++|+..+.||+|+||+||+++.. +|+.||+|++.... ......+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4445556789999999999999999999985 68999999986422 2223458899999999999999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
++..|+||||+++|+|.+++.. .+..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999963 234699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCC-cccccccccCccCccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 299 LAITDGSQNK-NNLKLSGTLGYVAPEYLL-------DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 299 l~~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 9976543332 223457999999999987 45789999999999999999999999988765543222211100
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC---CChHHHHH
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR---PLITDVLH 421 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~ 421 (452)
. ...+. ... ....++.+++.+||+ +|.+| |+++|+++
T Consensus 288 ~----~~~p~-----~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 H----LSLPL-----VDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp H----CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred C----cCCCc-----ccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 01110 011 122467789999999 99998 69999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.79 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=204.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999976 78999999986432 223567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999863 45699999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. .....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...........+.. .....+..+
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~--- 239 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD------GIFYTPQYL--- 239 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT------TCCCCCTTC---
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc------CCcCCCccC---
Confidence 2 2334579999999999988765 6899999999999999999999987654332222111 111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+.+++.+||+.||++|||++|+++
T Consensus 240 ---------s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 ---------NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 235678999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.26 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=205.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 224 (452)
.++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+ ++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999876 6889999998643 34456779999999999999999999998854 567899
Q ss_pred eeeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEECCCCcEEEEecC
Q 012975 225 VYELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPA-----VIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
||||+++|+|.+++... .....+++..++.++.|++.||+|||+. + ++||||||+||++++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999988642 1234599999999999999999999998 6 9999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
++..............||..|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~~ 236 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRI 236 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----ccccC
Confidence 9876544333333456899999999999999999999999999999999999999887654322222110 00011
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccc
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIP 425 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 425 (452)
+. .....+.+++.+||+.||++|||+.|+++.+..
T Consensus 237 ~~------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 PY------------RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Cc------------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 123467789999999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=336.45 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=208.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.+.|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999875 68899999986443 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999853 4699999999999999999999999 99999999999999999999999999997654443
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||...........+... .... +.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~--------~~ 240 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-----NPPT--------LE 240 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----CCCC--------CC
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-----CCCC--------Cc
Confidence 3344567899999999999999999999999999999999999999876654322221110 0001 11
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GN----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cc----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 12357789999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.01 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=201.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
..++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999976 68899999986442 3335779999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999863 34699999999999999999999999 99999999999999999999999999986543
Q ss_pred CCC-CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 305 SQN-KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 305 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
... .......||..|+|||.+.+..++.++||||||+++|||++|+.||............... .......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~- 257 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-------IPRPSTV- 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC-------CCCGGGT-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC-------CCCcccc-
Confidence 322 2223456899999999999999999999999999999999999999876543221111110 0000000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHhccccCccccC
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-LITDVLHSLIPLVPVELG 432 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~l~~~~~~ 432 (452)
.. .....+.+++.+||+.||++|| +++++++.|++.+.....
T Consensus 258 ---~~----~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 258 ---RP----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ---ST----TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ---CC----CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 11 1223577899999999999999 999999999988776443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=337.66 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=201.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-----hhhHHHHHHHHHHHHcC---CCCceeeeEEEEEcC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-----QDAGREFENEVDLLSNI---HHPNVVCLLGYSAHD 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 219 (452)
..++|+..+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999974 68899999985332 11234566777777766 499999999999876
Q ss_pred C-----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 220 D-----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 220 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
. ..++||||++ |+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 69998887522 34599999999999999999999999 9999999999999999999999
Q ss_pred EecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 295 SDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 295 ~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+........
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~- 239 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP- 239 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence 9999997654322 23456799999999999999999999999999999999999999988765543222211111100
Q ss_pred CCCCCcccc---hhhc-------ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVD---PVIK-------STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d---~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...++.... .... .....+....+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 001100000 0000 00001223567889999999999999999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.60 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=200.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT- 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 221 (452)
..++|...+.||+|+||+||+|+.. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567888899999999999999764 3558999998644 34455779999999999999999999999987653
Q ss_pred ----eeeeeeecCCCChhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 012975 222 ----RFIVYELMENRSLDIQLHGP---SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKL 294 (452)
Q Consensus 222 ----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl 294 (452)
.++||||+++|+|.+++... .....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 49999999999999888421 2345799999999999999999999999 9999999999999999999999
Q ss_pred EecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 295 SDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 295 ~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 9999996543322 12223457889999999999999999999999999999999 99999876654322221110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+ ......+.+++.+||+.||++|||+.++++.|++++..
T Consensus 266 --~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 266 --HRLKQP------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --CCCCCB------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCC------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000010 11234678899999999999999999999999988654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=335.78 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=199.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|...+.||+|+||+||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999875 58899999986442 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcccC
Q 012975 229 MENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 229 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~~ 304 (452)
+++|+|.+++... ..+..+++..++.++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887532 1235699999999999999999999999 99999999999999 456889999999996543
Q ss_pred CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 305 SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
... ......||..|+|||.+. ..++.++||||||+++|||++|+.||......+......+...... ..
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------~~--- 247 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------VE--- 247 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------C----
T ss_pred Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------cc---
Confidence 322 233456899999999875 5689999999999999999999999988765543333322111110 00
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 --CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 1235678999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=340.42 Aligned_cols=252 Identities=25% Similarity=0.277 Sum_probs=206.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|...+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999976 588999999864322 1357799999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEecC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Dfg 298 (452)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999864 35689999999999999999999999 999999999999999888 79999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ...
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~- 236 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------SYD- 236 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------CCC-
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------ccc-
Confidence 997654332 223456999999999999999999999999999999999999999876654322221110 000
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.++...... ...+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 ---FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---cChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111112 2457789999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.00 Aligned_cols=268 Identities=26% Similarity=0.361 Sum_probs=209.9
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHc--CCCCceeeeEEEEEcCC
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSN--IHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~ 220 (452)
....+...++|...+.||+|+||.||+|+.. ++.||||.+.. .....+.+|++++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3444556678999999999999999999984 88999999853 344667888998887 78999999999998876
Q ss_pred ----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCCEEECC
Q 012975 221 ----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--------EHCNPAVIHRDLKSSNILLDS 288 (452)
Q Consensus 221 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~i~H~Dlk~~NIll~~ 288 (452)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +. +++||||||+|||+++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 78999999999999999863 35999999999999999999999 66 9999999999999999
Q ss_pred CCcEEEEecCCCcccCCCCC----cccccccccCccCcccccCC------CCCchhhHHHHHHHHHHHHcC---------
Q 012975 289 KFNAKLSDFGLAITDGSQNK----NNLKLSGTLGYVAPEYLLDG------KLTDKSDVYAFGVVLLELLLG--------- 349 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~s~Gvll~elltG--------- 349 (452)
++.+||+|||++........ ......||..|+|||.+.+. .++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 99999999999965433221 12344699999999998775 334689999999999999999
Q ss_pred -CCCCCCCChhhh--hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 350 -RRPVEKLAPAQC--QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 350 -~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
+.||........ ....... .. ......+.. .....+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVV----CE-QKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHH----TT-SCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCccccCcCcccHHHHHHHH----HH-HHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 778876533211 1111110 00 011111111 112235677899999999999999999999999999987
Q ss_pred Ccc
Q 012975 427 VPV 429 (452)
Q Consensus 427 ~~~ 429 (452)
...
T Consensus 335 ~~~ 337 (342)
T 1b6c_B 335 SQQ 337 (342)
T ss_dssp HHT
T ss_pred HHH
Confidence 654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=343.43 Aligned_cols=268 Identities=30% Similarity=0.377 Sum_probs=201.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh-----hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
..++|...+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999976 5889999998643221 124688999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++ +|..++.. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78877763 345689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-----cccCC
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ-----LTDRS 376 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-----~~~~~ 376 (452)
............||+.|+|||.+.+. .++.++|||||||++|||++|..||......+....+...... +.+..
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 65444444556799999999998764 4789999999999999999999999887654322211111000 00000
Q ss_pred CCCcccchhhcccCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 377 KLPNIVDPVIKSTMD-----LKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.+++.+......... ......+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111111000000000 1223578889999999999999999999964
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.58 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=207.1
Q ss_pred hcCCCccC-eEeecCcEEEEEEEe---CCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 150 TDSFHESN-ILGEGGFGCVYKAKL---DDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 150 ~~~f~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
.++|...+ .||+|+||+||+|.+ .++..||||.+.... ....+++.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 246889999986543 33457899999999999999999999999 567789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999864 34699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 304 GSQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 304 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .....+
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 242 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCP 242 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence 433221 122346788999999998889999999999999999999 99999887654432222211 011111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
......+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 243 ------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 243 ------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1223467789999999999999999999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=345.76 Aligned_cols=261 Identities=26% Similarity=0.316 Sum_probs=206.2
Q ss_pred CCccCeEeecCcEEEEEEEeC-----CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--Cceee
Q 012975 153 FHESNILGEGGFGCVYKAKLD-----DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD--DTRFI 224 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 224 (452)
|+..+.||+|+||+||++.+. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999998653 67889999997543 34567799999999999999999999999874 56799
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999863 2499999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh---------hcccc
Q 012975 305 SQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW---------AMPQL 372 (452)
Q Consensus 305 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~---------~~~~~ 372 (452)
.... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+ .....
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence 3321 1223457888999999999999999999999999999999999987543211 000000 00000
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcccc
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVEL 431 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~ 431 (452)
..... ..........+.+++.+||+.||++|||++|+++.|+++...-.
T Consensus 265 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERGER----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccC----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00000 01111233568889999999999999999999999988765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.81 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=195.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 225 (452)
.+.|+..+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568889999999999999999989999999998643 34455789999999999976 9999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|| +.+|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||++.....
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999864 35699999999999999999999999 999999999999997 67899999999976533
Q ss_pred CCC--cccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 306 QNK--NNLKLSGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 306 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~-- 236 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP-- 236 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCT--
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhcC--
Confidence 222 2234579999999999865 678899999999999999999999997643321 111111100
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+... ...+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~------------~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEIEFPDIP------------EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCCCCCCCS------------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCcccC------------CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0011111111 2356789999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.24 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=194.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCC--ce
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDD--TR 222 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 222 (452)
..++|+..+.||+|+||.||+|.+. +|..||||++... .......+.+|+.+++++. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999875 6889999998543 3455677889999999997 999999999997654 68
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
|+|||||+ |+|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 688888763 4689999999999999999999999 999999999999999999999999999965
Q ss_pred cCCC---------------------CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 303 DGSQ---------------------NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 303 ~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
.... .......+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4221 111234579999999999887 678999999999999999999999998876543
Q ss_pred hhhhhhhhcccccc-------------------------CCCCCcccchh---h-cccCCHHHHHHHHHHHHHhcCCCCC
Q 012975 361 CQSIVTWAMPQLTD-------------------------RSKLPNIVDPV---I-KSTMDLKHLYQVAAVAVLCVQPEPS 411 (452)
Q Consensus 361 ~~~~~~~~~~~~~~-------------------------~~~~~~~~d~~---l-~~~~~~~~~~~l~~li~~Cl~~dP~ 411 (452)
....+......... .......+... + ..........++.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 22222111000000 00000110000 0 0000001234678999999999999
Q ss_pred CCCChHHHHHh
Q 012975 412 YRPLITDVLHS 422 (452)
Q Consensus 412 ~RPs~~evl~~ 422 (452)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=347.88 Aligned_cols=264 Identities=26% Similarity=0.365 Sum_probs=208.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-----CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC--ce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-----DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD--TR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 222 (452)
.++|+..+.||+|+||.||+++. .++..||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35678889999999999999984 368899999998777777788999999999999999999999987654 78
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999874 235699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc---ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh---------hhhhhhhcc
Q 012975 303 DGSQNKN---NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC---------QSIVTWAMP 370 (452)
Q Consensus 303 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~---------~~~~~~~~~ 370 (452)
....... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+......-. .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 5433221 1233467789999999998899999999999999999999999864321100 000000000
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.+......+ .......++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 275 ~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 275 LLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCCCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011111100 011223567889999999999999999999999988754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.10 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=198.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|+..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999875 5889999999643 4455678899999999999999999999997654
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..|+||||++++ |...+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999865 545553 2389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc-----------
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM----------- 369 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~----------- 369 (452)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 7654322 2344679999999999999999999999999999999999999998876433211111000
Q ss_pred -----cccccCCCCCc-----ccchhhccc---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 370 -----PQLTDRSKLPN-----IVDPVIKST---MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 370 -----~~~~~~~~~~~-----~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........... .+...+... .......++.+++.+||+.||++|||++|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000001000 010100000 011225678899999999999999999999963
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=342.78 Aligned_cols=259 Identities=29% Similarity=0.459 Sum_probs=206.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcE--EEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLH--VAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999865 4554 489988643 334456789999999999 899999999999999999999
Q ss_pred eeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 226 YELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
|||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987532 235799999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+...
T Consensus 182 kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~--- 257 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--- 257 (327)
T ss_dssp EECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT---
T ss_pred EEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC---
Confidence 99999998643221 11223457889999999998889999999999999999998 99999877654322211110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
. ....+. .....+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 258 ~--~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 258 Y--RLEKPL------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp C--CCCCCT------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred C--CCCCCC------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 000110 12246778999999999999999999999998887654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.32 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=202.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||+||+++.. +|+.||+|.+..........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357888999999999999999976 6889999999765544556789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcccCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~~~ 305 (452)
+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++ ++++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988853 34689999999999999999999999 99999999999999 7889999999999865432
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.||...........+... . ..... +
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~----~~~~~---~- 229 (304)
T 2jam_A 162 G--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG--Y----YEFES---P- 229 (304)
T ss_dssp B--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC--C----CCCCT---T-
T ss_pred C--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--C----CCCCc---c-
Confidence 2 223456899999999999999999999999999999999999999876654322222111 0 00000 0
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWD----DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011 12346778999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=344.26 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=198.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCcChh-----------hHHHHHHHHHHHHcCCCCceeeeEE
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCATQD-----------AGREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
.++|...+.||+|+||+||+|+.. ++..+|+|........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999986 5788999998654321 1134678889999999999999999
Q ss_pred EEEc----CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 012975 215 YSAH----DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF 290 (452)
Q Consensus 215 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~ 290 (452)
++.. ++..++||||+ +++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9988 67889999999 9999999864 23799999999999999999999999 999999999999999887
Q ss_pred --cEEEEecCCCcccCCCC-------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-
Q 012975 291 --NAKLSDFGLAITDGSQN-------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ- 360 (452)
Q Consensus 291 --~~kl~Dfgl~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~- 360 (452)
.+||+|||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999996542211 11234579999999999999999999999999999999999999996532211
Q ss_pred -hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 361 -CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 361 -~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
......... ..++..+..... ......++.+++..||+.||++||++++|++.|+++..
T Consensus 269 ~~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLL------DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHH------HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhc------ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111000 011111111110 00223467889999999999999999999999988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=327.90 Aligned_cols=251 Identities=28% Similarity=0.386 Sum_probs=203.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999976 6889999998643 23455789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999863 35699999999999999999999999 99999999999999999999999999996542211
Q ss_pred --CcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 308 --KNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 308 --~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.......||..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+... ..... +
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~~~~~----~ 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KTYLN----P 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT----CTTST----T
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc----ccccC----c
Confidence 12234568999999999987765 779999999999999999999998755322 111111110 00000 0
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 231 --~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 --WK----KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hh----hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01 12235678999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.86 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=199.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-Cceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 228 (452)
.++|+..+.||+|+||+||+++.. |..||||.+... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457888999999999999999875 779999998643 3456799999999999999999999997655 478999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998631 122388999999999999999999999 99999999999999999999999999986543322
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... .....+
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~-------- 236 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAP-------- 236 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----CCCCCC--------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCc--------
Confidence 23357889999999999999999999999999999998 99999876543322111100 000011
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
. .....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 237 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1 1234677899999999999999999999999887554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=345.07 Aligned_cols=251 Identities=26% Similarity=0.321 Sum_probs=189.4
Q ss_pred cCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHH-cCCCCceeeeEEEEEc----CCcee
Q 012975 151 DSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLS-NIHHPNVVCLLGYSAH----DDTRF 223 (452)
Q Consensus 151 ~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 223 (452)
++|... +.||+|+||+||+++.. ++..||||.+... ..+.+|++++. ..+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 355554 68999999999999876 5889999998532 35678888874 4589999999999875 55789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLA 300 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~ 300 (452)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999752 234699999999999999999999999 9999999999999998 789999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhccccccCCCCC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAMPQLTDRSKLP 379 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 379 (452)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...... ......+
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~~~~ 287 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFP 287 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCCCCC
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcccCC
Confidence 7654322 2235678999999999999999999999999999999999999998654322100 000000 0000000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. +. .. ....++.+++.+||+.||++|||+.|+++.
T Consensus 288 ~---~~-~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 N---PE-WS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T---TT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---cc-cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 01 123467789999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.11 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=201.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
..++|...+.||+|+||+||+|+.. ++..||||.+..... .....+.+|+.++++++||||+++++++.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567999999999999999999864 688999999864321 1334578899999999999999999999999
Q ss_pred CceeeeeeecCCC-ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 220 DTRFIVYELMENR-SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 220 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
+..++||||+.+| +|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 99988864 34699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~~~ 242 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAAIH 242 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTCCC
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhccC
Confidence 997654332 2334579999999999988877 789999999999999999999997632210 00111
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.+.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~------------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 PPYL------------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSSC------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCcc------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 12357789999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.38 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=204.9
Q ss_pred HHHhhcCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 146 LEKATDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 146 l~~~~~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
.+...+.|... +.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 44455567666 88999999999999876 58899999986432 33467899999999999 5699999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEec
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDF 297 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Df 297 (452)
..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||++ +++||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999999999864 2346799999999999999999999999 9999999999999998 789999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+......
T Consensus 179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 251 (327)
T 3lm5_A 179 GMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD------ 251 (327)
T ss_dssp GGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred ccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc------
Confidence 9997654332 223457999999999999999999999999999999999999999887654432222211100
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
... + ... .....+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~---~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 YSE---E-TFS----SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCT---T-TTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCc---h-hhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0 001 123457789999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.49 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=199.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..++|+..+.||+|+||.||+++.. +|+.||+|.+..... .+.+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467888999999999999999876 688999999965432 235688888887 7999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEecCCCcc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAIT 302 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~----~~~kl~Dfgl~~~ 302 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998864 34699999999999999999999999 99999999999998543 3599999999976
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
...........+||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+..... ........
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~~~~~~-- 244 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SGKFSLSG-- 244 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HCCCCCCS--
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cCCcccCc--
Confidence 5444444455679999999999988889999999999999999999999998643221111111110 00000000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 245 --~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 --GYWN----SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --TTTT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001 12345778999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=345.49 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=188.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEc--------C
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAH--------D 219 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~ 219 (452)
..+|+..+.||+|+||.||+|++. ++..||+|++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 347888999999999999999975 68899999987666667788999999999996 9999999999942 3
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEec
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
...++||||++ |+|.+++........+++..++.++.|++.||+|||+. + ++||||||+|||+++++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 35799999996 78888876433445799999999999999999999998 7 999999999999999999999999
Q ss_pred CCCcccCCCCC------------cccccccccCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh
Q 012975 298 GLAITDGSQNK------------NNLKLSGTLGYVAPEYL---LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ 362 (452)
Q Consensus 298 gl~~~~~~~~~------------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~ 362 (452)
|++........ ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 99976433211 11134589999999998 566789999999999999999999999976433211
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.. ....... .. .....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 262 --~~-------~~~~~~~------~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 --VN-------GKYSIPP------HD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------CCCCT------TC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --hc-------CcccCCc------cc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 10 0000000 00 0112356799999999999999999999999888654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=352.11 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=196.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCC--CCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH--HPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 226 (452)
+.|...+.||+|+||.||++...++..||||.+... .....+.+.+|+.++++++ |+||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 3445678999999999996 599999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
| +.+++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||++......
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 568899999864 34689999999999999999999999 999999999999995 589999999999765332
Q ss_pred CC--cccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc
Q 012975 307 NK--NNLKLSGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373 (452)
Q Consensus 307 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 373 (452)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.....+ .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~~~--~ 284 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP--N 284 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHCT--T
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHhCc--c
Confidence 21 2234579999999999865 368899999999999999999999997654221 111111100 0
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.....+... ...+.+++.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~~~~------------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HEIEFPDIP------------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SCCCCCCCS------------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCccc------------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111111 2356789999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.81 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=200.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
..++|+..+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467888999999999999999986 588999999976666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999988763 235699999999999999999999999 99999999999999999999999999874321111
Q ss_pred CcccccccccCccCcccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 308 KNNLKLSGTLGYVAPEYL-----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
.......||..|+|||.+ .+..++.++||||||+++|||++|+.||.............. . . .+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-----~-~~~~~ 243 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--S-----D-PPTLL 243 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--S-----C-CCCCS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc--c-----C-CcccC
Confidence 122234689999999988 367789999999999999999999999987665332111110 0 0 00111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TP---S----KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SG---G----GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Cc---c----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 1 12245778999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.08 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=198.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC--CC--cEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD--DN--LHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|+..+.||+|+||+||+|++. ++ ..||+|.+... .....+.+.+|++++++++||||+++++++..++ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888999999999999999853 23 36899988643 2345678999999999999999999999998765 88
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999998863 235689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 304 GSQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... ....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------GERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS------CCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc------CCCCC
Confidence 43322 1223457788999999998889999999999999999999 99999877654322222111 00000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccC
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELG 432 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~ 432 (452)
........+.+++.+||+.||++|||+.++++.|+++.+....
T Consensus 246 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 246 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred ----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 0011234677899999999999999999999999988766543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.21 Aligned_cols=245 Identities=24% Similarity=0.401 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 57789999985332 223467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999998863 24689999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.. .....+.
T Consensus 168 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~------ 233 (284)
T 2vgo_A 168 R--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPP------ 233 (284)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCT------
T ss_pred c--cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------cccCCCC------
Confidence 2 2345689999999999999999999999999999999999999987665432222111 1111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 234 ------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11235678999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.57 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=201.8
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
...++|+..+.||+|+||.||+|+.. +|..||+|.+.... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567889999999999999999876 58899999986432 3467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998852 245699999999999999999999999 9999999999999999999999999999765444
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
........||..|+|||.+.+..++.++||||||+++|||++|+.||............... . ......+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~-~~~~~~~-- 248 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-------P-PPTFRKP-- 248 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------C-CCCCSSG--
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-------C-CcccCCc--
Confidence 33344557899999999999999999999999999999999999999876543321111100 0 0000001
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 249 -~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 -E----LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -G----GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 11245778999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.60 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=205.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEE-EcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 227 (452)
.++|...+.||+|+||+||+|+. .+++.||+|.+..... ..++.+|+.+++.++|+|++..++++ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999997 5789999999864432 24688999999999988877766665 55667899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~~ 304 (452)
|+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||+ ++++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999863 235699999999999999999999999 99999999999999 488999999999997543
Q ss_pred CCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 305 SQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..................... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cc
Confidence 3222 123457999999999999999999999999999999999999999875432211111100000000 00
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.+.+.. .....+.+++.+||+.||++|||+.||++.|+++....
T Consensus 239 -----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 -----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -----HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----hHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 001111 12346788999999999999999999999999886653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=369.33 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=199.8
Q ss_pred CeEeecCcEEEEEEEeC---CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD---DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+|.+. .+..||||.+.... ....+++.+|+++|++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999996533 3446789999999999999999999999975 568899999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC---C
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN---K 308 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~---~ 308 (452)
|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999963 45699999999999999999999999 99999999999999999999999999997553322 1
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.... ....+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----~~~~p~------- 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-----RMGCPA------- 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----CCCCCT-------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCC-------
Confidence 2223346788999999999999999999999999999998 999998877654333322110 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
....++.+++..||+.||++||++.+|++.|+++.
T Consensus 596 -----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 596 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22346778999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.35 Aligned_cols=250 Identities=26% Similarity=0.309 Sum_probs=202.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|...+.||+|+||.||+++.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999987 688999999854321 13678999999999999999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEecCC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFGL 299 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Dfgl 299 (452)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999853 34699999999999999999999999 999999999999999877 899999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ...
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~-- 229 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------NYD-- 229 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCC--
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc------ccC--
Confidence 97654322 223456899999999999999999999999999999999999999876654322221110 000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 --FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111111 1245778999999999999999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=344.55 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=204.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||+||+++.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999986 6889999998654 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999864 346899999999999999999999832 7999999999999999999999999998543211
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc---------CCCC
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD---------RSKL 378 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 378 (452)
......||..|+|||.+.+..++.++||||||+++|||++|+.||......+.............. ....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 122356899999999999999999999999999999999999999876654322211100000000 0000
Q ss_pred -------------Ccccchhhcc----cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 379 -------------PNIVDPVIKS----TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 379 -------------~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+..+..... .........+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000 000112346788999999999999999999995
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=356.10 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=205.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|...+.||+|+||+||+++.. +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999986 68999999985432 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++|+|..++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999886432 245699999999999999999999999 999999999999999999999999999976654
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccccccCCCCCcccch
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... .......+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~~~~~p~---- 414 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQAVTYPD---- 414 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHCCCCCCT----
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhcccCCCc----
Confidence 44334456899999999999999999999999999999999999999987542111 1111111 111111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 421 (452)
.....+.+++.+||+.||++||++ +|+++
T Consensus 415 --------~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 --------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --------TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --------ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 122456789999999999999975 56663
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.49 Aligned_cols=242 Identities=19% Similarity=0.226 Sum_probs=189.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecC---cChhhHHHHHHHH---HHHHcCCCCceeeeE-------EE
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDC---ATQDAGREFENEV---DLLSNIHHPNVVCLL-------GY 215 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 215 (452)
.++|...+.||+|+||+||+|++ .+|+.||||.+.. ......+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788889999999999999996 4689999999863 3345567899999 555566899999998 77
Q ss_pred EEcCCc-----------------eeeeeeecCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012975 216 SAHDDT-----------------RFIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAV 274 (452)
Q Consensus 216 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 274 (452)
+.+++. .++||||+ +|+|.+++.... ....+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665543 78999999 689999886311 123355788999999999999999999 99
Q ss_pred eeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCC-----------CCCchhhHHHHHHHH
Q 012975 275 IHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-----------KLTDKSDVYAFGVVL 343 (452)
Q Consensus 275 ~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~s~Gvll 343 (452)
+||||||+|||++.++.+||+|||++..... ......| ..|+|||.+.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999976433 2234567 999999999887 899999999999999
Q ss_pred HHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 344 LELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 344 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
|||++|+.||............. ... . .....+.+++.+||+.||++|||+.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~------~~~------------~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF------RSC------------K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG------SSC------------C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchhhhh------hhc------------c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999997654322111100 000 1 11245778999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.63 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=204.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChh-----------------hHHHHHHHHHHHHcCCCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD-----------------AGREFENEVDLLSNIHHPNVVCL 212 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 212 (452)
.++|...+.||+|+||.||+|+. ++..||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999999999 8999999998533211 12789999999999999999999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhh------ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEE
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQ------LHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIl 285 (452)
++++.+++..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ . +++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 543 225679999999999999999999999 8 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCh-hhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTD-KSDVYAFGVVLLELLLGRRPVEKLAP-AQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~s~Gvll~elltG~~P~~~~~~-~~~~ 362 (452)
++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999764332 23345689999999999887 6666 99999999999999999999987654 2221
Q ss_pred hhhhhhccccccCCCCCcccchhhc---ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIK---STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..+........ ........+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIRTKNIEYP--LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHTSCCCCCC--CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhccCcCCc--cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111100000 000001111000 0001123356788999999999999999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.22 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=201.5
Q ss_pred cHHHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC-----------hhhHHHHHHHHHHHHcCCCCcee
Q 012975 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT-----------QDAGREFENEVDLLSNIHHPNVV 210 (452)
Q Consensus 142 ~~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~niv 210 (452)
...+++...++|...+.||+|+||.||+|+..+|..||||++.... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567788899999999999999999999999889999999985322 22347899999999999999999
Q ss_pred eeEEEEEcC-----CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 211 CLLGYSAHD-----DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 211 ~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
++++++... ...++||||++ |+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999998543 35799999998 678777763 345799999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~ 364 (452)
++.++.+||+|||++....... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999996543322 2234568999999999877 6789999999999999999999999988664432211
Q ss_pred hhhhccccc---------------cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 365 VTWAMPQLT---------------DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 365 ~~~~~~~~~---------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+........ .............. .........+.+++.+||+.||++|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 110000000 00000000000000 000122346788999999999999999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=335.90 Aligned_cols=264 Identities=20% Similarity=0.241 Sum_probs=203.0
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEE-EcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYS-AHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 226 (452)
..++|...+.||+|+||+||+|+. .++..||||.+.... ....+.+|+++++.++|+|++..++++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 456899999999999999999997 578899999875332 223578899999999988877777666 5666789999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~ 303 (452)
||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||+ ++++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999863 234699999999999999999999999 99999999999999 78999999999999754
Q ss_pred CCCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 304 GSQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 304 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..................... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-T 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-S
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-c
Confidence 33221 223457999999999999999999999999999999999999999875433211111110000000 0
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
. .+.+.. .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 238 ~-----~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 238 P-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp C-----HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred h-----hhhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0 000111 11346788999999999999999999999999887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=339.59 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=198.5
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc-----
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH----- 218 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----- 218 (452)
+....++|+..+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3345678999999999999999999974 68899999986443 3446789999999999 89999999999977
Q ss_pred -CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 219 -DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 219 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 45789999999999999998642 235689999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
|++..............||..|+|||.+. +..++.++||||||+++|||++|+.||..............
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 248 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 248 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-----
Confidence 99876543333334457899999999987 56788999999999999999999999987664432211110
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...+.... . .....+.+++.+||+.||++||++.|+++
T Consensus 249 ---~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 ---NPAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---SCCCCCSC----S----CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---CccccCCc----c----ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00011111 1 11246778999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.35 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=205.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|+++|++++||||+++++++.+++..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999976 68999999985431 23456688999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++|+|..++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999987522 34599999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ......++.
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~----- 410 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSE----- 410 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCT-----
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCc-----
Confidence 32 2234579999999999999999999999999999999999999998754321111111100 011111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 421 (452)
.....+.+++.+||+.||++|| +++|+++
T Consensus 411 -------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 -------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1224677899999999999999 7888885
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=328.18 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=196.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 68899999985432 23356789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999863 34589999999999999999999999 999999999999999999999999999866543
Q ss_pred CCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......||..|+|||.+.+..+ +.++||||||+++|||++|+.||...........+... ....+..
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~--- 233 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEY--- 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTT---
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchh---
Confidence 22 2234468999999999988765 68999999999999999999999876544322222111 1111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+.+++.+||+.||++|||++|+++.
T Consensus 234 ---------~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 ---------LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12356789999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=345.94 Aligned_cols=257 Identities=16% Similarity=0.175 Sum_probs=206.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEE------eCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAK------LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHD 219 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 219 (452)
..++|...+.||+|+||+||+|. ..++..||+|.+.... ..++..|++++..++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678889999999999999994 4468899999996543 456778888888886 99999999999999
Q ss_pred CceeeeeeecCCCChhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---------
Q 012975 220 DTRFIVYELMENRSLDIQLHGP--SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--------- 288 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~--------- 288 (452)
+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999998631 1345799999999999999999999998 9999999999999998
Q ss_pred --CCcEEEEecCCCcccC--CCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh
Q 012975 289 --KFNAKLSDFGLAITDG--SQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI 364 (452)
Q Consensus 289 --~~~~kl~Dfgl~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~ 364 (452)
++.+||+|||+++... ..........||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 8999999999996432 22233345679999999999999999999999999999999999999996533211
Q ss_pred hhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC-CChHHHHHhccccCccccCC
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR-PLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~~l~~~~~~~ 433 (452)
+.. ... ...... ...+.+++..|++.+|.+| |+++++.+.|++.+......
T Consensus 293 --~~~-----~~~--------~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~ 344 (365)
T 3e7e_A 293 --CKP-----EGL--------FRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344 (365)
T ss_dssp --EEE-----CSC--------CTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --eee-----chh--------ccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhh
Confidence 000 000 011111 3355678889999999998 78899999988887765443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=329.38 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=198.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC----hhhHHHHHHHHHHHHcCCCCceeeeEEEEE--cCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT----QDAGREFENEVDLLSNIHHPNVVCLLGYSA--HDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~ 221 (452)
..++|...+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3468999999999999999999975 68899999986432 234577999999999999999999999984 4457
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++||||++++ |.+++.. .....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999887 6555543 2245799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC--CCcccccccccCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 302 TDGSQ--NKNNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 302 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
..... ........||..|+|||.+.+.. .+.++||||||+++|||++|+.||......+....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~ 231 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYA 231 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCC
Confidence 65322 22223456899999999987654 377999999999999999999999876644322222111 111
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
++. +....+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 IPG------------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCS------------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC------------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 122356789999999999999999999964
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.45 Aligned_cols=261 Identities=29% Similarity=0.399 Sum_probs=206.5
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
..++|...+.||+|+||.||+|++ .++..||||.+... ......++.+|+.++++++||||+++++++.+++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346788899999999999999984 24678999999643 34556789999999999999999999999999999
Q ss_pred eeeeeeecCCCChhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEE
Q 012975 222 RFIVYELMENRSLDIQLHGPS----HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKL 294 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl 294 (452)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999987432 124599999999999999999999999 9999999999999984 456999
Q ss_pred EecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccc
Q 012975 295 SDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 295 ~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+|||++....... .......||..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--- 261 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG--- 261 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC---
Confidence 9999986432211 22234467899999999999999999999999999999998 99999876654332222111
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+ . .....+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 262 --~~~~~~--------~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 --GRMDPP--------K----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp --CCCCCC--------T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCCCC--------C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 000111 1 1224677899999999999999999999999876554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.22 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=207.6
Q ss_pred HHHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcC-CCCceeee
Q 012975 143 YKLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNI-HHPNVVCL 212 (452)
Q Consensus 143 ~~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l 212 (452)
........++|...+.||+|+||.||+|++. +|..||||.+.... ....+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4445556678999999999999999999986 68999999986432 11245688999999999 79999999
Q ss_pred EEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 213 LGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 213 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999863 34699999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhh
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT 366 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~ 366 (452)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999997654322 2234679999999998863 357889999999999999999999998765433222111
Q ss_pred hhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 367 WAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 367 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. ... ...+.. . +....+.+++.+||+.||++|||+.|+++
T Consensus 319 ~~------~~~---~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EG------QYQ---FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HT------CCC---CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hC------CCC---CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 000 001111 1 11245778999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.31 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=201.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--------
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-------- 219 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 219 (452)
++|+..+.||+|+||+||+|+.. +|+.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999984 68899999985433 22345788999999999999999999999874
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
+..++||||+++ +|...+.. ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 467999999985 66666653 235699999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCC----CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 300 AITDGSQ----NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 300 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9654321 122234568999999999876 45799999999999999999999999987665433333221111110
Q ss_pred CCCCCcccchhhc--------ccCC-HHH------HHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNIVDPVIK--------STMD-LKH------LYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~~d~~l~--------~~~~-~~~------~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+..-+.... .... .+. ...+.+++.+||+.||++|||++|+++.
T Consensus 251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 -EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp -TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 001110000000 0000 011 2357789999999999999999999963
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.48 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=203.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc---------
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--------- 218 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 218 (452)
..++|+..+.||+|+||.||+|+.. +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999986 78999999997543 246789999999999999999998864
Q ss_pred -------CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 012975 219 -------DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN 291 (452)
Q Consensus 219 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~ 291 (452)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 34579999999999999998642 235699999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+||+|||++....... ......||..|+|||.+.+..++.++||||||+++|||++|..|+.... .....
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~---- 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTD---- 230 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHH----
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHH----
Confidence 9999999997654332 2234568999999999999999999999999999999999998874321 11110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
+. ...++.. . ...+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 231 ~~-~~~~~~~--------~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 LR-DGIISDI--------F----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HH-TTCCCTT--------S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hh-ccccccc--------C----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00 1111111 1 23466899999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.91 Aligned_cols=273 Identities=23% Similarity=0.339 Sum_probs=197.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHH--HHcCCCCceeeeEEEEEc-----CCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDL--LSNIHHPNVVCLLGYSAH-----DDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~ 222 (452)
.++|+..+.||+|+||+||+|+. ++..||||.+.... ...+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 57899999986432 2344444444 445899999999986543 2256
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC------NPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
++||||+++|+|.+++.. ...++..+++++.|++.||+|||+.+ .++|+||||||+|||+++++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999863 34589999999999999999999863 34899999999999999999999999
Q ss_pred cCCCcccCCC--------CCcccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-
Q 012975 297 FGLAITDGSQ--------NKNNLKLSGTLGYVAPEYLLD-------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ- 360 (452)
Q Consensus 297 fgl~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~- 360 (452)
||++...... ........||..|+|||.+.+ ..++.++|||||||++|||++|..|+.......
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999654321 111224469999999999877 456679999999999999999987765432211
Q ss_pred hhhhhhh----------hccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 361 CQSIVTW----------AMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 361 ~~~~~~~----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....... ......... ....+..... ........+.+++.+||+.||++|||++|+++.|++++..-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREK-QRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccc-cCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 0000000 000000000 0011111111 11245667899999999999999999999999999988654
Q ss_pred cCC
Q 012975 431 LGG 433 (452)
Q Consensus 431 ~~~ 433 (452)
...
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.61 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred cCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 227 (452)
+.|... +.||+|+||+||+|+.. ++..||||.+..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 78999999999999865 6889999999766555677899999999985 79999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfgl~~~~~ 304 (452)
|+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999864 34689999999999999999999999 9999999999999998776 9999999986432
Q ss_pred CCC-------CcccccccccCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-----------
Q 012975 305 SQN-------KNNLKLSGTLGYVAPEYLLD-----GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC----------- 361 (452)
Q Consensus 305 ~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~----------- 361 (452)
... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 111 11223459999999999875 5578999999999999999999999987543220
Q ss_pred -hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 362 -QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 362 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..+.... .......+ +. ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~i---~~~~~~~~---~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESI---QEGKYEFP---DK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHH---HHCCCCCC---HH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHH---hccCcccC---ch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 00000010 00 001 123467789999999999999999999973
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.05 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=204.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC---------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceee----------
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD---------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVC---------- 211 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 211 (452)
++|...+.||+|+||.||+|+... ++.||+|.+... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999998764 789999998643 36789999999999999987
Q ss_pred -----eEEEEEc-CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 212 -----LLGYSAH-DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 212 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6777776 67889999999 99999999742 135799999999999999999999999 9999999999999
Q ss_pred ECCCC--cEEEEecCCCcccCCCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 012975 286 LDSKF--NAKLSDFGLAITDGSQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKL 356 (452)
Q Consensus 286 l~~~~--~~kl~Dfgl~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~ 356 (452)
++.++ .+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999965432211 113347999999999999999999999999999999999999999875
Q ss_pred ChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 357 APAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.... ............. ...+.+..... ......+.+++.+||+.||++|||++|+++.|++++...
T Consensus 272 ~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFVDK---PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTCH-HHHHHHHHHHHHS---CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCH-HHHHHHHHhccCC---hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 4221 1111111000011 11111111110 011246778999999999999999999999999887653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.12 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=191.9
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEc
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 218 (452)
...++|...+.||+|+||+||+|... ++..||||.+.... ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999876 57899999985431 1122358899999999999999999999864
Q ss_pred CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEE
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLS 295 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~ 295 (452)
+..++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 557999999999999988853 45699999999999999999999999 99999999999999754 459999
Q ss_pred ecCCCcccCCCCCcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-hhhhhhhccc
Q 012975 296 DFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC-QSIVTWAMPQ 371 (452)
Q Consensus 296 Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~-~~~~~~~~~~ 371 (452)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+..
T Consensus 285 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---- 359 (419)
T 3i6u_A 285 DFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---- 359 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----
T ss_pred ecccceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----
Confidence 999997654322 2234679999999999864 5678899999999999999999999976543211 111110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... . ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 360 ----~~~-~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 ----GKY-N-FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----TCC-C-CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCC-C-CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0 01111111 2346788999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=335.79 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=187.7
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
...++|...+.||+|+||.||+|+.. ++..||||.+.... ....+++.+|+.++++++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999864 68899999986433 33456789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 226 YELMENRSLDIQLHG-----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
|||+++++|.+++.. ......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999988852 11245699999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCC-----CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 301 ITDGSQN-----KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 301 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
....... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-----ND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-----SS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-----cC
Confidence 6543221 11234568999999999876 5689999999999999999999999987654332111110 00
Q ss_pred CCCCCc-ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 RSKLPN-IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 ~~~~~~-~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...... ..++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001100 11111111 12346778999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=343.14 Aligned_cols=202 Identities=25% Similarity=0.346 Sum_probs=174.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcC------CCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNI------HHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 222 (452)
.++|+..+.||+|+||+||+|+.. ++..||||.+.. .....+++.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457888999999999999999876 588999999964 334456778888888876 577999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEEecCCC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN--AKLSDFGLA 300 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~--~kl~Dfgl~ 300 (452)
++||||+. ++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6888887642 234599999999999999999999999 9999999999999999987 999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 250 CYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 664332 234578999999999999999999999999999999999999998876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=365.09 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=207.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCcee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 223 (452)
..++|+..+.||+|+||.||+|+.. +++.||||.+... .......+..|..++..+ +|+||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999976 5788999998632 223456688999999988 7999999999999999999
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
|||||+++|+|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999964 24699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
..........+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+. .....++..
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~~~~p~~-- 564 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNVAYPKS-- 564 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------SSCCCCCTT--
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCCCCCCcc--
Confidence 444444556789999999999999999999999999999999999999999876544322221 111122211
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHH
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI-----TDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 421 (452)
...++.+++.+||+.||++||++ +||++
T Consensus 565 ----------~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 ----------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----------SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----------CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 22357789999999999999998 77774
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.01 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=196.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 224 (452)
.|...+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3566778999999999999875 5788999998643 34556789999999999999999999999875 345799
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEC-CCCcEEEEecCCCc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPA--VIHRDLKSSNILLD-SKFNAKLSDFGLAI 301 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~ 301 (452)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. + ++||||||+||+++ +++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999863 35689999999999999999999998 6 99999999999998 78999999999996
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......... .... .. ...+..
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~----~~-~~~~~~ 250 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRV----TS-GVKPAS 250 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHH----TT-TCCCGG
T ss_pred ccccc--ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHH----hc-cCCccc
Confidence 54332 223456999999999776 45899999999999999999999999875432211 1110 00 000111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... ...+.+++.+||+.||++|||+.|+++
T Consensus 251 ----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ----FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 235778999999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=346.01 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=197.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc------eee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT------RFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 224 (452)
.+|...+.||+|+||+||+|++.++..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999998777899999854322 12469999999999999999999865443 789
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~~~ 303 (452)
||||++++.+....+.......+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||++...
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998765544432222345799999999999999999999999 999999999999999 7999999999999765
Q ss_pred CCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhh-hhhh-----------cc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSI-VTWA-----------MP 370 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~-~~~~-----------~~ 370 (452)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.... .... .+
T Consensus 193 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 193 IAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred cCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 3322 23345789999999998765 589999999999999999999999988765432111 1100 00
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. .....+.................++.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NY-MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GG-SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hh-hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0011111111111111111233578899999999999999999999963
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=340.53 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=196.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|...+.||+|+||.||+|+.. +|..||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457888999999999999999975 6899999998543 3444677899999999999999999999998764
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988863 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc----C
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----R 375 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~ 375 (452)
+..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+......... .
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 765432 234578999999999887 67999999999999999999999999877653322111110000000 0
Q ss_pred ----------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 376 ----------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 376 ----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..++......... ........+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000000 00122346788999999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=342.52 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=197.5
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------ 219 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 219 (452)
+...++|...+.||+|+||+||+|+.. +|..||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 446678999999999999999999874 689999999864322 234799999999999999999998543
Q ss_pred --------------------------------CceeeeeeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012975 220 --------------------------------DTRFIVYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYL 266 (452)
Q Consensus 220 --------------------------------~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~L 266 (452)
...++||||++ |+|.+.+.. ...+..+++..+..++.|++.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 24789999998 577666542 12345799999999999999999999
Q ss_pred HhcCCCCeeeCCCCCCCEEEC-CCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHH
Q 012975 267 HEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLL 344 (452)
Q Consensus 267 H~~~~~~i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~ 344 (452)
|+. +|+||||||+|||++ +++.+||+|||++....... ......||..|+|||.+.+. .++.++|||||||++|
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 999 999999999999998 68999999999997653332 23345689999999998875 4899999999999999
Q ss_pred HHHcCCCCCCCCChhhhhhhhhhhccc-----------cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCC
Q 012975 345 ELLLGRRPVEKLAPAQCQSIVTWAMPQ-----------LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYR 413 (452)
Q Consensus 345 elltG~~P~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 413 (452)
||++|+.||......+....+...... .......+..................+.+++.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999887654322111100000 000111111111111111222234567899999999999999
Q ss_pred CChHHHHH
Q 012975 414 PLITDVLH 421 (452)
Q Consensus 414 Ps~~evl~ 421 (452)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999984
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=350.79 Aligned_cols=193 Identities=26% Similarity=0.396 Sum_probs=153.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (452)
.++|+..+.||+|+||+||+|+.. ++..||||++... .....+.+.+|+.+|++++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999876 6889999998643 344567899999999999999999999998543 46
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+||||+ +|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 4788888853 35699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC---------------------------CcccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHcC
Q 012975 302 TDGSQN---------------------------KNNLKLSGTLGYVAPEYL-LDGKLTDKSDVYAFGVVLLELLLG 349 (452)
Q Consensus 302 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gvll~elltG 349 (452)
...... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 543211 112345689999999976 456799999999999999999993
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=325.58 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=198.4
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 224 (452)
..++|+..+.||+|+||+||+|+.. ++..||+|.+... ......++.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467888999999999999999986 7899999998643 334567789999999999 99999999999999999999
Q ss_pred eeeecCCCChhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--------------
Q 012975 225 VYELMENRSLDIQLHGPS-HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-------------- 289 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-------------- 289 (452)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999986421 125689999999999999999999999 99999999999999844
Q ss_pred -----CcEEEEecCCCcccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh
Q 012975 290 -----FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS 363 (452)
Q Consensus 290 -----~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~ 363 (452)
..+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|||++|..|+...... ..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--HE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--HH
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--HH
Confidence 479999999997654332 23589999999999876 5668999999999999999999877543211 11
Q ss_pred hhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 364 IVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
... .....++. .....+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~------~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQ------GRLPRIPQ------------VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHT------TCCCCCSS------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHc------CCCCCCCc------------ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 00011111 112457789999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.91 Aligned_cols=199 Identities=28% Similarity=0.392 Sum_probs=167.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (452)
.++|...+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999876 5788999999643 344567899999999999999999999999776 56
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 699988863 35699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC----------------------cccccccccCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 302 TDGSQNK----------------------NNLKLSGTLGYVAPEYL-LDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 302 ~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
....... ......||+.|+|||.+ ....++.++|||||||++|||++|..||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 6533211 12456799999999986 556799999999999999999986665543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.36 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=205.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|...+.||+|+||+||+++.. +|..||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999986 68899999985432 34567899999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~ 302 (452)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988864 34699999999999999999999999 99999999999999 5678999999999976
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
..... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+....+.... ....
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------~~~~--- 247 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK------YTFE--- 247 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCC---
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------CCCC---
Confidence 54332 2234579999999998876 68999999999999999999999998876544332222110 0000
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQW-K----KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGG-G----GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0110 1 12345778999999999999999999995
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.70 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=204.8
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---------hhhHHHHHHHHHHHHcCC-CCceeeeEEEE
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---------QDAGREFENEVDLLSNIH-HPNVVCLLGYS 216 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~ 216 (452)
...++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578899999999999999999986 68899999986442 123466889999999995 99999999999
Q ss_pred EcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 217 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
..++..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999863 34699999999999999999999999 999999999999999999999999
Q ss_pred cCCCcccCCCCCcccccccccCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLL------DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 297 fgl~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
||++....... ......||..|+|||.+. ...++.++||||||+++|||++|+.||......+....+...
T Consensus 168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-- 244 (298)
T 1phk_A 168 FGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 244 (298)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred ccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC--
Confidence 99997654322 223456899999999885 456889999999999999999999999876654322222111
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... .+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 245 ----~~~~~---~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 ----NYQFG---SPEW-D----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----CCCCC---TTTG-G----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CcccC---cccc-c----ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000 0100 1 12346778999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=352.17 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=199.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+.|+..+.||+|+||+||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999986 68899999986432 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~~~~ 303 (452)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888753 34699999999999999999999999 9999999999999976 455999999999765
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||......+....+....... ..
T Consensus 190 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~ 258 (494)
T 3lij_A 190 ENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF---------DS 258 (494)
T ss_dssp BTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------CS
T ss_pred CCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------Cc
Confidence 4332 233457999999999876 569999999999999999999999999877654333322111000 00
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+.. . .....+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 1 112357789999999999999999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=330.10 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=202.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe--CCCcEEEEEEecCcCh--hhHHHHHHHHHHHHcC---CCCceeeeEEEEE----
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL--DDNLHVAVKKLDCATQ--DAGREFENEVDLLSNI---HHPNVVCLLGYSA---- 217 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 217 (452)
+.++|...+.||+|+||+||+|+. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999854321 1223466777777666 8999999999987
Q ss_pred -cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 218 -HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 218 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
.....++||||++ |+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69988886422 34599999999999999999999999 999999999999999999999999
Q ss_pred cCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhh-hhhc-c---c
Q 012975 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV-TWAM-P---Q 371 (452)
Q Consensus 297 fgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~-~~~~-~---~ 371 (452)
||++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .... + .
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99996543222 223456899999999999999999999999999999999999999877654322111 1100 0 0
Q ss_pred cccCCCCC-----cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hcccc
Q 012975 372 LTDRSKLP-----NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPL 426 (452)
Q Consensus 372 ~~~~~~~~-----~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l 426 (452)
+......+ ......+. ....+....+.+++.+||+.||++|||+.|+++ .++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccccchhhhcccCcchhh-hccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 00000000 00000000 011122346778999999999999999999995 34444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=336.00 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=200.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 222 (452)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999976 68899999996433 34456788999999999999999999998764 578
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888763 4699999999999999999999999 999999999999999999999999999965
Q ss_pred cCCCCC----------cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 303 DGSQNK----------NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 303 ~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 432211 1123468999999998765 67899999999999999999999999887644322211111110
Q ss_pred cccCCCCCcccchh---------------hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 LTDRSKLPNIVDPV---------------IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ~~~~~~~~~~~d~~---------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
............+. +.. ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 000 00122346778999999999999999999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.51 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=200.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEe----CCCcEEEEEEecCcC----hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCAT----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
.++|+..+.||+|+||+||+++. .++..||||.+.... ......+.+|+++++++ +|+||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999987 368899999986432 22345677899999999 6999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999864 34699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC-CCcccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 301 ITDGSQ-NKNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 301 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. ........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccCCC
Confidence 654322 222334579999999999986 3478999999999999999999999975443221111110 01111111
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHhc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHSL 423 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L 423 (452)
.+. +....+.+++.+||+.||++|| +++|+++..
T Consensus 285 ~~~------------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCT------------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCc------------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 1223567899999999999999 999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=334.65 Aligned_cols=263 Identities=24% Similarity=0.299 Sum_probs=194.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|...+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999875 6889999998643 3445577899999999999999999999997765
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999974 6777764 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc-----------
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM----------- 369 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~----------- 369 (452)
....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 175 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 7654322 2234578999999999999999999999999999999999999998766433211111000
Q ss_pred -----cccccCCCCCc-----ccchhhccc---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 370 -----PQLTDRSKLPN-----IVDPVIKST---MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 370 -----~~~~~~~~~~~-----~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........... .+....... ........+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 000000000 011235678899999999999999999999963
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.27 Aligned_cols=252 Identities=12% Similarity=0.113 Sum_probs=180.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHH---HHHHcCCCCceeeeE-------EEE
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEV---DLLSNIHHPNVVCLL-------GYS 216 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~ 216 (452)
.+|...+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+ ..|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35778899999999999999975 78899999997543 23455677885 45555 799988754 555
Q ss_pred EcCC-----------------ceeeeeeecCCCChhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 012975 217 AHDD-----------------TRFIVYELMENRSLDIQLHGPSHGSALTWHMR------MKIALDTARGLEYLHEHCNPA 273 (452)
Q Consensus 217 ~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 273 (452)
..++ ..++||||++ |+|.+++... +..+.+..+ +.++.|++.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 4332 3799999999 8999998742 223455556 78889999999999999 9
Q ss_pred eeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCC
Q 012975 274 VIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 274 i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
|+||||||+|||++.++.+||+|||++...+... ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999997654322 13457799999999987 679999999999999999999999
Q ss_pred CCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 352 PVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 352 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
||.......... +........... ....+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS---WKRPSLRVPGTD-SLAFGSC-T----PLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC---CCBCCTTSCCCC-SCCCTTS-S----CCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc---hhhhhhhhcccc-ccchhhc-c----CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998765432110 100000000000 0000100 1 22346778999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.81 Aligned_cols=251 Identities=26% Similarity=0.326 Sum_probs=202.1
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-------------hhHHHHHHHHHHHHcCCCCceeeeEE
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-------------DAGREFENEVDLLSNIHHPNVVCLLG 214 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 214 (452)
..++|...+.||+|+||+||+|+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568899999999999999999976 578999999864321 23567899999999999999999999
Q ss_pred EEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---c
Q 012975 215 YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF---N 291 (452)
Q Consensus 215 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~---~ 291 (452)
++.+++..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988853 34699999999999999999999999 999999999999998876 6
Q ss_pred EEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 292 AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 292 ~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
+||+|||++....... ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~- 264 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY- 264 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999999997654332 233457999999999876 5689999999999999999999999998765543332221100
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. .+...... ...++.+++.+||+.||++|||++|+++
T Consensus 265 -----~----~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 -----Y----FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----C----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----C----CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000111 1245778999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=345.24 Aligned_cols=261 Identities=24% Similarity=0.297 Sum_probs=192.5
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------ceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 224 (452)
+|...+.||+|+||.||+|++. +|..||||++..... .+.+|++++++++|+||+++++++...+ ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5777899999999999999986 589999999864322 2357999999999999999999985422 3679
Q ss_pred eeeecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEecCCCcc
Q 012975 225 VYELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAIT 302 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-~~~kl~Dfgl~~~ 302 (452)
||||+++ +|...+.. ......+++..++.++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 44444321 12345799999999999999999999998 99999999999999965 6789999999976
Q ss_pred cCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh-hhhhhc-------cccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS-IVTWAM-------PQLT 373 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~-~~~~~~-------~~~~ 373 (452)
..... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......+... ++.... ....
T Consensus 207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 53322 22345789999999998765 78999999999999999999999998876433211 111000 0000
Q ss_pred ---cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 ---DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++.+........+......++.+++.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 001111111111111111122356889999999999999999999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=351.31 Aligned_cols=263 Identities=19% Similarity=0.264 Sum_probs=206.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC-CceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|...+.||+|+||.||+|++ .++..||||.+..... ..++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999997 4688999998764332 2357899999999976 556666667777888899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEecCCCcccC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll---~~~~~~kl~Dfgl~~~~~ 304 (452)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||++....
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999863 235699999999999999999999999 99999999999999 688999999999997543
Q ss_pred CCCC-------cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCC
Q 012975 305 SQNK-------NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377 (452)
Q Consensus 305 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (452)
.... ......||..|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence 3221 12256799999999999999999999999999999999999999987654322222211110000
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
....+ .+.. ....++.+++..||+.||++||++.+|++.|++++...
T Consensus 234 -~~~~~-~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 234 -ATSIE-ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -HSCHH-HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -cccHH-HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00000 1111 12346788999999999999999999999999886543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.39 Aligned_cols=251 Identities=28% Similarity=0.370 Sum_probs=202.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||+||+++.. +++.||||.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457888999999999999999976 6889999998532 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~---~~~~~kl~Dfgl~~~~ 303 (452)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888853 34699999999999999999999999 999999999999995 4667999999999755
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+...... ...
T Consensus 175 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----~~~----- 243 (486)
T 3mwu_A 175 QQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA----FDL----- 243 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----SCS-----
T ss_pred CCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCC-----
Confidence 3322 2234579999999998875 5899999999999999999999999887654432222211000 000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+.. . .....+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~-~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQW-R----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGG-G----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ccc-C----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 1 112456789999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.15 Aligned_cols=274 Identities=22% Similarity=0.222 Sum_probs=192.9
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT- 221 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 221 (452)
.......++|...+.||+|+||+||+|+.. +|..||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566789999999999999999999985 68899999985432 233456778888999999999999999976443
Q ss_pred ------eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeCCCCCCCEEECC-CCcE
Q 012975 222 ------RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH--EHCNPAVIHRDLKSSNILLDS-KFNA 292 (452)
Q Consensus 222 ------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~i~H~Dlk~~NIll~~-~~~~ 292 (452)
.++||||++++.+............+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999987543322221133567899999999999999999999 77 9999999999999997 8999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||++....... ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+......
T Consensus 172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999997654332 223456899999999987654 899999999999999999999999887654322221110000
Q ss_pred --------cccCCCC------CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 --------LTDRSKL------PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 --------~~~~~~~------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....... ...--.........+....+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 00000011111122345678899999999999999999999963
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=334.23 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=202.0
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+...++|+..+.||+|+||.||+|+..+ .+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3356788899999999999999999865 48999986432 2334567889999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999964 345699999999999999999999999 999999999999998 6799999999985432
Q ss_pred C-----CCCcccccccccCccCcccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc
Q 012975 305 S-----QNKNNLKLSGTLGYVAPEYLLD---------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP 370 (452)
Q Consensus 305 ~-----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~ 370 (452)
. .........||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 258 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-- 258 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT--
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC--
Confidence 1 1122223458999999999864 45788999999999999999999999876654322211110
Q ss_pred ccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 371 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
..+..... .....+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 259 ------~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 ------MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ------CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ------CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00111100 01124678999999999999999999999999988763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.11 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC--------CCceeeeEEEEE---
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH--------HPNVVCLLGYSA--- 217 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 217 (452)
.++|...+.||+|+||+||+|+.. +++.||||.+.. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467999999999999999999865 688999999964 3445677899999999885 788999999987
Q ss_pred -cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC------
Q 012975 218 -HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF------ 290 (452)
Q Consensus 218 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~------ 290 (452)
+....++||||+. ++|.+++.. .....+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 5567899999995 555555442 22356999999999999999999999864 799999999999999775
Q ss_pred -------------------------------------------cEEEEecCCCcccCCCCCcccccccccCccCcccccC
Q 012975 291 -------------------------------------------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (452)
Q Consensus 291 -------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 327 (452)
.+||+|||++...... .....||..|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999999765432 234468999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-------hhhhh--------------hccccccCCCCCcccch--
Q 012975 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-------SIVTW--------------AMPQLTDRSKLPNIVDP-- 384 (452)
Q Consensus 328 ~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-------~~~~~--------------~~~~~~~~~~~~~~~d~-- 384 (452)
..++.++|||||||++|||++|+.||......+.. ..... ....+.....+..+.+.
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999865432211 00000 00001111111111000
Q ss_pred -----hh--cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 -----VI--KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 -----~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+ ......+....+.+++.+||+.||++|||++|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 11234566778999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=335.35 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=185.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------C
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------D 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 220 (452)
.++|+..+.||+|+||.||+|+.. +|..||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367888999999999999999865 6889999998643 344567789999999999999999999998754 4
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899888753 4699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc-------
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL------- 372 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~------- 372 (452)
...... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+.......
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 764322 234578999999999887 678999999999999999999999998876543222211110000
Q ss_pred ----------ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 373 ----------TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 373 ----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
..-...+..--..+.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFI----GANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCC----CCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000001 112457889999999999999999999963
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=328.49 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=197.8
Q ss_pred cCCCccCeEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEc--CCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAH--DDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+. .++..||+|.+... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5788899999999999999986 46889999998643 3467899999999997 9999999999988 56789999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~ 305 (452)
||+++++|..++. .+++..+..++.|++.||+|||++ +++||||||+|||++.++ .+||+|||++.....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999998874 388999999999999999999999 999999999999999776 899999999976543
Q ss_pred CCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--hhhh---------hhhcccc-
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QSIV---------TWAMPQL- 372 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--~~~~---------~~~~~~~- 372 (452)
... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .... .+.....
T Consensus 184 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 322 234568999999999877 6789999999999999999999999965432210 0000 0000000
Q ss_pred cc--------CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 373 TD--------RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 373 ~~--------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. ........+..............+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00000000111111111112456788999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=326.44 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=196.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEE-----------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSA----------- 217 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 217 (452)
.++|...+.||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999999874 8899999998777777788999999999999999999999874
Q ss_pred ---cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEE
Q 012975 218 ---HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAK 293 (452)
Q Consensus 218 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~k 293 (452)
+.+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3357799999998 699988853 4689999999999999999999999 999999999999997 577999
Q ss_pred EEecCCCcccCCC---CCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc
Q 012975 294 LSDFGLAITDGSQ---NKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 294 l~Dfgl~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~ 369 (452)
|+|||++...... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999754322 112233457899999998865 678999999999999999999999998876543222211111
Q ss_pred cccccC------CCCCcccchhhcc-c-----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 370 PQLTDR------SKLPNIVDPVIKS-T-----MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 370 ~~~~~~------~~~~~~~d~~l~~-~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+..... ..++..+...... . ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 0000000000000 0 00112356788999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=331.55 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=200.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 222 (452)
.++|...+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999876 68889999996433 34457799999999999999999999999765 367
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 588888753 3599999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC---cccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccc-----
Q 012975 303 DGSQNK---NNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT----- 373 (452)
Q Consensus 303 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~----- 373 (452)
...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 533221 1234579999999998754 4589999999999999999999999987765442222111000000
Q ss_pred ------------cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 ------------DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 ------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
........-...... .....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFP----NADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCC----CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000111 12346788999999999999999999996
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=326.54 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=204.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEe--CCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC------ceeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKL--DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP------NVVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~~~~~ 221 (452)
.++|+..+.||+|+||+||+|.. .+++.||||.+... ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788899999999999999987 36889999998643 34556788999999988765 49999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------------
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS------------- 288 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~------------- 288 (452)
.++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888642 234689999999999999999999999 9999999999999987
Q ss_pred ------CCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh
Q 012975 289 ------KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ 362 (452)
Q Consensus 289 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~ 362 (452)
++.+||+|||++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...+..+..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999764332 23457899999999999999999999999999999999999999887654432
Q ss_pred hhhhhhcccccc---------------CCCCCccc----------chhh-cccCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 363 SIVTWAMPQLTD---------------RSKLPNIV----------DPVI-KSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 363 ~~~~~~~~~~~~---------------~~~~~~~~----------d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
............ ...+.... .+.. .......+...+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 222211110000 00000000 0000 001123456788999999999999999999
Q ss_pred HHHHH
Q 012975 417 TDVLH 421 (452)
Q Consensus 417 ~evl~ 421 (452)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.94 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=195.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 220 (452)
.++|...+.||+|+||.||+|+.. ++..||||.+.... ......+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457888999999999999999876 57899999986432 122345889999999999999999999987655
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEec
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDF 297 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Df 297 (452)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998853 45699999999999999999999999 9999999999999987664 999999
Q ss_pred CCCcccCCCCCcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh-hhhhhhhhccccc
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLT 373 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~-~~~~~~~~~~~~~ 373 (452)
|++....... ......||..|+|||.+. ...++.++||||||+++|||++|+.||....... ....+..
T Consensus 162 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------ 234 (322)
T 2ycf_A 162 GHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS------ 234 (322)
T ss_dssp TTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH------
T ss_pred ccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh------
Confidence 9997654322 223456899999999874 5678899999999999999999999997654321 1111110
Q ss_pred cCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 374 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~----~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYN----FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccc----cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000 01111111 2346778999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.39 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=185.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hh-hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QD-AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||+||+++.. +|+.||+|++.... .. ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 68899999986542 22 2334455555688889999999999999999999999
Q ss_pred eecCCCChhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHG-PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||++ |+|.+++.. ......+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 587666642 123457999999999999999999999853 899999999999999999999999999965533
Q ss_pred CCCcccccccccCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 306 QNKNNLKLSGTLGYVAPEYL----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ......... . ...
T Consensus 163 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---~---~~~ 234 (290)
T 3fme_A 163 DVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVEEP---S---PQL 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHHSC---C---CCC
T ss_pred ccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhccC---C---CCc
Confidence 322 2234689999999996 556789999999999999999999999986433221 111111000 0 000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PA----D----KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CT----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc----c----cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 0 12345778999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.04 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=207.7
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT 221 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 221 (452)
+...++|+..+.||+|+||.||+|++.. +..||+|.+... .....+.|.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3345678889999999999999998742 467999998654 3444577999999999999999999999985 466
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999873 234699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 302 TDGSQNK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 302 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
....... ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+....+... .....+
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~ 614 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMP 614 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-----CCCCCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence 6533221 2223457789999999999999999999999999999997 99999877654432222110 011111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
. .....+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 615 ~------------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 615 P------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp T------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1 1234677899999999999999999999999887654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=321.54 Aligned_cols=251 Identities=29% Similarity=0.400 Sum_probs=192.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH---------- 218 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 218 (452)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999975 688999999863 34456789999999999999999999998865
Q ss_pred ---CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 012975 219 ---DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLS 295 (452)
Q Consensus 219 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~ 295 (452)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 3467999999999999999973 345688999999999999999999999 99999999999999999999999
Q ss_pred ecCCCcccCCC--------------CCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 296 DFGLAITDGSQ--------------NKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 296 Dfgl~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
|||++...... ........||..|+|||.+.+. .++.++||||||+++|||++ ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 99998654321 1122345689999999998764 68999999999999999998 55432111
Q ss_pred hhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 361 CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........ ......+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 -VNILKKLR---SVSIEFPPD--------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHH---STTCCCCTT--------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHHHhcc---ccccccCcc--------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111110 011111111 111233456789999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=329.95 Aligned_cols=260 Identities=21% Similarity=0.284 Sum_probs=197.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR---- 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 222 (452)
.++|...+.||+|+||+||+|+.. +|..||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999875 6889999999653 334467889999999999999999999999887755
Q ss_pred --eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 223 --FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 223 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877763 3499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc--CCC
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD--RSK 377 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--~~~ 377 (452)
...... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.............. ...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 754332 234568999999999887 67899999999999999999999999877644321111100000000 000
Q ss_pred CC------------cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 378 LP------------NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 378 ~~------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
+. ......... ........+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000000 001123567889999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=320.33 Aligned_cols=252 Identities=28% Similarity=0.371 Sum_probs=203.0
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
...++|+..+.||+|+||+||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999986 6889999998543 23456789999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEecCCCc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLAI 301 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~---~~~kl~Dfgl~~ 301 (452)
||||+++++|.+++.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888753 24689999999999999999999999 99999999999999764 479999999987
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
...... ......||..|+|||.+.+ .++.++||||||+++|||++|+.||......+....+... .....
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~-- 242 (287)
T 2wei_A 173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------KYAFD-- 242 (287)
T ss_dssp TBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCC--
T ss_pred eecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCC--
Confidence 554332 2223458999999998865 4899999999999999999999999887654322222110 00000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 243 -~~~-~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 -LPQ-WR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -SGG-GT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -chh-hh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 01 11245778999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=332.33 Aligned_cols=271 Identities=22% Similarity=0.308 Sum_probs=202.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-----------CCceeeeEEEEEc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----------HPNVVCLLGYSAH 218 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 218 (452)
++|...+.||+|+||+||+|+.. +++.||||.+.. .......+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57888999999999999999974 688999999864 3345567889999999886 8999999999876
Q ss_pred CC----ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC------C
Q 012975 219 DD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD------S 288 (452)
Q Consensus 219 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~------~ 288 (452)
.+ ..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++ +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 89999888642 2345999999999999999999999953 899999999999994 4
Q ss_pred CCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh-------
Q 012975 289 KFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC------- 361 (452)
Q Consensus 289 ~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~------- 361 (452)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 458999999999765332 2234689999999999999999999999999999999999999986542211
Q ss_pred hhhhhhhc--------------cccccCCCCCccc-------chhh--cccCCHHHHHHHHHHHHHhcCCCCCCCCChHH
Q 012975 362 QSIVTWAM--------------PQLTDRSKLPNIV-------DPVI--KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITD 418 (452)
Q Consensus 362 ~~~~~~~~--------------~~~~~~~~~~~~~-------d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 418 (452)
..+..... ..+.....+..+. ...+ ...........+.+++.+||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 01110000 0000000000000 0000 11234567788999999999999999999999
Q ss_pred HHH--hccccCcc
Q 012975 419 VLH--SLIPLVPV 429 (452)
Q Consensus 419 vl~--~L~~l~~~ 429 (452)
+++ .+++....
T Consensus 331 ll~hp~f~~~~~~ 343 (373)
T 1q8y_A 331 LVNHPWLKDTLGM 343 (373)
T ss_dssp HHTCGGGTTCTTC
T ss_pred HhhChhhhcccCc
Confidence 997 45554443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.96 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=195.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCC--CCceeeeEEEEEcCCceee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIH--HPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 224 (452)
..++|...+.||+|+||.||+++..+++.||||.+... .......+.+|++++.+++ |+||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34578889999999999999999988999999998643 3445678999999999997 5999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||| +.+++|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||++++ +.+||+|||++....
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 668899999864 34689999999999999999999999 9999999999999964 899999999996543
Q ss_pred CCCC--cccccccccCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 305 SQNK--NNLKLSGTLGYVAPEYLLD-----------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 305 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
.... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~- 255 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDP- 255 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCT-
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HHHHHHHhc-
Confidence 3221 1224468999999999875 468889999999999999999999997654321 111111100
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
......+.. ....+.+++.+||+.||++||++.|+++.
T Consensus 256 -~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 256 -NHEIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -TSCCCCCCC------------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccccCCccc------------chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 000111111 12357789999999999999999999963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.10 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=196.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 221 (452)
.++|...+.||+|+||.||+|+.. +|..||||.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999875 6899999998643 33445778999999999999999999999987754
Q ss_pred -eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 222 -RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 222 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
.++||||++ |+|.+++. ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68877763 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc--------
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ-------- 371 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-------- 371 (452)
...... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+......
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 654322 234568999999999877 67899999999999999999999999876643321111100000
Q ss_pred cccC------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 372 LTDR------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 372 ~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+.+. ..++....+.... ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000000000000 01123456788999999999999999999995
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=327.65 Aligned_cols=205 Identities=24% Similarity=0.319 Sum_probs=173.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CC-----ceeeeEEEEEcCCc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HP-----NVVCLLGYSAHDDT 221 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 221 (452)
..++|...+.||+|+||+||+|+.. +++.||||.+.. ......++..|+.+++.++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999876 678899999964 3444567888999888874 55 49999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEecCC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFGL 299 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~--~~~~~kl~Dfgl 299 (452)
.++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59988886422 34599999999999999999999952 23899999999999995 478899999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhh
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ 360 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~ 360 (452)
+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus 208 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 208 SCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9765432 234578999999999999999999999999999999999999999876543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.12 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=177.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHH-HHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVD-LLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999985 68899999996543 334455666666 677789999999999999999999999
Q ss_pred eecCCCChhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 227 ELMENRSLDIQLHG--PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 227 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 77666532 112456999999999999999999999852 79999999999999999999999999996543
Q ss_pred CCCCcccccccccCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQNKNNLKLSGTLGYVAPEYL----LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
... ......||..|+|||.+ .+..++.++||||||+++|||++|+.||....... ........ .....
T Consensus 178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~--~~~~~ 249 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVK--GDPPQ 249 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC--SCCCC
T ss_pred ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhc--CCCCC
Confidence 322 22234689999999998 45678999999999999999999999998643211 00000000 00001
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+ ...... .....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~-~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 L-SNSEER----EFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-CCCSSC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-CCcccc----cCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 000011 22346788999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.50 Aligned_cols=263 Identities=20% Similarity=0.263 Sum_probs=201.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CC-cEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc------eeeeEEEEEcCCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DN-LHVAVKKLDCATQDAGREFENEVDLLSNIHHPN------VVCLLGYSAHDDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 221 (452)
.++|+..+.||+|+||+||+|+.. ++ ..||+|.+.. .....+.+.+|++++++++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467888999999999999999875 33 6899999864 3345567889999999997665 8999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---------------
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL--------------- 286 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll--------------- 286 (452)
.++||||+ +++|.+++.. .....+++.+++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5566556543 2235699999999999999999999999 99999999999999
Q ss_pred ----CCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh
Q 012975 287 ----DSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ 362 (452)
Q Consensus 287 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~ 362 (452)
+.++.+||+|||++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999764332 23457999999999999999999999999999999999999999877654322
Q ss_pred hhhhhhcccccc---------------CCCCCccc----------ch-hhcccCCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 012975 363 SIVTWAMPQLTD---------------RSKLPNIV----------DP-VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLI 416 (452)
Q Consensus 363 ~~~~~~~~~~~~---------------~~~~~~~~----------d~-~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 416 (452)
............ ...+.... .+ ......+..+..++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 221111100000 00000000 00 00011122445678899999999999999999
Q ss_pred HHHHH
Q 012975 417 TDVLH 421 (452)
Q Consensus 417 ~evl~ 421 (452)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99994
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=331.94 Aligned_cols=201 Identities=29% Similarity=0.403 Sum_probs=154.0
Q ss_pred cCCCc-cCeEeecCcEEEEEEEeC---CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceee
Q 012975 151 DSFHE-SNILGEGGFGCVYKAKLD---DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFI 224 (452)
Q Consensus 151 ~~f~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 224 (452)
+.|+. .++||+|+||+||+|+.. ++..||+|++.... ....+.+|+.+|++++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 458999999999999975 57889999996433 23467899999999999999999999954 568899
Q ss_pred eeeecCCCChhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEE
Q 012975 225 VYELMENRSLDIQLHG------PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL----DSKFNAKL 294 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll----~~~~~~kl 294 (452)
||||+++ +|.+++.. ......+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999974 67666531 11223599999999999999999999999 99999999999999 77899999
Q ss_pred EecCCCcccCCCC---CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 012975 295 SDFGLAITDGSQN---KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLA 357 (452)
Q Consensus 295 ~Dfgl~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~ 357 (452)
+|||++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999997654321 222345789999999999874 58999999999999999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.41 Aligned_cols=250 Identities=27% Similarity=0.336 Sum_probs=187.8
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeeecC
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999998777778999999998642 345678999999876 89999999999999999999999995
Q ss_pred CCChhhhccCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-------------CcEE
Q 012975 231 NRSLDIQLHGPSHGS----ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-------------FNAK 293 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~-------------~~~k 293 (452)
|+|.+++....... ..++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999987532111 123345678999999999999999 99999999999999754 4899
Q ss_pred EEecCCCcccCCCCC----cccccccccCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhh
Q 012975 294 LSDFGLAITDGSQNK----NNLKLSGTLGYVAPEYLLD-------GKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQC 361 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~ 361 (452)
|+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999976543321 1224579999999999876 678999999999999999999 999997654332
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....... ..... .....+.....++.+++.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~-------~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRGI-------FSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTC-------CCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCC-------CCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111110 01111 011123355678889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.91 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=171.5
Q ss_pred hhcCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCce
Q 012975 149 ATDSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTR 222 (452)
Q Consensus 149 ~~~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 222 (452)
..++|... ++||+|+||+||+|+.. +++.||+|.+... .... .+....++.++|+||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 34677774 46999999999999987 6899999998642 2222 222334566799999999999876 4457
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl 299 (452)
++||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +++||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999752 235799999999999999999999999 9999999999999986 45599999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............... ........+
T Consensus 178 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~ 253 (336)
T 3fhr_A 178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR--IRLGQYGFP 253 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------CCC
T ss_pred ceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh--hhccccccC
Confidence 97543322 23456899999999998889999999999999999999999999765433211000000 000000000
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. + .. ......+.+++.+||+.||++|||+.|+++
T Consensus 254 ~---~-~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 254 N---P-EW----SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp T---T-TS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c---h-hh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 00 122346778999999999999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.02 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=190.7
Q ss_pred HHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcC----CCCceeeeEE
Q 012975 146 LEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNI----HHPNVVCLLG 214 (452)
Q Consensus 146 l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g 214 (452)
.+...++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455678999999999999999999874 688999999864432 1233466799999988 8999999999
Q ss_pred EEEcCCceeeeeee-cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcE
Q 012975 215 YSAHDDTRFIVYEL-MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNA 292 (452)
Q Consensus 215 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~ 292 (452)
++.+.+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 899999999864 34699999999999999999999999 999999999999999 89999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLT-DKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||++....... .....||..|+|||.+.+..+. .++||||||+++|||++|+.||..... ...
T Consensus 180 kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~----- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILE----- 247 (312)
T ss_dssp EECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-----
T ss_pred EEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhh-----
Confidence 999999997654332 2345689999999998877664 589999999999999999999975321 111
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....++. .....+.+++.+||+.||++|||++|+++.
T Consensus 248 --~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --AELHFPA------------HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TCCCCCT------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hccCCcc------------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 112356789999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=328.32 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=200.8
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcCC--CCceeeeEEE
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIH--HPNVVCLLGY 215 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~ 215 (452)
+.+...++|+..+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999864 688999999864321 12245778999999996 5999999999
Q ss_pred EEcCCceeeeeeecCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEE
Q 012975 216 SAHDDTRFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAK 293 (452)
Q Consensus 216 ~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~k 293 (452)
+.+++..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999986 899998863 35689999999999999999999999 999999999999999 789999
Q ss_pred EEecCCCcccCCCCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 294 LSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 294 l~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
|+|||++....... .....||..|+|||.+.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 191 L~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~------ 257 (320)
T 3a99_A 191 LIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR------ 257 (320)
T ss_dssp ECCCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH------
T ss_pred EeeCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhc------
Confidence 99999997654322 234569999999999887765 6789999999999999999999975321 110
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hccccC
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPLV 427 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l~ 427 (452)
...... . .....+.+++.+||+.||++|||++|+++ .+++..
T Consensus 258 -~~~~~~--------~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 -GQVFFR--------Q----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -CCCCCS--------S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -cccccc--------c----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 000011 1 11235778999999999999999999997 344443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=333.76 Aligned_cols=248 Identities=27% Similarity=0.370 Sum_probs=186.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..+|...++||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+++..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345778899999999997666667788999999864332 2356899999999 799999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCcEEEEecCCCccc
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-----KFNAKLSDFGLAITD 303 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-----~~~~kl~Dfgl~~~~ 303 (452)
++ |+|.+++... ...+.+..++.++.|++.||+|||+. +|+||||||+|||++. ...+||+|||++...
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 6999888742 23345556788999999999999999 9999999999999953 335889999999654
Q ss_pred CCCC---CcccccccccCccCccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 304 GSQN---KNNLKLSGTLGYVAPEYLL---DGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
.... .......||+.|+|||.+. ...++.++|||||||++|||++ |..||............. ..
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~--------~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--------AC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT--------CC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc--------cC
Confidence 3221 2233457999999999987 4567889999999999999999 999996554322111110 00
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. ....+ .......+.+++.+||+.||++|||+.||++
T Consensus 246 ~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 00000 1133445778999999999999999999994
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=317.65 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=178.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-hh-HHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-DA-GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.++|+..+.||+|+||.||+|+.. +|+.||||.+..... .. .+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888899999999999999986 688999999965432 22 334455556788889999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||+ ++.+..+.. .....+++..++.++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 445544443 223568999999999999999999998 5 899999999999999999999999999865433
Q ss_pred CCCcccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.. ......||..|+|||.+. ...++.++||||||+++|||++|+.||........ ....... .....++.
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~--~~~~~~~~ 252 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKVLQ--EEPPLLPG 252 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHH--SCCCCCCS
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHHhc--cCCCCCCc
Confidence 22 223446899999999984 45688999999999999999999999986432211 1110000 00000110
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. .....+.+++.+||+.||.+||+++|+++
T Consensus 253 ------~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ------HM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------cC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 11235778999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=313.83 Aligned_cols=236 Identities=17% Similarity=0.092 Sum_probs=184.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+..+.+++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999986 48999999996542 334578999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. . ....++.+++.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999852 1 35667899999999999999999 99999999999999999999998544
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
|++| ++.++||||||+++|||+||+.||......+.. .......... .. .....
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~--~~--~~~~~ 228 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQ--PI--EPADI 228 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSC--BC--CHHHH
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccC--CC--Chhhc
Confidence 3333 588999999999999999999999876542210 0000000000 00 00011
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccccCC
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVELGG 433 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 433 (452)
.. +....+.+++.+||+.||++| |+.|+++.|+++.......
T Consensus 229 ~~----~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 229 DR----DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp CT----TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred cc----CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 11 123457789999999999999 9999999999988765443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=343.70 Aligned_cols=269 Identities=24% Similarity=0.313 Sum_probs=204.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc------CCc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH------DDT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 221 (452)
.++|...+.||+|+||+||+|.+. +|..||||.+... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999875 6889999998653 44556779999999999999999999999765 667
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEecC
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFG 298 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~---~kl~Dfg 298 (452)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. +++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998655555799999999999999999999999 9999999999999997765 9999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-------
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ------- 371 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~------- 371 (452)
++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .|....
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEH 243 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchh
Confidence 997654332 2234579999999999999999999999999999999999999997643211 111000
Q ss_pred ------cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHH-----HHHhccccCcc
Q 012975 372 ------LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITD-----VLHSLIPLVPV 429 (452)
Q Consensus 372 ------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-----vl~~L~~l~~~ 429 (452)
........... .............+.+++.+||+.||++|||+.| +.+.+++++..
T Consensus 244 ~~~~~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSCCCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000000000 0011223345677889999999999999999987 33455444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.70 Aligned_cols=241 Identities=27% Similarity=0.375 Sum_probs=194.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC--CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc-----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD--DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT----- 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 221 (452)
.++|...+.||+|+||+||+|.+. +|+.||||.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 5889999998643 34455678999999999999999999999988765
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.||||||+++++|.+++.. .+++.+++.++.|++.||+|||++ +|+||||||+|||++++ .+||+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887642 699999999999999999999999 99999999999999986 89999999997
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+...... .++.
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~~- 286 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLPE- 286 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCCT-
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------cccc-
Confidence 65433 3456999999999887654 88999999999999999999887642110 0000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHhccccCc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-ITDVLHSLIPLVP 428 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L~~l~~ 428 (452)
..+. ......+.+++.+||+.||++||+ ++++.+.|..++.
T Consensus 287 ~~~~------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 DDPV------LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp TCHH------HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cccc------cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0010 122356778999999999999995 6666677666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=323.17 Aligned_cols=240 Identities=19% Similarity=0.214 Sum_probs=178.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh---hhHHHHHHHHHHHHcCCC-Cce----------eee---
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ---DAGREFENEVDLLSNIHH-PNV----------VCL--- 212 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~ni----------v~l--- 212 (452)
..|...+.||+|+||+||+|++. +|+.||||.+..... ...+.|.+|+.+++.++| +|. +.+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45667789999999999999964 688999999873332 235679999999999987 221 111
Q ss_pred --------EEEEEc-----CCceeeeeeecCCCChhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 012975 213 --------LGYSAH-----DDTRFIVYELMENRSLDIQLHG----PSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275 (452)
Q Consensus 213 --------~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~ 275 (452)
..++.. ....+++|+++ +++|.+++.. ......+++..++.++.|++.||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111 12346667655 6899888731 12345688999999999999999999999 999
Q ss_pred eCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccc----------cCCCCCchhhHHHHHHHHHH
Q 012975 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL----------LDGKLTDKSDVYAFGVVLLE 345 (452)
Q Consensus 276 H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~s~Gvll~e 345 (452)
||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||.+ .+..++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998765433 334567 999999999 55668889999999999999
Q ss_pred HHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 346 LLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 346 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
|++|+.||......+....+ +.... .. ...+.+++.+||+.||++||++.|++
T Consensus 310 lltg~~Pf~~~~~~~~~~~~------~~~~~------------~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI------FRSCK------------NI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG------GSSCC------------CC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCcchhhhHHHH------Hhhcc------------cC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999875433211110 11100 11 24677899999999999999987765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=302.89 Aligned_cols=230 Identities=23% Similarity=0.296 Sum_probs=176.6
Q ss_pred cCCCcc-CeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHH-HcCCCCceeeeEEEEEc----CCcee
Q 012975 151 DSFHES-NILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLL-SNIHHPNVVCLLGYSAH----DDTRF 223 (452)
Q Consensus 151 ~~f~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 223 (452)
++|... +.||+|+||.||++... ++..||+|.+.. ...+.+|++++ +..+||||+++++++.. ++..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 78999999999999874 688999999853 23567888888 55699999999999876 66789
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCC
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLA 300 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~ 300 (452)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998752 234699999999999999999999999 9999999999999998 789999999998
Q ss_pred cccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.... +..++.++||||||+++|||++|+.||............. ... ..... .
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---~~~-~~~~~-~ 220 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRI-RMGQY-E 220 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---CSS-CTTCC-S
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---HHH-hhccc-c
Confidence 5432 2456789999999999999999999997654322100000 000 00000 0
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....... .....+.+++.+||+.||++|||+.|+++
T Consensus 221 -~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 -FPNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCchhcc----cCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000001 12346788999999999999999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.86 Aligned_cols=241 Identities=17% Similarity=0.138 Sum_probs=182.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--------hhhHHHHHHHHHHHHcCC---------CCceeeeE
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--------QDAGREFENEVDLLSNIH---------HPNVVCLL 213 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 213 (452)
++|+..+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ |+||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4677789999999999999998 67899999986442 223467889999988885 77777777
Q ss_pred EEEE------------------------------cCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 012975 214 GYSA------------------------------HDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263 (452)
Q Consensus 214 g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 263 (452)
+.+. .++..++||||+++|++.+.+.. ..+++..++.++.|++.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 7643 26788999999999987666642 4589999999999999999
Q ss_pred HHHH-hcCCCCeeeCCCCCCCEEECCCC--------------------cEEEEecCCCcccCCCCCcccccccccCccCc
Q 012975 264 EYLH-EHCNPAVIHRDLKSSNILLDSKF--------------------NAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322 (452)
Q Consensus 264 ~~LH-~~~~~~i~H~Dlk~~NIll~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aP 322 (452)
+||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||+.|+||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCS
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccCh
Confidence 9999 88 999999999999999887 899999999976532 234799999999
Q ss_pred ccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHH
Q 012975 323 EYLLDGKLTDKSDVYAFGVV-LLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAV 401 (452)
Q Consensus 323 E~~~~~~~~~~sDv~s~Gvl-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 401 (452)
|.+.+.. +.++||||+|++ .+++++|..||...... ................. .+ ........++.++
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~----~~----~~~~~~s~~~~dl 315 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKC----NT----PAMKQIKRKIQEF 315 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCC----CS----HHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCccc----ch----hhhhhcCHHHHHH
Confidence 9998766 899999998777 77788999998532100 00111110000000000 00 0112456788999
Q ss_pred HHHhcCCCCCCCCChHHHH
Q 012975 402 AVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 402 i~~Cl~~dP~~RPs~~evl 420 (452)
+.+||+.| |++|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=278.20 Aligned_cols=183 Identities=18% Similarity=0.155 Sum_probs=129.3
Q ss_pred EeecCcEEEEEEE-eCCCcEEEEEEecCcC----------hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeeee
Q 012975 159 LGEGGFGCVYKAK-LDDNLHVAVKKLDCAT----------QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 159 ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 226 (452)
.+.|++|.+..++ .--|..+++|.+.... +...++|.+|+++|+++ +|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666555543 2246789999985331 22346799999999999 7999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||++|++|.+.|.. ++.++.. +|+.||+.||+|||++ +|+||||||+|||++++|.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999964 3456654 5889999999999999 9999999999999999999999999999876555
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR 351 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~ 351 (452)
.......+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 555566789999999998875 46778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=253.64 Aligned_cols=183 Identities=16% Similarity=0.176 Sum_probs=146.3
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh--------hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..+.||+|+||+||+|+. .+..+++|+...... ...+++.+|++++++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 466889988643221 12355899999999999999997777777788889999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++++|.+++.. ++.++.|++.||+|||++ +|+||||||+|||+++ .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999863 568999999999999999 9999999999999999 9999999999776443
Q ss_pred CCc-------ccccccccCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 012975 307 NKN-------NLKLSGTLGYVAPEYLLD--GKLTDKSDVYAFGVVLLELLLGRRPVE 354 (452)
Q Consensus 307 ~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~s~Gvll~elltG~~P~~ 354 (452)
... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 135679999999999977 567888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-25 Score=208.18 Aligned_cols=153 Identities=16% Similarity=0.140 Sum_probs=122.4
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh------------------hhHHHHHHHHHHHHcCC
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ------------------DAGREFENEVDLLSNIH 205 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 205 (452)
..+......|...+.||+|+||.||+|++.+|+.||+|.+..... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334444556777799999999999999997799999999854321 13467899999999999
Q ss_pred CCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 206 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 5 666665543 56699999999999987 421 12457999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccC
Q 012975 286 LDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 327 (452)
++ ++.+||+|||+++. +..|+|||.+..
T Consensus 226 l~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE-------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE-------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE-------------CCCCCHHHHHHH
Confidence 99 99999999999853 345788997743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-20 Score=174.73 Aligned_cols=136 Identities=21% Similarity=0.149 Sum_probs=105.2
Q ss_pred CCccCeEeecCcEEEEEEEe-CCCcE--EEEEEecCcChh------------------------hHHHHHHHHHHHHcCC
Q 012975 153 FHESNILGEGGFGCVYKAKL-DDNLH--VAVKKLDCATQD------------------------AGREFENEVDLLSNIH 205 (452)
Q Consensus 153 f~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 205 (452)
|...+.||+|+||.||+|.. .+|.. ||||.+...... ....+.+|+..|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999998 67888 999986432111 1236889999999998
Q ss_pred CCce--eeeEEEEEcCCceeeeeeecCC-C----ChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeC
Q 012975 206 HPNV--VCLLGYSAHDDTRFIVYELMEN-R----SLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH-EHCNPAVIHR 277 (452)
Q Consensus 206 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~i~H~ 277 (452)
|+|+ ..++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8754 334432 356899999952 4 55554321 234467889999999999999 87 99999
Q ss_pred CCCCCCEEECCCCcEEEEecCCCccc
Q 012975 278 DLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 278 Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=161.50 Aligned_cols=137 Identities=13% Similarity=0.107 Sum_probs=100.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcCh--------------hhH--------HHHHHHHHHHHcCCCCc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQ--------------DAG--------REFENEVDLLSNIHHPN 208 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~H~n 208 (452)
.-|.+.+.||+|+||.||+|...+|+.||||.+..... ... ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999999999999998642100 001 11245666677765444
Q ss_pred ee--eeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 012975 209 VV--CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILL 286 (452)
Q Consensus 209 iv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll 286 (452)
+. ..+++ ...+|||||+++++|...... .....++.|++.+|.|||+. +|+||||||.|||+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 32 22222 223799999999988765421 12456789999999999998 99999999999999
Q ss_pred CCCC----------cEEEEecCCCccc
Q 012975 287 DSKF----------NAKLSDFGLAITD 303 (452)
Q Consensus 287 ~~~~----------~~kl~Dfgl~~~~ 303 (452)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8877 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=123.02 Aligned_cols=145 Identities=18% Similarity=0.140 Sum_probs=112.4
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeee
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 225 (452)
....+.|.....++.|+.+.||++... +..+++|............+.+|+.+++.+. +.++.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567877777888888999999865 5789999986422122346889999999884 67788899999988899999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH------------------------------------ 269 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------ 269 (452)
|||+++.+|.+.+.. ......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999765421 112347788999999999981
Q ss_pred --------------------CCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 270 --------------------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 270 --------------------~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..+.++|+|+++.||+++++..+.|+||+.+
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 0135899999999999987666779999976
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=7e-12 Score=116.85 Aligned_cols=128 Identities=16% Similarity=0.106 Sum_probs=97.1
Q ss_pred eecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeEEEEEcCCceeeeeeecCCCChhhh
Q 012975 160 GEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLLGYSAHDDTRFIVYELMENRSLDIQ 237 (452)
Q Consensus 160 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 237 (452)
+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 345569999998877888999997543 2245788999999886545 455888888888889999999999884
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 012975 238 LHGPSHGSALTWHMRMKIALDTARGLEYLHEHC----------------------------------------------- 270 (452)
Q Consensus 238 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------------- 270 (452)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2356778888888888742
Q ss_pred --------CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 271 --------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 271 --------~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+.++|+|++|.||++++++.+.|.||+.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667899999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2e-10 Score=112.62 Aligned_cols=142 Identities=13% Similarity=0.157 Sum_probs=107.5
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEec--CcC-hhhHHHHHHHHHHHHcCC--CCceeeeEEEEEcC---Cceeeee
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLD--CAT-QDAGREFENEVDLLSNIH--HPNVVCLLGYSAHD---DTRFIVY 226 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 226 (452)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +.++.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998765 478888765 222 123456888999999986 45678889998876 3579999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC------------------------------------ 270 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 270 (452)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998885422 124788889999999999999999731
Q ss_pred -------------------CCCeeeCCCCCCCEEECCCCc--EEEEecCCCcc
Q 012975 271 -------------------NPAVIHRDLKSSNILLDSKFN--AKLSDFGLAIT 302 (452)
Q Consensus 271 -------------------~~~i~H~Dlk~~NIll~~~~~--~kl~Dfgl~~~ 302 (452)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.8e-10 Score=108.08 Aligned_cols=186 Identities=22% Similarity=0.228 Sum_probs=123.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCc--eeeeEEEEEcCC---ceeeeeeec
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPN--VVCLLGYSAHDD---TRFIVYELM 229 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 229 (452)
.+.++.|.+..||+.. ..+++|.... ......+.+|+.+|+.+. +.. +.++++.....+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999864 4688888642 244567899999998873 333 334455443333 348899999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH---------------------------------------- 269 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 269 (452)
++.++..... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864322 2367778888889999999998861
Q ss_pred ---------------CCCCeeeCCCCCCCEEECC--CCcEEEEecCCCcccCCCCCcccc--------------cccccC
Q 012975 270 ---------------CNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQNKNNLK--------------LSGTLG 318 (452)
Q Consensus 270 ---------------~~~~i~H~Dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~~--------------~~gt~~ 318 (452)
..+.++|+|+++.||++++ +..+.|.||+.+............ .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1145899999999999998 556889999988543211000000 000011
Q ss_pred ccC-cccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 012975 319 YVA-PEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354 (452)
Q Consensus 319 y~a-PE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~ 354 (452)
... |+.... .....+.|++|.++|++.+|..+|.
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 221111 1223689999999999999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=8.6e-07 Score=84.71 Aligned_cols=136 Identities=22% Similarity=0.252 Sum_probs=96.3
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC---ceeeeEEEEE-cCCceeeeeeecCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP---NVVCLLGYSA-HDDTRFIVYELMEN 231 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 231 (452)
.+.++.|....||+. |..+++|.-. .......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888999988 4578888853 334456789999999999643 3556677764 44567899999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH------------------------------------------ 269 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 269 (452)
.++..... ..++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1244555556666666666666642
Q ss_pred ---------------CCCCeeeCCCCCCCEEECC---CCc-EEEEecCCCcc
Q 012975 270 ---------------CNPAVIHRDLKSSNILLDS---KFN-AKLSDFGLAIT 302 (452)
Q Consensus 270 ---------------~~~~i~H~Dlk~~NIll~~---~~~-~kl~Dfgl~~~ 302 (452)
..+.++|+|+++.||+++. ++. ..|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235699999999999987 455 58999998744
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=4.8e-07 Score=84.54 Aligned_cols=134 Identities=15% Similarity=0.100 Sum_probs=95.8
Q ss_pred eEeecCcE-EEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 158 ILGEGGFG-CVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 158 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
.+..|..| .||+.... ++..+++|.-.. .....+.+|...|+.+. +--+-++++++.+++..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68998765 456788888642 34556888999998884 33466788999999999999999999887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC-------------------------------------------- 270 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------- 270 (452)
.+.... .......+..+++..|.-||+.-
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654321 11223345666666666666420
Q ss_pred -----------CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 271 -----------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 271 -----------~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988777899999873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=6.7e-07 Score=87.22 Aligned_cols=80 Identities=8% Similarity=-0.014 Sum_probs=55.0
Q ss_pred CeE-eecCcEEEEEEEeC-------CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCC-C--CceeeeEEEEEcC---
Q 012975 157 NIL-GEGGFGCVYKAKLD-------DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIH-H--PNVVCLLGYSAHD--- 219 (452)
Q Consensus 157 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 219 (452)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999998765 26678888764322 001245678888888874 2 3466788887665
Q ss_pred CceeeeeeecCCCChhh
Q 012975 220 DTRFIVYELMENRSLDI 236 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~ 236 (452)
+..++||||+++.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.3e-05 Score=77.25 Aligned_cols=140 Identities=20% Similarity=0.327 Sum_probs=80.2
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-----CCceeeeE-E--EEEcCCceeeeeee
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----HPNVVCLL-G--YSAHDDTRFIVYEL 228 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~E~ 228 (452)
+.|+.|..+.||+....+| .+++|.... .. ..+..|..+++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455567889999988766 488998864 22 23334555555442 34444310 1 12345677899999
Q ss_pred cCCCChh--------------hhccCC--CC----C-----CCCCHHHHH------------------------------
Q 012975 229 MENRSLD--------------IQLHGP--SH----G-----SALTWHMRM------------------------------ 253 (452)
Q Consensus 229 ~~~gsL~--------------~~l~~~--~~----~-----~~l~~~~~~------------------------------ 253 (452)
+++.++. ..+|.. .. . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 112210 00 0 112343211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 254 -KIALDTARGLEYLHE----------HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 254 -~i~~~ia~~L~~LH~----------~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+...+..++++|+. ...+.++|+|+++.||+++.++.+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666763 124589999999999999888899999999773
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.2e-05 Score=79.53 Aligned_cols=75 Identities=13% Similarity=0.127 Sum_probs=49.0
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh-------hhHHHHHHHHHHHHcCCC--Ccee-eeEEEEEcCCceee
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ-------DAGREFENEVDLLSNIHH--PNVV-CLLGYSAHDDTRFI 224 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l 224 (452)
.+.||.|.++.||+++.. ++..++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 467899997643211 122456778888887732 4444 45544 3455689
Q ss_pred eeeecCCC
Q 012975 225 VYELMENR 232 (452)
Q Consensus 225 V~E~~~~g 232 (452)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.00 E-value=1.3e-05 Score=75.65 Aligned_cols=79 Identities=19% Similarity=0.185 Sum_probs=57.7
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC---CceeeeEEEEEcCCceeeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH---PNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.....+.+|.|..+.||+.++.+|+.+++|+-..........|..|+..|+.+.- --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4455678999999999999999999999998754443334568899999888742 1244455542 34789999
Q ss_pred cCCCCh
Q 012975 229 MENRSL 234 (452)
Q Consensus 229 ~~~gsL 234 (452)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.6e-05 Score=72.75 Aligned_cols=138 Identities=18% Similarity=0.217 Sum_probs=92.8
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC---CCceeeeEEEEEcCCceeeeeeecCCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH---HPNVVCLLGYSAHDDTRFIVYELMENR 232 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 232 (452)
.+.|+.|....+|+.... +..+++|.... .....+..|+..|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 467899999999999864 56788888653 23567889999988883 356788899888888899999999988
Q ss_pred Chh-----------hhccCCCC----C---------------CCCCHHHHH---HHHH--H--------------HHHH-
Q 012975 233 SLD-----------IQLHGPSH----G---------------SALTWHMRM---KIAL--D--------------TARG- 262 (452)
Q Consensus 233 sL~-----------~~l~~~~~----~---------------~~l~~~~~~---~i~~--~--------------ia~~- 262 (452)
.+. ..||.... + -.-+|.... ++.. + +...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 12332111 0 012565432 1111 1 1111
Q ss_pred HHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 263 LEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 263 L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2356899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=71.16 Aligned_cols=78 Identities=14% Similarity=0.080 Sum_probs=47.3
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCccccc-ccccCccCcccccCC---CCCchhhHHHHHHHHHHH
Q 012975 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL-SGTLGYVAPEYLLDG---KLTDKSDVYAFGVVLLEL 346 (452)
Q Consensus 271 ~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDv~s~Gvll~el 346 (452)
.+.++|+|+++.|||+++++ +++.||+.+............. .-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999998876 9999999885432111000000 011245666544321 112245666788888877
Q ss_pred HcC
Q 012975 347 LLG 349 (452)
Q Consensus 347 ltG 349 (452)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0004 Score=66.25 Aligned_cols=158 Identities=15% Similarity=0.145 Sum_probs=87.9
Q ss_pred ccHHHHHHhhcCCCc-----cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc--eeeeE
Q 012975 141 IEYKLLEKATDSFHE-----SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN--VVCLL 213 (452)
Q Consensus 141 ~~~~~l~~~~~~f~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 213 (452)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... .....+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345555555555654 23456688889999988766 6888887642 11234556777776663212 22222
Q ss_pred EE------EEcCCceeeeeeecCCCChhh--------------hccCC--C--CC-----CCCCHHHHHHH---------
Q 012975 214 GY------SAHDDTRFIVYELMENRSLDI--------------QLHGP--S--HG-----SALTWHMRMKI--------- 255 (452)
Q Consensus 214 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~--~--~~-----~~l~~~~~~~i--------- 255 (452)
.. ....+..+++++|+++..+.. .+|.. . .. ....|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 122355689999999876421 12210 0 00 00124331110
Q ss_pred ---HHHHHHHHHHHHhc----CCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 256 ---ALDTARGLEYLHEH----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 256 ---~~~ia~~L~~LH~~----~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
...+...+++++.. ....++|+|+++.||+++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11244556666542 23479999999999999987666899999773
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00057 Score=64.62 Aligned_cols=138 Identities=16% Similarity=0.075 Sum_probs=74.7
Q ss_pred cCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeeeeec-CCCC
Q 012975 156 SNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELM-ENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 233 (452)
.+.|+.|....+|+. ..+++|........ .....+|+.+++.+...++ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 677888999999999 46888877532211 1123467777776642233 345544 344457899999 6655
Q ss_pred hhh------------------hccCCCC--CCCCCHHH-HHHHHH--------------HHHHHHHHHH----h-cCCCC
Q 012975 234 LDI------------------QLHGPSH--GSALTWHM-RMKIAL--------------DTARGLEYLH----E-HCNPA 273 (452)
Q Consensus 234 L~~------------------~l~~~~~--~~~l~~~~-~~~i~~--------------~ia~~L~~LH----~-~~~~~ 273 (452)
+.. .+|.... ....+... ...+.. .+...+..+. . ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 531 1222110 00111111 111100 0111111111 1 12345
Q ss_pred eeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 274 VIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 274 i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++|+|+.+.||+ .+++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00038 Score=69.52 Aligned_cols=73 Identities=12% Similarity=0.118 Sum_probs=49.1
Q ss_pred cCeEeecCcEEEEEEEeCC--------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeee
Q 012975 156 SNILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 226 (452)
.+.|+.|....+|+....+ +..+++|...... ....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998763 4678888874311 11345578888888753333 456665542 3899
Q ss_pred eecCCCCh
Q 012975 227 ELMENRSL 234 (452)
Q Consensus 227 E~~~~gsL 234 (452)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0013 Score=63.08 Aligned_cols=141 Identities=11% Similarity=0.069 Sum_probs=71.5
Q ss_pred CeEeecCcEE-EEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCCceeeeeeecCCCC
Q 012975 157 NILGEGGFGC-VYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 157 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.++.+.+ +++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565554 6677765466777776543211 233456666666532 23455666644333 78999997765
Q ss_pred hhhhc---------------------cCCCCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 012975 234 LDIQL---------------------HGPSHG--SALTWHMRM-------K-------------IALDTARGLEYLHE-- 268 (452)
Q Consensus 234 L~~~l---------------------~~~~~~--~~l~~~~~~-------~-------------i~~~ia~~L~~LH~-- 268 (452)
+.+.+ |..... ...+..... . ....+...++.+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54322 211100 111111100 0 00011122233321
Q ss_pred -cCCCCeeeCCCCCCCEEECCC----CcEEEEecCCCcc
Q 012975 269 -HCNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAIT 302 (452)
Q Consensus 269 -~~~~~i~H~Dlk~~NIll~~~----~~~kl~Dfgl~~~ 302 (452)
...+.++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999875 6799999998854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0035 Score=59.71 Aligned_cols=142 Identities=17% Similarity=0.188 Sum_probs=81.8
Q ss_pred CeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCC--ceeeeEEE-----EEcCCceeeeeeec
Q 012975 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHP--NVVCLLGY-----SAHDDTRFIVYELM 229 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~E~~ 229 (452)
..++ |....||+....+|..+++|...... .....+..|..+++.+... .+.+++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999888777789999985321 1234566788877776422 23334432 12234567899999
Q ss_pred CCCChhh--------------hccCC------CCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 012975 230 ENRSLDI--------------QLHGP------SHGSALTWHMR----MKI---------------ALDTARGLEYLHEH- 269 (452)
Q Consensus 230 ~~gsL~~--------------~l~~~------~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~- 269 (452)
++..+.. .+|.. ......++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 01210 00112232211 001 01111223333322
Q ss_pred ---CCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 270 ---CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 270 ---~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
....++|+|+++.||+++ + .+.+.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999997743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0014 Score=64.27 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=82.3
Q ss_pred CeEeecCcEEEEEEEeCC--------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCc-eeeeEEEEEcCCceeeeee
Q 012975 157 NILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN-VVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 227 (452)
+.|..|-...+|+....+ +..+++|+.... ........+|..+++.+.-.+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456667788899988752 467888875321 123455668999888874222 3456666543 28999
Q ss_pred ecCCCChhhh-----------------ccCC--CCCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 012975 228 LMENRSLDIQ-----------------LHGP--SHGSALT--WHMRMKIALDTA-------------------RGLEYLH 267 (452)
Q Consensus 228 ~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia-------------------~~L~~LH 267 (452)
|+++.+|... ||.. ..+.... |.+..++..++. ..++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766411 2321 1122222 445555544332 1233333
Q ss_pred h----c-CCCCeeeCCCCCCCEEECCC----CcEEEEecCCCc
Q 012975 268 E----H-CNPAVIHRDLKSSNILLDSK----FNAKLSDFGLAI 301 (452)
Q Consensus 268 ~----~-~~~~i~H~Dlk~~NIll~~~----~~~kl~Dfgl~~ 301 (452)
. . ....++|+|+.+.||+++.+ +.+.+.||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 1 22368999999999999876 789999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0027 Score=63.78 Aligned_cols=74 Identities=15% Similarity=0.114 Sum_probs=47.5
Q ss_pred cCeEeecCcEEEEEEEeCC-CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeeeeecCCCC
Q 012975 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVYELMENRS 233 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 233 (452)
.+.|+.|-...+|+....+ +..+++|......... -+-.+|..+++.+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998876 4678888764322111 112578888888865555 45676662 2 35999999866
Q ss_pred h
Q 012975 234 L 234 (452)
Q Consensus 234 L 234 (452)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0017 Score=63.21 Aligned_cols=73 Identities=11% Similarity=0.069 Sum_probs=42.8
Q ss_pred CeEeecCcEEEEEEEeCCC---------cEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeee
Q 012975 157 NILGEGGFGCVYKAKLDDN---------LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 226 (452)
..|+.|....+|+....++ ..+++|....... .......|..+++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567788889999987642 5777777643221 11123577888877743333 3555543 2 36899
Q ss_pred eecCCCCh
Q 012975 227 ELMENRSL 234 (452)
Q Consensus 227 E~~~~gsL 234 (452)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.014 Score=51.84 Aligned_cols=100 Identities=14% Similarity=0.104 Sum_probs=65.3
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCcc
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNN 310 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 310 (452)
.-+|.+.|. ..+.++++.++|.++.|.+.+|.-+-.+..+ ..+=+.+..|++..+|++...+ +.+.
T Consensus 32 ~vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 346777776 4578999999999999999988776221111 1223456899999999988864 1110
Q ss_pred cccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 012975 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL 348 (452)
Q Consensus 311 ~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt 348 (452)
.....+.+||... ...+.+.-|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888653 345789999999999999985
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0096 Score=57.24 Aligned_cols=31 Identities=16% Similarity=0.326 Sum_probs=27.5
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 272 PAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 272 ~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.033 Score=55.19 Aligned_cols=140 Identities=13% Similarity=0.165 Sum_probs=82.3
Q ss_pred cCeEeecCcEEEEEEEeCC--------CcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce-eeeEEEEEcCCceeeee
Q 012975 156 SNILGEGGFGCVYKAKLDD--------NLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV-VCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 226 (452)
.+.+..|-...+|+....+ +..++++....... ..-+-.+|..+++.+.-.++ .++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567677888999998763 56788887643221 11123567777777742233 3455433 2 37899
Q ss_pred eecCCCChhh-----------------hccCC--------C--CCCCCCHHHHHHHHHHH-------------------H
Q 012975 227 ELMENRSLDI-----------------QLHGP--------S--HGSALTWHMRMKIALDT-------------------A 260 (452)
Q Consensus 227 E~~~~gsL~~-----------------~l~~~--------~--~~~~l~~~~~~~i~~~i-------------------a 260 (452)
||+++.+|.. .+|.. . ...+.-|.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876531 01210 0 11112244444443222 2
Q ss_pred HHHHHHHhc---------------------CCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 261 RGLEYLHEH---------------------CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 261 ~~L~~LH~~---------------------~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
..+.+|.+. ....++|+|+.+.||+ ++++.+.+.||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 233443321 1236899999999999 888899999999874
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.029 Score=35.94 Aligned_cols=23 Identities=26% Similarity=0.189 Sum_probs=10.6
Q ss_pred eehhHHHHHHHHHHHHHHHHHHH
Q 012975 72 IALIIACSALCLIILALLCLWLY 94 (452)
Q Consensus 72 i~~~i~~~~~~~i~~~~~~~~~~ 94 (452)
|+..++++++++++++++++++.
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~ 35 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFM 35 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeehhHHHHHHHHHHHHHHHHh
Confidence 55555554444444443333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.68 E-value=0.036 Score=35.44 Aligned_cols=18 Identities=28% Similarity=0.320 Sum_probs=7.7
Q ss_pred eehhHHHHHHHHHHHHHH
Q 012975 72 IALIIACSALCLIILALL 89 (452)
Q Consensus 72 i~~~i~~~~~~~i~~~~~ 89 (452)
|+..++++++++++++++
T Consensus 12 IA~gVVgGv~~v~ii~~~ 29 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLT 29 (44)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHHHH
Confidence 444444444444443433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.97 E-value=0.19 Score=44.51 Aligned_cols=117 Identities=12% Similarity=0.142 Sum_probs=81.1
Q ss_pred CCCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 012975 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNI 284 (452)
Q Consensus 205 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NI 284 (452)
.||++++. ....+++...+.|+.-+++.=+..+ ..++...+++++.+++...+++++. +|--|+|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 68888876 4566666666666654432222223 3488899999999999887666544 7888999999
Q ss_pred EECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 285 LLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 285 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
+++.++.+++.=.|+-.. ++|. ..+...=.-.+=+++..+++++..|+.
T Consensus 111 ~f~~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999987664311 1222 223333445788899999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.33 E-value=0.25 Score=48.38 Aligned_cols=29 Identities=34% Similarity=0.442 Sum_probs=24.7
Q ss_pred CeeeCCCCCCCEEE------CCCCcEEEEecCCCc
Q 012975 273 AVIHRDLKSSNILL------DSKFNAKLSDFGLAI 301 (452)
Q Consensus 273 ~i~H~Dlk~~NIll------~~~~~~kl~Dfgl~~ 301 (452)
.++|+|+.+.|||+ +++..+.++||.++.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 456779999999884
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.04 E-value=0.093 Score=33.45 Aligned_cols=7 Identities=14% Similarity=0.074 Sum_probs=2.7
Q ss_pred eehhHHH
Q 012975 72 IALIIAC 78 (452)
Q Consensus 72 i~~~i~~ 78 (452)
|+.++++
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 3333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.21 E-value=0.61 Score=41.36 Aligned_cols=116 Identities=11% Similarity=0.129 Sum_probs=78.1
Q ss_pred CCCceeeeEEEEEcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeCCCCCCC
Q 012975 205 HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLE-YLHEHCNPAVIHRDLKSSN 283 (452)
Q Consensus 205 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~i~H~Dlk~~N 283 (452)
.||++ -...-.+++...+.|+.-+++.=...+. .++...+++++.+++.... ++++ -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 3444466677767676554433333332 4788999999999887666 5543 4788899999
Q ss_pred EEECCCCcEEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012975 284 ILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355 (452)
Q Consensus 284 Ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~ 355 (452)
+++|.++.+++.-.|+- .-++|.. .+..-=.-.+=+++..++.++..|+.
T Consensus 115 L~f~~~~~p~i~hRGi~-----------------~~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK-----------------ESLPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EEECTTCCEEESCCEET-----------------TTBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEEeCCCcEEEEEcCCc-----------------ccCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999876643 2223331 12222233678888899999888754
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.81 E-value=0.27 Score=30.42 Aligned_cols=24 Identities=17% Similarity=0.097 Sum_probs=10.6
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHh
Q 012975 72 IALIIACSALCLIILALLCLWLYH 95 (452)
Q Consensus 72 i~~~i~~~~~~~i~~~~~~~~~~~ 95 (452)
|+-+++++++.+++++++++|++|
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred eeeeehHHHHHHHHHHHHHHHHee
Confidence 333444444444444444455444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.90 E-value=0.11 Score=52.17 Aligned_cols=60 Identities=10% Similarity=0.140 Sum_probs=17.7
Q ss_pred cCeEeecCcEEEEEEEeCC-CcEEEE------EEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc
Q 012975 156 SNILGEGGFGCVYKAKLDD-NLHVAV------KKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 218 (452)
.+.|| ||.||+|.+.. ..+||| |+.... +.+....|.+|..+++.++|+|+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45566 99999999864 467888 766432 23334568899999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 452 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 2e-69
Identities = 81/278 (29%), Positives = 125/278 (44%), Gaps = 23/278 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+G G FG VYK K ++ V + + T + F+NEV +L H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
+GYS IV + E SL LH + + IA TA+G++YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGYVAPEYLL-- 326
+IHRDLKS+NI L K+ DFGLA + S + +LSG++ ++APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 327 -DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385
+ +SDVYAFG+VL EL+ G+ P + + D SK+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+K + C++ + RPL +L S+
Sbjct: 242 MKR------------LMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-63
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 35/288 (12%)
Query: 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENE 197
+ KL+E+ LG G FG V+ + + VAVK L + F E
Sbjct: 10 VPRETLKLVER----------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAE 58
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
+L+ + H +V L + +I+ E MEN SL L P G LT + + +A
Sbjct: 59 ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAA 116
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGT 316
A G+ ++ E IHRDL+++NIL+ + K++DFGLA + + ++
Sbjct: 117 QIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 317 LGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDR 375
+ + APE + G T KSDV++FG++L E++ GR P + + + R
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----R 228
Query: 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P+ ++ + LC + P RP + L
Sbjct: 229 MVRPDNCPE------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-62
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
+E D F + + LG G G V+K L +A K + + A R E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
+ P +V G D I E M+ SLD L + + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
YL E ++HRD+K SNIL++S+ KL DFG++ N+ GT Y++PE
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPE 173
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
L + +SD+++ G+ L+E+ +GR P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-60
Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 25/276 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
LG G FG V K VA+K + + EF E ++ N+ H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G FI+ E M N L L H +++ D +EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
+HRDL + N L++ + K+SDFGL+ + +++ + + PE L+ K
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
+ KSD++AFGV++ E+ LG+ P E+ ++ + + R P++
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RLYRPHLASE---- 228
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
+V + C + RP +L +++
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPN 208
D + LG+G FG VYKA+ + ++ A K +D +++ ++ E+D+L++ HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V LL +++ +I+ E ++D + LT + T L YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-- 326
+ +IHRDLK+ NIL + KL+DFG++ + + GT ++APE ++
Sbjct: 129 NK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 327 ---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-CQSIVTWAMPQLTDRSKLPNIV 382
D K+DV++ G+ L+E+ P +L P + I P L S+ +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
+K C++ R + +L
Sbjct: 246 KDFLKK----------------CLEKNVDARWTTSQLLQ 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-59
Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 23/274 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+G G FG V+ + VA+K + +F E +++ + HP +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L G +V+E ME+ L + + + + LD G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
VIHRDL + N L+ K+SDFG+ Q ++ + + +PE +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 330 LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389
+ KSDV++FGV++ E+ + P + +S + D S + P + ST
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI-----PYENRS----NSEVVEDISTGFRLYKPRLAST 229
Query: 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
V + C + P RP + +L L
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-59
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 29/288 (10%)
Query: 159 LGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAH 218
+G+G FG V++ K VAVK + ++ E E+ + H N++ +
Sbjct: 11 IGKGRFGEVWRGKWRGEE-VAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 219 DD----TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC---- 270
D+ ++V + E+ SL L+ + +T +K+AL TA GL +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 271 -NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS----GTLGYVAPEYL 325
PA+ HRDLKS NIL+ ++D GLA+ S GT Y+APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 326 LD------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ----SIVTWAMPQLTDR 375
D + ++D+YA G+V E+ Q ++ ++
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 376 SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ + + L +A + C + R + +L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 2e-58
Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 42/305 (13%)
Query: 143 YKLLEKATDSFHES---------NILGEGGFGCVYKAKL----DDNLHVAVKKLD-CATQ 188
++ +A F + ++G G FG V L + VA+K L T+
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 189 DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
R+F +E ++ HPNV+ L G I+ E MEN SLD L + T
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFT 126
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308
+ + A G++YL + +HRDL + NIL++S K+SDFGL+
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 309 NNLKLS-----GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQ 362
+ S + + APE + K T SDV+++G+V+ E++ G RP +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241
Query: 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422
+ N ++ + + + + + C Q + ++RP ++++
Sbjct: 242 ---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 423 LIPLV 427
L ++
Sbjct: 287 LDKMI 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 3e-58
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA---TQDAGREFENEVDLLSNIH 205
F + +G G FG VY A+ + ++ VA+KK+ + + + ++ EV L +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HPN + G + T ++V E + D+ H L + +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH H +IHRD+K+ NILL KL DFG A N GT ++APE +
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPEVI 183
Query: 326 L---DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382
L +G+ K DV++ G+ +EL + P+ + + + Q +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPALQSGHW 239
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
++ +D C+Q P RP +L
Sbjct: 240 SEYFRNFVD------------SCLQKIPQDRPTSEVLL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 77/291 (26%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 135 GSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREF 194
G A++ E KLL+ +G+G FG V N VAVK + + F
Sbjct: 1 GWALNMKELKLLQT----------IGKGEFGDVMLGDYRGNK-VAVKCIK--NDATAQAF 47
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
E +++ + H N+V LLG + +IV E M SL L S L +
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLL 106
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
K +LD +EYL + +HRDL + N+L+ AK+SDFGL S
Sbjct: 107 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---G 160
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQL 372
+ + APE L + K + KSDV++FG++L E+ GR P ++ V
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--- 217
Query: 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ P+ P + M C + + RP + L
Sbjct: 218 --KMDAPDGCPPAVYEVMK------------NCWHLDAAMRPSFLQLREQL 254
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-58
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 30/274 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
+ F LG+G FG VY A+ +A+K L + EV++ S++ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
PN++ L GY +++ E ++ +L S + A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H VIHRD+K N+LL S K++DFG ++ S + L GTL Y+ PE +
Sbjct: 123 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC--GTLDYLPPEMIE 177
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
+K D+++ GV+ E L+G+ P E + ++ P+ V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------TFPDFVTEGA 231
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+ + ++ PS RP++ +VL
Sbjct: 232 RDLIS------------RLLKHNPSQRPMLREVL 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 7e-58
Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 23/284 (8%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDL 200
Y E + LG G +G VY+ +L VAVK L T + EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ I HPN+V LLG + +I+ E M +L L + ++ + + +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGY 319
+EYL + IHRDL + N L+ K++DFGL+ + G + + +
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
APE L K + KSDV+AFGV+L E+ D S++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQVY 226
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+++ + +V + C Q PS RP ++ +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-58
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 46/299 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y EK +G+G G VY A + VA+++++ Q NE+ ++
Sbjct: 22 YTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+PN+V L D ++V E + SL + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQ 127
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVA 321
LE+LH + VIHRD+KS NILL + KL+DFG + + GT ++A
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 322 PEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP-AQCQSIVTWAMPQLTDRSKLPN 380
PE + K D+++ G++ +E++ G P P I T P+L + KL
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH-----------SLIPLVP 428
I + C+ + R ++L SL PL+
Sbjct: 245 IFRDFLNR----------------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-57
Identities = 64/273 (23%), Positives = 109/273 (39%), Gaps = 30/273 (10%)
Query: 157 NILGEGGFGCVYKAKL-DDNLHVAVKKLDC--ATQDAGREFENEVDLLSNIHHPNVVCLL 213
+G G F VYK + + VA +L T+ + F+ E ++L + HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 214 GY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
+V ELM + +L L + + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 270 CNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDG 328
P +IHRDLK NI + + K+ D GLA + + GT ++APE +
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEMY-EE 187
Query: 329 KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
K + DVYAFG+ +LE+ P + Q + + + + + P +K
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
++ C++ R I D+L+
Sbjct: 245 IIE------------GCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-57
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 26/283 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHP 207
+ + +G G +G K + D + K+LD + + +EV+LL + HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 208 NVVCLLGY--SAHDDTRFIVYELMENRSLDIQLH-GPSHGSALTWHMRMKIALDTARGLE 264
N+V + T +IV E E L + G L +++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHEH--CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
H V+HRDLK +N+ LD K N KL DFGLA GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382
E + +KSD+++ G +L EL P + + + ++P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIREGKFRRIPYRY 238
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL-HSLI 424
+ + + + +RP + ++L + LI
Sbjct: 239 SDELNEIIT------------RMLNLKDYHRPSVEEILENPLI 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-57
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV 210
+S LG+G FG V+ + VA+K L T F E ++ + H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
L + + +IV E M SL L G + + +A A G+ Y+
Sbjct: 76 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN 133
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEYLLDGK 329
+HRDL+++NIL+ K++DFGLA + + ++ + + APE L G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 330 LTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388
T KSDV++FG++L EL GR P + + V R P
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----RMPCPPECPE---- 241
Query: 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ + C + EP RP + L
Sbjct: 242 --------SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-57
Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 30/290 (10%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLD-CATQDAGREFENEVDL 200
E ++G G FG VYK L + + VA+K L T+ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ H N++ L G + I+ E MEN + + + + + A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTL 317
G++YL +HRDL + NIL++S K+SDFGL+ D +
Sbjct: 121 AGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
+ APE + K T SDV++FG+V+ E++ +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----------------PYWELSNHE 221
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427
+ ++ + + + + + C Q E + RP D++ L L+
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-55
Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 39/293 (13%)
Query: 140 FIEYKLLEKATDSFHESNILGEGGFGCVYKAKLDD---NLHVAVKKLDCATQDAG--REF 194
+++ KLL E LG G FG V K VAVK L D E
Sbjct: 2 YLDRKLL------TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
E +++ + +P +V ++G ++ +V E+ E L+ L H + ++
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIE 111
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNL 311
+ + G++YL E +HRDL + N+LL ++ AK+SDFGL+ D + K
Sbjct: 112 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 312 KLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMP 370
+ + APE + K + KSDV++FGV++ E G++P + ++ +++
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-- 226
Query: 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+R P ++ + LC + RP V L
Sbjct: 227 ---ERMGCPAGCPR------------EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-55
Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 33/281 (11%)
Query: 154 HESNILGEGGFGCVYKAKLDDN----LHVAVKKLD-CATQDAGREFENEVDLLSNIHHPN 208
H + ++G G FGCVY L DN +H AVK L+ +F E ++ + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 209 VVCLLGYSAHDDTR-FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
V+ LLG + +V M++ L + T + L A+G+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQNKNNLKLSGTLGYVAPE 323
+ +HRDL + N +LD KF K++DFGLA + N + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 324 YLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD-RSKLPNIV 382
L K T KSDV++FGV+L EL+ P P + + L R P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ V + C P+ RP ++++ +
Sbjct: 260 PD------------PLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-55
Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 40/296 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDN---LHVAVKKLD-CATQDAGREFENEVDLLSNI-H 205
+ +++GEG FG V KA++ + + A+K++ A++D R+F E+++L + H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG-------------PSHGSALTWHMR 252
HPN++ LLG H ++ E + +L L S S L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 253 MKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLK 312
+ A D ARG++YL + IHRDL + NIL+ + AK++DFGL+ K +
Sbjct: 130 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185
Query: 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQ 371
+ ++A E L T SDV+++GV+L E++ LG P + A+ +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-- 243
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427
R + P D +V + C + +P RP +L SL ++
Sbjct: 244 ---RLEKPLNCDD------------EVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 4e-55
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 49/308 (15%)
Query: 146 LEKATDSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLD-CATQDAGREFENEV 198
LE ++ +GEG FG V++A+ L VAVK L A+ D +F+ E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGS------------- 245
L++ +PN+V LLG A +++E M L+ L S +
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 246 --------ALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297
L+ ++ IA A G+ YL E +HRDL + N L+ K++DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 184
Query: 298 GLA--ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEK 355
GL+ I K + + + ++ PE + + T +SDV+A+GVVL E+
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--- 241
Query: 356 LAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL 415
P + ++ + NI+ ++L +L LC P+ RP
Sbjct: 242 --PYYGMA-----HEEVIYYVRDGNILACPENCPLELYNL------MRLCWSKLPADRPS 288
Query: 416 ITDVLHSL 423
+ L
Sbjct: 289 FCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-55
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 37/289 (12%)
Query: 138 ISFIE-YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCA-TQDAGREF 194
+ F+E + L++ LGEG +G V A VAVK +D D
Sbjct: 1 VPFVEDWDLVQT----------LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI 50
Query: 195 ENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMK 254
+ E+ + ++H NVV G+ + +++ E L ++ + +
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQR 107
Query: 255 IALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLK 312
G+ YLH + HRD+K N+LLD + N K+SDFGLA ++ + K
Sbjct: 108 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 313 LSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ 371
+ GTL YVAPE L + + DV++ G+VL +L G P ++ + + +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP---------SDSCQE 215
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+D + ++P K L + PS R I D+
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLH------KILVENPSARITIPDIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 144 KLLEKATDSFHESNI-LGEGGFGCVYKAKL---DDNLHVAVKKLD-CATQDAGREFENEV 198
K L D+ ++I LG G FG V + + VA+K L + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
++ + +P +V L+G + +V E+ L L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---G 315
+ G++YL E +HRDL + N+LL ++ AK+SDFGL+ G+ + S
Sbjct: 118 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTD 374
L + APE + K + +SDV+++GV + E L G++P +K+ + + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----K 229
Query: 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
R + P P ++ A+ C + RP V +
Sbjct: 230 RMECPPECPP------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 33/288 (11%)
Query: 148 KATDSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKL-DCATQDAGREFENEVDLL 201
K T+ F + +LG G FG VYK + VA+K+L + + A +E +E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+++ +P+V LLG + I + LD + H + + + A+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD---YVREHKDNIGSQYLLNWCVQIAK 122
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQNKNNLKLSGTLGY 319
G+ YL + ++HRDL + N+L+ + + K++DFGLA + + + + +
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378
+A E +L T +SDV+++GV + EL+ G +P + + ++ SI+ +R
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQ 234
Query: 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426
P I V + V C + RP +++ +
Sbjct: 235 PPICTI------------DVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-54
Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 50/304 (16%)
Query: 151 DSFHESNILGEGGFGCVYKA------KLDDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
++ +LG G FG V A K ++ VAVK L + RE +E+ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 204 I-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSH------------------- 243
+ H N+V LLG ++++E L L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 244 -GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-- 300
+ LT+ + A A+G+E+L +HRDL + N+L+ K+ DFGLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPA 359
I S + ++APE L +G T KSDV+++G++L E+ LG P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 360 QCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDV 419
P + + ++ K ++ + C + RP ++
Sbjct: 267 ---------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 420 LHSL 423
L
Sbjct: 318 TSFL 321
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-53
Identities = 67/298 (22%), Positives = 108/298 (36%), Gaps = 43/298 (14%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCATQDAGRE-FENEVDLLSN 203
+ LG G FG V +A D + VAVK L + RE +E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 204 I-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHG---------------PSHGSAL 247
+ +H N+V LLG ++ E L L AL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 248 TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ + A+G+ +L IHRDL + NILL K+ DFGLA I + S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV 365
+ ++APE + + T +SDV+++G+ L EL
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP------------ 247
Query: 366 TWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P + SK ++ + ++ + C +P RP ++ +
Sbjct: 248 ---YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-51
Identities = 73/298 (24%), Positives = 112/298 (37%), Gaps = 43/298 (14%)
Query: 138 ISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLD---CATQDA 190
I + +LLEK LG+G FG V + + D + VAVK L + +A
Sbjct: 5 IGEKDLRLLEK----------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 54
Query: 191 GREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWH 250
+F EV+ + ++ H N++ L G +V EL SL H
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLL--DRLRKHQGHFLLG 111
Query: 251 MRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQN 307
+ A+ A G+ YL IHRDL + N+LL ++ K+ DFGL +
Sbjct: 112 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVT 366
+ APE L + SD + FGV L E+ G+ P L +Q +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----IL 224
Query: 367 WAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
+ + +R P + V V C +P RP + L+
Sbjct: 225 HKIDKEGERLPRPEDCPQ------------DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-51
Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCATQDAGRE-FENEVDLLSNIH 205
+ +GEG FG V++ + L VA+K T D+ RE F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HP++V L+G ++ +I+ EL L +L + A + L Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA-ITDGSQNKNNLKLSGTLGYVAPEY 324
L +HRD+ + N+L+ S KL DFGL+ + S K + ++APE
Sbjct: 124 LESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 325 LLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
+ + T SDV+ FGV + E+L+ G +P + + + +R +P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPPNCP 235
Query: 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
P + S + C +PS RP T++ L
Sbjct: 236 PTLYS------------LMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 7e-51
Identities = 59/273 (21%), Positives = 103/273 (37%), Gaps = 23/273 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
D + LG G FG V++ + A K + + E+ +S + HP +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 210 VCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH 269
V L D+ ++YE M L ++ + ++ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 270 CNPAVIHRDLKSSNILLDSKFN--AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
+H DLK NI+ +K + KL DFGL + +GT + APE
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEVAEG 199
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387
+ +D+++ GV+ LL G P + V + D S I
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-DDSAFSGI------ 252
Query: 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+ D K + + +P+ R I L
Sbjct: 253 -SEDGKDFIR------KLLLADPNTRMTIHQAL 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-50
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 37/290 (12%)
Query: 151 DSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLD-CATQDAGREFENEVDLLSN 203
+ S LG+G FG VY+ + VA+K ++ A+ EF NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSA-------LTWHMRMKIA 256
+ +VV LLG + ++ ELM L L A + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 257 LDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL--AITDGSQNKNNLKLS 314
+ A G+ YL+ + +HRDL + N ++ F K+ DFG+ I + + K
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 315 GTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSIVTWAMPQLT 373
+ +++PE L DG T SDV++FGVVL E+ L +P + L+ Q V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------- 249
Query: 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
L + D +L +C Q P RP +++ S+
Sbjct: 250 -EGGLLDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSI 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 4e-50
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 37/283 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y +LE+ LG G FG V++ K ++ +NE+ ++
Sbjct: 31 YDILEE----------LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+ +HHP ++ L ++ E + L ++ + ++ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACE 138
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLAITDGSQNKNNLKLSGTLGY 319
GL+++HEH ++H D+K NI+ ++K + K+ DFGLA + T +
Sbjct: 139 GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTTATAEF 194
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
APE + + +D++A GV+ LL G P D L
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----------------FAGEDDLETLQ 238
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVL--CVQPEPSYRPLITDVL 420
N+ + D A + +Q EP R + D L
Sbjct: 239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-49
Identities = 61/280 (21%), Positives = 104/280 (37%), Gaps = 30/280 (10%)
Query: 147 EKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLS 202
+K + F ILGEG F V A+ L + A+K L+ ++ E D++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 203 NIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARG 262
+ HP V L D+ + +N L + + +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120
Query: 263 LEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNL--KLSGTLGYV 320
LEYLH +IHRDLK NILL+ + +++DFG A ++K GT YV
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 321 APEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPN 380
+PE L + SD++A G ++ +L+ G P + + P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKLEYDFPE 231
Query: 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
P + ++ + + + R ++
Sbjct: 232 KFFPKARDLVE------------KLLVLDATKRLGCEEME 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 3e-48
Identities = 70/272 (25%), Positives = 109/272 (40%), Gaps = 31/272 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCAT------QDAGREFENEVDLLSN 203
+ F I+G GGFG VY + D A+K LD + + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
P +VC+ D + +LM L L + A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPE 323
E++H V++RDLK +NILLD + ++SD GLA + + GT GY+APE
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 324 YLLDGKLTD-KSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382
L G D +D ++ G +L +LL G P + I LT +LP+
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDSF 232
Query: 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
P ++S ++ +Q + + R
Sbjct: 233 SPELRSLLE------------GLLQRDVNRRL 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-48
Identities = 81/303 (26%), Positives = 118/303 (38%), Gaps = 46/303 (15%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLH------VAVKKLD-CATQDAGREFENEVDLLSN 203
D LG G FG V +A VAVK L AT R +E+ +L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 204 I-HHPNVVCLLGYSAHDDTR-FIVYELMENRSLDIQLHG-------------PSHGSALT 248
I HH NVV LLG ++ E + +L L + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGSQ 306
+ + A+G+E+L IHRDL + NILL K K+ DFGLA I
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVT 366
L ++APE + D T +SDV++FGV+L E+ P I
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 367 WAMPQLTD--RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424
+L + R + P+ P ++ + C EPS RP ++++ L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP------------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 425 PLV 427
L+
Sbjct: 293 NLL 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-48
Identities = 87/282 (30%), Positives = 124/282 (43%), Gaps = 23/282 (8%)
Query: 157 NILGEGGFGCVYKAK-LDDNLHVAVKKLDC-----ATQDAGREFENEVDLLSNIHHPNVV 210
+ LGEG F VYKA+ + N VA+KK+ A R E+ LL + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 211 CLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC 270
LL H +V++ ME I + LT L T +GLEYLH+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 271 NPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKL 330
++HRDLK +N+LLD KL+DFGLA + GS N+ T Y APE L ++
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 331 TD-KSDVYAFGVVLLELLLGRRPVEKLAPAQ-----CQSIVTWAMPQLTDRSKLPNIVDP 384
D++A G +L ELLL + + +++ T Q D LP+ V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 385 VIKSTMDLKHLYQVAAVAVL-----CVQPEPSYRPLITDVLH 421
+ L H++ A +L P R T L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-47
Identities = 75/299 (25%), Positives = 117/299 (39%), Gaps = 46/299 (15%)
Query: 151 DSFHESNILGEGGFGCVYKAKL--------DDNLHVAVKKLD-CATQDAGREFENEVDLL 201
D LGEG FG V A+ + VAVK L AT+ + +E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 202 SNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLH-------------GPSHGSAL 247
I H N++ LLG D +++ E +L L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 248 TWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA--ITDGS 305
+ + A ARG+EYL IHRDL + N+L+ K++DFGLA I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELL-LGRRPVEKLAPAQCQSI 364
K + ++APE L D T +SDV++FGV+L E+ LG P + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 365 VTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSL 423
+ R P+ ++ + C PS RP ++ L
Sbjct: 250 LKEG-----HRMDKPSNCTN------------ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 7e-47
Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 26/284 (9%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDC-ATQDAGREFENEVDL 200
+K E D + ++LG G F V A+ VA+K + A + ENE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 201 LSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
L I HPN+V L +++ +L+ L ++ T ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILL---DSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
++YLH+ ++HRDLK N+L D +SDFGL+ + + + GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTP 173
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
GYVAPE L + D ++ GV+ LL G P A+ + A + S
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--DSP 231
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
+ + K + ++ +P R L
Sbjct: 232 YWDDISDSAKDFIR------------HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (407), Expect = 7e-47
Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 36/289 (12%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIH 205
+D + ILG GG V+ A+ L + VAVK L F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 206 HPNVVCLLGYSAHDDTR----FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
HP +V + + +IV E ++ +L +H +T +++ D +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLS---GTLG 318
L + H++ +IHRD+K +NI++ + K+ DFG+A + + + GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 319 YVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QSIVTWAMPQLTDRS 376
Y++PE + +SDVY+ G VL E+L G P +P Q + +P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-ITDVLHSLI 424
L +D V+ + P R ++ L+
Sbjct: 240 GLSADLDAVVLK----------------ALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-46
Identities = 48/283 (16%), Positives = 101/283 (35%), Gaps = 38/283 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y + E LG G FG V++ K + D + E+ +L
Sbjct: 7 YMIAED----------LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISIL 55
Query: 202 SNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTAR 261
+ H N++ L + +++E + + +++ + L +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCE 113
Query: 262 GLEYLHEHCNPAVIHRDLKSSNILLDSKFNA--KLSDFGLAITDGSQNKNNLKLSGTLGY 319
L++LH H + H D++ NI+ ++ ++ K+ +FG A N L Y
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA-RQLKPGDNFRLLFTAPEY 169
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
APE ++ +D+++ G ++ LL G P T++ +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----------------FLAETNQQIIE 213
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVL--CVQPEPSYRPLITDVL 420
NI++ + + A+ + + E R ++ L
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-45
Identities = 64/275 (23%), Positives = 102/275 (37%), Gaps = 29/275 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLS-NIH 205
+ F +LG+G FG V+ A+ N A+K L D E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 206 HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEY 265
HP + + + F V E + L + A + GL++
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 266 LHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
LH +++RDLK NILLD + K++DFG+ + + GT Y+APE L
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 326 LDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385
L K D ++FGV+L E+L+G+ P + + P P ++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------YPRWLEKE 229
Query: 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
K + EP R + +
Sbjct: 230 AKDLLV------------KLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (396), Expect = 8e-45
Identities = 60/277 (21%), Positives = 102/277 (36%), Gaps = 41/277 (14%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENE 197
++++L LG G FG V+ + + + A+K L +E
Sbjct: 5 DFQILRT----------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 198 VDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIAL 257
+LS + HP ++ + G F++ + +E L L + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAA 111
Query: 258 DTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTL 317
+ LEYLH +I+RDLK NILLD + K++DFG A L GT
Sbjct: 112 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCGTP 165
Query: 318 GYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSK 377
Y+APE + D ++FG+++ E+L G P + + L +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAELR 219
Query: 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
P + +K + + + S R
Sbjct: 220 FPPFFNEDVKDLLS------------RLITRDLSQRL 244
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-44
Identities = 69/294 (23%), Positives = 110/294 (37%), Gaps = 27/294 (9%)
Query: 148 KATDSFHESNILGEGGFGCVYKAK--LDDNLHVAVKKLDCATQDAG--REFENEVDLLSN 203
+A + +GEG +G V+KA+ + VA+K++ T + G EV +L +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 204 I---HHPNVVCLLGY-----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
+ HPNVV L + + +V+E ++ P G + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDM 121
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSG 315
RGL++LH H V+HRDLK NIL+ S KL+DFGLA Q +
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVV 177
Query: 316 TLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-----CQSIVTWAMP 370
TL Y APE LL D+++ G + E+ + + I
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 371 QLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAV----LCVQPEPSYRPLITDVL 420
LP + K + + + C+ P+ R L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 20/286 (6%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKL--DCATQDAGREFENEVDLLSNIHHP 207
++F + +GEG +G VYKA+ VA+KK+ D T+ E+ LL ++HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N+V LL ++ ++V+E + G + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH 119
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
H V+HRDLK N+L++++ KL+DFGLA G + TL Y APE LL
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 328 GK-LTDKSDVYAFGVVLLELLLGRRP-----VEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381
K + D+++ G + E++ R +++ T + +P+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 382 VD--PVIKSTMDLKHLYQVAAVAV----LCVQPEPSYRPLITDVLH 421
P K + + + +P+ R L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 4e-43
Identities = 65/287 (22%), Positives = 105/287 (36%), Gaps = 38/287 (13%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCAT---------QDAGREFENEVDL 200
+++ ILG G V + AVK +D Q+ EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 201 LSNIH-HPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
L + HPN++ L + F+V++LM+ L L L+ KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+ LH+ ++HRDLK NILLD N KL+DFG + K ++ GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-EVCGTPSY 175
Query: 320 VAPEYLL------DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLT 373
+APE + + D+++ GV++ LL G P ++ Q
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 374 DRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
S + +K + + +P R + L
Sbjct: 236 --SPEWDDYSDTVKDLVS------------RFLVVQPQKRYTAEEAL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 67/282 (23%), Positives = 105/282 (37%), Gaps = 32/282 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGR------EFENEVDLLSN 203
D + LG G F V K + L A K + + R + E EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 204 IHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
I HPNV+ L + ++ EL+ L + +LT + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGV 126
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDS----KFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
YLH + H DLK NI+L K K+ DFGLA N+ + GT +
Sbjct: 127 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEF 182
Query: 320 VAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379
VAPE + L ++D+++ GV+ LL G P + + V+ + D +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--EYF 240
Query: 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
+ + K + + +P R I D L
Sbjct: 241 SNTSALAKDFIR------------RLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 3e-42
Identities = 62/284 (21%), Positives = 114/284 (40%), Gaps = 20/284 (7%)
Query: 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHHPN 208
+ +H +GEG +G VYKA+ + A+KK+ +D G E+ +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
+V L +V+E ++ + L L G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL-D 327
V+HRDLK N+L++ + K++DFGLA G + TL Y AP+ L+
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 328 GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQ-----CQSIVTWAMPQLTDRSKLP--N 380
K + D+++ G + E++ G ++ A + + T + ++LP +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 381 IVDPVIKSTMDLKHLYQVAAVAV----LCVQPEPSYRPLITDVL 420
V + L + + ++ +P+ R L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 64/268 (23%), Positives = 97/268 (36%), Gaps = 28/268 (10%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
+ F +LG+G FG V + + A+K L +D E +L N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P + L D V E L L T + LEYL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H V++RD+K N++LD + K++DFGL S GT Y+APE L
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
D D + GVV+ E++ GR P + ++ L + + P + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEIRFPRTLSPEA 232
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
KS + ++ +P R
Sbjct: 233 KSLLA------------GLLKKDPKQRL 248
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-42
Identities = 63/290 (21%), Positives = 99/290 (34%), Gaps = 26/290 (8%)
Query: 151 DSFHESNILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV 209
S+ ++ ++G G FG VY+AKL D VA+KK+ R E+ ++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 210 VCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGL 263
V L + + +V + + + H L R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 264 EYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAP 322
Y+H + HRD+K N+LLD KL DFG A N +
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 323 EYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAP-AQCQSIVT----------WAMPQ 371
T DV++ G VL ELLLG+ + Q I+ M
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
K P I + + A+ ++ P+ R +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 38/289 (13%)
Query: 142 EYKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDL 200
+YK+ + +LG G G V + A+K L + EV+L
Sbjct: 12 DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVEL 57
Query: 201 LSNI-HHPNVVCLLGY----SAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKI 255
P++V ++ A IV E ++ L ++ + T +I
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEI 116
Query: 256 ALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFN---AKLSDFGLAITDGSQNKNNLK 312
++YLH + HRD+K N+L SK KL+DFG A S N
Sbjct: 117 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-T 172
Query: 313 LSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372
T YVAPE L K D+++ GV++ LL G P + ++ M
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF----YSNHGLAISPGMKTR 228
Query: 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421
+ + + ++K L + ++ EP+ R IT+ ++
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-40
Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 22/290 (7%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD-CATQDAGREFENEVDLLSNIHHP 207
+ + +GEG +G V A + + VA+KK+ Q + E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 208 NVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLH 267
N++ + + + + L+ L+ RGL+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 268 EHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA---ITDGSQNKNNLKLSGTLGYVAPEY 324
V+HRDLK SN+LL++ + K+ DFGLA D + T Y APE
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 325 LLDGKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383
+L+ K KS D+++ G +L E+L R + + + + I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 384 PVIKSTMDLKHLYQV-----------AAVAVL--CVQPEPSYRPLITDVL 420
+ L H +V A+ +L + P R + L
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 4e-40
Identities = 53/286 (18%), Positives = 92/286 (32%), Gaps = 44/286 (15%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y+L K +G G FG +Y + VA+K T+ + E +
Sbjct: 9 YRLGRK----------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIY 56
Query: 202 SNIHHPNVVCLLGYSAHD-DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ + + + + D +V EL+ D+ + + +A
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMI 113
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSK---FNAKLSDFGLA-------ITDGSQNKNN 310
+EY+H IHRD+K N L+ + DFGLA + N
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 311 LKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIV--TWA 368
L+GT Y + L + + + D+ + G VL+ LG P + L A +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 369 MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
T L + ++ C +P
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLN------------FCRSLRFDDKP 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-40
Identities = 64/274 (23%), Positives = 106/274 (38%), Gaps = 42/274 (15%)
Query: 158 ILGEGGFGCVYKAK-LDDNLHVAVKKL------DCATQDAGREFENEVDLLSNIH--HPN 208
+LG GGFG VY + DNL VA+K + D G EV LL +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 VVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE 268
V+ LL + D+ ++ E E + AL + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 269 HCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLD 327
V+HRD+K NIL+D ++ KL DFG + GT Y PE++
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRY 183
Query: 328 GKLTDKS-DVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
+ +S V++ G++L +++ G P E + I+ Q+ R ++ + +I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRG---QVFFRQRVSSECQHLI 235
Query: 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420
+ C+ PS RP ++
Sbjct: 236 RW----------------CLALRPSDRPTFEEIQ 253
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-39
Identities = 70/295 (23%), Positives = 112/295 (37%), Gaps = 32/295 (10%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ LEK +GEG +G V+KAK + + VA+K++ D G E+
Sbjct: 4 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 200 LLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDT 259
LL + H N+V L D +V+E + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQL 110
Query: 260 ARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGY 319
+GL + H V+HRDLK N+L++ KL++FGLA G + TL Y
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 320 VAPEYLLDGKLTD-KSDVYAFGVVLLELLLGRRP------VEKLAPAQCQSIVTWAMPQL 372
P+ L KL D+++ G + EL RP V+ + + T Q
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 373 TDRSKLPNIVD-PVIKSTMDLKHLYQVAAVAVL-----CVQPEPSYRPLITDVLH 421
+KLP+ P+ +T L ++ ++ P R + L
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (350), Expect = 2e-38
Identities = 48/301 (15%), Positives = 94/301 (31%), Gaps = 49/301 (16%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
YK+ + +GEG FG +++ L +N VA+K + + +E
Sbjct: 7 YKVGRR----------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY 54
Query: 202 SNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
+ + + + +V +L+ D+ G + A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQML 111
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFN-----AKLSDFGLA-------ITDGSQNK 308
++ +HE +++RD+K N L+ + + DFG+ +
Sbjct: 112 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA 368
LSGT Y++ L + + + D+ A G V + L G P + L A +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 369 --MPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP---LITDVLHSL 423
Q T +L M P + + +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMH------------YARNLAFDATPDYDYLQGLFSKV 276
Query: 424 I 424
+
Sbjct: 277 L 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-38
Identities = 61/302 (20%), Positives = 102/302 (33%), Gaps = 44/302 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L+ +G G +G V A VA+KKL Q + E+
Sbjct: 20 YRDLQP----------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
LL ++ H NV+ LL D+T ++V M + H L
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQ 124
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ +GL Y+H HRDLK N+ ++ K+ DFGLA S+ +
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-- 179
Query: 314 SGTLGYVAPEYLL-DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372
T Y APE +L + T D+++ G ++ E++ G+ + +
Sbjct: 180 -VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVL-------------CVQPEPSYRPLITDV 419
D L L + ++L + + R +
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
Query: 420 LH 421
L
Sbjct: 299 LA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 1e-37
Identities = 64/278 (23%), Positives = 101/278 (36%), Gaps = 32/278 (11%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLD---CATQDAGREFENEVDLLSNIHH 206
D F LG G FG V K + H A+K LD NE +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 207 PNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
P +V L + ++V E + + L + A EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLL 326
H +I+RDLK N+L+D + +++DFG A + L GT +APE +L
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEALAPEIIL 211
Query: 327 DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386
D +A GV++ E+ G P P Q + + P+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------RFPSHFSS-- 263
Query: 387 KSTMDLKHLYQVAAVAVLCVQPE---PSYRPLITDVLH 421
DLK L + +L V + + + D+ +
Sbjct: 264 ----DLKDLLR----NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 64/309 (20%), Positives = 114/309 (36%), Gaps = 46/309 (14%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L K +G+G FG V+KA+ VA+KK+ + G E+
Sbjct: 12 YEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 200 LLSNIHHPNVVCLLG--------YSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHM 251
+L + H NVV L+ Y+ + ++V++ E+ + + T
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSE 118
Query: 252 RMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA----ITDGSQN 307
++ GL Y+H + ++HRD+K++N+L+ KL+DFGLA + SQ
Sbjct: 119 IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 308 KNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQ------ 360
TL Y PE LL + D++ G ++ E+ ++
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 361 --CQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVL------CVQPEPSY 412
C SI P + + + + L + +P+
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 413 RPLITDVLH 421
R D L+
Sbjct: 296 RIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 42/296 (14%)
Query: 131 VSKKGSAISFIEYKLLEKATDSFHESNILGEGGFGCVYKAKL----DDNLHVAVKKLDCA 186
++ + ++LL+ LG G +G V+ + D A+K L A
Sbjct: 14 LTGHAEKVGIENFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63
Query: 187 T----QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGP 241
T E +L +I P +V L + ++ + + L L
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 242 SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301
+ + + + L +I+RD+K NILLDS + L+DFGL+
Sbjct: 124 ERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 302 T-DGSQNKNNLKLSGTLGYVAPEYLLDGK--LTDKSDVYAFGVVLLELLLGRRPVEKLAP 358
+ + GT+ Y+AP+ + G D ++ GV++ ELL G P
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VD 235
Query: 359 AQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP 414
+ S + L P + + K + + +P R
Sbjct: 236 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ------------RLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (314), Expect = 4e-33
Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 151 DSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPN 208
D + LG G + V++A + +N V VK L + ++ + E+ +L N+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 209 VVCLLGYSAHDDTR--FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYL 266
++ L +R +V+E + N QL+ LT + + + L+Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQT-----LTDYDIRFYMYEILKALDYC 145
Query: 267 HEHCNPAVIHRDLKSSNILLDSKFN-AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYL 325
H ++HRD+K N+++D + +L D+GLA + + + PE L
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELL 201
Query: 326 LDGKLTD-KSDVYAFGVVLLELLLGRRP 352
+D ++ D D+++ G +L ++ + P
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 9e-32
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVD 199
Y+ L+ +G G G V A + +VA+KKL Q+ + E+
Sbjct: 19 YQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 200 LLSNIHHPNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRM 253
L+ ++H N++ LL T ++V ELM+ +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMS 122
Query: 254 KIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKL 313
+ G+++LH IHRDLK SNI++ S K+ DFGLA T G+
Sbjct: 123 YLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-PY 178
Query: 314 SGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP 352
T Y APE +L + D+++ G ++ E++ +
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 150 TDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAG--REFENEVDLLSNIHH 206
+ + + +G G +G V A L VAVKKL Q + E+ LL ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 207 PNVVCLLGYSAHDDTR------FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTA 260
NV+ LL + ++V LM +I LT +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQIL 131
Query: 261 RGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKNNLKLSGTLGYV 320
RGL+Y+H HRDLK SN+ ++ K+ DFGLA + + T Y
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA---TRWYR 185
Query: 321 APEYLLDGKLTD-KSDVYAFGVVLLELLLGRRP 352
APE +L+ + D+++ G ++ ELL GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 6e-28
Identities = 47/229 (20%), Positives = 84/229 (36%), Gaps = 30/229 (13%)
Query: 143 YKLLEKATDSFHESNILGEGGFGCVYKAK-LDDNLHVAVKKLDCATQDAGREFENEVDLL 201
Y L+ K LG G F V+ AK + +N HVA+K + E+E+ LL
Sbjct: 15 YILVRK----------LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLL 63
Query: 202 SNIHHPNVVCLLGYSA-------------HDDTRFIVYELMENRSLDIQLHGPSHGSALT 248
++ + A + +V + L +
Sbjct: 64 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 123
Query: 249 WHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK-FNAKLSDFGLAITDGS-- 305
+I+ GL+Y+H C +IH D+K N+L++ L +A +
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE 354
+++ T Y +PE LL +D+++ ++ EL+ G E
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 4e-20
Identities = 22/169 (13%), Positives = 49/169 (28%), Gaps = 36/169 (21%)
Query: 157 NILGEGGFGCVYKAKLDDNLHVAVKKLDCATQD------------------AGREFENEV 198
++GEG V+ + VK A R NE
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 199 DLLSNIHHPNVVCLLGYSAHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALD 258
L + V + + + ++ EL++ + + ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAK----------ELYRVRVENPDEVLDM 111
Query: 259 TARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307
+ + ++H DL N+L+ + + DF ++ G +
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 452 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=413.32 Aligned_cols=258 Identities=32% Similarity=0.493 Sum_probs=204.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|...+.||+|+||+||+|++++ .||||++... +....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678889999999999999998764 5999998643 34566789999999999999999999999865 56899999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
||++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999973 345699999999999999999999999 9999999999999999999999999999664322
Q ss_pred -CCcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhh-hhhhhhccccccCCCCCcc
Q 012975 307 -NKNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQ-SIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 307 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 381 (452)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||.+....... ..+.. ....+.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~~p~- 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-------GYLSPD- 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-------TSCCCC-
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-------CCCCCc-
Confidence 222345679999999999865 35789999999999999999999999876543321 11111 000000
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
+. ....+....+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 231 ----~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 ----LS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----GG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----ch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 0111233467789999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=413.27 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=202.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||+||+|++.++..||||++.... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999988899999997533 345689999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-c
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 309 (452)
+|+|.+++.. ....++|..+++++.|+|.||+|||++ +|+||||||+|||+++++++||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999874 346799999999999999999999999 999999999999999999999999999976543322 2
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+.... +...+.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-----~~~~p~-------- 225 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----RLYKPR-------- 225 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----CCCCCT--------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----CCCCcc--------
Confidence 234568999999999999999999999999999999999 566666655443332222110 111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
.+..++.+++.+||+.||++||||+||++.|+++.
T Consensus 226 ----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 ----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11246778999999999999999999999998874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-55 Score=418.47 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=202.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-C---cEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-N---LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 445667899999999999998753 2 35889988643 445567899999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||++|+|.+++.. ....++|.++++++.|+++||+|||++ +|+||||||+|||+++++++||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998873 345799999999999999999999999 999999999999999999999999999975433
Q ss_pred CCCc-----ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 306 QNKN-----NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 306 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
.... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+....+....+.. ....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-------~~~~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------DYRLP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------TCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence 2211 122457899999999999999999999999999999998 8999988776543332221 11111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
. ..+...++.+++.+||+.||++|||++||++.|++++.
T Consensus 254 ~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 P----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 11223467789999999999999999999999998865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=402.71 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=214.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecC
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELME 230 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 230 (452)
++|+..+.||+|+||+||+|++++++.||||++..... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999999899999999975433 45689999999999999999999999999999999999999
Q ss_pred CCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC-c
Q 012975 231 NRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK-N 309 (452)
Q Consensus 231 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 309 (452)
+|+|..++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999988763 345789999999999999999999999 999999999999999999999999999975443322 2
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhcc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKS 388 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 388 (452)
.....||..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... .+...++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~-------- 224 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPH-------- 224 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCT--------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-----CCCCCcc--------
Confidence 334568999999999999999999999999999999998 89999988766544333211 1111111
Q ss_pred cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 389 TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 389 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
....++.+++.+||+.||++|||++|+++.|.++
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1124677899999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=407.92 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=207.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
..++|+..+.||+|+||+||+|+++++..||||++.... ...++|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 346788889999999999999999988999999997543 345679999999999999999999998865 567999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN- 307 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~- 307 (452)
+++|+|.++++. .....++|..+++|+.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999988764 2234699999999999999999999999 99999999999999999999999999997654332
Q ss_pred CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRR-PVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.......||+.|+|||.+.+..++.++|||||||++|||+||.. |+......+....+... .+...++
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-----~~~~~p~------ 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPD------ 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT------
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCCCCcc------
Confidence 22334568999999999999999999999999999999999555 45544433322222110 0011111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
....++.+++.+||+.||++||||+||++.|++...
T Consensus 234 ------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 122357789999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=407.48 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=209.9
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999875 68999999997655556678999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++.........
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988753 3599999999999999999999999 9999999999999999999999999999876554445
Q ss_pred ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhccc
Q 012975 310 NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKST 389 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 389 (452)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+........ ....+ -.+ .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~~~~~---~~~---~- 240 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-----GTPEL---QNP---E- 240 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----CSCCC---SSG---G-
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----CCCCC---CCc---c-
Confidence 55668999999999999999999999999999999999999999876654322111100 00000 000 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 390 MDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 390 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++|||++|+++
T Consensus 241 ---~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 ---KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11245678999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=409.64 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=208.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
+.|+..+.||+|+||+||+|++. +|..||||++........+.|.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999975 68899999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
++|+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++.........
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 99999988763 245699999999999999999999999 9999999999999999999999999999654333233
Q ss_pred ccccccccCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 310 NLKLSGTLGYVAPEYLL-----DGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||......+....+... . .+....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------~--~~~~~~~ 238 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------E--PPTLAQP 238 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS------C--CCCCSSG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------C--CCCCCcc
Confidence 34567999999999984 456889999999999999999999999887654432221110 0 0011011
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....++.+++.+||+.||++|||++|+++
T Consensus 239 -------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 -------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112346778999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-54 Score=411.30 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=212.8
Q ss_pred HhhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 148 KATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 148 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
...++|+..+.||+|+||+||+|++. +++.||||++.... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888899999999999999986 58889999986443 34568999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|.+++.. .....+++..++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999999864 2346799999999999999999999999 9999999999999999999999999999765443
Q ss_pred CC-cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 NK-NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVE-KLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+. ..+..+....+... .....++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-----~~~~~~~---- 239 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERPE---- 239 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----CCCCCCT----
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-----CCCCCCc----
Confidence 32 2334458899999999999999999999999999999999766654 44433322222110 0111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+.+++.+||+.||++|||++||++.|+.+...
T Consensus 240 --------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 240 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1224677899999999999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=401.56 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=207.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+.. +++.||+|.+... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888999999999999999986 6889999998532 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999863 35699999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... ...+++.+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~---- 227 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDFV---- 227 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTS----
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCccC----
Confidence 234567999999999999999999999999999999999999999887655433322211 11122211
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..++.+++.+||+.||++|||++|+++
T Consensus 228 --------s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 --------TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 235678999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=402.02 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=202.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.++|+..+.||+|+||+||+|++. +|+.||||.+.... .+..+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357888999999999999999975 68999999986543 2344678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC-
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ- 306 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~- 306 (452)
|+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999863 45799999999999999999999999 9999999999999999999999999999764322
Q ss_pred -CCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 -NKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.......+||+.|||||++.+..+ +.++|||||||++|||+||+.||......... ...+. ....... +
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~-----~~~~~~~---~ 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKTYLN---P 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH-----TTCTTST---T
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh-----cCCCCCC---c
Confidence 223345679999999999988876 57899999999999999999999765432211 11111 0000000 0
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.. ....++.+++.+||+.||++|||++|+++
T Consensus 229 --~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WK----KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 11235668999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-54 Score=405.74 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=196.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc--CCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH--DDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 225 (452)
++|+..+.||+|+||+||+|+.. +|+.||||.+... +....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57888999999999999999875 6889999998654 34456779999999999999999999999865 4567999
Q ss_pred eeecCCCChhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 226 YELMENRSLDIQLHGP-SHGSALTWHMRMKIALDTARGLEYLHEHC--NPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
||||++|+|.+++... .....+++..++.++.|++.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988532 22457999999999999999999999972 12499999999999999999999999999977
Q ss_pred cCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
............||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+... ....++.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-----~~~~~~~-- 236 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIPY-- 236 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----CCCCCCT--
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----CCCCCCc--
Confidence 654444445678999999999999999999999999999999999999999887655432222111 0011111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
....++.+++.+||+.||++|||+.|+++
T Consensus 237 ----------~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 237 ----------RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12235778999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=404.43 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=207.1
Q ss_pred cCCCccCe-EeecCcEEEEEEEeC---CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNI-LGEGGFGCVYKAKLD---DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|...+. ||+|+||+||+|.+. ++..||||.+... .....++|.+|+++|++++|||||+++|+|.. +..|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 999999999999764 4567999999654 34556789999999999999999999999975 568999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||++|+|.+++.. ....+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998763 345799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 306 QNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 306 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+... .+...+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~- 235 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPP- 235 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCCT-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCC-
Confidence 322 2234468999999999999999999999999999999998 99999887654433222211 0111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
....++.+++.+||+.||++|||+.+|++.|+...
T Consensus 236 -----------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 236 -----------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -----------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12246778999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=401.44 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=201.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCC-----cEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDN-----LHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
+.|+..++||+|+||+||+|.++++ ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999987542 47999998643 34455679999999999999999999999999999999
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+.+|++.+++.. ....++|.++++++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887763 345799999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChhhhhhhhhhhccccccCCCCCc
Q 012975 305 SQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRP-VEKLAPAQCQSIVTWAMPQLTDRSKLPN 380 (452)
Q Consensus 305 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (452)
.... ......||..|+|||++.+..++.++|||||||++|||++|..| +......+....+.. ....+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-------~~~~~- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------GFRLP- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------TCCCC-
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-------cCCCC-
Confidence 3221 22234689999999999999999999999999999999996555 444443332222211 11110
Q ss_pred ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 381 IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 381 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...+....+.+++.+||+.||++||||.||++.|++++..
T Consensus 234 ---------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 ---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0112234677899999999999999999999999887753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=397.27 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=199.9
Q ss_pred CeEeecCcEEEEEEEeC---CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeecCC
Q 012975 157 NILGEGGFGCVYKAKLD---DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELMEN 231 (452)
Q Consensus 157 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 231 (452)
+.||+|+||+||+|.++ .++.||||++... +....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 3568999998643 33445789999999999999999999999965 567899999999
Q ss_pred CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC---
Q 012975 232 RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK--- 308 (452)
Q Consensus 232 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--- 308 (452)
|+|.+++.. ...+++.++++++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999864 45699999999999999999999999 999999999999999999999999999976543322
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......||++|+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+... .+...+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~------- 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPA------- 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCT-------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCc-------
Confidence 2233568999999999999999999999999999999998 99999987765433333211 1111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
....++.+++.+||+.||++|||++||++.|++.
T Consensus 234 -----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 234 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1234677899999999999999999999888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=408.92 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=204.7
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..++|+..+.||+|+||+||+|+.. +|+.||+|++... ......++.+|+.+|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999999999999975 6899999998654 3444578999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
|||++|+|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||+++++++||+|||+|.....
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999863 3469999999999999999999997 5 799999999999999999999999999975422
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh-cccccc----------
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA-MPQLTD---------- 374 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~---------- 374 (452)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+........ ......
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 1 223468999999999999999999999999999999999999999876543211110000 000000
Q ss_pred --------CCCCCc---ccchhhcc----cCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 375 --------RSKLPN---IVDPVIKS----TMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 375 --------~~~~~~---~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...... ..+..... ........++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000 00000000 000011246778999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=397.52 Aligned_cols=257 Identities=27% Similarity=0.380 Sum_probs=204.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++|+..+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788899999999999999999988899999996443 345789999999999999999999999854 5679999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC-C
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-K 308 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~ 308 (452)
++|+|..++... ....++|.+++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++...... .
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999888642 234699999999999999999999999 99999999999999999999999999997653222 2
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPV-EKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
......||+.|+|||++.+..++.++|||||||++|||+||..|+ ......+....+.... +...+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-----~~~~~~------- 237 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----RMPCPP------- 237 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----CCCCCT-------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CCCCCc-------
Confidence 233456899999999999999999999999999999999965554 4444333322222110 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....++.+++.+||+.||++||||++|++.|++....
T Consensus 238 -----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1234677899999999999999999999999887754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=404.21 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=204.6
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeCC------CcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLDD------NLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|+..+.||+|+||+||+|++.. ...||+|.+... .......+.+|+.+|.++ +|||||+++|+|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 44678889999999999999998643 236999998543 334456799999999998 8999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSH--------------------GSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLK 280 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk 280 (452)
..++|||||++|+|.++++.... ...+++..++.++.|++.||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999975321 24589999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 012975 281 SSNILLDSKFNAKLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLA 357 (452)
Q Consensus 281 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~ 357 (452)
|+|||++.++.+||+|||+++....... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999965433222 2234568999999999999999999999999999999998 899998765
Q ss_pred hhhh-hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcc
Q 012975 358 PAQC-QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLI 424 (452)
Q Consensus 358 ~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 424 (452)
..+. ...+... .+...+. ....++.+++.+||+.||++|||++||++.|.
T Consensus 272 ~~~~~~~~~~~~-----~~~~~p~------------~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANFYKLIQNG-----FKMDQPF------------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHHHHHHHHTT-----CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHhcC-----CCCCCCC------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 4332 1111110 0111111 12246778999999999999999999999884
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=388.53 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=195.6
Q ss_pred CccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEc----CCceeeee
Q 012975 154 HESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAH----DDTRFIVY 226 (452)
Q Consensus 154 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 226 (452)
+..+.||+|+||+||+|++. ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ++..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999976 5889999998643 34456779999999999999999999999865 34579999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD-SKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~-~~~~~kl~Dfgl~~~~~~ 305 (452)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999863 35699999999999999999999998 22399999999999997 578999999999976433
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ +.... .. ...+..
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i----~~-~~~~~~---- 233 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV----TS-GVKPAS---- 233 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH----TT-TCCCGG----
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHH----Hc-CCCCcc----
Confidence 2 2345689999999998865 699999999999999999999999976543221 11110 11 111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
..... ..++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 234678999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-51 Score=400.20 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=211.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457889999999999999999975 6899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS--KFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~ 306 (452)
|++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++......
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998863 345699999999999999999999999 9999999999999964 678999999999776443
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+... ...... ..
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~----~~ 248 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWNMDD----SA 248 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCSCC----GG
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCc----cc
Confidence 3 234567999999999999999999999999999999999999999877654432222111 111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
... ....+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 12356789999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=399.01 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=203.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+.. +|+.||||.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999975 6889999998632 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988863 35699999999999999999999999 9999999999999999999999999999765432
Q ss_pred --CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 307 --NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 307 --~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+. .....+++.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~~~~p~~--- 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPEK--- 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TTCCCCCTT---
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH------cCCCCCCcc---
Confidence 223345679999999999999999999999999999999999999998876544322221 111112211
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
...++.+++.+||+.||++|||++|++
T Consensus 233 ---------~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 ---------FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---------CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---------CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 123567899999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-51 Score=395.72 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=201.3
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999875 68899999986543 3344679999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
||++|+|..++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999766542 45699999999999999999999999 999999999999999999999999999975433
Q ss_pred CcccccccccCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccch
Q 012975 308 KNNLKLSGTLGYVAPEYLLD---GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDP 384 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 384 (452)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||.+....+....+.. ...+...+.
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~ 237 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NESPALQSG 237 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCCCCCSCT
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CCCCCCCCC
Confidence 234579999999999864 4689999999999999999999999987665432211111 001111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 385 VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 385 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.....+.+++.+||+.||++|||+.|+++
T Consensus 238 --------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 --------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11246778999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-52 Score=398.87 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=214.5
Q ss_pred HHHHHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEE
Q 012975 144 KLLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYS 216 (452)
Q Consensus 144 ~~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 216 (452)
..+|...++|+..+.||+|+||+||+|+.. ++..||||++.... ....++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345557788999999999999999999864 46789999996543 34457799999999999999999999999
Q ss_pred EcCCceeeeeeecCCCChhhhccCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 012975 217 AHDDTRFIVYELMENRSLDIQLHGPS---------------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVI 275 (452)
Q Consensus 217 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~ 275 (452)
.+.+..+++|||+++|+|.++++... ....+++..+++|+.|++.||+|||++ +++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999885321 123589999999999999999999999 999
Q ss_pred eCCCCCCCEEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CC
Q 012975 276 HRDLKSSNILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR-RP 352 (452)
Q Consensus 276 H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~-~P 352 (452)
||||||+|||++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999996543222 2233456889999999999999999999999999999999985 67
Q ss_pred CCCCChhhhhhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccC
Q 012975 353 VEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLV 427 (452)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~ 427 (452)
|......+....+.. ...++. .. ....++.+++.+||+.||++||||.||++.|+++.
T Consensus 243 ~~~~~~~e~~~~v~~--------~~~~~~-----p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRD--------GNILAC-----PE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHHHT--------TCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHc--------CCCCCC-----Cc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 887766554333221 111111 01 12235778999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-52 Score=397.78 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=192.9
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
..+.|+..+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+++|++++|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467889999999999999999976 68899999986443 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEecCCCccc
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD---SKFNAKLSDFGLAITD 303 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~---~~~~~kl~Dfgl~~~~ 303 (452)
|||++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999964 45699999999999999999999999 999999999999994 5789999999999755
Q ss_pred CCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccc
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVD 383 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 383 (452)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+... ......
T Consensus 161 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~~~--- 230 (307)
T d1a06a_ 161 DPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------EYEFDS--- 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------CCCCCT---
T ss_pred cCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------CCCCCC---
Confidence 3322 233567999999999999999999999999999999999999999887654432222111 111100
Q ss_pred hhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 384 PVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 384 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.... +....+.+++.+||+.||++|||++|+++.
T Consensus 231 -~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 -PYWD----DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -TTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cccc----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0001 122457789999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-51 Score=398.75 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=211.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||.+..........+.+|+++|++++|||||++++++.+++..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357888999999999999999975 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLD--SKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~--~~~~~kl~Dfgl~~~~~~~ 306 (452)
|++|+|.+++. .....+++.+++.++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988775 3345799999999999999999999999 999999999999998 6789999999999776443
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+... ....+...
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------~~~~~~~~---- 251 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------DWEFDEDA---- 251 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------CCCCCSST----
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccc----
Confidence 2 334567999999999999999999999999999999999999999887654432222111 11111100
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
.. ....++.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 252 FS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01 112356789999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=391.02 Aligned_cols=252 Identities=28% Similarity=0.391 Sum_probs=200.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-Cceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 228 (452)
.++|+..+.||+|+||.||+|+++ |.+||||+++.. ...++|.+|++++++++||||++++|+|.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356777899999999999999985 678999999643 3457799999999999999999999999654 568999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+++|+|.++++.. ....++|..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998642 223589999999999999999999999 9999999999999999999999999999764332
Q ss_pred cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhhc
Q 012975 309 NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVIK 387 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 387 (452)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.||......+....+.. ..+...+.
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-----~~~~~~~~------- 223 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPD------- 223 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----TCCCCCCT-------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----CCCCCCCc-------
Confidence 223468899999999999999999999999999999998 7888887665443222211 01111111
Q ss_pred ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 388 STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 388 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
....++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 224 -----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 224 -----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 122466789999999999999999999999988743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=392.70 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=210.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 225 (452)
.++|+..+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357889999999999999999975 6899999998633 233457789999999999999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||++|+|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998864 35689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....... ....++..+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~------~~~~~p~~~--- 228 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EEIRFPRTL--- 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCCTTS---
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc------CCCCCCccC---
Confidence 55555667899999999999999999999999999999999999999998776543322221 112222211
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
..++.+++.+||+.||++||+ +.|+++
T Consensus 229 ---------s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 ---------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 235668999999999999995 788875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=395.73 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=204.8
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCc----EEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNL----HVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
++|+..+.||+|+||+||+|++. +|+ +||+|++... +....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999875 333 6899998643 344567899999999999999999999999874 5678
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
++||+.+|+|.+++.. ....+++..+++++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888763 356799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCc--ccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 305 SQNKN--NLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 305 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
..... .....||..|+|||.+.++.++.++|||||||++|||+| |+.||......+....+.... +...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-----~~~~p~- 236 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----RLPQPP- 236 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-----CCCCCT-
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----CCCCCc-
Confidence 33222 233468999999999999999999999999999999998 899998876655443333211 111111
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.....+.+++.+||+.||++|||++||++.|.++..
T Consensus 237 -----------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 237 -----------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 123457789999999999999999999999877643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=387.69 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=200.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeCC----CcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLDD----NLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 224 (452)
.++|+..+.||+|+||+||+|++.. +..||||.+.... ....+.|.+|++++++++||||++++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578889999999999999998753 4568999986443 444577999999999999999999999996 467899
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccC
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDG 304 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~ 304 (452)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988763 345799999999999999999999999 99999999999999999999999999997643
Q ss_pred CCC-CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCCccc
Q 012975 305 SQN-KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIV 382 (452)
Q Consensus 305 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (452)
... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+....+... .....+.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~-- 232 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPP-- 232 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCT--
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCC--
Confidence 322 23344568999999999999999999999999999999998 89999887765433322211 0111111
Q ss_pred chhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 383 DPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 383 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....++.+++.+||+.||++|||+.||++.|++++..
T Consensus 233 ----------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 233 ----------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1234677899999999999999999999999877644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=386.40 Aligned_cols=251 Identities=26% Similarity=0.305 Sum_probs=207.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC------hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT------QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.+.|+..+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999975 68999999985332 22357899999999999999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEecC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF----NAKLSDFG 298 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~----~~kl~Dfg 298 (452)
|||||||++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999863 34699999999999999999999999 999999999999998876 49999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+... ....
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYEF 235 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc------CCCC
Confidence 997654332 233457999999999999999999999999999999999999999987654432222111 1111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
+ +..... ....+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 E----DEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C----HHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----chhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111111 1245678999999999999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=387.16 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=197.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC--C--CcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCcee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD--D--NLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 223 (452)
++|+..+.||+|+||+||+|++. + +..||||++... .....++|.+|+++|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888899999999999999863 2 347899988543 33445789999999999999999999999976 4678
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
+||||+++|++.+++.. ....+++..+++++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988763 345699999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC---cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 304 GSQNK---NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 304 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
..... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+....+.. .. .+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~---~~-~~~~~~ 237 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK---EG-ERLPRP 237 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---SC-CCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh---CC-CCCCCc
Confidence 33322 2223457889999999999999999999999999999998 8999988766543222211 00 000111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhcccc
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPL 426 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l 426 (452)
+ .....+.+++.+||+.||++|||+.||.+.|++.
T Consensus 238 ~------------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 E------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp T------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1123577899999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=386.48 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=201.3
Q ss_pred cCeEeecCcEEEEEEEeCCC----cEEEEEEecC-cChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-Cceeeeeeec
Q 012975 156 SNILGEGGFGCVYKAKLDDN----LHVAVKKLDC-ATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-DTRFIVYELM 229 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 229 (452)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+++|++++||||++++|+|.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999987542 3589999964 3455667899999999999999999999998764 5789999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC--
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN-- 307 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-- 307 (452)
++|+|.++++. ....+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998873 455688999999999999999999999 99999999999999999999999999997543222
Q ss_pred --CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 308 --KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 308 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.......||..|+|||.+.+..++.++||||||+++|||+||+.||....... ....+.... .+...++
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g--~~~~~p~----- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQG--RRLLQPE----- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT--CCCCCCT-----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC--CCCCCcc-----
Confidence 12223568999999999999999999999999999999999888776533211 111111100 0111111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
....++.+++.+||+.||++||+|+||++.|++++..
T Consensus 258 -------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 258 -------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1123577899999999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=388.09 Aligned_cols=264 Identities=29% Similarity=0.378 Sum_probs=201.4
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEE
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYS 216 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 216 (452)
.++...++|+..+.||+|+||+||+|++. +++.||||++... .....+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 34445578999999999999999999853 3568999998643 344566788888888877 789999999998
Q ss_pred EcCC-ceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012975 217 AHDD-TRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSS 282 (452)
Q Consensus 217 ~~~~-~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~ 282 (452)
.+++ ..++|||||++|+|.++++... ....+++.+++.++.|++.||+|||++ +|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 7654 6899999999999999986422 134589999999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChh
Q 012975 283 NILLDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLG-RRPVEKLAPA 359 (452)
Q Consensus 283 NIll~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG-~~P~~~~~~~ 359 (452)
|||+++++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+|| ..||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997543322 233456799999999999999999999999999999999986 5678765433
Q ss_pred hh-hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 360 QC-QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 360 ~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
+. ...+... .....++. ...++.+++.+||+.||++|||++||++.|++++.
T Consensus 244 ~~~~~~~~~~-----~~~~~~~~------------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEG-----TRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHT-----CCCCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcC-----CCCCCCcc------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 21 1111110 01111111 12357789999999999999999999999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=390.60 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=206.3
Q ss_pred cCCCccCeEeecCcEEEEEEEeCC-Cc--EEEEEEecCc-ChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDD-NL--HVAVKKLDCA-TQDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||+||+|++.+ |. .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577788999999999999998753 33 5788887543 344566899999999998 799999999999999999999
Q ss_pred eeecCCCChhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 226 YELMENRSLDIQLHGP-------------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
|||+++|+|.++++.. .....++|.++++++.|+|.||.|||++ +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 2346799999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChhhhhhhhhhhccc
Q 012975 293 KLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGR-RPVEKLAPAQCQSIVTWAMPQ 371 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~-~P~~~~~~~~~~~~~~~~~~~ 371 (452)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. .||...+..+....+...
T Consensus 167 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~--- 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--- 242 (309)
T ss_dssp EECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT---
T ss_pred EEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc---
Confidence 999999996543322 223456899999999999999999999999999999999965 577776654432222110
Q ss_pred cccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 372 LTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 372 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.+...+. ....++.+++.+||+.||++||||+||++.|++++..
T Consensus 243 --~~~~~~~------------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 243 --YRLEKPL------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --CCCCCCT------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCCc------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0111111 1234677899999999999999999999999888754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-49 Score=383.96 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=206.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56888999999999999999975 6899999998532 2334577999999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
|||++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888853 45688999999999999999999999 9999999999999999999999999999775433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+.. .....+..+
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~---- 224 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------AELRFPPFF---- 224 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------CCCCCCTTS----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc------CCCCCCCCC----
Confidence 2356899999999999999999999999999999999999999988766543332221 111222211
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHh
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRP-----LITDVLHS 422 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 422 (452)
...+.+++.+||+.||.+|+ |++|+++.
T Consensus 225 --------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 --------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 23567899999999999995 89999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.4e-50 Score=379.79 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=201.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCc----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDT---- 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 221 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||.+... .......|.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467889999999999999999874 6899999999643 23445679999999999999999999999876543
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+||||+++|+|..++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988753 35699999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCC---CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 302 TDGSQN---KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 302 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+...... ......
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~------~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------REDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH------hcCCCC
Confidence 543222 23345679999999999999999999999999999999999999998876544221111 111111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHhcccc
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRP-LITDVLHSLIPL 426 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~l 426 (452)
+.. ... +...++.+++.+||+.||++|| |++++++.|.++
T Consensus 234 ~~~----~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 PSA----RHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GGG----TSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cch----hcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 000 111 1224677899999999999999 899999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-49 Score=376.50 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=206.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---------hhhHHHHHHHHHHHHcCC-CCceeeeEEEEEc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---------QDAGREFENEVDLLSNIH-HPNVVCLLGYSAH 218 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 218 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... +...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367889999999999999999974 78999999986432 122346889999999997 9999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecC
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFG 298 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfg 298 (452)
++..|||||||++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999963 35699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccCCCCCcccccccccCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc
Q 012975 299 LAITDGSQNKNNLKLSGTLGYVAPEYLLD------GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL 372 (452)
Q Consensus 299 l~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~ 372 (452)
++....... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+...
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~---- 230 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG---- 230 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC----
Confidence 997764433 2345679999999999853 35688999999999999999999999987654432222111
Q ss_pred ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 373 TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 373 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
....+... .. ....++.+++.+||+.||++|||++||++.
T Consensus 231 --~~~~~~~~----~~----~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 --NYQFGSPE----WD----DYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --CCCCCTTT----GG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --CCCCCCcc----cc----cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111100 01 122467789999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=384.55 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=207.8
Q ss_pred hhcCCCccCeEeecCcEEEEEEEeC--------CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKLD--------DNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAH 218 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 218 (452)
..++|+..+.||+|+||.||+|+.. ++..||||++.... .....++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3457888899999999999999753 23579999996543 34457889999999888 89999999999999
Q ss_pred CCceeeeeeecCCCChhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 219 DDTRFIVYELMENRSLDIQLHGPS-------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 219 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
++..++||||+++|+|.+++.... ....+++.++++++.|++.||+|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 999999999999999999996432 134689999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCC--CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhhh
Q 012975 286 LDSKFNAKLSDFGLAITDGSQ--NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQCQ 362 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~~ 362 (452)
++.++.+||+|||+++..... ........||+.|+|||.+.++.++.++||||||+++|||++ |+.||......+..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999999999999654322 223344568999999999999999999999999999999998 79999877654433
Q ss_pred hhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 363 SIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
..+... .....+. .....+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 248 ~~i~~~-----~~~~~p~------------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 KLLKEG-----HRMDKPS------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTT-----CCCCCCS------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcC-----CCCCCCc------------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 222211 0111111 1123577899999999999999999999999888654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=378.44 Aligned_cols=260 Identities=31% Similarity=0.364 Sum_probs=199.4
Q ss_pred cCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChh-----hHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeeec
Q 012975 156 SNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQD-----AGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYELM 229 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 229 (452)
.++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 6889999998643322 1346889999999999999999999999999999999999
Q ss_pred CCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCCc
Q 012975 230 ENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNKN 309 (452)
Q Consensus 230 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 309 (452)
+++++..+.. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9988876653 345689999999999999999999999 9999999999999999999999999999776555555
Q ss_pred ccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-----cccCCCCCcccc
Q 012975 310 NLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ-----LTDRSKLPNIVD 383 (452)
Q Consensus 310 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~d 383 (452)
.....||+.|+|||.+.+. .++.++|||||||++|||+||+.||......+....+...... ..+.........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5566799999999998754 5799999999999999999999999877654432222111000 000000000000
Q ss_pred hhhcccCCH-----HHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 384 PVIKSTMDL-----KHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 384 ~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
-........ .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 12346788999999999999999999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=386.96 Aligned_cols=263 Identities=27% Similarity=0.395 Sum_probs=213.4
Q ss_pred HHhhcCCCccCeEeecCcEEEEEEEeC------CCcEEEEEEecCc-ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC
Q 012975 147 EKATDSFHESNILGEGGFGCVYKAKLD------DNLHVAVKKLDCA-TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD 219 (452)
Q Consensus 147 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 219 (452)
|...++|+..+.||+|+||+||+|.+. ++..||||+++.. .......|.+|++++++++||||++++|+|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334567888999999999999999864 3578999999643 344456799999999999999999999999999
Q ss_pred CceeeeeeecCCCChhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 012975 220 DTRFIVYELMENRSLDIQLHGP-------SHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNA 292 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~ 292 (452)
+..++||||+++|+|.++++.. .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 9999999999999999887632 2234579999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCcccCCCCC--cccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhhhhhhhhhhc
Q 012975 293 KLSDFGLAITDGSQNK--NNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLG-RRPVEKLAPAQCQSIVTWAM 369 (452)
Q Consensus 293 kl~Dfgl~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG-~~P~~~~~~~~~~~~~~~~~ 369 (452)
||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||+|| +.||......+....+...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~- 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG- 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999975433222 22334689999999999999999999999999999999997 5788776655433322110
Q ss_pred cccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 370 PQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 370 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.....+. .....+.+++.+||+.||++||||+||++.|++.+..
T Consensus 252 ----~~~~~p~------------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 252 ----GLLDKPD------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----CCCCCcc------------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0011111 1224688899999999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=384.65 Aligned_cols=268 Identities=27% Similarity=0.317 Sum_probs=198.0
Q ss_pred CCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC----ceeeeee
Q 012975 152 SFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRFIVYE 227 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 227 (452)
+|...+.||+|+||+||+|++ +|+.||||++.... .....++.|+..+.+++||||++++|+|.+++ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 455678899999999999997 47799999986432 22222344555556789999999999998764 4789999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEH-----CNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
||++|+|.++++. ..++|.++++++.|+|.||+|||+. .+++|+||||||+|||+++++++||+|||++..
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999974 3599999999999999999999973 134999999999999999999999999999965
Q ss_pred cCCCCC----cccccccccCccCcccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh--h------
Q 012975 303 DGSQNK----NNLKLSGTLGYVAPEYLLDGK------LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS--I------ 364 (452)
Q Consensus 303 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~--~------ 364 (452)
...... ......||++|+|||++.+.. ++.++|||||||+||||+||..|+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 433221 223457999999999987643 5779999999999999999998875433211000 0
Q ss_pred hhhhccccccCCCCCcccchhhc-ccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCccc
Q 012975 365 VTWAMPQLTDRSKLPNIVDPVIK-STMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPVE 430 (452)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~~ 430 (452)
.......... .. .+|.+. .....+....+.+++.+||+.||++|||+.||++.|+++..++
T Consensus 238 ~~~~~~~~~~-~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTT-SC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc-cc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0000000000 01 111111 1112356677889999999999999999999999998876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=386.63 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=206.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHH-cCCCCceeeeEEEEEcCCceeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLS-NIHHPNVVCLLGYSAHDDTRFIV 225 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 225 (452)
++|+..+.||+|+||+||+|+.. +|+.||||.+... .....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999876 6899999999632 2233456677777765 68999999999999999999999
Q ss_pred eeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCC
Q 012975 226 YELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGS 305 (452)
Q Consensus 226 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 305 (452)
||||++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999863 34689999999999999999999999 999999999999999999999999999976655
Q ss_pred CCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchh
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPV 385 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 385 (452)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+... ....+..+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~--- 226 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWL--- 226 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTS---
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccC---
Confidence 555555678999999999999999999999999999999999999999987765533333211 11222111
Q ss_pred hcccCCHHHHHHHHHHHHHhcCCCCCCCCChH-HHHH
Q 012975 386 IKSTMDLKHLYQVAAVAVLCVQPEPSYRPLIT-DVLH 421 (452)
Q Consensus 386 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 421 (452)
...+.+++.+||+.||++|||+. |+++
T Consensus 227 ---------s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 ---------EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---------CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 23567899999999999999996 6763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=382.76 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=211.2
Q ss_pred hhcCCCccCeEeecCcEEEEEEEe------CCCcEEEEEEecCcC-hhhHHHHHHHHHHHHcC-CCCceeeeEEEEEcCC
Q 012975 149 ATDSFHESNILGEGGFGCVYKAKL------DDNLHVAVKKLDCAT-QDAGREFENEVDLLSNI-HHPNVVCLLGYSAHDD 220 (452)
Q Consensus 149 ~~~~f~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 220 (452)
..++|+..+.||+|+||.||+|++ .++..||||++.... .....+|.+|+.+++++ +|||||+++|+|.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346788899999999999999985 346789999997543 44556799999999999 7999999999999999
Q ss_pred ceeeeeeecCCCChhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 012975 221 TRFIVYELMENRSLDIQLHGPS---------------HGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNIL 285 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIl 285 (452)
..++|||||++|+|.++++... ....+++..+++++.||+.||+|||++ +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 9999999999999999986432 223699999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCCcccCCCC--CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhhh-
Q 012975 286 LDSKFNAKLSDFGLAITDGSQN--KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLL-GRRPVEKLAPAQC- 361 (452)
Q Consensus 286 l~~~~~~kl~Dfgl~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~ellt-G~~P~~~~~~~~~- 361 (452)
++.++.+|++|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+|+......+.
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997654332 22334578999999999999999999999999999999999 5666655443322
Q ss_pred hhhhhhhccccccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 362 QSIVTWAMPQLTDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
...+.... +...+. .....+.+++.+||+.||++||||.||+++|++.+..
T Consensus 258 ~~~i~~~~-----~~~~~~------------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGF-----RMLSPE------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTC-----CCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCC-----CCCCcc------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22222111 011111 1234677899999999999999999999999887655
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=377.55 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh--hhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ--DAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||+||+|++. +|+.||||++..... ...+++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57889999999999999999974 689999999964432 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
|+.++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998665544333 3345799999999999999999999999 99999999999999999999999999997766555
Q ss_pred CcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcc--------ccccC---
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMP--------QLTDR--- 375 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~--------~~~~~--- 375 (452)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+.......... .....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 5556678999999999887765 47899999999999999999999987664432111110000 00000
Q ss_pred -CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 376 -SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 376 -~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
...+......... .......++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000000 000122467789999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=378.73 Aligned_cols=251 Identities=17% Similarity=0.216 Sum_probs=207.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
.++|...+.||+|+||+||+|++. +|+.||||.+.... .....+.+|+++|++++||||+++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467889999999999999999976 68899999997544 3445688999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CcEEEEecCCCcccCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSK--FNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~--~~~kl~Dfgl~~~~~~~ 306 (452)
|++|+|.+++.. .+..+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999863 345699999999999999999999999 99999999999999854 58999999999765433
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.. .....+ ...
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~------~~~~~~----~~~ 226 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------AEYTFD----EEA 226 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCC----HHH
T ss_pred C-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCC----hhh
Confidence 2 23445789999999999999999999999999999999999999988765443222211 111111 111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
.... ..++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 235678999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-49 Score=385.18 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=205.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc---ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA---TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 226 (452)
++|+..+.||+|+||+||+|++. +|+.||||.+... .....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57888999999999999999975 6899999998532 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQ 306 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 306 (452)
||+.+|+|..++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999988863 34699999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcccchhh
Q 012975 307 NKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNIVDPVI 386 (452)
Q Consensus 307 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 386 (452)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...+.......+... ....+..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~----- 260 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSH----- 260 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTT-----
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------CCCCCcc-----
Confidence 23467999999999999999999999999999999999999999887654432222211 1111111
Q ss_pred cccCCHHHHHHHHHHHHHhcCCCCCCC-----CChHHHHH
Q 012975 387 KSTMDLKHLYQVAAVAVLCVQPEPSYR-----PLITDVLH 421 (452)
Q Consensus 387 ~~~~~~~~~~~l~~li~~Cl~~dP~~R-----Ps~~evl~ 421 (452)
....+.+++.+||+.||.+| ||++|+++
T Consensus 261 -------~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 -------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12356789999999999999 48999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-48 Score=383.24 Aligned_cols=249 Identities=27% Similarity=0.341 Sum_probs=199.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC---hhhHHHH---HHHHHHHHcCCCCceeeeEEEEEcCCce
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT---QDAGREF---ENEVDLLSNIHHPNVVCLLGYSAHDDTR 222 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~ 222 (452)
.++|++.+.||+|+||.||+|+.. +|+.||||.+.... ......+ .+|+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367889999999999999999976 68999999985321 1122233 3457778888999999999999999999
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
|+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999863 35689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCCcc
Q 012975 303 DGSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLPNI 381 (452)
Q Consensus 303 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (452)
.... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...+... ........+..
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDS 231 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSSCCCCCCSS
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccCCCCCCCC
Confidence 5433 2234579999999999875 5689999999999999999999999987654332222221 11111112221
Q ss_pred cchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 382 VDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 382 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
+ ..++.+++.+||+.||++||| ++|+++
T Consensus 232 ~------------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 232 F------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp S------------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C------------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1 235678999999999999999 588874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-48 Score=372.39 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=203.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC--hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT--QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQNK 308 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 308 (452)
+.++++..+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 99888777664 346799999999999999999999999 999999999999999999999999999977655444
Q ss_pred cccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccc--------ccCCCCC
Q 012975 309 NNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQL--------TDRSKLP 379 (452)
Q Consensus 309 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 379 (452)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+....... .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 44556789999999998764 56899999999999999999999998776543222111110000 0000000
Q ss_pred ---cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 ---NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ---~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
...++.............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000011112346778999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=379.69 Aligned_cols=252 Identities=25% Similarity=0.297 Sum_probs=196.8
Q ss_pred hcCCCccC-eEeecCcEEEEEEEe-CCCcEEEEEEecCcChhhHHHHHHHHHHHHcC-CCCceeeeEEEEEc----CCce
Q 012975 150 TDSFHESN-ILGEGGFGCVYKAKL-DDNLHVAVKKLDCATQDAGREFENEVDLLSNI-HHPNVVCLLGYSAH----DDTR 222 (452)
Q Consensus 150 ~~~f~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 222 (452)
.++|.+.. +||+|+||+||+|+. .+++.||||++.. ...+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787764 699999999999987 4689999999853 23567899987654 89999999999865 3568
Q ss_pred eeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCC
Q 012975 223 FIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGL 299 (452)
Q Consensus 223 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl 299 (452)
|+|||||++|+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999974 2235799999999999999999999999 9999999999999986 56799999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKLP 379 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (452)
++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+............ .........+
T Consensus 161 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--~i~~~~~~~~ 237 (335)
T d2ozaa1 161 AKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFP 237 (335)
T ss_dssp CEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSCC
T ss_pred eeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--HHhcCCCCCC
Confidence 976544332 3456799999999999999999999999999999999999999976543221111100 0000000111
Q ss_pred cccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 380 NIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 380 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
. + .. .....++.+++.+||+.||++|||+.|+++
T Consensus 238 ~---~-~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 238 N---P-EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp T---T-HH----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C---c-cc----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 00 122356788999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=367.19 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=199.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-C-CcEEEEEEecCcC--hhhHHHHHHHHHHHHcC---CCCceeeeEEEEEc----
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-D-NLHVAVKKLDCAT--QDAGREFENEVDLLSNI---HHPNVVCLLGYSAH---- 218 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 218 (452)
.++|+..+.||+|+||+||+|++. + ++.||||++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 6679999985432 22233466777776665 89999999999853
Q ss_pred -CCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEec
Q 012975 219 -DDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDF 297 (452)
Q Consensus 219 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Df 297 (452)
....+++|||++++++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 236799999999988765544 3346789999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccc-----c
Q 012975 298 GLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQ-----L 372 (452)
Q Consensus 298 gl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~-----~ 372 (452)
|++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+...... +
T Consensus 161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 998654332 2334567999999999999999999999999999999999999999887654432222111000 0
Q ss_pred ccCCCCCc-----ccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 373 TDRSKLPN-----IVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 373 ~~~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
........ ....... .........+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchh-hccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0000000 0011123456789999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=365.58 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=196.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcCh------hhHHHHHHHHHHHHcCC--CCceeeeEEEEEcCCc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQ------DAGREFENEVDLLSNIH--HPNVVCLLGYSAHDDT 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 221 (452)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999975 689999999853211 12234678999999986 8999999999999999
Q ss_pred eeeeeeecCC-CChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEecCC
Q 012975 222 RFIVYELMEN-RSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-KFNAKLSDFGL 299 (452)
Q Consensus 222 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-~~~~kl~Dfgl 299 (452)
.++||||+.+ +++.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 577777643 45699999999999999999999999 9999999999999985 57999999999
Q ss_pred CcccCCCCCcccccccccCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 300 AITDGSQNKNNLKLSGTLGYVAPEYLLDGKL-TDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 300 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
+...... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... ... . ...+
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~~-~------~~~~ 223 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR-G------QVFF 223 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-C------CCCC
T ss_pred ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hhh-c------ccCC
Confidence 9765332 2345679999999999987765 5678999999999999999999975321 111 0 1111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hcccc
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPL 426 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l 426 (452)
+. .. ..++.+++.+||+.||++|||++|+++ .++++
T Consensus 224 ~~--------~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 224 RQ--------RV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SS--------CC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CC--------CC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11 11 235678999999999999999999997 35543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=366.10 Aligned_cols=267 Identities=24% Similarity=0.282 Sum_probs=197.4
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------ceee
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------TRFI 224 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 224 (452)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++|+||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677889999999999999986 689999999965432 2357999999999999999999985432 4689
Q ss_pred eeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCccc
Q 012975 225 VYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITD 303 (452)
Q Consensus 225 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~ 303 (452)
|||||++|.+....+.......+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998776554443223356799999999999999999999998 999999999999999775 8999999999765
Q ss_pred CCCCCcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhc---------ccc-
Q 012975 304 GSQNKNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAM---------PQL- 372 (452)
Q Consensus 304 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~---------~~~- 372 (452)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ...
T Consensus 174 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 174 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred cCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 4332 2334579999999998875 468999999999999999999999998776543221111100 000
Q ss_pred -ccCCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hcccc
Q 012975 373 -TDRSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPL 426 (452)
Q Consensus 373 -~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l 426 (452)
......+.................++.+++.+||+.||++|||+.|+++ .++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0001111111111111111123346788999999999999999999995 24444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=357.88 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=199.5
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC--------
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-------- 219 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 219 (452)
++|+..+.||+|+||+||+|++. +|+.||||++... ......++.+|+++|++++|+|++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999975 7899999998543 334456789999999999999999999988553
Q ss_pred CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCC
Q 012975 220 DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGL 299 (452)
Q Consensus 220 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl 299 (452)
+..++||||++++++..... ....++...+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 45799999999888776553 345689999999999999999999999 999999999999999999999999999
Q ss_pred CcccCCCC----CcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc
Q 012975 300 AITDGSQN----KNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD 374 (452)
Q Consensus 300 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 374 (452)
+....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 96543222 122335699999999998765 6899999999999999999999999877655433332222111110
Q ss_pred CCCCCcc--------cchhhcccCCH-------HHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 375 RSKLPNI--------VDPVIKSTMDL-------KHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 375 ~~~~~~~--------~d~~l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
. ..... ........... .....+.+++.+||+.||++|||++|+++.
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 E-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp T-TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred h-hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00000 00000000011 112356689999999999999999999963
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=351.16 Aligned_cols=270 Identities=22% Similarity=0.261 Sum_probs=208.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCCceeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDDTRFIVYE 227 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 227 (452)
++|+..+.||+|+||+||+|++. +++.||||++... ......++.+|+.+|++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999975 6888999998543 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCcccCCCC
Q 012975 228 LMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITDGSQN 307 (452)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 307 (452)
++.+++|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999887753 45689999999999999999999999 99999999999999999999999999998765555
Q ss_pred CcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCh-hhhhhhhhhhccccc-----------c
Q 012975 308 KNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAP-AQCQSIVTWAMPQLT-----------D 374 (452)
Q Consensus 308 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~-~~~~~~~~~~~~~~~-----------~ 374 (452)
.......++..|+|||.+.+.. ++.++|||||||++|||++|+.||..... .+....+........ .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 4455556888999999987765 68999999999999999999999754432 221111111000000 0
Q ss_pred CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hcccc
Q 012975 375 RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPL 426 (452)
Q Consensus 375 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l 426 (452)
...........-......+....+.+++.+||+.||++|||++|+++ .+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 00000000000000111122346778999999999999999999986 34443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=354.72 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=197.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC------
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD------ 220 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 220 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467888999999999999999975 6899999999643 3445678999999999999999999999998765
Q ss_pred ceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCC
Q 012975 221 TRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLA 300 (452)
Q Consensus 221 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~ 300 (452)
..++||||+ +++|..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 566766654 24699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc----C
Q 012975 301 ITDGSQNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----R 375 (452)
Q Consensus 301 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~ 375 (452)
....... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+................. .
T Consensus 169 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 169 RQADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp EECCSSC---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eccCCcc---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 7654332 345799999999998764 5689999999999999999999999887644322111111000000 0
Q ss_pred ----------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--ccccCc
Q 012975 376 ----------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIPLVP 428 (452)
Q Consensus 376 ----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~l~~ 428 (452)
..+.......+.. ........+.+++.+||+.||++|||++|+++. ++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000000000 000112356789999999999999999999974 665543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=360.13 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=198.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcC-hhhHHHHHHHHHHHHcCCCCceeeeEEEEEcCC----cee
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCAT-QDAGREFENEVDLLSNIHHPNVVCLLGYSAHDD----TRF 223 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 223 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356888999999999999999864 79999999996443 445678999999999999999999999997654 235
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCccc
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAITD 303 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~~ 303 (452)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999853 3599999999999999999999999 9999999999999999999999999999654
Q ss_pred CCCC---CcccccccccCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc-----
Q 012975 304 GSQN---KNNLKLSGTLGYVAPEYLLD-GKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----- 374 (452)
Q Consensus 304 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 374 (452)
.... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 3221 22334569999999999854 56788999999999999999999999877643322211111000000
Q ss_pred -------------CCCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh--cccc
Q 012975 375 -------------RSKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS--LIPL 426 (452)
Q Consensus 375 -------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~l 426 (452)
........ ..+.... ..++.+++.+||+.||++|||+.|+++. |++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPW-NRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCH-HHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCH-HHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000000 0011111 2357789999999999999999999974 4444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-45 Score=350.10 Aligned_cols=259 Identities=20% Similarity=0.238 Sum_probs=195.1
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCceeee-EEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVVCL-LGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~ 228 (452)
++|+..+.||+|+||+||+|++. +|+.||||.+..... ..++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46888999999999999999874 689999998864432 2457889999999987765555 5555677788999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEecCCCcccCC
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS---KFNAKLSDFGLAITDGS 305 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~---~~~~kl~Dfgl~~~~~~ 305 (452)
+. |+|...+. .....+++..++.++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++....
T Consensus 85 ~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 55555544 2245699999999999999999999999 9999999999999864 55799999999976432
Q ss_pred CC-------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhh-ccccccCCC
Q 012975 306 QN-------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWA-MPQLTDRSK 377 (452)
Q Consensus 306 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~~ 377 (452)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||............... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--TP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--SC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--CC
Confidence 21 1223457999999999999999999999999999999999999999876543322211110 00000 00
Q ss_pred CCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCc
Q 012975 378 LPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVP 428 (452)
Q Consensus 378 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~ 428 (452)
.+.+.. ....++.+++..||+.||++||++.++.+.|+++..
T Consensus 237 -----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 -----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 011111 123467789999999999999999999988877643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-44 Score=349.28 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=195.6
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcC--Cceeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHD--DTRFIVY 226 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 226 (452)
++|++.+.||+|+||+||+|+.. +|+.||||++... ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57889999999999999999974 6899999998643 3467889999999995 99999999999754 4689999
Q ss_pred eecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEecCCCcccCC
Q 012975 227 ELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKF-NAKLSDFGLAITDGS 305 (452)
Q Consensus 227 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~-~~kl~Dfgl~~~~~~ 305 (452)
||+++|+|..+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++.....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997653 3589999999999999999999999 999999999999998655 699999999976543
Q ss_pred CCCcccccccccCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhh--hhhh---------hhhcc-cc
Q 012975 306 QNKNNLKLSGTLGYVAPEYLLDG-KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQC--QSIV---------TWAMP-QL 372 (452)
Q Consensus 306 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~--~~~~---------~~~~~-~~ 372 (452)
.. ......||..|+|||.+.+. .++.++||||+||++|||++|+.||........ .... .+... ..
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 23445789999999998775 479999999999999999999999976543211 0000 00000 00
Q ss_pred ccC--------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q 012975 373 TDR--------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH 421 (452)
Q Consensus 373 ~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 421 (452)
... .....................++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000111011112345778999999999999999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.5e-45 Score=346.96 Aligned_cols=261 Identities=17% Similarity=0.200 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC-CceeeeEEEEEcCCceeeeeee
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDTRFIVYEL 228 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~ 228 (452)
++|++.+.||+|+||+||+|++. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57889999999999999999975 68899999885432 23457789999999965 8999999999999999999999
Q ss_pred cCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCcEEEEecCCCccc
Q 012975 229 MENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDS-----KFNAKLSDFGLAITD 303 (452)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~-----~~~~kl~Dfgl~~~~ 303 (452)
+ +++|.+++.. .+..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 6899888763 345799999999999999999999999 9999999999999974 578999999999754
Q ss_pred CCCC-------CcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCC
Q 012975 304 GSQN-------KNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRS 376 (452)
Q Consensus 304 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 376 (452)
.... .......||+.|||||.+.+..++.++||||||+++|||+||+.||.................. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCCC
Confidence 3221 1223457999999999999999999999999999999999999999865443221111110000 0000
Q ss_pred CCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHhccccCcc
Q 012975 377 KLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLHSLIPLVPV 429 (452)
Q Consensus 377 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~l~~~ 429 (452)
.. +.+... ...++.+++..|++.+|++||+++.+.+.|++++..
T Consensus 236 ~~-----~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 236 PL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp CH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Ch-----HHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 00 111111 224577889999999999999999999888877643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=352.13 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=199.4
Q ss_pred cCCCccCeEeecCcEEEEEEEeC----CCcEEEEEEecCc----ChhhHHHHHHHHHHHHcCCC-CceeeeEEEEEcCCc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD----DNLHVAVKKLDCA----TQDAGREFENEVDLLSNIHH-PNVVCLLGYSAHDDT 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 221 (452)
++|+..+.||+|+||+||+|+.. +|+.||||.+... .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 4789999998532 12334568899999999966 899999999999999
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+++|||+.+|+|.+++.. ...+....+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999864 34578889999999999999999999 99999999999999999999999999996
Q ss_pred ccCCC-CCcccccccccCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhccccccCCCC
Q 012975 302 TDGSQ-NKNNLKLSGTLGYVAPEYLLDG--KLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTDRSKL 378 (452)
Q Consensus 302 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (452)
..... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+... ........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~~~~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKSEPPY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHCCCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cccCCCCC
Confidence 54332 2233456799999999998765 4678999999999999999999999876543322211111 00111111
Q ss_pred CcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHH
Q 012975 379 PNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPL-----ITDVLH 421 (452)
Q Consensus 379 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 421 (452)
+ .+...++.+++.+||+.||++||| ++|+++
T Consensus 256 ~------------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 256 P------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred c------------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 122356778999999999999994 788885
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=348.55 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=192.7
Q ss_pred cCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC------Cc
Q 012975 151 DSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD------DT 221 (452)
Q Consensus 151 ~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 221 (452)
++|+..+.||+|+||+||+|++. +|+.||||++... +.....++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999976 6999999999643 345556799999999999999999999999643 57
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.|+||||+.++++.. ++ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 799999997765554 32 3489999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhh-h------------
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTW-A------------ 368 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~-~------------ 368 (452)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.. .
T Consensus 168 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 554322 33345799999999999999999999999999999999999999987654332111100 0
Q ss_pred ---ccccccCCCCCc-----ccchhhcccC---CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHh
Q 012975 369 ---MPQLTDRSKLPN-----IVDPVIKSTM---DLKHLYQVAAVAVLCVQPEPSYRPLITDVLHS 422 (452)
Q Consensus 369 ---~~~~~~~~~~~~-----~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 422 (452)
............ .......... .......+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 1111111111 12345678899999999999999999999954
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=348.20 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=199.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCc--ChhhHHHHHHHHHHHHcCCCCceeeeEEEEEcC-----Cc
Q 012975 150 TDSFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCA--TQDAGREFENEVDLLSNIHHPNVVCLLGYSAHD-----DT 221 (452)
Q Consensus 150 ~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 221 (452)
.++|+..+.||+|+||+||+|+.. +|+.||||++... +....+++.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467889999999999999999865 6999999999644 334556789999999999999999999998643 34
Q ss_pred eeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 222 RFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 222 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+++++|+.+|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 5777888899999999853 4599999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhhhhhhhcccccc----C-
Q 012975 302 TDGSQNKNNLKLSGTLGYVAPEYLLDGK-LTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQSIVTWAMPQLTD----R- 375 (452)
Q Consensus 302 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~- 375 (452)
.... ......||..|+|||...+.. ++.++|||||||++|||++|+.||...+.......+......... .
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 5432 233457899999999877754 688999999999999999999999877654332222111100000 0
Q ss_pred ---------CCCCcccchhhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHH--hcccc
Q 012975 376 ---------SKLPNIVDPVIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVLH--SLIPL 426 (452)
Q Consensus 376 ---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~l 426 (452)
......-...+.... ......+.+++.+||+.||++|||++|+++ .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cchhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000000000000000 012245678999999999999999999997 45554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=319.58 Aligned_cols=271 Identities=20% Similarity=0.244 Sum_probs=195.2
Q ss_pred CCCccCeEeecCcEEEEEEEeC-CCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-----------CCceeeeEEEEEcC
Q 012975 152 SFHESNILGEGGFGCVYKAKLD-DNLHVAVKKLDCATQDAGREFENEVDLLSNIH-----------HPNVVCLLGYSAHD 219 (452)
Q Consensus 152 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 219 (452)
+|+..+.||+|+||+||+|+.. +|+.||||++... ....+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999975 7899999999743 334467788999888875 57899999988654
Q ss_pred --CceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCc-----
Q 012975 220 --DTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHE-HCNPAVIHRDLKSSNILLDSKFN----- 291 (452)
Q Consensus 220 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~i~H~Dlk~~NIll~~~~~----- 291 (452)
...+++++++..+..............+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 4566777776665543333222445678999999999999999999998 5 8999999999999987653
Q ss_pred -EEEEecCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhhhhh----hh-
Q 012975 292 -AKLSDFGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVLLELLLGRRPVEKLAPAQCQS----IV- 365 (452)
Q Consensus 292 -~kl~Dfgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll~elltG~~P~~~~~~~~~~~----~~- 365 (452)
+|++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||.......... +.
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999754332 234579999999999999999999999999999999999999997654221000 00
Q ss_pred -hhhcc---------------ccccC---CCCCcc----cch--hhcccCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 012975 366 -TWAMP---------------QLTDR---SKLPNI----VDP--VIKSTMDLKHLYQVAAVAVLCVQPEPSYRPLITDVL 420 (452)
Q Consensus 366 -~~~~~---------------~~~~~---~~~~~~----~d~--~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 420 (452)
.+... ..... ..+... ... .............+.+++.+||+.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 00000 000000 000 011223456778899999999999999999999999
Q ss_pred Hh--ccccCcc
Q 012975 421 HS--LIPLVPV 429 (452)
Q Consensus 421 ~~--L~~l~~~ 429 (452)
+. +++....
T Consensus 327 ~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 327 NHPWLKDTLGM 337 (362)
T ss_dssp TCGGGTTCTTC
T ss_pred cCcccCCCCCc
Confidence 74 6655544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.6e-24 Score=191.10 Aligned_cols=168 Identities=15% Similarity=0.173 Sum_probs=120.7
Q ss_pred ccCeEeecCcEEEEEEEeCCCcEEEEEEecCcC------------------hhhHHHHHHHHHHHHcCCCCceeeeEEEE
Q 012975 155 ESNILGEGGFGCVYKAKLDDNLHVAVKKLDCAT------------------QDAGREFENEVDLLSNIHHPNVVCLLGYS 216 (452)
Q Consensus 155 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 216 (452)
+.+.||+|+||+||+|++.+|++||||.+.... ......+.+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999999999999999864211 01123456788999999999999887663
Q ss_pred EcCCceeeeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 012975 217 AHDDTRFIVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHCNPAVIHRDLKSSNILLDSKFNAKLSD 296 (452)
Q Consensus 217 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dlk~~NIll~~~~~~kl~D 296 (452)
..+++|||++++.+.. ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2379999998876543 23334567899999999999999 99999999999999865 489999
Q ss_pred cCCCcccCCCCCcccccccccCccCcccccCCCCCchhhHHHHHHHH
Q 012975 297 FGLAITDGSQNKNNLKLSGTLGYVAPEYLLDGKLTDKSDVYAFGVVL 343 (452)
Q Consensus 297 fgl~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s~Gvll 343 (452)
||.+........... ...+... -.| ...+.|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~-l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREI-LERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHH-HHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHH-HHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999966543322110 0000000 011 1235678899999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=4.6e-08 Score=88.83 Aligned_cols=148 Identities=18% Similarity=0.131 Sum_probs=98.1
Q ss_pred HHHHhhcCCCccCeEeecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCC-CCceeeeEEEEEcCCcee
Q 012975 145 LLEKATDSFHESNILGEGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIH-HPNVVCLLGYSAHDDTRF 223 (452)
Q Consensus 145 ~l~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 223 (452)
++....+.|+..+..+-+..+.||+...+ +..+++|+...........+.+|...+..+. +--+-+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 44555556654443333334689998754 4567888876444334445678888877763 433567788888888899
Q ss_pred eeeeecCCCChhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 012975 224 IVYELMENRSLDIQLHGPSHGSALTWHMRMKIALDTARGLEYLHEHC--------------------------------- 270 (452)
Q Consensus 224 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 270 (452)
+||+++++.++....... . ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886543211 1 12334555666666666321
Q ss_pred -----------------------CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 271 -----------------------NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 271 -----------------------~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+.++|+|+.+.||++++++..-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987767799999773
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=8.5e-06 Score=72.92 Aligned_cols=130 Identities=16% Similarity=0.109 Sum_probs=85.7
Q ss_pred eEeecCc-EEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC--CceeeeEEEEEcCCceeeeeeecCCCCh
Q 012975 158 ILGEGGF-GCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH--PNVVCLLGYSAHDDTRFIVYELMENRSL 234 (452)
Q Consensus 158 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL 234 (452)
.+..|.. +.||+...+++..+++|...... ...+..|+..++.+.. -.+.++++++.+++..++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 68999998888888888765332 2346677777776643 3356678888888889999999998776
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 012975 235 DIQLHGPSHGSALTWHMRMKIALDTARGLEYLH----------------------------------------------- 267 (452)
Q Consensus 235 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH----------------------------------------------- 267 (452)
.... ..- ...+.+++..|.-||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 110 111223333333333
Q ss_pred ----hcC----CCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 268 ----EHC----NPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 268 ----~~~----~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
... .+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1247999999999999988777899999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.54 E-value=8.4e-05 Score=71.04 Aligned_cols=77 Identities=14% Similarity=0.122 Sum_probs=47.4
Q ss_pred cCeEeecCcEEEEEEEeCC-CcEEEEEEecCc----C---hhhHHHHHHHHHHHHcCC-C-C-ceeeeEEEEEcCCceee
Q 012975 156 SNILGEGGFGCVYKAKLDD-NLHVAVKKLDCA----T---QDAGREFENEVDLLSNIH-H-P-NVVCLLGYSAHDDTRFI 224 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-H-~-niv~l~g~~~~~~~~~l 224 (452)
.+.||.|....||+.+..+ ++.++||.-... . .....+...|.+.|+.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998764 667889864321 1 112233456777777662 2 3 34455544 4556689
Q ss_pred eeeecCCCCh
Q 012975 225 VYELMENRSL 234 (452)
Q Consensus 225 V~E~~~~gsL 234 (452)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.0011 Score=61.15 Aligned_cols=136 Identities=16% Similarity=0.182 Sum_probs=78.2
Q ss_pred cEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCCCce--eeeEE-----EEEcCCceeeeeeecCCCChhh
Q 012975 164 FGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHHPNV--VCLLG-----YSAHDDTRFIVYELMENRSLDI 236 (452)
Q Consensus 164 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 236 (452)
--.||+++..+|..+++|..... ....+++..|...+..|...++ +..+. ....++..+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999987543 2234667788888877742221 11111 2234556788999998754421
Q ss_pred --------------hccC------CCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCC
Q 012975 237 --------------QLHG------PSHGSALTWHM-------------------RMKIALDTARGLEYLHEH----CNPA 273 (452)
Q Consensus 237 --------------~l~~------~~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~~----~~~~ 273 (452)
.+|. .......++.. +..+...+.+.++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0110 01111222211 111222223333344322 2347
Q ss_pred eeeCCCCCCCEEECCCCcEEEEecCCCcc
Q 012975 274 VIHRDLKSSNILLDSKFNAKLSDFGLAIT 302 (452)
Q Consensus 274 i~H~Dlk~~NIll~~~~~~kl~Dfgl~~~ 302 (452)
++|+|+.+.|||++++ ..+.||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45889998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.71 E-value=0.0018 Score=61.33 Aligned_cols=73 Identities=12% Similarity=0.117 Sum_probs=47.8
Q ss_pred cCeEeecCcEEEEEEEeCCC--------cEEEEEEecCcChhhHHHHHHHHHHHHcCCCCcee-eeEEEEEcCCceeeee
Q 012975 156 SNILGEGGFGCVYKAKLDDN--------LHVAVKKLDCATQDAGREFENEVDLLSNIHHPNVV-CLLGYSAHDDTRFIVY 226 (452)
Q Consensus 156 ~~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ 226 (452)
.+.|+-|-.-.+|+....++ ..|.++... .... .....+|..+++.+.-.++. ++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35687788899999987643 345555543 3222 33456788888888533444 67777643 5899
Q ss_pred eecCCCCh
Q 012975 227 ELMENRSL 234 (452)
Q Consensus 227 E~~~~gsL 234 (452)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.23 E-value=0.013 Score=53.18 Aligned_cols=157 Identities=13% Similarity=0.139 Sum_probs=80.5
Q ss_pred cHHHHHHhhcCCCccCeEe-----ecCcEEEEEEEeCCCcEEEEEEecCcChhhHHHHHHHHHHHHcCCC-----Cceee
Q 012975 142 EYKLLEKATDSFHESNILG-----EGGFGCVYKAKLDDNLHVAVKKLDCATQDAGREFENEVDLLSNIHH-----PNVVC 211 (452)
Q Consensus 142 ~~~~l~~~~~~f~~~~~ig-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-----~niv~ 211 (452)
+.++++....+|...+... .|---+.|+.+.++| .+++|...... ...+...|++++..+.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 4677888888887755543 455578899998877 58899875321 22344556666666632 22221
Q ss_pred eE-E--EEEcCCceeeeeeecCCCChhh--------------hccC-------CCCCCCCCHHHHH--------------
Q 012975 212 LL-G--YSAHDDTRFIVYELMENRSLDI--------------QLHG-------PSHGSALTWHMRM-------------- 253 (452)
Q Consensus 212 l~-g--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~-------~~~~~~l~~~~~~-------------- 253 (452)
.. | +....+....++.+..+..... .+|. ........+....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 10 0 1122334455666665533311 0000 0000001010000
Q ss_pred HHHHHHHHHHHHHHh----cCCCCeeeCCCCCCCEEECCCCcEEEEecCCCc
Q 012975 254 KIALDTARGLEYLHE----HCNPAVIHRDLKSSNILLDSKFNAKLSDFGLAI 301 (452)
Q Consensus 254 ~i~~~ia~~L~~LH~----~~~~~i~H~Dlk~~NIll~~~~~~kl~Dfgl~~ 301 (452)
.+...+....+.+-. ....+++|+|+.++||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222 123479999999999999998877899999874
|